A810

AU

THO

R D

ISCL

OSU

RE

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

A., Ligen ............................................... Disclosed no confl ict of interest.Aakhus, Svend ..................................... Disclosed no confl ict of interest.Aas, Vigdis ........................................... Disclosed no confl ict of interest.Abadi, Sakineh E. ................................ Disclosed no confl ict of interest.Abate, Nicola ...................................... Disclosed no confl ict of interest.Abbott, Scott ....................................... Employee: Valeritas. Abbott, Shaun ..................................... Disclosed no confl ict of interest.Abdalla, Mohamed M. ........................ Disclosed no confl ict of interest.Abdalla, Moustafa M. ........................ Disclosed no confl ict of interest.Abdelhameed, Mosaad ...................... Disclosed no confl ict of interest.Abdraimova-Meyramova, Aizhan G. .... Disclosed no confl ict of interest.Abdukadier, Abulizi ............................. Disclosed no confl ict of interest.Abdul Murad, Nor Azian ..................... Disclosed no confl ict of interest.Abdul Wahed, Aya .............................. Disclosed no confl ict of interest.Abdulhamid, Sarah ............................. Disclosed no confl ict of interest.Abdulina, Galiya A. ............................. Research Support: Karaganda State Medical University. Abdullah, Chowdhury S. ..................... Disclosed no confl ict of interest.Abdullah, Noraidatulakma ................. Disclosed no confl ict of interest.Abdulreda, Midhat H. ......................... Disclosed no confl ict of interest.Abe, Masanori ..................................... Disclosed no confl ict of interest.Abe, Yoshimi ........................................ Disclosed no confl ict of interest.Abedini, Andisheh ............................... Other Relationship: Patent application for the screening of

IAPP toxic intermediates, and co-inventor on a patent application for fl uorescent analogs of h-IAPP.

Abel, E. Dale ........................................ Disclosed no confl ict of interest.Abellán, Pablo ..................................... Disclosed no confl ict of interest.Abels, Mia ........................................... Disclosed no confl ict of interest.Abelson, Jamie ................................... Disclosed no confl ict of interest.Aberer, Felix ........................................ Disclosed no confl ict of interest.Abiko, Atsuko ...................................... Consultant: Novo Nordisk Inc., Ono Pharmaceutical Co.,

Ltd.; Speaker’s Bureau: Astellas Pharma US, Inc., AstraZeneca Pharmaceuticals LP, Bayer HealthCare, Daiichi-Sankyo Co., Ltd., Eli Lilly Japan K.K., Kowa Pharmaceuticals, Merck Sharp & Dohme, Nippon Boehringer Ingelheim Co., Ltd., Novartis Corporation, Novo Nordisk Inc., Sanofi U.S., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited.

Abiru, Akiko ......................................... Employee: Takeda Pharmaceutical Company Limited. Abolfotouh, Mostafa A. ..................... Disclosed no confl ict of interest.Abood, Beth ......................................... Disclosed no confl ict of interest.Abouzaid, Mona .................................. Disclosed no confl ict of interest.Abrahamsen, Trine Julie .................... Employee: Novo Nordisk A/S. Abrahamson, Martin J. ...................... Advisory Panel: Halozyme Therapeutics, Janssen

Pharmaceutical Companies of Johnson & Johnson, Novo Nordisk Inc., WebMD; Research Support: Metagenics, Inc.

Abrahamsson, Niclas .......................... Disclosed no confl ict of interest.Abramowitz, Jessica .......................... Disclosed no confl ict of interest.Abreu, Damien .................................... Disclosed no confl ict of interest.Abreu, Maria M. .................................. Disclosed no confl ict of interest.Abribat, Thierry ................................... Board Member: Alize Pharma; Employee: Alize Pharma;

Stock/Shareholder: Alize Pharma. Abu Bakar, Mohamad Hafi zi ............... Disclosed no confl ict of interest.Abuaysheh, Sanaa .............................. Disclosed no confl ict of interest.Abubaker, Jehad ................................. Disclosed no confl ict of interest.Abuduli, Maerjianghan ....................... Disclosed no confl ict of interest.Abu-Farha, Mohamed ......................... Disclosed no confl ict of interest.Abulizi, Abudukadier ........................... Disclosed no confl ict of interest.Abumrad, Naji N. ................................ Disclosed no confl ict of interest.Aburima, Ahmed ................................. Disclosed no confl ict of interest.Accili, Domenico ................................. Disclosed no confl ict of interest.Accogli, Andrea ................................... Disclosed no confl ict of interest.Acerini, Carlo L. ................................... Disclosed no confl ict of interest.Acheampong, Joseph ......................... Disclosed no confl ict of interest.Ackart, David ....................................... Disclosed no confl ict of interest.Ackermann, Ronald T. ......................... Disclosed no confl ict of interest.Ackermans, Mariette T. ...................... Disclosed no confl ict of interest.Acord, Chelsea R. ................................ Disclosed no confl ict of interest.Acosta-Delgado, Domingo ................. Disclosed no confl ict of interest.Acton, Anthony J. ............................... Disclosed no confl ict of interest.Acusta, Andre P. .................................. Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline.

Adachi, Kei ........................................... Disclosed no confl ict of interest.Adachi, Yasuhiro ................................. Disclosed no confl ict of interest.Adachi, Yusuke .................................... Disclosed no confl ict of interest.Adams, David B. .................................. Disclosed no confl ict of interest.Adams, Jeneva .................................... Disclosed no confl ict of interest.Adams, Jessica M. ............................. Disclosed no confl ict of interest.Adams, Rachel .................................... Disclosed no confl ict of interest.Adams, Sara R. .................................... Employee: Kaiser Permanente of Northern California;

Research Support: National Institute of Diabetes and Digestive and Kidney Diseases.

Adamska, Agnieszka ........................... Disclosed no confl ict of interest.Adamska, Edyta .................................. Disclosed no confl ict of interest.Addo-Yobo, Charles ............................ Disclosed no confl ict of interest.Adebamowo, Clement ........................ Disclosed no confl ict of interest.Adel, Heba ........................................... Disclosed no confl ict of interest.Adeleye, Jokotade .............................. Disclosed no confl ict of interest.Adeli, Khosrow .................................... Disclosed no confl ict of interest.Adem, Abdu ......................................... Disclosed no confl ict of interest.Adetunji, Omolara ............................... Employee: Eli Lilly and Company. Adeyemo, Adebowale ........................ Disclosed no confl ict of interest.Adi, Saleh ............................................ Disclosed no confl ict of interest.Adkins, Laura ....................................... Disclosed no confl ict of interest.Adler, Gail ............................................ Disclosed no confl ict of interest.Adorini, Luciano .................................. Disclosed no confl ict of interest.Advani, Andrew .................................. Advisory Panel: Boehringer Ingelheim Pharmaceuticals,

Inc., Novo Nordisk A/S; Consultant: Novo Nordisk A/S; Other Relationship: AstraZeneca Pharmaceuticals LP; Research Support: Boehringer Ingelheim GmbH, Novo Nordisk A/S.

Afanasyev, Dmitriy Y. ......................... Disclosed no confl ict of interest.Afek, Arnon ......................................... Disclosed no confl ict of interest.Affarah, Lynn ....................................... Disclosed no confl ict of interest.Afi fi , Nahla M. ..................................... Disclosed no confl ict of interest.Afonso, Milessa S. .............................. Disclosed no confl ict of interest.Agakov, Felix ....................................... Other Relationship: Stakeholder in Pharmatics Ltd. Agardh, Daniel .................................... Disclosed no confl ict of interest.Agarwal, Mukesh M. .......................... Disclosed no confl ict of interest.Agbakoba, Nneka R. ........................... Disclosed no confl ict of interest.Agee, Susan C. .................................... Disclosed no confl ict of interest.Agle, Steven Carl ................................ Disclosed no confl ict of interest.Aglione, Johnpaul ............................... Employee: Regeneron Pharmaceuticals, Inc. Agoram, Balaji ..................................... Employee: MedImmune, Inc. Agosti, Barbara ................................... Disclosed no confl ict of interest.Agostini, Lebaron ................................ Disclosed no confl ict of interest.Agrawal, Pankaj .................................. Disclosed no confl ict of interest.Agrawal, Rajendra P. .......................... Disclosed no confl ict of interest.Aguayo-Mazzucato, Cristina .............. Disclosed no confl ict of interest.Aguilar, David ...................................... Disclosed no confl ict of interest.Aguilar, Montserrat ............................ Disclosed no confl ict of interest.Aguilar-Diosdado, Manuel ................. Disclosed no confl ict of interest.Aguilar-Jiménez, Miriam .................... Disclosed no confl ict of interest.Aguilar-Salinas, Carlos ....................... Disclosed no confl ict of interest.Aguirre-Sánchez-Covisa, Miguel ....... Disclosed no confl ict of interest.Agus, Michael ..................................... Consultant: Roche Diagnostics; Research Support: Dexcom,

Inc., Edwards Scientifi c, NOVA Biomedical. Agyenim-Boateng, Kofi ....................... Disclosed no confl ict of interest.Ahima, Rexford S. ............................... Disclosed no confl ict of interest.Ahlkvist, Linda ..................................... Disclosed no confl ict of interest.Ahlqvist, Emma ................................... Disclosed no confl ict of interest.Ahluwalia, Tarunveer S. ..................... Disclosed no confl ict of interest.Ahmann, Andrew J. ............................ Disclosed no confl ict of interest.Ahn, Chang Ho ..................................... Disclosed no confl ict of interest.Ahn, Chul Woo .................................... Disclosed no confl ict of interest.Ahn, Jae Hee ....................................... Disclosed no confl ict of interest.Ahn, Jee Hyun ..................................... Disclosed no confl ict of interest.Ahn, Jin Hee ........................................ Disclosed no confl ict of interest.Ahn, Kang Hee ..................................... Disclosed no confl ict of interest.Ahn, Kyu Jeung ................................... Disclosed no confl ict of interest.Ahn, Sylvie A. ...................................... Disclosed no confl ict of interest.Ahn, Yu-Bae ......................................... Disclosed no confl ict of interest.Ahrén, Bo ............................................. Advisory Panel: Merck Sharp & Dohme, Novartis Pharma

GmbH, Novo Nordisk A/S, Sanofi U.S., Takeda

ABSTRACT AUTHOR DISCLOSURE INFORMATION

All presenters/authors are required to disclose to the program audience any fi nancial relationships related to the subject matter of this program. The intent of this disclosure is not to prevent a presenter or author from being involved in the activity, but rather to provide participants with information on which they may make their own judgments.

A811

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Pharmaceutical Company Limited; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Merck Sharp & Dohme, Novartis Pharma GmbH, Novo Nordisk A/S.

Ahroni, Jessie H. ................................. Disclosed no confl ict of interest.Aida, Eri ............................................... Disclosed no confl ict of interest.Aiello, Lloyd M. ................................... Disclosed no confl ict of interest.Aiello, Lloyd P. ..................................... Advisory Panel: Foreseehome, Genzyme Corporation,

KalVista Pharmaceuticals Inc.; Consultant: Opthotech, Sanovas, ThromboGenics; Other Relationship: Optos plc.

Aiello, Vito ........................................... Disclosed no confl ict of interest.Aigner, Elmar ....................................... Disclosed no confl ict of interest.Aihara, Haruna .................................... Disclosed no confl ict of interest.Aihara, Ken-Ichi .................................. Disclosed no confl ict of interest.Aitken, Karen ....................................... Disclosed no confl ict of interest.Aitkulov, Aidar M. ............................... Disclosed no confl ict of interest.Aizawa, Toru ........................................ Disclosed no confl ict of interest.Ajai, Neethu A. .................................... Disclosed no confl ict of interest.Ajay, Vamadevan S. ............................ Disclosed no confl ict of interest.Ajluni, Nevin ........................................ Disclosed no confl ict of interest.Akai, Yasuhiro ..................................... Disclosed no confl ict of interest.Akamatsu, Yosuke .............................. Disclosed no confl ict of interest.Akamizu, Takashi ................................ Disclosed no confl ict of interest.Akanuma, Yasuo .................................. Disclosed no confl ict of interest.Akasu, Shoko ....................................... Disclosed no confl ict of interest.Akcicek, Fehmi .................................... Disclosed no confl ict of interest.Akel, Bridget ........................................ Disclosed no confl ict of interest.Akeroyd, Julia ..................................... Disclosed no confl ict of interest.Akhmetova, Saule B. .......................... Research Support: Karaganda State Medical University. Akhter, Jaweed ................................... Disclosed no confl ict of interest.Aki, Nanako ......................................... Disclosed no confl ict of interest.Aki, Saito ............................................. Disclosed no confl ict of interest.Akihisa, Momoko ................................ Disclosed no confl ict of interest.Akimoto, Yoshiro ................................. Disclosed no confl ict of interest.Akinseye, Leah I. ................................. Disclosed no confl ict of interest.Akinseye, Oluwaseun A. .................... Disclosed no confl ict of interest.Akiyama, Masaru ................................ Disclosed no confl ict of interest.Akiyama, Taro ..................................... Employee: Merck & Co., Inc. Akiyama, Yoshitaka ............................ Disclosed no confl ict of interest.Akkermans, Reinier P. ......................... Disclosed no confl ict of interest.Akolkar, Beena .................................... Disclosed no confl ict of interest.Aktas, Serife ....................................... Disclosed no confl ict of interest.Al Araj, Sumayya ................................ Research Support: Novo Nordisk A/S. Al Busaidi, Noor .................................. Disclosed no confl ict of interest.Al Sayah, Fatima ................................. Disclosed no confl ict of interest.Alafi fi , Jamal ....................................... Disclosed no confl ict of interest.Alagol, Faruk ....................................... Disclosed no confl ict of interest.Al-Ajmi, Hanaa N. ............................... Disclosed no confl ict of interest.Alam, Maqsood ................................... Disclosed no confl ict of interest.Alam, Uazman ..................................... Disclosed no confl ict of interest.Al-Amin, Maha A. ............................... Disclosed no confl ict of interest.Alarcon, Javier .................................... Employee: Becton, Dickinson and Company. Al-Arouj, Monira ................................. Disclosed no confl ict of interest.Alawieh, Mohamad ............................ Disclosed no confl ict of interest.Albai, Alin ............................................ Disclosed no confl ict of interest.Albai, Oana .......................................... Disclosed no confl ict of interest.Albarrak, Abdulmajeed ....................... Disclosed no confl ict of interest.Albaugh, Vance L. ............................... Disclosed no confl ict of interest.Albrecht, Diego ................................... Employee: Novartis AG; Stock/Shareholder: Novartis AG. Albrecht, Tobias .................................. Disclosed no confl ict of interest.Albrechtsen, Reidar ............................ Disclosed no confl ict of interest.Albright, Ann L. ................................... Disclosed no confl ict of interest.Alcaide-Torres, Juan ........................... Disclosed no confl ict of interest.Aldana, Paola C. .................................. Disclosed no confl ict of interest.Alderisio, Antonio ............................... Disclosed no confl ict of interest.Aldini, Giancarlo .................................. Disclosed no confl ict of interest.Aldossari, Khaled K. ........................... Disclosed no confl ict of interest.Alejandro, Emilyn ................................ Disclosed no confl ict of interest.Alejandro, Rodolfo .............................. Disclosed no confl ict of interest.Alemany, Pedro Maria ........................ Disclosed no confl ict of interest.Aleppo, Grazia ..................................... Disclosed no confl ict of interest.Alessi, Tom .......................................... Disclosed no confl ict of interest.Aletras, Vassilis H. .............................. Disclosed no confl ict of interest.Alexander, Jamin ................................ Disclosed no confl ict of interest.Alexander-Chacko, Jesline T. ............. Employee: Eli Lilly and Company. Alexanian, Sara ................................... Disclosed no confl ict of interest.Alfaro, Freddy ...................................... Disclosed no confl ict of interest.Alfonso Ross Terres, Jorge ................ Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline. Algatt-Bergstrom, Pamela ................. Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &

Co., Inc. Alharbi, Majed A. ................................ Disclosed no confl ict of interest.Al-Hasani, Hadi ................................... Disclosed no confl ict of interest.

Ali, Aktar .............................................. Disclosed no confl ict of interest.Ali, Mohammed K. .............................. Research Support: National Institute of Diabetes and

Digestive and Kidney Diseases. Ali, Safi na ............................................ Disclosed no confl ict of interest.Al-Ibraheemi, Zainab .......................... Disclosed no confl ict of interest.Alkanani, Aimon .................................. Disclosed no confl ict of interest.Al-Khairi, Irina ..................................... Disclosed no confl ict of interest.Allard, Camille ..................................... Disclosed no confl ict of interest.Allas, Soraya ....................................... Employee: Alize Pharma; Stock/Shareholder: Alize Pharma. Allayee, Hooman ................................. Disclosed no confl ict of interest.Allen, Isabel E. .................................... Disclosed no confl ict of interest.Allen, Janet M. .................................... Disclosed no confl ict of interest.Allen, Terri ........................................... Disclosed no confl ict of interest.Allenback, Gayle ................................. Disclosed no confl ict of interest.Aller, Rocio .......................................... Disclosed no confl ict of interest.Allison, Matthew ................................ Disclosed no confl ict of interest.Allister, Emma M. ................................ Disclosed no confl ict of interest.Alluis, Bertrand ................................... Employee: Adocia; Stock/Shareholder: Adocia. Almahmeed, Buthaina ........................ Disclosed no confl ict of interest.Alman, Amy ......................................... Disclosed no confl ict of interest.Al-Maqbali, Ali .................................... Other Relationship: Johnson & Johnson, Merck Sharp &

Dohme, Novartis Pharmaceuticals Corporation. Almario, Rogelio .................................. Disclosed no confl ict of interest.Almasy, Laura ...................................... Disclosed no confl ict of interest.Almdal, Thomas .................................. Stock/Shareholder: Novo Nordisk A/S. Almeda-Valdez, Paloma ...................... Disclosed no confl ict of interest.Almeida, Fabio A. ................................ Disclosed no confl ict of interest.Almeida-Pititto, Bianca ...................... Disclosed no confl ict of interest.Almgren, Peter .................................... Disclosed no confl ict of interest.Al-Mrabeh, Ahmad ............................. Disclosed no confl ict of interest.Aloi, Joseph ......................................... Disclosed no confl ict of interest.Alon, Tal ............................................... Employee: Insuline Medical Ltd. Alonso, Laura C. .................................. Disclosed no confl ict of interest.Alonzo, Ryan ........................................ Disclosed no confl ict of interest.Alpha, David ........................................ Disclosed no confl ict of interest.Alqarzaee, Abdulelah ......................... Disclosed no confl ict of interest.Al-Rasadi, Khalid ................................ Other Relationship: Abbott, Aegerion Pharmaceuticals, Inc.,

AstraZeneca Pharmaceuticals LP, Pfi zer Inc. Alrasheed, Nawal M. ......................... Disclosed no confl ict of interest.Alrasheed, Nouf M. ............................ Disclosed no confl ict of interest.Alsadun, Sarah .................................... Disclosed no confl ict of interest.Alsaheel, Abdulhameed ..................... Disclosed no confl ict of interest.Alshehabi, Erica .................................. Disclosed no confl ict of interest.Alsifri, Saud N. .................................... Disclosed no confl ict of interest.Altaf, Faseeha K. ................................. Disclosed no confl ict of interest.Alter, Markus L. ................................... Disclosed no confl ict of interest.Altschul, Randiece L. .......................... Advisory Panel: PopTest LLC; Board Member: PopTest LLC;

Employee: PopTest LLC. Altschuler, Andrea .............................. Disclosed no confl ict of interest.Altshuler, David M. ............................. Disclosed no confl ict of interest.Alunno, Alessia ................................... Disclosed no confl ict of interest.Alvarez Fallas, Mario Enrique ............ Disclosed no confl ict of interest.Alvarez, Andrea .................................. Disclosed no confl ict of interest.Alvarez-Perez, Juan C. ........................ Disclosed no confl ict of interest.Alvarez-Viejo, Maria ........................... Disclosed no confl ict of interest.Alvarsson, Michael ............................. Advisory Panel: AstraZeneca Pharmaceuticals LP, Eli Lilly

and Company, Novo Nordisk Inc., Sanofi U.S.; Speaker’s Bureau: Eli Lilly and Company, Novo Nordisk Inc., Sanofi U.S.

Alves, Tiago C. .................................... Disclosed no confl ict of interest.Al-Waili, Khalid ................................... Disclosed no confl ict of interest.Amaral, Cláudia ................................... Disclosed no confl ict of interest.Amarnani, Dhanesh S. ........................ Disclosed no confl ict of interest.Ambrosino, Jodie M. .......................... Disclosed no confl ict of interest.Ametov, Alexander ............................. Disclosed no confl ict of interest.Amiel, Stephanie A. ............................ Disclosed no confl ict of interest.Amini, Sam .......................................... Disclosed no confl ict of interest.Amir Levy, Yifat ................................... Disclosed no confl ict of interest.Amital, Daniela ................................... Disclosed no confl ict of interest.Amital, Howard ................................... Disclosed no confl ict of interest.Ammons, Ann ...................................... Disclosed no confl ict of interest.Ammori, Basil ...................................... Disclosed no confl ict of interest.Amoah, Albert ..................................... Disclosed no confl ict of interest.Amor, Paul A. ....................................... Employee: Pfi zer Inc. Amoussou-Guenou, K. Daniel ............ Disclosed no confl ict of interest.Amouzegar, Atieh ................................ Disclosed no confl ict of interest.Ampudia-Blasco, Francisco J. ............ Advisory Panel: Sanofi . Amrani, Abdelaziz ............................... Disclosed no confl ict of interest.Amundson, Gerald H. .......................... Disclosed no confl ict of interest.An, Hyun Ju ......................................... Disclosed no confl ict of interest.An, JaeJin ........................................... Research Support: Genentech, Inc. An, Jee Hyun ....................................... Disclosed no confl ict of interest.

A812

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

An, Ping ................................................ Disclosed no confl ict of interest.An, Seung Min ..................................... Disclosed no confl ict of interest.An, So-Yeon ......................................... Disclosed no confl ict of interest.An, Yali ................................................. Disclosed no confl ict of interest.Anand, Praveen ................................... Disclosed no confl ict of interest.Andel, Michal ...................................... Disclosed no confl ict of interest.Andersen, Birgitte .............................. Employee: Novo Nordisk A/S. Andersen, Charles .............................. Disclosed no confl ict of interest.Andersen, Emilie S. ............................. Disclosed no confl ict of interest.Andersen, Grit ..................................... Disclosed no confl ict of interest.Andersen, Henrik U. ............................ Advisory Panel: Abbott; Employee: Steno Diabetes Center

A/S; Stock/Shareholder: Novo Nordisk A/S. Andersen, Steen ................................. Disclosed no confl ict of interest.Anderson, Barbara J. .......................... Advisory Panel: Sanofi U.S.; Consultant: The Leona M. and

Harry B. Helmsley Charitable Trust; Research Support: Juvenile Diabetes Research Foundation, National Institutes of Health.

Anderson, Brian .................................. Disclosed no confl ict of interest.Anderson, Jessica .............................. Disclosed no confl ict of interest.Anderson, Lise Lotte ........................... Disclosed no confl ict of interest.Anderson, Simon G. ............................ Disclosed no confl ict of interest.Anderson, Stacey ................................ Consultant: Senseonics; Research Support: Dexcom, Inc.,

Medtronic, Inc., Roche USA. Anderson, Stewart J. ......................... Disclosed no confl ict of interest.Andersson, Gert S. .............................. Disclosed no confl ict of interest.Andersson, Lotta ................................ Disclosed no confl ict of interest.Ando, Kiyotaka .................................... Disclosed no confl ict of interest.Ando, Ryotaro ..................................... Employee: Kurume University School of Medicine. Andrade, Sara ..................................... Disclosed no confl ict of interest.Andre, Anthony D. ............................... Consultant: GlaxoSmithKline. Andreasen, Camilla ............................. Disclosed no confl ict of interest.Andreassen, Kim V. ............................. Employee: Nordic Bioscience. Andreoli, Christopher ......................... Disclosed no confl ict of interest.Andreoni, Luca .................................... Disclosed no confl ict of interest.Andrews, David M. ............................. Disclosed no confl ict of interest.Andrews, James C. ............................. Disclosed no confl ict of interest.Andrikopoulos, Sof ............................. Research Support: AstraZeneca/Bristol-Myers Squibb. Andrulli Buccheri, Valentina .............. Disclosed no confl ict of interest.Andrzejewski, Danielle ....................... Disclosed no confl ict of interest.Ang, Lynn ............................................. Disclosed no confl ict of interest.Ang, Wei .............................................. Disclosed no confl ict of interest.Angeletti, Silvia .................................. Disclosed no confl ict of interest.Angelucci, Ermanno ............................ Disclosed no confl ict of interest.Anghel, Valentin .................................. Disclosed no confl ict of interest.Anglin, Greg ......................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Angueira, Anthony .............................. Disclosed no confl ict of interest.Anhe, Gabriel F. ................................... Disclosed no confl ict of interest.Anhut, Jennifer L. ............................... Disclosed no confl ict of interest.Anichini, Roberto ................................ Disclosed no confl ict of interest.Anjana, Ranjit M. ................................ Disclosed no confl ict of interest.Annamalai, Mani ................................. Disclosed no confl ict of interest.Annamalai, Palam ............................... Disclosed no confl ict of interest.Annunziata, Kathy ............................... Consultant: Employee at Kantar Health, working as a

consultant with Takeda. Annuzzi, Giovanni ................................ Disclosed no confl ict of interest.Anokye-Danso, Fred ........................... Disclosed no confl ict of interest.Anthony, Sarah M. .............................. Disclosed no confl ict of interest.Antinozzi, Peter ................................... Disclosed no confl ict of interest.Antonenko, Viktoriia ........................... Disclosed no confl ict of interest.Antoun, Joseph ................................... Disclosed no confl ict of interest.Antunes, Manuel ................................ Disclosed no confl ict of interest.Anupunpisit, Vipavee ......................... Disclosed no confl ict of interest.Anyfanti, Panagiota ............................ Disclosed no confl ict of interest.Anzalone, Deborah ............................. Employee: AstraZeneca Pharmaceuticals LP. Aoki, Chie ............................................. Disclosed no confl ict of interest.Aoki, Ema ............................................. Disclosed no confl ict of interest.Aoki, Masako ...................................... Disclosed no confl ict of interest.Aomo, Mayumi .................................... Disclosed no confl ict of interest.Aono, Mayumi ..................................... Disclosed no confl ict of interest.Aono, Shigeo ....................................... Disclosed no confl ict of interest.Aoun, Charlie ....................................... Disclosed no confl ict of interest.Apodaca, Timothy ............................... Disclosed no confl ict of interest.Apostolopoulou, Maria ....................... Disclosed no confl ict of interest.Apostolou, Ourania ............................. Disclosed no confl ict of interest.Apovian, Caroline M. .......................... Research Support: National Institute of Diabetes and

Digestive and Kidney Diseases, National Institutes of Health.

Appana, Deepika ................................. Disclosed no confl ict of interest.Appelt, Dieter ...................................... Disclosed no confl ict of interest.Apuzzo, Roberto .................................. Disclosed no confl ict of interest.Araki, Atsushi ...................................... Disclosed no confl ict of interest.

Araki, Eiichi .......................................... Disclosed no confl ict of interest.Araki, Shin-Ichi .................................... Disclosed no confl ict of interest.Aranda, Cristina .................................. Employee: Sanofi Aventis S.A. Arase, Yasuji ....................................... Disclosed no confl ict of interest.Arathuzik, Gillian ................................. Disclosed no confl ict of interest.Araujo, Debora B. ................................ Disclosed no confl ict of interest.Araujo, Fabiana ................................... Disclosed no confl ict of interest.Araújo, Thiago ..................................... Disclosed no confl ict of interest.Araujo-Vilar, David .............................. Consultant: AstraZeneca/Bristol-Myers Squibb. Arbelaez, Ana Maria ........................... Disclosed no confl ict of interest.Arbit, Ehud ........................................... Consultant: Oramed Pharmaceuticals. Arboleda-Velasquez, Joseph F. .......... Disclosed no confl ict of interest.Arena, Vincent C. ................................ Disclosed no confl ict of interest.Arends, Derk ........................................ Disclosed no confl ict of interest.Arends, Valerie .................................... Disclosed no confl ict of interest.Argento, Nicholas B. ........................... Advisory Panel: BD Medical-Diabetes Care, Eli Lilly and

Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Roche USA; Consultant: Animas Corporation, Johnson and Johnson Diabetes Institute; Research Support: Dexcom, Inc.; Speaker’s Bureau: Animas Corporation, AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Dexcom, Inc., Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Novo Nordisk Inc.

Ari, Csilla ............................................. Disclosed no confl ict of interest.Arita, Mikio ......................................... Disclosed no confl ict of interest.Ariyachet, Chaiyaboot ........................ Disclosed no confl ict of interest.Arky, Ronald A. .................................... Disclosed no confl ict of interest.Armas, Danielle ................................... Employee: Celerion, Inc. Armistead, Niti S. ............................... Disclosed no confl ict of interest.Armstrong, Loren ................................ Disclosed no confl ict of interest.Arnold, Amy C. .................................... Disclosed no confl ict of interest.Arnold, Lindsay ................................... Disclosed no confl ict of interest.Arnold, Lindsay M. .............................. Disclosed no confl ict of interest.Arnold, Susan ...................................... Employee: PhaseBio Pharmaceuticals, Inc.; Stock/

Shareholder: PhaseBio Pharmaceuticals, Inc. Aro Guardia, Pedro A. ......................... Disclosed no confl ict of interest.Aroda, Vanita R. .................................. Consultant: Novo Nordisk A/S, Sanofi U.S.; Research

Support: Amylin Pharmaceuticals, LLC., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH, Eisai Co., Ltd., Hanmi, Novo Nordisk A/S, Sanofi U.S., Takeda Pharmaceutical Company Limited.

Aron, David C. ..................................... Disclosed no confl ict of interest.Aronson, Ronnie .................................. Advisory Panel: AstraZeneca Pharmaceuticals LP, Bristol-

Myers Squibb Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Janssen Pharmaceuticals, Medtronic, Inc., Novo Nordisk A/S, Sanofi U.S., Takeda Pharmaceutical Company Limited; Consultant: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Medtronic, Inc., Novo Nordisk A/S, Sanofi U.S., Takeda Pharmaceutical Company Limited; Other Relationship: Sanofi U.S., Takeda Pharmaceutical Company Limited; Research Support: AbbVie, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Covance, Eisai Co., Ltd., Eli Lilly and Company, Genkyotex, GlaxoSmithKline, ICON plc., Inventive Health, Janssen Inc, Joslin Diabetes, Medpace, Medtronic, Inc., Merck & Co., Inc., Novo Nordisk A/S, Parexel, Pfi zer Inc., PPD, Quintiles Inc., Regeneron Pharmaceuticals, Inc., Retrophin, RhoWorld, Sanofi U.S., Takeda Pharmaceutical Company Limited, WCT and TIMI Group; Speaker’s Bureau: Bristol-Myers Squibb Company.

Aroor, Annayya R. ............................... Disclosed no confl ict of interest.Arora, Shilpkumar ............................... Disclosed no confl ict of interest.Arredouani, Abdelilah ......................... Disclosed no confl ict of interest.Arregui-Reyes, Marcela ..................... Disclosed no confl ict of interest.Arriga, Roberto ................................... Disclosed no confl ict of interest.Arroba, Ana I. ...................................... Disclosed no confl ict of interest.Arruda-Marques, Maria do Carmo .... Disclosed no confl ict of interest.Arslanian, Silva A. .............................. Disclosed no confl ict of interest.Arthur, Susan ...................................... Employee: Relypsa, Inc.; Stock/Shareholder: Relypsa, Inc. Arthurs, Blake ..................................... Disclosed no confl ict of interest.Artuso, Rosangela .............................. Disclosed no confl ict of interest.Arulmoli, Gowri ................................... Disclosed no confl ict of interest.Arumugam, Somasundaran ................ Disclosed no confl ict of interest.Arvan, Peter ........................................ Disclosed no confl ict of interest.Aryal, Pratik ......................................... Disclosed no confl ict of interest.Asada, Mariko ..................................... Disclosed no confl ict of interest.Asahara, Shun-Ichiro .......................... Disclosed no confl ict of interest.Asahina, Takayuki ............................... Disclosed no confl ict of interest.

A813

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Asaka, Hiroyuki ................................... Disclosed no confl ict of interest.Asano, Motochika ............................... Disclosed no confl ict of interest.Asano, Tomoichiro .............................. Disclosed no confl ict of interest.Asao, Keiko .......................................... Disclosed no confl ict of interest.Asare Bediako, Isaac .......................... Disclosed no confl ict of interest.Asatiani, Natalia G. ............................ Disclosed no confl ict of interest.Asato, Tadashi ..................................... Disclosed no confl ict of interest.Ascencio-Montiel, Iván de Jesús ...... Disclosed no confl ict of interest.Ascher-Svanum, Haya ........................ Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Asghar, Ali ........................................... Disclosed no confl ict of interest.Asghar, Omar ....................................... Disclosed no confl ict of interest.Asha, Hesarghatta Shyamasunder .... Disclosed no confl ict of interest.Ashe, Maureen .................................... Disclosed no confl ict of interest.Ashford, Michael ................................ Disclosed no confl ict of interest.Ashley, Jane ........................................ Disclosed no confl ict of interest.Asik, Mehmet ...................................... Disclosed no confl ict of interest.Askin, Gulce ......................................... Disclosed no confl ict of interest.Askins, Nissa ....................................... Disclosed no confl ict of interest.Aslam, Nadeem ................................... Consultant: Boehringer Ingelheim Pharmaceuticals,

Inc., Sanofi U.S.; Research Support: AstraZeneca/Bristol-Myers Squibb, Eli Lilly and Company, Isis Pharmaceuticals, Inc., Janssen Pharmaceutical Companies of Johnson & Johnson, Merck & Co., Inc., Novo Nordisk Inc., Sanofi U.S.

Asmar, Ali ............................................ Disclosed no confl ict of interest.Asmar, Meena ..................................... Disclosed no confl ict of interest.Aso, Yoshimasa ................................... Disclosed no confl ict of interest.Asp, Lauren L. ...................................... Disclosed no confl ict of interest.Aspelund, Thor Aspelund ................... Stock/Shareholder: Risk Medical Solutions. Aspholm, Susanna .............................. Employee: Novo Nordisk Farma. Asplund, Olof ....................................... Disclosed no confl ict of interest.Assaly, Rana ........................................ Research Support: Boehringer Ingelheim Pharmaceuticals,

Inc. Atageldiyeva, Kuralay K. .................... Disclosed no confl ict of interest.Atakov-Castillo, Astrid ....................... Disclosed no confl ict of interest.Ataseven, Huseyin .............................. Disclosed no confl ict of interest.Atherley, Anique ................................. Disclosed no confl ict of interest.Atisso, Charles M. .............................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Atkin, Stephen L. ................................. Disclosed no confl ict of interest.Atkinson, Mark A. ............................... Disclosed no confl ict of interest.Atlas, Eran ........................................... Disclosed no confl ict of interest.Atlas, Steven J. ................................... Disclosed no confl ict of interest.Atsuda, Koichiro .................................. Disclosed no confl ict of interest.Atsumi, Yoshihito ................................ Speaker’s Bureau: Eli Lilly Japan K.K., Johnson & Johnson,

Medtronic, Inc., Novo Nordisk Inc., Ono Pharmaceutical Co., Ltd.

Attaoua, Redha ................................... Disclosed no confl ict of interest.Attia, John ........................................... Disclosed no confl ict of interest.Attinger, Christopher E. ...................... Disclosed no confl ict of interest.Atto, Zaid ............................................. Disclosed no confl ict of interest.Attucks, Otis C. ................................... Employee: TransTech Pharma, LLC. Audibert, Francois ............................... Disclosed no confl ict of interest.Auer, Simon ......................................... Disclosed no confl ict of interest.Augustin, Robert ................................. Disclosed no confl ict of interest.Augustin, Thomas ............................... Disclosed no confl ict of interest.Aukrust, Ingvild ................................... Disclosed no confl ict of interest.Aust, Gabriela ..................................... Disclosed no confl ict of interest.Auster, Michael E. ............................... Disclosed no confl ict of interest.Autier, Philippe .................................... Disclosed no confl ict of interest.Autier, Valé rie ..................................... Disclosed no confl ict of interest.Avery, Elizabeth .................................. Disclosed no confl ict of interest.Avery, Robert L. ................................... Disclosed no confl ict of interest.Avilés-Santa, Larissa .......................... Disclosed no confl ict of interest.Avogaro, Angelo ................................. Advisory Panel: Eli Lilly and Company, Sanofi Pasteur

SA; Consultant: AstraZeneca/Bristol-Myers Squibb, Boehringer Ingelheim GmbH, Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Novartis AG, Novo Nordisk Inc., Sanofi Pasteur SA, Servier, Takeda Pharmaceutical Company Limited; Research Support: AstraZeneca/Bristol-Myers Squibb, Boehringer Ingelheim GmbH.

Avotina, Gita ....................................... Disclosed no confl ict of interest.Ayala, Jennifer E. ................................ Disclosed no confl ict of interest.Ayala, Julio E. ...................................... Disclosed no confl ict of interest.Aydin, Sinem ........................................ Disclosed no confl ict of interest.Aye, Myint M. ...................................... Disclosed no confl ict of interest.Aylor, Kevin W. .................................... Disclosed no confl ict of interest.Ayumi, Hirose ...................................... Disclosed no confl ict of interest.Azagury, Dan ....................................... Disclosed no confl ict of interest.Azar, Kristen M. .................................. Disclosed no confl ict of interest.

Azar, Sami ............................................ Advisory Panel: Janssen Research & Development LLC, Merck Sharp & Dohme, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi -Aventis.

Azeem, Rehan ..................................... Employee: Intarcia Therapeutics, Inc. Azevedo, Mirela J. .............................. Disclosed no confl ict of interest.Azhar, Salman ..................................... Research Support: Artery Therapeutics. Azharuddin K.O., Mohammed ............ Disclosed no confl ict of interest.Azinheira, Jorge .................................. Disclosed no confl ict of interest.Azizi, Fereidoun ................................... Disclosed no confl ict of interest.Azizi, Paymon M. ................................. Disclosed no confl ict of interest.Azmi, Shazli ......................................... Disclosed no confl ict of interest.Azuma, Nobuyuki ................................ Disclosed no confl ict of interest.Azzano, Silvana ................................... Disclosed no confl ict of interest.B. Vera, Nicolas ................................... Disclosed no confl ict of interest.Ba, Fatou .............................................. Disclosed no confl ict of interest.Babar, Neelofur ................................... Disclosed no confl ict of interest.Bacak, Stephen J. ............................... Disclosed no confl ict of interest.Bach, Ermina ........................................ Disclosed no confl ict of interest.Bach, Leon ........................................... Disclosed no confl ict of interest.Bacha, Fida .......................................... Disclosed no confl ict of interest.Bachmann, Martin .............................. Stock/Shareholder: Cytos Biotechnology AG. Backus, Carey ...................................... Disclosed no confl ict of interest.Baculescu, Nicoleta ............................ Disclosed no confl ict of interest.Bader, Angela ...................................... Disclosed no confl ict of interest.Bader, Erik ............................................ Disclosed no confl ict of interest.Bader, Giovanni ................................... Employee: Novartis Pharma AG. Bae, Jaehyun ....................................... Disclosed no confl ict of interest.Bae, Jay P. ............................................ Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Bae, Ji Cheol ....................................... Disclosed no confl ict of interest.Bae, Myung Ae .................................... Disclosed no confl ict of interest.Baek, HongSun .................................... Disclosed no confl ict of interest.Baek, YoungHa .................................... Disclosed no confl ict of interest.Baez, Eileen ......................................... Disclosed no confl ict of interest.Bagger, Jonatan I. ............................... Disclosed no confl ict of interest.Bagiella, Emilia .................................... Disclosed no confl ict of interest.Bagwell, Benjamin M. ........................ Disclosed no confl ict of interest.Bahaee, Jamsheed ............................. Disclosed no confl ict of interest.Bahendeka, Silver K. ........................... Disclosed no confl ict of interest.Bahne, Emile ........................................ Disclosed no confl ict of interest.Bai, Fan ................................................ Disclosed no confl ict of interest.Bai, Johnny-Wei .................................. Disclosed no confl ict of interest.Bai, Juli ................................................ Disclosed no confl ict of interest.Baier, Leslie J. ..................................... Disclosed no confl ict of interest.Baig, Arshiya A. .................................. Research Support: AHQR, National Institutes of Health. Baig, Sonia ........................................... Disclosed no confl ict of interest.Baik, Sei Hyun ..................................... Disclosed no confl ict of interest.Bailbé, Danielle ................................... Disclosed no confl ict of interest.Bailey, Clifford J. ................................. Disclosed no confl ict of interest.Bailey, James E. .................................. Disclosed no confl ict of interest.Bailey, Robert A. ................................. Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Bailey, Timothy S. ............................... Consultant: AstraZeneca Pharmaceuticals LP, Bayer

HealthCare, BD Medical-Diabetes Care, Lilly Deutschland GmbH, Medtronic, Inc., Novo Nordisk Inc., Sanofi U.S.; Research Support: Abbott Laboratories, Inc., ACON, Alere, Animas Corporation, Bayer HealthCare, BD Medical-Diabetes Care, Bristol-Myers Squibb Company, Cebix, Inc., Dexcom, Inc., GlaxoSmithKline, Halozyme Therapeutics, Insulet Corporation, LifeScan, Inc., LifeScan, Inc., Lilly Deutschland GmbH, MannKind Corporation, Medtronic, Inc., Merck & Co., Inc., Novo Nordisk Inc., Orexigen Therapeutics, Inc., Sanofi U.S., Tandem Diabetes Care, Inc.; Speaker’s Bureau: Abbott, Novo Nordisk Inc., Sanofi U.S.

Bain, James ......................................... Disclosed no confl ict of interest.Bainbridge, Kathleen E. ...................... Disclosed no confl ict of interest.Bajaj, Harpreet S. ................................ Advisory Panel: AstraZeneca/Bristol-Myers Squibb,

Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck & Co., Inc., Sanofi U.S.; Consultant: AstraZeneca/Bristol-Myers Squibb, Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck & Co., Inc.; Research Support: AstraZeneca/Bristol-Myers Squibb, Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck & Co., Inc., Novo Nordisk Inc., Pfi zer Inc., Regeneron Pharmaceuticals, Inc., Sanofi U.S., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Abbott Diabetes Care, Inc., AstraZeneca/Bristol-Myers Squibb, Bayer HealthCare,

A814

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck & Co., Inc., Novo Nordisk Inc., Sanofi U.S., Servier.

Bajpeyi, Sudip ...................................... Disclosed no confl ict of interest.Bakaj, Ivona ......................................... Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Baker, Chris .......................................... Disclosed no confl ict of interest.Baker, Nathaniel ................................. Disclosed no confl ict of interest.Baker, Scott ......................................... Disclosed no confl ict of interest.Bakillah, Ahmed .................................. Disclosed no confl ict of interest.Bakker, Jessie P. .................................. Disclosed no confl ict of interest.Bakris, George L. ................................. Consultant: Abbvie, Bayer HealthCare, CVRx, Eli Lilly and

Company, GlaxoSmithKline, Janssen Pharmaceutical Companies of Johnson & Johnson, Medtronic, Inc., Novartis Corporation; Research Support: Medtronic, Inc., Relypsa, Takeda Pharmaceutical Company Limited.

Bala, Malgorzata M. ........................... Disclosed no confl ict of interest.Balasubramanian, Kumar ................... Disclosed no confl ict of interest.Balasubramanyam, Muthusamy ........ Disclosed no confl ict of interest.Balcázar-Nava, Patricia ...................... Disclosed no confl ict of interest.Baldzizhar, Raman ............................... Disclosed no confl ict of interest.Balfour, David J. .................................. Disclosed no confl ict of interest.Balinski, Brenda .................................. Disclosed no confl ict of interest.Balis, Dainius ....................................... Employee: Janssen Research & Development, LLC. Balkau, Beverley ................................. Disclosed no confl ict of interest.Balk-Møller, Emilie .............................. Disclosed no confl ict of interest.Ballance, Jim ....................................... Employee: PhaseBio Pharmaceuticals, Inc.; Stock/

Shareholder: PhaseBio Pharmaceuticals, Inc. Ballantyne, Christie M. ....................... Advisory Panel: Merck & Co., Inc., Pfi zer Inc.; Consultant:

Abbott, Amarin Pharma, Inc., Amgen Inc., AstraZeneca Pharmaceuticals LP, Cerenis, Esperion Therapeutics, Inc., Genentech, Inc., Genzyme Corporation, Kowa Pharmaceuticals, Merck & Co., Inc., Novartis Corporation, Pfi zer Inc., Regeneron Pharmaceuticals, Inc., Sanofi -Synthelabo; Research Support: Abbott, Amarin Pharma, Inc., American Heart Association, Amgen Inc., Eli Lilly and Company, Esperion Therapeutics, Inc., Genentech, Inc., GlaxoSmithKline, Merck & Co., Inc., National Institutes of Health, Novartis Corporation, Pfi zer Inc., Regeneron Pharmaceuticals, Inc., Roche Diagnostics.

Balliro, Courtney ................................. Disclosed no confl ict of interest.Balo, Andrew ....................................... Employee: Dexcom, Inc. Balogh, Elemer .................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Balogun, Williams ............................... Disclosed no confl ict of interest.Baltimore, David ................................. Disclosed no confl ict of interest.Baltzinger, Philippe ............................. Disclosed no confl ict of interest.Baltzis, Dimitrios ................................. Disclosed no confl ict of interest.Banba, Nobuyuki ................................. Disclosed no confl ict of interest.Banchereau, Jacques ......................... Disclosed no confl ict of interest.Bandeira, Francisco ............................ Disclosed no confl ict of interest.Bandeira, Leonardo ............................. Disclosed no confl ict of interest.Bandholtz, Sebastian .......................... Disclosed no confl ict of interest.Banerjee, Mary Ann ............................ Disclosed no confl ict of interest.Banerjee, Rajarshi ............................... Disclosed no confl ict of interest.Bang, Claudia ...................................... Disclosed no confl ict of interest.Banks, Alexander ................................ Disclosed no confl ict of interest.Banks, Jaminelli L. .............................. Disclosed no confl ict of interest.Bansal, Anubhuti ................................. Employee: Medtronic, Inc. Bantle, Anne ........................................ Disclosed no confl ict of interest.Banton, Tom ......................................... Research Support: LifeScan, Inc. Bantwal, Ganapathi M. ...................... Advisory Panel: Novo Nordisk Inc. Banu, Isabela ....................................... Disclosed no confl ict of interest.Bao, Haikun ......................................... Disclosed no confl ict of interest.Bao, Rudi .............................................. Disclosed no confl ict of interest.Bao, Wei .............................................. Disclosed no confl ict of interest.Bao, Yuqian .......................................... Disclosed no confl ict of interest.Baptiste, Amandine ............................ Disclosed no confl ict of interest.Baqar, Sara .......................................... Disclosed no confl ict of interest.Bar Ilan, Ahuva .................................... Disclosed no confl ict of interest.Bar, Merav ........................................... Disclosed no confl ict of interest.Barabanov, Valeriy M. ........................ Disclosed no confl ict of interest.Baragaba, Basim ................................. Disclosed no confl ict of interest.Barak-Corren, Yuval ............................ Disclosed no confl ict of interest.Baranov, Oleg ...................................... Disclosed no confl ict of interest.Barash, Hilla ........................................ Disclosed no confl ict of interest.Barataud, Aude ................................... Disclosed no confl ict of interest.Barb, Diana .......................................... Disclosed no confl ict of interest.Barbaresso, Rebecca .......................... Disclosed no confl ict of interest.Barbas, Coral ....................................... Disclosed no confl ict of interest.

Barbee, Melanie .................................. Disclosed no confl ict of interest.Barbosa, Margarida B. ....................... Disclosed no confl ict of interest.Barbour, April M. ................................. Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &

Co., Inc. Barbour, Linda A. ................................. Disclosed no confl ict of interest.Bar-Dayan, Yosefa .............................. Disclosed no confl ict of interest.Bardenheier, Barbara .......................... Disclosed no confl ict of interest.Barett, Eugene .................................... Disclosed no confl ict of interest.Bargellini, Irene ................................... Disclosed no confl ict of interest.Barger, Kelly ........................................ Disclosed no confl ict of interest.Bargiota, Alexandra ............................ Disclosed no confl ict of interest.Barker, Natalie .................................... Disclosed no confl ict of interest.Barker, Sarah ....................................... Disclosed no confl ict of interest.Barkhof, Frederik ................................. Disclosed no confl ict of interest.Barlow, Christopher K. ........................ Disclosed no confl ict of interest.Barlow, Susan ..................................... Employee: Valeritas. Barnea, Maayan .................................. Disclosed no confl ict of interest.Barnes, Catherine S. ........................... Disclosed no confl ict of interest.Barnes, Tammy M. .............................. Disclosed no confl ict of interest.Barnett, Anthony H. ............................ Advisory Panel: Boehringer Ingelheim GmbH, Bristol-

Myers Squibb/AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck Sharp & Dohme, Novartis Corporation, Novo Nordisk A/S, Roche Diagnostics, Sanofi Pasteur SA, Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Boehringer Ingelheim GmbH, Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck Sharp & Dohme, Novartis Corporation, Novo Nordisk A/S, Roche Diagnostics, Sanofi Pasteur SA, Takeda Pharmaceutical Company Limited.

Bärnighausen, Till W. ......................... Disclosed no confl ict of interest.Baron, Alain ......................................... Employee: Elcelyx Therapeutics, Inc.; Stock/Shareholder:

Elcelyx Therapeutics, Inc. Baron, Michelle ................................... Employee: Intarcia Therapeutics, Inc. Barone, Bianca .................................... Disclosed no confl ict of interest.Barone, Francesca .............................. Disclosed no confl ict of interest.Barrat, Christophe .............................. Disclosed no confl ict of interest.Barrett, Amy ........................................ Disclosed no confl ict of interest.Barrett, Eugene J. ............................... Disclosed no confl ict of interest.Barrett, Terrance ................................. Employee: Janssen Research & Development LLC. Barrett, Yu Chen .................................. Employee: AstraZeneca Pharmaceuticals LP. Barrett-Connor, Elizabeth ................... Disclosed no confl ict of interest.Barrientos, Roberto ............................ Disclosed no confl ict of interest.Barron, John ........................................ Consultant: Genentech, Inc. Barros, Allan K. ................................... Disclosed no confl ict of interest.Barrow, Breanne M. ............................ Disclosed no confl ict of interest.Barsnes, Harald ................................... Disclosed no confl ict of interest.Bartasis, Megan L. .............................. Disclosed no confl ict of interest.Bartels, Dorothee ................................ Employee: Boehringer Ingelheim GmbH. Barter, Philip ........................................ Consultant: Resverlogix Corp. Bartlett, Katy ....................................... Disclosed no confl ict of interest.Bartman, Wojciech ............................. Disclosed no confl ict of interest.Bartoli, Manuela ................................. Disclosed no confl ict of interest.Bartolomé, Alberto ............................. Disclosed no confl ict of interest.Bartykowszki, Andrea ........................ Disclosed no confl ict of interest.Bartz, Sara ........................................... Disclosed no confl ict of interest.Barzi, Federica ..................................... Disclosed no confl ict of interest.Barzilai, Nir .......................................... Disclosed no confl ict of interest.Basani, Samata ................................... Disclosed no confl ict of interest.Basaraba, Randall J. ........................... Disclosed no confl ict of interest.Basch, Peter ........................................ Disclosed no confl ict of interest.Basile, Giorgio ..................................... Disclosed no confl ict of interest.Basile, Kevin J. .................................... Disclosed no confl ict of interest.Basina, Marina .................................... Disclosed no confl ict of interest.Bassi, Roberto ..................................... Disclosed no confl ict of interest.Basta, Giuseppe .................................. Disclosed no confl ict of interest.Bastean, Brian ..................................... Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson (Spouse/Partner), Johnson & Johnson; Stock/Shareholder: Johnson & Johnson, Johnson & Johnson (Spouse/Partner).

Bastie, Claire C. ................................... Disclosed no confl ict of interest.Bastyr III, Edward J. ........................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Basu, Ananda ...................................... Disclosed no confl ict of interest.Basu, Arpita ......................................... Disclosed no confl ict of interest.Basu, Rita ............................................ Research Support: Dexcom, Inc. Basu, Sanjay ........................................ Disclosed no confl ict of interest.Batch, Bryan ........................................ Disclosed no confl ict of interest.Batchu, Sri N. ...................................... Disclosed no confl ict of interest.Batista, Thiago .................................... Disclosed no confl ict of interest.

A815

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Batra, Manav ....................................... Disclosed no confl ict of interest.Batra, Meenakshi ............................... Employee: Voxiva, Inc. Battezzati, Alberto .............................. Disclosed no confl ict of interest.Bauduceau, Bernard ........................... Disclosed no confl ict of interest.Bauer, John A. ..................................... Disclosed no confl ict of interest.Bauer, Tim A. ....................................... Disclosed no confl ict of interest.Bauer, Witold ...................................... Disclosed no confl ict of interest.Baugh, Christopher ............................. Disclosed no confl ict of interest.Baum, Diana ........................................ Disclosed no confl ict of interest.Baum, Ellen Z. ...................................... Disclosed no confl ict of interest.Baumann, Matthias ............................ Employee: NOXXON Pharma AG. Baumann, Petra M. ............................. Disclosed no confl ict of interest.Baumgartner, Amy .............................. Disclosed no confl ict of interest.Bautista, Kimberly A. .......................... Disclosed no confl ict of interest.Baverel, Gabriel .................................. Stock/Shareholder: Metabolys Inc. Bavinger, Clay ...................................... Disclosed no confl ict of interest.Baxter, Judith ...................................... Disclosed no confl ict of interest.Baxter, Mark A. ................................... Disclosed no confl ict of interest.Bayer, Allison L. ................................... Disclosed no confl ict of interest.Baz, Baz ............................................... Disclosed no confl ict of interest.Bazinet, Richard P. .............................. Disclosed no confl ict of interest.Bazyka, Dmitrii .................................... Disclosed no confl ict of interest.Beal, John ............................................ Disclosed no confl ict of interest.Beall, Craig .......................................... Disclosed no confl ict of interest.Beals, John M. .................................... Board Member: Rose Human Institute of Technology,

Biology and Biomedical Engineering; Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner).

Beamish, Christine A. ......................... Disclosed no confl ict of interest.Bean, Eric ............................................. Employee: DiabetOmics, Inc. Beaton, Joan ....................................... Disclosed no confl ict of interest.Beauharnais, Catherine C. ................. Disclosed no confl ict of interest.Beauregard, Natalie ........................... Disclosed no confl ict of interest.Bebakar, Wan Mohamad W. .............. Advisory Panel: Novo Nordisk A/S. Bebu, Ionut .......................................... Disclosed no confl ict of interest.Beccaria, Andrea ................................ Disclosed no confl ict of interest.Bechaz, Marisa ................................... Disclosed no confl ict of interest.Beck, Hans C. ...................................... Disclosed no confl ict of interest.Beck, Joni K. ........................................ Disclosed no confl ict of interest.Beck, Roy W. ....................................... Disclosed no confl ict of interest.Beck, Stephan ..................................... Disclosed no confl ict of interest.Becker, Ann ......................................... Disclosed no confl ict of interest.Becker, Dorothy ................................... Disclosed no confl ict of interest.Becker, Reinhard ................................. Employee: Sanofi . Becker, Robert ..................................... Disclosed no confl ict of interest.Beckers, Johannes .............................. Disclosed no confl ict of interest.Beckles, Gloria L. ................................ Disclosed no confl ict of interest.Beck-Nielsen, Henning ....................... Other Relationship: Novo Nordisk A/S; Research Support:

Novo Nordisk A/S. Beddow, Sara A. ................................. Disclosed no confl ict of interest.Bedini, Jose Luis ................................. Disclosed no confl ict of interest.Bednarek, Maria ................................. Employee: MedImmune, Inc. Bednarik, Petr ...................................... Disclosed no confl ict of interest.Bedogni, Giorgio .................................. Disclosed no confl ict of interest.Bee, Yong M. ....................................... Disclosed no confl ict of interest.Beegle, Richard ................................... Disclosed no confl ict of interest.Beeney, Linda J. .................................. Disclosed no confl ict of interest.Beer, Zivan ........................................... Disclosed no confl ict of interest.Beggio, Valentina ................................ Disclosed no confl ict of interest.Begovatz, Paul ..................................... Disclosed no confl ict of interest.Begtrup, Kamilla ................................. Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Behar, Mourad ..................................... Employee: Sanofi France. Behbehani, Kazem .............................. Disclosed no confl ict of interest.Behr-Roussel, Delphine ...................... Research Support: Boehringer Ingelheim Pharmaceuticals,

Inc. Beilman, Gregory J. ............................ Disclosed no confl ict of interest.Belardinelli, Luiz .................................. Employee: Gilead; Stock/Shareholder: Gilead. Belfort-DeAguiar, Renata ................... Disclosed no confl ict of interest.Beli, Eleni ............................................. Disclosed no confl ict of interest.Belichenko, Pavel ................................ Disclosed no confl ict of interest.Belinova, Lenka ................................... Disclosed no confl ict of interest.Bell, Douglas ....................................... Disclosed no confl ict of interest.Bell, Graeme I. ..................................... Disclosed no confl ict of interest.Bell, Kelly ............................................. Employee: AstraZeneca Pharmaceuticals LP. Bell, Kirstine J. .................................... Disclosed no confl ict of interest.Bell, Ronny A. ...................................... Disclosed no confl ict of interest.Bellamy, David J. ................................. Disclosed no confl ict of interest.Bellan, Mattia ..................................... Disclosed no confl ict of interest.Bellia, Alfonso ..................................... Disclosed no confl ict of interest.Bellido, Diego ...................................... Disclosed no confl ict of interest.Bellili-Muñoz, Naïma .......................... Disclosed no confl ict of interest.

Bellin, Melena D. ................................. Consultant: Viacyte; Research Support: Dompe Pharmaceuticals, Medtronic, Inc., Merck & Co., Inc.

Bello, Gabriela B. ................................ Disclosed no confl ict of interest.Belokovskaya, Regina ......................... Disclosed no confl ict of interest.Below, Jennifer E. ............................... Disclosed no confl ict of interest.Belton, Anne ........................................ Advisory Panel: Abbot, Boehringer Ingelheim, Sanofi on

programs for the International Diabetes Federation; Consultant: Lifescan Canada.

Ben Nasr, Moufi da .............................. Disclosed no confl ict of interest.Bena, James ........................................ Disclosed no confl ict of interest.Benbenek-Klupa, Teresa .................... Disclosed no confl ict of interest.Bendeck, Michelle .............................. Disclosed no confl ict of interest.Bender, Corey ...................................... Disclosed no confl ict of interest.Bendre, Rohan ..................................... Disclosed no confl ict of interest.Benes, Marek ...................................... Disclosed no confl ict of interest.Benetti, Alberto .................................. Disclosed no confl ict of interest.Benias, Petros ..................................... Disclosed no confl ict of interest.Benitez, Amanda ................................. Research Support: National Institutes of Health. Beniwal, Sanjay .................................. Disclosed no confl ict of interest.Benjamin, Santhosh J. ........................ Disclosed no confl ict of interest.Ben-Mayor, Ram ................................. Disclosed no confl ict of interest.Bennakhi, Abdullah ............................. Disclosed no confl ict of interest.Bennedetti, Luiza ................................ Disclosed no confl ict of interest.Bennet, Michael .................................. Disclosed no confl ict of interest.Bennett, Amanda J. ............................ Disclosed no confl ict of interest.Bennett, Heather ................................ Disclosed no confl ict of interest.Bennett, Peter H. ................................ Disclosed no confl ict of interest.Benninger, Richard K. ......................... Disclosed no confl ict of interest.Bensenor, Isabela M. .......................... Disclosed no confl ict of interest.Bentley, Amy ....................................... Disclosed no confl ict of interest.Bentley-Lewis, Rhonda ...................... Consultant: Sanofi U.S.; Research Support: Novartis

Pharmaceuticals Corporation (Spouse/Partner), Sanofi U.S., Sanofi U.S. (Spouse/Partner).

Bequette, B. Wayne ............................ Consultant: Becton, Dickinson and Company. Bera, Amal Kanti K. ............................. Disclosed no confl ict of interest.Berard, Lori .......................................... Advisory Panel: Abbott, AstraZeneca, Bayer, BD, Eli Lilly

Canada, Janssen, Lifescan, Merck, Novo Nordisk, Sanofi ; Consultant: Abbott, AstraZeneca, Bayer, BD, Eli Lilly Canada, Janssen, Lifescan, Merck, Novo Nordisk, Sanofi ; Speaker’s Bureau: Abbott, AstraZeneca, Bayer, BD, Eli Lilly Canada, Janssen, Lifescan, Merck, Novo Nordisk, Sanofi .

Berends, Frits ...................................... Disclosed no confl ict of interest.Berg, Cynthia A. .................................. Research Support: National Institute of Diabetes and

Digestive and Kidney Diseases. Bergamini, Corinna ............................. Disclosed no confl ict of interest.Bergenheim, Klas ................................ Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP. Bergenstal, Richard M. ....................... Advisory Panel: Abbott Diabetes Care, Inc., AstraZeneca/

Bristol-Myers Squibb, Bayer HealthCare, Boehringer Ingelheim GmbH, Calibra, Eli Lilly and Company, Halozyme Therapeutics, Hygieia, Johnson & Johnson, Medtronic, Inc., Novo Nordisk Inc., Roche USA, Sanofi U.S., Takeda Pharmaceuticals U.S.A., Inc., The Leona M. and Harry B. Helmsley Charitable Trust, Valeritas; Research Support: Abbott Diabetes Care, Inc., AstraZeneca/Bristol-Myers Squibb, Bayer HealthCare, Becton, Dickinson and Company, Boehringer Ingelheim GmbH, Calibra, Eli Lilly and Company, Halozyme Therapeutics, Hygieia, Johnson & Johnson, Medtronic, Inc., Merck & Co., Inc., National Institutes of Health, Novo Nordisk Inc., ResMed, Roche USA, Sanofi U.S., Takeda Pharmaceuticals U.S.A., Inc., The Leona M. and Harry B. Helmsley Charitable Trust.

Berger, Andrea L. ................................ Disclosed no confl ict of interest.Berger-Marshall, Michelle ................. Disclosed no confl ict of interest.Bergeron, Valerie ................................ Disclosed no confl ict of interest.Berggren, Erica K. ............................... Disclosed no confl ict of interest.Berggren, Johan .................................. Disclosed no confl ict of interest.Berggren, Per-Olof .............................. Disclosed no confl ict of interest.Bergh, Eric ........................................... Disclosed no confl ict of interest.Bergheim, Ina ...................................... Disclosed no confl ict of interest.Bergholt, Thomas ................................ Disclosed no confl ict of interest.Bergis-Jurgan, Nikola ......................... Research Support: Berlin-Chemie AG; Speaker’s Bureau:

Berlin-Chemie AG. Berglund, Eric ...................................... Disclosed no confl ict of interest.Bergman, Arthur ................................. Disclosed no confl ict of interest.Bergman, Bryan C. .............................. Research Support: Eli Lilly and Company. Bergman, Richard N. ........................... Consultant: Amylin Pharmaceuticals, LLC., Ingredion, Novo

Nordisk Inc.; Speaker’s Bureau: Merck-Schering Plough; Stock/Shareholder: Tethys Bioscience.

Bergmann, Karin ................................. Employee: Sanofi ; Stock/Shareholder: Sanofi .

A816

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Bergmeier, Stephen ............................ Disclosed no confl ict of interest.Bergouignan, Audrey .......................... Disclosed no confl ict of interest.Berkowitz, Seth A. .............................. Disclosed no confl ict of interest.Berkseth, Kathryn E. ........................... Disclosed no confl ict of interest.Berlanga Escalera, Eugenio ............... Disclosed no confl ict of interest.Berlie, Helen ........................................ Disclosed no confl ict of interest.Berman, Dora M. ................................. Disclosed no confl ict of interest.Berman, Lance .................................... Employee: Relypsa, Inc.; Stock/Shareholder: Relypsa, Inc. Bernabé, Jacques ............................... Research Support: Boehringer Ingelheim Pharmaceuticals,

Inc. Bernal-Mizrachi, Ernesto ................... Disclosed no confl ict of interest.Bernheim, Susannah M. ..................... Disclosed no confl ict of interest.Bernjak, Alan ....................................... Disclosed no confl ict of interest.Bernlohr, David A. ............................... Disclosed no confl ict of interest.Berrah, Abdelkrim ............................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Bayer

HealthCare, Merck Sharp & Dohme, Novartis AG, Novo Nordisk A/S, Pfi zer Inc., Sanofi U.S.; Consultant: Saidal, Sanofi U.S.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, HIKMA, Merck Serono, Novartis AG, Novo Nordisk A/S, Saidal, Sanofi U.S.

Berria, Rachele .................................... Employee: Sanofi ; Stock/Shareholder: Sanofi . Berry, Barbara ..................................... Disclosed no confl ict of interest.Berry, Pam C. ....................................... Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline. Berry, Rodney ...................................... Disclosed no confl ict of interest.Berryman, Darlene E. .......................... Disclosed no confl ict of interest.Bertola, Susana Carolina .................... Disclosed no confl ict of interest.Bertoli, Simona .................................... Disclosed no confl ict of interest.Bertolotto, Alessandra ....................... Disclosed no confl ict of interest.Bertoni, Alain ...................................... Disclosed no confl ict of interest.Bertran, Elizabeth A. ........................... Disclosed no confl ict of interest.Bertrand, Anne-Marie ........................ Disclosed no confl ict of interest.Bertrand, Gyslaine .............................. Disclosed no confl ict of interest.Besenböck, Carolin ............................. Disclosed no confl ict of interest.Best, James D. .................................... Research Support: Roche Diagnostics, Roche Diagnostics

(Spouse/Partner), sanofi , sanofi (Spouse/Partner). Bethin, Kathleen E. ............................. Disclosed no confl ict of interest.Betsholtz, Christer .............................. Disclosed no confl ict of interest.Beverly, Elizabeth A. ........................... Disclosed no confl ict of interest.Bevier, Wendy C. ................................. Disclosed no confl ict of interest.Bevilacqua, Sarah C. ........................... Disclosed no confl ict of interest.Beyan, Huriya ...................................... Disclosed no confl ict of interest.Beyazyildiz, Emrullah .......................... Disclosed no confl ict of interest.Beyersmann, Jan ................................ Disclosed no confl ict of interest.Beysen, Carine .................................... Employee: KineMed, Inc. Bezwada, Padma ................................. Employee: XOMA Corporation. Bgatova, Natalia P. ............................. Disclosed no confl ict of interest.Bhagroo, Nicholas ............................... Disclosed no confl ict of interest.Bhan, Arti ............................................ Disclosed no confl ict of interest.Bhandari, Amit .................................... Employee: Boehringer Ingelheim Pharmaceuticals Inc. Bhandari, Sudhir .................................. Disclosed no confl ict of interest.Bhanot, Sanjay .................................... Employee: Isis Pharmaceuticals, Inc. Bhargava, Anuj .................................... Advisory Panel: Abbott, AstraZeneca; Research Support:

AstraZeneca, Bristol-Myers Squibb Company, Duke Clinical Research Inst, Eli Lilly and Company, GlaxoSmithKline, Halozyme Therapeutics, JAEB, Janssen, Medtronic, Mylan, Novo Nordisk, Orexigen Therapeutics, Inc., Sanofi , Univ. of Oxford; Speaker’s Bureau: AstraZeneca, Janssen, Sanofi .

Bharucha, Adil E. ................................. Disclosed no confl ict of interest.Bhat, Sathesh ...................................... Disclosed no confl ict of interest.Bhatt, Deepak ....................................Advisory Panel: Cardax, Elsevier Practice Update

Cardiology, Medscape Cardiology, Regado Biosciences; Board Member: Boston VA Research Institute, Society of Cardiovascular Patient Care;Chair: American Heart Association Get With The Guidelines Steering Committee; Consultant: American College of Cardiology (Senior Associate Editor, Clinical Trials and News, ACC.org), Belvoir Publications (Editor in Chief, Harvard Heart Letter), Duke Clinical Research Institute (clinical trial steering committees), Harvard Clinical Research Institute (clinical trial steering committee), HMP Communications (Editor in Chief, Journal of Invasive Cardiology), Journal of the American College of Cardiology (Associate Editor; Section Editor, Pharmacology), Population Health Research Institute (clinical trial steering committee), Slack Publications (Chief Medical Editor, Cardiology Today’s Intervention), WebMD (CME steering committees); Other Relationship: Duke Clinical Research Institute, Harvard Clinical Research Institute, Mayo Clinic,

Population Health Research Institute, Unfunded Research: FlowCo, PLx Pharma, Takeda.; Research Support: Amarin, AstraZeneca, Bristol-Myers Squibb, Eisai, Ethicon, Forest Laboratories, Ischemix, Medtronic, Pfizer, Roche, Sanofi Aventis, The Medicines Company.

Bhattacharjee, Sandipan .................... Research Support: Sanofi U.S. Bhattacharya, Rituparna .................... Research Support: Sanofi U.S. Bhattacharya, Sudipta ....................... Employee: AstraZeneca Pharmaceuticals LP. Bhatwadekar, Ashay D. ...................... Disclosed no confl ict of interest.Bhoi, Bibhuti ........................................ Employee: Cadila Healthcare Limited. Bi, Yan .................................................. Disclosed no confl ict of interest.Biaggioni, Italo .................................... Disclosed no confl ict of interest.Bian, Hua ............................................. Disclosed no confl ict of interest.Bianchi, Cristina .................................. Disclosed no confl ict of interest.Bider, Zoe ............................................. Disclosed no confl ict of interest.Bielicki, John ....................................... Advisory Panel: Artery Therapeutics; Research Support:

Artery Therapeutics. Biermans, Marion C. ........................... Disclosed no confl ict of interest.Biernacki, Diane .................................. Disclosed no confl ict of interest.Bierwagen, Alessandra ...................... Disclosed no confl ict of interest.Biester, Torben .................................... Disclosed no confl ict of interest.Bieszk, Nella ........................................ Employee: Sanofi U.S. Bigger-Allen, Alexander A. ................. Disclosed no confl ict of interest.Biggio, Joseph R. ................................ Disclosed no confl ict of interest.Biggs, Mary Lou .................................. Disclosed no confl ict of interest.Bijos, Pawel ......................................... Disclosed no confl ict of interest.Bilic Curcic, Ines .................................. Disclosed no confl ict of interest.Bilic, Jelena ......................................... Disclosed no confl ict of interest.Bilir, Sara P. .......................................... Consultant: Takeda Pharmaceutical Company Limited. Billestrup, Nils ..................................... Disclosed no confl ict of interest.Billger, Martin ..................................... Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP. Billheimer, Dean .................................. Disclosed no confl ict of interest.Bilodeau, Jean-François ..................... Disclosed no confl ict of interest.Bilous, Mary ........................................ Disclosed no confl ict of interest.Bilous, Rudy ......................................... Disclosed no confl ict of interest.Bimson, Brianne .................................. Disclosed no confl ict of interest.Bin, Huang ........................................... Disclosed no confl ict of interest.Bing, Chen ............................................ Disclosed no confl ict of interest.Bing, Sun .............................................. Disclosed no confl ict of interest.Binikos, Isidoros .................................. Disclosed no confl ict of interest.Binkley, Philip ...................................... Disclosed no confl ict of interest.Binko, Deborah .................................... Disclosed no confl ict of interest.Binstock, Anna .................................... Disclosed no confl ict of interest.Biondi, Giuseppina .............................. Disclosed no confl ict of interest.Birdsey, Nicholas ................................ Disclosed no confl ict of interest.Birk, Jesper B. ..................................... Disclosed no confl ict of interest.Birkeland, Kåre I. ................................. Disclosed no confl ict of interest.Birkenfeld, Andreas L. ........................ Disclosed no confl ict of interest.Birnbaum, Howard G. ......................... Research Support: Eli Lilly and Company. Bisceglia, Luigi .................................... Disclosed no confl ict of interest.Bissonnette, Simon ............................. Disclosed no confl ict of interest.Bittner, Stefanie .................................. Disclosed no confl ict of interest.Bitton, Gabriel ..................................... Employee: Insuline Medical Ltd. Bjerre Knudsen, Lotte ......................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Bjoernshave, Ann ................................ Disclosed no confl ict of interest.Björk, Magnus B. ................................. Disclosed no confl ict of interest.Bjørkhaug Gundersen, Lise ................ Disclosed no confl ict of interest.Bjørkhaug, Lise .................................... Disclosed no confl ict of interest.Björkman, Anders ............................... Disclosed no confl ict of interest.Bjørling-Poulsen, Marina .................... Disclosed no confl ict of interest.Bjørlykke, Yngvild ............................... Disclosed no confl ict of interest.Bjørner, Jakob B. ................................. Employee: Optum. Bjornstad, Petter ................................. Disclosed no confl ict of interest.Blaak, Ellen .......................................... Disclosed no confl ict of interest.Black, Mary Helen ............................... Disclosed no confl ict of interest.Blackberry, Irene ................................. Research Support: Roche Diagnostics, sanofi . Blackburn, Brian K. ............................. Disclosed no confl ict of interest.Blackburn, Mary Clare ........................ Disclosed no confl ict of interest.Blackshear, Chad ................................. Disclosed no confl ict of interest.Blagajcevic, Alen ................................ Disclosed no confl ict of interest.Blair, A.B. ............................................. Disclosed no confl ict of interest.Blandino-Rosano, Manuel .................. Disclosed no confl ict of interest.Blaner, William S. ............................... Disclosed no confl ict of interest.Blangero, John .................................... Disclosed no confl ict of interest.Blankert, Femke M. ............................. Disclosed no confl ict of interest.Blankfard, Martin ................................ Disclosed no confl ict of interest.Blaslov, Kristina .................................. Disclosed no confl ict of interest.Blaszkiewicz, Magdalena ................... Disclosed no confl ict of interest.Blaychfeld– Magnazi, Moran ............ Disclosed no confl ict of interest.

A817

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Blecker, Saul ........................................ Disclosed no confl ict of interest.Blevins, Thomas .................................. Advisory Panel: Eli Lilly and Company, Sanofi U.S.;

Consultant: Eli Lilly and Company; Research Support: Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck & Co., Inc., Mylan, Novo Nordisk Inc., Sanofi U.S.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck & Co., Inc., Sanofi U.S.

Blicher, Marie K. .................................. Disclosed no confl ict of interest.Block, Clifford H. ................................. Other Relationship: NutritionQuest co-owner. Block, Gladys ....................................... Other Relationship: NutritionQuest. Block, Torin J. ...................................... Other Relationship: co-owner, NutritionQuest. Blom, Dirk ............................................ Consultant: Aegerion Pharmaceuticals, Inc., Merck Sharp &

Dohme, Sanofi Pasteur SA; Other Relationship: Aegerion Pharmaceuticals, Inc., Amgen Inc., AstraZeneca Pharmaceuticals LP, Merck Sharp & Dohme, PharmaDynamics, Sanofi Pasteur SA.

Blonde, Lawrence ............................... Consultant: AstraZeneca Pharmaceuticals LP, GlaxoSmithKline, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck & Co., Inc., Novo Nordisk A/S, Quest Diagnostics, Sanofi -aventis; Research Support: Eli Lilly and Company, Novo Nordisk A/S, Sanofi -aventis; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck & Co., Inc., Novo Nordisk A/S, Sanofi -aventis.

Blondeau, Bertrand ............................. Disclosed no confl ict of interest.Bloom, David E. ................................... Disclosed no confl ict of interest.Bloomgarden, Noah ............................ Disclosed no confl ict of interest.Blouin, Jean-Louis .............................. Disclosed no confl ict of interest.Blüher, Matthias ................................. Advisory Panel: AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim GmbH, Eli Lilly and Company, Novartis Pharma GmbH, Novo Nordisk A/S, Sanofi U.S.; Consultant: AstraZeneca Pharmaceuticals LP, Berlin-Chemie AG, Boehringer Ingelheim GmbH, Eli Lilly and Company, Novartis Pharma GmbH, Novo Nordisk A/S, Sanofi U.S.; Research Support: ALTANA, Boehringer Ingelheim GmbH, Riemser; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH, Eli Lilly and Company, Johnson & Johnson, Novartis Pharma GmbH, Novo Nordisk A/S, Pfi zer Inc., Riemser, Sanofi U.S.

Bluhmki, Tobias ................................... Disclosed no confl ict of interest.Blum, Janice ........................................ Disclosed no confl ict of interest.Blumer, Ian ........................................... Advisory Panel: Animas Corporation, Bayer HealthCare,

BD Medical-Diabetes Care, Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Medtronic, Inc., Merck & Co., Inc., Novo Nordisk Inc., Roche USA, Sanofi U.S.

Boa, Beatriz C. ..................................... Disclosed no confl ict of interest.Bobelu, J. ............................................. Disclosed no confl ict of interest.Bobo, Janet K. ..................................... Disclosed no confl ict of interest.Boccio, Mindy ...................................... Disclosed no confl ict of interest.Bode, Bruce W. .................................... Advisory Panel: Janssen, Novo Nordisk A/S, Sanofi U.S.;

Consultant: Janssen, Novo Nordisk A/S, Sanofi U.S.; Research Support: Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Novo Nordisk A/S, Sanofi U.S.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, GlaxoSmithKline, Merck & Co., Inc., Novo Nordisk A/S, Sanofi U.S.

Bodegard, Johan ................................. Employee: AstraZeneca Pharmaceuticals LP. Boegelund, Mette ............................... Consultant: Novo Nordisk A/S. Boehm, Bernhard ................................ Disclosed no confl ict of interest.Boehnke, Michael ............................... Disclosed no confl ict of interest.Boerwinkle, Eric .................................. Disclosed no confl ict of interest.Bogardus, Clifton ................................ Disclosed no confl ict of interest.Bogdanov, Patricia .............................. Disclosed no confl ict of interest.Boggi, Ugo ........................................... Disclosed no confl ict of interest.Boh, Eileen T. ....................................... Disclosed no confl ict of interest.Bohnett, Lucas .................................... Employee: Dexcom, Inc. Boisen, Ida ........................................... Disclosed no confl ict of interest.Bojsen-Møller, Kirstine N. .................. Disclosed no confl ict of interest.Bokvist, Krister ................................... Employee: Eli Lilly and Company. Bolanis, Esther M. ............................... Disclosed no confl ict of interest.Bolen, Shari ......................................... Disclosed no confl ict of interest.Bolge, Susan C. ................................... Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson; Stock/Shareholder: Johnson & Johnson. Bolick, Natasha G. .............................. Employee: Becton, Dickinson and Company; Stock/

Shareholder: Becton, Dickinson and Company.

Bolli, Geremia B. .................................. Advisory Panel: Sanofi ; Consultant: Novartis; Speaker’s Bureau: Eli Lilly.

Bolo, Nicolas R. ................................... Disclosed no confl ict of interest.Bolz, Steffen T. .................................... Disclosed no confl ict of interest.Bolze, Sebastien ................................. Disclosed no confl ict of interest.Bombo, Renata .................................... Disclosed no confl ict of interest.Bompada, Pradeep .............................. Disclosed no confl ict of interest.Bonaca, Marc ...................................... Consultant: AstraZeneca Pharmaceuticals LP, Bayer

HealthCare, Merck & Co., Inc., Roche Diagnostics; Research Support: AstraZeneca/Bristol-Myers Squibb, Bayer HealthCare, Daiichi-Sankyo Co., Ltd., Eisai Co., Ltd., Gilead, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc.

Bonadonna, Riccardo C. ..................... Disclosed no confl ict of interest.Bonafede, Machaon ........................... Consultant: Truven Health Analytics Inc. Bonami, Rachel H. ............................... Disclosed no confl ict of interest.Bonapace, Stefano ............................. Disclosed no confl ict of interest.Bonàs, Sílvia ........................................ Disclosed no confl ict of interest.Bondor, Cosmina I. .............................. Consultant: Worwag Pharma. Bone, Derek B. ..................................... Disclosed no confl ict of interest.Bonfadini, Silvia .................................. Disclosed no confl ict of interest.Bonfi glio, Amedeo ............................... Disclosed no confl ict of interest.Bongaerts, Brenda W.C. ..................... Disclosed no confl ict of interest.Bonifacio, Ezio ..................................... Disclosed no confl ict of interest.Bonilla, Cindy D. .................................. Disclosed no confl ict of interest.Bonine, Nicole ..................................... Other Relationship: employee of HealthCore, Inc.,

contracted on behalf of Sanofi US, Inc. Boniol, Mathieu ................................... Disclosed no confl ict of interest.Böni-Schnetzler, Marianne ................ Disclosed no confl ict of interest.Bonnefond, Amélie ............................. Disclosed no confl ict of interest.Bonner-Weir, Susan ............................ Disclosed no confl ict of interest.Bonnes, Harmony ................................ Disclosed no confl ict of interest.Bonnici, François ................................. Research Support: AstraZeneca Pharmaceuticals LP, Novo

Nordisk Inc.; Speaker’s Bureau: Sanofi U.S. Bonomi, Lara ....................................... Disclosed no confl ict of interest.Bonora, Enzo ........................................ Disclosed no confl ict of interest.Boodhansingh, Kara E. ........................ Disclosed no confl ict of interest.Boonin, Alan ........................................ Disclosed no confl ict of interest.Booth, Gillian L. ................................... Disclosed no confl ict of interest.Booth, Robby ....................................... Employee: Glytec. Borch-Johnsen, Knut .......................... Stock/Shareholder: Novo Nordisk A/S. Borck, Anja .......................................... Employee: Sanofi . Bordier, Lyse ........................................ Disclosed no confl ict of interest.Bordin, Silvana .................................... Disclosed no confl ict of interest.Borg, Danielle J. .................................. Disclosed no confl ict of interest.Borges-Yañez, Socorro Aida .............. Disclosed no confl ict of interest.Borgman, Sarah K. .............................. Consultant: Eli Lilly and Company. Boright, Andrew P. .............................. Disclosed no confl ict of interest.Boron-Brenner, Daniel ........................ Disclosed no confl ict of interest.Borowiak, Malgorzata ........................ Disclosed no confl ict of interest.Borowiec, Maciej ................................ Disclosed no confl ict of interest.Børsheim, Elisabet .............................. Disclosed no confl ict of interest.Boscari, Federico ................................ Speaker’s Bureau: Roche Diagnostics. Bosch, Tyler ......................................... Disclosed no confl ict of interest.Boscheinen, Oliver .............................. Disclosed no confl ict of interest.Boschmann, Michael .......................... Disclosed no confl ict of interest.Bose, Tanushree .................................. Employee: Metagenics, Inc. Boselli, Linda ....................................... Disclosed no confl ict of interest.Bosnic, Nevzeta .................................Employee: IMS Brogan; Research Support:

GlaxoSmithKline. Bossowski, Artur ................................ Disclosed no confl ict of interest.Bostick, Brian P. .................................. Disclosed no confl ict of interest.Boström, Pontus .................................. Disclosed no confl ict of interest.Bosworth, Hayden B. .......................... Disclosed no confl ict of interest.Bota, Maria ......................................... Disclosed no confl ict of interest.Bøtker, Hans Erik ................................. Disclosed no confl ict of interest.Botros, Fady T. ..................................... Employee: Eli Lilly and Company, Eli Lilly and Company

(Spouse/Partner); Stock/Shareholder: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner).

Bou, Ricardo ........................................ Disclosed no confl ict of interest.Boucai, Laura ....................................... Disclosed no confl ict of interest.Bouchard, Jo ....................................... Disclosed no confl ict of interest.Bouchard, Jonathan ........................... Employee: Novo Nordisk Inc. Boucher, Jeremie ................................ Disclosed no confl ict of interest.Bouchi, Ryotaro ................................... Disclosed no confl ict of interest.Bouchier-Hayes, David ....................... Disclosed no confl ict of interest.Boudaba, Nadia ................................... Disclosed no confl ict of interest.Boudina, Sihem ................................... Disclosed no confl ict of interest.Boudou, Philippe ................................. Disclosed no confl ict of interest.Bouenizabila, Evariste ........................ Disclosed no confl ict of interest.Boulet, Genevieve ............................... Disclosed no confl ict of interest.Boulton, Andrew J. ............................. Disclosed no confl ict of interest.

A818

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Boulton, David W. ............................... Employee: Bristol-Myers Squibb Company; Stock/Shareholder: Bristol-Myers Squibb Company.

Boulton, Michael E. ............................. Disclosed no confl ict of interest.Boulware, David .................................. Disclosed no confl ict of interest.Bounthavong, Mark ............................ Disclosed no confl ict of interest.Bousboulas, Stavros ........................... Disclosed no confl ict of interest.Bouskela, Eliete ................................... Disclosed no confl ict of interest.Boutchueng-Djidjou, Martial ............. Disclosed no confl ict of interest.Bouw, René ......................................... Employee: AstraZeneca Pharmaceuticals LP. Bouziana, Stella .................................. Disclosed no confl ict of interest.Bouzidi, Amira ..................................... Employee: Novo Nordisk A/S. Bove, Gerald ........................................ Disclosed no confl ict of interest.Bowden, Donald W. ............................ Disclosed no confl ict of interest.Bowen, Michael E. .............................. Disclosed no confl ict of interest.Bowering, Keith .................................. Advisory Panel: AstraZeneca, Boehringer Ingelheim, Eli

Lilly, Johnson & Johnson, Merck, Novo Nordisk; Consultant: Eli Lilly, Merck; Research Support: Eli Lilly, Novo Nordisk; Speaker’s Bureau: AstraZeneca, Eli Lilly,, Merck, Novo Nordisk.

Bowers, Daniel T. ................................ Disclosed no confl ict of interest.Bowlby, Deborah ................................. Disclosed no confl ict of interest.Bowskill, Bridgit B. .............................. Disclosed no confl ict of interest.Bowyer, Vicky ...................................... Disclosed no confl ict of interest.Boye Knudsen, Carsten ...................... Disclosed no confl ict of interest.Boye, Kristina S. .................................. Employee: Eli Lilly and Company, Eli Lilly and Company

(Spouse/Partner); Stock/Shareholder: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner).

Boyko, Edward J. ................................ Disclosed no confl ict of interest.Boyle, Karen D. .................................... Disclosed no confl ict of interest.Boyle, Kristen ...................................... Disclosed no confl ict of interest.Boyle, Luke D. ...................................... Disclosed no confl ict of interest.Boyle, Peter ......................................... Disclosed no confl ict of interest.Boynton, Grace E. ................................ Disclosed no confl ict of interest.Boza, Lorenzo C. .................................. Disclosed no confl ict of interest.Bozadjieva, Nadejda ........................... Disclosed no confl ict of interest.Bozadjieva, Nadia ............................... Disclosed no confl ict of interest.Boztowicz-Wikarek, Maria ................. Disclosed no confl ict of interest.Bozkurt, Latife ..................................... Disclosed no confl ict of interest.Boztepe, Harika ................................... Disclosed no confl ict of interest.Bozzetto, Lutgarda .............................. Disclosed no confl ict of interest.Brabant, Marie-Josée ........................ Employee: IMS Brogan; Research Support: GlaxoSmithKline. Bracy, Deanna P. .................................. Disclosed no confl ict of interest.Bradfi eld, Jonathan P. ......................... Disclosed no confl ict of interest.Bradford, Claire M. ............................. Disclosed no confl ict of interest.Bradley, Paige K. ................................. Disclosed no confl ict of interest.Brady, Cassandra C. ............................ Disclosed no confl ict of interest.Brændgaard, Hans .............................. Disclosed no confl ict of interest.Braffett, Barbara H. ............................ Disclosed no confl ict of interest.Bragg, Fiona ........................................ Disclosed no confl ict of interest.Brahma, Manoja K. ............................. Disclosed no confl ict of interest.Bramlage, Peter .................................. Advisory Panel: AstraZeneca Pharmaceuticals LP, Bristol-

Myers Squibb Company, Takeda Pharmaceutical Company Limited; Consultant: AstraZeneca Pharmaceuticals LP, Berlin-Chemie AG, Bristol-Myers Squibb Company, Eli Lilly and Company, Novartis Pharma GmbH, Takeda Pharmaceutical Company Limited.

Brancato, Davide ................................ Disclosed no confl ict of interest.Brandon, Amanda E. ........................... Disclosed no confl ict of interest.Brandt, Ann-Sofi e ............................... Employee: Medtronic, Inc. Brandt, Nicole ..................................... Disclosed no confl ict of interest.Brangani, Corinna ............................... Disclosed no confl ict of interest.Branigan, Michelle .............................. Disclosed no confl ict of interest.Brannon, Marianne F. .......................... Disclosed no confl ict of interest.Brantley, Phillip ................................... Disclosed no confl ict of interest.Brath, Helmut ...................................... Advisory Panel: Eli Lilly & Co., Novo Nordisk, Boehringer

Ingelheim, Novartis, Sanofi , AstraZeneca, Merck & Co., Takeda, Janssen-Cilag; Speaker’s Bureau: Eli Lilly & Co., Novo Nordisk, Boehringer Ingelheim, Novartis, Sanofi , AstraZeneca, Merck & Co., Takeda, Janssen-Cilag, Servier.

Braun, Kathryn .................................... Disclosed no confl ict of interest.Braunwald, Eugene ............................. Research Support: AstraZeneca Pharmaceuticals LP, Bristol-

Myers Squibb Company. Bray, George ........................................ Disclosed no confl ict of interest.Brayman, Kenneth L. ........................... Disclosed no confl ict of interest.Brazg, Ronald ...................................... Research Support: PhaseBio Pharmaceuticals, Inc. Brazier, John E. .................................... Consultant: Novo Nordisk A/S. Bréant, Bernadette ............................. Disclosed no confl ict of interest.Breault, David ..................................... Disclosed no confl ict of interest.Breen, Gerome .................................... Research Support: National Institute for Health Research

Biomedical Research Centre for Mental Health.

Breen, Tracy ......................................... Disclosed no confl ict of interest.Breiner, Ari .......................................... Disclosed no confl ict of interest.Brennan, Meghan ............................... Disclosed no confl ict of interest.Brennand, Cath ................................... Disclosed no confl ict of interest.Brenner, Jeffrey .................................. Disclosed no confl ict of interest.Brenner, Kathy ..................................... Disclosed no confl ict of interest.Brenner, Michael B. ............................ Disclosed no confl ict of interest.Brent, Michael ..................................... Disclosed no confl ict of interest.Brethauer, Stacy A. ............................. Disclosed no confl ict of interest.Breton, Marc D. ................................... Research Support: Animas Corporation, Dexcom, Inc.,

Insulet Corporation, Sanofi U.S., Tandem Diabetes Care, Inc.; Speaker’s Bureau: Bayer HealthCare, Roche Diagnostics, Sanofi U.S.

Brett, Jason ......................................... Employee: Novo Nordisk Inc.; Stock/Shareholder: Novo Nordisk Inc.

Brewer, Amy ........................................ Disclosed no confl ict of interest.Brey, Eric .............................................. Disclosed no confl ict of interest.Bridges, Jamie .................................... Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &

Co., Inc. Bridges, Melissa ................................. Disclosed no confl ict of interest.Briggs Early, Kathaleen ...................... Disclosed no confl ict of interest.Briggs, Andrew ................................... Advisory Panel: Eli Lilly and Company; Consultant:

AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, GlaxoSmithKline, Sanofi .

Brightwell-Conrad, Angela ................ Employee: Metabolic Solutions Development Company, LLC. Bril, Fernando ...................................... Disclosed no confl ict of interest.Bril, Vera .............................................. Disclosed no confl ict of interest.Brinton, John T. ................................... Disclosed no confl ict of interest.Brioschi, Marcos L. ............................. Disclosed no confl ict of interest.Brismar, Kerstin ................................... Other Relationship: AstraZeneca Pharmaceuticals LP, Eli

Lilly and Company, Novo Nordisk Inc., Sanofi U.S. Brito, Gilberto N. ................................. Disclosed no confl ict of interest.Britton, Steven L. ................................ Disclosed no confl ict of interest.Brixen, Kim .......................................... Disclosed no confl ict of interest.Broca, Christophe ............................... Disclosed no confl ict of interest.Brock, Birgitte ..................................... Board Member: Allergan, Inc., Novo Nordisk A/S; Research

Support: Novo Nordisk A/S; Speaker’s Bureau: Pfi zer Inc. Brock, Christina ................................... Research Support: Novo Nordisk A/S. Brock, Ricky ......................................... Disclosed no confl ict of interest.Brod, Meryl .......................................... Consultant: Novo Nordisk A/S. Broderick, Tom L. ................................. Disclosed no confl ict of interest.Brodovicz, Kimberly G. ....................... Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &

Co., Inc. Broedl, Uli C. ........................................ Employee: Boehringer Ingelheim GmbH. Broholm, Christa ................................. Disclosed no confl ict of interest.Broichhagen, Johannes ...................... Disclosed no confl ict of interest.Brokaw, Sarah ..................................... Disclosed no confl ict of interest.Bron-Green, Morgan ........................... Employee: Owns company granted stocks and long term

incentives, Takeda Pharmaceuticals U.S.A., Inc. Brøns, Charlotte .................................. Stock/Shareholder: Novo Nordisk A/S. Brookhart, Alan M. ............................. Disclosed no confl ict of interest.Brooks, Augustin ................................. Disclosed no confl ict of interest.Brooks, Belinda A. ............................... Disclosed no confl ict of interest.Brøsen, Kim ......................................... Disclosed no confl ict of interest.Brosius, Frank C. ................................. Disclosed no confl ict of interest.Brosnan, Julia ..................................... Employee: Pfi zer Inc. Broughton, Terri .................................. Disclosed no confl ict of interest.Brown, Adam S. .................................. Disclosed no confl ict of interest.Brown, Alex ......................................... Disclosed no confl ict of interest.Brown, Alison ...................................... Disclosed no confl ict of interest.Brown, Eric .......................................... Disclosed no confl ict of interest.Brown, Florence M. ............................ Disclosed no confl ict of interest.Brown, Jennifer J. .............................. Disclosed no confl ict of interest.Brown, Kyle ......................................... Research Support: AstraZeneca Pharmaceuticals LP. Brown, Mark ........................................ Disclosed no confl ict of interest.Brown, Melissa ................................... Disclosed no confl ict of interest.Brown, Rebecca J. .............................. Disclosed no confl ict of interest.Brown, Sue A. ..................................... Research Support: Animas Corporation, Dexcom, Inc.,

Medtronic, Inc., Roche Diagnostics. Brown, Susan D. .................................. Disclosed no confl ict of interest.Browne, Jessica L. .............................. Consultant: Roche Diagnostics Australia, Sanofi Australia;

Research Support: AstraZaneca Australia, Sanofi Australia.

Brown-Kerr, Alana G. .......................... Disclosed no confl ict of interest.Brozinick, Joseph T. ............................ Disclosed no confl ict of interest.Brubaker, Patricia L. ............................ Research Support: Novo Nordisk A/S. Bruckbauer, Antje ............................... Employee: NuSirt Biopharma. Brudno, Yevgeny ................................. Disclosed no confl ict of interest.Brüggemann, Jutta ............................. Disclosed no confl ict of interest.Bruke, George W. ................................ Disclosed no confl ict of interest.Brulle-Wohlhueter, Claire ................... Employee: Sanofi . Brumfeld, Alexandria .......................... Disclosed no confl ict of interest.

A819

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Brun, Alex ............................................ Employee: AstraZeneca Pharmaceuticals LP. Brunak, Søren ...................................... Disclosed no confl ict of interest.Brüning, Jens C. .................................. Disclosed no confl ict of interest.Brunner, Eric ........................................ Disclosed no confl ict of interest.Brunner, Martina ................................. Disclosed no confl ict of interest.Bruno, Antonio .................................... Disclosed no confl ict of interest.Bruno, Graziella ................................... Disclosed no confl ict of interest.Bruno, Joanne H. ................................. Disclosed no confl ict of interest.Brunt, Jara J. ....................................... Disclosed no confl ict of interest.Brusko, Todd M. .................................. Disclosed no confl ict of interest.Brustman, Lois .................................... Disclosed no confl ict of interest.Brutsaert, Erika F. ............................... Disclosed no confl ict of interest.Bruttomesso, Daniela ......................... Advisory Panel: Abbott Diabetes Care, Inc.; Speaker’s

Bureau: Eli Lilly and Company, LifeScan, Inc., Roche Diagnostics, Sanofi U.S.

Bruzzese, Mariella .............................. Disclosed no confl ict of interest.Bry, Lynn .............................................. Disclosed no confl ict of interest.Brzozowska, Aniceta .......................... Disclosed no confl ict of interest.Bu, Le ................................................... Disclosed no confl ict of interest.Bu, Shi .................................................. Disclosed no confl ict of interest.Buanes, Trond ...................................... Disclosed no confl ict of interest.Bucci, John .......................................... Employee: Life Technologies - manufacturer of microarays

used in study. Buchanan, Thomas A. ......................... Disclosed no confl ict of interest.Bucheli, Jose R. ................................... Disclosed no confl ict of interest.Buchwald, Peter .................................. Disclosed no confl ict of interest.Buckeridge, Clare ................................ Employee: Pfi zer Inc. Buckingham, Bruce A. ........................ Advisory Panel: Animas Corporation, BD Medical-Diabetes

Care, Halozyme Therapeutics, Medtronic MiniMed, Inc., Novo Nordisk Inc., Sanofi U.S., Tandem Diabetes Care, Inc.; Research Support: Dexcom, Inc.

Buckley, Stephen T. ............................. Employee: Novo Nordisk A/S. Buckman, Melanie .............................. Disclosed no confl ict of interest.Buday, Barbara .................................... Disclosed no confl ict of interest.Budiman-Mak, Elly .............................. Disclosed no confl ict of interest.Buettner, Christoph ............................. Disclosed no confl ict of interest.Bue-Valleskey, Juliana ....................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Buffolo, Márcio ................................... Disclosed no confl ict of interest.Bugliani, Marco ................................... Disclosed no confl ict of interest.Buhl, Thora .......................................... Disclosed no confl ict of interest.Bui, Hai ................................................. Disclosed no confl ict of interest.Bui, Nancy ........................................... Disclosed no confl ict of interest.Bull, Shelley B. .................................... Disclosed no confl ict of interest.Bullano, Michael ................................. Employee: AstraZeneca Pharmaceuticals LP. Bullard, Kai M. ..................................... Disclosed no confl ict of interest.Buller, R. Mark L. ................................. Disclosed no confl ict of interest.Bulotta, Angela ................................... Employee: Novo Nordisk Inc. Bülow, Jens ......................................... Disclosed no confl ict of interest.Bulum, Tomislav .................................. Disclosed no confl ict of interest.Bun, Socheath ..................................... Disclosed no confl ict of interest.Bunker, Clareann ................................. Disclosed no confl ict of interest.Buranasupkajorn, Patinut ................... Disclosed no confl ict of interest.Burant, Charles F. ................................ Consultant: Zydus Research Centre, Cadila Healthcare

Limited, Ahmedabad, India. Burch, Miguel ...................................... Research Support: GI Dynamics, Inc. Burda, Vaclav ....................................... Disclosed no confl ict of interest.Burg, Ashley R. .................................... Disclosed no confl ict of interest.Burge, Mark R. .................................... Research Support: Research Study, Unrelated, Sanofi U.S. Burgeiro, Ana ...................................... Disclosed no confl ict of interest.Burger, Douglas ................................... Disclosed no confl ict of interest.Burgess, Jenna E. ............................... Disclosed no confl ict of interest.Burgess, Shawn C. .............................. Disclosed no confl ict of interest.Burgos, Sergio A. ................................ Disclosed no confl ict of interest.Burguera, Bartolome .......................... Disclosed no confl ict of interest.Burguete, Ana I. .................................. Disclosed no confl ict of interest.Buring, Julie E. .................................... Disclosed no confl ict of interest.Burk, David .......................................... Disclosed no confl ict of interest.Burkart, Alison .................................... Disclosed no confl ict of interest.Burkart, Volker .................................... Disclosed no confl ict of interest.Burke III, George W. ............................ Disclosed no confl ict of interest.Burkhardt, Brant R. ............................. Disclosed no confl ict of interest.Burkhardt, Ralph ................................. Disclosed no confl ict of interest.Burlina, Silvia ...................................... Disclosed no confl ict of interest.Burmeister, Melissa A. ....................... Disclosed no confl ict of interest.Burnet, Deborah L. .............................. Disclosed no confl ict of interest.Burns, Colleen ..................................... Employee: Elcelyx Therapeutics, Inc. Burns, Kharis ....................................... Disclosed no confl ict of interest.Burnside, Amy ..................................... Disclosed no confl ict of interest.Burrell, Louise M. ................................ Disclosed no confl ict of interest.Burris, Marcie ...................................... Disclosed no confl ict of interest.Burrows, Nilka R. ................................ Disclosed no confl ict of interest.

Bursill, Christina .................................. Disclosed no confl ict of interest.Burtman, Elizabeth ............................. Disclosed no confl ict of interest.Burton, Jeffrey H. ............................... Disclosed no confl ict of interest.Burtt, Noël ........................................... Disclosed no confl ict of interest.Busch, Robert S. .................................. Advisory Panel: Janssen Pharmaceutical Companies

of Johnson & Johnson, Merck & Co., Inc., Sanofi U.S.; Employee: VMS Biomarketing (Spouse/Partner); Research Support: Abbvie, AstraZeneca Pharmaceuticals LP, Eisai Co., Ltd., Eli Lilly and Company, Novo Nordisk Inc.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Eisai Co., Ltd., Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Novo Nordisk Inc., Takeda Pharmaceuticals U.S.A., Inc.

Buschard, Karsten ............................... Disclosed no confl ict of interest.Busciglio, Jorge ................................... Disclosed no confl ict of interest.Buse, John B. ....................................... Consultant: PhaseBio Pharmaceuticals, Inc.;

Other Relationship: Andromeda, AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Elcelyx Therapeutics, Inc., Eli Lilly and Company, F. Hoffmann-La Roche, Ltd., GI Dynamics, Inc., GlaxoSmithKline, Halozyme Therapeutics, Intarcia Therapeutics, Inc., Johnson & Johnson, Lexicon Pharmaceuticals, Inc., LipoScience, Inc., Medtronic, Inc., Merck & Co., Inc., Metabolon, Inc., Metavention, Novo Nordisk A/S, Orexigen Therapeutics, Inc., Osiris Therapeutics, Inc., Pfi zer Inc., PhaseBio Pharmaceuticals, Inc., Quest Diagnostics, Rhythm Pharmaceuticals, Sanofi U.S., Spherix Inc., Takeda Pharmaceutical Company Limited, ToleTx, TransTech Pharma, LLC.; Stock/Shareholder: PhaseBio Pharmaceuticals, Inc.

Busha, Ryan ......................................... Disclosed no confl ict of interest.Bushinsky, David ................................. Consultant: Relypsa, Inc.; Stock/Shareholder: Relypsa, Inc. Busik, Julia .......................................... Disclosed no confl ict of interest.Busjahn, Andreas ................................ Disclosed no confl ict of interest.Butcher, Marcene ............................... Disclosed no confl ict of interest.Buteau, Jean ....................................... Disclosed no confl ict of interest.Butler, Deborah A. .............................. Disclosed no confl ict of interest.Butler, Kenneth ................................... Disclosed no confl ict of interest.Butler, Melissa G. ............................... Research Support: Novartis Corporation. Butner, Jonathan E. ............................ Research Support: National Institute of Diabetes and

Digestive and Kidney Diseases. Butrico, Gina ........................................ Disclosed no confl ict of interest.Butros, Fady T. ..................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Butte, Atul ........................................... Disclosed no confl ict of interest.Butterworth, Martha .......................... Disclosed no confl ict of interest.Büttner, Petra ...................................... Disclosed no confl ict of interest.Buxton, Joanne ................................... Disclosed no confl ict of interest.Buysman, Erin K. ................................. Other Relationship: Janssen Pharmaceutical Companies of

Johnson & Johnson. Buzea, Mihaela ................................... Disclosed no confl ict of interest.Buzzetti, Raffaella .............................. Disclosed no confl ict of interest.Bychkova, Ielizaveta ........................... Disclosed no confl ict of interest.Byerly, Sara J. ..................................... Disclosed no confl ict of interest.Byers, Joyce ........................................ Disclosed no confl ict of interest.Bynoe, Karen A. .................................. Disclosed no confl ict of interest.Bytoft, Birgitte .................................... Disclosed no confl ict of interest.Byun, Dongwon ................................... Disclosed no confl ict of interest.Caan, Matthan W. ............................... Disclosed no confl ict of interest.Caballero, A. Enrique .......................... Disclosed no confl ict of interest.Caballero-Ruiz, Estefanía ................... Disclosed no confl ict of interest.Cabrera, Over ...................................... Employee: Eli Lilly and Company. Cabrera, Susanne M. .......................... Disclosed no confl ict of interest.Cabzuca, Carolina ............................... Disclosed no confl ict of interest.Caccioppoli, Cristina ........................... Disclosed no confl ict of interest.Cade, Brian .......................................... Disclosed no confl ict of interest.Caetano, Lilian A. ................................ Disclosed no confl ict of interest.Cahn, Avivit ......................................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals,

Inc., Novo Nordisk Inc., Sanofi U.S.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Merck Sharp & Dohme, Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Sanofi U.S., Teva Pharmaceutical Industries Ltd.

Cahn, Frederick ................................... Consultant: Freedom Meditech, Inc. Cai, Beilei ............................................. Employee: Boehringer Ingelheim Pharmaceuticals, Inc. Cai, Erica P. .......................................... Disclosed no confl ict of interest.Cai, Jinjin ............................................. Disclosed no confl ict of interest.Cai, Lu .................................................. Disclosed no confl ict of interest.Cai, Mona ............................................ Disclosed no confl ict of interest.Cai, Qin ................................................. Employee: Novartis Pharmaceuticals Corporation.

A820

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Cai, Weikang ....................................... Disclosed no confl ict of interest.Cai, Xiaoling ........................................ Disclosed no confl ict of interest.Cain, Valerie ........................................ Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP. Cakirca, Mustafa ................................ Disclosed no confl ict of interest.Calabrese Donihi, Amy ....................... Disclosed no confl ict of interest.Calabuig-Navarro, Virtu ..................... Disclosed no confl ict of interest.Calafi ore, Riccardo .............................. Disclosed no confl ict of interest.Calcaterra, Francesco ......................... Disclosed no confl ict of interest.Calderon, Rosanna .............................. Disclosed no confl ict of interest.Caldwell, Gary W. ............................... Disclosed no confl ict of interest.Caldwell, Tom A. ................................. Disclosed no confl ict of interest.Cali, Anna M. ....................................... Employee: Sanofi . Callahan, Holly .................................... Disclosed no confl ict of interest.Calles, Jorge ....................................... Disclosed no confl ict of interest.Calvert, Nathan ................................... Employee: Eli Lilly and Company. Camacho, Jenny .................................. Disclosed no confl ict of interest.Camara, Soumaïla ............................... Disclosed no confl ict of interest.Cameron, Amy R. ................................ Disclosed no confl ict of interest.Cameron, Fergus J. ............................. Speaker’s Bureau: Takeda Pharmaceutical Company Limited. Cameron, Hilary .................................. Employee: LifeScan, Inc. Cammarata, Matteo ........................... Disclosed no confl ict of interest.Campanale, Kristina M. ...................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Campbell, Latoya E. ............................ Disclosed no confl ict of interest.Campbell, Laura .................................. Disclosed no confl ict of interest.Campbell, Paul ..................................... Disclosed no confl ict of interest.Campbell-Thompson, Martha ............ Disclosed no confl ict of interest.Campion, Nicole .................................. Consultant: AstraZeneca Pharmaceuticals LP. Camporez, João-Paulo G. ................... Disclosed no confl ict of interest.Campos-Hernández, Ángel ................ Disclosed no confl ict of interest.Can Tamer, Søren ................................ Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Canani, Luis H. ..................................... Research Support: AstraZeneca/Bristol-Myers Squibb,

Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company.

Canas, Jose A. .................................... Disclosed no confl ict of interest.Cancer Minchot, Emilia ...................... Disclosed no confl ict of interest.Candeloro, Paola ................................. Disclosed no confl ict of interest.Canel, Clemence ................................. Disclosed no confl ict of interest.Cañete, Elena ...................................... Disclosed no confl ict of interest.Cangelosi, Andrew .............................. Disclosed no confl ict of interest.Cankaya, Ali B. .................................... Disclosed no confl ict of interest.Canney, Lori ......................................... Employee: Biodel Inc.; Stock/Shareholder: Biodel Inc. Cannon, Christopher P. ....................... Advisory Panel: Takeda Pharmaceuticals U.S.A., Inc.;

Consultant: Bristol-Myers Squibb Company, CSL Behring, Essentialis, GlaxoSmithKline, Lipimedix, Merck & Co., Inc., Pfi zer Inc., Regeneron Pharmaceuticals, Inc., Sanofi U.S., Takeda Pharmaceuticals U.S.A., Inc.; Research Support: Accumetrics, Arisaph, AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck & Co., Inc., Takeda Pharmaceuticals U.S.A., Inc.

Cano Palomares, Albert ...................... Disclosed no confl ict of interest.Cánovas Molina, Gloria ...................... Disclosed no confl ict of interest.Canovatchel, William ......................... Employee: Janssen Research & Development, LLC. Cantonwine, David ............................. Disclosed no confl ict of interest.Canty, Angelo J. .................................. Disclosed no confl ict of interest.Cao, Dachuang .................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Cao, Haiming ....................................... Disclosed no confl ict of interest.Cao, Julia X. ......................................... Employee: Eli Lilly and Company. Cao, Ping .............................................. Other Relationship: Co-inventor on a patent application for

inhibitors of IAPP toxicity. Cao, Qiang ........................................... Disclosed no confl ict of interest.Cao, Xiaopei ........................................ Disclosed no confl ict of interest.Cao, Xu ................................................. Disclosed no confl ict of interest.Cao, Yanan ........................................... Disclosed no confl ict of interest.Capehorn, Matthew ........................... Advisory Panel: Boehringer Ingelheim/Lilly, Merck Sharp &

Dohme, Novo Nordisk; Research Support: Cambridge Weight Plan, Lighter Life, Novo Nordisk; Speaker’s Bureau: Boehringer Ingelheim/Lilly, Merck Sharp & Dohme; Stock/Shareholder: RIO Weight Management Ltd, RIO Weight Management Ltd (Spouse/Partner).

Cappell, Katherine .............................. Employee: Truven Health Analytics. Caprio, Sonia ....................................... Disclosed no confl ict of interest.Capuani, Barbara ................................ Disclosed no confl ict of interest.Capuano, George ................................ Employee: Janssen Research & Development, LLC. Capuano, Palma .................................. Disclosed no confl ict of interest.Caputo, Maria Paola ........................... Disclosed no confl ict of interest.Caramori, M. Luiza .............................. Disclosed no confl ict of interest.

Caratelli, Sara ..................................... Disclosed no confl ict of interest.Carbery, Baevin S. ............................... Disclosed no confl ict of interest.Carbillon, Lionel .................................. Disclosed no confl ict of interest.Carbone, Kyle ...................................... Disclosed no confl ict of interest.Carbonne, Christine ............................ Disclosed no confl ict of interest.Card, Casey ......................................... Disclosed no confl ict of interest.Cardona, Saumeth .............................. Disclosed no confl ict of interest.Carefoot, Esther .................................. Disclosed no confl ict of interest.Carella, Massimo ................................ Disclosed no confl ict of interest.Carey, Andrew L. ................................. Disclosed no confl ict of interest.Carey, Michelle ................................... Disclosed no confl ict of interest.Caribe, Ana .......................................... Disclosed no confl ict of interest.Cariou, Bertrand .................................. Board Member: Amgen Inc., AstraZeneca/Bristol-Myers

Squibb, Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Novo Nordisk A/S, Regeneron Pharmaceuticals, Inc., Sanofi Pasteur SA, Takeda Pharmaceutical Company Limited; Consultant: Genfi t.

Carita, Paulo ........................................ Employee: Sanofi . Caritis, Steve ....................................... Disclosed no confl ict of interest.Carle, Flavia ......................................... Disclosed no confl ict of interest.Carls, Ginger S. ................................... Disclosed no confl ict of interest.Carlsson, Björn .................................... Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP. Carlsson, Nils ...................................... Disclosed no confl ict of interest.Carmody, Louise .................................. Disclosed no confl ict of interest.Carneiro, Everardo .............................. Disclosed no confl ict of interest.Carneiro, Mara S. ................................ Disclosed no confl ict of interest.Carnero, Andres M. ............................ Disclosed no confl ict of interest.Carnethon, Mercedes R. .................... Disclosed no confl ict of interest.Carnevale Schianca, Gian Piero ......... Disclosed no confl ict of interest.Carone, Anna ....................................... Disclosed no confl ict of interest.Carpenedo, Dorota .............................. Disclosed no confl ict of interest.Carpinito, Gianpaolo ........................... Disclosed no confl ict of interest.Carpio, Gandahari ............................... Disclosed no confl ict of interest.Carr, J. Jeffrey .................................... Disclosed no confl ict of interest.Carr, John J. ........................................ Disclosed no confl ict of interest.Carr, Molly C. ....................................... Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline. Carrasco-Sánchez, Francisco Javier . Disclosed no confl ict of interest.Carrat, Gaelle R. .................................. Disclosed no confl ict of interest.Carreira, Marcos C. ............................. Disclosed no confl ict of interest.Carria, Lori ........................................... Disclosed no confl ict of interest.Carroll, Aaron ...................................... Disclosed no confl ict of interest.Carroll, Chad C. ................................... Disclosed no confl ict of interest.Carson, Richard ................................... Disclosed no confl ict of interest.Carstensen, Bendix ............................. Stock/Shareholder: Novo Nordisk A/S. Carstensen, Lisbeth ............................ Disclosed no confl ict of interest.Carstensen, Maren ............................. Disclosed no confl ict of interest.Carstensen-Kirberg, Maren ............... Disclosed no confl ict of interest.Cartee, Amanda K. .............................. Disclosed no confl ict of interest.Carter, Rickey E. .................................. Disclosed no confl ict of interest.Caruso, Michael .................................. Disclosed no confl ict of interest.Carvajal-Gonzalez, Santos ................. Employee: Pfi zer Inc. Carvalho, Davide C. ............................ Disclosed no confl ict of interest.Carvalho, Eugenia ............................... Disclosed no confl ict of interest.Carver, Catherine ................................ Disclosed no confl ict of interest.Casal, Eileen ........................................ Employee: Dexcom, Inc. Casañ, Rosa ......................................... Disclosed no confl ict of interest.Casanova, Ramon ............................... Disclosed no confl ict of interest.Casanueva, Filipe ................................ Disclosed no confl ict of interest.Casas, Mariana ................................... Disclosed no confl ict of interest.Caslake, Muriel J. ............................... Disclosed no confl ict of interest.Castaneda, Javier ............................... Employee: Medtronic, Inc. Castañeda, Tamara R. ........................ Disclosed no confl ict of interest.Castellino, Giuseppa ........................... Disclosed no confl ict of interest.Castillo, Melany .................................. Disclosed no confl ict of interest.Castillo, Oscar A. ................................ Disclosed no confl ict of interest.Castillo, Walter ................................... Disclosed no confl ict of interest.Castorino, Kristin ................................ Disclosed no confl ict of interest.Castrejón Pérez, Roberto Carlos ........ Disclosed no confl ict of interest.Castro, Gisele ...................................... Disclosed no confl ict of interest.Castro, Simone H. ............................... Disclosed no confl ict of interest.Castro-Giménez, Joaquín ................... Disclosed no confl ict of interest.Catala-Bauset, Miguel ....................... Disclosed no confl ict of interest.Catalano, Patrick M. ........................... Disclosed no confl ict of interest.Cataldo, Rodrigo ................................. Disclosed no confl ict of interest.Catanozi, Sergio .................................. Disclosed no confl ict of interest.Caton, Paul W. ..................................... Disclosed no confl ict of interest.Catov, Janet ........................................ Disclosed no confl ict of interest.Catrinoiu, Doina .................................. Disclosed no confl ict of interest.Caudle, Jane M. .................................. Disclosed no confl ict of interest.

A821

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Caumo, Andrea .................................... Disclosed no confl ict of interest.Cavallerano, Jerry D. .......................... Disclosed no confl ict of interest.Cavelti-Weder, Claudia ....................... Disclosed no confl ict of interest.Cavener, Douglas R. ............................ Disclosed no confl ict of interest.Cavino, Katie ....................................... Employee: Regeneron Pharmaceuticals, Inc. Cavitt, Rachel ...................................... Employee: Eli Lilly and Company. Cazaledes, Delphine ........................... Disclosed no confl ict of interest.Cazeau, Rachel .................................... Disclosed no confl ict of interest.Cechin, Sirlene R. ................................ Disclosed no confl ict of interest.Cédrin, Isabelle ................................... Disclosed no confl ict of interest.Ceesay, Fatoumatta ............................ Disclosed no confl ict of interest.Cefalo, Chiara M. ................................ Disclosed no confl ict of interest.Cefalu, William T. ................................ Advisory Panel: Intarcia Therapeutics, Inc., Sanofi U.S.;

Consultant: Intarcia Therapeutics, Inc., Sanofi U.S.; Research Support: AstraZeneca Pharmaceuticals LP, GlaxoSmithKline, Johnson & Johnson, Lexicon Pharmaceuticals, Inc., Sanofi U.S.

Celeng, Csilla ....................................... Disclosed no confl ict of interest.Celik, Huseyin ...................................... Disclosed no confl ict of interest.Celinski, Aleksander ........................... Disclosed no confl ict of interest.Cengiz, Eda .......................................... Disclosed no confl ict of interest.Ceperuelo-Mallafre, Victoria ............. Disclosed no confl ict of interest.Ceppo, Franck ...................................... Disclosed no confl ict of interest.Ceriani, Valerio .................................... Disclosed no confl ict of interest.Ceriello, Antonio ................................. Advisory Panel: AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim GmbH, Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck Sharp & Dohme, Novartis AG, Novo Nordisk A/S, Roche Diagnostics, Sanofi Pasteur SA, Takeda Pharmaceutical Company Limited; Research Support: Mitsubishi Tanabe Pharma Corporation, Novartis AG, Novo Nordisk A/S; Speaker’s Bureau: Bayer HealthCare, Eli Lilly and Company, Mitsubishi Tanabe Pharma Corporation, Novartis Pharma GmbH, Novo Nordisk A/S.

Cerrillos González, Lucas ................... Disclosed no confl ict of interest.Cersosimo, Eugenio ............................ Speaker’s Bureau: Janssen Pharmaceutical Companies of

Johnson & Johnson, Takeda Pharmaceuticals U.S.A., Inc.

Cervantes, Christopher ...................... Disclosed no confl ict of interest.Cervesato, Eugenio ............................. Disclosed no confl ict of interest.Cescon, Marzia ................................... Disclosed no confl ict of interest.Cescutti, Jessica ................................ Employee: Boehringer Ingelheim GmbH. Cetta, Francesco ................................. Disclosed no confl ict of interest.Cha, Bongsoo ...................................... Disclosed no confl ict of interest.Cha, Bong-Yun ..................................... Disclosed no confl ict of interest.Cha, Seon-Ah ...................................... Disclosed no confl ict of interest.Chabosseau, Pauline L. ....................... Disclosed no confl ict of interest.Chadwick, Thomas .............................. Disclosed no confl ict of interest.Chagnac, Avry ..................................... Disclosed no confl ict of interest.Chai, Shangyu ..................................... Disclosed no confl ict of interest.Chai, Shuiqin ........................................ Disclosed no confl ict of interest.Chai, Weidong ..................................... Disclosed no confl ict of interest.Chakkalakal, Joe ................................. Disclosed no confl ict of interest.Chakrabarti, Subrata .......................... Disclosed no confl ict of interest.Chakravarthy, Manu V. ....................... Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &

Co., Inc. Chalasani, Naga .................................. Disclosed no confl ict of interest.Chalew, Stuart .................................... Disclosed no confl ict of interest.Chalkiadaki, Corina ............................. Disclosed no confl ict of interest.Chamarthi, Bindu ................................ Consultant: VeroScience, LLC. Chan, Christine L. ................................ Disclosed no confl ict of interest.Chan, Clement ..................................... Disclosed no confl ict of interest.Chan, Cyrus Y. ..................................... Disclosed no confl ict of interest.Chan, Donald ....................................... Disclosed no confl ict of interest.Chan, Hung Ching ................................ Employee: United Health Group-Optum. Chan, Juliana C. .................................. Advisory Panel: Asia Diabetes Foundation; Board Member:

Merck Sharp & Dohme. Chan, Leo Ka Yu ................................... Disclosed no confl ict of interest.Chan, Owen ......................................... Disclosed no confl ict of interest.Chandalia, Manisha ............................ Disclosed no confl ict of interest.Chandler, LuWanda C. ........................ Employee: Becton, Dickinson and Company. Chandler-Laney, Paula C. .................... Disclosed no confl ict of interest.Chandni, Radhakrishnan ..................... Disclosed no confl ict of interest.Chandran, Arthi ................................... Employee: BD Medical-Diabetes Care. Chandrasekar, Eeshwar K. ................. Disclosed no confl ict of interest.Chandrasekaran, Krish ....................... Disclosed no confl ict of interest.Chandrasekharappa, Settara ............. Disclosed no confl ict of interest.Chandurkar, Vikram ............................. Disclosed no confl ict of interest.Chang, Annette M. ............................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Chang, Chia-Hsuin .............................. Disclosed no confl ict of interest.

Chang, Douglas C. ............................... Disclosed no confl ict of interest.Chang, Kiyuk ........................................ Disclosed no confl ict of interest.Chang, Man-Huei ................................ Disclosed no confl ict of interest.Chang, Su-Hsin .................................... Disclosed no confl ict of interest.Chang, Sung-A .................................... Disclosed no confl ict of interest.Chang, Tien-Jyun ................................ Disclosed no confl ict of interest.Chang, Wan-Jung ............................... Disclosed no confl ict of interest.Chang, Xinxia ...................................... Disclosed no confl ict of interest.Chang, Yi-Cheng ................................. Disclosed no confl ict of interest.Chang, Yuchiao .................................... Disclosed no confl ict of interest.Chao, Ariana ........................................ Disclosed no confl ict of interest.Chao, Pin-Tsun ..................................... Employee: iXensor Inc.; Research Support: iXensor Inc. Chao, Tony ........................................... Disclosed no confl ict of interest.Chapla, Aaron ...................................... Disclosed no confl ict of interest.Chapman, Alyson ................................ Disclosed no confl ict of interest.Chapman, Marianne J. ....................... Disclosed no confl ict of interest.Chapman, Richard ............................... Consultant: Avalere Health LLC. Chapnick, Jonathan ............................ Consultant: Employee at Kantar Health working with

Takeda. Chappell, Jill C. ................................... Employee: Eli Lilly and Company, Eli Lilly and Company

(Spouse/Partner); Stock/Shareholder: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner).

Charan, Manisha ................................. Disclosed no confl ict of interest.Charbonnel, Bernard ........................... Advisory Panel: AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck Sharp & Dohme, Novartis, Novo Nordisk Inc., Sanofi , Takeda Pharmaceutical Company Limited; Board Member: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck Sharp & Dohme, Novartis, Novo Nordisk Inc., Sanofi , Takeda Pharmaceutical Company Limited; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck Sharp & Dohme, Novartis, Novo Nordisk Inc., Sanofi , Takeda Pharmaceutical Company Limited.

Charnock, Colin ................................... Disclosed no confl ict of interest.Charpentier, Guillaume ....................... Board Member: Novo Nordisk A/S. Charrier-Savournin, Fabienne ............ Disclosed no confl ict of interest.Charron-Prochownik, Denise C. ......... Research Support: Eli Lilly and Company. Chartier-Logan, Catherine .................. Disclosed no confl ict of interest.Charwat-Resl, Silvia ........................... Disclosed no confl ict of interest.Chase, H. Peter .................................... Disclosed no confl ict of interest.Chase, Jocelyn .................................... Disclosed no confl ict of interest.Chase, Peter ........................................ Disclosed no confl ict of interest.Chatterjee, Biprabuddha .................... Disclosed no confl ict of interest.Chatterjee, Ranee ............................... Disclosed no confl ict of interest.Chatterjee, Samir ................................ Disclosed no confl ict of interest.Chatterjee, Sanjay .............................. Disclosed no confl ict of interest.Chatterjee, Somik ............................... Disclosed no confl ict of interest.Chatterjee, Subroto ............................ Disclosed no confl ict of interest.Chaturvedi, Mridul .............................. Disclosed no confl ict of interest.Chau, Donald ....................................... Disclosed no confl ict of interest.Chaudhari, Umesh ............................... Employee: Sanofi U.S. Chaudhuri, Ajay ................................... Disclosed no confl ict of interest.Chaussabel, Damien ........................... Disclosed no confl ict of interest.Chava, Pavan ....................................... Speaker’s Bureau: Sanofi U.S. Chavarro, Jorge E. ............................... Disclosed no confl ict of interest.Chaves, Fernanda M. .......................... Disclosed no confl ict of interest.Chavez, Alberto O. .............................. Disclosed no confl ict of interest.Chawla, Aastha ................................... Disclosed no confl ict of interest.Chawla, Aastik .................................... Disclosed no confl ict of interest.Chawla, Manoj S. ................................ Advisory Panel: AstraZeneca/Bristol-Myers Squibb,

Novo Nordisk Inc.; Employee: Piramal Life Sciences (Spouse/Partner); Research Support: Abbott Diabetes Care, Inc.; Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals, Inc., Merck Sharp & Dohme, Novartis Pharmaceuticals Corporation, Sanofi Pasteur SA.

Chawla, Rajeev ................................... Disclosed no confl ict of interest.Chaykin, Louis B. ................................. Speaker’s Bureau: Novo Nordisk. Chaykovska, Lyubov ............................ Disclosed no confl ict of interest.Chaytor, Naomi S. ............................... Disclosed no confl ict of interest.Checchin, Daniella .............................. Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline. Cheeley, Mary Katherine .................... Disclosed no confl ict of interest.Cheesman, Khadeen C. ....................... Disclosed no confl ict of interest.Cheetham, Sharon C. .......................... Disclosed no confl ict of interest.

A822

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Cheetham, T. Craig .............................. Disclosed no confl ict of interest.Chelan, Claudia-Valeria ...................... Disclosed no confl ict of interest.Chen, Changya .................................... Disclosed no confl ict of interest.Chen, Chang-Yi .................................... Disclosed no confl ict of interest.Chen, Chao H. ...................................... Disclosed no confl ict of interest.Chen, Chen-Yi ...................................... Disclosed no confl ict of interest.Chen, Chieh Hsiao ............................... Research Support: iXensor Inc.; Stock/Shareholder: iXensor

Inc. Chen, Chien-Yu .................................... Disclosed no confl ict of interest.Chen, Ching J. ..................................... Disclosed no confl ict of interest.Chen, Guanjie ...................................... Disclosed no confl ict of interest.Chen, Hong .......................................... Disclosed no confl ict of interest.Chen, Hongmei .................................... Disclosed no confl ict of interest.Chen, Hongzhi ..................................... Disclosed no confl ict of interest.Chen, Hungta ....................................... Employee: AstraZeneca Pharmaceuticals LP,

GlaxoSmithKline (Spouse/Partner); Stock/Shareholder: Novartis Corporation.

Chen, Jiande ........................................ Disclosed no confl ict of interest.Chen, Jiaqi ........................................... Disclosed no confl ict of interest.Chen, Jie .............................................. Disclosed no confl ict of interest.Chen, Jing ............................................ Disclosed no confl ict of interest.Chen, Junqin ........................................ Disclosed no confl ict of interest.Chen, Jyu-Lin ....................................... Disclosed no confl ict of interest.Chen, Kai .............................................. Disclosed no confl ict of interest.Chen, Keyang ....................................... Disclosed no confl ict of interest.Chen, Kim ............................................. Consultant: Elcelyx Therapeutics, Inc.; Stock/Shareholder:

Elcelyx Therapeutics, Inc. Chen, Kong Y. ...................................... Disclosed no confl ict of interest.Chen, Lei .............................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Chen, Li ................................................ Disclosed no confl ict of interest.Chen, Liangkai ..................................... Disclosed no confl ict of interest.Chen, Liming ........................................ Disclosed no confl ict of interest.Chen, Miao .......................................... Disclosed no confl ict of interest.Chen, Mingling .................................... Disclosed no confl ict of interest.Chen, Mu ............................................. Disclosed no confl ict of interest.Chen, Pan ............................................. Disclosed no confl ict of interest.Chen, Peng ........................................... Disclosed no confl ict of interest.Chen, Rony ........................................... Disclosed no confl ict of interest.Chen, Shali ........................................... Disclosed no confl ict of interest.Chen, Shu-Ting .................................... Disclosed no confl ict of interest.Chen, Sijing .......................................... Disclosed no confl ict of interest.Chen, Stephanie .................................. Disclosed no confl ict of interest.Chen, Tao ............................................. Disclosed no confl ict of interest.Chen, Wei ............................................ Disclosed no confl ict of interest.Chen, Wei-Min .................................... Disclosed no confl ict of interest.Chen, Weiqin ....................................... Disclosed no confl ict of interest.Chen, Xi ................................................ Disclosed no confl ict of interest.Chen, Xiaoli ......................................... Disclosed no confl ict of interest.Chen, Xiaoyan ..................................... Disclosed no confl ict of interest.Chen, Xinhua ....................................... Disclosed no confl ict of interest.Chen, Xuanrong ................................... Disclosed no confl ict of interest.Chen, Xueying ..................................... Disclosed no confl ict of interest.Chen, Xuqing ....................................... Disclosed no confl ict of interest.Chen, Yan ............................................. Disclosed no confl ict of interest.Chen, Yanming ..................................... Disclosed no confl ict of interest.Chen, Yanyun ....................................... Employee: Eli Lilly and Company. Chen, Y-D Ida ....................................... Disclosed no confl ict of interest.Chen, Yi-Guang ................................... Disclosed no confl ict of interest.Chen, Yih Yang .................................... Disclosed no confl ict of interest.Chen, Yii-Der I. .................................... Disclosed no confl ict of interest.Chen, Ying ........................................... Disclosed no confl ict of interest.Chen, Yingxian .................................... Disclosed no confl ict of interest.Chen, Yong ........................................... Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &

Co., Inc. Chen, Yue ............................................. Disclosed no confl ict of interest.Chen, Yumay ........................................ Disclosed no confl ict of interest.Chen, Yuqi ............................................ Disclosed no confl ict of interest.Chen, ZaoPing ..................................... Disclosed no confl ict of interest.Chen, Zhengming ................................ Disclosed no confl ict of interest.Chen, Zhouji ......................................... Disclosed no confl ict of interest.Chen, Zonglan ...................................... Disclosed no confl ict of interest.Cheng, Anton K.S. ............................... Disclosed no confl ict of interest.Cheng, Chengyi ................................... Disclosed no confl ict of interest.Cheng, Daojun ..................................... Disclosed no confl ict of interest.Cheng, Han-Ling .................................. Disclosed no confl ict of interest.Cheng, K.K. .......................................... Disclosed no confl ict of interest.Cheng, Peiyao ...................................... Disclosed no confl ict of interest.Cheng, Rui ........................................... Disclosed no confl ict of interest.Cheng, Sam Tsz Wai ........................... Research Support: Boehringer Ingelheim Pharmaceuticals,

Inc. (Spouse/Partner). Cheng, Shi-Yann .................................. Research Support: iXensor Inc.

Cheng, Xi .............................................. Employee: Sanofi . Cheng, Yan ........................................... Disclosed no confl ict of interest.Cheng, Yanli ......................................... Disclosed no confl ict of interest.Cheng, Yiling J. ................................... Disclosed no confl ict of interest.Cheng, Yinan ....................................... Disclosed no confl ict of interest.Cheng, Zhiyong .................................... Disclosed no confl ict of interest.Cherian, Preethi .................................. Disclosed no confl ict of interest.Cherian, Sam ....................................... Disclosed no confl ict of interest.Cherñavvsky, Daniel R. ....................... Disclosed no confl ict of interest.Cherney, David .................................... Research Support: Astellas Pharma US, Inc., Boehringer

Ingelheim GmbH; Speaker’s Bureau: Boehringer Ingelheim GmbH, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck & Co., Inc.

Chernicova, Natalia ............................ Disclosed no confl ict of interest.Chernikov, Valeriy P. ............................ Disclosed no confl ict of interest.Cherrington, Alan D. ........................... Advisory Panel: Biocon, Fractyl, Hanmi, Merck & Co., Inc.,

Metavention, NuSirt, Sensulin, LLC, Thetis, Zafgen; Consultant: Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Gilead, Moderna, NGM, Novo Nordisk A/S, Pennington Biomedical Research Center, Profi l Institute for Clinical Research, Inc., Thermalin, TransTech Pharma, LLC., ViaCyte, Viking; Research Support: Eli Lilly and Company, Novo Nordisk A/S, Thermalin - SBIR.

Chertok, Ilana ...................................... Disclosed no confl ict of interest.Cherubini, Valentino ........................... Disclosed no confl ict of interest.Chesi, Alessandra ............................... Disclosed no confl ict of interest.Chessler, Steven D. ............................. Disclosed no confl ict of interest.Cheta, Dan ........................................... Disclosed no confl ict of interest.Cheung, Vanessa ................................ Disclosed no confl ict of interest.Chevalier, Stephanie ........................... Disclosed no confl ict of interest.Chew, Daniel E. ................................... Disclosed no confl ict of interest.Chew, Paul ........................................... Employee: Sanofi . Chew, Phyllis ....................................... Disclosed no confl ict of interest.Chhabra, Kavaljit H. ............................ Disclosed no confl ict of interest.Chhabra, Preeti ................................... Disclosed no confl ict of interest.Chhatwal, Jagpreet ............................ Consultant: Novosys Health. Chi, Han-Lin ......................................... Disclosed no confl ict of interest.Chi, Liguo ............................................. Employee: Gilead; Stock/Shareholder: Gilead. Chia, Dennis ........................................ Disclosed no confl ict of interest.Chiang, Chien-Hsieh ........................... Disclosed no confl ict of interest.Chiang, Simon ..................................... Disclosed no confl ict of interest.Chiappetta, Sonja ............................... Disclosed no confl ict of interest.Chiasson, Jean-Louise ....................... Disclosed no confl ict of interest.Chien, Hung-Yu .................................... Disclosed no confl ict of interest.Chien, Jenny Y. .................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Chieu, My Quyen ................................. Disclosed no confl ict of interest.Chiguluri, Vinay ................................... Disclosed no confl ict of interest.Chiheb, Sabrina ................................... Disclosed no confl ict of interest.Chika, Horikawa .................................. Disclosed no confl ict of interest.Chilelli, Nino Cristiano ........................ Disclosed no confl ict of interest.Chillarge, Gauri ................................... Disclosed no confl ict of interest.Chilloux, Julien .................................... Disclosed no confl ict of interest.Chilton, Robert J. ................................ Consultant: Boehringer Ingelheim GmbH, Boston Scientifi c

Corporation, Bristol-Myers Squibb Company, Eli Lilly and Company, Medtronic, Inc., Merck Sharp & Dohme, Pfi zer Inc., Takeda Pharmaceutical Company Limited.

Chin, Bun .............................................. Disclosed no confl ict of interest.Chin, Jiyoung ....................................... Consultant: Sanofi . Ching, Jenny ........................................ Disclosed no confl ict of interest.Chini, Barbara ...................................... Disclosed no confl ict of interest.Chinnakotla, Srinath ........................... Disclosed no confl ict of interest.Chipashvili, Vaja .................................. Disclosed no confl ict of interest.Chiquette, Elaine ................................. Employee: GI Dynamics, Inc. Chirakalwasan, Naricha ..................... Disclosed no confl ict of interest.Chita, Teodora ..................................... Disclosed no confl ict of interest.Chiu, Abraham S. ................................ Disclosed no confl ict of interest.Chiu, Ken C. ......................................... Disclosed no confl ict of interest.Chiu, Yen-Hui ....................................... Disclosed no confl ict of interest.Chlebeck, Peter ................................... Disclosed no confl ict of interest.Chlup, Rudolf ....................................... Research Support: Medtronic International, Tolochenaz,

Swiss. Chmelova, Helena ............................... Disclosed no confl ict of interest.Chmielowiec, Jolanta ......................... Disclosed no confl ict of interest.Chng, Keefe ......................................... Disclosed no confl ict of interest.Cho, Eunpi ............................................ Disclosed no confl ict of interest.Cho, Jae-Hyoung ................................. Disclosed no confl ict of interest.Cho, Jae-Hyung ................................... Disclosed no confl ict of interest.Cho, Nam H. ......................................... Disclosed no confl ict of interest.Cho, Pyone ........................................... Disclosed no confl ict of interest.Cho, Soohun ........................................ Disclosed no confl ict of interest.

A823

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Cho, Yong-Wook .................................. Disclosed no confl ict of interest.Cho, Young Min ................................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Boeringer-

Ingelheim, Hanmi, LG Life Sciences. Chodick, Gabriel .................................. Research Support: AbbVie, Medial Cancer Research, Merck

Sharp & Dohme, Pfi zer Inc. Choe, Eun Yeong ................................. Disclosed no confl ict of interest.Choe, Yeon Hyeon ............................... Disclosed no confl ict of interest.Choi, Bo Mee ....................................... Disclosed no confl ict of interest.Choi, Dong Seop .................................. Disclosed no confl ict of interest.Choi, Haysook ...................................... Disclosed no confl ict of interest.Choi, In Young ...................................... Employee: Hanmi Pharmaceuticals Inc. Choi, Jessica ....................................... Disclosed no confl ict of interest.Choi, Jin-A ........................................... Disclosed no confl ict of interest.Choi, Jin-Ho ......................................... Disclosed no confl ict of interest.Choi, Kui Sung ..................................... Disclosed no confl ict of interest.Choi, Kyung Mook ............................... Disclosed no confl ict of interest.Choi, Ran Hee ...................................... Disclosed no confl ict of interest.Choi, Siak Leng .................................... Employee: Eli Lilly and Company. Choi, Soo Bong .................................... Stock/Shareholder: Sooil Development Corporation. Choi, Soo Youn .................................... Disclosed no confl ict of interest.Choi, Soomin ....................................... Employee: Hanmi Pharmaceutical Co., Ltd. Choi, Sung Hee .................................... Disclosed no confl ict of interest.Choi, Sung-E ........................................ Disclosed no confl ict of interest.Choi, Sunghee ..................................... Disclosed no confl ict of interest.Choi, Yoon Jeong ................................ Disclosed no confl ict of interest.Choi, Young Sik .................................... Disclosed no confl ict of interest.Chomko, Maureen E. ........................... Disclosed no confl ict of interest.Chon, Janet ......................................... Disclosed no confl ict of interest.Chon, Suk ............................................. Disclosed no confl ict of interest.Chon, W. James .................................. Disclosed no confl ict of interest.Chondronikola, Maria ......................... Disclosed no confl ict of interest.Chong, Chee P. ..................................... Disclosed no confl ict of interest.Chorepsima, Stamatina ...................... Disclosed no confl ict of interest.Chou, Chiu-Fang .................................. Disclosed no confl ict of interest.Chou, Engels ........................................ Employee: Sanofi . Chou, Jeff ............................................ Disclosed no confl ict of interest.Choudhary, Pratik ................................ Research Support: Medtronic MiniMed, Inc. Chouinard, Julie A. ............................. Research Support: Boehringer Ingelheim GmbH. Choung, Sorim ..................................... Disclosed no confl ict of interest.Chow, Billy K. ....................................... Disclosed no confl ict of interest.Chow, Bryna ........................................ Disclosed no confl ict of interest.Chow, Elaine ........................................ Disclosed no confl ict of interest.Chow, Lisa ........................................... Disclosed no confl ict of interest.Chow, Wing ......................................... Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson; Stock/Shareholder: Janssen Pharmaceutical Companies of Johnson & Johnson.

Chrétien, Michel ................................. Disclosed no confl ict of interest.Chrisogonidis, Ioannis ........................ Disclosed no confl ict of interest.Christe, Michael .................................. Employee: Eli Lilly and Company. Christensen, Britt ................................ Disclosed no confl ict of interest.Christensen, Kaare ............................. Disclosed no confl ict of interest.Christensen, Mette Marie H. ............. Disclosed no confl ict of interest.Christensen, Mikkel ............................ Disclosed no confl ict of interest.Christian, Anna J. ............................... Disclosed no confl ict of interest.Christiansen, Cindy L. ......................... Disclosed no confl ict of interest.Christiansen, Jens S. .......................... Disclosed no confl ict of interest.Christiansen, Mark ............................. Research Support: PhaseBio Pharmaceuticals, Inc. Christmann, Benjamin S. .................... Disclosed no confl ict of interest.Christoffersen, Berit O. ...................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Christopherson, Jenica ...................... Disclosed no confl ict of interest.Christophi, Costas ............................... Disclosed no confl ict of interest.Chu, Audrey Y. ..................................... Disclosed no confl ict of interest.Chu, Bong-Chul .................................... Employee: Truven Health Analytics. Chu, John M. ....................................... Disclosed no confl ict of interest.Chu, Kwan-Yi ....................................... Disclosed no confl ict of interest.Chu, Ruth ............................................. Disclosed no confl ict of interest.Chu, Zili David ..................................... Disclosed no confl ict of interest.Chua, Streamson ................................. Disclosed no confl ict of interest.Chuang, Hsiang Hsun .......................... Disclosed no confl ict of interest.Chuang, Lee-Ming ............................... Disclosed no confl ict of interest.Chudek, Jerzy ...................................... Disclosed no confl ict of interest.Chuengsamarn, Somlak ...................... Disclosed no confl ict of interest.Chujo, Daisuke ..................................... Disclosed no confl ict of interest.Chun, Hyung ........................................ Disclosed no confl ict of interest.Chun, Sung Wan .................................. Disclosed no confl ict of interest.Chung, Chen-Chih ............................... Disclosed no confl ict of interest.Chung, Choon Hee ............................... Disclosed no confl ict of interest.Chung, Hsing-Wen .............................. Consultant: Sanofi . Chung, Michelle .................................. Disclosed no confl ict of interest.Chung, Myung Hee ............................. Disclosed no confl ict of interest.Chung, Sookja K. ................................. Disclosed no confl ict of interest.

Chung, Stephanie T. ............................ Disclosed no confl ict of interest.Chung, Sung Chang ............................. Disclosed no confl ict of interest.Church, Timothy S. .............................. Disclosed no confl ict of interest.Churilov, Leonard ................................ Disclosed no confl ict of interest.Ciaraldi, Theodore P. ........................... Consultant: Shionogi Inc. Ciavarella, Alessandro ....................... Disclosed no confl ict of interest.Ciborowski, Michal ............................. Disclosed no confl ict of interest.Cibula, Donald ..................................... Research Support: National Institute of Diabetes and

Digestive and Kidney Diseases. Ciccosanti, Fabiola .............................. Disclosed no confl ict of interest.Cichosz, Simon L. ................................ Disclosed no confl ict of interest.Cicorelli, Antonello ............................. Disclosed no confl ict of interest.Ciecko, Ashley ..................................... Disclosed no confl ict of interest.Cignarelli, Angelo ................................ Disclosed no confl ict of interest.Cignarelli, Mauro ................................ Disclosed no confl ict of interest.Cigolle, Christine ................................. Consultant: Health Resources and Services Administration;

Research Support: National Institutes of Health. Cigrovski Berkovic, Maja .................... Disclosed no confl ict of interest.Cikim, Ayse S. ...................................... Disclosed no confl ict of interest.Cikrikcioglu, Mehmet A. ..................... Disclosed no confl ict of interest.Cilfone, Nicholas ................................. Research Support: National Institutes of Health. Cincotta, Anthony H. .......................... Employee: VeroScience, LLC; Stock/Shareholder:

VeroScience, LLC. Cinkajzlova, Anna ................................ Disclosed no confl ict of interest.Cinti, Francesca ................................... Disclosed no confl ict of interest.Cintra, Dennys E. ................................. Disclosed no confl ict of interest.Cintron, Miriam ................................... Disclosed no confl ict of interest.Ciociaro, Demetrio .............................. Disclosed no confl ict of interest.Cioletti, Anne ...................................... Disclosed no confl ict of interest.Cioni, Roberto ...................................... Disclosed no confl ict of interest.Cisneros-González, Nelly ................... Disclosed no confl ict of interest.Citko, Anna .......................................... Disclosed no confl ict of interest.Citro, Antonio ...................................... Disclosed no confl ict of interest.Ciubotaru, Vasile ................................. Disclosed no confl ict of interest.Civantos Modino, Soralla ................... Disclosed no confl ict of interest.Clancy, Kerri ........................................ Disclosed no confl ict of interest.Clapper, Wilmelenne .......................... Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Claridge, Laura E. ................................ Disclosed no confl ict of interest.Clark, Amy L. ....................................... Disclosed no confl ict of interest.Clark, Douglas ..................................... Employee: Boehringer Ingelheim Pharma GmbH & Co. KG. Clark, Pamela ...................................... Disclosed no confl ict of interest.Clarke, Michelle .................................. Disclosed no confl ict of interest.Clarke, Robin ....................................... Disclosed no confl ict of interest.Clarkson Fletcher, Myles .................... Disclosed no confl ict of interest.Clarson, Cheril ..................................... Board Member: Novo Nordisk Canada; Speaker’s Bureau: Eli

Lily Canada, Medtronic Canada. Claudius, Birgitte ................................ Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Clausen, Tine D. .................................. Disclosed no confl ict of interest.Clayton, Zoë E. .................................... Disclosed no confl ict of interest.Cleal, Bryan ......................................... Employee: Steno Diabetes Center A/S. Cleary, Patricia .................................... Disclosed no confl ict of interest.Clemens, Andreas ............................... Employee: Novartis Pharma AG. Clemens, Quentin ................................ Disclosed no confl ict of interest.Clement, Stephen ............................... Disclosed no confl ict of interest.Clemente, Eliete L. .............................. Disclosed no confl ict of interest.Clements, Mark A. .............................. Disclosed no confl ict of interest.Clermont, Allen C. ............................... Disclosed no confl ict of interest.Clifton, Peter M. .................................. Speaker’s Bureau: AstraZeneca/Bristol-Myers Squibb,

Takeda Pharmaceutical Company Limited. Cline, Gary W. ...................................... Disclosed no confl ict of interest.Clish, Clary ........................................... Disclosed no confl ict of interest.Clopp, Bailey ........................................ Disclosed no confl ict of interest.Close, Kelly L. ...................................... Disclosed no confl ict of interest.Cloutier, Alexandre ............................. Disclosed no confl ict of interest.Cloutier, Marie-Pier ............................ Disclosed no confl ict of interest.Clu-Fernández, Carlos ........................ Disclosed no confl ict of interest.Cnop, Miriam ....................................... Disclosed no confl ict of interest.Coates, Toby ........................................ Disclosed no confl ict of interest.Coates, Vivien ..................................... Disclosed no confl ict of interest.Cobb, Jeff E. ........................................ Employee: Metabolon, Inc.; Stock/Shareholder: Metabolon,

Inc. Cobden, David ..................................... Employee: AstraZeneca Pharmaceuticals LP. Cobelli, Claudio ................................... Advisory Panel: Merck & Co., Inc.; Consultant: Dexcom, Inc.;

Research Support: Dexcom, Inc., Roche Diagnostics, Sanofi U.S.

Coberg, Sheri R. .................................. Disclosed no confl ict of interest.Cochrane, Katherine ........................... Disclosed no confl ict of interest.Cocks, Matthew .................................. Disclosed no confl ict of interest.Cocks-Eschler, Deirdre ....................... Disclosed no confl ict of interest.Coculescu, Mihail ............................... Disclosed no confl ict of interest.

A824

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Coelho, Izabel C. .................................. Disclosed no confl ict of interest.Coen, Paul ............................................ Disclosed no confl ict of interest.Coester, Hans-Veit .............................. Disclosed no confl ict of interest.Coffey, Julie ........................................ Disclosed no confl ict of interest.Coffman, Cynthia J. ............................ Disclosed no confl ict of interest.Cogan, Lindsay W. .............................. Disclosed no confl ict of interest.Cogen, Fran R. ..................................... Consultant: Dexcom, Inc.; Other Relationship: Healthcentral.

com. Coghlan, Michael ................................ Employee: Eli Lilly and Company. Cohen, Allison ..................................... Disclosed no confl ict of interest.Cohen, David E. ................................... Disclosed no confl ict of interest.Cohen, Jessica L. ................................ Disclosed no confl ict of interest.Cohen, Joshua L. ................................. Speaker’s Bureau: AstraZeneca/Bristol-Myers Squibb. Cohen, Kerryn ...................................... Disclosed no confl ict of interest.Cohen, Lindsey L. ................................ Disclosed no confl ict of interest.Cohen, Neale ....................................... Consultant: Abbott, AstraZeneca/Bristol-Myers Squibb,

Boehringer Ingelheim Pharmaceuticals, Inc., Lilly, Medtronic, Inc., Merck, Sanofi ; Other Relationship: Lilly - support to travel to meetings, Novartis - support for travel to meetings, Novo Nordisk Inc., Support for travel; Research Support: Novartis, Sanofi .

Cohen, Ohad ........................................ Board Member: Medtronic; Consultant: Medtronic. Cohen, Ronald ..................................... Disclosed no confl ict of interest.Coín-Arangüez, Laura ......................... Disclosed no confl ict of interest.Colarelli, Michela Luisa ...................... Disclosed no confl ict of interest.Colberg, Sheri R. ................................. Disclosed no confl ict of interest.Colca, Jerry ......................................... Board Member: Metabolic Solutions Development Company,

LLC.; Employee: Metabolic Solutions Development Company, LLC.; Stock/Shareholder: Metabolic Solutions Development Company, LLC.

Colditz, Graham ................................... Disclosed no confl ict of interest.Cole, Jo-Anne ...................................... Disclosed no confl ict of interest.Cole, Serena ........................................ Employee: Metabolic Solutions Development Company, LLC. Cole, Stuart ......................................... Disclosed no confl ict of interest.Coleman, Craig I. ................................. Research Support: Boehringer Ingelheim Pharmaceuticals,

Inc. Coleman, Karia .................................... Disclosed no confl ict of interest.Coleman, Kevin ................................... Disclosed no confl ict of interest.Coleman, Ruth L. ................................. Disclosed no confl ict of interest.Coletta, Dawn K. ................................. Disclosed no confl ict of interest.Coletta, Richard L. .............................. Disclosed no confl ict of interest.Colhoun, Helen M. .............................. Advisory Panel: Regeneron Pharmaceuticals, Inc., Sanofi ;

Other Relationship: Merck, Novartis; Research Support: AstraZeneca, Boehringer-Ingelheim, Eli Lilly and Company, Pfi zer Inc., Roche, Sanofi ; Stock/Shareholder: Roche, Roche (Spouse/Partner).

Colin, Henri .......................................... Disclosed no confl ict of interest.Colin, Ides M. ...................................... Disclosed no confl ict of interest.Collard-Simard, Gabriel ...................... Disclosed no confl ict of interest.Collier, Suzanne ................................... Disclosed no confl ict of interest.Collingwood, Ellen .............................. Disclosed no confl ict of interest.Collins, Francis S. ................................ Disclosed no confl ict of interest.Collins, Justin ...................................... Disclosed no confl ict of interest.Collinson, Andie .................................. Disclosed no confl ict of interest.Colman, Mike ...................................... Disclosed no confl ict of interest.Colman, Peter G. ................................. Research Support: Medtronic, Inc. Colombo, Marco .................................. Disclosed no confl ict of interest.Colomo, Natalia .................................. Disclosed no confl ict of interest.Colón Vega, Gildred ............................ Advisory Panel: BMS Diabetes; Speaker’s Bureau: Eli Lilly

and Company. Colosimo, Lucy K. ................................ Disclosed no confl ict of interest.Coltell, Oscar ....................................... Disclosed no confl ict of interest.Colwell, Hilary ..................................... Disclosed no confl ict of interest.Combs, Terry ....................................... Disclosed no confl ict of interest.Comeau, Mary ..................................... Disclosed no confl ict of interest.Compagnie, Sandrine ......................... Research Support: Boehringer Ingelheim Pharmaceuticals,

Inc. Comuzzie, Anthony ............................. Disclosed no confl ict of interest.Conceição, Gildásio ............................ Disclosed no confl ict of interest.Condezo Aliaga, Diana I. .................... Disclosed no confl ict of interest.Conget, Ignacio ................................... Advisory Panel: Eli Lilly and Company; Consultant: Eli Lilly

and Company. Conneely, Danielle .............................. Disclosed no confl ict of interest.Connell, Anna ...................................... Disclosed no confl ict of interest.Connors, Christine .............................. Disclosed no confl ict of interest.Conrey, Elizabeth J. ............................ Disclosed no confl ict of interest.Considine, Robert V. ........................... Consultant: Eli Lilly and Company, Merck & Co., Inc.;

Research Support: Eli Lilly and Company, Merck & Co., Inc.

Consoli, Agostino ................................ Disclosed no confl ict of interest.Constable, Todd .................................. Disclosed no confl ict of interest.Constantin, Ciprian ............................. Disclosed no confl ict of interest.

Constantin, Georgiana ........................ Disclosed no confl ict of interest.Constantino, Maria I. .......................... Disclosed no confl ict of interest.Conte, Caterina ................................... Disclosed no confl ict of interest.Conti, David ......................................... Disclosed no confl ict of interest.Contreras, Ariel ................................... Disclosed no confl ict of interest.Conway, Baqiyyah .............................. Disclosed no confl ict of interest.Cook, Marie ......................................... Disclosed no confl ict of interest.Cook, William ...................................... Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP. Cooksey, Robert .................................. Disclosed no confl ict of interest.Cooney, Gregory J. .............................. Disclosed no confl ict of interest.Cooper, Ameila .................................... Disclosed no confl ict of interest.Cooper, Andrew .................................. Disclosed no confl ict of interest.Cooper, Blake A. .................................. Disclosed no confl ict of interest.Cooper, Jason ...................................... Disclosed no confl ict of interest.Cooper, Jennifer .................................. Disclosed no confl ict of interest.Cooper, Mark E. ................................... Advisory Panel: AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim GmbH, Eli Lilly and Company, Novo Nordisk A/S, Takeda Pharmaceutical Company Limited; Consultant: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH, Eli Lilly and Company, Novo Nordisk A/S, Servier, Takeda Pharmaceutical Company Limited.

Cooper, Michael .................................. Disclosed no confl ict of interest.Cooper, Paul S. .................................... Disclosed no confl ict of interest.Copetti, Massimiliano ........................ Disclosed no confl ict of interest.Coppelli, Alberto ................................. Disclosed no confl ict of interest.Coppola, Andrea ................................. Disclosed no confl ict of interest.Copps, Kyle .......................................... Disclosed no confl ict of interest.Corathers, Sarah D. ............................ Disclosed no confl ict of interest.Corbett, John A. .................................. Disclosed no confl ict of interest.Corcoy, Rosa ........................................ Disclosed no confl ict of interest.Cordeiro, Maria C. ............................... Disclosed no confl ict of interest.Cordell, Paul A. .................................... Disclosed no confl ict of interest.Cordier, Tristan .................................... Disclosed no confl ict of interest.Corella, Dolores .................................. Disclosed no confl ict of interest.Coresh, Josef ...................................... Disclosed no confl ict of interest.Corinth, Helle ...................................... Disclosed no confl ict of interest.Corkey, Barbara E. ............................... Disclosed no confl ict of interest.Cornejo, Manuel .................................. Disclosed no confl ict of interest.Cornejo-Pareja, Isabel M. .................. Disclosed no confl ict of interest.Corraliza, Lidia .................................... Disclosed no confl ict of interest.Correa, Adolfo ..................................... Disclosed no confl ict of interest.Correa, João Antonio ......................... Disclosed no confl ict of interest.Correa-Medina, Mayrin ...................... Disclosed no confl ict of interest.Correia, M.R.S. .................................... Disclosed no confl ict of interest.Corritore, Elisa .................................... Disclosed no confl ict of interest.Corvera, Silvia ..................................... Disclosed no confl ict of interest.Coschigano, Karen T. .......................... Disclosed no confl ict of interest.Coskun, Pinar ....................................... Disclosed no confl ict of interest.Coskun, Tamer ..................................... Employee: Eli Lilly and Company. Cosson, Emmanuel .............................. Disclosed no confl ict of interest.Costa, Madalena ................................. Disclosed no confl ict of interest.Costache, Adrian ................................. Disclosed no confl ict of interest.Costacou, Tina .................................... Disclosed no confl ict of interest.Costigan, Timothy M. ......................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Couch, Kim ........................................... Disclosed no confl ict of interest.Couch, Sarah C. ................................... Disclosed no confl ict of interest.Coucha, Maha ..................................... Disclosed no confl ict of interest.Coudriet, Gina M. ................................ Disclosed no confl ict of interest.Coughlan, Kimberly A. ........................ Disclosed no confl ict of interest.Coughlan, Melinda T. .......................... Disclosed no confl ict of interest.Coulter, Kristin .................................... Employee: Metabolic Solutions Development Company, LLC. Couper, David ...................................... Disclosed no confl ict of interest.Courreges, Jean-Pierre ...................... Board Member: Novo Nordisk A/S; Consultant: AstraZeneca

Pharmaceuticals LP, Eli Lilly and Company; Research Support: Eli Lilly and Company, Janssen, Merck Sharp & Dohme, Novo Nordisk A/S; Speaker’s Bureau: Eli Lilly and Company, Janssen, Merck Sharp & Dohme, Novo Nordisk A/S.

Courtade, Jaques A. ........................... Disclosed no confl ict of interest.Cousins, Caroline E. ............................ Disclosed no confl ict of interest.Cousins, Marion .................................. Disclosed no confl ict of interest.Cousminer, Diana L. ............................ Disclosed no confl ict of interest.Covington, Jeffrey D. ......................... Disclosed no confl ict of interest.Cowie, Catherine ................................ Disclosed no confl ict of interest.Cox, Daniel J. ...................................... Research Support: LifeScan, Inc. Cox, Nancy J. ...................................... Disclosed no confl ict of interest.Craik, Sam ........................................... Disclosed no confl ict of interest.Crain, A.L. ............................................ Disclosed no confl ict of interest.Cramb, Robert ..................................... Disclosed no confl ict of interest.

A825

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Crandall, Jill P. ..................................... Disclosed no confl ict of interest.Crandell, Jamie L. ............................... Disclosed no confl ict of interest.Craven, Meredith ................................ Disclosed no confl ict of interest.Craven, Pam ......................................... Disclosed no confl ict of interest.Cravens, James ................................... Disclosed no confl ict of interest.Crawford, Rochanda ........................... Disclosed no confl ict of interest.Cree-Green, Melanie .......................... Disclosed no confl ict of interest.Crews, John ......................................... Disclosed no confl ict of interest.Crews, Ryan T. ..................................... Disclosed no confl ict of interest.Crickmore, Kim .................................... Disclosed no confl ict of interest.Crisalli, Joseph .................................... Disclosed no confl ict of interest.Criscimanna, Angela ........................... Disclosed no confl ict of interest.Crispim, Daisy ...................................... Disclosed no confl ict of interest.Crites, Yvonne ..................................... Disclosed no confl ict of interest.Croall, Stephanie ................................ Disclosed no confl ict of interest.Croce, Kevin ........................................ Disclosed no confl ict of interest.Croci, Andrea ....................................... Disclosed no confl ict of interest.Croft, Janet B. ..................................... Disclosed no confl ict of interest.Croft, Marie ......................................... Employee: XCeleron Inc. Cromer, Gail ......................................... Disclosed no confl ict of interest.Cross, Andrew ..................................... Disclosed no confl ict of interest.Crowe, Susanne .................................. Employee: Boehringer Ingelheim GmbH. Crowley, Matthew J. .......................... Disclosed no confl ict of interest.Cruickshanks, Karen J. ....................... Disclosed no confl ict of interest.Crume, Tessa L. ................................... Disclosed no confl ict of interest.Crutchlow, Michael ............................. Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &

Co., Inc. Cruz, Miguel ........................................ Disclosed no confl ict of interest.Cruz-Cortés, Carlos ............................. Disclosed no confl ict of interest.Csisceri, Aaron .................................... Disclosed no confl ict of interest.Cubbins, Lisa ....................................... Disclosed no confl ict of interest.Cui, Ran ................................................ Disclosed no confl ict of interest.Cui, Xiangqin ....................................... Disclosed no confl ict of interest.Cui, Xianwei ........................................ Disclosed no confl ict of interest.Cui, Xin ................................................. Disclosed no confl ict of interest.Cui, Xuewei .......................................... Employee: Eli Lilly and Company. Cui, Yuan .............................................. Disclosed no confl ict of interest.Cukierman-Yaffe, Tali ......................... Disclosed no confl ict of interest.Cummings, Alice Kate ......................... Research Support: Eli Lilly and Company. Cummings, Doyle M. ........................... Advisory Panel: Sanofi U.S. Cummins, Martin J. ............................ Employee: employee, Xeris Pharmaceuticals, Inc. Cunningham, Francesca ..................... Disclosed no confl ict of interest.Cunningham, Solveig A. ..................... Research Support: National Institute of Diabetes and

Digestive and Kidney Diseases. Cunningham, Stephanie ..................... Disclosed no confl ict of interest.Cupples, Adrienne L. ........................... Disclosed no confl ict of interest.Curhan, Gary C. ................................... Disclosed no confl ict of interest.Curran, Joanne E. ................................ Disclosed no confl ict of interest.Cursaru, Andrian ................................. Disclosed no confl ict of interest.Curtis, Bradley H. ................................ Employee: Eli Lilly and Company, Eli Lilly and Company

(Spouse/Partner); Stock/Shareholder: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner).

Curtis, Jeffrey M. ............................... Disclosed no confl ict of interest.Curtis, Sarah ........................................ Employee: Eli Lilly and Company. Cushman, William C. ........................... Consultant: Takeda Pharmaceuticals (uncompensated);

Research Support: Eli Lilly and Company, Merck & Co., Inc., National Heart, Lung and Blood Institute.

Cusi, Kenneth ...................................... Disclosed no confl ict of interest.Cussac-Pillegand, Camille .................. Disclosed no confl ict of interest.Cutler, David L. .................................... Employee: Merck & Co., Inc.; Other Relationship: Amgen Inc.

(Spouse/Partner), Celgene Corporation (Spouse/Partner), Kynex Pharmaceuticals (Spouse/Partner); Stock/Shareholder: Merck & Co., Inc.

Cwenar, Betsy ..................................... Disclosed no confl ict of interest.Cypess, Aaron M. ................................ Disclosed no confl ict of interest.Cyphert, Travis .................................... Disclosed no confl ict of interest.Cyr, Yannick ......................................... Disclosed no confl ict of interest.Czech, Michael P. ................................ Disclosed no confl ict of interest.Czernichow, Paul ................................. Employee: EndoCells. Czich, Andreas ..................................... Disclosed no confl ict of interest.Czupryniak, Leszek .............................. Disclosed no confl ict of interest.Czyzyk, Jan .......................................... Disclosed no confl ict of interest.D’Agati, Vivette D. .............................. Disclosed no confl ict of interest.D’Amore, Patricia A. ........................... Disclosed no confl ict of interest.D’Aoust, Émilie .................................... Disclosed no confl ict of interest.Da Costa, Alessandra S. ..................... Disclosed no confl ict of interest.da Rocha Fernandes, Joao Diogo ...... Disclosed no confl ict of interest.da Silva, Crislaine C. ........................... Disclosed no confl ict of interest.da Silva, Sandro A. ............................. Disclosed no confl ict of interest.Dabbas, Myriam .................................. Disclosed no confl ict of interest.Dabelea, Dana ..................................... Disclosed no confl ict of interest.Dabrowski, Mariusz ............................ Disclosed no confl ict of interest.

Dadan, Jacek ....................................... Disclosed no confl ict of interest.D’Addio, Francesca ............................. Disclosed no confl ict of interest.Dadi, Prasanna K. ................................ Disclosed no confl ict of interest.Dadlani, Vikash ................................... Disclosed no confl ict of interest.Dadu, Razvan ....................................... Disclosed no confl ict of interest.Dafoulas, George E. ............................ Disclosed no confl ict of interest.Dagdeviren, Sezin ............................... Disclosed no confl ict of interest.Dagogo-Jack, Samuel ........................ Disclosed no confl ict of interest.Dagon, Yossi ........................................ Disclosed no confl ict of interest.D’Agostino, Jr., Ralph ......................... Disclosed no confl ict of interest.D’Agostino, Ralph ............................... Research Support: Harvard Clinical Research Institute. Dahiya, Rachana ................................. Disclosed no confl ict of interest.Dahlback, Bjorn ................................... Disclosed no confl ict of interest.Dahlin, Erik ........................................... Disclosed no confl ict of interest.Dahlin, Lars B. ..................................... Disclosed no confl ict of interest.Dahl-Jørgensen, Knut ......................... Disclosed no confl ict of interest.Dahmen, Raphael ................................ Employee: Sanofi . Dai, Ge ................................................. Employee: Merck Sharp & Dohme. Dai, Ying .............................................. Disclosed no confl ict of interest.Dailey, George ..................................... Consultant: Sanofi ; Research Support: Gilead,

GlaxoSmithKline, Halozyme Therapeutics, Hammi, Novo Nordisk, Roche, Sanofi ; Speaker’s Bureau: AstraZeneca, Merck & Co., Inc., Sanofi .

Dalal, Mehul ........................................ Employee: Sanofi U.S. Dalan, Rinkoo ...................................... Disclosed no confl ict of interest.Dalbøge, Louise S. .............................. Disclosed no confl ict of interest.D’Alessio, David .................................. Disclosed no confl ict of interest.Daley, Khalilah .................................... Disclosed no confl ict of interest.Dall, Mads ........................................... Employee: CeQur SA. Dall, Tara .............................................. Employee: Health Diagnostics Laboratory, Inc. Dalla Man, Chiara ............................... Disclosed no confl ict of interest.Dalla Paola, Luca ................................. Disclosed no confl ict of interest.Dallabrida, Susan M. .......................... Employee: PHT Corporation. Dallaire, Maryse ................................. Disclosed no confl ict of interest.Dalle, Stéphane ................................... Consultant: Consultance, Merck Sharp & Dohme; Research

Support: Financial support for research, Novo Nordisk Inc.

Dalmas, Elise ....................................... Disclosed no confl ict of interest.Dalton, Jennifer .................................. Disclosed no confl ict of interest.Dalton, Neil ......................................... Disclosed no confl ict of interest.Damacharla, Divyasri ......................... Disclosed no confl ict of interest.Damaso, Ligeia .................................... Disclosed no confl ict of interest.Damcott, Coleen M. ............................ Disclosed no confl ict of interest.Damian, Vincent .................................. Disclosed no confl ict of interest.Damiano, Edward R. ........................... Other Relationship: Abbott Diabetes Care, Inc., Dexcom,

Inc., Eli Lilly and Company, Insulet Corporation, International Biomedical, Medtronic MiniMed, Inc., Tandem Diabetes Care, Inc.

Damkier, Per ........................................ Disclosed no confl ict of interest.Damm, Peter ........................................ Speaker’s Bureau: Novo Nordisk Inc. D’amore, Patricia ................................. Disclosed no confl ict of interest.Danaei, Goodarz .................................. Disclosed no confl ict of interest.Danai, Laura V. .................................... Disclosed no confl ict of interest.Dandona, Paresh ................................. Disclosed no confl ict of interest.Dang, Mary A. ..................................... Disclosed no confl ict of interest.Dang, Tri T. ........................................... Employee: Medtronic, Inc. D’Angelo, Angela ................................ Disclosed no confl ict of interest.Dangwal, Seema ................................. Disclosed no confl ict of interest.Daniele, Giuseppe ............................... Disclosed no confl ict of interest.Daniell, Henry ...................................... Other Relationship: Novo Nordisk Inc. Daniels, Mark J. .................................. Disclosed no confl ict of interest.Danielsson, Anders P. ......................... Disclosed no confl ict of interest.Danielsson, Angelika .......................... Disclosed no confl ict of interest.Danis, Daniel ....................................... Disclosed no confl ict of interest.Danne, Thomas ................................... Advisory Panel: Eli Lilly and Company, Medtronic, Inc.,

Novo Nordisk A/S, Roche USA, Sanofi U.S.; Consultant: Unomedical; Research Support: AstraZeneca Pharmaceuticals LP; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Medtronic, Inc., Novo Nordisk A/S, Roche USA, Sanofi U.S., Unomedical.

d’Annunzio, Giuseppe ......................... Advisory Panel: Novo nordisk; Board Member: Value Relations; Consultant: Regional Health Agency - Liguria Region.

Dantas, Joana ..................................... Disclosed no confl ict of interest.Danus, Susanne .................................. Disclosed no confl ict of interest.Danyliv, Andrii ..................................... Disclosed no confl ict of interest.Daoudi, Ahmed .................................... Disclosed no confl ict of interest.Dar, Moahad ........................................ Consultant: AstraZeneca Pharmaceuticals LP, Medimmune;

Research Support: Medtronic, Inc. Dardano, Angela ................................. Disclosed no confl ict of interest.Dario, Claudio ...................................... Disclosed no confl ict of interest.

A826

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Das Gupta, Riddhi ............................... Disclosed no confl ict of interest.Das, Shaonli ........................................ Disclosed no confl ict of interest.Das, Swapan K. ................................... Disclosed no confl ict of interest.Dasari, Surendra ................................. Disclosed no confl ict of interest.Dash, Satya ......................................... Disclosed no confl ict of interest.Dashinamoothy, Janani ...................... Disclosed no confl ict of interest.Dashti, Hassan S. ................................ Disclosed no confl ict of interest.Daskalova, Ivona ................................. Disclosed no confl ict of interest.Dassau, Eyal ........................................ Research Support: Animas Corporation, Dexcom, Inc.,

LifeScan, Inc. Datar, Ashlesha ................................... Disclosed no confl ict of interest.Date, Masamichi ................................. Disclosed no confl ict of interest.Datz, Christian ..................................... Disclosed no confl ict of interest.Datz, Nicolin ........................................ Disclosed no confl ict of interest.Dauch, Jacqueline R. .......................... Disclosed no confl ict of interest.Daugaard, Jens R. ............................... Employee: Zealand Pharma A/S. Dauriz, Marco ...................................... Disclosed no confl ict of interest.Davenport, Clemontina ...................... Disclosed no confl ict of interest.Davenport, Colin ................................. Disclosed no confl ict of interest.Davi, Giovanni ..................................... Disclosed no confl ict of interest.Davidson, Jaime A. ............................. Advisory Panel: Amgen Inc., AspireBariatrics, AstraZeneca,

Boston Therapeutics, Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck & Co., Inc., Novo Nordisk; Consultant: Amgen Inc., AspireBariatrics, AstraZeneca, Boston Therapeutics, Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck & Co., Inc., Novo Nordisk; Speaker’s Bureau: AstraZeneca, Janssen, Merck-Serono, Novo Nordisk, Takeda.

Davidson, W. Sean .............................. Disclosed no confl ict of interest.Davies, Joanna D. ............................... Disclosed no confl ict of interest.Davies, Melanie J. .............................. Advisory Panel: AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim Pharmaceuticals, Inc., Janssen Pharmaceutical Companies of Johnson & Johnson, Lilly, Merck Sharp & Dohme, Novo Nordisk A/S, Sanofi -Aventis; Consultant: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Janssen Pharmaceutical Companies of Johnson & Johnson, Lilly, Merck Sharp & Dohme, Novo Nordisk A/S, Sanofi -Aventis; Research Support: Lilly, Novo Nordisk A/S, Sanofi -Aventis; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Janssen Pharmaceutical Companies of Johnson & Johnson, Lilly, Merck Sharp & Dohme, Mitsubishi Tanabe Pharma Corporation, Novo Nordisk A/S, Sanofi -Aventis.

Davies, Michael J. .............................. Employee: Janssen Research & Development LLC; Stock/Shareholder: Johnson & Johnson.

Davis, Barry ......................................... Disclosed no confl ict of interest.Davis, Brian ......................................... Disclosed no confl ict of interest.Davis, Cralen ....................................... Research Support: Sanofi U.S. Davis, Donna ....................................... Disclosed no confl ict of interest.Davis, Fred ........................................... Disclosed no confl ict of interest.Davis, J. ............................................... Disclosed no confl ict of interest.Davis, Nakiya ...................................... Disclosed no confl ict of interest.Davis, Neelam ..................................... Consultant: Valeritas. Davis, Rich M. ..................................... Research Support: National Institute of Diabetes and

Digestive and Kidney Diseases, National Institute of Diabetes and Digestive and Kidney Diseases (Spouse/Partner), National Institutes of Health, National Institutes of Health (Spouse/Partner).

Davis, Richard ..................................... Disclosed no confl ict of interest.Davis, Roger J. .................................... Disclosed no confl ict of interest.Davis, Sonia ......................................... Research Support: Medtronic MiniMed, Inc. Davis, Stephen N. ............................... Disclosed no confl ict of interest.Davis, Timothy ..................................... Advisory Panel: Merck Sharp & Dohme, Novo Nordisk A/S;

Research Support: Merck Sharp & Dohme, Sanofi U.S., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: AstraZeneca/Bristol-Myers Squibb, Boehringer Ingelheim GmbH, Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck Sharp & Dohme, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Takeda Pharmaceutical Company Limited.

Davis, Wendy A. .................................. Advisory Panel: Merck Sharp & Dohme (Spouse/Partner), Novo Nordisk A/S (Spouse/Partner); Research Support: Merck Sharp & Dohme, Merck Sharp & Dohme (Spouse/Partner), Novo Nordisk A/S, Sanofi U.S., Sanofi U.S. (Spouse/Partner), Takeda Pharmaceutical Company Limited (Spouse/Partner), Takeda Pharmaceutical Company Limited; Speaker’s Bureau: AstraZeneca/

Bristol-Myers Squibb (Spouse/Partner), Boehringer Ingelheim GmbH (Spouse/Partner), Eli Lilly and Company (Spouse/Partner), Janssen Pharmaceutical Companies of Johnson & Johnson (Spouse/Partner), Merck Sharp & Dohme (Spouse/Partner), Novartis Pharmaceuticals Corporation (Spouse/Partner), Novo Nordisk A/S (Spouse/Partner), Takeda Pharmaceutical Company Limited (Spouse/Partner).

Davoudi, Samaneh .............................. Disclosed no confl ict of interest.Daw, E. Warwick ................................. Disclosed no confl ict of interest.Day, Danielle ....................................... Employee: AstraZeneca Pharmaceuticals LP. Day, Samantha E. ................................ Disclosed no confl ict of interest.de Andrade, Mariza ............................ Disclosed no confl ict of interest.de Bakker, Paul .................................... Disclosed no confl ict of interest.De Beaufort, Carine ............................ Board Member: Medtronic; Speaker’s Bureau: Medtronic. De Block, Christophe .......................... Disclosed no confl ict of interest.de Bock, Martin ................................... Other Relationship: Pfi zer Inc., Sanofi U.S.; Research Support:

Novo Nordisk Inc. de Boer, Ian H. ..................................... Research Support: Abbvie. De Cesare, Domenico ......................... Disclosed no confl ict of interest.De Coppi, Paolo ................................... Disclosed no confl ict of interest.De Cosmo, Salvatore .......................... Disclosed no confl ict of interest.de Courten, Barbora ........................... Advisory Panel: Eli Lilly and Company. de Courten, Maximilian ...................... Disclosed no confl ict of interest.De Filippis, Elena ................................. Disclosed no confl ict of interest.de Franceschi, Karine ......................... Disclosed no confl ict of interest.de Galan, Bastiaan E. .......................... Consultant: Merck Sharp & Dohme, Novo Nordisk A/S,

Sanofi Pasteur SA. de Grauw, Wim J. ............................... Disclosed no confl ict of interest.De Gregorio, Veronica ........................ Disclosed no confl ict of interest.de Groot, Mary K. ................................ Disclosed no confl ict of interest.De Jesus, Dario F. ............................... Disclosed no confl ict of interest.de Lana, Janaina M. ........................... Employee: Eli Lilly and Company, Medical Advisor. De Leon, Diva D. .................................. Disclosed no confl ict of interest.De Leon, Mary Rosalynn B. ................ Disclosed no confl ict of interest.de Luis, Daniel ..................................... Disclosed no confl ict of interest.De Marinis, Yang ................................. Disclosed no confl ict of interest.de Matos, Alexandre H. ...................... Disclosed no confl ict of interest.De Nigris, Valeria ................................ Disclosed no confl ict of interest.de Oliveira, Alanne L. .......................... Disclosed no confl ict of interest.De Pascalis, Mariangela ..................... Disclosed no confl ict of interest.de Portu, Simone ................................. Employee: Medtronic, Inc. De Sousa Coelho, Ana Luisa .............. Disclosed no confl ict of interest.De Souza, Errol .................................... Board Member: Biodel Inc.; Employee: Biodel Inc.; Stock/

Shareholder: Biodel Inc. De Tata, Vincenzo ............................... Disclosed no confl ict of interest.De Vadder, Filipe ................................. Disclosed no confl ict of interest.de Veer, Michael J. ............................. Research Support: Eli Lilly and Company. de Weijer, Barbara A. ......................... Disclosed no confl ict of interest.de Wit, Helena M. ............................... Disclosed no confl ict of interest.Deacon, Carolyn F. .............................. Consultant: Merck Sharp & Dohme, Novartis

Pharmaceuticals Corporation, Novo Nordisk A/S; Employee: Merck Sharp & Dohme (Spouse/Partner); Research Support: Merck Sharp & Dohme, Novartis Pharma GmbH; Speaker’s Bureau: Merck Sharp & Dohme, Novartis Pharmaceuticals Corporation.

Deane, Adam M. ................................. Disclosed no confl ict of interest.DeBoer, Mark D. .................................. Disclosed no confl ict of interest.Dedic, Christopher .............................. Disclosed no confl ict of interest.Dedov, Ivan I. ....................................... Disclosed no confl ict of interest.Deeg, Mark A. ..................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Deepa, Mohan ..................................... Disclosed no confl ict of interest.Deepak, Doddabele S. ........................ Disclosed no confl ict of interest.Deerochanawong, Chaicharn ............. Disclosed no confl ict of interest.Defeudis, Giuseppe ............................. Disclosed no confl ict of interest.deFilippi, Christopher R. ..................... Disclosed no confl ict of interest.DeFronzo, Ralph A. .............................. Advisory Panel: Amylin Pharmaceuticals, LLC., AstraZeneca

Pharmaceuticals LP, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Janssen Research & Development LLC, Lexicon Pharmaceuticals, Inc., Novo Nordisk Inc., Takeda Pharmaceuticals U.S.A., Inc.; Research Support: Amylin Pharmaceuticals, LLC., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Takeda Pharmaceuticals U.S.A., Inc.; Speaker’s Bureau: AstraZeneca/Bristol-Myers Squibb, Janssen Research & Development LLC, Novo Nordisk Inc.

DeGueme, Amy ................................... Disclosed no confl ict of interest.Dehghan, Abbas .................................. Disclosed no confl ict of interest.Dehn, Clayton ...................................... Disclosed no confl ict of interest.Dejgaard, Thomas F. ........................... Research Support: Novo Nordisk A/S.

A827

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Del Favero, Simone ............................. Disclosed no confl ict of interest.Del Guerra, Silvia ................................ Disclosed no confl ict of interest.Del Prato, Stefano .............................. Disclosed no confl ict of interest.del Re, Luigi ......................................... Disclosed no confl ict of interest.Del Toro, Rossella ............................... Disclosed no confl ict of interest.DeLaCruz, Marie ................................. Research Support: AstraZeneca/Bristol-Myers Squibb. Delale, Thomas ................................... Employee: Alize Pharma; Stock/Shareholder: Alize Pharma. Delaney, Joseph A. ............................. Disclosed no confl ict of interest.Delgado Olivencia, Eva M. ................. Disclosed no confl ict of interest.Delgado, Elias ...................................... Disclosed no confl ict of interest.D’Elia, John A. ..................................... Disclosed no confl ict of interest.Delibasi, Tuncay .................................. Disclosed no confl ict of interest.Della Morte, David .............................. Disclosed no confl ict of interest.Dellinger, Elaine .................................. Disclosed no confl ict of interest.Delong, Thomas .................................. Disclosed no confl ict of interest.DeLozier, Amy M. ................................ Employee: Eli Lilly and Company. Delshad, Hossein ................................ Disclosed no confl ict of interest.DeLurgio, Stephen .............................. Disclosed no confl ict of interest.DeMarco, Vincent G. .......................... Research Support: Boehringer Ingelheim Pharmaceuticals,

Inc. Demarest, Keith T. .............................. Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson; Stock/Shareholder: Johnson & Johnson. d’Emden, Michael C. ........................... Advisory Panel: AstraZeneca, Eli Lilly, Takeda; Speaker’s

Bureau: AstraZeneca, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Takeda.

Demir, Ali ............................................. Disclosed no confl ict of interest.Demir, Muzaffer .................................. Disclosed no confl ict of interest.Demircik, Filiz ...................................... Disclosed no confl ict of interest.Demissie, Marek ................................. Employee: Novo Nordisk A/S. Demons, Jamehl ................................. Disclosed no confl ict of interest.Deng, Bin ............................................. Disclosed no confl ict of interest.Deng, Ruifen ........................................ Disclosed no confl ict of interest.Deng, Shunyou .................................... Disclosed no confl ict of interest.Deng, Wanping .................................... Disclosed no confl ict of interest.Dengel, Donald R. ............................... Disclosed no confl ict of interest.Denham, Douglas S. ........................... Research Support: Intarcia Therapeutics, Inc. Denhoff, Erica ..................................... Disclosed no confl ict of interest.Denic, Hristina ..................................... Disclosed no confl ict of interest.Dennis, Michael D. .............................. Disclosed no confl ict of interest.Dentello, Andre ................................... Disclosed no confl ict of interest.Deogaonkar, Narayan ......................... Disclosed no confl ict of interest.D’Eon, Stephanie ................................ Disclosed no confl ict of interest.Der, Ken ............................................... Employee: XOMA Corporation. Derave, Wim ........................................ Disclosed no confl ict of interest.Derazne, Estela ................................... Disclosed no confl ict of interest.Derby, Teresa ...................................... Disclosed no confl ict of interest.Dereke, Jonatan .................................. Disclosed no confl ict of interest.Derendorf, Hartmut ............................ Disclosed no confl ict of interest.Derezinski, Tadeusz ............................ Disclosed no confl ict of interest.Derner, Brian ....................................... Disclosed no confl ict of interest.Derosa, Giuseppe ................................ Disclosed no confl ict of interest.Deryabina, Maria A. ........................... Employee: Zealand Pharma A/S. Desai, Ankush ..................................... Disclosed no confl ict of interest.Desai, Jay ............................................ Disclosed no confl ict of interest.Desai, Kaniksha ................................... Disclosed no confl ict of interest.Desai, Mehul ....................................... Employee: Janssen Research & Development, LLC. Desai, Urvi ........................................... Research Support: Eli Lilly and Company. Desale, Sameer ................................... Disclosed no confl ict of interest.DeSalvo, Daniel J. ............................... Disclosed no confl ict of interest.Desborough, Lane ............................... Disclosed no confl ict of interest.Deshmukh, Harshal ............................. Disclosed no confl ict of interest.Deshmukh, Sreehari ........................... Disclosed no confl ict of interest.Deshpande, Gaurav ............................. Employee: HealthCore Inc. Desmond, Clinton ................................ Disclosed no confl ict of interest.Desoye, Gernot ................................... Disclosed no confl ict of interest.Detournay, Bruno ................................ Board Member: AstraZeneca Pharmaceuticals LP,

Daiichi-Sankyo Co., Ltd., Novartis, Pfi zer Inc., Sanofi ; Consultant: Most pharmaceutical companies and public institutions in France; Employee: Cemka-Eval; Stock/Shareholder: Cemka-Eval.

Deutsch, Aaron ................................... Disclosed no confl ict of interest.Devarajan, Raji .................................... Disclosed no confl ict of interest.Devarajan, Sankar ............................... Disclosed no confl ict of interest.Devecchi, Elisabetta ........................... Disclosed no confl ict of interest.DeVita, Lauren ..................................... Disclosed no confl ict of interest.Devkota, Suzanne ............................... Disclosed no confl ict of interest.Devlieger, Roland ................................ Disclosed no confl ict of interest.Devlin, Heather M. .............................. Disclosed no confl ict of interest.Dex, Terry ............................................ Employee: Sanofi U.S.; Stock/Shareholder: Sanofi . Dey, Soumyadeep ............................... Disclosed no confl ict of interest.Dhaheri, Ayesha A. ............................. Disclosed no confl ict of interest.Dhalla, Arvinder K. .............................. Employee: Gilead; Stock/Shareholder: Gilead.

Dhankhar, Praveen .............................. Employee: AstraZeneca Pharmaceuticals LP, Merck & Co., Inc. (Spouse/Partner); Stock/Shareholder: Merck & Co., Inc. (Spouse/Partner).

Dhar, Sumitrajit ................................... Disclosed no confl ict of interest.Dharmalingam, Mala .......................... Disclosed no confl ict of interest.Dhatt, Navdeep ................................... Disclosed no confl ict of interest.Dhindsa, Sandeep ............................... Disclosed no confl ict of interest.Di Bartolo, Paolo ................................. Advisory Panel: Abbott, Eli Lilly and Company, Novartis

Corporation, Novo Nordisk Inc.; Speaker’s Bureau: Abbott, AstraZeneca Pharmaceuticals LP, Bayer HealthCare, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Medtronic, Inc., Menarini Group, Merck Sharp & Dohme, Novartis Corporation, Novo Nordisk Inc., Roche Diagnostics, Sanofi Pasteur SA, Ypsomed.

Di Benedetto, Antonino ...................... Disclosed no confl ict of interest.Di Emidio, Chiara ................................. Disclosed no confl ict of interest.Di Marco, Elyse ................................... Disclosed no confl ict of interest.Di Noto, Anna ...................................... Disclosed no confl ict of interest.Di Palma, Federico .............................. Disclosed no confl ict of interest.Di Vieste, Giacoma ............................. Disclosed no confl ict of interest.Diaconu, Laura .................................... Disclosed no confl ict of interest.Diallo, Abdourahmane ........................ Disclosed no confl ict of interest.Diamant, Michaela ............................. Consultant: Abbott, AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, GI Dynamics, Inc., Merck Sharp & Dohme, Novo Nordisk Inc., Poxel Pharmaceutical Company, Sanofi U.S.; Research Support: Abbott, AstraZeneca/Bristol-Myers Squibb, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Medtronic, Inc., Merck Sharp & Dohme, Novo Nordisk Inc., Sanofi U.S.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb/AstraZeneca, Eli Lilly and Company, Novo Nordisk Inc., Sanofi U.S.

Diamond, Anne .................................... Research Support: LifeScan, Inc. Dias, Lisiane S. .................................... Disclosed no confl ict of interest.Diaz Pujol, Encarna ............................. Disclosed no confl ict of interest.Diaz, Ana ............................................. Disclosed no confl ict of interest.Diaz-Contreras, Daniela ..................... Disclosed no confl ict of interest.Dib, Sergio A. ...................................... Disclosed no confl ict of interest.Dickinson, Keith .................................. Disclosed no confl ict of interest.Dickson, Lorna ..................................... Disclosed no confl ict of interest.Didangelos, Triantafyllos ................... Disclosed no confl ict of interest.Diehl, Leandro A. ................................ Other Relationship: Co-owner of the game (InsuOnLine)

assessed in this study; Speaker’s Bureau: AstraZeneca/Bristol-Myers Squibb.

Diessel, Stephan ................................. Disclosed no confl ict of interest.Dieuzeide, Guillermo ........................... Advisory Panel: AstraZeneca/Bristol-Myers Squibb,

GlaxoSmithKline, Novo Nordisk A/S; Research Support: AstraZeneca/Bristol-Myers Squibb, Merck Sharp & Dohme, Novo Nordisk A/S; Speaker’s Bureau: AstraZeneca/Bristol-Myers Squibb, GlaxoSmithKline, Montpellier, Novo Nordisk A/S.

DiGenio, Andres .................................. Employee: Isis Pharmaceuticals, Inc. Dijk, Derk-Jan ...................................... Disclosed no confl ict of interest.Dilzer, Stacy ......................................... Employee: Clinical Pharmacology of Miami. DiMarchi, Richard D. ........................... Disclosed no confl ict of interest.DiMario, Stefan ................................... Employee: BD Medical-Diabetes Care. DiMeglio, Linda A. .............................. Consultant: Sanofi U.S.; Other Relationship: Novo Nordisk

Inc.; Research Support: Astellas Pharma US, Inc., Bayer HealthCare, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases.

Dimitrov, Latchezar ............................. Disclosed no confl ict of interest.Dimmock, Jacqueline ......................... Research Support: National Institute of Diabetes and

Digestive and Kidney Diseases. Dinapoli, Gina ...................................... Disclosed no confl ict of interest.Dinccag, Nevin .................................... Speaker’s Bureau: Eli Lilly and Company, Medtronic

MiniMed, Inc., Merck Sharp & Dohme, Sanofi U.S. Dinces, Elizabeth A. ............................ Disclosed no confl ict of interest.Ding, Cherlyn ....................................... Disclosed no confl ict of interest.Ding, Eric L. .......................................... Disclosed no confl ict of interest.Ding, Liyun ........................................... Employee: Eli Lilly and Company, Yangtze River

Pharmaceutical Group (Spouse/Partner). Ding, Min ............................................. Disclosed no confl ict of interest.Ding, Ming ........................................... Disclosed no confl ict of interest.Ding, Sheng ......................................... Disclosed no confl ict of interest.Ding, Shenhua ..................................... Disclosed no confl ict of interest.Ding, Shiying ....................................... Disclosed no confl ict of interest.Ding, Shi-Ying ...................................... Disclosed no confl ict of interest.Ding, Su Ann ........................................ Disclosed no confl ict of interest.

A828

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Ding, Victoria ....................................... Disclosed no confl ict of interest.Ding, Xunhua ....................................... Employee: Crown Bioscience, Inc. Ding, YanHua ....................................... Disclosed no confl ict of interest.Ding, Yu-Shin ....................................... Disclosed no confl ict of interest.Ding, Yuyan .......................................... Disclosed no confl ict of interest.Dinh, Thanh ......................................... Disclosed no confl ict of interest.Diniz, Roseane C. ................................ Disclosed no confl ict of interest.Dinnies, Daniela .................................. Disclosed no confl ict of interest.Dinu, Valentin ...................................... Disclosed no confl ict of interest.Dirice, Ercument .................................. Disclosed no confl ict of interest.Dirksen, Carsten ................................. Disclosed no confl ict of interest.Distelmaier, Klaus ............................... Disclosed no confl ict of interest.Divers, Jasmin ..................................... Disclosed no confl ict of interest.Divieti Pajevic, Paola .......................... Disclosed no confl ict of interest.Divine, George W. ............................... Disclosed no confl ict of interest.Dixit, Madhulika .................................. Disclosed no confl ict of interest.Dixon, Jeffrey ...................................... Employee: Eli Lilly and Company. Djedjos, C. Stephen ............................ Employee: Amgen Inc.; Stock/Shareholder: Amgen Inc. Djousse, Luc ........................................ Disclosed no confl ict of interest.Doan, John .......................................... Disclosed no confl ict of interest.Dobrecky-Mery, Idit ............................ Research Support: Novartis Pharmaceuticals Corporation. Dobrinskikh, Evgenia .......................... Disclosed no confl ict of interest.Dobrosielski, Devon ............................ Disclosed no confl ict of interest.Dobrzyn, Agnieszka ............................ Disclosed no confl ict of interest.Doherty, Donna ................................... Disclosed no confl ict of interest.Dohil, Ranjan ....................................... Disclosed no confl ict of interest.Döhring, Carmen ................................. Disclosed no confl ict of interest.Dolan, Lawrence M. ........................... Disclosed no confl ict of interest.Doleh, Yunes ....................................... Disclosed no confl ict of interest.Doliba, Nicolai M. ............................... Disclosed no confl ict of interest.Dolz, Manuel ....................................... Disclosed no confl ict of interest.Dombkowski, Kevin J. ........................ Disclosed no confl ict of interest.Dombrovska, Natali ............................ Disclosed no confl ict of interest.Domenger, Catherine .......................... Employee: Sanofi . Dominguez II, James ........................... Disclosed no confl ict of interest.Dominguez, Melissa G. ....................... Employee: Regeneron Pharmaceuticals, Inc. Donadel, Giulia .................................... Disclosed no confl ict of interest.Donaldson, Julie ................................. Disclosed no confl ict of interest.Donath, Marc Y. .................................. Disclosed no confl ict of interest.Donatto, Sheletta G. ........................... Disclosed no confl ict of interest.Dondoi, Carmen ................................... Disclosed no confl ict of interest.Dong, Fran ........................................... Disclosed no confl ict of interest.Dong, Guangyu .................................... Disclosed no confl ict of interest.Dong, Huansheng ................................ Disclosed no confl ict of interest.Dong, Kun ............................................ Disclosed no confl ict of interest.Dong, Lily Q. ........................................ Disclosed no confl ict of interest.Dong, Yanhu ........................................ Disclosed no confl ict of interest.Dong, Yunzhou .................................... Disclosed no confl ict of interest.Donnelly, Louise .................................. Disclosed no confl ict of interest.Donnelly, Richard ................................ Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,

Eli Lilly and Company, Merck Sharp & Dohme, Novo Nordisk Inc.

Donoghue, Stephen ............................ Consultant: Genmedica Therapeutics S.L. Donovan, Cynthia ................................ Disclosed no confl ict of interest.Donovan, Lois ...................................... Disclosed no confl ict of interest.Dooms, Hans ....................................... Disclosed no confl ict of interest.Dore, David D. ..................................... Research Support: Novo Nordisk A/S. Doria, Alessandro ............................... Research Support: Sanofi U.S. D’Oria, Rossella ................................... Disclosed no confl ict of interest.dos Santos, Ana L. .............................. Disclosed no confl ict of interest.dos Santos, Andrey ............................. Disclosed no confl ict of interest.dos Santos, Claudia C. ........................ Disclosed no confl ict of interest.Døskeland, Anne ................................. Disclosed no confl ict of interest.Dostou, Jean M. .................................. Research Support: Astellas Pharma US, Inc., Bayer

HealthCare, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases.

Dotiwala, Zenobia ............................... Consultant: AstraZeneca Pharmaceuticals LP. Dotzert, Michelle S. ............................ Disclosed no confl ict of interest.Dougher, Carly E. ................................. Disclosed no confl ict of interest.Douma, Stella ...................................... Disclosed no confl ict of interest.Doumas, Michael ................................ Disclosed no confl ict of interest.Doumatey, Ayo .................................... Disclosed no confl ict of interest.Dourliou, Vasiliki ................................. Disclosed no confl ict of interest.Dover, Ellen .......................................... Disclosed no confl ict of interest.Dowda, Marsha ................................... Disclosed no confl ict of interest.Down, Susan ....................................... Advisory Panel: Abbot, AstraZeneca/ Bristol-Myers Squibb,

Boehringer Ingelheim/Lilly, Johnson and Johnson, Novo Nordisk, Sanofi ; Board Member: Forum for Injection Technique; Speaker’s Bureau: OmniaMed, SB Communications.

Downs, John ....................................... Disclosed no confl ict of interest.

Downs, Julie ........................................ Disclosed no confl ict of interest.Doyle III, Francis J. .............................. Research Support: Animas Corporation, Dexcom, Inc.,

LifeScan, Inc. Doyle, Elizabeth A. .............................. Disclosed no confl ict of interest.Doyle, Francis ...................................... Disclosed no confl ict of interest.Draghici, Sorin ..................................... Disclosed no confl ict of interest.Dragomir, Andreea Diana ................... Disclosed no confl ict of interest.Dragut, Ramona .................................. Disclosed no confl ict of interest.Dragut, Ramona Maria ....................... Disclosed no confl ict of interest.Dregni, Aurelio .................................... Disclosed no confl ict of interest.Drent, Madeleine L. ............................ Disclosed no confl ict of interest.Drevon, Christian A. ............................ Disclosed no confl ict of interest.Drew, Brian G. ..................................... Disclosed no confl ict of interest.Drexel, Heinz ....................................... Disclosed no confl ict of interest.Dreyer, Manfred .................................. Speaker’s Bureau: Aventis, Eli Lilly and Company. Dreyfuss, Jonathan ............................ Disclosed no confl ict of interest.Driscoll, Henry K. ................................ Disclosed no confl ict of interest.Driver, John P. ...................................... Disclosed no confl ict of interest.Drobni, Zsofi a D. .................................. Disclosed no confl ict of interest.Drucker, Daniel .................................... Disclosed no confl ict of interest.Drye, Elizabeth .................................... Disclosed no confl ict of interest.D’Souza, Anna ..................................... Consultant: Boehringer Ingelheim Pharmaceuticals, Inc. D’Souza, Stephanie ............................ Disclosed no confl ict of interest.Du, Fuyong ........................................... Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson, Janssen Pharmaceutical Companies of Johnson & Johnson (Spouse/Partner); Stock/Shareholder: Johnson & Johnson.

Duan, Dayue D. .................................... Disclosed no confl ict of interest.Duan, Ran ............................................ Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Duarte, Camila K. ................................ Disclosed no confl ict of interest.Dube, Simmi ........................................ Disclosed no confl ict of interest.DuBose, Stephanie N. ........................ Disclosed no confl ict of interest.Duca, Lindsey ...................................... Disclosed no confl ict of interest.Duceppe, Jean-Simon ........................ Disclosed no confl ict of interest.Duchampt, Adeline ............................. Disclosed no confl ict of interest.Duclos, Marc ....................................... Employee: IMS Brogan; Research Support: GlaxoSmithKline. Duclos, Michelle ................................. Research Support: Andromeda, Boehringer Ingelheim

Pharmaceuticals, Inc., Eli Lilly and Company, GI Dynamics, Inc., Halozyme Therapeutics, Hoffman-La Roche Limited, Johnson & Johnson, Medtronic MiniMed, Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Orexigen Therapeutics, Inc., Osiris Therapeutics, Inc., Pfi zer Inc., Sanofi U.S., Takeda Pharmaceuticals U.S.A., Inc., Tolerex.

Dudley, Katherine A. ........................... Disclosed no confl ict of interest.Duffi eld, Michael ................................ Disclosed no confl ict of interest.Duffy, Stephen J. ................................ Research Support: Resverlogix Corp. Dufour, Ines ......................................... Disclosed no confl ict of interest.Dufour, Robert ..................................... Research Support: Amgen Inc., AstraZeneca

Pharmaceuticals LP, Eli Lilly and Company, Regeneron Pharmaceuticals, Inc.

Duggirala, Ravindranath .................... Disclosed no confl ict of interest.Dugi, Klaus ........................................... Employee: Boehringer Ingelheim GmbH. Dugnani, Erica ..................................... Disclosed no confl ict of interest.Duke, Danny C. .................................... Disclosed no confl ict of interest.DuLong, Anne C. .................................. Disclosed no confl ict of interest.Dulude, Hélène .................................... Disclosed no confl ict of interest.Dumser, Susan .................................... Disclosed no confl ict of interest.Dunbar, James A. ................................ Disclosed no confl ict of interest.Duncan, Bruce B. ................................. Research Support: Eli Lilly Company. Duncan, Jane E. .................................. Disclosed no confl ict of interest.Dundua, Mzia G. .................................. Disclosed no confl ict of interest.Dungan, Kathleen M. .......................... Consultant: Eli Lilly and Company; Research Support:

AstraZeneca/Bristol-Myers Squibb, GlaxoSmithKline, Grifols USA, LLC, Merck & Co., Inc., Mylan, Novo Nordisk Inc.

Dunger, David B. .................................. Disclosed no confl ict of interest.Dunn, Jennifer C. ................................ Disclosed no confl ict of interest.Dunn, Louise L. .................................... Disclosed no confl ict of interest.Dunn, Rodney L. .................................. Disclosed no confl ict of interest.Dunn, Steven P. ................................... Disclosed no confl ict of interest.Dunn, Ty B. ........................................... Disclosed no confl ict of interest.Dunne, Fidelma ................................... Disclosed no confl ict of interest.Dunnigan, Diana L. .............................. Disclosed no confl ict of interest.Dunseath, Gareth J. ............................ Disclosed no confl ict of interest.Dunstan, David .................................... Disclosed no confl ict of interest.Dunston, Georgia ................................ Disclosed no confl ict of interest.Duong, Michelle T. .............................. Disclosed no confl ict of interest.Duplany, Agnes ................................... Stock/Shareholder: Metabolys Inc. Dupont, Olivia-Nezryn J. .................... Disclosed no confl ict of interest.Dupont-Versteegden, Esther E. .......... Disclosed no confl ict of interest.

A829

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Dupuis, Josée ...................................... Disclosed no confl ict of interest.Duraccio, Kara ..................................... Disclosed no confl ict of interest.Duran Garcia, Santiago ...................... Disclosed no confl ict of interest.Duran, Xavier ....................................... Disclosed no confl ict of interest.Durham, Timothy B. ............................ Employee: Eli Lilly and Company. Durracio, Kara ..................................... Disclosed no confl ict of interest.Duru, O.K. ............................................ Disclosed no confl ict of interest.Dutia, Roxanne .................................... Disclosed no confl ict of interest.Duvnjak, Lea ........................................ Disclosed no confl ict of interest.Dvorak, Justin D. ................................. Disclosed no confl ict of interest.Dye, Tim ............................................... Disclosed no confl ict of interest.Dyer, Thomas D. .................................. Disclosed no confl ict of interest.Eaglehouse, Yvonne L. ........................ Disclosed no confl ict of interest.Easter, Linda ........................................ Disclosed no confl ict of interest.Eaton, Charles B. ................................. Disclosed no confl ict of interest.Eaton, Sherry ....................................... Research Support: National Institutes of Health. Ebenezer, Philip ................................... Disclosed no confl ict of interest.Ebenibo, Sotonte ................................. Disclosed no confl ict of interest.Eberly, Lynn ......................................... Disclosed no confl ict of interest.Ebner, Eric ............................................ Employee: Dexcom, Inc. Echtay, Akram ..................................... Advisory Panel: AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim GmbH, Merck Sharp & Dohme, Novartis AG, Novo Nordisk A/S, Sanofi U.S.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH, Eli Lilly and Company, Merck & Co., Inc., Merck Sharp & Dohme, Novartis AG, Novo Nordisk A/S, Sanofi U.S., Servier.

Eckardt, Kristin .................................... Disclosed no confl ict of interest.Eckel, Jürgen ....................................... Research Support: Hanmi Pharmaceuticals Inc. Eckel, Robert H. ................................... Disclosed no confl ict of interest.Eckersdorff, Mark ............................... Employee: Regeneron Pharmaceuticals, Inc. Eckert, Emily A. ................................... Disclosed no confl ict of interest.Eckfeldt, John H. ................................. Disclosed no confl ict of interest.Eckhart, Andrea .................................. Employee: Metabolon, Inc.; Stock/Shareholder: Metabolon,

inc. Edelman, David ................................... Disclosed no confl ict of interest.Edelman, Steve ................................... Research Support: Dexcom, Inc. Edelman, Steven ................................. Advisory Panel: Boehringer Ingelheim, Eli Lilly; Speaker’s

Bureau: Boehringer Ingelheim, EIi Lilly. Edelstein, Sharon L. ............................ Disclosed no confl ict of interest.Edgell, Eric T. ....................................... Employee: Eli Lilly and Company; Research Support: Eli Lilly

and Company; Stock/Shareholder: Eli Lilly and Company. Edgerton, Dale S. ................................ Disclosed no confl ict of interest.Edidin, Deborah V. ............................... Disclosed no confl ict of interest.Edwards, Victoria ................................ Disclosed no confl ict of interest.Edwin, Bjørn ........................................ Disclosed no confl ict of interest.Efanov, Alexander M. ......................... Employee: Eli Lilly and Company. Efron, Nathan ...................................... Disclosed no confl ict of interest.Efstathiou, Stamatis ........................... Disclosed no confl ict of interest.Egan, Josephine M. ............................ Disclosed no confl ict of interest.Egefjord, Lærke ................................... Disclosed no confl ict of interest.Egglefi eld, Katherine L. ....................... Disclosed no confl ict of interest.Eghan, Benjamin ................................. Disclosed no confl ict of interest.Eguchi, Jun .......................................... Disclosed no confl ict of interest.Ehklaspour, Laya ................................. Disclosed no confl ict of interest.Ehlers, Mario R. ................................... Disclosed no confl ict of interest.Ehrler, Sandra ...................................... Disclosed no confl ict of interest.Ehrlich, Brigid ...................................... Disclosed no confl ict of interest.Ehrlich, Samantha F. ........................... Disclosed no confl ict of interest.Ehrmann, Dominic ............................... Research Support: Berlin-Chemie AG, Roche Diagnostics;

Speaker’s Bureau: Berlin-Chemie AG. Eichinger, Felix .................................... Disclosed no confl ict of interest.Eiken, Aleksander ............................... Disclosed no confl ict of interest.Eilbracht, Jens .................................... Employee: Boehringer Ingelheim GmbH. Einarsson, Stefan ................................ Employee: Risk Medical Solutions. Eisenberg, Debra ................................. Employee: HealthCore Inc; Stock/Shareholder: Anthem Inc. Eizirik, Decio L. .................................... Disclosed no confl ict of interest.Ejarque, Miriam ................................... Disclosed no confl ict of interest.Ekeblad, Sara ...................................... Disclosed no confl ict of interest.Ekholm, Ella ......................................... Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP. Ekinci, Elif I. ......................................... Speaker’s Bureau: AstraZeneca Pharmaceuticals LP. Ekstrom, Heidi L. ................................. Disclosed no confl ict of interest.El Azzouny, Mahmoud ......................... Disclosed no confl ict of interest.El Bach, Jessica L. .............................. Disclosed no confl ict of interest.El Bilali, Jason ..................................... Disclosed no confl ict of interest.El Borno, Dana ..................................... Disclosed no confl ict of interest.El Hage, Maha ..................................... Employee: Metabolys Inc. El Khattabi, Ilham ................................ Disclosed no confl ict of interest.El Makni, Mouna ................................. Disclosed no confl ict of interest.El Ouaamari, Abdelfattah ................... Disclosed no confl ict of interest.El-Ansary, Mervat ............................... Disclosed no confl ict of interest.

Elashoff, Robert M. ............................. Disclosed no confl ict of interest.El-Bizri, Nesrine .................................. Employee: Gilead; Stock/Shareholder: Gilead. Eldahshan, Wael S. ............................. Disclosed no confl ict of interest.Eldelekli, Devrim ................................. Disclosed no confl ict of interest.Elder, Deborah A. ................................ Disclosed no confl ict of interest.Eleftheriadou, Ioanna ......................... Disclosed no confl ict of interest.El-Gohary, Yousef ............................... Disclosed no confl ict of interest.Eliaschewitz, Freddy G. ...................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Eli

Lilly and Company, Merck Sharp & Dohme, Novo Nordisk Inc., Sanofi U.S.; Board Member: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Merck Sharp & Dohme, Novo Nordisk Inc., Sanofi U.S.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Novo Nordisk Inc., Sanofi U.S.

Eliasson, Bjorn ..................................... Consultant: Sanofi U.S.; Research Support: Boehringer Ingelheim GmbH; Speaker’s Bureau: Eli Lilly and Company, Merck Sharp & Dohme, Novo Nordisk A/S, Sanofi Pasteur SA.

Eliasson, Lena ..................................... Disclosed no confl ict of interest.Elie, Caroline ....................................... Disclosed no confl ict of interest.Elisabet, Salas ..................................... Disclosed no confl ict of interest.Elkahloun, Abdel ................................. Disclosed no confl ict of interest.El-Khatib, Firas H. ............................... Disclosed no confl ict of interest.Elkholm, Ella ........................................ Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP. Elkum, Naser ....................................... Disclosed no confl ict of interest.Ellard, Sian ........................................... Disclosed no confl ict of interest.Elliot, Lisa ............................................ Employee: Novo Nordisk. Elliott, Mary ......................................... Employee: Amgen Inc.; Stock/Shareholder: Amgen Inc. Elliott, Michael .................................... Disclosed no confl ict of interest.Elmquist, Joel K. ................................. Disclosed no confl ict of interest.El-Remessy, Azza B. ............................ Disclosed no confl ict of interest.Elsasser, Ulrich .................................... Employee: Boehringer Ingelheim GmbH. Elsayed, Nuha ..................................... Disclosed no confl ict of interest.Elsen, Manuela ................................... Disclosed no confl ict of interest.Elshaer, Sally L. ................................... Disclosed no confl ict of interest.Elston Lafata, Jennifer ....................... Disclosed no confl ict of interest.Emami, Ali ............................................ Disclosed no confl ict of interest.Emanuele, Nicholas ............................ Disclosed no confl ict of interest.Emanuelli, Brice .................................. Disclosed no confl ict of interest.Emery, Corinne .................................... Consultant: Most pharmaceutical companies and public

institutions in France; Employee: Cemka-Eval; Stock/Shareholder: Cemka-Eval.

Emery, Martine ................................... Disclosed no confl ict of interest.Emirova, Aida ...................................... Employee: Novartis Pharma GmbH. Emoto, Masanori ................................. Research Support: Asahi Kasei Pharm Corporation, Astellas

Pharma Inc, Daiichi Sankyo Co., Ltd.,, Mitsubisi Tanabe Pharma Corporation,, Takeda Pharmaceutical Company Limited.

Enache, Georgiana .............................. Disclosed no confl ict of interest.Endo, Ginji ............................................ Disclosed no confl ict of interest.Eng, Alvin ............................................. Disclosed no confl ict of interest.Engel, Samuel ...................................... Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &

Co., Inc. Engelgau, Michael .............................. Disclosed no confl ict of interest.Engeli, Stefan ...................................... Disclosed no confl ict of interest.Engelman, William A. ......................... Employee: Eli Lilly and Company; Research Support: Eli Lilly

and Company. Engelmann, Katrin ............................... Disclosed no confl ict of interest.Engle, Sarah ........................................ Disclosed no confl ict of interest.English, Thomas .................................. Disclosed no confl ict of interest.Engstler, Janina .................................. Disclosed no confl ict of interest.Engwerda, Elsemiek E. ....................... Disclosed no confl ict of interest.Entrup, Leon ........................................ Disclosed no confl ict of interest.Eny, Karen M. ...................................... Disclosed no confl ict of interest.Epstein, Noam ..................................... Disclosed no confl ict of interest.Epstein, Paul ........................................ Disclosed no confl ict of interest.Epworth, Joshua ................................. Disclosed no confl ict of interest.Eriksson, Frank .................................... Disclosed no confl ict of interest.Eriksson, Jan W. ................................. Disclosed no confl ict of interest.Eriksson, Olof ...................................... Disclosed no confl ict of interest.Eringa, Etto C. ...................................... Disclosed no confl ict of interest.Erion, Derek ......................................... Disclosed no confl ict of interest.Erion, Karel .......................................... Disclosed no confl ict of interest.Erkoc, Reha .......................................... Disclosed no confl ict of interest.Ermakova, Ekaterina ........................... Disclosed no confl ict of interest.Eroglu, Mustafa .................................. Disclosed no confl ict of interest.Erqou, Sebhat ...................................... Disclosed no confl ict of interest.Ershova, Ekaterina V. .......................... Disclosed no confl ict of interest.Ertekin, Ali ........................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company.

A830

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Esa, Wael ............................................. Disclosed no confl ict of interest.Escalada, Javier .................................. Advisory Panel: Merck Sharp & Dohme, Sanofi ; Speaker’s

Bureau: AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Sanofi .

Escalante, Mirna ................................. Disclosed no confl ict of interest.Eschwège, Eveline .............................. Board Member: Novo Nordisk A/S. Esfandiari, Nazanene H. ..................... Disclosed no confl ict of interest.Eskelinen, Joonas ............................... Disclosed no confl ict of interest.Esler, William P. ................................... Employee: Pfi zer Inc. Esni, Farzad ......................................... Disclosed no confl ict of interest.Espelage, Britta C. .............................. Disclosed no confl ict of interest.Espes, Daniel ....................................... Disclosed no confl ict of interest.Espina, Cora ......................................... Disclosed no confl ict of interest.Espinoza, Daniel .................................. Disclosed no confl ict of interest.Espinoza, Sara ..................................... Disclosed no confl ict of interest.Esposito, Fabrizio ................................ Disclosed no confl ict of interest.Esquivel-Santoveña, Esteban E. ........ Disclosed no confl ict of interest.Esterson, Yonah .................................. Disclosed no confl ict of interest.Esteves, Roberto Z. ............................. Disclosed no confl ict of interest.Eszlinger, Markus ................................ Disclosed no confl ict of interest.Etoh, Rica ............................................. Disclosed no confl ict of interest.Ettner, Susan L. ................................... Disclosed no confl ict of interest.Euesden, Jack ..................................... Research Support: National Institute for Health Research

Biomedical Research Centre for Mental Health. Eulberg, Dirk ........................................ Employee: NOXXON Pharma AG. Eurich, Dean ........................................ Disclosed no confl ict of interest.Evans, Charles R. ................................ Disclosed no confl ict of interest.Evans, Christopher .............................. Employee: Endpoint Outcomes. Evans, Karen K. ................................... Disclosed no confl ict of interest.Evans, Marc ......................................... Advisory Panel: Merck Sharp & Dohme, Novartis

Pharmaceuticals Corporation, Novo Nordisk Inc., Sanofi U.S.; Consultant: Janssen Pharmaceutical Companies of Johnson & Johnson, Merck Sharp & Dohme, Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Sanofi U.S.; Research Support: Novo Nordisk Inc., Sanofi U.S., Takeda Pharmaceutical Company Limited.

Evans, Mark L. ..................................... Disclosed no confl ict of interest.Evans, Rhobert W. .............................. Disclosed no confl ict of interest.Evans-Molina, Carmella ..................... Disclosed no confl ict of interest.Everaert, Inge ...................................... Disclosed no confl ict of interest.Everett, Brendan ................................. Research Support: Novartis, Roche Diagnostics. Eversley, Judith A. .............................. Disclosed no confl ict of interest.Evert, Alison B. .................................... Disclosed no confl ict of interest.Evran, Mehtap ..................................... Disclosed no confl ict of interest.Ewis, Soliman A. ................................. Disclosed no confl ict of interest.Ezeanolue, Echezona .......................... Research Support: National Institutes of Health. Ezenwaka, Chidum E. .......................... Disclosed no confl ict of interest.Ezrokhi, Michael .................................. Employee: VeroScience, LLC. Ezzy, Stephen M. ................................. Research Support: Novo Nordisk A/S. Faber, T. ............................................... Disclosed no confl ict of interest.Faber-Heinemann, Gabriele ............... Disclosed no confl ict of interest.Fabra, Amparo ..................................... Disclosed no confl ict of interest.Fadavi, Hassan .................................... Disclosed no confl ict of interest.Fadini, Gian Paolo ............................... Disclosed no confl ict of interest.Fadista, Joao ....................................... Disclosed no confl ict of interest.Færch, Kristine .................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Fagerholm, Emma ............................... Disclosed no confl ict of interest.Fagerholm, Susanna C. ....................... Disclosed no confl ict of interest.Fahlbusch, Pia ..................................... Disclosed no confl ict of interest.Fahrbach, Jessie L. ............................. Employee: Eli Lilly and Company. Fahrmann, Elke R. ............................... Disclosed no confl ict of interest.Fakih, Doaa .......................................... Disclosed no confl ict of interest.Falappa, Marcelo ................................ Disclosed no confl ict of interest.Falk, Christine S. ................................. Disclosed no confl ict of interest.Falk, Marni J. ....................................... Disclosed no confl ict of interest.Fall, Tove .............................................. Disclosed no confl ict of interest.Falzano, Valeriana ............................... Disclosed no confl ict of interest.Famulla, Susanne ................................ Disclosed no confl ict of interest.Fan, Bei ................................................ Employee: Boehringer Ingelheim (China) Investment Co., Ltd. Fan, Chun-Po Steve ............................. Consultant: Asclepius Analytics. Fan, David ............................................ Disclosed no confl ict of interest.Fan, Guanjie ......................................... Disclosed no confl ict of interest.Fan, Hong Wei ..................................... Disclosed no confl ict of interest.Fan, Shengjie ....................................... Disclosed no confl ict of interest.Fan, Yong ............................................. Disclosed no confl ict of interest.Fandino, Luis ........................................ Disclosed no confl ict of interest.Fanelli, Carmine G. .............................. Advisory Panel: Sanofi U.S.; Research Support: Bristol-

Myers Squibb Company, Menarini Group, Merck & Co., Inc.

Fang, Chen ........................................... Disclosed no confl ict of interest.Fang, Hong ........................................... Disclosed no confl ict of interest.

Fang, Wei-Jin ...................................... Disclosed no confl ict of interest.Fang, Xingyuan .................................... Disclosed no confl ict of interest.Fang, Zhe ............................................. Disclosed no confl ict of interest.Fang, Zhiwei ........................................ Disclosed no confl ict of interest.Fanin, Alice .......................................... Disclosed no confl ict of interest.Fantus, George I. ................................. Disclosed no confl ict of interest.Farabi, Sarah S. ................................... Disclosed no confl ict of interest.Farah, Rafi c .......................................... Disclosed no confl ict of interest.Farahani, Pendar ................................. Consultant: AstraZeneca Canada, Amgen Canada; Research

Support: AstraZeneca Canada. Faraj, May ............................................ Disclosed no confl ict of interest.Farb, Thomas B. ................................... Employee: Eli Lilly and Company. Farchoukh, Lama ................................. Disclosed no confl ict of interest.Farese, Robert ..................................... Disclosed no confl ict of interest.Farese-Higgs, Margaret ..................... Disclosed no confl ict of interest.Farges, Blandine ................................. Disclosed no confl ict of interest.Faria, Juliana ....................................... Disclosed no confl ict of interest.Farmen, Mark W. ................................ Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Farmer, Adam D. .................................. Speaker’s Bureau: Almirall, S. A. Farmer, Andrew ................................... Disclosed no confl ict of interest.Farmer, Ben ......................................... Disclosed no confl ict of interest.Farmer, Stephen R. ............................. Disclosed no confl ict of interest.Farney, Alan ......................................... Disclosed no confl ict of interest.Farngren, Johan .................................. Disclosed no confl ict of interest.Farnsworth, Nikki L. ............................ Disclosed no confl ict of interest.Farooqi, Mohammed A. ...................... Disclosed no confl ict of interest.Farr, Sarah L. ....................................... Disclosed no confl ict of interest.Farran, Bassam ................................... Disclosed no confl ict of interest.Farrell, Kaye ........................................ Disclosed no confl ict of interest.Farret, Anne ......................................... Disclosed no confl ict of interest.Farrow, Reginald ................................. Disclosed no confl ict of interest.Farsiu, Sina .......................................... Disclosed no confl ict of interest.Fasanmade, Olufemi ........................... Disclosed no confl ict of interest.Fasold, Mario ...................................... Disclosed no confl ict of interest.Fath, Maryam ...................................... Disclosed no confl ict of interest.Fathman, C. Garrison .......................... Disclosed no confl ict of interest.Faure, Robert ....................................... Disclosed no confl ict of interest.Faustman, Denise L. ............................ Disclosed no confl ict of interest.Favreau, Colette .................................. Disclosed no confl ict of interest.Fayfman, Maya ................................... Disclosed no confl ict of interest.Fayman, Gila ........................................ Disclosed no confl ict of interest.Fazakerely, Daniel J. ........................... Disclosed no confl ict of interest.Fealy, Ciarán E. .................................... Disclosed no confl ict of interest.Fedders, Mark D. ................................. Disclosed no confl ict of interest.Federico, Virginia ................................ Disclosed no confl ict of interest.Federspiel, Cecilie A. .......................... Disclosed no confl ict of interest.Feener, Edward P. ................................ Disclosed no confl ict of interest.Feghali, Maisa ..................................... Disclosed no confl ict of interest.Feher, Michael ..................................... Advisory Panel: Merck Sharp & Dohme, Novo Nordisk

Inc., Sanofi U.S.; Research Support: Amgen Inc., Novo Nordisk Inc.; Speaker’s Bureau: AstraZeneca/Bristol-Myers Squibb, Boehringer Ingelheim Pharmaceuticals, Inc., Johnson & Johnson.

Fei, Wenjie ........................................... Disclosed no confl ict of interest.Feig, Denice S. .................................... Disclosed no confl ict of interest.Feigl, Andrea B. ................................... Disclosed no confl ict of interest.Fek, Attila ............................................ Disclosed no confl ict of interest.Felder, Thomas .................................... Disclosed no confl ict of interest.Feldman, Dmitry .................................. Consultant: Insuline Medical Ltd. Feldman, Eva L. ................................... Disclosed no confl ict of interest.Feldman, Jonah ................................... Disclosed no confl ict of interest.Felix, Janine F. ..................................... Disclosed no confl ict of interest.Felner, Eric I. ........................................ Research Support: Astellas Pharma US, Inc., Bayer

HealthCare, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases.

Fels, Johannes J. ................................ Employee: Novo Nordisk A/S; Stock/Shareholder: Novo Nordisk A/S.

Fendler, Wojciech ............................... Disclosed no confl ict of interest.Feng, Biao ............................................ Disclosed no confl ict of interest.Feng, Juanran ...................................... Disclosed no confl ict of interest.Feng, Wei ............................................. Disclosed no confl ict of interest.Feng, Wu .............................................. Disclosed no confl ict of interest.Feng, Yingmei ...................................... Disclosed no confl ict of interest.Feng, Yue ............................................. Employee: Merck & Co., Inc. Fenici, Peter ......................................... Employee: AstraZeneca; Stock/Shareholder: AstraZeneca,

Bristol Myers Squibb. Fenwick, Stephen W. .......................... Disclosed no confl ict of interest.Feoktistov, Vitalij A. ........................... Research Support: Karaganda State Medical University. Feo-Ortega, Gara ................................ Disclosed no confl ict of interest.Ferber, Sarah ....................................... Disclosed no confl ict of interest.

A831

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Ferdinand, Keith C. .............................. Consultant: Amgen Inc., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Sanofi U.S.; Research Support: Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company.

Ferdousi, Maryam ............................... Disclosed no confl ict of interest.Ferguson, Jessica ............................... Disclosed no confl ict of interest.Fernandes, Gabriel R. ......................... Disclosed no confl ict of interest.Fernandes, Jonita E. ........................... Disclosed no confl ict of interest.Fernandes, Salomao ........................... Disclosed no confl ict of interest.Fernandez Lando, Laura ...................... Employee: Eli Lilly and Company. Fernandez Tajes, Juan ........................ Disclosed no confl ict of interest.Fernandez, Louis ................................. Disclosed no confl ict of interest.Fernandez, Marlene ............................ Disclosed no confl ict of interest.Fernandez, Stephen ............................ Disclosed no confl ict of interest.Fernández-Garate, José Esteban ...... Disclosed no confl ict of interest.Fernandez-Navarro, Jose Ignacio ...... Disclosed no confl ict of interest.Fernandez-Tresguerres, Beatriz ......... Employee: Bayer HealthCare. Fernandez-Veledo, Sonia .................... Disclosed no confl ict of interest.Ferrannini, Ele ..................................... Advisory Panel: Astra Zeneca, Eli Lilly & Co., Johnson &

Johnson, Merck Sharp & Dohme, Sanofi , Takeda; Research Support: Boehringer Ingelheim, Eli Lilly & Co.

Ferrara, Assiamira .............................. Research Support: Takeda Pharmaceutical Company Limited.

Ferrara, Lidia ....................................... Disclosed no confl ict of interest.Ferrazzoli, Valentina ........................... Disclosed no confl ict of interest.Ferreira, Danilo .................................... Disclosed no confl ict of interest.Ferreira, Mari C. .................................. Disclosed no confl ict of interest.Ferreira, Rute ...................................... Disclosed no confl ict of interest.Ferreira, Sandra R. .............................. Disclosed no confl ict of interest.Ferreira, Victor H. ................................ Disclosed no confl ict of interest.Ferrell, Robert E. ................................. Disclosed no confl ict of interest.Ferrelli, Francesca ............................... Disclosed no confl ict of interest.Ferri, Leticia ......................................... Employee: Bristol-Myers Squibb Company; Stock/

Shareholder: Bristol-Myers Squibb Company. Ferrier, Bernard ................................... Stock/Shareholder: Metabolys Inc. Ferris, Heather .................................... Disclosed no confl ict of interest.Ferrito, Lucia ........................................ Disclosed no confl ict of interest.Ferullo, Andrea .................................... Disclosed no confl ict of interest.Fesinmeyer, Megan ............................ Disclosed no confl ict of interest.Festa, Andreas .................................... Disclosed no confl ict of interest.Fetchick, Dianne .................................. Disclosed no confl ict of interest.Fiaschi-Taesch, Nathalie M. ............... Disclosed no confl ict of interest.Ficarella, Romina ................................ Disclosed no confl ict of interest.Ficorilli, James V. ................................ Employee: Eli Lilly and Company. Fiedler, Jan .......................................... Disclosed no confl ict of interest.Fielding, Robert M. ............................. Disclosed no confl ict of interest.Fields, David A. ................................... Research Support: Abbott. Figueroa, Katherine ............................ Employee: Janssen Research & Development LLC. Figueroa-Romero, Claudia .................. Disclosed no confl ict of interest.Fik, Ewa ................................................ Disclosed no confl ict of interest.Filarski, Remigiusz .............................. Disclosed no confl ict of interest.Filatova, Nika ...................................... Disclosed no confl ict of interest.Filipponi, Franco .................................. Disclosed no confl ict of interest.Filippova, Ekaterina ............................ Employee: Medinet, LLC. Fima, Eyal ............................................ Disclosed no confl ict of interest.Fimia, Gian Maria ................................ Disclosed no confl ict of interest.Finck, Brian N. ..................................... Disclosed no confl ict of interest.Fincke, Benjamin G. ............................. Disclosed no confl ict of interest.Fineman, Mark .................................... Employee: Elcelyx Therapeutics, Inc.; Stock/Shareholder:

Elcelyx Therapeutics, Inc. Fink, Brian D. ....................................... Disclosed no confl ict of interest.Fink, James B. ..................................... Consultant: Aerogen, Ansun, Aridis, Parion, Quark;

Employee: Dance Biopharm; Stock/Shareholder: Dance Biopharm.

Finkelstein, Jonathan ......................... Disclosed no confl ict of interest.Finlayson, Alexander .......................... Disclosed no confl ict of interest.Finlayson, Jean ................................... Disclosed no confl ict of interest.Finlin, Brian S. ..................................... Disclosed no confl ict of interest.Finner, Helmut ..................................... Disclosed no confl ict of interest.Fino, Nora ............................................ Disclosed no confl ict of interest.Fioretto, Paola ..................................... Advisory Panel: Bristol-Myers Squibb/AstraZeneca;

Speaker’s Bureau: Bristol-Myers Squibb/AstraZeneca, Janssen Research & Development LLC.

Fiori, Jennifer L. .................................. Disclosed no confl ict of interest.Fiorina, Paolo ....................................... Disclosed no confl ict of interest.Fischer, Annelie ................................... Disclosed no confl ict of interest.Fischer, Gerald .................................... Disclosed no confl ict of interest.Fischer, Stuart G. ................................ Disclosed no confl ict of interest.Fischl, Andrea ...................................... Disclosed no confl ict of interest.Fish, Shayna ........................................ Disclosed no confl ict of interest.Fisher, Edwin B. ................................... Research Support: Bristol-Myers Squibb Company, Eli Lilly

and Company.

Fisher, Elizabeth .................................. Disclosed no confl ict of interest.Fisher, Lawrence ................................. Consultant: Eli Lilly and Company, Roche USA; Research

Support: National Institute of Diabetes and Digestive and Kidney Diseases.

Fisher, Maxine ..................................... Consultant: Genentech, Inc. Fisher, Miles ........................................ Advisory Panel: Boehringer Ingelheim, Eli Lilly, Janssen,

Merck Sharp & Dohme, Novo Nordisk, Sanofi , Takeda; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Merck Sharp & Dohme, Novo Nordisk, Sanofi .

Fitzgibbon, Margret L. ........................ Disclosed no confl ict of interest.Fitz-Randolph, Marcy .......................... Employee: PatientsLikeMe; Research Support: Abbvie,

Accorda, Actelion Pharmaceuticals Ltd., Amgen Inc., AstraZeneca Pharmaceuticals LP, Avanir, Biogen Idec, Boehringer Ingelheim Pharmaceuticals, Inc., Genzyme Corporation, Janssen Pharmaceutical Companies of Johnson & Johnson, Johnson & Johnson, Kaiser Permanente, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Robert Wood Johnson Foundation, Sage Bionetworks, Sanofi U.S., The AKU Society, The University of Maryland, UCB; Stock/Shareholder: PatientsLikeMe.

Fjeld, Karianne .................................... Disclosed no confl ict of interest.Flak, Jonathan N. ................................ Disclosed no confl ict of interest.Flanagan, Daniel ................................. Disclosed no confl ict of interest.Flannick, Jason A. ............................... Disclosed no confl ict of interest.Flatmark, Torgeir ................................. Disclosed no confl ict of interest.Fleck, Penny R. .................................... Employee: Takeda Pharmaceutical Company Limited. Fleischer, Jesper ................................. Consultant: Medicus Engineering; Stock/Shareholder:

Medicus Engineering. Fleming, Thomas H. ............................ Disclosed no confl ict of interest.Fleres, Mattia ...................................... Disclosed no confl ict of interest.Fleury, Michelle ................................... Disclosed no confl ict of interest.Fligner, Corinne L. ............................... Disclosed no confl ict of interest.Flood, Emuella M. ............................... Research Support: AstraZeneca/Bristol-Myers Squibb. Florea, Bogdan .................................... Disclosed no confl ict of interest.Flores, Isidore ...................................... Disclosed no confl ict of interest.Flores, Juana ....................................... Disclosed no confl ict of interest.Flores, Natalia M. Flores .................... Disclosed no confl ict of interest.Florey, Garrett ..................................... Disclosed no confl ict of interest.Florez, Hermes .................................... Disclosed no confl ict of interest.Florez, Jose C. ..................................... Consultant: consulting fees, PanGenX - consulting fees,

Pfi zer Inc. Floyd, Lillie ........................................... Disclosed no confl ict of interest.Flynn, Charles ...................................... Disclosed no confl ict of interest.Focht, Brian ......................................... Disclosed no confl ict of interest.Fog, Jacob U. ....................................... Employee: Zealand Pharma A/S. Fogel, Aviel .......................................... Disclosed no confl ict of interest.Fogelfeld, Leon .................................... Disclosed no confl ict of interest.Foghsgaard, Signe .............................. Research Support: Novo Nordisk A/S; Speaker’s Bureau:

Merck Sharp & Dohme, Novo Nordisk A/S. Folaron, Irene ...................................... Disclosed no confl ict of interest.Foley, James E. .................................... Employee: Novartis Pharmaceuticals Corporation; Stock/

Shareholder: Novartis Pharmaceuticals Corporation. Foncea, Rocio ...................................... Disclosed no confl ict of interest.Fong, Natalie K. ................................... Disclosed no confl ict of interest.Fong, Tung M. ...................................... Disclosed no confl ict of interest.Fonseca, Vivian ................................... Disclosed no confl ict of interest.Fontana, Andrea ................................. Disclosed no confl ict of interest.Forbes, Josephine ............................... Disclosed no confl ict of interest.Ford, Derek .......................................... Disclosed no confl ict of interest.Foretz, Marc ........................................ Disclosed no confl ict of interest.Forken, Patricia ................................... Research Support: National Institute of Diabetes and

Digestive and Kidney Diseases. Forlenza, Gregory P. ............................ Research Support: Medtronic MiniMed, Inc. Forman, John P. ................................... Disclosed no confl ict of interest.Formosa, Melissa F. ............................ Disclosed no confl ict of interest.Fornaciari, Silvia ................................. Disclosed no confl ict of interest.Fornage, Myriam ................................. Disclosed no confl ict of interest.Fornoni, Alessia .................................. Consultant: Roche Diagnostics. Forostyan, Tanya ................................. Disclosed no confl ict of interest.Foroutan, Janelle ................................ Disclosed no confl ict of interest.Forsbäck, Sarita .................................. Disclosed no confl ict of interest.Forsberg, Matthew H. ........................ Disclosed no confl ict of interest.Forsblom, Carol ................................... Disclosed no confl ict of interest.Forst, Thomas ...................................... Advisory Panel: AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, Sanofi U.S.; Research Support: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH, Novartis Corporation, Sanofi U.S.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Berlin-Chemie AG, Boehringer Ingelheim GmbH, Bristol-

A832

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Myers Squibb Company, Eli Lilly and Company, Novartis Corporation, Novo Nordisk Inc., Sanofi U.S.

Forteath, Calum .................................. Disclosed no confl ict of interest.Fortier, Suzanne .................................. Disclosed no confl ict of interest.Fortmann, Addie L. .............................. Disclosed no confl ict of interest.Fosgerau, Keld ..................................... Stock/Shareholder: Zealand Pharma A/S. Foster, Karla ........................................ Disclosed no confl ict of interest.Foster, Kathleen .................................. Disclosed no confl ict of interest.Foster, Leonard J. ............................... Disclosed no confl ict of interest.Foster, Nicole C. .................................. Disclosed no confl ict of interest.Foster-Schubert, Karen ...................... Disclosed no confl ict of interest.Fotieo, Gregory .................................... Disclosed no confl ict of interest.Fotino, Carmen .................................... Disclosed no confl ict of interest.Foucat, Emile ....................................... Disclosed no confl ict of interest.Foucher, Julie A. ................................. Advisory Panel: CrossFit Inc.; Employee: CrossFit Inc.; Other

Relationship: CrossFit Inc. Founds, Sandra .................................... Disclosed no confl ict of interest.Fountaine, Robert ............................... Employee: Pfi zer Inc.; Stock/Shareholder: Pfi zer Inc. Fountoulakis, Nikos ............................ Disclosed no confl ict of interest.Fouqueray, Pascale ............................. Disclosed no confl ict of interest.Fourcaudot, Marcel ............................ Disclosed no confl ict of interest.Fouts, Alexandra R. ............................. Disclosed no confl ict of interest.Fowler, Samantha ............................... Disclosed no confl ict of interest.Fox, Caroline S. ................................... Disclosed no confl ict of interest.Fox, Claudia K. ..................................... Disclosed no confl ict of interest.Fox, Ervin ............................................. Disclosed no confl ict of interest.Fox, Larry A. ........................................ Disclosed no confl ict of interest.Fox, Peter ............................................. Disclosed no confl ict of interest.Fra, Gian Paolo .................................... Disclosed no confl ict of interest.Fradkin, Judith E. ................................ Disclosed no confl ict of interest.Frahnow, Turid ..................................... Disclosed no confl ict of interest.Fraige Filho, Fadlo ............................... Disclosed no confl ict of interest.Fraker, Christopher ............................. Disclosed no confl ict of interest.Franc, Sylvia ........................................ Disclosed no confl ict of interest.Frances, Francisco .............................. Disclosed no confl ict of interest.Francesconi, Paolo .............................. Disclosed no confl ict of interest.Franchow, Emilie I. .............................. Disclosed no confl ict of interest.Francia, Piergiorgio ............................. Disclosed no confl ict of interest.Franco, Oscar H. .................................. Disclosed no confl ict of interest.Frandsen, Christian S. ........................ Research Support: Novo Nordisk A/S. Frandsen, Erik ...................................... Disclosed no confl ict of interest.Franek, Edward ................................... Speaker’s Bureau: Sanofi -Aventis New Zealand Ltd. Franik, Grzegorz .................................. Disclosed no confl ict of interest.Frank, James A. .................................. Disclosed no confl ict of interest.Fraser, William .................................... Disclosed no confl ict of interest.Fraty, Mathilde .................................... Disclosed no confl ict of interest.Fraunberger, Peter .............................. Disclosed no confl ict of interest.Frazier-Wood, Alexis ........................... Disclosed no confl ict of interest.Freathy, Rachel M. .............................. Disclosed no confl ict of interest.Freckmann, Guido ............................... Advisory Panel: Abbott Diabetes Care, Inc., Bayer

HealthCare, Sanofi ; Consultant: Novo Nordisk A/S; Speaker’s Bureau: Abbott Diabetes Care, Inc., Bayer HealthCare, Berlin-Chemie AG, Roche Diagnostics, Sanofi , Ypsomed.

Frederiks, Pascal ................................. Disclosed no confl ict of interest.Free, Almena ....................................... Research Support: PhaseBio Pharmaceuticals, Inc. Free, Colette ........................................ Disclosed no confl ict of interest.Freed, Gary L. ...................................... Disclosed no confl ict of interest.Freedman, Barry I. ............................... Research Support: Impeto Medical. Freeman, Jennifer L. ........................... Employee: TransTech Pharma, LLC. Freeman, Kurt ...................................... Disclosed no confl ict of interest.Frej, Cecilia .......................................... Disclosed no confl ict of interest.Fric, Premysl ........................................ Disclosed no confl ict of interest.Fried, Susan K. .................................... Disclosed no confl ict of interest.Friedemann Smith, Clair ..................... Consultant: Novo Nordisk A/S. Friedline, Randall H. ............................ Disclosed no confl ict of interest.Friedman, Jacob E. (Jed) .................... Disclosed no confl ict of interest.Friedman, Nir ....................................... Disclosed no confl ict of interest.Friedman, Theodore ............................ Disclosed no confl ict of interest.Friedrichsen, Martin ........................... Stock/Shareholder: Novo Nordisk A/S. Friis, Steffen U. ................................... Disclosed no confl ict of interest.Frisk, Thomas ...................................... Disclosed no confl ict of interest.Fritsche, Andreas ................................ Disclosed no confl ict of interest.Fritsch-Fredin, Maria .......................... Employee: AstraZeneca Pharmaceuticals LP. Fritschi, Cynthia .................................. Disclosed no confl ict of interest.Frizzell, Norma .................................... Disclosed no confl ict of interest.Froguel, Philippe .................................. Disclosed no confl ict of interest.Fröhlich-Reiterer, Elke ........................ Disclosed no confl ict of interest.Frohnert, Brigitte I. ............................. Disclosed no confl ict of interest.Frois, Christian .................................... Employee: Analysis Group. Frongia, Annapaola ............................. Disclosed no confl ict of interest.Frongillo, Edward A. ........................... Disclosed no confl ict of interest.

Frost, Shaun D. .................................... Disclosed no confl ict of interest.Froy, Oren ............................................. Disclosed no confl ict of interest.Fruchter, Eyal ....................................... Disclosed no confl ict of interest.Frykberg, Robert G. ............................. Disclosed no confl ict of interest.Fu, Alex Z. ............................................ Research Support: Merck & Co., Inc. Fu, Amy W. ........................................... Disclosed no confl ict of interest.Fu, Chia-Po ........................................... Disclosed no confl ict of interest.Fu, Dongxu ........................................... Disclosed no confl ict of interest.Fu, Feng ................................................ Disclosed no confl ict of interest.Fu, Haoda ............................................. Employee: Eli Lilly and Company, Eli Lilly and Company

(Spouse/Partner); Stock/Shareholder: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner).

Fu, Hsin-Mei ........................................ Disclosed no confl ict of interest.Fu, Jeffrey ........................................... Disclosed no confl ict of interest.Fu, Kui .................................................. Disclosed no confl ict of interest.Fu, Mei ................................................. Disclosed no confl ict of interest.Fu, Xiaorong ........................................ Disclosed no confl ict of interest.Fu, Yingyu ............................................ Disclosed no confl ict of interest.Fu, Yuchang ......................................... Disclosed no confl ict of interest.Fu, Zhuo ............................................... Disclosed no confl ict of interest.Fueger, Patrick T. ................................. Disclosed no confl ict of interest.Fufaa, Gudeta ...................................... Disclosed no confl ict of interest.Fuhlbrigge, Rebecca ........................... Disclosed no confl ict of interest.Fuhrmann, Amelia ............................... Disclosed no confl ict of interest.Fujihara, Kazuya .................................. Disclosed no confl ict of interest.Fujikawa, Jun ...................................... Disclosed no confl ict of interest.Fujimaki, Yuko ..................................... Disclosed no confl ict of interest.Fujimori, Shin ....................................... Disclosed no confl ict of interest.Fujimoto, Kanta ................................... Disclosed no confl ict of interest.Fujimoto, Wilfred Y. ............................ Disclosed no confl ict of interest.Fujimura, Takanori ............................... Disclosed no confl ict of interest.Fujioka, Kei .......................................... Disclosed no confl ict of interest.Fujioka, Kenneth ................................. Advisory Panel: Enteromedics Inc., Isis Pharmaceuticals,

Inc., NaZura, Novo Nordisk Inc., Zafgen; Consultant: Enteromedics Inc., Isis Pharmaceuticals, Inc., NaZura, Novo Nordisk Inc., Zafgen; Research Support: Eisai Co., Ltd., Enteromedics Inc., Novo Nordisk Inc., Orexigen Therapeutics, Inc., Shire, Weight Watchers International, Inc.; Speaker’s Bureau: Abbott, Eisai Co., Ltd., Takeda Pharmaceuticals U.S.A., Inc., Vivus Inc.

Fujioka, Youhei .................................... Disclosed no confl ict of interest.Fujisaka, Shiho .................................... Disclosed no confl ict of interest.Fujisawa, Yuhki ................................... Disclosed no confl ict of interest.Fujishiro, Midori .................................. Disclosed no confl ict of interest.Fujita, Hideo ........................................ Other Relationship: NTT DOCOMO. Fujita, Masamichi ............................... Disclosed no confl ict of interest.Fujita, Satoshi ..................................... Disclosed no confl ict of interest.Fujita, Yoshihito .................................. Disclosed no confl ict of interest.Fujita, Yukihiro .................................... Research Support: Eli Lilly and Company, Merck Sharp &

Dohme, Novo Nordisk Inc.; Speaker’s Bureau: Astellas Pharma US, Inc., Boehringer Ingelheim GmbH, Daiichi-Sankyo Co., Ltd., Kowa Pharmaceuticals, Merck Sharp & Dohme, Mitsubishi Tanabe Pharma Corporation, Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Sanofi U.S., Taisho Pharmaceutical Co., Ltd.

Fujita, Yukio ......................................... Disclosed no confl ict of interest.Fujitani, Yishio ..................................... Research Support: MSD, Takeda Pharmaceutical Company

Limited. Fujitani, Yoshio .................................... Research Support: MSD, Takeda Pharmaceutical Company

Limited. Fujitani, Yosio ...................................... Research Support: MDS, Inc., Takeda Pharmaceutical

Company Limited. Fujiwara, Toshimasa ........................... Disclosed no confl ict of interest.Fukagawa, Masafumi ......................... Disclosed no confl ict of interest.Fukuda, Kazuhito ................................. Disclosed no confl ict of interest.Fukuda, Takuya .................................... Disclosed no confl ict of interest.Fukuda, Tatsuya .................................. Disclosed no confl ict of interest.Fukui, Michiaki .................................... Disclosed no confl ict of interest.Fukui, R.T. ............................................. Disclosed no confl ict of interest.Fukui, Rosa .......................................... Disclosed no confl ict of interest.Fukumoto, Shinya ................................ Research Support: Asahi Kasei Pharm Corporation, Astellas

Pharma Inc, Daiichi Sankyo Co., Ltd, Mitsubisi Tanabe Pharma Corporation, Takeda Pharmaceutical Company Limited.

Fukuoka, Yoshimi ................................ Disclosed no confl ict of interest.Fukushima, Sayaka ............................. Disclosed no confl ict of interest.Fukushima, Toru .................................. Disclosed no confl ict of interest.Fukushima, Toshiaki ............................ Disclosed no confl ict of interest.Fulcher, Greg ....................................... Disclosed no confl ict of interest.Fulkerson, Candice .............................. Disclosed no confl ict of interest.Fuller, Miles ......................................... Disclosed no confl ict of interest.Fulzele, Keertik .................................... Disclosed no confl ict of interest.

A833

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Fumeron, Frédéric ............................... Disclosed no confl ict of interest.Funaki, Makoto .................................... Disclosed no confl ict of interest.Funakoshi, Satoshi .............................. Disclosed no confl ict of interest.Funayama, Takashi .............................. Disclosed no confl ict of interest.Funayama, Takasi ................................ Disclosed no confl ict of interest.Funch, Donnie P. .................................. Research Support: Novo Nordisk A/S. Funck, Kristian L. ................................. Disclosed no confl ict of interest.Funda, David P. .................................... Disclosed no confl ict of interest.Fundova, Petra .................................... Disclosed no confl ict of interest.Fung, Kinwah ....................................... Disclosed no confl ict of interest.Fung, Teresa T. .................................... Disclosed no confl ict of interest.Funnell, Martha M. ............................. Advisory Panel: Hygieia. Furer, Ariel ........................................... Disclosed no confl ict of interest.Furler, John .......................................... Research Support: Roche Diagnostics, Sanofi . Furshong, Ginny .................................. Disclosed no confl ict of interest.Furukawa, Asami ................................ Disclosed no confl ict of interest.Furukawa, Shinya ................................ Disclosed no confl ict of interest.Furukawa, Shoko ................................. Disclosed no confl ict of interest.Furukawa, Yasuhiko ............................ Disclosed no confl ict of interest.Furuta, Hiroto ...................................... Disclosed no confl ict of interest.Furuya, Futoshi .................................... Disclosed no confl ict of interest.Fuse, Yukie ........................................... Disclosed no confl ict of interest.Fushimi, Nobutoshi ............................. Disclosed no confl ict of interest.Fyalka, Robert ..................................... Disclosed no confl ict of interest.Fysekidis, Marinos .............................. Disclosed no confl ict of interest.Gabay, Cem .......................................... Disclosed no confl ict of interest.Gabrielsen, J. Scott ............................ Disclosed no confl ict of interest.Gachupin, Francine ............................. Disclosed no confl ict of interest.Gadir, Noga .......................................... Employee: Merck & Co., Inc. Gafter, Uzi ............................................ Disclosed no confl ict of interest.Gagnon, Anne Marie ........................... Disclosed no confl ict of interest.Gagnon, Jeffrey .................................. Disclosed no confl ict of interest.Gagnon, Lyne ....................................... Disclosed no confl ict of interest.Gai, Xiaowu ......................................... Disclosed no confl ict of interest.Gaillard, Trudy ..................................... Advisory Panel: Daiichi-Sankyo Co., Ltd. Gaisano, Herbert Y. ............................. Disclosed no confl ict of interest.Galan, Amanda K. ............................... Disclosed no confl ict of interest.Galassetti, Pietro ................................ Disclosed no confl ict of interest.Galasso, Silvia ..................................... Disclosed no confl ict of interest.Gale, Nicholas W. ............................... Employee: Regeneron Pharmaceuticals, Inc. Galecki, Andrzej T. .............................. Disclosed no confl ict of interest.Galekman, Olga ................................... Disclosed no confl ict of interest.Galesanu, Corina ................................. Disclosed no confl ict of interest.Galgani, Jose E. ................................... Disclosed no confl ict of interest.Galieva, Marina O. .............................. Disclosed no confl ict of interest.Galindo, Rodolfo J. .............................. Disclosed no confl ict of interest.Galjaard, Sander ................................. Disclosed no confl ict of interest.Gallagher, Emily J. .............................. Disclosed no confl ict of interest.Gallagher, Jennifer R. ......................... Disclosed no confl ict of interest.Gallagher, Katherine ........................... Disclosed no confl ict of interest.Gallagher, Martin ................................ Disclosed no confl ict of interest.Gallaugher, Michael ............................ Disclosed no confl ict of interest.Gallezot, Jean-Dominique .................. Disclosed no confl ict of interest.Galli, Angelica ..................................... Disclosed no confl ict of interest.Galloway, Jamie .................................. Disclosed no confl ict of interest.Gallwitz, Baptist ................................. Advisory Panel: AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck Sharp & Dohme, Novartis Pharmaceuticals Corporation; Consultant: GlaxoSmithKline; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck Sharp & Dohme, Novartis Corporation, Novo Nordisk Inc., Sanofi U.S.

Galstyan, Gagik ................................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Merck Sharp & Dohme, Novo Nordisk A/S; Research Support: BC Pharma, Novartis Pharmaceuticals Corporation; Speaker’s Bureau: Berlin-Chemie AG, Eli Lilly and Company, MDS, Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi U.S.

Galuschka, Laura ................................. Disclosed no confl ict of interest.Gamerman, Victoria ............................ Employee: Boehringer Ingelheim Pharmaceuticals Inc. Gan, Ryan W. ....................................... Disclosed no confl ict of interest.Gan, Wei .............................................. Disclosed no confl ict of interest.Ganbold, Munkhzul ............................. Disclosed no confl ict of interest.Gancheva, Sofi ya ................................ Disclosed no confl ict of interest.Gand, Elise ........................................... Disclosed no confl ict of interest.Gandhi, Gunjan .................................... Disclosed no confl ict of interest.Gandhi, R. ............................................ Disclosed no confl ict of interest.Gandhi, Rajiv ....................................... Disclosed no confl ict of interest.

Gandhi, Shriya ..................................... Disclosed no confl ict of interest.Ganesan, Goutham ............................. Disclosed no confl ict of interest.Ganetsky, Valerie S. ............................ Disclosed no confl ict of interest.Ganguly, Sonali ................................... Disclosed no confl ict of interest.Gani, Linsey U. ..................................... Disclosed no confl ict of interest.Gannon, Maureen A. ........................... Disclosed no confl ict of interest.Gantz, Ira ............................................. Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &

Co., Inc. Ganz, Xenia .......................................... Disclosed no confl ict of interest.Gao, Chenlin ........................................ Disclosed no confl ict of interest.Gao, Fabao ........................................... Disclosed no confl ict of interest.Gao, He ................................................ Disclosed no confl ict of interest.Gao, Jing .............................................. Disclosed no confl ict of interest.Gao, Junhong ...................................... Disclosed no confl ict of interest.Gao, Leili .............................................. Disclosed no confl ict of interest.Gao, Ling .............................................. Other Relationship: A consultant at Sanofi US, Inc., Analysta

Inc., Somerset, NJ. Gao, Long ............................................. Disclosed no confl ict of interest.Gao, Mingming .................................... Disclosed no confl ict of interest.Gao, Peng ............................................. Disclosed no confl ict of interest.Gao, Qian ............................................. Disclosed no confl ict of interest.Gao, Shan ............................................ Disclosed no confl ict of interest.Gao, Xiaoli ........................................... Disclosed no confl ict of interest.Gao, Xin ................................................ Disclosed no confl ict of interest.Gao, Xiuying ........................................ Disclosed no confl ict of interest.Gao, Yan ............................................... Disclosed no confl ict of interest.Gao, Yong ............................................. Disclosed no confl ict of interest.Gao, Yongyi .......................................... Disclosed no confl ict of interest.Gao, Yue ............................................... Disclosed no confl ict of interest.Gao, Yun ............................................... Disclosed no confl ict of interest.Gao, Zhiqian ........................................ Disclosed no confl ict of interest.Gao, Zhi-Qin ......................................... Disclosed no confl ict of interest.Garber, Channing ................................ Disclosed no confl ict of interest.Garcia de Quevedo, Isabel ................. Disclosed no confl ict of interest.García Vicente, Silvia ......................... Employee: Genmedica Therapeutics S.L. Garcia Zarco, Mar ............................... Disclosed no confl ict of interest.Garcia, Cyril ......................................... Disclosed no confl ict of interest.Garcia, Jeanette ................................. Research Support: LifeScan, Inc. Garcia-Alcala, Hector ......................... Disclosed no confl ict of interest.Garcia-Contreras, Marta .................... Disclosed no confl ict of interest.Garcia-Dolagaray, Gabriela ................ Disclosed no confl ict of interest.García-Hernández, Pedro A. ............... Consultant: Amgen Inc., Merck Sharp & Dohme; Research

Support: Amgen Inc., Eli Lilly and Company, Merck Sharp & Dohme, Novo Nordisk A/S; Speaker’s Bureau: Amgen Inc., Eli Lilly and Company, Merck Sharp & Dohme.

Garcia-Ocaña, Adolfo ......................... Disclosed no confl ict of interest.García-Sáez, Gema ............................. Disclosed no confl ict of interest.Garcia-Sanchez, Ricardo .................... Employee: AstraZeneca/Bristol-Myers Squibb; Stock/

Shareholder: Bristol-Myers Squibb Company. Gardner, Thomas W. ........................... Consultant: Johnson & Johnson, KalVista Pharmaceuticals

Inc., Novo Nordisk Inc. Gardon Rose, Jessica ......................... Disclosed no confl ict of interest.Garduno Garcia, Jose de Jesus ......... Disclosed no confl ict of interest.Garg, Abhimanyu ................................ Consultant: Amgen Inc., Back Bay Life Sciences, BioMarin,

Eli Lilly and Company, Engage Health, Gerson Lehman Group, Hyperion Therapeutics, Ipsen Bioscience, Inc., MEDACorp; Research Support: Amylin Pharmaceuticals, LLC., AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Pfi zer Inc.

Garg, Rajesh ........................................ Research Support: AstraZeneca/Bristol-Myers Squibb. Garg, Satish K. .................................... Advisory Panel: Eisai Co., Ltd., JAEB Center, Juvenile

Diabetes Research Foundation, Lexicon Pharmaceuticals, Inc., Medtronic, National Institute of Diabetes and Digestive and Kidney Diseases, Novo Nordisk, Roche Diagnostics, sanofi; Research Support: Eli Lilly and Company, Halozyme Therapeutics, Juvenile Diabetes Research Foundation, Lexicon Pharmaceuticals, Inc., MannKind Corporation, Medtronic, Merck, National Institute of Diabetes and Digestive and Kidney Diseases, Novo Nordisk, Sanofi, T1D Exchange; Speaker’s Bureau: Eisai Co., Ltd., JAEB Center, Juvenile Diabetes Research Foundation, Lexicon Pharmaceuticals, Inc., Medtronic, National Institute of Diabetes and Digestive and Kidney Diseases, Novo Nordisk, Roche Diagnostics, Sanofi.

Garhyan, Parag .................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner).

Garlick, Jonathan ................................ Disclosed no confl ict of interest.Garnero, Theresa ................................ Disclosed no confl ict of interest.Garofalo, Carole .................................. Disclosed no confl ict of interest.

A834

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Garofolo, Monia .................................. Disclosed no confl ict of interest.Garrido, Gloria ..................................... Disclosed no confl ict of interest.Garrido-Sanchez, Lourdes .................. Disclosed no confl ict of interest.Garro, Mona ........................................ Disclosed no confl ict of interest.Gärtner, Babette ................................. Disclosed no confl ict of interest.Garufi , Gabriella .................................. Disclosed no confl ict of interest.Garvey, Cindy ...................................... Disclosed no confl ict of interest.Garvey, Katharine C. ........................... Disclosed no confl ict of interest.Garvey, W. John .................................. Disclosed no confl ict of interest.Garvey, W. Timothy ............................ Disclosed no confl ict of interest.Garvin, Jane ........................................ Disclosed no confl ict of interest.Garwood, Caitlin S. ............................. Disclosed no confl ict of interest.Gary, Sarah .......................................... Employee: PHT Corporation. Garza, Dahlia ....................................... Employee: Relypsa, Inc.; Stock/Shareholder: Relypsa, Inc. Gasperikova, Daniela .......................... Disclosed no confl ict of interest.Gastaldelli, Amalia ............................. Consultant: Eli Lilly and Company, Hoffman-La Roche

Limited; Research Support: Amylin Pharmaceuticals, LLC.

Gaster, Michael ................................... Disclosed no confl ict of interest.Gately, Robert V. ................................. Disclosed no confl ict of interest.Gates, Simon ....................................... Disclosed no confl ict of interest.Gatlin, Peggy ....................................... Disclosed no confl ict of interest.Gattu, Arijeet K. .................................. Disclosed no confl ict of interest.Gaudier, Martin ................................... Employee: Adocia; Stock/Shareholder: Adocia. Gaudreau, Simon ................................. Disclosed no confl ict of interest.Gaulton, Kyle ....................................... Disclosed no confl ict of interest.Gaur, Subash ....................................... Disclosed no confl ict of interest.Gause-Nilsson, Ingrid ......................... Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP. Gausserès, Blandine ........................... Disclosed no confl ict of interest.Gautam, Shiva ..................................... Disclosed no confl ict of interest.Gautier, Jean Francois ........................ Advisory Panel: AstraZeneca/Bristol-Myers Squibb, Merck

Sharp & Dohme, Novartis AG, Novo Nordisk A/S, Sanofi Pasteur SA, Servier; Research Support: Eli Lilly and Company, Novo Nordisk A/S, Sanofi Pasteur SA; Speaker’s Bureau: Eli Lilly and Company, Novartis AG, Novo Nordisk A/S, Servier.

Gautier-Stein, Amandine .................... Disclosed no confl ict of interest.Gavan, Norina A. ................................. Employee: Worwag Pharma. Gavriilaki, Eleni ................................... Disclosed no confl ict of interest.Gavrilova, Julia S. ............................... Disclosed no confl ict of interest.Ge, Qian ............................................... Disclosed no confl ict of interest.Ge, Yaorong ......................................... Disclosed no confl ict of interest.Ge, Ying ............................................... Disclosed no confl ict of interest.Ge, Zhijuan ........................................... Disclosed no confl ict of interest.Gebremariam, Achamyeleh ................ Disclosed no confl ict of interest.Gee, Kyuhoon ...................................... Disclosed no confl ict of interest.Geerts, Lilianne ................................... Disclosed no confl ict of interest.Gegg, Moritz ........................................ Disclosed no confl ict of interest.Geidenstam, Nina ............................... Disclosed no confl ict of interest.Geiger, Kathrin .................................... Disclosed no confl ict of interest.Geiss, Linda S. ..................................... Disclosed no confl ict of interest.Gejl Jensen, Michael .......................... Disclosed no confl ict of interest.Gejl, Michael ....................................... Disclosed no confl ict of interest.Gelaye, Bizu ......................................... Disclosed no confl ict of interest.Gelrud, Andres .................................... Disclosed no confl ict of interest.Gencer, Baran ...................................... Disclosed no confl ict of interest.Genders, Amanda ............................... Disclosed no confl ict of interest.Genest, Jacques ................................. Disclosed no confl ict of interest.Gentile, Michela .................................. Disclosed no confl ict of interest.Gentile, Sandro ................................... Disclosed no confl ict of interest.Georgiadi, Anastasia .......................... Disclosed no confl ict of interest.Georgopoulos, Lynne .......................... Employee: PhaseBio Pharmaceuticals, Inc. Gerami-Naini, Behzad ......................... Disclosed no confl ict of interest.Gerard, Anne-Catherine ..................... Disclosed no confl ict of interest.Gerety, Gregg ...................................... Research Support: Dexcom, Inc. Gerich, John E. .................................... Disclosed no confl ict of interest.Gerli, Roberto ...................................... Disclosed no confl ict of interest.Gerling, Ivan ........................................ Disclosed no confl ict of interest.German, Michael S. ............................ Disclosed no confl ict of interest.Gerrits, Charles ................................... Employee: Sanofi . Gerstein, Hertzel C. ............................ Advisory Panel: Sanofi , Lilly, Novo Nordisk, Abbot, GSK,

AstraZeneca, Boehringer Ingelheim; Consultant: Sanofi , Lilly, Novo Nordisk, Abbot, GSK, AstraZeneca, Boehringer Ingelheim; Research Support: Sanofi , Lilly.

Gerszten, Robert E. ............................. Disclosed no confl ict of interest.Gerth, Suvadra S. ................................ Employee: Becton, Dickinson and Company. Gervais, Liette ..................................... Disclosed no confl ict of interest.Gervino, Ernest ................................... Disclosed no confl ict of interest.Gesta, Stephane ................................. Disclosed no confl ict of interest.Gesualdo, Patricia D. .......................... Disclosed no confl ict of interest.Gesuita, Rosaria .................................. Disclosed no confl ict of interest.

Getahun, Darios .................................. Disclosed no confl ict of interest.Getaneh, Asqual ................................. Disclosed no confl ict of interest.Gewelber, Civon .................................. Disclosed no confl ict of interest.Ghaedi, Leila ........................................ Employee: Health Diagnostics Laboratory, Inc. Ghahate, D. .......................................... Disclosed no confl ict of interest.Ghanim, Husam ................................... Disclosed no confl ict of interest.Ghannam, Ameen ................................ Employee: AstraZeneca; Stock/Shareholder: Abbott Labs,

Abbvie Inc, AstraZeneca, BMS, Pfi zer. Gharibzadeh, Safoora ......................... Disclosed no confl ict of interest.Ghavideldarestani, Maryam .............. Disclosed no confl ict of interest.Ghazi, Tara ........................................... Disclosed no confl ict of interest.Ghislain, Julien .................................... Disclosed no confl ict of interest.Gholampur, Mehrzad .......................... Disclosed no confl ict of interest.Gholson, Georica ................................. Disclosed no confl ict of interest.Ghosh, Sangeeta ................................. Disclosed no confl ict of interest.Giacca, Adria ....................................... Disclosed no confl ict of interest.Giaccari, Andrea ................................. Consultant: AstraZeneca, Boheringer Ingelheim; Research

Support: Merck Sharp & Dohme, Novartis; Speaker’s Bureau: AstraZeneca.

Giacco, Angela .................................... Disclosed no confl ict of interest.Giambra, Egle ...................................... Disclosed no confl ict of interest.Giampatzis, Vasilios ............................ Disclosed no confl ict of interest.Gianchandani, Maya ........................... Disclosed no confl ict of interest.Giani, Elisa ........................................... Disclosed no confl ict of interest.Giani, Guido ......................................... Disclosed no confl ict of interest.Giannone, JoAnn ................................. Disclosed no confl ict of interest.Giatsidis, Giorgio ................................. Disclosed no confl ict of interest.Gibb, Fraser W. .................................... Disclosed no confl ict of interest.Gibbons, Sean ..................................... Disclosed no confl ict of interest.Gibney, Michael .................................. Employee: BD Medical-Diabetes Care; Stock/Shareholder:

Becton, Dickinson and Company. GIbson, Bradford W. ........................... Disclosed no confl ict of interest.Gidding, Samuel .................................. Disclosed no confl ict of interest.Giehm, Lise .......................................... Employee: Zealand Pharma A/S. Gielen, Charles-Edouard ..................... Disclosed no confl ict of interest.Giglio, Rosaria Vincenza ..................... Disclosed no confl ict of interest.Giglio, Sabrina ..................................... Disclosed no confl ict of interest.Gilbert, Jack ........................................ Disclosed no confl ict of interest.Gilbert, Matthew ................................ Disclosed no confl ict of interest.Gilbert, Richard E. ............................... Consultant: AstraZeneca Pharmaceuticals LP, Boehringer

Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Research & Development LLC; Research Support: AstraZeneca Pharmaceuticals LP; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Janssen Research & Development LLC.

Gilbert, Robert G. ................................ Disclosed no confl ict of interest.Gilijamse, Pim W. ................................ Disclosed no confl ict of interest.Gill, Jasvinder ...................................... Employee: Sanofi U.S.; Stock/Shareholder: Sanofi . Gillani, Syed M. ................................... Disclosed no confl ict of interest.Gilles, Ashley K. .................................. Disclosed no confl ict of interest.Gillespie, Cathleen .............................. Disclosed no confl ict of interest.Gilliland, M.G.F .................................... Disclosed no confl ict of interest.Gillon-Keren, Michal ........................... Disclosed no confl ict of interest.Giménez Álvarez, Margarita .............. Speaker’s Bureau: Eli Lilly, Merck Sharp & Dohme, Novo

Nordisk, Sanofi . Gimenez-Palop, Olga ........................... Disclosed no confl ict of interest.Gimeno, Ruth E. ................................... Employee: Eli Lilly and Company. Gin, Henri ............................................. Disclosed no confl ict of interest.Ginchereau-Sowell, France ................ Research Support: AstraZeneca/Bristol-Myers Squibb. Ginnivan, Louise .................................. Other Relationship: Medtronic, Inc.; Research Support:

Roche Diagnostics, sanofi . Ginsberg, Henry N. ............................. Advisory Panel: Merck, Regeneron Pharmaceuticals,

Inc., Sanofi ; Consultant: Amarin Pharma, Inc., Amgen Inc., AstraZeneca, Bristol-Myers Squibb Company, GlaxoSmithKline, Isis Pharmaceuticals, Inc., Janssen Pharmaceutical Companies of Johnson & Johnson, Kowa Pharmaceuticals, Merck, Novartis, Pfi zer Inc.; Research Support: Amgen Inc., Genzyme Corporation, Merck, Regeneron Pharmaceuticals, Inc., Sanofi .

Giorgini, Marisa .................................. Disclosed no confl ict of interest.Giorgino, Francesco ............................ Advisory Panel: AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim GmbH, Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, LifeScan, Inc., Novartis Pharma GmbH, Novo Nordisk A/S, Roche Diagnostics, Sanofi Pasteur SA, Takeda Pharmaceutical Company Limited; Consultant: Novartis Pharma GmbH, Sanofi Pasteur SA; Research Support: AstraZeneca/Bristol-Myers Squibb, Eli Lilly and Company, LifeScan, Inc., Sanofi Pasteur SA.

Girbes-Borras, Juan ............................ Consultant: AstraZeneca/Bristol-Myers Squibb, Novartis Pharma GmbH, Novo Nordisk A/S.

A835

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Girdano, Daniel .................................... Employee: Walden University. Girdhar, Robin ...................................... Disclosed no confl ict of interest.Girelli, Angela ...................................... Disclosed no confl ict of interest.Giri, Suresh .......................................... Employee: Zydus Research Centre, Cadila Healthcare

Limited, Ahmedabad, India. Girman, Cynthia J. .............................. Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &

Co., Inc. Giroux, Isabelle ................................... Disclosed no confl ict of interest.Gishoma, Crispin ................................. Disclosed no confl ict of interest.Gislason, Gunnar H. ............................ Disclosed no confl ict of interest.Gitelman, Stephen E. .......................... Research Support: Astellas Pharma US, Inc., Bayer

HealthCare, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases.

Gitt, Anselm K. .................................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Daiichi-Sankyo Co., Ltd., Eli Lilly and Company, Merck Sharp & Dohme, Novartis Pharma GmbH, Novo Nordisk Inc., Sanofi Aventis, Takeda Pharmaceutical Company Limited; Research Support: Bristol-Myers Squibb Company, Merck Sharp & Dohme, Novartis Pharma GmbH, Sanofi , Takeda Pharmaceutical Company Limited.

Gittes, George K. ................................ Disclosed no confl ict of interest.Giuliano, François A. ........................... Disclosed no confl ict of interest.Giusti, Laura ........................................ Disclosed no confl ict of interest.Gjedde, Albert ..................................... Consultant: Novo Nordisk A/S. Gjelsvik, Annie .................................... Disclosed no confl ict of interest.Gkaliagkousi, Eugene .......................... Disclosed no confl ict of interest.Glaesner, Wolfgang ............................ Employee: Eli Lilly and Company, Eli Lilly and Company

(Spouse/Partner); Stock/Shareholder: Eli Lilly and Company, GlaxoSmithKline.

Glantz, Christopher J. ......................... Disclosed no confl ict of interest.Glazebrook, Patricia ............................ Disclosed no confl ict of interest.Gleason, Joseph ................................. Disclosed no confl ict of interest.Glenn, Lindsey ..................................... Disclosed no confl ict of interest.Glezer, Stanislav ................................. Employee: Sanofi , Sanofi (Spouse/Partner). Gloyn, Anna L. ..................................... Research Support: Novo Nordisk A/S. Glueck, Deborah H. ............................. Disclosed no confl ict of interest.Gluud, Lise L. ....................................... Disclosed no confl ict of interest.Glynn, Liam .......................................... Disclosed no confl ict of interest.Glynn, Robert ...................................... Research Support: AstraZeneca, Novartis. Gnudi, Luigi .......................................... Disclosed no confl ict of interest.Go, Gwang-Woong .............................. Disclosed no confl ict of interest.Go, Yoshie ............................................ Disclosed no confl ict of interest.Göbl, Christian S. ................................ Disclosed no confl ict of interest.Godinez, Sergio A. .............................. Disclosed no confl ict of interest.Godsland, Ian F. ................................... Disclosed no confl ict of interest.Godsoe, Lauren E. ............................... Disclosed no confl ict of interest.Godzien, Joanna ................................. Disclosed no confl ict of interest.Goebel-Fabbri, Ann ............................. Disclosed no confl ict of interest.Goehring, Isabel .................................. Disclosed no confl ict of interest.Goel, Satyender .................................. Disclosed no confl ict of interest.Goelzer Neto, Claudio Fernando ........ Disclosed no confl ict of interest.Goelzer, Mickael ................................. Disclosed no confl ict of interest.Goetz, Doug ......................................... Disclosed no confl ict of interest.Goh, Kian Peng .................................... Disclosed no confl ict of interest.Goh, Liuh Ling ...................................... Disclosed no confl ict of interest.Goh, Su-Yen ......................................... Disclosed no confl ict of interest.Gohda, Tomohito ................................. Disclosed no confl ict of interest.Golab, Karolina .................................... Disclosed no confl ict of interest.Golato, Maria ...................................... Disclosed no confl ict of interest.Goldberg, Nadia .................................. Disclosed no confl ict of interest.Goldberg, Ronald B. ............................ Disclosed no confl ict of interest.Goldberg, Saveli .................................. Disclosed no confl ict of interest.Goldberger, Nehama ........................... Disclosed no confl ict of interest.Goldby, Stephanie ............................... Disclosed no confl ict of interest.Golden, Aaron ..................................... Disclosed no confl ict of interest.Golden, Sherita ................................... Disclosed no confl ict of interest.Goldenberg, Ronald B. ........................ Advisory Panel: AstraZeneca, Böehringer Ingelheim,

Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen, Merck, Novo Nordisk Inc., Roche, Sanofi , Takeda; Consultant: AstraZeneca, Böehringer Ingelheim, Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen, Novo Nordisk Inc., Takeda; Research Support: Abbott, AstraZeneca, Böehringer Ingelheim, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline, Janssen, Medtronic, Inc., Merck, Novartis, Novo Nordisk Inc., Roche, Sanofi , Takeda; Speaker’s Bureau: Abbott, AstraZeneca, Böehringer Ingelheim, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck, Novo Nordisk Inc., Sanofi , Servier.

Goldenberg, Ronald M. ....................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Research & Development LLC, Merck & Co., Inc., Novo Nordisk Inc., Roche Diagnostics, Sanofi U.S., Takeda Pharmaceuticals U.S.A., Inc.; Consultant: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Research & Development LLC, Novo Nordisk Inc., Takeda Pharmaceuticals U.S.A., Inc.; Research Support: Abbott Diabetes Care, Inc., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline, Janssen Research & Development LLC, Medtronic, Inc., Merck & Co., Inc., Novartis Corporation, Novo Nordisk Inc., Roche Diagnostics, Sanofi U.S., Takeda Pharmaceuticals U.S.A., Inc.; Speaker’s Bureau: Abbott Diabetes Care, Inc., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk Inc., Sanofi U.S., Servier.

Goldfi ne, Allison B. .............................. Research Support: Amneal Pharmaceuticals - Amneal pharmaceuticals, LifeScan, Inc., Nestlé, Novo Nordisk Inc., supplies for investigator studies, supplies for investigator studies, supplies for investigator studies.

Goldfracht, Margalit ........................... Disclosed no confl ict of interest.Goldis, Marina ..................................... Disclosed no confl ict of interest.Goldshtein, Inbal ................................. Disclosed no confl ict of interest.Goldstein, Dalit ................................... Disclosed no confl ict of interest.Goler, Nancy ........................................ Disclosed no confl ict of interest.Golson, Maria L. .................................. Disclosed no confl ict of interest.Gomes, Everton P. ............................... Disclosed no confl ict of interest.Gomes, K.F.B. ...................................... Disclosed no confl ict of interest.Gomes, Marilia B. ............................... Consultant: AstraZeneca Pharmaceuticals LP. Gomez Zamudio, Jaime ...................... Disclosed no confl ict of interest.Gómez, Enrique J. ............................... Disclosed no confl ict of interest.Gómez, Fernando ................................ Disclosed no confl ict of interest.Gómez, José ........................................ Disclosed no confl ict of interest.Gomez-Foix, Anna M. ......................... Disclosed no confl ict of interest.Gómez-Huelgas, Ricardo .................... Disclosed no confl ict of interest.Gómez-Pérez, Ana M. ......................... Disclosed no confl ict of interest.Gomis, Ramon ..................................... Disclosed no confl ict of interest.Gonai, Megumi .................................... Disclosed no confl ict of interest.Gonçalves, Marta ............................... Disclosed no confl ict of interest.Goncharova, Natalya V. ...................... Disclosed no confl ict of interest.Gonder-Frederick, Linda ..................... Advisory Panel: AstraZeneca Pharmaceuticals LP;

Consultant: Abbott, Dexcom, Inc., Johnson & Johnson, Merck & Co., Inc.; Research Support: Abbott Laboratories, Inc.

Gondhalekar, Ravi ............................... Disclosed no confl ict of interest.Gondim, Fernando ............................... Disclosed no confl ict of interest.Gong, Chunxiu ..................................... Disclosed no confl ict of interest.Gong, Li ................................................ Disclosed no confl ict of interest.Gong, Qi ............................................... Disclosed no confl ict of interest.Gong, Qiuhong ..................................... Disclosed no confl ict of interest.Gong, Siqian ........................................ Disclosed no confl ict of interest.Gong, Yan ............................................. Employee: Boehringer Ingelheim GmbH & Co. KG. Gong, Yanping ..................................... Disclosed no confl ict of interest.Gong, Zhenwei .................................... Disclosed no confl ict of interest.Gonulalan, Gulsum .............................. Disclosed no confl ict of interest.Gonynor, Caroline J. ........................... Disclosed no confl ict of interest.Gonzalez Mariscal, Isabel .................. Disclosed no confl ict of interest.Gonzalez Sastre, Montserrat ............. Disclosed no confl ict of interest.Gonzalez, Claudio ................................ Disclosed no confl ict of interest.Gonzalez, Concepcion ......................... Disclosed no confl ict of interest.Gonzalez, Franklyn .............................. Disclosed no confl ict of interest.Gonzalez, Jeffrey S. ............................ Disclosed no confl ict of interest.Gonzalez-Clemente, Jose-Miguel ..... Disclosed no confl ict of interest.González-Heredia, Tonatiuh ............... Disclosed no confl ict of interest.González-Ortiz, Manuel ...................... Disclosed no confl ict of interest.Gonzalez-Ruiz, Katherine ................... Disclosed no confl ict of interest.Gonzalez-Vega, Magdalis ................... Disclosed no confl ict of interest.Goodpaster, Bret H. ............................ Disclosed no confl ict of interest.Goodwill, Adam G. .............................. Disclosed no confl ict of interest.Goodyear, Laurie J. ............................. Disclosed no confl ict of interest.Gooley, Ted .......................................... Disclosed no confl ict of interest.Goossens, Gijs ..................................... Disclosed no confl ict of interest.Gopalakrishnan, Chandrasekar .......... Disclosed no confl ict of interest.Gordan, Pedro A. ................................. Other Relationship: Co-owner of the game (InsuOnLine)

assessed in this study.

A836

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Gordillo, Ruth ...................................... Disclosed no confl ict of interest.Gordon, Allan ....................................... Employee: Resverlogix Corp. Gordon, Jason ..................................... Research Support: Bristol-Myers Squibb/AstraZeneca,

Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Takeda Pharmaceutical Company Limited.

Gorelik, Alexandra .............................. Disclosed no confl ict of interest.Görgens, Sven W. ............................... Disclosed no confl ict of interest.Gorgojo-Martinez, Juan J. ................. Advisory Panel: AstraZeneca/Bristol-Myers Squibb, Eli Lilly

and Company, Merck Sharp & Dohme, Novo Nordisk Inc.; Board Member: AstraZeneca/Bristol-Myers Squibb; Consultant: AstraZeneca/Bristol-Myers Squibb, Eli Lilly and Company, Merck Sharp & Dohme, Novo Nordisk Inc.

Goring, Sarah ...................................... Disclosed no confl ict of interest.Gorny, Diane ........................................ Research Support: Boehringer Ingelheim Pharmaceuticals,

Inc. Gorogawa, Shin-ichi ........................... Disclosed no confl ict of interest.Gorska, Maria ...................................... Disclosed no confl ict of interest.Goto, Atsushi ....................................... Disclosed no confl ict of interest.Goto, Nobuko ....................................... Disclosed no confl ict of interest.Goto, Rieko .......................................... Disclosed no confl ict of interest.Goto, Shigemi ...................................... Disclosed no confl ict of interest.Gottdiener, John S. ............................. Disclosed no confl ict of interest.Gottlieb, Peter A. ................................ Other Relationship: Baxter, Genentech, Inc., Juvenile

Diabetes Research Foundation, National Institutes of Health, Novartis Pharmaceuticals Corporation, Omni BioPharmaceuticals, Inc, Pfi zer Inc., Valeritas; Research Support: Astellas Pharma US, Inc., Bayer HealthCare, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases.

Gottrup, Hanne .................................... Disclosed no confl ict of interest.Gotzamani-Psarrakou, Anna .............. Disclosed no confl ict of interest.Gouet, Didier ....................................... Disclosed no confl ict of interest.Goulart, Alessandra C. ....................... Disclosed no confl ict of interest.Goulden, Peter A. ................................ Disclosed no confl ict of interest.Gourdy, Pierre ...................................... Advisory Panel: AstraZeneca/Bristol-Myers Squibb,

Boehringer Ingelheim GmbH, Eli Lilly and Company, GlaxoSmithKline, Novo Nordisk A/S, Sanofi Pasteur SA, Takeda Pharmaceutical Company Limited; Research Support: AstraZeneca/Bristol-Myers Squibb, Novo Nordisk A/S, Sanofi Pasteur SA; Speaker’s Bureau: AstraZeneca/Bristol-Myers Squibb, Boehringer Ingelheim GmbH, Eli Lilly and Company, Merck Sharp & Dohme, Novartis Pharma GmbH, Novo Nordisk A/S, Sanofi Pasteur SA, Servier.

Gourmelen, Julie ................................. Disclosed no confl ict of interest.Gouveia, Clotilde ................................. Disclosed no confl ict of interest.Gower, Barbara A. .............................. Disclosed no confl ict of interest.Gozani, Shai N. .................................... Employee: NeuroMetrix, Inc. Grabman, Jesse H. .............................. Disclosed no confl ict of interest.Grabner, Michael ................................ Other Relationship: employee of HealthCore, Inc.,

contracted on behalf of Sanofi US, Inc. Graciano, Pamela Á. ........................... Disclosed no confl ict of interest.Gradišer, Marina ................................. Disclosed no confl ict of interest.Graf, Rolf .............................................. Stock/Shareholder: Inventor of the PSP/reg assay for which

the University of Zurich owns patents. Graf, Scott ........................................... Disclosed no confl ict of interest.Graffy, Jonathan P. ............................. Disclosed no confl ict of interest.Graham, Claudia .................................. Employee: Dexcom, Inc.; Stock/Shareholder: Dexcom, Inc. Graham, Joanne .................................. Disclosed no confl ict of interest.Graham, Timothy E. ............................. Consultant: Health Diagnostics Laboratory, Inc.; Speaker’s

Bureau: Health Diagnostics Laboratory, Inc. Graham, Wayne .................................. Disclosed no confl ict of interest.Granados-Silvestre, María de los A. .... Disclosed no confl ict of interest.Grancini, Valeria .................................. Disclosed no confl ict of interest.Grande, Mirtha .................................... Disclosed no confl ict of interest.Grandy, Susan ..................................... Employee: AstraZeneca. Graninger, Winfried ............................ Disclosed no confl ict of interest.Grant, Maria B. .................................... Disclosed no confl ict of interest.Grant, Richard W. ................................ Disclosed no confl ict of interest.Grant, Struan F. ................................... Disclosed no confl ict of interest.Grarup, Niels ....................................... Disclosed no confl ict of interest.Grassi, Claudio .................................... Disclosed no confl ict of interest.Graue, Marit ........................................ Disclosed no confl ict of interest.Graue-Hernández, Enrique ................. Disclosed no confl ict of interest.Graves, Dana T. ................................... Disclosed no confl ict of interest.Gravholt, Claus H. ............................... Disclosed no confl ict of interest.Gray, Laura J. ...................................... Disclosed no confl ict of interest.Gray, Sarah M. .................................... Disclosed no confl ict of interest.Gray, Stephen ...................................... Research Support: Boehringer Ingelheim GmbH. Grayson, Truman ................................. Disclosed no confl ict of interest.

Green, Kelly ......................................... Disclosed no confl ict of interest.Greenbaum, Carla J. ........................... Other Relationship: Bristol-Myers Squibb Company,

MacroGenics, Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk A/S; Research Support: Astellas Pharma US, Inc., Bayer HealthCare, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases.

Greene, Carmine ................................. Employee: Bayer HealthCare LLC, Diabetes Care. Greene, Natasha ................................. Research Support: National Institutes of Health. Greene, Rachel .................................... Disclosed no confl ict of interest.Greenspan, Louise C. .......................... Disclosed no confl ict of interest.Greenspan, Susan L. ........................... Disclosed no confl ict of interest.Greenway, Frank ................................. Advisory Panel: Jenny Craig, Novo Nordisk Inc., Orexigen

Therapeutics, Inc., Pam Labs, Zafgen; Consultant: ALIGN2ACTION, BARONova, Basic Research, Citius Pharmaceutical, Diabetic Living, Eisai Co., Ltd., General Nutrition Corporation, Guidepoint Global, Japan Tobacco Pharmaceutical Division, Lithera Inc, MEDACorp/Leerink Swann, Thetis Pharmaceuticals, Unigene Labs; Other Relationship: NeuroQuest; Research Support: Hanmi Pharmaceuticals, Novo Nordisk Inc.; Stock/Shareholder: NeuroQuest, NuMe Health, Origin Biomed, PlenSat.

Greenwood, Jeremy ........................... Disclosed no confl ict of interest.Gregersen, Soeren .............................. Disclosed no confl ict of interest.Gregg, Brigid ....................................... Disclosed no confl ict of interest.Gregg, Edward W. ............................... Disclosed no confl ict of interest.Gregorevic, Paul .................................. Disclosed no confl ict of interest.Greig, Marni ........................................ Disclosed no confl ict of interest.Greuel, Marius .................................... Disclosed no confl ict of interest.Greve, Sara V. ...................................... Disclosed no confl ict of interest.Grey, Margaret .................................... Disclosed no confl ict of interest.Gribble, Fiona M. ................................. Disclosed no confl ict of interest.Gribhild, Maria .................................... Disclosed no confl ict of interest.Griffi n, Kurt J. ...................................... Research Support: Astellas Pharma US, Inc., Bayer

HealthCare, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases.

Griffi n, Timothy ................................... Disclosed no confl ict of interest.Griffi ths, Rachael ................................ Employee: Health Diagnostics Laboratory, Inc. Griggs, Robert ..................................... Disclosed no confl ict of interest.Grigorescu, Florin ................................ Disclosed no confl ict of interest.Grigoropoulou, Pinelopi ...................... Disclosed no confl ict of interest.Grimsby, Joe ........................................ Disclosed no confl ict of interest.Grimsby, Joseph .................................. Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP. Grioni, Sara .......................................... Disclosed no confl ict of interest.Grisoni, Marie-Lise ............................. Consultant: Sanofi . Griva, Theodora ................................... Disclosed no confl ict of interest.Grohl, Anke .......................................... Employee: Aptiv Solutions GmbH. Groh-Wargo, Sharon L. ....................... Disclosed no confl ict of interest.Gromada, Jesper ................................. Employee: Regeneron Pharmaceuticals, Inc. Grønbæk, Henning .............................. Disclosed no confl ict of interest.Grøndahl, Magnus .............................. Disclosed no confl ict of interest.Groop, Leif ........................................... Disclosed no confl ict of interest.Groop, Per-Henrik ................................ Advisory Panel: Abbott, Boehringer Ingelheim

Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation; Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Genzyme Corporation, Merck Sharp & Dohme, Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Sanofi U.S.

Groot, Paul F.C. .................................... Disclosed no confl ict of interest.Grosman, Benyamin ............................ Employee: Medtronic MiniMed, Inc. Gross, Jorge L. .................................... Advisory Panel: AstraZeneca/Bristol-Myers Squibb,

Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Novo Nordisk Inc.; Research Support: AstraZeneca/Bristol-Myers Squibb, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, MannKind Corporation, Novo Nordisk Inc.; Speaker’s Bureau: AstraZeneca/Bristol-Myers Squibb, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Novo Nordisk Inc.

Gross, Tal ............................................. Disclosed no confl ict of interest.Grossi, Glenda ..................................... Disclosed no confl ict of interest.Grossmann, Morella ........................... Disclosed no confl ict of interest.Grosu, Larisa ....................................... Disclosed no confl ict of interest.Grosz, Andrea ...................................... Disclosed no confl ict of interest.Grouix, Brigitte .................................... Disclosed no confl ict of interest.Groves, Christopher J. ........................ Disclosed no confl ict of interest.Grozou, Anna ....................................... Disclosed no confl ict of interest.

A837

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Gruber-Baldini, Ann ............................ Disclosed no confl ict of interest.Gruener, Alf ......................................... Employee: Sanofi U.S. Grunberger, George ............................ Research Support: AstraZeneca Pharmaceuticals LP, Eli

Lilly and Company, Merck & Co., Inc., Novo Nordisk Inc., Sanofi U.S.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Eisai Co., Ltd., Eli Lilly and Company, GlaxoSmithKline, Merck & Co., Inc., Novo Nordisk Inc., Sanofi U.S., Valeritas.

Grunnet, Louise G. .............................. Stock/Shareholder: Novo Nordisk A/S. Gruss, Stephanie ................................. Disclosed no confl ict of interest.Grzesik, Wojciech ............................... Disclosed no confl ict of interest.Grzeszczak, Władysław ..................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Bristol-

Myers Squibb Company, Lilly Deutschland GmbH, Novo Nordisk A/S, Servier; Board Member: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Lilly Deutschland GmbH, Novo Nordisk A/S, Servier; Consultant: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Lilly Deutschland GmbH, Novo Nordisk A/S, Servier; Employee: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Lilly Deutschland GmbH, Novo Nordisk A/S, Servier; Research Support: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Lilly Deutschland GmbH, Novo Nordisk A/S, Servier; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Lilly Deutschland GmbH, Novo Nordisk A/S, Servier; Stock/Shareholder: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Lilly Deutschland GmbH, Novo Nordisk A/S, Servier.

Gu, Fusheng ......................................... Disclosed no confl ict of interest.Gu, Haihua ........................................... Disclosed no confl ict of interest.Gu, Liqun .............................................. Employee: Eli Lilly and Company. Gu, Nan ................................................ Disclosed no confl ict of interest.Gu, Tao ................................................. Consultant: Genentech, Inc. Gu, Zhimin ............................................ Disclosed no confl ict of interest.Guadarrama-Vallejo, Dalia C. ............. Disclosed no confl ict of interest.Guagnano, Maria Teresa .................... Disclosed no confl ict of interest.Guan, Chengyu .................................... Disclosed no confl ict of interest.Guan, Gongchang ................................ Disclosed no confl ict of interest.Guardado-Mendoza, Rodolfo ............. Disclosed no confl ict of interest.Guariguata, Leonor ............................. Disclosed no confl ict of interest.Guay, Claudiane .................................. Disclosed no confl ict of interest.Gubitosi-Klug, Rose A. ....................... Disclosed no confl ict of interest.Gudbjornsdottir, Soffi a ....................... Disclosed no confl ict of interest.Gudmundsdottir, Arna ........................ Board Member: Risk medical Solutions; Stock/Shareholder:

Risk Medical Solutions. Guerci, Bruno ....................................... Advisory Panel: Abbott, Boehringer Ingelheim

Pharmaceuticals, Inc., Bristol-Myers Squibb, Dinno Santé, Eli Lilly, GlaxoSmithKline, Janssen, Medtronic, Inc., Menarini Diagnostic, Merck Sharp & Dohme, MetaCure Inc., Novartis, Novo Nordisk Inc., Orkyn, Pfi zer Inc., Roche Diagnostics, Sanofi Aventis, Vitalaire; Consultant: Eli Lilly, GlaxoSmithKline, Novo Nordisk Inc., Sanofi Aventis.

Guerrero Vázquez, Raquel .................. Disclosed no confl ict of interest.Guess, Nicola D. .................................. Disclosed no confl ict of interest.Guest, Claire ........................................ Disclosed no confl ict of interest.Guihan, Marylou ................................. Disclosed no confl ict of interest.Guilherme, Adilson .............................. Disclosed no confl ict of interest.Guindi, Chantal .................................... Disclosed no confl ict of interest.Guindi, Edward .................................... Disclosed no confl ict of interest.Guinn, Zack .......................................... Disclosed no confl ict of interest.Guinness, Mary ................................... Employee: Biodel Inc. Guja, Cristian ....................................... Disclosed no confl ict of interest.Gülden, Elke ......................................... Disclosed no confl ict of interest.Guldiken, Sibel .................................... Disclosed no confl ict of interest.Gulisano, Massimo ............................. Disclosed no confl ict of interest.Gullestad, Lars .................................... Disclosed no confl ict of interest.Gullström, Monika .............................. Disclosed no confl ict of interest.Gumprecht, Janusz ............................. Consultant: Eli Lilly and Company, Kowa Pharmaceuticals,

Merck & Co., Inc., Merck Sharp & Dohme, Polpharma SA Pharmaceutical Works; Speaker’s Bureau: Bayer HealthCare, Bioton SA, Eli Lilly and Company, Merck & Co., Inc., Merck Sharp & Dohme, Novo Nordisk Inc.

Gunisik, Sibel ....................................... Disclosed no confl ict of interest.Gunnet, Joseph ................................... Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Guntur, Kalyani V. ................................ Disclosed no confl ict of interest.Guo, Hong ............................................ Disclosed no confl ict of interest.Guo, Jianjin .......................................... Disclosed no confl ict of interest.Guo, Lian .............................................. Disclosed no confl ict of interest.Guo, Shaodong .................................... Disclosed no confl ict of interest.

Guo, Sherry .......................................... Employee: Eli Lilly and Company. Guo, Xiao H. ......................................... Disclosed no confl ict of interest.Guo, Xiaoning ...................................... Disclosed no confl ict of interest.Guo, Xirong .......................................... Disclosed no confl ict of interest.Guo, Xiuqing ........................................ Disclosed no confl ict of interest.Guo, Yan ............................................... Disclosed no confl ict of interest.Guo, Yu ................................................. Disclosed no confl ict of interest.Guo, Zhiguang ..................................... Disclosed no confl ict of interest.Guo, Zijing ............................................ Disclosed no confl ict of interest.Gupta, Aloke K. ................................... Disclosed no confl ict of interest.Gupta, Deepak ..................................... Disclosed no confl ict of interest.Gupta, Jugal B. .................................... Disclosed no confl ict of interest.Gupta, Rana ......................................... Disclosed no confl ict of interest.Gupta, Shaloo ...................................... Consultant: Eisai Co., Ltd.; Employee: Kantar Health. Gupta, Suruchi ..................................... Disclosed no confl ict of interest.Gupta, Vishal ....................................... Advisory Panel: AstraZeneca, Eli Lilly and Company, MSD,

Novartis AG, Novo Nordisk A/S; Board Member: Bristol-Myers Squibb Company, Eli Lilly and Company, MSD, Novartis AG, Novo Nordisk A/S; Speaker’s Bureau: AstraZeneca/Bristol-Myers Squibb, Eli Lilly and Company, MSD, Novartis AG, Novo Nordisk A/S.

Guramatunhu, Solomon ...................... Disclosed no confl ict of interest.Gurrola-Peña, Gloria M. ..................... Disclosed no confl ict of interest.Guth, Lisa M. ....................................... Disclosed no confl ict of interest.Guthikonda, Kranthi S. ....................... Disclosed no confl ict of interest.Guthoff, Martina ................................. Disclosed no confl ict of interest.Gutierrez Cuevas, Jorge ..................... Disclosed no confl ict of interest.Gutierrez, Antonio ............................... Consultant: Boehringer Ingelheim Pharmaceuticals, Inc. Gutierrez, Cesar .................................. Disclosed no confl ict of interest.Gutierrez, Liliana ................................. Disclosed no confl ict of interest.Gutsaeva, Diana .................................. Disclosed no confl ict of interest.Gutsmann, Beate ................................ Disclosed no confl ict of interest.Guy, Vanessa C. ................................... Disclosed no confl ict of interest.Gwanzura, Lovemore .......................... Disclosed no confl ict of interest.Gydesen, Sofi e .................................... Employee: Nordic Bioscience. Gygi, Steven ........................................ Disclosed no confl ict of interest.Gylling, Helena .................................... Disclosed no confl ict of interest.H., Vishnu ............................................. Disclosed no confl ict of interest.Ha, Eun Suk .......................................... Disclosed no confl ict of interest.Ha, Hu Joo ........................................... Disclosed no confl ict of interest.Ha, Hunjoo ........................................... Disclosed no confl ict of interest.Ha, Hyekyung ...................................... Disclosed no confl ict of interest.Ha, Jiyoon ............................................ Disclosed no confl ict of interest.Ha, Joon ............................................... Disclosed no confl ict of interest.Ha, Kyoung Hwa .................................. Disclosed no confl ict of interest.Haagen Nielsen, Ulrik ......................... Research Support: Steno Diabetes Center A/S. Haahr, Hanne L. ................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Haak, Thomas ...................................... Advisory Panel: Abbott, AstraZeneca/Bristol-Myers Squibb,

Roche Diagnostics; Research Support: AstraZeneca/Bristol-Myers Squibb, Berlin-Chemie AG, Roche Diagnostics; Speaker’s Bureau: Abbott.

Haaland, Wren .................................... Disclosed no confl ict of interest.Haan, Mary N. ..................................... Disclosed no confl ict of interest.Haaparanta-Solin, Merja ................... Disclosed no confl ict of interest.Haas, Christian S. ............................... Disclosed no confl ict of interest.Haas, Richard A. ................................. Disclosed no confl ict of interest.Haas, Verena ....................................... Disclosed no confl ict of interest.Haas, Waltraud ................................... Disclosed no confl ict of interest.Haastert, Burkhard ............................. Disclosed no confl ict of interest.Haataja, Leena .................................... Disclosed no confl ict of interest.Habata, Yugo ....................................... Employee: Takeda Pharmaceutical Company Limited. Habegger, Kirk M. ............................... Disclosed no confl ict of interest.Habib, Samy L. ..................................... Disclosed no confl ict of interest.Habibi, Javad ....................................... Disclosed no confl ict of interest.Hach, Thomas ...................................... Employee: Boehringer Ingelheim GmbH. Hachiya, Hiroki .................................... Disclosed no confl ict of interest.Hada, Yusuke ....................................... Disclosed no confl ict of interest.Haddad, Fadia ..................................... Disclosed no confl ict of interest.Haddad, Francois ................................ Disclosed no confl ict of interest.Haddad, Jihad ..................................... Advisory Panel: MSD, Novo Nordisk A/S; Speaker’s Bureau:

Algorithm, AstraZeneca, Boehringer Ingelheim GmbH, Ferring, Menarini Group, Merck-Serono, MSD, Novartis AG, Novo Nordisk A/S.

Hadjadj, Samy ..................................... Board Member: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Novo Nordisk Inc., Takeda Pharmaceutical Company Limited; Consultant: Merck Sharp & Dohme; Speaker’s Bureau: Merck Sharp & Dohme, Novo Nordisk A/S, Sanofi Pasteur SA, Servier.

Hadjiyianni, Irene ................................ Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly and Company.

A838

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Haering, Hans-Ulrich .......................... Disclosed no confl ict of interest.Haffner, Steven M. ............................. Disclosed no confl ict of interest.Hafi ane, Anouar .................................. Disclosed no confl ict of interest.Hager, Brandon ................................... Disclosed no confl ict of interest.Hager, Joerg ........................................ Disclosed no confl ict of interest.Haghiac, Maricela ............................... Disclosed no confl ict of interest.Haghiac, Mary ..................................... Disclosed no confl ict of interest.Hagiac, Mary ....................................... Disclosed no confl ict of interest.Hagman, Derek K. ............................... Disclosed no confl ict of interest.Hagopian, William A. .......................... Disclosed no confl ict of interest.Hagstedt, Therese .............................. Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP. Hahn, Scott .......................................... Disclosed no confl ict of interest.Hahn, Seokyung .................................. Disclosed no confl ict of interest.Haidar, Ahmad ..................................... Other Relationship: Owns IP in the artifi cial pancreas area,

SNELL Medical Communication Inc; Speaker’s Bureau: Diabetic Children’s Foundation.

Haight, Brian ....................................... Disclosed no confl ict of interest.Haile, Zelalem ..................................... Disclosed no confl ict of interest.Hairston, Kristen G. ............................ Disclosed no confl ict of interest.Hajjar, Roger J. .................................... Disclosed no confl ict of interest.Hakkarainen, Antti .............................. Disclosed no confl ict of interest.Haklai, Ziona ........................................ Disclosed no confl ict of interest.Hakonarson, Hakon ............................. Disclosed no confl ict of interest.Halbron, Marine .................................. Disclosed no confl ict of interest.Halcox, Julian P. .................................. Consultant: AstraZeneca; Other Relationship: AstraZeneca. Hald, Stine ........................................... Disclosed no confl ict of interest.Hale, Stephen J. .................................. Disclosed no confl ict of interest.Halimi Jean Michel ............................. Disclosed no confl ict of interest.Hall, Gerrit V. ....................................... Disclosed no confl ict of interest.Hall, Jessica ........................................ Disclosed no confl ict of interest.Hall, Michael ....................................... Disclosed no confl ict of interest.Hall, Stephanie .................................... Disclosed no confl ict of interest.Hall, Tom .............................................. Employee: Dexcom, Inc. Hallahan, Nicole .................................. Disclosed no confl ict of interest.Haller, April .......................................... Disclosed no confl ict of interest.Haller, Hermann G. .............................. Advisory Panel: Bayer HealthCare, NOXXON Pharma AG;

Speaker’s Bureau: Alexion, Janssen. Haller, Michael J. ................................ Disclosed no confl ict of interest.Hällsten, Kirsti .................................... Disclosed no confl ict of interest.Halm, Ethan ......................................... Disclosed no confl ict of interest.Halperin, Florencia .............................. Disclosed no confl ict of interest.Halpern, Elise ...................................... Disclosed no confl ict of interest.Halseth, Amy E. ................................... Employee: Eli Lilly and Company (Spouse/Partner), Orexigen

Therapeutics, Inc.; Stock/Shareholder: Eli Lilly and Company (Spouse/Partner), Orexigen Therapeutics, Inc.

Halter, Jeffrey B. ................................. Disclosed no confl ict of interest.Haluzik, Martin .................................... Disclosed no confl ict of interest.Haluzikova, Denisa .............................. Disclosed no confl ict of interest.Ham, Dong-Sik ..................................... Disclosed no confl ict of interest.Hamada, Junpei .................................. Disclosed no confl ict of interest.Hamaguchi, Masahide ........................ Disclosed no confl ict of interest.Hamaguchi, Yuriko .............................. Disclosed no confl ict of interest.Hamamoto, Yoshiyuki ......................... Research Support: Eli Lilly Japan K.K.; Speaker’s Bureau:

Novo Nordisk A/S. Hamano, Kumiko ................................. Disclosed no confl ict of interest.Hamano, Kunihisa ............................... Disclosed no confl ict of interest.Hamasaki, Akihiro ............................... Disclosed no confl ict of interest.Hamaty, Marwan ................................ Disclosed no confl ict of interest.Hambidge, Bertha ............................... Disclosed no confl ict of interest.Hambleton, Ian .................................... Disclosed no confl ict of interest.Hamdan, Mahmoud A. ........................ Disclosed no confl ict of interest.Hamdouchi, Chafi q .............................. Employee: Eli Lilly and Company. Hamdy, Osama .................................... Advisory Panel: Metagenics, Inc; Consultant: Abbott

Nutrition, Merck & Co., Inc.; Research Support: Metagenics, Inc, NeuroMetrix, Inc.

Hamman, Richard F. ............................ Disclosed no confl ict of interest.Hammar, Niklas ................................... Employee: AstraZeneca. Hammer, Marilyn J. ............................ Disclosed no confl ict of interest.Hamming, Cecilia ................................ Disclosed no confl ict of interest.Hammoudi, Nadjib .............................. Disclosed no confl ict of interest.Han, Buhm ........................................... Disclosed no confl ict of interest.Han, Eugene ........................................ Disclosed no confl ict of interest.Han, Je Ho ........................................... Disclosed no confl ict of interest.Han, Jenny ........................................... Employee: AstraZeneca Pharmaceuticals LP, AstraZeneca/

Bristol-Myers Squibb, Bristol-Myers Squibb Company, Pharmapace.

Han, Ju Young ..................................... Disclosed no confl ict of interest.Han, Kyungdo ...................................... Disclosed no confl ict of interest.Han, Oakpil .......................................... Employee: Hanmi Pharmaceutical Co., Ltd. Han, Seung Jin .................................... Disclosed no confl ict of interest.Han, Seung-Yun ................................... Disclosed no confl ict of interest.

Han, Soo Min ....................................... Disclosed no confl ict of interest.Han, Weiping ....................................... Disclosed no confl ict of interest.Han, Xueyao ........................................ Disclosed no confl ict of interest.Han, Yamei .......................................... Disclosed no confl ict of interest.Han, Yonghwan ................................... Disclosed no confl ict of interest.Hanafusa, Toshiaki ............................. Disclosed no confl ict of interest.Hancer, Nancy ..................................... Disclosed no confl ict of interest.Hancock, Chad R. ................................ Disclosed no confl ict of interest.Hancock, Heather ............................... Disclosed no confl ict of interest.Han-Conrad, Laurie ............................. Employee: Profi l Institute for Clinical Research, Inc. Handelsman, Yehuda .......................... Consultant: Amarin Pharma, Inc., Amgen Inc., Amylin

Pharmaceuticals, LLC., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, diaDeux, DSI, Eisai Co., Ltd., Gilead, Halozyme Therapeutics, Janssen, LipoScience, Inc., Merck & Co., Inc., Novo Nordisk A/S, Sanofi U.S., Santarus, Inc., Vivus Inc.; Other Relationship: Associate Editor – Journal of Diabetes, Past President – American Association of Clinical Endocrinologists, President – American College of Endocrinology; Research Support: Amgen Inc., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Gilead, GlaxoSmithKline, Grifols USA, LLC, Hanmi, Intarcia Therapeutics, Inc., Lexicon Pharmaceuticals, Inc., Merck & Co., Inc., Novo Nordisk A/S, Sanofi U.S., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Amarin Pharma, Inc., Amylin Pharmaceuticals, LLC., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, DSI, Eli Lilly and Company, GlaxoSmithKline, Janssen, Novo Nordisk A/S, Santarus, Inc., Vivus Inc.

Hane, Christopher A. .......................... Employee: Optum Labs. Haneda, Masakazu ............................. Consultant: Boehringer Ingelheim GmbH, Mitsubishi Tanabe

Pharma Corporation, Taisho Pharmaceutical Co., Ltd.; Research Support: Astellas Pharma US, Inc., Boehringer Ingelheim GmbH, Daiichi-Sankyo Co., Ltd., Eli Lilly and Company, Merck Sharp & Dohme, Mitsubishi Tanabe Pharma Corporation, Novo Nordisk Inc., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Astellas Pharma US, Inc., Boehringer Ingelheim GmbH, Daiichi-Sankyo Co., Ltd., Merck Sharp & Dohme, Mitsubishi Tanabe Pharma Corporation, Novo Nordisk Inc., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited.

Hanefeld, Markolf ............................... Disclosed no confl ict of interest.Hanes, Sarah ....................................... Disclosed no confl ict of interest.Hang, Xin Mei ...................................... Disclosed no confl ict of interest.Hangai, Mari ........................................ Disclosed no confl ict of interest.Haniak, Prue ........................................ Disclosed no confl ict of interest.Hanis, Craig L. ..................................... Disclosed no confl ict of interest.Hankins, Matthew .............................. Employee: IMS Health. Hanley, Anthony J. .............................. Disclosed no confl ict of interest.Hanna, Becky ....................................... Consultant: Asclepius Analytics. Hänni, Arvo .......................................... Disclosed no confl ict of interest.Hannon, Tamara S. .............................. Disclosed no confl ict of interest.Hannukainen, Jarna C. ....................... Disclosed no confl ict of interest.Hans Devries, J ................................... Advisory Panel: Eli Lilly and Company, Johnson & Johnson,

Novo Nordisk Inc., Roche Diagnostics; Research Support: Dexcom, Inc., Medtronic, Inc.; Speaker’s Bureau: Dexcom, Inc., Eli Lilly and Company, Novo Nordisk Inc., Roche Diagnostics.

Hansen, Ann Kathrine ......................... Employee: Novo Nordisk A/S. Hansen, Axel K. ................................... Disclosed no confl ict of interest.Hansen, Barbara ................................. Disclosed no confl ict of interest.Hansen, Bo F. ....................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Hansen, Carsten P. .............................. Disclosed no confl ict of interest.Hansen, Charlotte T. ........................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Hansen, Christian S. ........................... Employee: Steno Diabetes Center A/S. Hansen, David W. ............................... Disclosed no confl ict of interest.Hansen, Jakob ..................................... Disclosed no confl ict of interest.Hansen, Karen R. ................................. Disclosed no confl ict of interest.Hansen, Klavs W. ................................ Advisory Panel: Novo Nordisk A/S. Hansen, Lars ........................................ Employee: Bristol-Myers Squibb Company; Stock/

Shareholder: Bristol-Myers Squibb Company, Novo Nordisk A/S.

Hansen, Maria L. ................................. Disclosed no confl ict of interest.Hansen, Mette .................................... Disclosed no confl ict of interest.Hansen, Morten .................................. Disclosed no confl ict of interest.Hansen, Ninna S. ................................ Disclosed no confl ict of interest.

A839

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Hansen, Søren B. ................................. Disclosed no confl ict of interest.Hansen, Stinus .................................... Disclosed no confl ict of interest.Hansen, Tanja S. ................................. Research Support: Novo Nordisk A/S. Hansen, Tine W. .................................. Disclosed no confl ict of interest.Hansen, Torben ................................... Stock/Shareholder: Novo Nordisk A/S. Hansen, Troels K. ................................ Disclosed no confl ict of interest.Hansis-Diarte, Andrea ........................ Disclosed no confl ict of interest.Hanson, Robert L. ................................ Disclosed no confl ict of interest.Hanson, Steven E. ............................... Disclosed no confl ict of interest.Hanssen, Kristian F. ............................ Disclosed no confl ict of interest.Hantel, Stefan ..................................... Employee: Boehringer Ingelheim GmbH. Hanyu, Osamu ..................................... Disclosed no confl ict of interest.Hao Ming, Tian .................................... Disclosed no confl ict of interest.Hao, Gang ............................................ Disclosed no confl ict of interest.Hao, Yaping ......................................... Disclosed no confl ict of interest.Hao, Ying ............................................. Disclosed no confl ict of interest.Hara, Kazuo ......................................... Disclosed no confl ict of interest.Hara, Kenji ........................................... Disclosed no confl ict of interest.Hara, Manami ...................................... Disclosed no confl ict of interest.Hara, Mizuki ........................................ Disclosed no confl ict of interest.Hara, Shigeko ...................................... Research Support: Mitsubishi Kagaku Iatron, Inc. Harada, Marina ................................... Disclosed no confl ict of interest.Harada, Nagakatsu ............................. Disclosed no confl ict of interest.Harada, Norio ...................................... Disclosed no confl ict of interest.Harada, Takanari ................................. Disclosed no confl ict of interest.Harada, Takashi .................................. Disclosed no confl ict of interest.Harashima, Shin-Ichi .......................... Disclosed no confl ict of interest.Harbeck, Birgit .................................... Disclosed no confl ict of interest.Harcourt, Brooke E. ............................. Disclosed no confl ict of interest.Hardee, Sandra ................................... Disclosed no confl ict of interest.Harding, Jessica L. .............................. Disclosed no confl ict of interest.Hardy, Dale .......................................... Disclosed no confl ict of interest.Hardy, Elise .......................................... Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP. Hari, Adithya ....................................... Disclosed no confl ict of interest.Harima, Meilei ..................................... Disclosed no confl ict of interest.Häring, Hans-Ulrich ............................ Disclosed no confl ict of interest.Hariri, Robert ....................................... Disclosed no confl ict of interest.Harjutsalo, Valma ............................... Disclosed no confl ict of interest.Harman, Jane ...................................... Disclosed no confl ict of interest.Harman-Boehm, Ilana ......................... Disclosed no confl ict of interest.Harper, Kristine ................................... Employee: Eli Lilly and Company. Harreiter, Juergen ............................... Disclosed no confl ict of interest.Harriman, Geraldine ........................... Disclosed no confl ict of interest.Harrington, Kara R. ............................. Disclosed no confl ict of interest.Harris, Kristina M. .............................. Disclosed no confl ict of interest.Harris, Melissa N. ............................... Disclosed no confl ict of interest.Harris, Michael A. ............................... Disclosed no confl ict of interest.Harris, Raymond .................................. Disclosed no confl ict of interest.Harris, Ronald ...................................... Research Support: Genentech, Inc., Novo Nordisk Inc.;

Stock/Shareholder: Merck & Co., Inc., Novartis Corporation, Pfi zer Inc., Sanofi U.S.

Harris, Stewart B. ............................... Consultant: Abbott, AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk Inc., Sanofi U.S.; Research Support: AstraZeneca Pharmaceuticals LP, Novo Nordisk Inc., Sanofi U.S.

Harris, Yael .......................................... Disclosed no confl ict of interest.Harrison, Bern ..................................... Employee: Bayer HealthCare LLC, Diabetes Care. Harrison, Bradley W. ........................... Disclosed no confl ict of interest.Hart, Gili .............................................. Disclosed no confl ict of interest.Hartemann, Agnès .............................. Disclosed no confl ict of interest.Hartman, Mark L. ................................ Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company, Eli Lilly and Company (Spouse/Partner). Hartmann, Bolette .............................. Disclosed no confl ict of interest.Hartmann, Dominik ............................. Disclosed no confl ict of interest.Hartmann, Thorsten ............................ Disclosed no confl ict of interest.Haruki, Takenori .................................. Disclosed no confl ict of interest.Harvey, Sophie .................................... Disclosed no confl ict of interest.Harwell, Todd ...................................... Disclosed no confl ict of interest.Harwood, H. James ............................ Disclosed no confl ict of interest.Hasan, Iman H. .................................... Disclosed no confl ict of interest.Hasebe, Makiko .................................. Employee: Teijin Pharma Limited. Hasegawa, Goji ................................... Disclosed no confl ict of interest.Hasegawa, Hiroyuki ........................... Disclosed no confl ict of interest.Hasegawa, Junko ............................... Disclosed no confl ict of interest.Hasenour, Clinton M. .......................... Disclosed no confl ict of interest.Hashida, Seiichi .................................. Disclosed no confl ict of interest.Hashigami, Kiyoshi ............................. Employee: AstraZeneca. Hashiguchi, Jyunichiro ....................... Disclosed no confl ict of interest.Hashimoto, Hideki ............................... Disclosed no confl ict of interest.Hashimoto, Kunihiko ........................... Disclosed no confl ict of interest.

Hashimoto, Naotake ........................... Disclosed no confl ict of interest.Hashimoto, Takuya ............................. Disclosed no confl ict of interest.Hashimoto, Tomomi ............................ Disclosed no confl ict of interest.Hashimoto, Yoshitaka ......................... Disclosed no confl ict of interest.Hashimura, Kayako ............................. Disclosed no confl ict of interest.Haskins, Kathryn ................................. Disclosed no confl ict of interest.Haslam, Philip ...................................... Disclosed no confl ict of interest.Hasler, William L. ................................ Disclosed no confl ict of interest.Hasnani, Dhruvi ................................... Disclosed no confl ict of interest.Hassali, Mohamed A. ......................... Disclosed no confl ict of interest.Hassan, Hazem .................................... Disclosed no confl ict of interest.Hassan, Kamal .................................... Disclosed no confl ict of interest.Hastings, Stephanie M. ...................... Disclosed no confl ict of interest.Hastings, Timothy ............................... Disclosed no confl ict of interest.Hasuo, Rika .......................................... Disclosed no confl ict of interest.Hata, Akiko .......................................... Disclosed no confl ict of interest.Hata, Masaki ....................................... Disclosed no confl ict of interest.Hatam, Mary ....................................... Disclosed no confl ict of interest.Hatanaka, Masayuki ........................... Disclosed no confl ict of interest.Hatanaka, Takashi .............................. Disclosed no confl ict of interest.Hatano, Megumi ................................. Disclosed no confl ict of interest.Hatsek, Avner ...................................... Disclosed no confl ict of interest.Hattersley, Andrew T. ......................... Disclosed no confl ict of interest.Hatzitolios, Apostolos ........................ Disclosed no confl ict of interest.Haufe, Sven ......................................... Disclosed no confl ict of interest.Haug, Cornelia ..................................... Disclosed no confl ict of interest.Haugen, Fred ....................................... Disclosed no confl ict of interest.Hauguel de-Mouzon, Sylvie ............... Disclosed no confl ict of interest.Haung, Jian ......................................... Disclosed no confl ict of interest.Haus, Jacob M. ................................... Disclosed no confl ict of interest.Häuselmann, Stéphanie P. .................. Disclosed no confl ict of interest.Hauser, Thomas .................................. Disclosed no confl ict of interest.Hausman, Sherry P. ............................. Disclosed no confl ict of interest.Have, Christian T. ................................ Disclosed no confl ict of interest.Havekes, Bastiaan .............................. Disclosed no confl ict of interest.Havel, Peter J. ..................................... Disclosed no confl ict of interest.Havens, Eric ......................................... Disclosed no confl ict of interest.Haw, Jeehea S. ................................... Disclosed no confl ict of interest.Haw, Sonya .......................................... Disclosed no confl ict of interest.Hawa, Mohammed I. .......................... Disclosed no confl ict of interest.Hawkins, Meredith ............................. Disclosed no confl ict of interest.Haworth, Laura ................................... Disclosed no confl ict of interest.Hayasaka, Kiyoshi ............................... Disclosed no confl ict of interest.Hayashi, Aiko ....................................... Disclosed no confl ict of interest.Hayashi, Reiko D. ................................ Disclosed no confl ict of interest.Hayashi, Shintaro ................................ Disclosed no confl ict of interest.Hayashi, Tatsuya ................................. Disclosed no confl ict of interest.Hayashi, Tomoshige ............................ Disclosed no confl ict of interest.Hayashi, Toshio ................................... Research Support: Bayer HealthCare. Hayashi, Yoshitaka ............................. Disclosed no confl ict of interest.Hayashino, Yasuaki ............................. Disclosed no confl ict of interest.Haydar, Sara ........................................ Disclosed no confl ict of interest.Hayden, Christine M. .......................... Disclosed no confl ict of interest.Hayes, Geoffrey .................................. Disclosed no confl ict of interest.Hayes, John ......................................... Disclosed no confl ict of interest.Haymond, Morey ................................. Advisory Panel: AstraZeneca Pharmaceuticals LP,

Daiichi-Sankyo Co., Ltd., Novo Nordisk Inc., Xeris Pharmaceuticals, Inc.; Board Member: AstraZeneca Pharmaceuticals LP, DSMB, Pediatric Endocrine Society; Consultant: Corn Growers Association; Research Support: NIH.

Haywood, Natalie J. ........................... Disclosed no confl ict of interest.Hazarika, Suwagmani ......................... Disclosed no confl ict of interest.Hazen, Rebecca ................................... Disclosed no confl ict of interest.Hazlett, Linda J. .................................. Disclosed no confl ict of interest.He, Bing ............................................... Disclosed no confl ict of interest.He, Lan ................................................. Disclosed no confl ict of interest.He, Lina ................................................ Disclosed no confl ict of interest.He, Linyun ............................................ Disclosed no confl ict of interest.He, Peng ............................................... Disclosed no confl ict of interest.He, Rui .................................................. Disclosed no confl ict of interest.He, Shengqing ..................................... Disclosed no confl ict of interest.He, Shuyang ........................................ Disclosed no confl ict of interest.He, Xiaoning ........................................ Disclosed no confl ict of interest.He, Xuemin .......................................... Disclosed no confl ict of interest.He, Yu-Lian .......................................... Disclosed no confl ict of interest.He, Zhi-Min .......................................... Disclosed no confl ict of interest.Heagerty, Tony M. .............................. Disclosed no confl ict of interest.Heald, Adrian H. .................................. Disclosed no confl ict of interest.Heard, Kevin ........................................ Disclosed no confl ict of interest.Hebblewhite, Harry ............................ Employee: Glytec. Hebert, Sebastien ............................... Disclosed no confl ict of interest.

A840

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Hecht, Joan ......................................... Disclosed no confl ict of interest.Hedderson, Monique M. ..................... Research Support: GlaxoSmithKline, Takeda Pharmaceutical

Company Limited. Hedenbro, Jan ..................................... Disclosed no confl ict of interest.Hedrington, Maka ............................... Disclosed no confl ict of interest.Hee, Siow-Wey ................................... Disclosed no confl ict of interest.Heegaard, Christian Würtz ................ Disclosed no confl ict of interest.Heemann, Uwe .................................... Employee: Klinikum rechts der Isar. Heerspink, H.J. Lambers .................... Consultant: AbbVie, Astellas Pharma US, Inc., Janssen

Pharmaceutical Companies of Johnson & Johnson, Reata Pharmaceuticals, Inc.

Hegde, Shefali ..................................... Research Support: LifeScan, Inc. Hehnke, Uwe ....................................... Employee: Boehringer Ingelheim GmbH & Co. KG. Heianza, Yoriko ................................... Disclosed no confl ict of interest.Heier, Margit ....................................... Disclosed no confl ict of interest.Heiman, Mark L. .................................. Employee: MicroBiome Therapeutics; Stock/Shareholder:

MicroBiome Therapeutics. Heinemann, Akos ................................ Disclosed no confl ict of interest.Heinemann, Lutz ................................. Consultant: Profi l; Stock/Shareholder: Profi l. Heinke, Peter ....................................... Disclosed no confl ict of interest.Heise, Tim ............................................ Employee: Profi l Institute for Clinical Research, Inc.; Other

Relationship: Eli Lilly and Company, Mylan, Novo Nordisk Inc.; Research Support: Adocia, AstraZeneca Pharmaceuticals LP, BD Medical-Diabetes Care, Biocon, Boehringer Ingelheim GmbH, Dance Biopharm, Eli Lilly and Company, Grünenthal, Medtronic, Inc., Novartis Pharma GmbH, Novo Nordisk Inc., Sanofi U.S., Senseonics; Speaker’s Bureau: Eli Lilly and Company, Mylan, Novo Nordisk Inc.

Heisler, Michele .................................. Disclosed no confl ict of interest.Helgerson, Steven .............................. Disclosed no confl ict of interest.Helgeson, Vicki ................................... Disclosed no confl ict of interest.Heller, Simon R. ................................... Advisory Panel: Becton, Dickinson and Company, Eli Lilly and

Company, Novo Nordisk A/S, Takeda Pharmaceutical Company Limited; Consultant: Eli Lilly and Company, Novo Nordisk A/S; Other Relationship: Boehringer Ingelheim GmbH, Eli Lilly and Company, Novo Nordisk A/S, Takeda Pharmaceutical Company Limited; Research Support: Medtronic, Inc.

Hellerstein, Marc ................................ Employee: KineMed, Inc. Hellgren, Margareta I. ........................ Disclosed no confl ict of interest.Hellinger, Walter ................................. Disclosed no confl ict of interest.Hellmund, Richard ............................... Disclosed no confl ict of interest.Hellström-Lindahl, Ewa ...................... Disclosed no confl ict of interest.Hellwege, Jacklyn N. .......................... Disclosed no confl ict of interest.Helmer, Catherine ............................... Disclosed no confl ict of interest.Helminen, Mika ................................... Disclosed no confl ict of interest.Helminen, Olli ...................................... Disclosed no confl ict of interest.Helmy, Nada ........................................ Disclosed no confl ict of interest.Hemi, Rina ........................................... Disclosed no confl ict of interest.Hemmati, Alireza ................................ Disclosed no confl ict of interest.Hempe, James .................................... Disclosed no confl ict of interest.Hendel, Jakob W. ................................ Disclosed no confl ict of interest.Henderson, Simon ............................... Employee: MedImmune, Inc. Hendrieckx, Christel ........................... Disclosed no confl ict of interest.Heng, Wee May .................................. Disclosed no confl ict of interest.Heni, Martin ........................................ Disclosed no confl ict of interest.Henk, Henry J. ..................................... Other Relationship: Janssen Pharmaceutical Companies of

Johnson & Johnson. Henkel, Elena ....................................... Disclosed no confl ict of interest.Henriksen, Jan Erik ............................. Disclosed no confl ict of interest.Henriksen, Kim .................................... Employee: Nordic Bioscience. Henriksen, Ole ..................................... Consultant: CeQur SA. Henriksson, Karin M. .......................... Employee: AstraZeneca. Henry, Kathy ........................................ Disclosed no confl ict of interest.Henry, Pierre-Gilles ............................. Disclosed no confl ict of interest.Henry, Robert ...................................... Advisory Panel: Amgen Inc., AstraZeneca Pharmaceuticals

LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eisai Co., Ltd., Elcelyx Therapeutics, Inc., Eli Lilly and Company, Gilead, Isis Pharmaceuticals, Inc., Johnson & Johnson, Merck & Co., Inc., Novo Nordisk Inc., Sanofi U.S., Vivus Inc.; Board Member: Boehringer Ingelheim Pharmaceuticals, Inc., Eisai Co., Ltd., Gilead, Isis Pharmaceuticals, Inc., Johnson & Johnson, Merck & Co., Inc., Sanofi U.S.; Research Support: Eli Lilly and Company, Sanofi U.S.

Henstridge, Darren C. ......................... Disclosed no confl ict of interest.Heo, Rok Won ...................................... Disclosed no confl ict of interest.Hepburn, David A. ............................... Disclosed no confl ict of interest.Heptulla, Rubina .................................. Disclosed no confl ict of interest.Herder, Christian ................................. Disclosed no confl ict of interest.Herman, Mark A. ................................. Disclosed no confl ict of interest.

Herman, William H. ............................. Disclosed no confl ict of interest.Herman-Edelstein, Michal ................. Disclosed no confl ict of interest.Hermann, Julia M. .............................. Disclosed no confl ict of interest.Hermann, Koepsell .............................. Disclosed no confl ict of interest.Hermann, Pernille ............................... Disclosed no confl ict of interest.Hermanns, Norbert ............................. Advisory Panel: Abbott, Dexcom, Inc., Eli Lilly and Company,

Novo Nordisk A/S; Research Support: Abbott, Berlin-Chemie AG, Roche Diagnostics.

Hermans, Michel P. ............................. Disclosed no confl ict of interest.Hermansen, Kjeld ................................ Advisory Panel: Novo Nordisk A/S, Pfi zer Inc., Roche

Diagnostics, Sanofi U.S.; Consultant: Novo Nordisk A/S. Hermanski, Lidia ................................. Disclosed no confl ict of interest.Hermansson, Karin ............................. Employee: Boehringer Ingelheim GmbH. Hernandez, Chihiro ............................. Disclosed no confl ict of interest.Hernández, Cristina ............................ Disclosed no confl ict of interest.Hernandez, Javier ............................... Disclosed no confl ict of interest.Hernandez, Sandra O. ......................... Disclosed no confl ict of interest.Hernandez, Sonia L. ............................ Disclosed no confl ict of interest.Hernandez, Teri L. ............................... Disclosed no confl ict of interest.Hernandez, Valentina ......................... Disclosed no confl ict of interest.Hernández-Corona, Diana M. ............ Disclosed no confl ict of interest.Hernández-Jiménez, Sergio ............... Disclosed no confl ict of interest.Hernando, Maria E. ............................. Disclosed no confl ict of interest.Herold, Kevan C. .................................. Disclosed no confl ict of interest.Herrera, Kimberly ................................ Disclosed no confl ict of interest.Herrera, Pedro L. ................................. Disclosed no confl ict of interest.Herrin, Jeph ......................................... Disclosed no confl ict of interest.Herring, B.P. ......................................... Disclosed no confl ict of interest.Herring, Roselle .................................. Disclosed no confl ict of interest.Herrington, David M. .......................... Disclosed no confl ict of interest.Hershey, Tamara ................................. Research Support: National Institutes of Health. Hershkovitz, Oren ............................... Disclosed no confl ict of interest.Hertz, Paul ........................................... Disclosed no confl ict of interest.Herzberg, Uri ....................................... Disclosed no confl ict of interest.Herzog, Raimund I. .............................. Disclosed no confl ict of interest.Hess, Gregor ........................................ Disclosed no confl ict of interest.Hess, Sibylle ........................................ Employee: Sanofi -Aventis. Hessler, Danielle M. ........................... Research Support: National Institute of Diabetes and

Digestive and Kidney Diseases. Heximer, Scott ..................................... Disclosed no confl ict of interest.Heyda, Lauren ..................................... Disclosed no confl ict of interest.Heydemann, Ahlke .............................. Disclosed no confl ict of interest.Heyne, Nils .......................................... Disclosed no confl ict of interest.Heywood, Sarah E. ............................. Disclosed no confl ict of interest.Hiasa, Yoichi ........................................ Disclosed no confl ict of interest.Hiatt, Nicholas .................................... Disclosed no confl ict of interest.Hickman, Mary A. ............................... Employee: Pfi zer Inc.; Stock/Shareholder: Pfi zer Inc. Hidaka, Teruo ...................................... Disclosed no confl ict of interest.Hietala, Jarmo ..................................... Disclosed no confl ict of interest.Higa, Mariko ........................................ Disclosed no confl ict of interest.Higa, Moritake .................................... Disclosed no confl ict of interest.Higashide, Takashi .............................. Disclosed no confl ict of interest.Hige, Hideki ......................................... Disclosed no confl ict of interest.Higgins, Gavin C. ................................. Disclosed no confl ict of interest.Higgins, Michelle L. ............................ Disclosed no confl ict of interest.Higgins, Victoria .................................. Disclosed no confl ict of interest.Highland, Heather M. ......................... Disclosed no confl ict of interest.Hikin, Laura J. ...................................... Disclosed no confl ict of interest.Hill Golden, Sherita ............................. Disclosed no confl ict of interest.Hill, Anita ............................................. Disclosed no confl ict of interest.Hill, David J. ........................................ Disclosed no confl ict of interest.Hill, Martin .......................................... Disclosed no confl ict of interest.Hill, Sian ............................................... Disclosed no confl ict of interest.Hill, Warren G. ..................................... Disclosed no confl ict of interest.Hillard, Mallory A. ............................... Disclosed no confl ict of interest.Hiller, Josh ........................................... Employee: IMS Health. Hilliard, Marisa E. ............................... Disclosed no confl ict of interest.Hillman, Magnus ................................. Disclosed no confl ict of interest.Hilsted, Jannik .................................... Disclosed no confl ict of interest.Hilsted, Karen Lisa .............................. Disclosed no confl ict of interest.Himeno, Tatsuhito ............................... Disclosed no confl ict of interest.Himmelsbach, Frank ............................ Disclosed no confl ict of interest.Hince, Kathy ........................................ Disclosed no confl ict of interest.Hinchcliffe, Marcus ............................ Disclosed no confl ict of interest.Hinder, Lucy M. ................................... Disclosed no confl ict of interest.Hingst, Janne R. .................................. Disclosed no confl ict of interest.Hinke, Simon ....................................... Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Hinko, Alexander ................................. Disclosed no confl ict of interest.Hinojosa, Cecilia ................................. Disclosed no confl ict of interest.Hinsbergh, Victor W. ........................... Disclosed no confl ict of interest.Hinshaw, Ling ...................................... Disclosed no confl ict of interest.

A841

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Hira, Ravi S. ......................................... Disclosed no confl ict of interest.Hirai, Aizan .......................................... Disclosed no confl ict of interest.Hirai, Hiroki .......................................... Disclosed no confl ict of interest.Hirai, Keiji ............................................ Disclosed no confl ict of interest.Hiraike, Yuta ........................................ Disclosed no confl ict of interest.Hiraki, Linda T. ..................................... Disclosed no confl ict of interest.Hirano, Hisashi .................................... Disclosed no confl ict of interest.Hirano, Tsutomu .................................. Disclosed no confl ict of interest.Hirao, Rieko A. .................................... Disclosed no confl ict of interest.Hirao, Saori .......................................... Disclosed no confl ict of interest.Hirasawa, Yoshikazu ........................... Disclosed no confl ict of interest.Hirashima, Takeshi .............................. Disclosed no confl ict of interest.Hirayama, Yoshiaki ............................. Disclosed no confl ict of interest.Hirohito, Sone ..................................... Disclosed no confl ict of interest.Hiromura, Munenori ........................... Disclosed no confl ict of interest.Hirooka, Masashi ................................ Disclosed no confl ict of interest.Hirose, Akira ........................................ Disclosed no confl ict of interest.Hirose, Hiroshi ..................................... Disclosed no confl ict of interest.Hirose, Takahisa .................................. Advisory Panel: Eli Lilly, Novo Nordisk, Sanofi ; Other

Relationship: Sanofi , insulin-dosing committee; Research Support: Astellas, Boehringer Ingelheim, Daiichi-Sankyo, Dainippon-Sumitomo, Eli Lilly, Johnson & Johnson, Kissei, Merck Sharp & Dohme, Novartis, Novo Nordisk, Ono, Roche, Sanofi , Takeda, Tanabe-Mitsubishi, Terumo; Speaker’s Bureau: Astellas, Boehringer Ingleheim, Daiichi-Sankyo, Dainippon-Sumitomo, Eli Lilly, Johnson & Johnson, Kissei, Merck Sharp & Dohme, Novartis, Novo Nordisk, Ono, Roche, Sanofi , Takeda, Tanabe-Mitsubishi, Terumo.

Hirsch, Irl B. ......................................... Advisory Panel: Abbott Diabetes Care, Roche Diagnostics, Valeritas; Research Support: Sanofi , Novo Nordisk.

Hirsch, Jan ........................................... Disclosed no confl ict of interest.Hirsch, Laurence ................................. Employee: BD Medical-Diabetes Care; Stock/Shareholder:

Becton, Dickinson and Company. Hirschey, Matthew D. ......................... Disclosed no confl ict of interest.Hirschler, Valeria ................................. Disclosed no confl ict of interest.Hirschmugl, Birgit ............................... Disclosed no confl ict of interest.Hirshberg, Boaz ................................... Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP. Hirst, Jane E. ....................................... Disclosed no confl ict of interest.Hirukawa, Hidenori ............................. Disclosed no confl ict of interest.Hitoglou, Areti ..................................... Disclosed no confl ict of interest.Hivert, Marie-France .......................... Disclosed no confl ict of interest.Hjort, Line ............................................ Disclosed no confl ict of interest.Hjorth, Marit ....................................... Disclosed no confl ict of interest.Hjortkjær, Henrik Ø. ............................ Disclosed no confl ict of interest.Hjuler, Sara T. ...................................... Employee: Nordic Bioscience. Ho, Evelyn Y. ........................................ Disclosed no confl ict of interest.Ho, George ........................................... Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Ho, Sam ................................................ Disclosed no confl ict of interest.Hoag, Janie ......................................... Research Support: National Institutes of Health. Hoang, Monica .................................... Disclosed no confl ict of interest.Hobbs, Todd ......................................... Employee: Novo Nordisk Inc. Hochberg, Irit ...................................... Disclosed no confl ict of interest.Hochberg, Marc .................................. Disclosed no confl ict of interest.Hocher, Berthold ................................. Employee: University of Potsdam. Hock, Kristen M. ................................. Disclosed no confl ict of interest.Hod, Moshe ......................................... Disclosed no confl ict of interest.Hoda, Mohamed N. ............................. Disclosed no confl ict of interest.Hodges, Wesley .................................. Disclosed no confl ict of interest.Hodish, Israel ...................................... Board Member: Hygieia. Hodson, David J. ................................. Disclosed no confl ict of interest.Hodson, Leanne .................................. Disclosed no confl ict of interest.Hoebaus, Clemens .............................. Disclosed no confl ict of interest.Hoekstra, Cindy ................................... Disclosed no confl ict of interest.Hoekstra, Joost ................................... Advisory Panel: AstraZeneca Pharmaceuticals LP. Hoene, Miriam ..................................... Disclosed no confl ict of interest.Hoepfner, Florian ................................ Disclosed no confl ict of interest.Hoerger, Thomas J. ............................. Disclosed no confl ict of interest.Hoevenaars, Femke P. ......................... Disclosed no confl ict of interest.Hofer, Sabine E. ................................... Disclosed no confl ict of interest.Hoffman, Howard J. ........................... Disclosed no confl ict of interest.Hoffman, Robert ................................. Disclosed no confl ict of interest.Hoffman, William H. ........................... Disclosed no confl ict of interest.Hoffmann, Barbara ............................. Disclosed no confl ict of interest.Hoffmann, Daniela .............................. Disclosed no confl ict of interest.Hofgartner, Wolfgang ........................ Disclosed no confl ict of interest.Hofman, Albert .................................... Disclosed no confl ict of interest.Hogan, Andrew ................................... Disclosed no confl ict of interest.Hogan, Meghan F. ............................... Disclosed no confl ict of interest.Hogrefe, Louis ..................................... Disclosed no confl ict of interest.

Hohenadel, Maximilian G. .................. Disclosed no confl ict of interest.Højlund, Kurt ....................................... Disclosed no confl ict of interest.Hokanson, John E. .............................. Disclosed no confl ict of interest.Holen, Torgeir ...................................... Disclosed no confl ict of interest.Holewa, Danielle ................................. Employee: Metabolic Solutions Development Company, LLC. Holl, Jane ............................................. Disclosed no confl ict of interest.Holl, Reinhard W. ................................ Disclosed no confl ict of interest.Holland, Jenna .................................... Disclosed no confl ict of interest.Holland, Scott ..................................... Disclosed no confl ict of interest.Holland, William L. .............................. Disclosed no confl ict of interest.Hollander, Priscilla .............................. Advisory Panel: Novo Nordisk, Eli Lilly and Company, and

Merck. Holleman, Cassie ................................ Disclosed no confl ict of interest.Holliday, Elizabeth G. .......................... Disclosed no confl ict of interest.Hollingsworth, Kieren G. .................... Disclosed no confl ict of interest.Hollister-Lock, Jennifer ...................... Disclosed no confl ict of interest.Holm, Tony ........................................... Disclosed no confl ict of interest.Holman, Daniel .................................... Disclosed no confl ict of interest.Holman, Geoffrey D. ........................... Disclosed no confl ict of interest.Holman, Rury R. ................................... Advisory Panel: Elcelyx Therapeutics, Inc., Merck & Co., Inc.,

Novartis; Research Support: Bayer HealthCare, Bristol-Myers Squibb/AstraZeneca, Merck & Co., Inc.

Holmberg, Mark .................................. Employee: United Health Group-Optum. Holmes, Ann M. .................................. Disclosed no confl ict of interest.Holmes, Mary ...................................... Disclosed no confl ict of interest.Holmes-Walker, Deborah J. ............... Disclosed no confl ict of interest.Holson, Edward ................................... Disclosed no confl ict of interest.Holst, Jens J. ...................................... Advisory Panel: AstraZeneca Pharmaceuticals LP,

GlaxoSmithKline, Halozyme Therapeutics, Intarcia Therapeutics, Inc., Merck Sharp & Dohme, Novo Nordisk A/S, Sanofi U.S., Zealand Pharma A/S; Board Member: AstraZeneca Pharmaceuticals LP, GlaxoSmithKline, Halozyme Therapeutics, Intarcia Therapeutics, Inc., Merck Sharp & Dohme, Novo Nordisk A/S, Sanofi U.S., Zealand Pharma A/S; Consultant: Novo Nordisk A/S; Research Support: Merck & Co., Inc., Novartis Corporation.

Holt, James B. ..................................... Disclosed no confl ict of interest.Holt, Richard I. ..................................... Disclosed no confl ict of interest.Holt, Sarah K. ...................................... Disclosed no confl ict of interest.Holte, Sarah E. .................................... Disclosed no confl ict of interest.Home, Philip ......................................... Advisory Panel: AntriaBio, AstraZeneca, Eli Lilly and

Company, GlaxoSmithKline, Janssen Pharmaceutical Companies of Johnson & Johnson, MSD, Novo Nordisk A/S, Roche Diagnostics, Roche Pharma, Sanofi , Skyepharma plc., Takeda Pharmaceutical Company Limited; Research Support: Eli Lilly and Company, GlaxoSmithKline, Sanofi ; Speaker’s Bureau: AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, MSD, Novo Nordisk A/S, Sanofi .

Hommel, Eva E. .................................... Advisory Panel: Medtronic, Inc.; Research Support: Roche Diagnostics; Stock/Shareholder: Novo Nordisk A/S.

Hompesch, Marcus ............................. Advisory Panel: Hanmi Pharmaceutical Co., Ltd; Employee: Profi l Institute for Clinical Research, Inc.; Stock/Shareholder: Profi l Institute for Clinical Research, Inc.

Honda, Hiroto ...................................... Disclosed no confl ict of interest.Honda, Kenjiro ..................................... Disclosed no confl ict of interest.Hong, Eun Shil ..................................... Disclosed no confl ict of interest.Hong, Eun-Gyoung .............................. Disclosed no confl ict of interest.Hong, Ho Cheol ................................... Disclosed no confl ict of interest.Hong, Jaeyoung .................................. Disclosed no confl ict of interest.Hong, Kwangik A. ................................ Disclosed no confl ict of interest.Hong, Kyung Hee ................................. Disclosed no confl ict of interest.Hong, Seong Bin .................................. Disclosed no confl ict of interest.Hong, Shangyu .................................... Disclosed no confl ict of interest.Hong, Soo Hyun ................................... Disclosed no confl ict of interest.Hong, Soo Min ..................................... Disclosed no confl ict of interest.Hong, Ting ........................................... Disclosed no confl ict of interest.Hong, Young Sun ................................. Disclosed no confl ict of interest.Hong, Yuling ........................................ Disclosed no confl ict of interest.Honjo, Jun ............................................ Disclosed no confl ict of interest.Honjo, Sachiko ..................................... Disclosed no confl ict of interest.Honka, Henri ........................................ Disclosed no confl ict of interest.Honoki, Hisae ...................................... Disclosed no confl ict of interest.Hood, Gillian ........................................ Disclosed no confl ict of interest.Hood, Korey K. ..................................... Disclosed no confl ict of interest.Hood, Robert C. .................................Board Member: Takeda Pharmaceuticals U.S.A., Inc.;

Consultant: Eli Lilly and Company, Novo Nordisk Inc.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, GlaxoSmithKline, Janssen Biotech, Inc., Novo Nordisk Inc., Takeda Pharmaceuticals U.S.A., Inc.

A842

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Hoogeveen, Ron .................................. Disclosed no confl ict of interest.Hoogwerf, Byron J. ............................. Employee: Eli Lilly and Company, Eli Lilly and Company

(Spouse/Partner); Stock/Shareholder: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner).

Hookham, Michelle ............................. Disclosed no confl ict of interest.Hopkins, Diane .................................... Disclosed no confl ict of interest.Hoppel, Charles L. ............................... Research Support: American Diabetes Association. Hörbelt, Tina ........................................ Disclosed no confl ict of interest.Horcsik, Dorottya V. ............................ Disclosed no confl ict of interest.Horenstein, Richard B. ........................ Disclosed no confl ict of interest.Horesh, Orit ......................................... Disclosed no confl ict of interest.Hori, Kenichiro ..................................... Disclosed no confl ict of interest.Hori, Kennichirou ................................ Disclosed no confl ict of interest.Horibe, Mayumi ................................... Disclosed no confl ict of interest.Horie, Kanako ...................................... Disclosed no confl ict of interest.Horie, Toru ........................................... Disclosed no confl ict of interest.Horigan, Geraldine .............................. Disclosed no confl ict of interest.Horii, Takeshi ....................................... Disclosed no confl ict of interest.Horikawa, Chika .................................. Disclosed no confl ict of interest.Horikawa, Yukio .................................. Disclosed no confl ict of interest.Horikoshi, Momoko ............................. Disclosed no confl ict of interest.Horinek, Ales ....................................... Disclosed no confl ict of interest.Hornburg, Daniel ................................. Disclosed no confl ict of interest.Hornemann, Silke ................................ Disclosed no confl ict of interest.Hornigold, David ................................. Employee: MedImmune, Inc. Horowitz, Jeffrey ................................ Disclosed no confl ict of interest.Horowitz, Michael .............................. Advisory Panel: AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Meyer Nutriceuticals, Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Sanofi U.S., Satiogen Pharmaceuticals, Inc.

Horsburgh, Jodie C. ............................ Research Support: Medtronic, Inc. Horton, Edward S. ............................... Advisory Panel: Amgen Inc., Merck & Co., Inc., Takeda

Pharmaceutical Company Limited, Theracos, Inc. Horvath, Karl ....................................... Speaker’s Bureau: Eli Lilly and Company, Novartis Pharma

GmbH. Horvath, Peter ..................................... Disclosed no confl ict of interest.Horvath, Tamas ................................... Disclosed no confl ict of interest.Hosaka, Toshio .................................... Disclosed no confl ict of interest.Hosojima, Michihiro ............................ Research Support: Merck & Co., Inc. Hosokawa, Masaya ............................ Disclosed no confl ict of interest.Hosomura, Naoshi .............................. Disclosed no confl ict of interest.Hossain, Jobayer ................................ Disclosed no confl ict of interest.Hossain, Munir .................................... Disclosed no confl ict of interest.Hosseini, S. Mohsen ........................... Disclosed no confl ict of interest.Hostrup, Susanne ................................ Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Hotaling, James M. ............................ Disclosed no confl ict of interest.Hother-Nielsen, Ole ............................ Disclosed no confl ict of interest.Hotta, Yuko .......................................... Disclosed no confl ict of interest.Hou, Xuhong ........................................ Disclosed no confl ict of interest.Houben, Alfons J. ............................... Disclosed no confl ict of interest.Houdijk, Lex ......................................... Disclosed no confl ict of interest.Hough, Tertius ..................................... Disclosed no confl ict of interest.Houmard, Joe ...................................... Disclosed no confl ict of interest.Houshmand-Oeregaard, Azadeh ....... Disclosed no confl ict of interest.Houston, Sara ...................................... Disclosed no confl ict of interest.Hövelmann, Ulrike ............................... Disclosed no confl ict of interest.Hovendal, Claus .................................. Disclosed no confl ict of interest.Hovorka, Roman .................................. Advisory Panel: Animas Corporation, Eli Lilly and Company,

Medtronic MiniMed, Inc.; Consultant: B. Braun Melsungen AG, Becton, Dickinson and Company, Profi l, Sanofi -Aventis; Other Relationship: B. Braun Melsungen AG, Becton, Dickinson and Company, University of Cambridge; Speaker’s Bureau: B. Braun Melsungen AG, Eli Lilly and Company, LifeScan, Inc., Medtronic MiniMed, Inc., Novo Nordisk Inc.

Howard, George .................................. Disclosed no confl ict of interest.Howard, Virginia ................................. Disclosed no confl ict of interest.Howe, Cheryl A. .................................. Disclosed no confl ict of interest.Howell, Mary E. ................................... Disclosed no confl ict of interest.Howorka, Eleonora ............................. Disclosed no confl ict of interest.Howson, Jo .......................................... Disclosed no confl ict of interest.Høyem, Pernille H. .............................. Disclosed no confl ict of interest.Hrabe de Angelis, Martin ................... Disclosed no confl ict of interest.Hsia, Daniel S. ..................................... Disclosed no confl ict of interest.Hsieh, Albert ....................................... Disclosed no confl ict of interest.Hsieh, Elaine ........................................ Disclosed no confl ict of interest.Hsu, Elise ............................................. Disclosed no confl ict of interest.Hsu, Kevin S. ....................................... Disclosed no confl ict of interest.Hsu, Stephen I. .................................... Employee: Prometheon Pharma, LLC, Prometheon Pharma,

LLC (Spouse/Partner).

Hsu, Tu Wen ........................................ Disclosed no confl ict of interest.Hsu, William C. .................................... Disclosed no confl ict of interest.Hsueh, Wen-Chi .................................. Disclosed no confl ict of interest.Hsueh, Willa A. ................................... Disclosed no confl ict of interest.Htun, Wynn .......................................... Disclosed no confl ict of interest.Hu, Betty .............................................. Disclosed no confl ict of interest.Hu, Cheng ............................................ Disclosed no confl ict of interest.Hu, Dayi ............................................... Disclosed no confl ict of interest.Hu, Derong ........................................... Disclosed no confl ict of interest.Hu, Fang ............................................... Disclosed no confl ict of interest.Hu, Frank B. ......................................... Disclosed no confl ict of interest.Hu, Gang .............................................. Research Support: National Institute of Diabetes and

Digestive and Kidney Diseases (Spouse/Partner), National Institute of Diabetes and Digestive and Kidney Diseases (Spouse/Partner).

Hu, Hao ................................................ Disclosed no confl ict of interest.Hu, Ji .................................................... Disclosed no confl ict of interest.Hu, Jiang .............................................. Disclosed no confl ict of interest.Hu, Jingjie ............................................ Disclosed no confl ict of interest.Hu, Li .................................................... Disclosed no confl ict of interest.Hu, Ming .............................................. Disclosed no confl ict of interest.Hu, Ming-Yue ....................................... Disclosed no confl ict of interest.Hu, Pei .................................................. Disclosed no confl ict of interest.Hu, Sophia H. ....................................... Disclosed no confl ict of interest.Hu, Xiaodi ............................................ Disclosed no confl ict of interest.Hu, Xingyun ......................................... Disclosed no confl ict of interest.Hu, Xinli ............................................... Disclosed no confl ict of interest.Hu, Yang ............................................... Disclosed no confl ict of interest.Hu, Yaqin .............................................. Disclosed no confl ict of interest.Hu, Yinghua ......................................... Disclosed no confl ict of interest.Hu, Zhimin ............................................ Disclosed no confl ict of interest.Hua, Duy H. .......................................... Disclosed no confl ict of interest.Hua, Li .................................................. Disclosed no confl ict of interest.Huang, Carol ........................................ Disclosed no confl ict of interest.Huang, Chien N. .................................. Disclosed no confl ict of interest.Huang, Elbert S. .................................. Disclosed no confl ict of interest.Huang, Feicong .................................... Disclosed no confl ict of interest.Huang, Hanxia ..................................... Disclosed no confl ict of interest.Huang, Hazel ....................................... Disclosed no confl ict of interest.Huang, Hong ........................................ Disclosed no confl ict of interest.Huang, Huan ........................................ Consultant: Quintiles Inc. Huang, Hui ........................................... Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Huang, Huibin ...................................... Disclosed no confl ict of interest.Huang, Jean ........................................ Disclosed no confl ict of interest.Huang, Jia ............................................ Disclosed no confl ict of interest.Huang, Jun-Yuan ................................. Disclosed no confl ict of interest.Huang, Ke ............................................ Disclosed no confl ict of interest.Huang, Mei .......................................... Disclosed no confl ict of interest.Huang, Meixin ..................................... Disclosed no confl ict of interest.Huang, Shichang ................................. Disclosed no confl ict of interest.Huang, Siyuan ..................................... Disclosed no confl ict of interest.Huang, Tao ........................................... Disclosed no confl ict of interest.Huang, Tianlian ................................... Disclosed no confl ict of interest.Huang, Wenyan ................................... Disclosed no confl ict of interest.Huang, Wenying .................................. Employee: AstraZeneca Pharmaceuticals LP, Bristol-Myers

Squibb Company, Pharmapace. Huang, Xiaochun ................................. Disclosed no confl ict of interest.Huang, Xinghua ................................... Employee: Merck & Co., Inc. Huang, Xinmei ..................................... Disclosed no confl ict of interest.Huang, Yueye ...................................... Disclosed no confl ict of interest.Huang, Yufeng ..................................... Disclosed no confl ict of interest.Huang, Yun .......................................... Disclosed no confl ict of interest.Huang, Zhimin ..................................... Disclosed no confl ict of interest.Huber, Jorg W. .................................... Disclosed no confl ict of interest.Huckova, Miroslava ............................ Disclosed no confl ict of interest.Hudson, Jonell .................................... Disclosed no confl ict of interest.Hudson, Margo .................................... Disclosed no confl ict of interest.Huebschle, Thomas ............................ Disclosed no confl ict of interest.Huebschmann, Amy G. ....................... Disclosed no confl ict of interest.Huet, Beverley ..................................... Disclosed no confl ict of interest.Huff, Chad ............................................ Disclosed no confl ict of interest.Huff, Robin ........................................... Disclosed no confl ict of interest.Huggins, Gordon S. ............................. Disclosed no confl ict of interest.Hughes, Amy ....................................... Disclosed no confl ict of interest.Hughes, Jing ........................................ Disclosed no confl ict of interest.Hughes, John ...................................... Disclosed no confl ict of interest.Hughey, Curtis C. ................................. Disclosed no confl ict of interest.Hugo, Marie ......................................... Disclosed no confl ict of interest.Huh, Joo Young ................................... Disclosed no confl ict of interest.Hull, Rebecca L. ................................... Disclosed no confl ict of interest.Hung, Yi-Jen ........................................ Disclosed no confl ict of interest.

A843

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Hunt, Hazel J. ...................................... Disclosed no confl ict of interest.Hunt, Kelly J. ....................................... Disclosed no confl ict of interest.Hunter Buskey, Robin N. ..................... Advisory Panel: Eli Lilly and Company. Hunter, Chad S. ................................... Disclosed no confl ict of interest.Huo, Zhiping ........................................ Disclosed no confl ict of interest.Hur, Junguk .......................................... Disclosed no confl ict of interest.Hur, Kyu Yeon ...................................... Disclosed no confl ict of interest.Hurren, Nicholas M. ............................ Disclosed no confl ict of interest.Hurwitz, Shelley .................................. Disclosed no confl ict of interest.Husain, Deeba ..................................... Disclosed no confl ict of interest.Husbands, Adrian ................................ Disclosed no confl ict of interest.Hussain, M. Mahmood ....................... Disclosed no confl ict of interest.Hutch, Chelsea R. ................................ Disclosed no confl ict of interest.Hutchings, David C. ............................. Disclosed no confl ict of interest.Hutfl ess, Susan ................................... Disclosed no confl ict of interest.Huxley, Rachel ..................................... Disclosed no confl ict of interest.Huyghe, Isabelle ................................. Employee: Pfi zer Inc. Huynh, Frank K. ................................... Disclosed no confl ict of interest.Huynh, Jennifer ................................... Disclosed no confl ict of interest.Hvid, Henning ...................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Hwang, Byung-Hee ............................. Disclosed no confl ict of interest.Hwang, Eun Sook ................................ Disclosed no confl ict of interest.Hwang, Janice J. ................................ Disclosed no confl ict of interest.Hwang, Sang Youn .............................. Disclosed no confl ict of interest.Hwang, Sena ....................................... Disclosed no confl ict of interest.Hwang, Sungsoon ............................... Disclosed no confl ict of interest.Hwang, Won-Min ................................ Disclosed no confl ict of interest.Hwang, You Cheol ............................... Disclosed no confl ict of interest.Hwangbo, Cheol .................................. Disclosed no confl ict of interest.Hyslop, Colin ........................................ Disclosed no confl ict of interest.Hyveled, Liselotte ............................... Board Member: Novo Nordisk A/S; Employee: Novo Nordisk

A/S. Iacobini, Andra-Evelin ........................ Disclosed no confl ict of interest.Iacopi, Elisabetta ................................ Disclosed no confl ict of interest.Iaea, David ........................................... Disclosed no confl ict of interest.Iafusco, Dario ...................................... Advisory Panel: Eli Lilly and Company, Roche, Sanofi ; Board

Member: Eli Lilly and Company, Roche, Sanofi . Iamendi, Carmen ................................. Disclosed no confl ict of interest.Iannilli, Antonio ................................... Disclosed no confl ict of interest.Ibberson, Mark .................................... Disclosed no confl ict of interest.Iberkleid, Laura ................................... Disclosed no confl ict of interest.Ibsen, Rikke ......................................... Disclosed no confl ict of interest.Ichihara, Takako .................................. Disclosed no confl ict of interest.Ichijo, Takamasa .................................. Disclosed no confl ict of interest.Ichiki, Toshihiro ................................... Disclosed no confl ict of interest.Ida, Shogo ............................................ Disclosed no confl ict of interest.Ide, Lisa ................................................ Disclosed no confl ict of interest.Ide, Makoto ......................................... Disclosed no confl ict of interest.Ido, Yasuo ............................................ Disclosed no confl ict of interest.Idris, Iskandar ...................................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,

Eli Lilly and Company, Merck Sharp & Dohme, Novo Nordisk Inc.

Idzior-Walus, Barbara ......................... Disclosed no confl ict of interest.Iepsen, Eva W. ..................................... Disclosed no confl ict of interest.Iga, Ryo ................................................ Disclosed no confl ict of interest.Igaki, Makoto ...................................... Disclosed no confl ict of interest.Igarashi, Ayumi ................................... Disclosed no confl ict of interest.Igarashi, Masahiko ............................. Disclosed no confl ict of interest.Igarashi, Risa ....................................... Disclosed no confl ict of interest.Igase, Michiya ..................................... Disclosed no confl ict of interest.Igata, Motoyuki ................................... Disclosed no confl ict of interest.Iglay, Kristy .......................................... Employee: Merck & Co., Inc. Iglay Reger, Heidi B. ............................ Disclosed no confl ict of interest.Ignotz, Keith ........................................ Board Member: Freedom Meditech, Inc.; Employee: Freedom

Meditech, Inc. Ihara, Yuka ........................................... Disclosed no confl ict of interest.Iijima, Toshie ....................................... Disclosed no confl ict of interest.Iizuka, Katsumi .................................... Disclosed no confl ict of interest.Ijzerman, Richard G. ............................ Disclosed no confl ict of interest.Ikade, Takahide ................................... Disclosed no confl ict of interest.Ikeda, Hiroki ........................................ Disclosed no confl ict of interest.Ikeda, Kouhei ....................................... Disclosed no confl ict of interest.Ikeda, Shinichiro .................................. Disclosed no confl ict of interest.Ikeda, Takahide ................................... Disclosed no confl ict of interest.Ikeda, Yasumasa ................................. Disclosed no confl ict of interest.Ikegami, Eri .......................................... Disclosed no confl ict of interest.Ilag, Liza L. ........................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Ilani, Jacob .......................................... Disclosed no confl ict of interest.Iliadis, Fotios ....................................... Disclosed no confl ict of interest.Ilias, Anissa ......................................... Disclosed no confl ict of interest.

Ilic, Dragan .......................................... Disclosed no confl ict of interest.Ilic, Jelena ........................................... Disclosed no confl ict of interest.Ilkayeva, Olga ...................................... Disclosed no confl ict of interest.Illuri, Vidhya D. .................................... Disclosed no confl ict of interest.Ilonen, Jorma ...................................... Disclosed no confl ict of interest.Ilves, Imre Ilves ................................... Disclosed no confl ict of interest.Im, Kyungah ......................................... Disclosed no confl ict of interest.Imai, Daiki ............................................ Disclosed no confl ict of interest.Imai, Junta ........................................... Disclosed no confl ict of interest.Imai, Masaru ....................................... Disclosed no confl ict of interest.Imai, Yumi ............................................ Disclosed no confl ict of interest.Imamura, Minako ................................ Disclosed no confl ict of interest.Imamura, Satoshi ................................ Disclosed no confl ict of interest.Imamura, Shigeki ................................ Disclosed no confl ict of interest.Imani-Nejad, Maryam ......................... Disclosed no confl ict of interest.Imaoka, Takeshi .................................. Employee: Eli Lilly Japan K.K. Imazeki, Masaru .................................. Disclosed no confl ict of interest.Imes, Sharleen .................................... Disclosed no confl ict of interest.Imperatore, Giuseppina ...................... Disclosed no confl ict of interest.Îna, Koichiro ......................................... Research Support: Bayer HealthCare. Inaba, Masaaki ................................... Research Support: Asahi Kasei Pharm Corporation, Astellas

Pharma Inc, Daiichi Sankyo Co., Ltd.,, Mitsubisi Tanabe Pharma Corporation, Takeda Pharmaceutical Company Limited.

Inaba, Wataru ..................................... Disclosed no confl ict of interest.Inagaki, Nobuya .................................. Disclosed no confl ict of interest.Inashima, Kunikazu ............................. Disclosed no confl ict of interest.Incalza, Maria Angela ......................... Disclosed no confl ict of interest.Indrakusuma, Ira ................................. Disclosed no confl ict of interest.Ingar-Pinedo, Jaime ............................ Disclosed no confl ict of interest.Inge, Thomas H. .................................. Research Support: Ethicon Endo-Surgery, Inc. Ingelsson, Erik ..................................... Disclosed no confl ict of interest.Inigo-Zaera, Pilar ................................. Disclosed no confl ict of interest.Inocencio, Timothy .............................. Consultant: Avalere Health LLC. Inoguchi, Toyoshi ................................ Disclosed no confl ict of interest.Inoue, Gaku .......................................... Disclosed no confl ict of interest.Inoue, Hiroyuki .................................... Disclosed no confl ict of interest.Inoue, Mamoru .................................... Disclosed no confl ict of interest.Inukai, Kouichi ..................................... Disclosed no confl ict of interest.Inukai, Toshihiko .................................. Disclosed no confl ict of interest.Inverardi, Luca ..................................... Disclosed no confl ict of interest.Inzucchi, Silvio E. ................................ Disclosed no confl ict of interest.Ionut, Viorica ....................................... Disclosed no confl ict of interest.Iovino, Salvatore ................................. Disclosed no confl ict of interest.Iozzo, Patricia ...................................... Disclosed no confl ict of interest.Ip, Blanche ........................................... Research Support: National Institutes of Health. Ippolito, Claudia .................................. Disclosed no confl ict of interest.Iqbal, Nayyar ....................................... Employee: Bristol-Myers Squibb Company. Irie, Jun-ichiro ..................................... Disclosed no confl ict of interest.Irmler, Martin ...................................... Disclosed no confl ict of interest.Ischenko, Irina J. ................................. Disclosed no confl ict of interest.Iser, Betine P. ....................................... Disclosed no confl ict of interest.Isganaitis, Elvira M. ............................ Disclosed no confl ict of interest.Ishibashi, Fukashi ................................ Disclosed no confl ict of interest.Ishibashi, Shun .................................... Disclosed no confl ict of interest.Ishida, Hitoshi ..................................... Research Support: Seiko Epson Corporation. Ishida, Yukari ....................................... Disclosed no confl ict of interest.Ishigaki, Yasushi ................................. Disclosed no confl ict of interest.Ishihara, Hisamitsu ............................. Advisory Panel: Astellas Pharma US, Inc.; Speaker’s Bureau:

Daiichi-Sankyo Co., Ltd., Eli Lilly Japan K.K., Merck Sharp & Dohme, Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Sanofi U.S.

Ishihara, Takashi ................................. Disclosed no confl ict of interest.Ishii, Eiichi ............................................ Disclosed no confl ict of interest.Ishii, Hitoshi ......................................... Research Support: Mitsubishi Tanabe Pharma Corporation,

Novo Nordisk Inc.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Eli Lilly Japan K.K., Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation, Novartis Corporation, Novo Nordisk Inc., Sanofi U.S., Sumimoto Dainippon Pharma Co., Ltd., Takeda Pharmaceutical Company Limited.

Ishii, Isao .............................................. Disclosed no confl ict of interest.Ishii, Naoki ........................................... Disclosed no confl ict of interest.Ishikado, Atsushi ................................. Disclosed no confl ict of interest.Ishikawa, Takahiro .............................. Disclosed no confl ict of interest.Ishikawa, Tomomi ............................... Disclosed no confl ict of interest.Ishiki, Manabu ..................................... Disclosed no confl ict of interest.Ishimaru, Naozumi .............................. Disclosed no confl ict of interest.Ishizaka, Masanori .............................. Disclosed no confl ict of interest.Ishizaki, Masao ................................... Disclosed no confl ict of interest.Ishizawa, Sho ...................................... Disclosed no confl ict of interest.

A844

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Ishizeki, Kanaki ................................... Disclosed no confl ict of interest.Ishizu, Katsura ..................................... Disclosed no confl ict of interest.Ishizuka, Tatsuo ................................... Disclosed no confl ict of interest.Islam, Najmul ...................................... Disclosed no confl ict of interest.Ismail, Khalida ..................................... Disclosed no confl ict of interest.Ismailoglu, Murat ................................ Disclosed no confl ict of interest.Isobe, Ken-Ichi .................................... Disclosed no confl ict of interest.Isogawa, Akihiro ................................. Disclosed no confl ict of interest.Isom, Scott .......................................... Disclosed no confl ict of interest.Isono, Momoko .................................... Disclosed no confl ict of interest.Isquith, Daniel ..................................... Disclosed no confl ict of interest.Israeli Yagev, Lital ............................... Disclosed no confl ict of interest.Isupov, Taisia ....................................... Employee: AstraZeneca Pharmaceuticals LP. Itaya-Hironaka, Asako ........................ Disclosed no confl ict of interest.Item, Flurin ........................................... Disclosed no confl ict of interest.Ito, Chikako .......................................... Disclosed no confl ict of interest.Ito, Hideki ............................................ Disclosed no confl ict of interest.Ito, Shun ............................................... Disclosed no confl ict of interest.Ito, Tetsuo ............................................ Disclosed no confl ict of interest.Itoh, Hiroshi ......................................... Disclosed no confl ict of interest.Iuchi, Hiroyuki ...................................... Disclosed no confl ict of interest.Iughetti, Lorenzo ................................. Disclosed no confl ict of interest.Ivanova, Jasmina I. ............................. Employee: Boehringer Ingelheim Pharmaceuticals, Inc.

(Spouse/Partner); Research Support: Eli Lilly and Company.

Ivanyi, Tibor ......................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly and Company.

Iversen, Marjolein M. ......................... Disclosed no confl ict of interest.Ivey, Robert ......................................... Disclosed no confl ict of interest.Iwabu, Masato .................................... Research Support: Mitsubishi Tanabe Pharma Corporation,

Mitsubishi Tanabe Pharma Corporation (Spouse/Partner), Novo Nordisk Inc. (Spouse/Partner), Novo Nordisk Inc., Ono Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd. (Spouse/Partner), Takeda Pharmaceutical Company Limited, Takeda Pharmaceutical Company Limited (Spouse/Partner); Speaker’s Bureau: Astellas Pharma Japan, Inc, Mitsubishi Tanabe Pharma Corporation (Spouse/Partner).

Iwabu, Miki .......................................... Disclosed no confl ict of interest.Iwaki, Yoshiki ...................................... Disclosed no confl ict of interest.Iwakura, Toshio ................................... Disclosed no confl ict of interest.Iwamoto, Noriyuki .............................. Employee: Eli Lilly Japan K.K. Iwasaki, Arata ..................................... Disclosed no confl ict of interest.Iwasaki, Kanako .................................. Disclosed no confl ict of interest.Iwasaki, Naoko .................................... Disclosed no confl ict of interest.Iwasaki, Yorihiro ................................. Disclosed no confl ict of interest.Iwata, Minoru ...................................... Disclosed no confl ict of interest.Iwata, Shinpei ..................................... Disclosed no confl ict of interest.Iwaya, Chihiro ..................................... Disclosed no confl ict of interest.Iwaya, Keiichi ...................................... Disclosed no confl ict of interest.Ix, Joachim H. ...................................... Disclosed no confl ict of interest.Iyer, Anand .......................................... Employee: WellDoc, Inc. Iyer, Malini S. ...................................... Disclosed no confl ict of interest.Izaola, Olatz ......................................... Disclosed no confl ict of interest.Izawa, Schoichiro ................................ Disclosed no confl ict of interest.Izuora, Kenneth E. ............................... Research Support: National Institutes of Health, Sanofi U.S. Jabbour, Georges ................................ Disclosed no confl ict of interest.Jabbour, Serge .................................... Advisory Panel: AstraZeneca, Eli Lilly, Jannsen; Consultant:

AstraZeneca, Eli Lilly, Jannsen. Jaber, Linda A. .................................... Disclosed no confl ict of interest.Jaber, Yahya ........................................ Disclosed no confl ict of interest.Jacewicz, Malgorzata ........................ Disclosed no confl ict of interest.Jackman, Matthew ............................. Disclosed no confl ict of interest.Jackson, George L. .............................. Disclosed no confl ict of interest.Jackson, Jeffrey A. ............................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Jackson, Kathryn L. ............................ Disclosed no confl ict of interest.Jackson, Nicholas ............................... Disclosed no confl ict of interest.Jackson, Nicola ................................... Disclosed no confl ict of interest.Jackson, Ralph .................................... Disclosed no confl ict of interest.Jackson, Richard A. ............................ Consultant: PatientsLikeMe. Jackson, Ron ....................................... Employee: MedImmune, Inc. Jackson, Sandra L. .............................. Disclosed no confl ict of interest.Jacob, Marrit ....................................... Disclosed no confl ict of interest.Jacob, Robert F. .................................. Disclosed no confl ict of interest.Jacober, Scott J. ................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company, Eli Lilly and Company (Spouse/Partner). Jacobs, David ...................................... Disclosed no confl ict of interest.Jacobsen, Elisabeth ............................ Disclosed no confl ict of interest.Jacobson, Alan M. .............................. Disclosed no confl ict of interest.Jacobson, David A. ............................. Consultant: Gilead.

Jacobson, Jennie G. ........................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly and Company.

Jacoby, Christine ................................ Disclosed no confl ict of interest.Jacqueminet, Sophie .......................... Disclosed no confl ict of interest.Jaddoe, Vincent W. ............................. Disclosed no confl ict of interest.Jae, Deborah ....................................... Consultant: AstraZeneca Pharmaceuticals LP. Jaeckel, Elmar ..................................... Advisory Panel: AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim GmbH, Eli Lilly and Company, Janssen, Merck Sharp & Dohme, Novartis Pharma GmbH, Novo Nordisk A/S, Roche; Research Support: Biotest, BMBF, EU, Fresenius DFG, Gilead, JDRF, Miltenyi Biotech, Novartis Pharma GmbH, Novo Nordisk A/S, Roche, VW-Stiftung, Wacker Chemie; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH, Eli Lilly and Company, Janssen, Merck Sharp & Dohme, Novartis Pharma GmbH, Novo Nordisk A/S, Roche.

Jagielnicki, Maciej .............................. Disclosed no confl ict of interest.Jähnert, Markus ................................. Disclosed no confl ict of interest.Jahnke, Johannes ............................... Disclosed no confl ict of interest.Jain, Anand ......................................... Employee: Novo Nordisk A/S. Jain, Chandni ....................................... Disclosed no confl ict of interest.Jain, Mukul R. ..................................... Employee: Cadila Healthcare Limited. Jain, Shalini ......................................... Disclosed no confl ict of interest.Jain, Sunil M. ...................................... Disclosed no confl ict of interest.Jain, Sushil K. ...................................... Disclosed no confl ict of interest.Jaiswal, Ashok D. ............................... Employee: Cadila Healthcare Ltd. Jaiswal, Mamta .................................. Disclosed no confl ict of interest.Jakicic, John M. .................................. Disclosed no confl ict of interest.Jakobsen, Poul E. ................................ Board Member: AstraZeneca Pharmaceuticals LP, Novo

Nordisk A/S; Research Support: Novo Nordisk A/S; Speaker’s Bureau: Eli Lilly and Company.

Jakubowicz, Daniela ........................... Disclosed no confl ict of interest.Jamal, Rahman .................................... Disclosed no confl ict of interest.Jambaljav, Byambatseren .................. Disclosed no confl ict of interest.Jambugulam, Mohan .......................... Disclosed no confl ict of interest.James, Brian ........................................ Disclosed no confl ict of interest.James, David E. ................................... Disclosed no confl ict of interest.James, Freyja D. .................................. Disclosed no confl ict of interest.James, Lisa K. ..................................... Disclosed no confl ict of interest.James, Tim J. ...................................... Disclosed no confl ict of interest.James-Todd, Tamarra ......................... Disclosed no confl ict of interest.Jan, Eric ............................................... Disclosed no confl ict of interest.Janas, John ......................................... Employee: President/CEO of Clinical Content Consultants. Jandeleit-Dahm, Karin ........................ Research Support: Abbott, Boehringer Ingelheim GmbH. Jang, Hak C. ........................................ Disclosed no confl ict of interest.Jang, Hakchul ...................................... Disclosed no confl ict of interest.Jang, Myoungock ................................ Disclosed no confl ict of interest.Janikiewicz, Justyna .......................... Disclosed no confl ict of interest.Jankowiak, Frank ................................ Disclosed no confl ict of interest.Janson, Susan ..................................... Disclosed no confl ict of interest.Janssen, Ignace .................................. Consultant: GI Dynamics, Inc. Janus, Charlotte .................................. Disclosed no confl ict of interest.Japa, Shanker ..................................... Disclosed no confl ict of interest.Japa, Usha ........................................... Disclosed no confl ict of interest.Japiassú, Letícia M. ............................ Disclosed no confl ict of interest.Jares, Pedro ........................................ Disclosed no confl ict of interest.Jariwala, Ravi ..................................... Disclosed no confl ict of interest.Jarlov, Henrik ...................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Jarosz-Chobot, Przemyslawa ............ Disclosed no confl ict of interest.Jarret, Lori ........................................... Disclosed no confl ict of interest.Jastreboff, Ania M. ............................ Disclosed no confl ict of interest.Jax, Thomas ........................................ Employee: Profi l. Jayatillake, Harsha ............................. Disclosed no confl ict of interest.Jazbec, Anamarija .............................. Disclosed no confl ict of interest.Jebasingh, Felix .................................. Disclosed no confl ict of interest.Jedrychowski, Mark ........................... Disclosed no confl ict of interest.Jee, Donghyun .................................... Disclosed no confl ict of interest.Jefferson, Leonard S. ......................... Disclosed no confl ict of interest.Jefferson-George, Kyra ...................... Disclosed no confl ict of interest.Jeganathan, Ramesh B. ..................... Disclosed no confl ict of interest.Jelenik, Tomas .................................... Disclosed no confl ict of interest.Jelmsa, Judith ..................................... Disclosed no confl ict of interest.Jendle, Johan ...................................... Advisory Panel: Abbott Laboratories, Inc., AstraZeneca

Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Medtronic, Inc., Novo Nordisk Inc., Roche Diagnostics; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, InfuCare, Ltd., Menarini Group, Merck Sharp & Dohme, Novo Nordisk Inc., Pfi zer Inc., Sanofi Pasteur SA.

A845

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Jenkins, Alicia ..................................... Advisory Panel: Abbott; Board Member: IDF Life for a child, Insulin for Life (Diabetes charity); Research Support: Sanofi -Aventis; Speaker’s Bureau: AMSL, Eli Lilly and Company, Taisho Pharmaceutical Co., Ltd.

Jenkins, Carol ...................................... Disclosed no confl ict of interest.Jenkins, Todd M. ................................. Disclosed no confl ict of interest.Jenkinson, Celia .................................. Consultant: Janssen Research & Development LLC. Jennings, Gary T. ................................ Stock/Shareholder: Cytos Biotechnology AG. Jensen, Dorte M. ................................ Advisory Panel: Novo Nordisk A/S. Jensen, Jens-Erik B. ........................... Disclosed no confl ict of interest.Jensen, Jorgen ................................... Disclosed no confl ict of interest.Jensen, Lisette O. ............................... Disclosed no confl ict of interest.Jensen, Magnus T. .............................. Disclosed no confl ict of interest.Jensen, Pia S. ...................................... Disclosed no confl ict of interest.Jensen, Stina R. .................................. Employee: Novo Nordisk Inc. Jensen, Tonny ..................................... Disclosed no confl ict of interest.Jeon, Eun Kyoung ................................ Disclosed no confl ict of interest.Jeon, Ja Young .................................... Disclosed no confl ict of interest.Jeon, Sangchoon ................................ Disclosed no confl ict of interest.Jeon, Won Seon .................................. Disclosed no confl ict of interest.Jeon, You-Jin ...................................... Disclosed no confl ict of interest.Jeon, Yun Kyung .................................. Disclosed no confl ict of interest.Jeong, Dongtak ................................... Disclosed no confl ict of interest.Jeong, Hana ........................................ Disclosed no confl ict of interest.Jeong, Ha-Won ................................... Disclosed no confl ict of interest.Jeong, Imju .......................................... Disclosed no confl ict of interest.Jeong, Su Jin ....................................... Disclosed no confl ict of interest.Jeppesen, Claus B. ............................. Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Jepsen, Sara L. .................................... Disclosed no confl ict of interest.Jepson, Lauren .................................... Employee: Dexcom, Inc. Jermendy, Adam L. ............................. Disclosed no confl ict of interest.Jermendy, György ............................... Advisory Panel: NovoNordisk in Hungary, Lilly in Hungary,

Sanofi in Hungary. Jermutus, Lutz ..................................... Employee: MedImmune, Inc. Jerónimo, Carmen ............................... Disclosed no confl ict of interest.Jerums, George ................................... Disclosed no confl ict of interest.Jessen, Lene ....................................... Disclosed no confl ict of interest.Jessen, Niels ....................................... Disclosed no confl ict of interest.Jessup, Claire ...................................... Disclosed no confl ict of interest.Jett, Donald ......................................... Employee: Eli Lilly and Company. Jetten, Anton M. ................................ Disclosed no confl ict of interest.Jeziorska, Maria ................................. Disclosed no confl ict of interest.Ji, Chenbo ............................................ Disclosed no confl ict of interest.Ji, Li Nong ............................................ Disclosed no confl ict of interest.Ji, Linong ............................................. Research Support: Becton, Dickinson and Company. Ji, Nan .................................................. Disclosed no confl ict of interest.Ji, Qiuhe ............................................... Disclosed no confl ict of interest.Ji, Wan-Sheng ..................................... Disclosed no confl ict of interest.Jia, Guanghong ................................... Disclosed no confl ict of interest.Jia, Guowei ......................................... Disclosed no confl ict of interest.Jia, Haomiao ....................................... Disclosed no confl ict of interest.Jia, Weiping ........................................ Disclosed no confl ict of interest.Jian, Kuang .......................................... Disclosed no confl ict of interest.Jian, Weixia ........................................ Disclosed no confl ict of interest.Jiang, C.Q. ........................................... Disclosed no confl ict of interest.Jiang, Dingfeng ................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Jiang, Feng .......................................... Disclosed no confl ict of interest.Jiang, Haoyang ................................... Disclosed no confl ict of interest.Jiang, Hong ......................................... Disclosed no confl ict of interest.Jiang, Hongfeng .................................. Disclosed no confl ict of interest.Jiang, Honghua ................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Jiang, Lei ............................................. Disclosed no confl ict of interest.Jiang, Lihong ....................................... Disclosed no confl ict of interest.Jiang, Xian-Cheng ............................... Disclosed no confl ict of interest.Jiang, Yi-Der ....................................... Disclosed no confl ict of interest.Jiang, Yu .............................................. Disclosed no confl ict of interest.Jiang, Zhen Y. ...................................... Disclosed no confl ict of interest.Jimenez, Soledad ................................ Disclosed no confl ict of interest.Jimenez-Corona, Aida ........................ Disclosed no confl ict of interest.Jiménez-Jacinto, Verónica ................. Disclosed no confl ict of interest.Jimenez-Palomares, Margarita ......... Disclosed no confl ict of interest.Jin Lu .................................................... Disclosed no confl ict of interest.Jin, Heung Yong .................................. Disclosed no confl ict of interest.Jin, Meina ............................................ Disclosed no confl ict of interest.Jin, Sang-Man ..................................... Disclosed no confl ict of interest.Jin, Tianru ............................................ Disclosed no confl ict of interest.Jin, Yan ................................................ Disclosed no confl ict of interest.Jin, Zhu-Qiu ......................................... Disclosed no confl ict of interest.Jinbo, Hu .............................................. Disclosed no confl ict of interest.

Jindal, Devraj ...................................... Disclosed no confl ict of interest.Jing, Enxuan ........................................ Disclosed no confl ict of interest.Jing, Gu ................................................ Disclosed no confl ict of interest.Jing, Ya-Li ............................................ Disclosed no confl ict of interest.Jinga, Mariana .................................... Disclosed no confl ict of interest.Jinnouchi, Hideaki .............................. Consultant: Novo Nordisk Inc., Sanofi U.S.; Research

Support: Astellas Pharma US, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Eli Lilly Japan K.K., GlaxoSmithKline, Novo Nordisk Inc., Sumimoto Dainippon Pharma Co., Ltd., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Astellas Pharma US, Inc., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Eli Lilly Japan K.K., Kissei Pharmaceutical Co., Ltd., Kowa Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., MSD, Inc., Novartis Pharmaceuticals Corporation, Sanofi U.S., Takeda Pharmaceutical Company Limited.

Jinzu, Hiroko ........................................ Disclosed no confl ict of interest.Jo, Kwanhoon ...................................... Disclosed no confl ict of interest.Joannides, Christos N. ....................... Disclosed no confl ict of interest.Joergensen, Torben ............................ Disclosed no confl ict of interest.Johannsen, Darcy L. ........................... Disclosed no confl ict of interest.Johansen, Martin B. ........................... Disclosed no confl ict of interest.Johansen, Nanna B. ............................ Employee: Steno Diabetes Center A/S; Stock/Shareholder:

Novo Nordisk A/S. Johansen, Odd Erik ............................. Employee: Boehringer Ingelheim GmbH. Johansen, Rakel F. .............................. Disclosed no confl ict of interest.Johansson, Bente B. ........................... Disclosed no confl ict of interest.Johansson, Jan ................................... Stock/Shareholder: Artery Therapeutics. Johansson, Kristoffer ......................... Employee: AstraZeneca Pharmaceuticals LP. Johansson, Lars .................................. Employee: Antaros Medical, AstraZeneca Pharmaceuticals

LP. Johansson, Peter A. ............................ Employee: AstraZeneca LP. Johansson, Stefan .............................. Disclosed no confl ict of interest.Johns, Michael .................................... Disclosed no confl ict of interest.Johnsen, Sigurd .................................. Disclosed no confl ict of interest.Johnson Oakes, Diana ........................ Disclosed no confl ict of interest.Johnson, Aimee .................................. Disclosed no confl ict of interest.Johnson, Ana ...................................... Disclosed no confl ict of interest.Johnson, Cathryn ................................ Disclosed no confl ict of interest.Johnson, Greg ..................................... Disclosed no confl ict of interest.Johnson, James D. ............................. Disclosed no confl ict of interest.Johnson, James W. ............................ Disclosed no confl ict of interest.Johnson, Jeffrey A. ............................ Disclosed no confl ict of interest.Johnson, Jolene .................................. Disclosed no confl ict of interest.Johnson, Jordan M. ............................ Disclosed no confl ict of interest.Johnson, Keith .................................... Disclosed no confl ict of interest.Johnson, Kevin B. ............................... Disclosed no confl ict of interest.Johnson, Kirk ....................................... Employee: XOMA Corporation. Johnson, Mary A. ................................ Disclosed no confl ict of interest.Johnson, Matthew ............................. Disclosed no confl ict of interest.Johnson, Matthew E. ......................... Disclosed no confl ict of interest.Johnson, Matthew L. ......................... Disclosed no confl ict of interest.Johnson, Michel .................................. Disclosed no confl ict of interest.Johnson, Nicole .................................. Disclosed no confl ict of interest.Johnson, Pamela ................................. Board Member: Voxiva, Inc.; Other Relationship: Senior

Manager; Stock/Shareholder: Voxiva, Inc. Johnson, Richard J. ............................ Disclosed no confl ict of interest.Johnson, Steven T. .............................. Disclosed no confl ict of interest.Johnson, Suzanne B. .......................... Disclosed no confl ict of interest.Johnson, Thomas ................................ Disclosed no confl ict of interest.Johnsson, Eva ..................................... Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP. Johnsson, Kristina .............................. Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP. Johnston, Brian T. ............................... Disclosed no confl ict of interest.Johnston, Karissa ............................... Disclosed no confl ict of interest.Johnston, Luke W. .............................. Disclosed no confl ict of interest.Johnston, Natalie R. ........................... Disclosed no confl ict of interest.Johnston, Stephen .............................. Employee: Truven Health Analytics. Joiner, Kevin ........................................ Disclosed no confl ict of interest.Jojima, Teruo ....................................... Disclosed no confl ict of interest.Joles, Jaap A. ..................................... Disclosed no confl ict of interest.Jonassen, Thomas .............................. Disclosed no confl ict of interest.Jones, Allison ...................................... Disclosed no confl ict of interest.Jones, Angus G. .................................. Disclosed no confl ict of interest.Jones, Barton T. .................................. Disclosed no confl ict of interest.Jones, Darlene .................................... Disclosed no confl ict of interest.Jones, Deborah ................................... Disclosed no confl ict of interest.

A846

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Jones, Gregory C. ............................... Advisory Panel: AstraZeneca/Bristol-Myers Squibb, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson.

Jones, Julie ......................................... Disclosed no confl ict of interest.Jones, Karen L. .................................... Research Support: Merck Sharp & Dohme, Sanofi U.S. Jones, Kathleen R. .............................. Research Support: Eli Lilly and Company. Jones, Richard ..................................... Disclosed no confl ict of interest.Jones, Robert B. .................................. Disclosed no confl ict of interest.Jones, Sidney ...................................... Research Support: PhaseBio Pharmaceuticals, Inc. Jones, Timothy W. .............................. Speaker’s Bureau: Lilly Deutschland GmbH, Medtronic

MiniMed, Inc., Sanofi U.S. Jonnalagadda, Pallavi ........................ Disclosed no confl ict of interest.Jonscher, Karen R. .............................. Disclosed no confl ict of interest.Joo, Erina ............................................. Disclosed no confl ict of interest.Joo, Masahiko ..................................... Disclosed no confl ict of interest.Joost, Hans-Georg .............................. Disclosed no confl ict of interest.Jor’dan, Azizah J. ............................... Research Support: National Institutes of Health, NIH-NIA

T32 (5T32AG023480) fellowship and Supplement Award (R01AG041785).

Jordan, Jens ........................................ Disclosed no confl ict of interest.Jordan, Jessica B. ............................... Consultant: Eli Lilly and Company. Jorge, Alexander L. ............................. Disclosed no confl ict of interest.Jorgensen, Andreas D. ....................... Employee: Merck Sharp & Dohme; Stock/Shareholder: Merck

Sharp & Dohme. Jørgensen, Jens O. ............................. Disclosed no confl ict of interest.Jørgensen, Marit E. ............................ Employee: Steno Diabetes Center A/S; Speaker’s Bureau:

AstraZeneca/Bristol-Myers Squibb; Stock/Shareholder: Novo Nordisk A/S.

Jørgensen, Niklas ............................... Disclosed no confl ict of interest.Jørgensen, Nils B. ............................... Disclosed no confl ict of interest.Jørgensen, Sine W. ............................. Disclosed no confl ict of interest.Joris, Peter J. ...................................... Disclosed no confl ict of interest.Joro, Raimo ......................................... Disclosed no confl ict of interest.Jorsal, Tina .......................................... Disclosed no confl ict of interest.Joseph, Corey ...................................... Consultant: AstraZeneca Pharmaceuticals LP. Joseph, Jamie W. ............................... Disclosed no confl ict of interest.Joseph, Rosamma ............................... Disclosed no confl ict of interest.Joshi Batajoo, Ruby ............................ Disclosed no confl ict of interest.Joshi, Amrita ....................................... Disclosed no confl ict of interest.Joshi, Peter K. ..................................... Disclosed no confl ict of interest.Joshi, Shashank .................................. Advisory Panel: AstraZeneca Pharmaceuticals LP, Janssen

Pharmaceutical Companies of Johnson & Johnson. Joshima, Teruo .................................... Disclosed no confl ict of interest.Joshipura, Kaumudi J. ........................ Disclosed no confl ict of interest.Jossan, Paula ...................................... Disclosed no confl ict of interest.Jothydev, Sunitha ............................... Disclosed no confl ict of interest.Jow, Jonathan .................................... Disclosed no confl ict of interest.Jowett, Jamie ..................................... Employee: PhaseBio Pharmaceuticals, Inc.; Stock/

Shareholder: PhaseBio Pharmaceuticals, Inc. Joy, Nino G. ......................................... Disclosed no confl ict of interest.Joyce, Erin K. ....................................... Disclosed no confl ict of interest.Ju, Liping ............................................. Disclosed no confl ict of interest.Juang, Charity ..................................... Disclosed no confl ict of interest.Juang, Jyuhn-Huarng ......................... Disclosed no confl ict of interest.Judd, Suzanne ..................................... Disclosed no confl ict of interest.Juhl, Kirstine ....................................... Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Julien, Michel ...................................... Employee: Alize Pharma. Julien, Pierre ....................................... Disclosed no confl ict of interest.Jun, Goo ............................................... Disclosed no confl ict of interest.Jun, Ji Eun ........................................... Disclosed no confl ict of interest.Jun, Liu ................................................. Disclosed no confl ict of interest.Jung, Chang Hee ................................. Disclosed no confl ict of interest.Jung, Christian .................................... Employee: Sanofi ; Stock/Shareholder: Sanofi . Jung, Dae Young ................................. Disclosed no confl ict of interest.Jung, Hye Seung ................................. Disclosed no confl ict of interest.Jung, Hye Sook ................................... Disclosed no confl ict of interest.Jung, Ikrak ........................................... Disclosed no confl ict of interest.Jung, In Ji ............................................ Disclosed no confl ict of interest.Jung, Inji .............................................. Disclosed no confl ict of interest.Jung, Jin Hyuk ..................................... Disclosed no confl ict of interest.Jung, Jong Gab ................................... Disclosed no confl ict of interest.Jung, Kyong Yeun ................................ Disclosed no confl ict of interest.Jung, KyoungYeon ............................... Disclosed no confl ict of interest.Jung, Molly .......................................... Disclosed no confl ict of interest.Jung, Sung Youb ................................. Disclosed no confl ict of interest.Jungtrakoon, Prapaporn ..................... Disclosed no confl ict of interest.Junker, Anders E. ................................ Disclosed no confl ict of interest.Jurczak, Michael J. ............................. Disclosed no confl ict of interest.Jurczyk, Agata .................................... Disclosed no confl ict of interest.Jurik, Anne Grethe .............................. Disclosed no confl ict of interest.

Justice, Tara ........................................ Disclosed no confl ict of interest.Juttukonda, Venkateswarlu ............... Disclosed no confl ict of interest.Juul, Svend .......................................... Disclosed no confl ict of interest.Kaabi, Juma A. .................................... Disclosed no confl ict of interest.Kaar, Jill ............................................... Disclosed no confl ict of interest.Kabadi, Udaya M. ................................ Speaker’s Bureau: Sanofi . Kabagambe, Edward ........................... Disclosed no confl ict of interest.Kabasawa, Hideyuki ........................... Disclosed no confl ict of interest.Kabayashi, Yasuko .............................. Disclosed no confl ict of interest.Kaberuka, Vedaste .............................. Disclosed no confl ict of interest.Kabeya, Yusuke ................................... Disclosed no confl ict of interest.Kabir, Morvarid ................................... Disclosed no confl ict of interest.Kabul, Samaneh .................................. Employee: Eli Lilly and Company. Kachoria, Rashmi ................................ Disclosed no confl ict of interest.Kaci, Alba ............................................. Disclosed no confl ict of interest.Kadam, Shekhar .................................. Employee: Cadila Healthecare Limited. Kaddis, John ........................................ Disclosed no confl ict of interest.Kadir, Muhammad M. ......................... Disclosed no confl ict of interest.Kado, Tomonobu .................................. Disclosed no confl ict of interest.Kadowaki, Takashi .............................. Advisory Panel: Boehringer Ingelheim GmbH, Daiichi-

Sankyo Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Novo Nordisk Inc., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited; Consultant: Boehringer Ingelheim GmbH, Merck & Co., Inc.; Research Support: AstraZeneca Pharmaceuticals LP, Chugai Pharmaceutical Co., Ltd., Daiichi-Sankyo Co., Ltd., Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation, Ono Pharmaceutical Co., Ltd., Sanofi U.S., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Astellas Pharma US, Inc., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH, Daiichi-Sankyo Co., Ltd., Eli Lilly Japan K.K., Kowa Pharmaceuticals, Kowa Pharmaceuticals, Kyowa Hakko Kirin Co., Ltd., Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation, Novartis Pharmaceuticals Corporation, Ono Pharmaceutical Co., Ltd., Sanofi U.S., Sanwa Kagaku Kenkyusho Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited.

Kafanas, Antonios .............................. Disclosed no confl ict of interest.Kaga, Hideyoshi .................................. Disclosed no confl ict of interest.Kaga, Hideyosi .................................... Disclosed no confl ict of interest.Kagaya, Hiroki ..................................... Disclosed no confl ict of interest.Kageyama, Takahiro ........................... Disclosed no confl ict of interest.Kahal, Hassan ..................................... Disclosed no confl ict of interest.Kahl, Sabine ........................................ Disclosed no confl ict of interest.Kahl, Steven D. .................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Kahle, Melanie .................................... Disclosed no confl ict of interest.Kahleova, Hana ................................... Disclosed no confl ict of interest.Kahlon, Amandeep .............................. Disclosed no confl ict of interest.Kahn, Barbara B. ................................. Other Relationship: Inventor on patent relating to the lipids

presented in this abstract. Kahn, C. Ronald ................................... Advisory Panel: Antriabio, Catabasis Pharmaceuticals,

Inc., CohBar, Inc., MedImmune, Merck & Co., Inc., Ozstar; Board Member: Ember Therapeutics; Research Support: Sanofi U.S.; Stock/Shareholder: Dicerna Pharmaceuticals, Inc., Five Prime Therapeutics, Inc.

Kahn, Mario ......................................... Disclosed no confl ict of interest.Kahn, Steven ....................................... Disclosed no confl ict of interest.Kaholokula, Joseph K. ........................ Disclosed no confl ict of interest.Kahraman, Sevim ................................ Disclosed no confl ict of interest.Kai, Hirofumi ........................................ Disclosed no confl ict of interest.Kaji, Yuiko ............................................ Disclosed no confl ict of interest.Kajimoto, Tadafumi ............................. Disclosed no confl ict of interest.Kajita, Kazuo ....................................... Disclosed no confl ict of interest.Kakehi, Saori ....................................... Disclosed no confl ict of interest.Kakei, Tsuyoshi .................................... Disclosed no confl ict of interest.Käkelä, Pirjo ......................................... Disclosed no confl ict of interest.Kaku, Hiroo .......................................... Disclosed no confl ict of interest.Kaku, Kohei .......................................... Consultant: NovoNordisk, Sanwa-Kagaku, Taisho, Takeda;

Research Support: Chugai, Daiichi-Sankyo, MSD, Novo Nordisk, Takeda; Speaker’s Bureau: Kowa, MSD, Novartis, NovoNordisk, Takeda, Tanabe-Mitsunishi.

Kaku, Kohei .......................................... Disclosed no confl ict of interest.Kakutani, Yoshinori ............................. Disclosed no confl ict of interest.Kalaca, Sibel ........................................ Disclosed no confl ict of interest.Kalavalapalli, Srilaxmi ........................ Disclosed no confl ict of interest.Kale, Shailaja ...................................... Disclosed no confl ict of interest.Kalliokoski, Kari ................................... Disclosed no confl ict of interest.Kalliokoski, Kari K. .............................. Disclosed no confl ict of interest.

A847

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Kalra, Sanjay ....................................... Advisory Panel: Novo Nordisk Inc. kalsekar, Ayaz ...................................... Disclosed no confl ict of interest.Kalsekar, Iftekhar ................................ Employee: AstraZeneca Pharmaceuticals LP. Kaltheuner, Lars .................................. Disclosed no confl ict of interest.Kaltheuner, Matthias .......................... Consultant: Sanofi . Kaltoft, Margit .................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Kalyani, Rita R. .................................... Disclosed no confl ict of interest.Kamata, Hideaki .................................. Disclosed no confl ict of interest.Kamath, Sonali .................................... Disclosed no confl ict of interest.Kambe, Hiroshi .................................... Disclosed no confl ict of interest.Kamble, Prasad ................................... Disclosed no confl ict of interest.Kamble, Pravin .................................... Research Support: Sanofi U.S. Kambo, Varinder .................................. Disclosed no confl ict of interest.Kamei, Nozomu ................................... Disclosed no confl ict of interest.Kaminska, Dorota ................................ Disclosed no confl ict of interest.Kaminski, Jana .................................... Disclosed no confl ict of interest.Kaminskyi, Oleksii V. ........................... Disclosed no confl ict of interest.Kamitani, Mai ...................................... Disclosed no confl ict of interest.Kamitz, Anne ....................................... Disclosed no confl ict of interest.Kamiya, Hideki .................................... Disclosed no confl ict of interest.Kamiya, Norihumi ............................... Disclosed no confl ict of interest.Kamiyama, Hiroshi .............................. Disclosed no confl ict of interest.Kamps, Jodi ......................................... Disclosed no confl ict of interest.Kan, Carol ............................................ Research Support: Novo Nordisk UK Research Foundation. Kan, Seyfullah ..................................... Disclosed no confl ict of interest.Kanada, Shigeto .................................. Research Support: Daiichi-Sankyo Co., Ltd., Kissei

Pharmaceutical Co., Ltd., MSD, Inc., Novo Nordisk Inc., Sanofi U.S., Taisho Pharmaceutical Co., Ltd.

Kanaparthi, Sai ................................... Disclosed no confl ict of interest.Kanasaki, Keizo ................................... Research Support: Boehringer Ingelheim Pharmaceuticals,

Inc., Eli Lilly Japan K.K., Mitsubishi Tanabe Pharma Corporation, Ono Pharmaceutical Co., Ltd.; Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Eli Lilly Japan K.K., Kowa Pharmaceuticals, Sanofi japan, Sumitomo Dainippon Pharma Co., Ltd.

Kanasaki, Megumi .............................. Disclosed no confl ict of interest.Kanaya, Alka M. .................................. Disclosed no confl ict of interest.Kanazawa, Ken .................................... Disclosed no confl ict of interest.Kandula, Namratha R. ........................ Disclosed no confl ict of interest.Kane, Naomi S. .................................... Disclosed no confl ict of interest.Kaneki, Masao .................................... Disclosed no confl ict of interest.Kaneko, Shizuka .................................. Disclosed no confl ict of interest.Kaneko, Shuichi ................................... Disclosed no confl ict of interest.Kanekura, Kohsuke ............................. Disclosed no confl ict of interest.Kaneto, Hideaki ................................... Research Support: Astellas Pharma Inc., AstraZeneca

Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Eli Lilly Japan K.K., Kissei Pharmaceutical Co., Ltd., Kowa Pharmaceuticals, Merck Sharp & Dohme, Mitsubishi Tanabe Pharma Corporation, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Ono Pharmaceutical Co., Ltd., Sanofi K.K., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Astellas Pharma Inc., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Eli Lilly Japan K.K., Kissei Pharmaceutical Co., Ltd., Kowa Pharmaceuticals, Merck Sharp & Dohme, Mitsubishi Tanabe Pharma Corporation, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Ono Pharmaceutical Co., Ltd., Sanofi K.K., Takeda Pharmaceutical Company Limited.

Kanety, Hannah ................................... Disclosed no confl ict of interest.Kang, Borami ....................................... Disclosed no confl ict of interest.Kang, Dong Ho ..................................... Disclosed no confl ict of interest.Kang, Eun Seok .................................... Disclosed no confl ict of interest.Kang, Eunsuk ....................................... Disclosed no confl ict of interest.Kang, Hong Soon ................................. Disclosed no confl ict of interest.Kang, Hyeon-Ji .................................... Disclosed no confl ict of interest.Kang, Ja Hoon ..................................... Disclosed no confl ict of interest.Kang, Jahoon ...................................... Employee: Hanmi Pharmaceutical Co., Ltd. Kang, Min-Cheol ................................. Disclosed no confl ict of interest.Kang, Minsung .................................... Disclosed no confl ict of interest.Kang, Nalae ......................................... Disclosed no confl ict of interest.Kang, Raymond ................................... Disclosed no confl ict of interest.Kang, Shinae ....................................... Disclosed no confl ict of interest.Kang, Yang Ho ..................................... Disclosed no confl ict of interest.Kang, Yea Eun ...................................... Disclosed no confl ict of interest.Kang, Yeonjoo ..................................... Employee: Profi le Institute for Clinical Research. Kang, Yup ............................................. Disclosed no confl ict of interest.Kanikarla-Marie, Preeti ...................... Disclosed no confl ict of interest.

Kanno, Ayumi ...................................... Disclosed no confl ict of interest.Kanwal, Alokik .................................... Disclosed no confl ict of interest.Kao, Anita ............................................ Disclosed no confl ict of interest.Kao, Shih Ling ...................................... Disclosed no confl ict of interest.Kapeller, Rosana ................................. Disclosed no confl ict of interest.Kapitza, Christoph .............................. Employee: Profi l Institute for Clinical Research, Inc.; Other

Relationship: Sanofi U.S.; Research Support: Adocia, AstraZeneca Pharmaceuticals LP, BD Medical-Diabetes Care, Biocon, Boehringer Ingelheim GmbH, Dance Biopharm, Eli Lilly and Company, Grünenthal, Medtronic, Inc., Novartis Pharma GmbH, Novo Nordisk Inc., Sanofi U.S., Senseonics; Speaker’s Bureau: Eli Lilly and Company, Mylan, Novo Nordisk Inc.

Kaplan, Lee M. .................................... Consultant: GI Dynamics, Inc. Kaplan, Robert .................................... Disclosed no confl ict of interest.Kaprio, Jaakko ..................................... Disclosed no confl ict of interest.Kapur, Rahul A. .................................... Employee: Novo Nordisk A/S. Kapusta, Maria ................................... Disclosed no confl ict of interest.Karakas, Sidika E. ................................ Disclosed no confl ict of interest.Karalliedde, Janaka ............................ Disclosed no confl ict of interest.Karasik, Avraham ................................ Advisory Panel: Merck, Sharpe & Dohme, Novo Nordisk;

Consultant: Boehringer Ingleheim, Merck, Sharpe & Dohme, Novo Nordisk; Research Support: Boehringer Ingleheim, Merck, Sharpe & Dohme, Novo Nordisk.

Karastergiou, Kalypso ........................ Disclosed no confl ict of interest.Karatoprak, Cumali ............................. Disclosed no confl ict of interest.Karavaeva, Oksana ............................. Employee: IPHARMA LLC. Karavalos, Kelly ................................... Disclosed no confl ict of interest.Karban, Jacky ...................................... Disclosed no confl ict of interest.Karczewska-Kupczewska, Monika .... Disclosed no confl ict of interest.Karhunen, Leila ................................... Disclosed no confl ict of interest.Kark, Jeremy ....................................... Disclosed no confl ict of interest.Karkas, Jennifer .................................. Employee: Bristol-Myers Squibb Company. Karlidag, Rifat ..................................... Disclosed no confl ict of interest.Karnchanasorn, Rudruidee ................. Disclosed no confl ict of interest.Karpe, Fredrik ...................................... Disclosed no confl ict of interest.Karsdal, Morten A. ............................. Employee: Nordic Bioscience; Stock/Shareholder: Nordic

Bioscience. Karsidag, Kubilay ................................ Consultant: Eli Lilly and Company. Karter, Andrew J. ................................ Disclosed no confl ict of interest.KaruppaGounder, Vengadeshprabhu . Disclosed no confl ict of interest.Kasahara, Yoshinori ............................ Employee: Teijin Pharma Limited. Kaseda, Ryohei ................................... Disclosed no confl ict of interest.Kaser, Susanne .................................... Research Support: Merck Sharp & Dohme, Pfi zer Inc. Kashihara, Yoneo ................................ Disclosed no confl ict of interest.Kashima, Koji ....................................... Disclosed no confl ict of interest.Kashimura, Ayaka ............................... Disclosed no confl ict of interest.Kashiwada, Yoshiki ............................. Disclosed no confl ict of interest.Kashiwagi, Atsunori ........................... Speaker’s Bureau: Astellas Pharma US, Inc., Sunstar Inc. Kashyap, Liladhar ................................ Disclosed no confl ict of interest.Kashyap, Sangeeta R. ......................... Disclosed no confl ict of interest.Kasmi, Ahmed-Amine ......................... Disclosed no confl ict of interest.Kaspers, Stefan ................................... Employee: Boehringer Ingelheim GmbH. Kassim, Saiful ..................................... Disclosed no confl ict of interest.Kaste, Renee ....................................... Employee: Boehringer Ingelheim Pharmaceuticals, Inc. Kasuga, Masato .................................. Disclosed no confl ict of interest.Kasumov, Takhar ................................. Disclosed no confl ict of interest.Katagiri, Hideki ................................... Disclosed no confl ict of interest.Katagiri, Sayaka .................................. Disclosed no confl ict of interest.Katakami, Naoto ................................. Research Support: Kowa Pharmaceuticals, Merck Sharp &

Dohme; Speaker’s Bureau: Astellas Pharma US, Inc., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K., Merck Sharp & Dohme, Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Ono Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Sanofi Pasteur SA, Shionogi Inc., Takeda Pharmaceutical Company Limited.

Katalenich, Bonnie L. .......................... Disclosed no confl ict of interest.Katasako, Aya ..................................... Disclosed no confl ict of interest.Katayama, Akihiro .............................. Disclosed no confl ict of interest.Katayama, Shigehiro .......................... Disclosed no confl ict of interest.Kathawala, Azeem .............................. Employee: Abbott Diabetes Care, Inc. Katic, Bozena J. ................................... Employee: PatientsLikeMe; Research Support: Abbvie,

Accorda, Actelion Pharmaceuticals Ltd., Amgen Inc., AstraZeneca Pharmaceuticals LP, Avanir, Biogen Idec, Boehringer Ingelheim Pharmaceuticals, Inc., Genzyme Corporation, Janssen Pharmaceutical Companies of Johnson & Johnson, Johnson & Johnson, Kaiser Permanente, Merck & Co., Inc., Novartis

A848

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Pharmaceuticals Corporation, Robert Wood Johnson Foundation, Sage Bionetworks, Sanofi U.S., The AKU Society, The University of Maryland, UCB; Stock/Shareholder: PatientsLikeMe.

Katikaneni, Ranjitha ........................... Disclosed no confl ict of interest.Kato, Asuka ......................................... Disclosed no confl ict of interest.Kato, Ayako ......................................... Disclosed no confl ict of interest.Kato, Hiroyuki ...................................... Employee: Ajinomoto Group. Kato, Koichi ......................................... Disclosed no confl ict of interest.Kato, Masahiko ................................... Disclosed no confl ict of interest.Kato, Norihiro ...................................... Disclosed no confl ict of interest.Kato, Shigeko ...................................... Other Relationship: NTT DOCOMO. Kato, Takehiro ..................................... Disclosed no confl ict of interest.Kato, Yoshiro ....................................... Disclosed no confl ict of interest.Katopodi, Anastasia ........................... Disclosed no confl ict of interest.Katsanos, Christos S. ......................... Research Support: American Diabetes Association, National

Institute of Diabetes and Digestive and Kidney Diseases.

Katsilambros, Nicholas ...................... Disclosed no confl ict of interest.Katsogiannos, Petros .......................... Disclosed no confl ict of interest.Katsuhito, Mori ................................... Research Support: Asahi Kasei Pharm Corporation, Astellas

Pharma Inc, Daiichi Sankyo Co., Ltd.,, Mitsubisi Tanabe Pharma Corporation, Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Daiichi-Sankyo Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Nippon Boehringer Ingelheim Co., Ltd., Sanofi U.S.

Katsuki, Takeshi .................................. Disclosed no confl ict of interest.Katsura, Takashi .................................. Disclosed no confl ict of interest.Katsura, Yoshiya ................................. Disclosed no confl ict of interest.Katz, Arie ............................................. Employee: AstraZeneca Pharmaceuticals LP. Katz, Laurence B. ................................ Employee: LifeScan, Inc. Katz, Liora S. ....................................... Disclosed no confl ict of interest.Katz, Michelle ..................................... Disclosed no confl ict of interest.Katz, Richard ....................................... Disclosed no confl ict of interest.Katzeff, Harvey ................................... Employee: Merck & Co., Inc. Kaufman, Elise .................................... Consultant: Quintiles Inc. Kaufman, Francine R. .......................... Employee: Medtronic MiniMed, Inc. Kaufman, Robert ................................. Consultant: Locemia Solutions, LP. Kaufman, Steven ................................. Disclosed no confl ict of interest.Kauhanen, Saila .................................. Disclosed no confl ict of interest.Kaul, Kirti ............................................. Disclosed no confl ict of interest.Kaul, Padma ......................................... Disclosed no confl ict of interest.Kaur, Arshpreet ................................... Disclosed no confl ict of interest.Kaur, Manmeet .................................... Disclosed no confl ict of interest.Kautzky-Willer, Alexandra ................. Speaker’s Bureau: Amgen Inc., AstraZeneca, Boehringer

Ingelheim, Eli Lilly and Company, Novartis, Novo Nordisk.

Kavalkova, Petra ................................. Disclosed no confl ict of interest.Kavanagh, Michael ............................. Disclosed no confl ict of interest.Kavvoura, Fotini K. .............................. Disclosed no confl ict of interest.Kawabe, Atsuhiko ............................... Disclosed no confl ict of interest.Kawaguchi, Minako ............................ Disclosed no confl ict of interest.Kawai, Hiromi ...................................... Disclosed no confl ict of interest.Kawakami, Soshi ................................. Disclosed no confl ict of interest.Kawamori, Dan .................................... Research Support: Astellas Pharma Inc., AstraZeneca

Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Eli Lilly Japan K.K., Kissei Pharmaceutical Co., Ltd., Kowa Pharmaceuticals, Merck Sharp & Dohme, Mitsubishi Tanabe Pharma Corporation, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Ono Pharmaceutical Co., Ltd., Sanofi K.K., Shionogi Inc., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Astellas Pharma Inc., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Eli Lilly Japan K.K., Kissei Pharmaceutical Co., Ltd., Kowa Pharmaceuticals, Merck Sharp & Dohme, Mitsubishi Tanabe Pharma Corporation, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Ono Pharmaceutical Co., Ltd., Sanofi K.K., Sanwa Kagaku Kenkyusho Co., Ltd., Takeda Pharmaceutical Company Limited.

Kawamori, Ryuzo ................................ Disclosed no confl ict of interest.Kawamoto, Ryuichi ............................. Disclosed no confl ict of interest.Kawamuki, Kousei .............................. Employee: Astellas Pharma Inc. Kawamura, Ryoichi ............................. Disclosed no confl ict of interest.Kawamura, Tomoyuki ......................... Disclosed no confl ict of interest.Kawanami, Takako .............................. Disclosed no confl ict of interest.Kawanishi, Ippei .................................. Disclosed no confl ict of interest.Kawano, Seiko ..................................... Disclosed no confl ict of interest.Kawano, Yoshinaga ............................ Disclosed no confl ict of interest.Kawasaki, Keitaro ............................... Disclosed no confl ict of interest.

Kawasaki, Michiko .............................. Disclosed no confl ict of interest.Kawase, Ryota .................................... Disclosed no confl ict of interest.Kawashima, Junji ................................ Disclosed no confl ict of interest.Kawatkar, Aniket A. ............................ Disclosed no confl ict of interest.Kawazu, Shoji ...................................... Disclosed no confl ict of interest.Kazakos, Kiriakos ................................ Disclosed no confl ict of interest.Kazdova, Ludmila ................................ Disclosed no confl ict of interest.Kazemi, Mahmood .............................. Employee: Sanofi U.S.; Stock/Shareholder: Sanofi U.S. Kazemian, Elham ................................. Disclosed no confl ict of interest.Kazierad, David J. ............................... Disclosed no confl ict of interest.Kazma, Carim ...................................... Disclosed no confl ict of interest.Kazoka, Dolly ....................................... Disclosed no confl ict of interest.Kazumi, Saito ...................................... Disclosed no confl ict of interest.Kazuta, Kenichi ................................... Employee: Astellas Pharma Inc. Kazuya, Fujihara .................................. Disclosed no confl ict of interest.Ke, Weijian .......................................... Disclosed no confl ict of interest.Kearney, Mark T. ................................. Disclosed no confl ict of interest.Kearns, Caitlyn C. ............................... Disclosed no confl ict of interest.Keating, Damien ................................. Research Support: Pfi zer Inc. Keaton, Jacob M. ................................ Disclosed no confl ict of interest.Keaveny, Andrew ................................ Disclosed no confl ict of interest.Keckhafer, Abigail M. ......................... Disclosed no confl ict of interest.Keech, Anthony C. ............................... Disclosed no confl ict of interest.Keenan, Hillary A. ............................... Disclosed no confl ict of interest.Kehlenbrink, Sylvia ............................. Disclosed no confl ict of interest.Keiding, Niels ...................................... Disclosed no confl ict of interest.Keil, Rudolf .......................................... Consultant: Almased Wellness GmbH. Keller, Cornelia .................................... Disclosed no confl ict of interest.Kelly, Aaron S. ..................................... Advisory Panel: Novo Nordisk A/S, Takeda Pharmaceuticals

U.S.A., Inc. Kelly, Caitlin S. .................................... Disclosed no confl ict of interest.Kelly, Isabelle ...................................... Disclosed no confl ict of interest.Kelly, Katherine ................................... Disclosed no confl ict of interest.Kelly, Thomas L. .................................. Disclosed no confl ict of interest.Kelstrup, Louise .................................. Disclosed no confl ict of interest.Kempf, Kerstin ..................................... Consultant: Almased Wellness GmbH; Research Support:

Almased Wellness GmbH. Kempton, Hannah ............................... Employee: Merck Sharp & Dohme. Kendall, David ..................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Kennedy, Christine .............................. Disclosed no confl ict of interest.Kennedy, John W. ............................... Advisory Panel: American College of Cardiology, American

Medical Group Foundation; Research Support: Novo Nordisk Inc.

Kennedy, Kit ........................................ Disclosed no confl ict of interest.Kennedy, Robert T. .............................. Disclosed no confl ict of interest.Kent, Tyler ............................................ Employee: Dexcom, Inc. Kenworthy, Yvonne ............................. Disclosed no confl ict of interest.Kenyon, Norma S. ............................... Disclosed no confl ict of interest.Kenyon, Norman M. ............................ Disclosed no confl ict of interest.Keogh, Jennifer B. .............................. Disclosed no confl ict of interest.Kerege, Anna ....................................... Disclosed no confl ict of interest.Kerényi, Zsuzsa ................................... Disclosed no confl ict of interest.Kergoat, Micheline ............................. Disclosed no confl ict of interest.Kern, David M. .................................... Disclosed no confl ict of interest.Kern, Matthias .................................... Disclosed no confl ict of interest.Kern, Philip A. ...................................... Disclosed no confl ict of interest.Kern, Timothy S. .................................. Disclosed no confl ict of interest.Kerner, Janos ...................................... Disclosed no confl ict of interest.Kerr, David ........................................... Disclosed no confl ict of interest.Kerr, Peter ............................................ Disclosed no confl ict of interest.Kerry, Christopher ............................... Disclosed no confl ict of interest.Kesary, Daphna ................................... Disclosed no confl ict of interest.Kesavadev, Jothydev .......................... Research Support: Merck & Co., Inc., Novo Nordisk Inc. Kesavan, Rushendhiran ...................... Disclosed no confl ict of interest.Keshavan, Matcheri ............................ Disclosed no confl ict of interest.Keskin, Lezzan ..................................... Disclosed no confl ict of interest.Kessler, Laurence ................................ Disclosed no confl ict of interest.Kessler, Lynn ........................................ Disclosed no confl ict of interest.Kessler, Romain ................................... Disclosed no confl ict of interest.Keum, Changwon ................................ Disclosed no confl ict of interest.Kevat, Dev A. ....................................... Disclosed no confl ict of interest.Keyes-Elstein, Lynette ........................ Disclosed no confl ict of interest.Khadgawat, Rajesh ............................. Disclosed no confl ict of interest.Khaja, Shamim .................................... Disclosed no confl ict of interest.Khakpour, Dorrine ............................... Disclosed no confl ict of interest.Khamaisi, Mogher ............................... Disclosed no confl ict of interest.Khamseh, Mohammad ........................ Advisory Panel: Novartis AG, Novo Nordisk A/S, Sanofi ;

Research Support: Novartis AG, Novo Nordisk A/S, Sanofi .

Khan, Ilvira .......................................... Disclosed no confl ict of interest.Khan, Zia A. ......................................... Disclosed no confl ict of interest.

A849

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Khandwala, Hasnain ........................... Advisory Panel: AstraZeneca/Bristol-Myers Squibb, Janssen Pharmaceutical Companies of Johnson & Johnson, Valeant; Research Support: AstraZeneca/Bristol-Myers Squibb, Eli Lilly and Company, Isis Pharmaceuticals, Inc., Janssen Pharmaceutical Companies of Johnson & Johnson, Merck & Co., Inc., Novo Nordisk Inc., Sanofi U.S.; Speaker’s Bureau: AstraZeneca/Bristol-Myers Squibb, Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck & Co., Inc., Novo Nordisk Inc., Sanofi U.S.

Khanna, Vishesh ................................. Disclosed no confl ict of interest.Kharlampieva, Eugenia ....................... Disclosed no confl ict of interest.Khatami, Hootan ................................. Employee: Sanofi ; Stock/Shareholder: Sanofi . Khaw, Chong H. ................................... Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Merck

Sharp & Dohme, Novartis Corporation, Novo Nordisk Inc., Sanofi Adventis.

Khimmaktong, Wipapan ..................... Disclosed no confl ict of interest.Khin, May O.O. .................................... Disclosed no confl ict of interest.Kho, Abel N. ........................................ Disclosed no confl ict of interest.Khoo, Chin Meng ................................. Disclosed no confl ict of interest.Khoo, Eric Y. ......................................... Disclosed no confl ict of interest.Khoo, Joan ........................................... Disclosed no confl ict of interest.Khorzad, Rebeca ................................. Disclosed no confl ict of interest.Khoury, Jane ........................................ Disclosed no confl ict of interest.Khunti, Kamlesh .................................. Advisory Panel: Astra Zeneca, Boehringer Ingelheim,

Janssen, Lilly, Merck Sharp & Dohme, Novo Nordisk, Sanofi - Aventis; Consultant: Astra Zeneca, Boehringer Ingelheim, Janssen, Lilly, Merck Sharp & Dohme, Novo Nordisk, Sanofi - Aventis; Research Support: Astra Zeneca, Boehringer Ingelheim, Lilly, Merck Sharp & Dohme, Novartis, Novo Nordisk, Roche, Sanofi - Aventis; Speaker’s Bureau: Astra Zeneca, Boehringer Ingelheim, Janssen, Lilly, Merck Sharp & Dohme, Novartis, Novo Nordisk, Sanofi - Aventis.

Khurana, Laura .................................... Employee: PHT Corporation. Khusnutdinova, Elza ............................ Disclosed no confl ict of interest.Kian Kai, Cheng ................................... Disclosed no confl ict of interest.Kibbey, Richard G. ............................... Disclosed no confl ict of interest.Kido, Teruhiko ...................................... Disclosed no confl ict of interest.Kido, Yoshiaki ...................................... Disclosed no confl ict of interest.Kidron, Miriam .................................... Employee: Oramed Pharmaceuticals. Kiebish, Michael ................................. Disclosed no confl ict of interest.Kiec-Wilk, Beata ................................. Disclosed no confl ict of interest.Kiefte-de Jong, Jessica C. ................. Disclosed no confl ict of interest.Kieswich, Julius .................................. Disclosed no confl ict of interest.Kigawa, Ikue ........................................ Disclosed no confl ict of interest.Kikimbaeva, Aisulu A. ......................... Disclosed no confl ict of interest.Kikuchi, Masatoshi ............................. Disclosed no confl ict of interest.Kikuchi, Takeshi ................................... Disclosed no confl ict of interest.Kikuchi, Tetsuhiro ................................ Disclosed no confl ict of interest.Kil, Siyoen ............................................ Disclosed no confl ict of interest.Kilborn, Michael .................................. Disclosed no confl ict of interest.Kildegaard, Jonas ............................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Kilgore, Karl ......................................... Disclosed no confl ict of interest.Kilicarslan, Murat ............................... Disclosed no confl ict of interest.Kilicarslan, Rukiye .............................. Disclosed no confl ict of interest.Kilkenny, Dawn M. .............................. Disclosed no confl ict of interest.Kilkuskie, Peter ................................... Employee: Metabolic Solutions Development Company, LLC. Killian, Michael ................................... Disclosed no confl ict of interest.Kilpatrick, Eric S. ................................. Advisory Panel: Novo Nordisk A/S; Speaker’s Bureau:

AstraZeneca Pharmaceuticals LP. Kim, Alexandra K. ............................... Disclosed no confl ict of interest.Kim, Bo Hyun ....................................... Disclosed no confl ict of interest.Kim, Bo-Yeon ....................................... Disclosed no confl ict of interest.Kim, Bu Kyung ..................................... Disclosed no confl ict of interest.Kim, Byung Gyu ................................... Disclosed no confl ict of interest.Kim, Catherine ..................................... Disclosed no confl ict of interest.Kim, Chong Hwa .................................. Disclosed no confl ict of interest.Kim, Chul Hoon .................................... Disclosed no confl ict of interest.Kim, Dae Jung ..................................... Disclosed no confl ict of interest.Kim, Dae-Hee ...................................... Disclosed no confl ict of interest.Kim, Do Gyun ....................................... Disclosed no confl ict of interest.Kim, Dongjoon ..................................... Disclosed no confl ict of interest.Kim, Dongwook ................................... Disclosed no confl ict of interest.Kim, Do-Sung ....................................... Disclosed no confl ict of interest.Kim, Eun Heui ...................................... Disclosed no confl ict of interest.Kim, Eun Ky .......................................... Disclosed no confl ict of interest.Kim, Eun Ran ........................................ Disclosed no confl ict of interest.Kim, Eun Sook ...................................... Disclosed no confl ict of interest.Kim, Eun-A ........................................... Disclosed no confl ict of interest.Kim, Eun-Mi ......................................... Disclosed no confl ict of interest.

Kim, Francis ......................................... Disclosed no confl ict of interest.Kim, Gabriel ......................................... Employee: Boehringer Ingelheim GmbH. Kim, Gyo hui ......................................... Disclosed no confl ict of interest.Kim, Gyuri ............................................ Disclosed no confl ict of interest.Kim, Hae Jin ........................................ Disclosed no confl ict of interest.Kim, Hae-Suk ....................................... Disclosed no confl ict of interest.Kim, Hee Yeon ..................................... Disclosed no confl ict of interest.Kim, Hee Young ................................... Disclosed no confl ict of interest.Kim, Hong Min ..................................... Disclosed no confl ict of interest.Kim, Hun-Sung ..................................... Disclosed no confl ict of interest.Kim, Hwajin ......................................... Disclosed no confl ict of interest.Kim, Hye In ........................................... Disclosed no confl ict of interest.Kim, Hye Kyung ................................... Disclosed no confl ict of interest.Kim, Hyejeong ..................................... Disclosed no confl ict of interest.Kim, Hyeon Chang ............................... Disclosed no confl ict of interest.Kim, Hyun Jin ...................................... Disclosed no confl ict of interest.Kim, Hyun Joo ..................................... Disclosed no confl ict of interest.Kim, Hyun Min ..................................... Disclosed no confl ict of interest.Kim, Hyung-Wook ............................... Disclosed no confl ict of interest.Kim, Hyunji .......................................... Disclosed no confl ict of interest.Kim, In Joo ........................................... Disclosed no confl ict of interest.Kim, Jae Geun ..................................... Disclosed no confl ict of interest.Kim, Jae Hyeon ................................... Disclosed no confl ict of interest.Kim, Jaehyeon ..................................... Disclosed no confl ict of interest.Kim, Jason K. ....................................... Disclosed no confl ict of interest.Kim, Jeong Ho ..................................... Disclosed no confl ict of interest.Kim, Jeong-A ....................................... Disclosed no confl ict of interest.Kim, Ji-Hun .......................................... Disclosed no confl ict of interest.Kim, Jin Young ..................................... Disclosed no confl ict of interest.Kim, Ji-Won ......................................... Disclosed no confl ict of interest.Kim, Jiwoon ......................................... Disclosed no confl ict of interest.Kim, Jong Ho ....................................... Disclosed no confl ict of interest.Kim, Jong Hun ..................................... Disclosed no confl ict of interest.Kim, Joo Young .................................... Disclosed no confl ict of interest.Kim, Joon Y. ......................................... Disclosed no confl ict of interest.Kim, Jung Kuk ...................................... Disclosed no confl ict of interest.Kim, Jwa-Jin ....................................... Disclosed no confl ict of interest.Kim, Kwang Joon ................................ Disclosed no confl ict of interest.Kim, Kyeong Jin ................................... Disclosed no confl ict of interest.Kim, Kyoung Min ................................. Disclosed no confl ict of interest.Kim, Kyung Jin ..................................... Disclosed no confl ict of interest.Kim, Kyung Rae ................................... Disclosed no confl ict of interest.Kim, Kyung-Soo ................................... Disclosed no confl ict of interest.Kim, Lee-Kyung ................................... Disclosed no confl ict of interest.Kim, Leo ............................................... Disclosed no confl ict of interest.Kim, Leo A. .......................................... Disclosed no confl ict of interest.Kim, Mi-kyung ..................................... Disclosed no confl ict of interest.Kim, Min Kyeong ................................. Disclosed no confl ict of interest.Kim, Myoung Soo ................................ Disclosed no confl ict of interest.Kim, Nam Hoon ................................... Disclosed no confl ict of interest.Kim, Nan Hee ...................................... Disclosed no confl ict of interest.Kim, Paul J. .......................................... Disclosed no confl ict of interest.Kim, Priscilla ........................................ Disclosed no confl ict of interest.Kim, Sang Soo ..................................... Disclosed no confl ict of interest.Kim, Seong Yeon ................................. Disclosed no confl ict of interest.Kim, Seoyoung .................................... Research Support: Pfi zer, Inc. Kim, Sharon ......................................... Disclosed no confl ict of interest.Kim, Shin Y. .......................................... Disclosed no confl ict of interest.Kim, Sin Gon ........................................ Advisory Panel: AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Takeda; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Novo Nordisk Inc., Sanofi , Takeda.

Kim, So Hun ......................................... Disclosed no confl ict of interest.Kim, So Ra ........................................... Disclosed no confl ict of interest.Kim, Sohee .......................................... Disclosed no confl ict of interest.Kim, Soo Hyun ..................................... Disclosed no confl ict of interest.Kim, Soojin ........................................... Employee: Hanmi Pharmaceutical Co., Ltd. Kim, Soo-Kyung ................................... Disclosed no confl ict of interest.Kim, Soul .............................................. Disclosed no confl ict of interest.Kim, Stella P. ........................................ Disclosed no confl ict of interest.Kim, Sun Hwa ...................................... Disclosed no confl ict of interest.Kim, Sung Hoon ................................... Disclosed no confl ict of interest.Kim, Sung Woon .................................. Disclosed no confl ict of interest.Kim, Sung-Woo ................................... Disclosed no confl ict of interest.Kim, Tae Ho .......................................... Disclosed no confl ict of interest.Kim, Tae Kyoon .................................... Disclosed no confl ict of interest.Kim, Tae Nyun ..................................... Disclosed no confl ict of interest.Kim, Taekyoon ..................................... Disclosed no confl ict of interest.Kim, Teayoun ....................................... Disclosed no confl ict of interest.Kim, Terri ............................................. Consultant: Zafgen; Employee: Elcelyx Therapeutics, Inc. Kim, Yeong Gi ...................................... Disclosed no confl ict of interest.Kim, Yong Ook ..................................... Disclosed no confl ict of interest.

A850

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Kim, Yong Seong ................................. Disclosed no confl ict of interest.Kim, Yoon Ji ......................................... Disclosed no confl ict of interest.Kim, You Mi ......................................... Disclosed no confl ict of interest.Kim, Young Hoon ................................. Disclosed no confl ict of interest.Kim, Young Il ........................................ Disclosed no confl ict of interest.Kim, Young Nam .................................. Disclosed no confl ict of interest.Kim, Young Seol .................................. Disclosed no confl ict of interest.Kim, Young soo .................................... Disclosed no confl ict of interest.Kim, Young-Bum .................................. Disclosed no confl ict of interest.Kim, Yu Jin ........................................... Disclosed no confl ict of interest.Kim, Yu Seun ....................................... Disclosed no confl ict of interest.Kimball, Edward .................................. Employee: Novo Nordisk Inc. Kimball, Scot R. ................................... Disclosed no confl ict of interest.Kimball, Thomas .................................. Disclosed no confl ict of interest.Kimbro, Lindsay ................................... Disclosed no confl ict of interest.Kimes, Teresa M. ................................ Disclosed no confl ict of interest.Kimoto, Naoya ..................................... Disclosed no confl ict of interest.Kimura, Ayuko ..................................... Disclosed no confl ict of interest.Kimura, Chizuko ................................... Disclosed no confl ict of interest.Kimura, Hiroshi .................................... Disclosed no confl ict of interest.Kimura, Kayo ....................................... Disclosed no confl ict of interest.Kimura, Maki ....................................... Disclosed no confl ict of interest.Kimura, Moritsugu .............................. Disclosed no confl ict of interest.Kimura, Shinichiro ............................... Disclosed no confl ict of interest.Kimura, Tomohiko ............................... Disclosed no confl ict of interest.King, Allen B. ....................................... Advisory Panel: Eli Lilly and Company, Novo Nordisk A/S,

Sanofi U.S.; Research Support: Eli Lilly and Company, Novo Nordisk A/S, Sanofi U.S.; Speaker’s Bureau: Eli Lilly and Company, Novo Nordisk A/S, Sanofi U.S.

King, Emily ........................................... Disclosed no confl ict of interest.King, George L. .................................... Research Support: Boehringer Ingelheim GmbH, National

Institutes of Health. King, Thomas ....................................... Disclosed no confl ict of interest.King, Timothy H. .................................. Disclosed no confl ict of interest.Kingry, Connie ..................................... Disclosed no confl ict of interest.Kingwell, Bronwyn A. ......................... Research Support: Resverlogix Corp. Kinney, Gregory L. ............................... Disclosed no confl ict of interest.Kinra, Sanjay ....................................... Disclosed no confl ict of interest.Kinuhata, Shigeki ................................ Disclosed no confl ict of interest.Kinz, Elena ........................................... Disclosed no confl ict of interest.Kinzell, John ........................................ Employee: Xeris Pharmaceuticals, Inc. Kirby, Jennifer L. ................................. Disclosed no confl ict of interest.Kircher, Robert .................................... Board Member: Dose Safety Inc.; Employee: Dose Safety

Inc.; Stock/Shareholder: Dose Safety Inc. Kirchner, H.L. ....................................... Disclosed no confl ict of interest.Kirchner, Thomas ................................ Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson; Stock/Shareholder: Johnson & Johnson. Kirchsteiger, Harald ............................ Disclosed no confl ict of interest.Kirian, Kari ........................................... Disclosed no confl ict of interest.Kirk, Isa K. ............................................ Disclosed no confl ict of interest.Kirkevold, Marit .................................. Disclosed no confl ict of interest.Kirkman, M. Sue .................................. Consultant: Eli Lilly and Company; Research Support: Novo

Nordisk Inc. Kirkwood, Marie ................................. Disclosed no confl ict of interest.Kirpitch, Amanda ................................ Disclosed no confl ict of interest.Kirson, Noam Y. ................................... Research Support: Eli Lilly and Company. Kirst, Claudia ....................................... Disclosed no confl ict of interest.Kirsten, Holger .................................... Disclosed no confl ict of interest.Kirtland, Karen .................................... Disclosed no confl ict of interest.Kirwan, John P. ................................... Disclosed no confl ict of interest.Kis, Janos T. ........................................ Disclosed no confl ict of interest.Kiselova, Irina ...................................... Disclosed no confl ict of interest.Kiselyov, Vladislav .............................. Employee: Eli Lilly and Company. Kishihara, Eriko ................................... Disclosed no confl ict of interest.Kishimoto, Junji .................................. Disclosed no confl ict of interest.Kishore, Preeti ..................................... Disclosed no confl ict of interest.Kiskac, Muharrem ............................... Disclosed no confl ict of interest.Kiss, Zsófi a V. ...................................... Disclosed no confl ict of interest.Kissela, Brett ....................................... Disclosed no confl ict of interest.Kissner, Thomas .................................. Disclosed no confl ict of interest.Kistler, Susan ...................................... Disclosed no confl ict of interest.Kitabchi, Abbas ................................... Disclosed no confl ict of interest.Kitada, Yoshihiko ................................ Disclosed no confl ict of interest.Kitada, Yoshihiro ................................. Disclosed no confl ict of interest.Kitagawa, Nanako .............................. Disclosed no confl ict of interest.Kitagawa, Noriyuki ............................. Disclosed no confl ict of interest.Kitajima, Hidetoshi ............................. Disclosed no confl ict of interest.Kitamoto, Takumi ................................ Disclosed no confl ict of interest.Kitamura, Tadahiro ............................. Disclosed no confl ict of interest.Kitano, Sayaka .................................... Disclosed no confl ict of interest.Kitano, Shigehiko ................................ Disclosed no confl ict of interest.Kitaoka, Haruko ................................... Disclosed no confl ict of interest.

Kitayama, Tetsuya .............................. Disclosed no confl ict of interest.Kittow, Louise ..................................... Disclosed no confl ict of interest.Kiuchi, Hiroko ...................................... Disclosed no confl ict of interest.Kivimäki, Mika ..................................... Disclosed no confl ict of interest.Kiviranta, Riku ..................................... Disclosed no confl ict of interest.Kizer, Jorge R. ..................................... Disclosed no confl ict of interest.Kizilgul, Muhammed ........................... Disclosed no confl ict of interest.Kjær, Michael ...................................... Disclosed no confl ict of interest.Kjellberg, Jakob .................................. Disclosed no confl ict of interest.Kjellstedt, Ann .................................... Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP. Kjems, Lise .......................................... Employee: Intarcia Therapeutics, Inc. Kjøbsted, Rasmus ............................... Disclosed no confl ict of interest.Klaff, Leslie J. ..................................... Research Support: Bayer, Roche, Abbott, Alere, and

Johnson and Johnson. Klaus, Katherine .................................. Disclosed no confl ict of interest.Klein, Barbara E. ................................. Disclosed no confl ict of interest.Klein, David ......................................... Employee: Medpace, Inc. Klein, Gernot K. ................................... Disclosed no confl ict of interest.Klein, Oliver ......................................... Employee: Profi l Institute for Clinical Research, Inc. Klein, Richard ...................................... Disclosed no confl ict of interest.Klein, Ronald ....................................... Disclosed no confl ict of interest.Klein, Thomas ...................................... Employee: Boehringer Ingelheim Pharmaceuticals, Inc. Kleinert, Maximilian ........................... Disclosed no confl ict of interest.Kletzien, Rolf ....................................... Board Member: Metabolic Solutions Development Company,

LLC.; Employee: Metabolic Solutions Development Company, LLC.; Stock/Shareholder: Metabolic Solutions Development Company, LLC.

Klimes, Iwar ......................................... Disclosed no confl ict of interest.Klimkowski, Valentine J. .................... Employee: Eli Lilly and Company. Klimontov, Vadim V. ............................ Disclosed no confl ict of interest.Klingensmith, Georgeanna J. ............. Consultant: Novo Nordisk Inc. Klink, Andrew ...................................... Employee: HealthCore Inc. Klonoff, David C. ................................. Advisory Panel: Google, Insuline, Lifecare, Novartis, Roche,

Sanofi , Tempramed, Voluntis; Research Support: Eli Lilly, Halozyme, Janssen, Novo Nordisk, Oramed; Stock/Shareholder: Tempramed.

Klöting, Nora ....................................... Disclosed no confl ict of interest.Klouckova, Jana .................................. Disclosed no confl ict of interest.Kluck, Thomas ..................................... Employee: BD Medical-Diabetes Care; Stock/Shareholder:

Becton, Dickinson and Company. Kluge, Reinhart ................................... Disclosed no confl ict of interest.Klupa, Tomasz ..................................... Disclosed no confl ict of interest.Klüppelholz, Birgit ............................... Disclosed no confl ict of interest.Klusmeier, Nadine ............................... Disclosed no confl ict of interest.Knadler, Mary P. .................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Knaub, Leslie ....................................... Disclosed no confl ict of interest.Knebel, Birgit ....................................... Disclosed no confl ict of interest.Knight, Richard .................................... Disclosed no confl ict of interest.Knip, Mikael ........................................ Disclosed no confl ict of interest.Knobler, Hilla ....................................... Disclosed no confl ict of interest.Knoefel, Wolfram T ............................. Disclosed no confl ict of interest.Knoops, Bernard ................................. Disclosed no confl ict of interest.Knop, Filip K. ........................................ Advisory Panel: AstraZeneca Pharmaceuticals LP, Eli Lilly

and Company, Novo Nordisk A/S, Sanofi U.S., Zealand Pharma A/S; Consultant: AstraZeneca Pharmaceuticals LP, Fractyl, Gilead, Merck Sharp & Dohme, Novo Nordisk A/S, Zealand Pharma A/S; Research Support: Gubra, Novo Nordisk A/S, Sanofi U.S., Zealand Pharma A/S; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead, Merck Sharp & Dohme, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Ono Pharmaceutical Co., Ltd., Sanofi U.S., Zealand Pharma A/S.

Knorr, Sine ........................................... Disclosed no confl ict of interest.Knowler, William C. ............................ Disclosed no confl ict of interest.Knudsen, Carsten B. ........................... Employee: Zealand Pharma A/S; Stock/Shareholder: Zealand

Pharma A/S. Knudsen, Knud Erik Bach .................... Disclosed no confl ict of interest.Knudsen, Lotte B. ................................ Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Knudsen, Søren T. ............................... Disclosed no confl ict of interest.Knüfer, Selina ...................................... Disclosed no confl ict of interest.Knuuti, Juhani ..................................... Disclosed no confl ict of interest.Ko, Hoo Sang ....................................... Disclosed no confl ict of interest.Ko, Seok-Chun ..................................... Disclosed no confl ict of interest.Ko, Seung-Hyun ................................... Disclosed no confl ict of interest.Kobayashi, Hiroyuki ............................ Disclosed no confl ict of interest.Kobayashi, Kazuki ............................... Disclosed no confl ict of interest.Kobayashi, Satoru ............................... Disclosed no confl ict of interest.

A851

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Kobayashi, Takuya .............................. Disclosed no confl ict of interest.Kobayashi, Tetsuro ............................. Disclosed no confl ict of interest.Kobayashi, Tsunefumi ......................... Employee: Teijin Pharma Limited. Køber, Lars ........................................... Disclosed no confl ict of interest.Kobes, Sayuko ..................................... Disclosed no confl ict of interest.Kocak, Mehmet ................................... Disclosed no confl ict of interest.Kocakaya, Ozan ................................... Disclosed no confl ict of interest.Kocakoc, Ercan .................................... Disclosed no confl ict of interest.Kocaman, Orhan .................................. Disclosed no confl ict of interest.Kocełak, Piotr ...................................... Disclosed no confl ict of interest.Koch, Cornelia ..................................... Employee: Novartis Pharma GmbH. Koch, Kenneth L. ................................. Disclosed no confl ict of interest.Koch, Lauren G. ................................... Disclosed no confl ict of interest.Kocherlakota, Chaithanya .................. Disclosed no confl ict of interest.Kodama, Keiichi .................................. Disclosed no confl ict of interest.Kodama, Mai ....................................... Disclosed no confl ict of interest.Kodama, Satoru .................................. Disclosed no confl ict of interest.Kodani, Noriko ..................................... Disclosed no confl ict of interest.Koebnick, Corinna ............................... Disclosed no confl ict of interest.Koechlin, Alice .................................... Disclosed no confl ict of interest.Koenig, Wolfgang ............................... Disclosed no confl ict of interest.Koenigsrainer, Alfred .......................... Disclosed no confl ict of interest.Köfalvi, Attila ...................................... Disclosed no confl ict of interest.Koffert, Jukka ..................................... Disclosed no confl ict of interest.Kofoed, Klaus F. ................................... Disclosed no confl ict of interest.Koga, Takashi ...................................... Disclosed no confl ict of interest.Kogot-Levin, Aviram ........................... Disclosed no confl ict of interest.Koh, Angela ......................................... Disclosed no confl ict of interest.Koh, Ho-Jin .......................................... Disclosed no confl ict of interest.Koh, Woon Puay .................................. Disclosed no confl ict of interest.Kohara, Katsuhiko ............................... Disclosed no confl ict of interest.Kohara, Kenji ....................................... Disclosed no confl ict of interest.Kohashi, Kyoko .................................... Disclosed no confl ict of interest.Köhler, Gerd ......................................... Advisory Panel: Eli Lilly and Company, Novo Nordisk A/S;

Research Support: Novo Nordisk A/S; Speaker’s Bureau: AstraZeneca/Bristol-Myers Squibb, Eli Lilly and Company, Merck Sharp & Dohme, Novartis Pharma GmbH, Novo Nordisk A/S, Roche Diagnostics.

Kohler, Peter ........................................ Disclosed no confl ict of interest.Kohler, Sven ......................................... Employee: Boehringer Ingelheim GmbH. Kohn, Christine G. ............................... Disclosed no confl ict of interest.Kohnert, Klaus-Dieter ......................... Disclosed no confl ict of interest.Koide, Keiko ......................................... Speaker’s Bureau: Eli Lilly Japan K.K., Johnson & Johnson,

Medtronic, Inc., Novo Nordisk Inc. Koike, Marcia ...................................... Disclosed no confl ict of interest.Kojima, Itaru ........................................ Disclosed no confl ict of interest.Kokkinos, Alexander ........................... Disclosed no confl ict of interest.Kolaczynski, Wlodzimierz M. ............. Employee: Novartis Pharma AG. Kolar, Matthew J. ............................... Disclosed no confl ict of interest.Kolehmainen, Marjukka ...................... Disclosed no confl ict of interest.Koliaki, Chrysi ...................................... Disclosed no confl ict of interest.Koliwad, Suneil ................................... Disclosed no confl ict of interest.Kolka, Cathryn ..................................... Disclosed no confl ict of interest.Kollar, Laura ......................................... Disclosed no confl ict of interest.Kollman, Craig ..................................... Consultant: Medtronic, Inc. Kolm, Paul ............................................ Disclosed no confl ict of interest.Kolnes, Kristoffer J. ............................ Disclosed no confl ict of interest.Kolotkin, Ronette ................................ Advisory Panel: Janssen Research & Development LLC,

Novo Nordisk Inc.; Consultant: Eisai Co., Ltd.; Other Relationship: Duke University (royalties), Novo Nordisk Inc., Orexigen Therapeutics, Inc.

Komatsu, Hidetoshi ............................ Employee: Takeda Pharmaceutical Company Limited. Komatsu, Mitsuhisa ............................ Disclosed no confl ict of interest.Komatsu, Shiho ................................... Disclosed no confl ict of interest.Komshilova, Ksenia A. ........................ Disclosed no confl ict of interest.Komuro, Manaho ................................. Disclosed no confl ict of interest.Kon, Kanta ........................................... Disclosed no confl ict of interest.Kondal, Dimple .................................... Disclosed no confl ict of interest.Kondo, Keiichi ...................................... Disclosed no confl ict of interest.Kondo, Keiko ........................................ Disclosed no confl ict of interest.Kondo, Manabu ................................... Disclosed no confl ict of interest.Kondo, Mari ......................................... Disclosed no confl ict of interest.Kondo, Masaki .................................... Disclosed no confl ict of interest.Kondo, Motoyuki ................................. Disclosed no confl ict of interest.Kondo, Takuma .................................... Disclosed no confl ict of interest.Kondo, Tatsuya .................................... Disclosed no confl ict of interest.Kondo, Yoshinobu ................................ Disclosed no confl ict of interest.Kong, Alice .......................................... Disclosed no confl ict of interest.Kong, Lili .............................................. Disclosed no confl ict of interest.Kong, Peixuan ...................................... Disclosed no confl ict of interest.Kong, Sheldon ..................................... Employee: Novo Nordisk Inc. Kong, Xing Xing ................................... Disclosed no confl ict of interest.

Kong, Ying Ying ................................... Disclosed no confl ict of interest.Kongsø, Jens Harald ........................... Employee: Novo Nordisk A/S. Konik-Comonfort, Selene ................... Disclosed no confl ict of interest.Konishi, Masahiro ............................... Disclosed no confl ict of interest.Konkar, Anish ...................................... Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP. Kono, Tatsuyoshi ................................. Disclosed no confl ict of interest.Konopka, Adam R. ............................... Disclosed no confl ict of interest.Konrad, Daniel ..................................... Disclosed no confl ict of interest.Konrad, Robert .................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Kontai, Yoshiko .................................... Disclosed no confl ict of interest.Konvalina, Noa .................................... Disclosed no confl ict of interest.Koo, Bo Kyung ..................................... Disclosed no confl ict of interest.Koo, Malcolm ...................................... Disclosed no confl ict of interest.Kooijman, Marjolein N. ....................... Disclosed no confl ict of interest.Koontz, Michaela B. ............................ Disclosed no confl ict of interest.Koopman, Karin E. ............................... Disclosed no confl ict of interest.Kopilova, Olga ..................................... Disclosed no confl ict of interest.Kopp, Jeffrey B. .................................. Disclosed no confl ict of interest.Kopp, Richard F. ................................... Disclosed no confl ict of interest.Koppaka, Sudha .................................. Disclosed no confl ict of interest.Koppe, Laetitia .................................... Disclosed no confl ict of interest.Koranyi, Laszlo .................................... Disclosed no confl ict of interest.Kordonouri, Olga ................................. Disclosed no confl ict of interest.Koren, Michael J. ................................ Research Support: Amgen Inc., Pfi zer Inc., Regeneron

Pharmaceuticals, Inc., Roche USA, Sanofi U.S. Koren, Shlomit ..................................... Disclosed no confl ict of interest.Korman, Jeremy E. .............................. Disclosed no confl ict of interest.Kornelius, Edy ...................................... Disclosed no confl ict of interest.Körner, Antje ....................................... Disclosed no confl ict of interest.Korolenko, Tatiana A. ......................... Disclosed no confl ict of interest.Korolenko, Tsezar P. ............................ Disclosed no confl ict of interest.Korsatko, Stefan ................................. Disclosed no confl ict of interest.Korsgren, Olle ...................................... Disclosed no confl ict of interest.Kosakai, Yoshinori ............................... Employee: Astellas Pharma Inc. Koseki, Masahiro ................................ Disclosed no confl ict of interest.Kosheleva, Anna ................................. Disclosed no confl ict of interest.Koshimizu, Yukiko ............................... Disclosed no confl ict of interest.Koshinsky, Janice ................................ Disclosed no confl ict of interest.Kosiborod, Mikhail .............................. Advisory Panel: AbbVie, Amgen Inc., AstraZeneca

Pharmaceuticals LP, Eli Lilly and Company, Genentech, Inc., Gilead, Regeneron Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited; Consultant: AstraZeneca Pharmaceuticals LP, Edwards Lifesciences, Genentech, Inc., Gilead, Regeneron Pharmaceuticals, Inc., ZS Pharma; Research Support: Eisai Co., Ltd., Genentech, Inc., Gilead, Glumetrics, Maquet, Optiscan, Sanofi U.S.

Koska, Juraj ......................................... Disclosed no confl ict of interest.Koskinen, Maarit ................................. Disclosed no confl ict of interest.Kosmas, Charlotte E. .......................... Consultant: Novo Nordisk A/S. Kostaki, Stavroula ............................... Disclosed no confl ict of interest.Kostev, Karel ....................................... Employee: IMS Health. Kostova, Deliana ................................. Disclosed no confl ict of interest.Kosuda, Minami .................................. Disclosed no confl ict of interest.Kotenyova, Yelena N. ......................... Research Support: Karaganda State Medical University. Kotsa, Kalliopi ..................................... Disclosed no confl ict of interest.Kotsani, Konstantia ............................ Disclosed no confl ict of interest.Kottgen, Anna ..................................... Disclosed no confl ict of interest.Kotwal, Anupam ................................. Disclosed no confl ict of interest.Kotzka, Joerg ...................................... Disclosed no confl ict of interest.Kotzka, Jörg ......................................... Disclosed no confl ict of interest.Kouba, Ethel ........................................ Disclosed no confl ict of interest.Kouhara, Haruhiko .............................. Disclosed no confl ict of interest.Koukoui, Francois ................................ Disclosed no confl ict of interest.Koukoulis, Georgios ............................ Disclosed no confl ict of interest.Koulajian, Khajag ................................ Disclosed no confl ict of interest.Koulis, Christine .................................. Disclosed no confl ict of interest.Koulmanda, Maria ............................... Disclosed no confl ict of interest.Koumanov, Francoise .......................... Disclosed no confl ict of interest.Koutsovasilis, Anastasios .................. Disclosed no confl ict of interest.Kovacs, Györgyi ................................... Disclosed no confl ict of interest.Kovacs, Peter ....................................... Disclosed no confl ict of interest.Kovatchev, Boris P. .............................. Advisory Panel: AstraZeneca Pharmaceuticals LP, Sanofi

U.S.; Other Relationship: Johnson & Johnson, Sanofi U.S.; Research Support: Animas Corporation, Dexcom, Inc., Insulet Corporation, Roche Diagnostics, Sanofi U.S., Tandem Diabetes Care, Inc.

Kowalska, Irina .................................... Disclosed no confl ict of interest.Kowalski, Greg M. .............................. Disclosed no confl ict of interest.

A852

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Koya, Daisuke ...................................... Research Support: Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly Japan K.K., Mitsubishi Tanabe Pharma Corporation, Ono Pharmaceutical Co., Ltd.; Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals, Inc., Dainippon Sumitomo, Eli Lilly Japan K.K., Kowa Pharmaceuticals, Kyowahakko, Mitsubishi Tanabe Pharma Corporation, MSD, Novo Nordisk Inc., Ono Pharmaceutical Co., Ltd., Pfizer Inc., Sanofi, Sanwa Kagaku Kenkyusho Co., Ltd., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited.

Koyama, Masayoshi ........................... Employee: Sanofi ; Stock/Shareholder: Sanofi . Koyama, Noriko ................................... Disclosed no confl ict of interest.Koziol, James ...................................... Disclosed no confl ict of interest.Koziol, Jim ........................................... Disclosed no confl ict of interest.Kozlovskaya, Veronika ........................ Disclosed no confl ict of interest.Kozuka, Chisayo .................................. Disclosed no confl ict of interest.Kraay, Alicia ........................................ Disclosed no confl ict of interest.Kraegen, Edward W. ........................... Disclosed no confl ict of interest.Kraft, Guillaume .................................. Disclosed no confl ict of interest.Kragh, Nana ......................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Kraja, Aldi T. ........................................ Disclosed no confl ict of interest.Krakoff, Jonathan ............................... Disclosed no confl ict of interest.Krall, Jodi ............................................ Research Support: Becton, Dickinson and Company. Kramer, Caroline K. ............................. Disclosed no confl ict of interest.Kramer, M. Kaye ................................. Disclosed no confl ict of interest.Kramer, Mark H. .................................. Disclosed no confl ict of interest.Kramer, Michael R. ............................. Research Support: National Institutes of Health. Kramer, William .................................. Consultant: PhaseBio Pharmaceuticals, Inc. Krasner, Alan ....................................... Employee: Biodel Inc.; Stock/Shareholder: Biodel Inc. Kratz, Mario ......................................... Disclosed no confl ict of interest.Kraus, Amy .......................................... Employee: Type 1 Diabetes Exchange. Krausch, Markus ................................. Disclosed no confl ict of interest.Kreiner-Møller, Eskil ........................... Disclosed no confl ict of interest.Kremers, Walter .................................. Disclosed no confl ict of interest.Kreminskaya, Vera .............................. Disclosed no confl ict of interest.Krenz, Chris ......................................... Disclosed no confl ict of interest.Kress, Stephan .................................... Advisory Panel: Sanofi . Kretowski, Adam ................................. Disclosed no confl ict of interest.Kretzler, Matthias ............................... Disclosed no confl ict of interest.Krieger, Nancy ..................................... Disclosed no confl ict of interest.Krischer, Jeffrey P. .............................. Disclosed no confl ict of interest.Krishnamurthy, Mansa ....................... Disclosed no confl ict of interest.Krishnamurthy, Rajesh ....................... Disclosed no confl ict of interest.Krishnamurthy, Ramkumar ................. Disclosed no confl ict of interest.Krishnan, Gopika ................................. Disclosed no confl ict of interest.Krishnarajah, Girishanthy ................... Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline. Krishnasamy, Sathya S. ...................... Research Support: Novo Nordisk Inc. Kriska, Andrea M. ............................... Disclosed no confl ict of interest.Kristensen, Jonas M. .......................... Disclosed no confl ict of interest.Kristensen, Lars P. ............................... Disclosed no confl ict of interest.Kristensen, Peter L. ............................. Employee: Steno Diabetes Center A/S. Kristiansen, Viggo B. .......................... Disclosed no confl ict of interest.Krivova, Yuliya S. ................................ Disclosed no confl ict of interest.Krogvold, Lars ..................................... Disclosed no confl ict of interest.Krolewski, Andrzej S. ......................... Consultant: Concert Pharmaceuticals; Research Support:

Boehringer Ingelheim GmbH, Eli Lilly and Company, Pfi zer Inc.

Kropff, Jort .......................................... Disclosed no confl ict of interest.Kruger, Marcus .................................... Disclosed no confl ict of interest.Kruger, Ruan ........................................ Disclosed no confl ict of interest.Krumholz, Harlan M. ........................... Research Support: Johnson & Johnson, Medtronic, Inc. Krupa, Wojciech .................................. Disclosed no confl ict of interest.Kruse, Michael .................................... Disclosed no confl ict of interest.Kruse, Rikke ......................................... Disclosed no confl ict of interest.Kryvalap, Yury ..................................... Disclosed no confl ict of interest.Ku, Bon Jeong ..................................... Disclosed no confl ict of interest.Ku, Eu Jeong ........................................ Disclosed no confl ict of interest.Ku, Gregory M. .................................... Disclosed no confl ict of interest.Kubisiak, Kristine ................................ Disclosed no confl ict of interest.Kubo, Ai ............................................... Disclosed no confl ict of interest.Kubo, Hitoshi ....................................... Disclosed no confl ict of interest.Kubo, Michiaki .................................... Disclosed no confl ict of interest.Kuchibhotla, Sarada ........................... Disclosed no confl ict of interest.Kuchroo, Vijay K. ................................. Disclosed no confl ict of interest.Kudo, Kana ........................................... Disclosed no confl ict of interest.Kudo, Yasusei ...................................... Disclosed no confl ict of interest.Kudomi, Nobu ...................................... Disclosed no confl ict of interest.Kudomi, Nobuyuki ............................... Disclosed no confl ict of interest.Kudva, Yogish C. .................................. Research Support: Roche Diagnostics.

Kuhadiya, Nitesh D. ............................ Disclosed no confl ict of interest.Kuhn, John ........................................... Disclosed no confl ict of interest.Kuhre, Runre E. .................................... Disclosed no confl ict of interest.Kühtreiber, Willem M. ........................ Disclosed no confl ict of interest.Kuipers, Allison ................................... Disclosed no confl ict of interest.Kujawa, Magdalena ............................ Disclosed no confl ict of interest.Kulina, Georgia .................................... Disclosed no confl ict of interest.Kulkarni, Hemant ................................. Disclosed no confl ict of interest.Kulkarni, Rohit N. ................................ Disclosed no confl ict of interest.Kullmann, Stephanie ........................... Disclosed no confl ict of interest.Kullo, Iftikhar ....................................... Disclosed no confl ict of interest.Kulshrestha, Atul ................................ Disclosed no confl ict of interest.Kulzer, Bernhard .................................. Advisory Panel: AstraZeneca/Bristol-Myers Squibb, Novo

Nordisk A/S, Roche Diagnostics, Sanofi U.S.; Research Support: Abbott, AstraZeneca/Bristol-Myers Squibb, Berlin-Chemie AG, Roche Diagnostics; Speaker’s Bureau: AstraZeneca/Bristol-Myers Squibb, Novo Nordisk A/S.

Kum, Maxwell C. ................................. Employee: Acon Laboratories, Inc. Kumada, Tatsuro ................................. Disclosed no confl ict of interest.Kumagai, Ryo ....................................... Disclosed no confl ict of interest.Kumagi, Teru ........................................ Disclosed no confl ict of interest.Kumah-Crystal, Yaa ............................ Disclosed no confl ict of interest.Kumar, Aditi ......................................... Disclosed no confl ict of interest.Kumar, Anand ...................................... Disclosed no confl ict of interest.Kumar, Anjali ....................................... Disclosed no confl ict of interest.Kumar, Deepak .................................... Disclosed no confl ict of interest.Kumar, Satish ...................................... Disclosed no confl ict of interest.Kumareswaran, Kavita ....................... Advisory Panel: Medtronic, Inc.; Speaker’s Bureau:

AstraZeneca Pharmaceuticals LP, Lilly Deutschland GmbH, Medtronic, Inc., Sanofi U.S.

Kumashiro, Naoki ................................ Disclosed no confl ict of interest.Kumate-Rodríguez, Jesús .................. Disclosed no confl ict of interest.Kume, Shinji ......................................... Disclosed no confl ict of interest.Kummer, Mark ..................................... Disclosed no confl ict of interest.Kumusoglu, Doga ................................ Disclosed no confl ict of interest.Kunath, Anne ....................................... Disclosed no confl ict of interest.Kunkel, Steven L. ................................. Disclosed no confl ict of interest.Kunori, Shunji ...................................... Disclosed no confl ict of interest.Kunze, Claudia ..................................... Disclosed no confl ict of interest.Kuo, Chien-Hung ................................. Disclosed no confl ict of interest.Kuo, Chih-Hao ...................................... Disclosed no confl ict of interest.Kuo, Ming ............................................ Disclosed no confl ict of interest.Kupfer, Stuart ...................................... Employee: Takeda Pharmaceutical Company Limited. Kurahashi, Kiyoe ................................. Disclosed no confl ict of interest.Kurasaki, Kotaro .................................. Disclosed no confl ict of interest.Kurashvili, Ramaz B. ........................... Disclosed no confl ict of interest.Kurisu, Seigo ....................................... Disclosed no confl ict of interest.Kuritzky, Louis ..................................... Consultant: Boehringer Ingelheim Pharmaceuticals, Inc.,

Consultant, Consultant, Consultant, Consultant, Consultant, Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Novo Nordisk Inc., Sanofi U.S.; Speaker’s Bureau: Janssen Pharmaceutical Companies of Johnson & Johnson.

Kuriyama, Kinuyo ................................ Disclosed no confl ict of interest.Kuroda, Akio ........................................ Disclosed no confl ict of interest.Kuroda, Masashi ................................. Disclosed no confl ict of interest.Kurosawa, Hiroyuki ............................. Disclosed no confl ict of interest.Kurose, Seiji ........................................ Disclosed no confl ict of interest.Kursawe, Romy ................................... Disclosed no confl ict of interest.Kurtyka, Karen .................................... Employee: Merck Sharp & Dohme. Kurtz, Natalie ...................................... Employee: Medtronic MiniMed, Inc. Kushi, Lawrence H. ............................. Disclosed no confl ict of interest.Kushima, Hideki .................................. Disclosed no confl ict of interest.Kushiyama, Akifumi ............................ Disclosed no confl ict of interest.Kushner, Jake A. ................................. Disclosed no confl ict of interest.Kushner, Robert F. ............................... Advisory Panel: Novo Nordisk Inc., Retrofi t, Inc., Vivus

Inc., Zafgen; Consultant: Eisai Co., Ltd., Takeda Pharmaceuticals U.S.A., Inc.; Research Support: Aspire Bariatrics, Weight Watchers International, Inc.

Kushnir, Talma ..................................... Disclosed no confl ict of interest.Kusters, Yvo H. .................................... Disclosed no confl ict of interest.Kusunoki, Masataka ........................... Disclosed no confl ict of interest.Kuusisto, Johanna .............................. Disclosed no confl ict of interest.Kuwabara, Remi .................................. Disclosed no confl ict of interest.Kuwamura, Yumi ................................. Disclosed no confl ict of interest.Kuzma, Jessica N. ............................... Disclosed no confl ict of interest.Kuznetsova, Alexandra ....................... Disclosed no confl ict of interest.Kuzuya, Hideshi ................................... Disclosed no confl ict of interest.Kuzuya, Takeshi ................................... Disclosed no confl ict of interest.Kwak, Soo Heon .................................. Disclosed no confl ict of interest.

A853

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Kwan, Anita ......................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly and Company.

Kwan, Christine M. ............................. Disclosed no confl ict of interest.Kwark, Leon ......................................... Disclosed no confl ict of interest.Kwon, Guim ......................................... Disclosed no confl ict of interest.Kwon, Hyug Moo ................................. Disclosed no confl ict of interest.Kwon, Hyuk-Sang ................................ Disclosed no confl ict of interest.Kwon, Kwang-Chul .............................. Disclosed no confl ict of interest.Kwon, Mi Hye ...................................... Disclosed no confl ict of interest.Kwon, Min Jeong ................................ Disclosed no confl ict of interest.Kwon, Sang Chang .............................. Disclosed no confl ict of interest.Kwon, Sangchang ............................... Disclosed no confl ict of interest.Kwon, Se Chang .................................. Employee: Hanmi Pharmaceuticals Inc. Kwon, Su Kyoung ................................ Disclosed no confl ict of interest.Kwong, Yvonne ................................... Disclosed no confl ict of interest.Kyanvash, Shadi .................................. Disclosed no confl ict of interest.Kyaw Tun, Tommy ................................ Disclosed no confl ict of interest.Kyohara, Mayu .................................... Disclosed no confl ict of interest.Kyoong, Andrew .................................. Disclosed no confl ict of interest.Kyriazis, George A. .............................. Disclosed no confl ict of interest.Kystaubaeva, Zaure T. ........................ Disclosed no confl ict of interest.Kyung, Chanhee .................................. Disclosed no confl ict of interest.la Fleur, Susanne E. ............................. Disclosed no confl ict of interest.La Fontaine, Javier ............................. Disclosed no confl ict of interest.La Loggia, Alfonso .............................. Board Member: Sanofi . La Ronde-Richard, Ann-Marie ........... Disclosed no confl ict of interest.La Sala, Luicia ..................................... Disclosed no confl ict of interest.Laakso, Markku ................................... Disclosed no confl ict of interest.Labarbuta, Rossella ............................ Disclosed no confl ict of interest.Labasky, Meghan ................................ Disclosed no confl ict of interest.Labbe, Sebastien M. ........................... Disclosed no confl ict of interest.Labrie, Fernand ................................... Disclosed no confl ict of interest.Lacadie, Cheryl .................................... Disclosed no confl ict of interest.Lacinova, Zdenka ................................ Disclosed no confl ict of interest.LaCouture, Michael ............................ Disclosed no confl ict of interest.LaCreta, Frank ..................................... Employee: Bristol-Myers Squibb Company; Stock/

Shareholder: Bristol-Myers Squibb Company. Lacy, J. Matthew ................................ Disclosed no confl ict of interest.Lacy, Mary B. ....................................... Disclosed no confl ict of interest.Lacy, Mary E. ....................................... Disclosed no confl ict of interest.Ladak, Farah ........................................ Disclosed no confl ict of interest.Ladenvall, Claes .................................. Disclosed no confl ict of interest.Ladouceur, Martin ............................... Employee: Quintiles. Laessing, Ute ....................................... Stock/Shareholder: Cytos Biotechnology AG. Laferrere, Blandine B. ......................... Disclosed no confl ict of interest.Laffel, Lori M. ...................................... Advisory Panel: Animas Corporation, AstraZeneca

Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Dexcom, Inc., Eli Lilly and Company, Johnson & Johnson, LifeScan, Inc., Menarini Group, Novo Nordisk Inc., Oshadi Drug Administration, Roche USA, Sanofi U.S.; Consultant: Animas Corporation, AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Consultant, Consultant, Consultant, Consultant, Consultant, Consultant, Consultant, Consultant, Consultant, Consultant, Consultant, Consultant, Dexcom, Inc., Eli Lilly and Company, Johnson & Johnson, LifeScan, Inc., Menarini Group, Novo Nordisk Inc., Oshadi Drug Administration, Roche USA, Sanofi U.S.; Research Support: Bayer HealthCare, Boehringer Ingelheim Pharmaceuticals, Inc., Dexcom, Inc., Grant Support, Grant Support, Grant Support.

Lafl amme, Collette .............................. Disclosed no confl ict of interest.Lafrance, Jean-Philippe ..................... Disclosed no confl ict of interest.Lagou, Vasiliki ..................................... Disclosed no confl ict of interest.Lagro-Janssen, Atoine L. ................... Disclosed no confl ict of interest.Lahav, Maor ......................................... Disclosed no confl ict of interest.Lahewala, Sopan ................................ Disclosed no confl ict of interest.Lahr, Brian D. ....................................... Disclosed no confl ict of interest.Lai, Chao Q. ......................................... Disclosed no confl ict of interest.Lai, Dejian ............................................ Disclosed no confl ict of interest.Lai, Eseng ............................................ Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &

Co., Inc. Lai, Fenghua ........................................ Disclosed no confl ict of interest.Lai, Forest ............................................ Disclosed no confl ict of interest.Lai, Mei-Shu ........................................ Disclosed no confl ict of interest.Lai, Oi Fah ............................................ Disclosed no confl ict of interest.Lai, Vesta ............................................. Disclosed no confl ict of interest.Laires, Pedro ........................................ Employee: Merck Sharp & Dohme. Laiteerapong, Neda ............................ Disclosed no confl ict of interest.Lajara, Rosemarie ............................... Advisory Panel: AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim Pharmaceuticals, Inc.,

Dexcom, Inc., Novo Nordisk Inc.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Dexcom, Inc., Insulet Corporation, Novo Nordisk Inc., Takeda Pharmaceuticals U.S.A., Inc., Valeritas.

Lajer, Maria ......................................... Disclosed no confl ict of interest.Lakey, Natalie ...................................... Disclosed no confl ict of interest.Lakhani, Laila ...................................... Disclosed no confl ict of interest.Laksmipathi, Jayalakshmi .................. Disclosed no confl ict of interest.Lalia, Antigoni ..................................... Disclosed no confl ict of interest.Lally, Jayasree .................................... Disclosed no confl ict of interest.Lam, David ........................................... Disclosed no confl ict of interest.Lam, Eric Chen Quin ............................ Employee: Eli Lilly and Company. Lam, Karen S. ...................................... Disclosed no confl ict of interest.Lam, Kenrick ........................................ Disclosed no confl ict of interest.Lam, T.H. .............................................. Disclosed no confl ict of interest.Lam, Yuen Ting .................................... Disclosed no confl ict of interest.Lam, Yui-Wing ..................................... Disclosed no confl ict of interest.Lamacchia, Olga .................................. Disclosed no confl ict of interest.Lamantia, Valérie ................................ Disclosed no confl ict of interest.Lamarche, Marie ................................. Disclosed no confl ict of interest.Lamichhane, Archana ......................... Disclosed no confl ict of interest.Lamoke, Folami ................................... Disclosed no confl ict of interest.Lamont, Benjamin J. ........................... Research Support: Boehringer Ingelheim GmbH, Sanofi

Pasteur SA. Lanaspa, Miguel A. ............................. Disclosed no confl ict of interest.Lanba, Adhiraj ..................................... Disclosed no confl ict of interest.Lancaster, Jack ................................... Disclosed no confl ict of interest.Lancerotto, Luca ................................. Disclosed no confl ict of interest.Landa, Nicole ...................................... Disclosed no confl ict of interest.Landau, Zohar ...................................... Disclosed no confl ict of interest.Lande’, Arnold J. ................................. Disclosed no confl ict of interest.Landgraf, Wolfgang ............................ Employee: Sanofi ; Stock/Shareholder: Sanofi . Landin-Olsson, Mona .......................... Disclosed no confl ict of interest.Landivar-Rocha, Adriana .................... Disclosed no confl ict of interest.Landry, Christian R. ............................. Disclosed no confl ict of interest.Landy, Ellen M. .................................... Disclosed no confl ict of interest.Lane, James T. .................................... Research Support: Eli Lilly and Company, EMD Serono,

Inc., Genkyotex, Merck & Co., Inc., Merck Sharp & Dohme, Novo Nordisk Inc., Pfi zer Inc., Sanofi U.S., VM Biopharma.

Lang, Alon ............................................ Disclosed no confl ict of interest.Lang, Jianan ........................................ Disclosed no confl ict of interest.Lang, Kathleen .................................... Consultant: Quintiles Inc. Lang, Kathy .......................................... Consultant: AstraZeneca Pharmaceuticals LP. Lang, Uwe ............................................ Disclosed no confl ict of interest.Lang, Wei ............................................. Disclosed no confl ict of interest.Lang, Wensheng ................................. Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson; Stock/Shareholder: Johnson & Johnson. Langbakke, Irene Hedelund ................ Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Lange, Leslie ........................................ Disclosed no confl ict of interest.Langefeld, Carl D. ............................... Disclosed no confl ict of interest.Langenickel, Thomas .......................... Employee: Novartis AG; Stock/Shareholder: Novartis AG. Langer, Thomas ................................... Disclosed no confl ict of interest.Langerman, Haya ................................ Employee: Merck Sharp & Dohme. Langholz, Ebbe .................................... Disclosed no confl ict of interest.Langleite, Torgrim ............................... Disclosed no confl ict of interest.Langman, Linda ................................... Disclosed no confl ict of interest.Lanham, Michael ................................. Disclosed no confl ict of interest.Lannoo, Matthias ................................ Research Support: Ethicon Endo-Surgery, Inc., Johnson &

Johnson. Lansang, M. Cecilia ............................ Disclosed no confl ict of interest.Lantier, Louise ..................................... Disclosed no confl ict of interest.Lanza, Ian R. ........................................ Disclosed no confl ict of interest.Lanzola, Giordano ............................... Disclosed no confl ict of interest.Lanzoni, Giacomo ................................ Disclosed no confl ict of interest.Lao, Gancheng ..................................... Disclosed no confl ict of interest.Lapolla, Annunziata ............................ Disclosed no confl ict of interest.Lara-Riegos, Julio C. ........................... Disclosed no confl ict of interest.Larbi, Daniel ........................................ Disclosed no confl ict of interest.Largay, Joseph F. ................................. Disclosed no confl ict of interest.Larkin, Amy .......................................... Disclosed no confl ict of interest.Laronga, Giuliana ................................ Disclosed no confl ict of interest.Larrabure-Torrealva, Gloria T. ............ Disclosed no confl ict of interest.Larrazolo, Joshua ................................ Disclosed no confl ict of interest.Larrivee, Sandra .................................. Disclosed no confl ict of interest.Larsen, Larsen R. ................................ Disclosed no confl ict of interest.Larsen, Marianne O. ........................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Larsen, Mette B. ................................. Disclosed no confl ict of interest.Larsen, Mette K. ................................. Disclosed no confl ict of interest.

A854

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Larsen, Philip J. ................................... Disclosed no confl ict of interest.Larsen, Steen ...................................... Disclosed no confl ict of interest.Larson, Joseph J. ................................ Disclosed no confl ict of interest.Larsson, Nils-Göran ............................ Disclosed no confl ict of interest.Laryushina, Elena M. .......................... Disclosed no confl ict of interest.Laskowski, Adrienne ........................... Disclosed no confl ict of interest.Lasseter, Kenneth ............................... Employee: Clinical Pharmacology of Miami. Lassota, Nathan .................................. Employee: Merck Sharp & Dohme; Stock/Shareholder: Merck

Sharp & Dohme, Novo Nordisk A/S. Latouche, Celine ................................. Disclosed no confl ict of interest.Lattanzio, Franca M. ........................... Disclosed no confl ict of interest.Lattuada, Guido ................................... Disclosed no confl ict of interest.Lau, Clara Bik San ............................... Disclosed no confl ict of interest.Lau, David C. ........................................ Advisory Panel: Amgen Inc., AstraZeneca Pharmaceuticals

LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Research & Development LLC, Novo Nordisk Inc., Roche Diagnostics, Valeant; Research Support: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Novo Nordisk Inc.; Speaker’s Bureau: Amgen Inc., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Research & Development LLC, Merck & Co., Inc., Novo Nordisk Inc., Valeant.

Lau, Eric ............................................... Disclosed no confl ict of interest.Lau, Jesper .......................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Lau, Ka Hei Karen ................................ Disclosed no confl ict of interest.Laubner, Katharina .............................. Disclosed no confl ict of interest.Lauffenburger, Douglas A. ................. Research Support: National Institutes of Health. Laugesen, Esben ................................. Disclosed no confl ict of interest.Laurence Matteau-Pelletier, Laurence Disclosed no confl ict of interest.Laurent, Cecile A. ............................... Disclosed no confl ict of interest.Lauria Pantano, Angelo ...................... Disclosed no confl ict of interest.Laurin, Pierre ....................................... Disclosed no confl ict of interest.Lauritzen, Hans ................................... Disclosed no confl ict of interest.Lauritzen, Torsten ............................... Research Support: AstraZeneca/Bristol-Myers Squibb,

GlaxoSmithKline, HemoCue Danmark A/S, Novo Nordisk A/S, Novo Nordisk Scandinavia AB, Pfi zer Inc., Servier; Stock/Shareholder: Novo Nordisk A/S.

Lauro, Davide ...................................... Disclosed no confl ict of interest.Lautz, David ......................................... Disclosed no confl ict of interest.Lavalle González, Fernando J. ........... Advisory Panel: AstraZeneca, Boehringer Ingelheim, Eli

Lilly, Janssen, Novo Nordisk, Sanofi ; Board Member: AstraZeneca, Boehringer Ingelheim, Janssen, Novo Nordisk, Sanofi ; Research Support: Boehringer Ingelheim, Janssen, Novo Nordisk, Sanofi ; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Merck Sharp & Dohme, Novo Nordisk, Sanofi .

Lavery, Larry ........................................ Disclosed no confl ict of interest.Laviola, Luigi ....................................... Advisory Panel: AstraZeneca/Bristol-Myers Squibb, Eli Lilly

and Company, Janssen Global Services LLC. Lavrador, Maria S. .............................. Disclosed no confl ict of interest.Law, Jennifer R. .................................. Disclosed no confl ict of interest.Lawrence, Jean ................................... Disclosed no confl ict of interest.Lawson, Francesca ............................. Employee: Sanofi ; Stock/Shareholder: Sanofi . Laybutt, Ross ...................................... Disclosed no confl ict of interest.Layden, Brian T. ................................... Disclosed no confl ict of interest.Layton, Jill ........................................... Disclosed no confl ict of interest.Lazar, Jason ......................................... Disclosed no confl ict of interest.Lazaridis, Antonios ............................. Disclosed no confl ict of interest.Le Floch, Jean-Pierre .......................... Consultant: Abbott Diabetes Care, Inc., Animas Corporation,

BD Medical-Diabetes Care, Janssen Pharmaceutical Companies of Johnson & Johnson, Medtronic MiniMed, Inc., Merck & Co., Inc., Novartis Pharma GmbH, Novo Nordisk A/S; Research Support: Merck & Co., Inc., Novo Nordisk Inc.

Le Lay, Agathe ..................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo Nordisk A/S.

Le Roux, Carel W. ................................ Consultant: GI Dynamics, Inc. Leach, Jake .......................................... Employee: Dexcom, Inc. Leal, Ermelindo .................................... Disclosed no confl ict of interest.Leaños, Rocio ...................................... Disclosed no confl ict of interest.Lebeche, Djamel .................................. Disclosed no confl ict of interest.Lebkowska, Agnieszka ....................... Disclosed no confl ict of interest.Lebovics, Gary ..................................... Consultant: AstraZeneca Pharmaceuticals LP. Lebovitz, Harold E. .............................. Disclosed no confl ict of interest.LeCates, Robert .................................. Disclosed no confl ict of interest.Lecce, Laura ........................................ Disclosed no confl ict of interest.LeClair, Katherine ................................ Disclosed no confl ict of interest.

Leclercq, Farah .................................... Disclosed no confl ict of interest.Lecornet-Sokol, Emmanuelle ............. Consultant: Danone, Inc. (Spouse/Partner), Enterome

(Spouse/Partner), ReImagine. LeCreta, Frank ..................................... Employee: Bristol-Myers Squibb Company; Stock/

Shareholder: Bristol-Myers Squibb Company. Lecube, Albert ..................................... Advisory Panel: Novo Nordisk Inc. Ledent, Catherine ............................... Disclosed no confl ict of interest.LeDuc, Charles A. ................................ Disclosed no confl ict of interest.Lee, Amy S. .......................................... Disclosed no confl ict of interest.Lee, Angela .......................................... Disclosed no confl ict of interest.Lee, Anne ............................................. Disclosed no confl ict of interest.Lee, Byung-Wan .................................. Disclosed no confl ict of interest.Lee, Chia-Lin ........................................ Disclosed no confl ict of interest.Lee, Chieh A. ....................................... Disclosed no confl ict of interest.Lee, Chien-Hsing ................................. Disclosed no confl ict of interest.Lee, Christine ...................................... Disclosed no confl ict of interest.Lee, Christopher .................................. Employee: Boehringer Ingelheim GmbH. Lee, Dae-Ho ......................................... Disclosed no confl ict of interest.Lee, Dicky K. ........................................ Disclosed no confl ict of interest.Lee, Dong-Hwa ................................... Disclosed no confl ict of interest.Lee, Dong-Sung ................................... Disclosed no confl ict of interest.Lee, Douglas S. ................................... Disclosed no confl ict of interest.Lee, Eun Ju .......................................... Disclosed no confl ict of interest.Lee, Eun Soo ........................................ Disclosed no confl ict of interest.Lee, Eun Young .................................... Disclosed no confl ict of interest.Lee, Eunjung ........................................ Disclosed no confl ict of interest.Lee, Eun-Sol ......................................... Disclosed no confl ict of interest.Lee, Ga Young ...................................... Disclosed no confl ict of interest.Lee, Gregory R. .................................... Disclosed no confl ict of interest.Lee, H.F. ............................................... Disclosed no confl ict of interest.Lee, Hanae ........................................... Other Relationship: NTT DOCOMO. Lee, Hong Kyu ...................................... Other Relationship: Dalim Biotech. Lee, Hwan Hee .................................... Disclosed no confl ict of interest.Lee, Hye Won ...................................... Disclosed no confl ict of interest.Lee, Hyejin ........................................... Disclosed no confl ict of interest.Lee, Hynagkyu ..................................... Disclosed no confl ict of interest.Lee, Hyun Chul .................................... Disclosed no confl ict of interest.Lee, Hyun Jung .................................... Disclosed no confl ict of interest.Lee, Hyunchul ...................................... Disclosed no confl ict of interest.Lee, I-Lynn ........................................... Speaker’s Bureau: Novo Nordisk Inc. Lee, In-Kyu ........................................... Disclosed no confl ict of interest.Lee, I-Te ............................................... Disclosed no confl ict of interest.Lee, James J. ...................................... Disclosed no confl ict of interest.Lee, Jason ........................................... Disclosed no confl ict of interest.Lee, Jie Eun ......................................... Disclosed no confl ict of interest.Lee, Ji-Hyeok ....................................... Disclosed no confl ict of interest.Lee, Jisoo ............................................ Employee: Boehringer Ingelheim Pharma GmbH & Co. KG. Lee, JiWon R. ...................................... Disclosed no confl ict of interest.Lee, Jiyeon .......................................... Disclosed no confl ict of interest.Lee, Jong Suk ...................................... Disclosed no confl ict of interest.Lee, Jong Woo .................................... Disclosed no confl ict of interest.Lee, Jongsoon ..................................... Disclosed no confl ict of interest.Lee, Joon Bok ...................................... Disclosed no confl ict of interest.Lee, Joseph H. ..................................... Disclosed no confl ict of interest.Lee, Joshua ......................................... Disclosed no confl ict of interest.Lee, Joyce M. ...................................... Disclosed no confl ict of interest.Lee, Ju Hee .......................................... Disclosed no confl ict of interest.Lee, Jun Ho .......................................... Disclosed no confl ict of interest.Lee, Ki Won ......................................... Disclosed no confl ict of interest.Lee, Kwan Woo ................................... Disclosed no confl ict of interest.Lee, Kwang Jae ................................... Disclosed no confl ict of interest.Lee, Kwan-Woo ................................... Disclosed no confl ict of interest.Lee, Mackenzie ................................... Disclosed no confl ict of interest.Lee, Mi Young ...................................... Disclosed no confl ict of interest.Lee, Mi-Jeong ..................................... Disclosed no confl ict of interest.Lee, Min Jin ......................................... Disclosed no confl ict of interest.Lee, Min Jung ...................................... Disclosed no confl ict of interest.Lee, Min Suk ........................................ Disclosed no confl ict of interest.Lee, Min-Young ................................... Disclosed no confl ict of interest.Lee, Moon Kyu ..................................... Disclosed no confl ict of interest.Lee, Moon-Kyu .................................... Disclosed no confl ict of interest.Lee, Myung-Shik ................................. Disclosed no confl ict of interest.Lee, Phong Ching ................................. Disclosed no confl ict of interest.Lee, S. Paul .......................................... Employee: Janssen Research & Development LLC. Lee, Sang Chol ..................................... Disclosed no confl ict of interest.Lee, Sang Hyun ................................... Disclosed no confl ict of interest.Lee, Sang Jin ....................................... Disclosed no confl ict of interest.Lee, Sang-A ......................................... Disclosed no confl ict of interest.Lee, Scott ............................................ Employee: Medtronic, Inc. Lee, Seohui .......................................... Disclosed no confl ict of interest.Lee, Seung Ku ...................................... Disclosed no confl ict of interest.Lee, Seung-Eun ................................... Disclosed no confl ict of interest.

A855

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Lee, Seung-Hong ................................. Disclosed no confl ict of interest.Lee, Seung-Hoon ................................. Disclosed no confl ict of interest.Lee, Seunghun P. ................................. Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Lee, Seung-Hwan ................................ Disclosed no confl ict of interest.Lee, Seung-Pyo ................................... Disclosed no confl ict of interest.Lee, Simon Biing Ming ........................ Disclosed no confl ict of interest.Lee, Sindre ........................................... Disclosed no confl ict of interest.Lee, Soh-Hyun ..................................... Disclosed no confl ict of interest.Lee, Sojung .......................................... Disclosed no confl ict of interest.Lee, Soon Hee ..................................... Disclosed no confl ict of interest.Lee, Sun Y. ........................................... Disclosed no confl ict of interest.Lee, Warren L. ..................................... Disclosed no confl ict of interest.Lee, Wen-Jane .................................... Disclosed no confl ict of interest.Lee, Won C. ......................................... Consultant: Takeda Pharmaceutical Company Limited. Lee, Won-Young .................................. Disclosed no confl ict of interest.Lee, Woo Je ......................................... Disclosed no confl ict of interest.Lee, Xue-Yuan ...................................... Disclosed no confl ict of interest.Lee, Yong-Ho ....................................... Disclosed no confl ict of interest.Lee, You-Bin ........................................ Disclosed no confl ict of interest.Lee, Young Mi ...................................... Employee: Hanmi Pharmaceuticals Inc. Lee, Young Sil ...................................... Disclosed no confl ict of interest.Lee, Young-Mi ..................................... Disclosed no confl ict of interest.Lee, Young-Sil ..................................... Disclosed no confl ict of interest.Leech, Colin ......................................... Disclosed no confl ict of interest.Lee-Kwon, Whaseon .......................... Disclosed no confl ict of interest.Leelarathna, Lalantha ......................... Disclosed no confl ict of interest.Leening, Maarten J. ........................... Disclosed no confl ict of interest.Leermakers, E.T.M. ............................. Disclosed no confl ict of interest.Leey, Julio A. ....................................... Disclosed no confl ict of interest.Lefebvre, Chelsea G. ........................... Disclosed no confl ict of interest.Lega, Iliana C. ...................................... Disclosed no confl ict of interest.Legault, Laurent .................................. Other Relationship: Owns IP in the area of artifi cial

pancreas. Lehman, Donna ................................... Disclosed no confl ict of interest.Lehmann, Anne ................................... Employee: Sanofi ; Stock/Shareholder: Sanofi . Lehmann, Lucine ................................. Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Lehmann, Rainer ................................. Disclosed no confl ict of interest.Lehr, Stefan ......................................... Disclosed no confl ict of interest.Lehrke, Michael ................................... Advisory Panel: Astra Zeneca, Bristol-Myers Squibb

Company, GlaxoSmithKline, Roche; Employee: University Hospital Aachen; Speaker’s Bureau: Astra Zeneca, Boehringer Ingelheim, Bristol-Myers Squibb Company, GlaxoSmithKline, Merck Sharp & Dohme, Roche.

Lei, Lanyu ............................................. Disclosed no confl ict of interest.Lei, Xinnuo ........................................... Disclosed no confl ict of interest.Leiba, Adi ............................................. Disclosed no confl ict of interest.Leibel, Rudolph L. ................................ Disclosed no confl ict of interest.Leibrand, Scott .................................... Disclosed no confl ict of interest.Leiferman, Jenn .................................. Disclosed no confl ict of interest.Leiherer, Andreas ................................ Disclosed no confl ict of interest.Leil, Tarek A. ........................................ Employee: Bristol-Myers Squibb Company; Stock/

Shareholder: Bristol-Myers Squibb Company. Leippe, Donna ..................................... Employee: Promega Corp. Leiria, Luiz O. ....................................... Disclosed no confl ict of interest.Leissring, Malcolm A. ......................... Disclosed no confl ict of interest.Leitão, Cristiane B. ............................. Disclosed no confl ict of interest.Leiter, Lawrence A. ............................. Advisory Panel: Abbott, Amgen Inc., Astra Zeneca,

Boehringer Ingelheim GmbH, Eli Lilly and Company, GlaxoSmithKline, Janssen, Merck & Co., Inc., Novo Nordisk Inc., Sanofi , Servier, Takeda; Employee: St. Michael’s Hospital, University of Toronto; Research Support: Astra Zeneca, Boehringer Ingelheim GmbH, Eli Lilly and Company, GlaxoSmithKline, Janssen, Merck.

Leitges, Michael ................................. Disclosed no confl ict of interest.Leith, Andrea ....................................... Disclosed no confl ict of interest.Lemaitre, Rozenn ................................ Disclosed no confl ict of interest.Lemas, Dominick J. ............................. Disclosed no confl ict of interest.Lemieux, Steven .................................. Disclosed no confl ict of interest.Lemm, Magdalena .............................. Disclosed no confl ict of interest.Lenchik, Nataliya ................................ Disclosed no confl ict of interest.Leng, Junhong ..................................... Disclosed no confl ict of interest.Lenglet, Christophe ............................ Disclosed no confl ict of interest.Lenhard, M. James ............................. Speaker’s Bureau: American Diabetes Association, Janssen

Pharmaceutical Companies of Johnson & Johnson. Lenz, Tobias ......................................... Disclosed no confl ict of interest.Leo, Marika .......................................... Disclosed no confl ict of interest.Leonard, James ................................... Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson.

Leonardini, Anna ................................. Research Support: Eli Lilly and Company. Leone, Alessandro .............................. Disclosed no confl ict of interest.Leone, Keri J. ....................................... Employee: Dexcom, Inc., Dexcom, Inc. (Spouse/Partner). Leonetti, Donna L. ............................... Disclosed no confl ict of interest.Leong, Aaron ....................................... Disclosed no confl ict of interest.Leow, Melvin K. .................................. Disclosed no confl ict of interest.Lernmark, Ake ..................................... Disclosed no confl ict of interest.LeRoith, Derek ..................................... Consultant: AstraZeneca Pharmaceuticals LP; Research

Support: Sanofi . Lertwattanarak, Raweewan .............. Disclosed no confl ict of interest.Leslie, R. David .................................... Disclosed no confl ict of interest.Leslie, Richard D. ................................ Disclosed no confl ict of interest.Lesniak, Wiktoria ................................ Disclosed no confl ict of interest.Lessmark, Anna ................................... Disclosed no confl ict of interest.Leto, Gaetano ...................................... Disclosed no confl ict of interest.Leucht, Thomas ................................... Disclosed no confl ict of interest.Leung, Genevieve ................................ Disclosed no confl ict of interest.Leung, Katherine ................................. Disclosed no confl ict of interest.Leung, Man Yee (Mallory) .................. Disclosed no confl ict of interest.Leung, Po Sing ..................................... Research Support: Boehringer Ingelheim Pharmaceuticals,

Inc. (Spouse/Partner). Leung, Sharon ..................................... Disclosed no confl ict of interest.Leung, Sherman .................................. Disclosed no confl ict of interest.Leutner, Michael ................................. Disclosed no confl ict of interest.Lev, Vered ............................................ Disclosed no confl ict of interest.Levi, Moshe ......................................... Disclosed no confl ict of interest.Levin, Philip ......................................... Consultant: AstraZeneca Pharmaceuticals LP, Sanofi U.S.;

Employee: Johns Hopkins School of Medicine. Levine, Hagai ....................................... Disclosed no confl ict of interest.Levister, Camilla .................................. Disclosed no confl ict of interest.Levitsky, Josh ...................................... Disclosed no confl ict of interest.Levkoff, Sue E. ..................................... Disclosed no confl ict of interest.Levy, Carol ........................................... Consultant: Janssen Pharmaceutical Companies of Johnson

& Johnson; Research Support: Novo Nordisk Inc., Roche Diagnostics.

Levy, Emile ........................................... Disclosed no confl ict of interest.Levy, Jonathan .................................... Disclosed no confl ict of interest.Levy, Sharon ........................................ Disclosed no confl ict of interest.Lewin, Andrew .................................... Disclosed no confl ict of interest.Lewis, Basil S. ..................................... Advisory Panel: Amgen Inc., AstraZeneca Pharmaceuticals

LP, Bristol-Myers Squibb Company, Merck Sharp & Dohme, Pfi zer Inc.; Research Support: AstraZeneca Pharmaceuticals LP; Speaker’s Bureau: Pfi zer Inc.

Lewis, Carrie R. ................................... Disclosed no confl ict of interest.Lewis, Cathryn M. ............................... Research Support: National Institute for Health Research

Biomedical Research Centre for Mental Health. Lewis, Dana M. ................................... Disclosed no confl ict of interest.Lewis, Dorothy .................................... Disclosed no confl ict of interest.Lewis, Gary F. ...................................... Disclosed no confl ict of interest.Lewis, Hannah B. ................................ Disclosed no confl ict of interest.Lewis, Jason ....................................... Employee: Dexcom, Inc. Ley, Sylvia H. ....................................... Disclosed no confl ict of interest.Leya, Marysa ....................................... Disclosed no confl ict of interest.Lezama, Vanessa ................................ Disclosed no confl ict of interest.Lezama, William .................................. Disclosed no confl ict of interest.Li, Changhong ...................................... Disclosed no confl ict of interest.Li, Chenghai ......................................... Disclosed no confl ict of interest.Li, Chenghui ......................................... Consultant: AstraZeneca Pharmaceuticals LP. Li, Chun-Jun ......................................... Disclosed no confl ict of interest.Li, Chunlin ............................................ Disclosed no confl ict of interest.Li, Danshi ............................................. Employee: Bristol-Myers Squibb. Li, Dongmei .......................................... Disclosed no confl ict of interest.Li, Elizabeth ......................................... Disclosed no confl ict of interest.Li, Feng ................................................. Disclosed no confl ict of interest.Li, Fengfei ............................................ Disclosed no confl ict of interest.Li, Guangwei ........................................ Disclosed no confl ict of interest.Li, Guilin ............................................... Disclosed no confl ict of interest.Li, GuoDong ......................................... Disclosed no confl ict of interest.Li, Hai ................................................... Disclosed no confl ict of interest.Li, Hechao ............................................ Disclosed no confl ict of interest.Li, Hong ................................................ Disclosed no confl ict of interest.Li, Hongwei .......................................... Disclosed no confl ict of interest.Li, Hui ................................................... Disclosed no confl ict of interest.Li, Huimin ............................................. Consultant: Takeda Pharmaceutical Company Limited. Li, Jialun .............................................. Disclosed no confl ict of interest.Li, Jibin ................................................. Disclosed no confl ict of interest.Li, Jinnan ............................................. Disclosed no confl ict of interest.Li, Jun ................................................... Disclosed no confl ict of interest.Li, Li ...................................................... Employee: Novo Nordisk A/S. Li, Liming .............................................. Disclosed no confl ict of interest.Li, Ling .................................................. Disclosed no confl ict of interest.Li, Lixin ................................................. Disclosed no confl ict of interest.

A856

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Li, Lucy ................................................. Disclosed no confl ict of interest.Li, Man ................................................. Disclosed no confl ict of interest.Li, Manna ............................................. Disclosed no confl ict of interest.Li, Meng ............................................... Disclosed no confl ict of interest.Li, Mengyao ......................................... Disclosed no confl ict of interest.Li, Mindian ........................................... Disclosed no confl ict of interest.Li, Ming ................................................ Employee: Biodel Inc. Li, Miranda .......................................... Disclosed no confl ict of interest.Li, Na .................................................... Disclosed no confl ict of interest.Li, Nina X. ............................................ Employee: Merck & Co., Inc. Li, Peng ................................................ Disclosed no confl ict of interest.Li, Peng Qiu .......................................... Disclosed no confl ict of interest.Li, Pengfei ............................................ Employee: Lilly Suzhou Pharmaceutical Co. Ltd. Li, Ping .................................................. Disclosed no confl ict of interest.Li, Qian ................................................. Employee: Evidera; Research Support: Eli Lilly and Company. Li, Qifu .................................................. Research Support: Becton, Dickinson and Company. Li, Renyuan .......................................... Disclosed no confl ict of interest.Li, Rong ................................................ Disclosed no confl ict of interest.Li, Rui ................................................... Disclosed no confl ict of interest.Li, Shanshan ........................................ Disclosed no confl ict of interest.Li, Stephen Yu Ting ............................. Research Support: Boehringer Ingelheim Pharmaceuticals,

Inc. (Spouse/Partner). Li, Suping ............................................. Disclosed no confl ict of interest.Li, Ting ................................................. Disclosed no confl ict of interest.Li, Wan-Chun ....................................... Disclosed no confl ict of interest.Li, Xiakoun ........................................... Disclosed no confl ict of interest.Li, Xiaochen ......................................... Disclosed no confl ict of interest.Li, Xiaofeng .......................................... Disclosed no confl ict of interest.Li, Xiaomu ............................................ Disclosed no confl ict of interest.Li, Xiao Ying ......................................... Disclosed no confl ict of interest.Li, Xilong .............................................. Disclosed no confl ict of interest.Li, Xinlong ............................................ Disclosed no confl ict of interest.Li, Xuanyi ............................................. Disclosed no confl ict of interest.Li, Xuefeng ........................................... Disclosed no confl ict of interest.Li, XueNing .......................................... Disclosed no confl ict of interest.Li, Yan ................................................... Disclosed no confl ict of interest.Li, Yanbing ........................................... Disclosed no confl ict of interest.Li, Yan Feng ......................................... Disclosed no confl ict of interest.Li, Yang ................................................ Employee: VeroScience, LLC. Li, Yanjie .............................................. Disclosed no confl ict of interest.Li, Yanping ........................................... Disclosed no confl ict of interest.Li, Yiming ............................................. Disclosed no confl ict of interest.Li, Yong Guo ......................................... Disclosed no confl ict of interest.Li, Yong-Xi ............................................ Employee: Medpace, Inc. Li, Yu ..................................................... Disclosed no confl ict of interest.Li, Yufeng ............................................. Disclosed no confl ict of interest.Li, Zhaoqing ......................................... Disclosed no confl ict of interest.Li, Zhiyi ................................................. Consultant: Asclepius Analytics. Li, Zhonggang ...................................... Disclosed no confl ict of interest.Li, Zhuo ................................................ Disclosed no confl ict of interest.Lian, Yun .............................................. Disclosed no confl ict of interest.Liang, Dan ............................................ Disclosed no confl ict of interest.Liang, Guang ........................................ Disclosed no confl ict of interest.Liang, Hanyu ........................................ Disclosed no confl ict of interest.Liang, Hua ............................................ Disclosed no confl ict of interest.Liang, Kae-Woei .................................. Disclosed no confl ict of interest.Liang, Liang ......................................... Disclosed no confl ict of interest.Liang, Qiangrong ................................. Disclosed no confl ict of interest.Liang, Shangdong ............................... Disclosed no confl ict of interest.Liang, Shangyan .................................. Disclosed no confl ict of interest.Liang, Sitai ........................................... Disclosed no confl ict of interest.Liang, Xiangyan ................................... Disclosed no confl ict of interest.Liang, Yali ............................................ Employee: Pfi zer Inc. Liang, Yin ............................................. Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson; Stock/Shareholder: Johnson & Johnson. Liang, Yinan ......................................... Disclosed no confl ict of interest.Liang, Yuanjie ...................................... Employee: Novo Nordisk Inc. Liao, Aurora ......................................... Employee: GI Dynamics, Inc. Liao, Jane ............................................ Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &

Co., Inc. Liao, Jianchun ..................................... Disclosed no confl ict of interest.Liao, Laura ........................................... Employee: Sanofi . Liao, Qinyuan ....................................... Disclosed no confl ict of interest.Liberti, Lauren ..................................... Disclosed no confl ict of interest.Libertini, Emmanuele .......................... Disclosed no confl ict of interest.Libianto, Renata .................................. Disclosed no confl ict of interest.Libman De Gordon, Ingrid ................... Disclosed no confl ict of interest.Libman, Ingrid M. ................................ Disclosed no confl ict of interest.Licker, Monica ..................................... Disclosed no confl ict of interest.Lickert, Heiko ...................................... Disclosed no confl ict of interest.Lieberman, Nicky ................................ Disclosed no confl ict of interest.Lier, Doug ............................................. Disclosed no confl ict of interest.

Liese, Angela D. .................................. Disclosed no confl ict of interest.Lieu, Christopher A. ............................ Disclosed no confl ict of interest.Liew, Aaron ......................................... Disclosed no confl ict of interest.Liew, Chong Wee ................................ Disclosed no confl ict of interest.Liew, Hui Ling ...................................... Disclosed no confl ict of interest.Lifshitz, Lawrence ............................... Disclosed no confl ict of interest.Light, John ........................................... Disclosed no confl ict of interest.Lightell, Jr., Daniel .............................. Disclosed no confl ict of interest.Lightfoot, Yaima L. .............................. Disclosed no confl ict of interest.Ligthart, Symen ................................... Disclosed no confl ict of interest.Lilly, Leslie C. ....................................... Employee: CeQur SA. Lim, Chang Ki ....................................... Disclosed no confl ict of interest.Lim, Dong-Mee .................................... Disclosed no confl ict of interest.Lim, Gareth E. ...................................... Disclosed no confl ict of interest.Lim, Jason ........................................... Disclosed no confl ict of interest.Lim, Kyu ................................................ Disclosed no confl ict of interest.Lim, Noha ............................................. Disclosed no confl ict of interest.Lim, Phei C. .......................................... Speaker’s Bureau: Merck Sharp & Dohme, Novo Nordisk Inc. Lim, Shueh L. ....................................... Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Eli Lilly

and Company, Johnson & Johnson, Merck & Co., Inc., Merck Sharp & Dohme, Novartis Corporation, Novo Nordisk Inc., Sanofi Adventis.

Lim, Soo ............................................... Disclosed no confl ict of interest.Lim, Su Chi ........................................... Disclosed no confl ict of interest.Lim, Suan Tee ...................................... Disclosed no confl ict of interest.Lim, Tae-Seok ...................................... Disclosed no confl ict of interest.Lim, Yejee ............................................ Disclosed no confl ict of interest.Lim, Yen L. ............................................ Disclosed no confl ict of interest.Lima, Ines ............................................ Disclosed no confl ict of interest.Lima, Margarida .................................. Disclosed no confl ict of interest.Limback, Elizabeth .............................. Disclosed no confl ict of interest.Lin, Beisi .............................................. Disclosed no confl ict of interest.Lin, Calvin ............................................ Employee: Regeneron Pharmaceuticals, Inc. Lin, Cha Ting ........................................ Disclosed no confl ict of interest.Lin, Chih-Li ........................................... Disclosed no confl ict of interest.Lin, Chih-Yuan ...................................... Disclosed no confl ict of interest.Lin, Feng ............................................... Disclosed no confl ict of interest.Lin, Huimei ........................................... Disclosed no confl ict of interest.Lin, Jay ................................................. Consultant: AstraZeneca Pharmaceuticals LP; Employee:

Novosys Health. Lin, Jenny J. ........................................ Disclosed no confl ict of interest.Lin, Ji .................................................... Disclosed no confl ict of interest.Lin, Jou-Wei ........................................ Disclosed no confl ict of interest.Lin, Mu ................................................. Disclosed no confl ict of interest.Lin, Pao Hwa ........................................ Disclosed no confl ict of interest.Lin, Shih-Yi ........................................... Disclosed no confl ict of interest.Lin, Shuo .............................................. Disclosed no confl ict of interest.Lin, Yi ................................................... Disclosed no confl ict of interest.Lin, Yi-Chun ......................................... Disclosed no confl ict of interest.Lin, Yu-Ru ............................................. Disclosed no confl ict of interest.Lin, Zhenqiu ......................................... Disclosed no confl ict of interest.Linarelli, Leah E. .................................. Disclosed no confl ict of interest.Lind Jepsen, Sara ............................... Disclosed no confl ict of interest.Lind, Lars ............................................. Disclosed no confl ict of interest.Lindi, Virpi ............................................ Disclosed no confl ict of interest.Lindqvist, Andreas .............................. Disclosed no confl ict of interest.Lineswala, Jayana .............................. Employee: Eli Lilly and Company. Linetzky, Bruno .................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Ling, Charlotte ..................................... Disclosed no confl ict of interest.Ling, Haiyun ......................................... Employee: Gilead; Stock/Shareholder: Gilead. Ling, Yan .............................................. Disclosed no confl ict of interest.Ling, Ying ............................................. Disclosed no confl ict of interest.Lingineni, Ravi ..................................... Disclosed no confl ict of interest.Lingohr-Smith, Melissa ...................... Employee: Novosys Health. Lingvay, Ildiko ...................................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Novo

Nordisk A/S; Other Relationship: Publication Support: Sanofi ; Research Support: GI Dynamics, Inc., Merck & Co., Inc., Novo Nordisk A/S, Pfi zer Inc.

Linjawi, Sultan .................................... Advisory Panel: Novo Nordisk A/S, Novo Nordisk Australia; Speaker’s Bureau: Novo Nordisk A/S.

Linker, Nicholas J. ............................... Disclosed no confl ict of interest.Linnebjerg, Helle ................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Linnenkamp, Ute ................................. Disclosed no confl ict of interest.Lioutas, Vasileios-Arsenios ................ Disclosed no confl ict of interest.Lipovich, Leonard ................................ Disclosed no confl ict of interest.Lipscombe, Lorraine L. ........................ Disclosed no confl ict of interest.Lipska, Kasia J. ................................... Disclosed no confl ict of interest.Literati-Nagy, Botond ......................... Disclosed no confl ict of interest.Lithander, Fiona ................................... Disclosed no confl ict of interest.Little, Stuart ........................................ Disclosed no confl ict of interest.

A857

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Littler, Peter ......................................... Disclosed no confl ict of interest.Littlewood, Kerry ................................ Disclosed no confl ict of interest.Littorin, Bengt ..................................... Disclosed no confl ict of interest.Litty, Anitha ......................................... Disclosed no confl ict of interest.Litvinov, Sergey ................................... Disclosed no confl ict of interest.Litwak, Leon E. .................................... Advisory Panel: AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Novo Nordisk Inc., Roche USA, Sanofi U.S.; Board Member: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Sanofi U.S.; Consultant: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Sanofi U.S.; Research Support: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Sanofi U.S.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Sanofi U.S.

Liu, Chang ............................................ Disclosed no confl ict of interest.Liu, Chao .............................................. Disclosed no confl ict of interest.Liu, Chen .............................................. Disclosed no confl ict of interest.Liu, Chengyang .................................... Disclosed no confl ict of interest.Liu, Ching-Ti ......................................... Disclosed no confl ict of interest.Liu, Chunyan ........................................ Disclosed no confl ict of interest.Liu, Dacheng ........................................ Employee: Boehringer Ingelheim Pharmaceuticals, Inc. Liu, Dexi ............................................... Disclosed no confl ict of interest.Liu, Edwin ............................................ Disclosed no confl ict of interest.Liu, Fang ............................................... Disclosed no confl ict of interest.Liu, Feng ............................................... Disclosed no confl ict of interest.Liu, Haiyan ........................................... Disclosed no confl ict of interest.Liu, Han ................................................ Disclosed no confl ict of interest.Liu, Hongtao ........................................ Disclosed no confl ict of interest.Liu, Huikun ........................................... Disclosed no confl ict of interest.Liu, Jennifer Y. .................................... Disclosed no confl ict of interest.Liu, Jialing ........................................... Disclosed no confl ict of interest.Liu, Jianying ........................................ Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Liu, Jie .................................................. Disclosed no confl ict of interest.Liu, Juan .............................................. Disclosed no confl ict of interest.Liu, Jun ................................................. Disclosed no confl ict of interest.Liu, Junhao .......................................... Employee: Becton, Dickinson and Company. Liu, Junjun ........................................... Disclosed no confl ict of interest.Liu, Kiang ............................................. Disclosed no confl ict of interest.Liu, Lenna L. ......................................... Advisory Panel: American Diabetes Association Asian/

Pacifi c Islander Diabetes Action Council. Liu, Libin ............................................... Disclosed no confl ict of interest.Liu, Liegang ......................................... Disclosed no confl ict of interest.Liu, Liehua ............................................ Disclosed no confl ict of interest.Liu, Limei .............................................. Disclosed no confl ict of interest.Liu, Lizhen ............................................ Disclosed no confl ict of interest.Liu, Lu ................................................... Disclosed no confl ict of interest.Liu, Lulu ................................................ Disclosed no confl ict of interest.Liu, Meilian .......................................... Disclosed no confl ict of interest.Liu, MIn ................................................ Disclosed no confl ict of interest.Liu, Ming .............................................. Disclosed no confl ict of interest.Liu, Qin ................................................. Disclosed no confl ict of interest.Liu, Shan .............................................. Disclosed no confl ict of interest.Liu, Shanying ....................................... Disclosed no confl ict of interest.Liu, Shiwei ........................................... Disclosed no confl ict of interest.Liu, Shuqian ......................................... Disclosed no confl ict of interest.Liu, Sichen ........................................... Disclosed no confl ict of interest.Liu, Simin ............................................. Disclosed no confl ict of interest.Liu, Tiemin ........................................... Disclosed no confl ict of interest.Liu, Wei ................................................ Disclosed no confl ict of interest.Liu, Winnie Y. ....................................... Disclosed no confl ict of interest.Liu, Xiaoni ............................................ Employee: Bristol-Myers Squibb Company; Stock/

Shareholder: Bristol-Myers Squibb Company. Liu, Xinyu ............................................. Disclosed no confl ict of interest.Liu, Xiwen ............................................ Disclosed no confl ict of interest.Liu, Xueli .............................................. Disclosed no confl ict of interest.Liu, Yan ................................................ Disclosed no confl ict of interest.Liu, Yanjun ........................................... Disclosed no confl ict of interest.Liu, Yanmei .......................................... Disclosed no confl ict of interest.Liu, Yanyan .......................................... Disclosed no confl ict of interest.Liu, Yinan ............................................. Disclosed no confl ict of interest.Liu, Ying ............................................... Disclosed no confl ict of interest.Liu, Yongqiang ..................................... Employee: Crown Bioscience, Inc. Liu, Yu ................................................... Disclosed no confl ict of interest.Liu, Yunyun .......................................... Disclosed no confl ict of interest.Liu, Zejian ............................................ Disclosed no confl ict of interest.

Liu, Zhenqi ........................................... Disclosed no confl ict of interest.Liu, Zhongwei ...................................... Disclosed no confl ict of interest.Livingston, Edward ............................. Disclosed no confl ict of interest.Livolsi, Patrizia .................................... Disclosed no confl ict of interest.Livote, Elayne ...................................... Consultant: Novo Nordisk A/S. Ljubic, Spomenka ................................ Disclosed no confl ict of interest.Llanos, Paola ....................................... Disclosed no confl ict of interest.Llaurado Cabot, Gemma ..................... Disclosed no confl ict of interest.Lloyd, Andrew J. ................................. Consultant: Novo Nordisk A/S. Lo, Chi-Wen ......................................... Disclosed no confl ict of interest.Lo, Clement .......................................... Disclosed no confl ict of interest.Loba, Jerzy .......................................... Disclosed no confl ict of interest.Lobelo, Felipe ...................................... Disclosed no confl ict of interest.Lobo, Peter I. ....................................... Disclosed no confl ict of interest.Locke, Alicia D. .................................... Disclosed no confl ict of interest.Lockhart, Samuel ................................ Disclosed no confl ict of interest.Lockman, Ann ...................................... Disclosed no confl ict of interest.Loehn, Matthias .................................. Disclosed no confl ict of interest.Loeken, Mary R. .................................. Disclosed no confl ict of interest.Loekkegaard, Ellen .............................. Disclosed no confl ict of interest.Loerup, Lise ......................................... Disclosed no confl ict of interest.Logan, Douglas .................................... Employee: Medpace, Inc. Loghin, Corina ..................................... Employee: Community Hospital Anderson, IN (Spouse/

Partner), Eli Lilly and Company; Stock/Shareholder: Eli Lilly and Company.

Loh, Ellen ............................................. Disclosed no confl ict of interest.Loh, Margaret ...................................... Disclosed no confl ict of interest.Loh, Tze Ping ........................................ Disclosed no confl ict of interest.Lombardo, Fortunato .......................... Disclosed no confl ict of interest.Lomonaco, Romina .............................. Disclosed no confl ict of interest.Lonergan, Mike ................................... Disclosed no confl ict of interest.Long, Qi ................................................ Disclosed no confl ict of interest.Long, Sarah A. ..................................... Disclosed no confl ict of interest.Longmore, Danielle ............................. Disclosed no confl ict of interest.Longo, Frank M. ................................... Other Relationship: Founder of PharmatrophiX Company. Lonier, Jacqueline Y. ........................... Disclosed no confl ict of interest.Looker, Helen C. .................................. Disclosed no confl ict of interest.Loos, Ruth J. ........................................ Disclosed no confl ict of interest.Loper, Alice .......................................... Employee: GlaxoSmithKline. Lopes-Cendes, Iscia ............................ Disclosed no confl ict of interest.Lopes-Virella, Maria F. ........................ Disclosed no confl ict of interest.López, Carolina .................................... Disclosed no confl ict of interest.Lopez, Janice ....................................... Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Lopez, Kerri .......................................... Disclosed no confl ict of interest.López-Larrea, Carlos ........................... Disclosed no confl ict of interest.Lopez-Ocejo, Omar .............................. Disclosed no confl ict of interest.López-Roldán, Verónica Miriam ......... Disclosed no confl ict of interest.Lorenz, Martin ..................................... Employee: Sanofi ; Stock/Shareholder: Sanofi . Lorenzato, Christelle ........................... Employee: Sanofi ; Stock/Shareholder: Sanofi . Lorenzen, Johan M. ............................ Disclosed no confl ict of interest.Lorenzini, Françoise ............................ Disclosed no confl ict of interest.Lorenzo, Carlos .................................... Disclosed no confl ict of interest.Lortie, Meghan .................................... Disclosed no confl ict of interest.Losada Viñau, Fernando ..................... Disclosed no confl ict of interest.Lottenberg, Ana M. ............................ Disclosed no confl ict of interest.Lottenberg, Simão .............................. Disclosed no confl ict of interest.Lotufo, Paulo A. ................................... Disclosed no confl ict of interest.Lou, Xiaohua ........................................ Disclosed no confl ict of interest.Loubato, Marilia M. ............................ Disclosed no confl ict of interest.Louche, Katie ....................................... Disclosed no confl ict of interest.Loustalot, Fleetwood .......................... Disclosed no confl ict of interest.Lovblom, Leif E. ................................... Disclosed no confl ict of interest.Lovre, Dragana .................................... Disclosed no confl ict of interest.Low, Malcolm J. .................................. Disclosed no confl ict of interest.Low, Philip A. ....................................... Disclosed no confl ict of interest.Lowe, Lynn P. ....................................... Disclosed no confl ict of interest.Lowe, Rob ............................................ Disclosed no confl ict of interest.Lowe, William L. .................................. Disclosed no confl ict of interest.Lowe, Jr., William L. ........................... Disclosed no confl ict of interest.Loyd, Christine .................................... Disclosed no confl ict of interest.Loza Munarriz, Cesar A. ..................... Disclosed no confl ict of interest.Lozano-Ortega, Greta ......................... Disclosed no confl ict of interest.Lozano-Suárez, César ......................... Disclosed no confl ict of interest.Lu, Chieh Hsiang .................................. Disclosed no confl ict of interest.Lu, Christine ........................................ Disclosed no confl ict of interest.Lu, Di F. ................................................. Disclosed no confl ict of interest.Lu, Hua ................................................. Disclosed no confl ict of interest.Lu, Huijuan ........................................... Disclosed no confl ict of interest.Lu, Huiyan ............................................ Disclosed no confl ict of interest.Lu, Juming ........................................... Disclosed no confl ict of interest.Lu, Junxi .............................................. Disclosed no confl ict of interest.

A858

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Lu, Min ................................................. Employee: Merck & Co., Inc. Lu, Ning ................................................ Disclosed no confl ict of interest.Lu, Ran ................................................. Disclosed no confl ict of interest.Lu, Simin .............................................. Disclosed no confl ict of interest.Lu, Sumei ............................................. Disclosed no confl ict of interest.Lu, Ting ................................................ Disclosed no confl ict of interest.Lu, Zhiqiang ......................................... Disclosed no confl ict of interest.Luan, Luan ........................................... Employee: Becton, Dickinson and Company. Luba, Magdalena ................................ Disclosed no confl ict of interest.Lubin, Susan ........................................ Employee: Bristol-Myers Squibb Company; Stock/

Shareholder: Bristol-Myers Squibb Company. Luca, Florina ........................................ Disclosed no confl ict of interest.Lucchesi, Daniela ................................ Disclosed no confl ict of interest.Lucchini, Fabrizio C. ............................ Disclosed no confl ict of interest.Luchs, Robert H. .................................. Disclosed no confl ict of interest.Lucidi, Paola ........................................ Disclosed no confl ict of interest.Lucisano, Giuseppe ............................. Disclosed no confl ict of interest.Lückemeyer, Kathrin ........................... Disclosed no confl ict of interest.Ludovico, Ornella ................................ Disclosed no confl ict of interest.Ludvigsen, Svend ................................ Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Ludvik, Anton E. .................................. Disclosed no confl ict of interest.Luft, Friedrich C. .................................. Disclosed no confl ict of interest.Lugar, Heather ..................................... Disclosed no confl ict of interest.Luippold, Gerd ..................................... Disclosed no confl ict of interest.Luiz, Henrique V. ................................. Disclosed no confl ict of interest.Luk, Andrea ......................................... Disclosed no confl ict of interest.Luk, Cynthia T. ..................................... Disclosed no confl ict of interest.Lum, Helen ........................................... Disclosed no confl ict of interest.Lumsden, Amanda L. ........................... Disclosed no confl ict of interest.Lunardi, Alessandro ............................ Disclosed no confl ict of interest.Lunati, Maria Elena ............................. Disclosed no confl ict of interest.Lund, Asger .......................................... Disclosed no confl ict of interest.Lund, Sigrun H. .................................... Employee: Risk Medical Solutions. Lund, Søren S. ..................................... Employee: Boehringer Ingelheim GmbH. Lundbom, Jan Olof Jesper ................. Disclosed no confl ict of interest.Lundbom, Jesper J. ............................. Disclosed no confl ict of interest.Lundbom, Nina .................................... Disclosed no confl ict of interest.Lundgren, Julie .................................... Disclosed no confl ict of interest.Lundh, Morten ..................................... Disclosed no confl ict of interest.Lunt, Helen .......................................... Speaker’s Bureau: Sanofi -Aventis New Zealand Ltd. Luo, Hai Dong ...................................... Disclosed no confl ict of interest.Luo, John ............................................. Disclosed no confl ict of interest.Luo, Junxiang ...................................... Employee: Eli Lilly and Company, Eli Lilly and Company

(Spouse/Partner); Stock/Shareholder: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner).

Luo, Lu Guang ...................................... Disclosed no confl ict of interest.Luo, Shuqin .......................................... Employee: VeroScience, LLC. Luo, Sihui ............................................. Disclosed no confl ict of interest.Luo, Ting .............................................. Disclosed no confl ict of interest.Luo, Xi .................................................. Disclosed no confl ict of interest.Luo, Yili ................................................ Disclosed no confl ict of interest.Luo, Yingying ....................................... Disclosed no confl ict of interest.Luo, Yuhuan ......................................... Disclosed no confl ict of interest.Luo, Yuqi .............................................. Disclosed no confl ict of interest.Luo, Zhong-Cheng ............................... Research Support: Canadian Institutes of Health Research,

National Science Foundation of China. Lupi, Roberto ....................................... Disclosed no confl ict of interest.Luque-Fernandez, Miguel-Angel ....... Disclosed no confl ict of interest.Lutes, Lesley ........................................ Disclosed no confl ict of interest.Lutfy, Kabir .......................................... Disclosed no confl ict of interest.Lutsey, Pamela .................................... Disclosed no confl ict of interest.Lutsky, Larry ........................................ Disclosed no confl ict of interest.Luttrell, Louis ...................................... Disclosed no confl ict of interest.Lutz, Céline .......................................... Disclosed no confl ict of interest.Lutz, Jens ............................................ Employee: Medizinische Klinik, Universitätsmedizin Mainz. Luzi, Livio ............................................. Advisory Panel: AstraZeneca/Bristol-Myers Squibb;

Consultant: McKinsey & Company; Speaker’s Bureau: Bristol-Myers Squibb Company, Menarini Group, Novo Nordisk Inc., Sanofi Pasteur SA.

Luzio, Stephen D. ................................ Disclosed no confl ict of interest.Lv, Dayu ................................................ Disclosed no confl ict of interest.Lv, Jing ................................................. Disclosed no confl ict of interest.Lv, Nan ................................................. Disclosed no confl ict of interest.Lv, Ying ................................................. Disclosed no confl ict of interest.Ly, Elizabeth ......................................... Disclosed no confl ict of interest.Ly, Trang T. ........................................... Research Support: Medtronic, Inc. Lybarger, Cindy .................................... Disclosed no confl ict of interest.Lydic, Todd ........................................... Disclosed no confl ict of interest.Lyles, Courtney .................................... Disclosed no confl ict of interest.Lyles, Shannon .................................... Disclosed no confl ict of interest.Lynch, Dustin O. .................................. Disclosed no confl ict of interest.

Lynch, Elizabeth B. .............................. Disclosed no confl ict of interest.Lynch, Kristian F. ................................. Disclosed no confl ict of interest.Lynch, Lydia ......................................... Disclosed no confl ict of interest.Lynes, Matthew .................................. Disclosed no confl ict of interest.Lynes, Maureen ................................... Disclosed no confl ict of interest.Lyon, Ellen ............................................ Disclosed no confl ict of interest.Lyons, Timthy J. .................................. Disclosed no confl ict of interest.Lysy, Philippe A. .................................. Disclosed no confl ict of interest.Lysy, Zoe .............................................. Disclosed no confl ict of interest.Lytvyn, Yuliya ...................................... Disclosed no confl ict of interest.Lyytikäinen, Leo-Pekka ....................... Disclosed no confl ict of interest.M.G., Joseraj ....................................... Disclosed no confl ict of interest.Ma, Danjun .......................................... Disclosed no confl ict of interest.Ma, Elizabeth ...................................... Disclosed no confl ict of interest.Ma, Hongfei ......................................... Disclosed no confl ict of interest.Ma, Huijuan ......................................... Disclosed no confl ict of interest.Ma, Huixuan ........................................ Disclosed no confl ict of interest.Ma, Jacey H. ....................................... Disclosed no confl ict of interest.Ma, Jianhua ........................................ Disclosed no confl ict of interest.Ma, Jiantao ......................................... Disclosed no confl ict of interest.Ma, Jian-Xing ...................................... Disclosed no confl ict of interest.Ma, Jun ................................................ Disclosed no confl ict of interest.Ma, Ke .................................................. Disclosed no confl ict of interest.Ma, Lijun .............................................. Disclosed no confl ict of interest.Ma, Lingzhi .......................................... Disclosed no confl ict of interest.Ma, Ronald C. ...................................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Janssen

Pharmaceutical Companies of Johnson & Johnson; Research Support: AstraZeneca Pharmaceuticals LP, Merck Sharp & Dohme.

Ma, Xiao W. ......................................... Disclosed no confl ict of interest.Ma, Xiaojing ........................................ Disclosed no confl ict of interest.Ma, Xiaoke .......................................... Disclosed no confl ict of interest.Ma, Yong .............................................. Disclosed no confl ict of interest.Ma, Zhimin ........................................... Disclosed no confl ict of interest.Maahs, David M. ................................. Board Member: Insulet Corporation; Other Relationship:

Dexcom, Inc., Medtronic, Inc. Mabrey, Melanie ................................. Advisory Panel: Sanofi U.S.; Employee: Glytec; Speaker’s

Bureau: Sanofi U.S. Mabundo, Lilian S. .............................. Disclosed no confl ict of interest.Maca, Jeff ........................................... Disclosed no confl ict of interest.Maccallini, Gustavo ............................ Disclosed no confl ict of interest.Maccarone, Marica ............................ Disclosed no confl ict of interest.MacDonald, Patrick ............................ Disclosed no confl ict of interest.Macdonald, Ruth ................................. Disclosed no confl ict of interest.MacDougald, Ormond A. .................... Disclosed no confl ict of interest.MacDougall, Margit ............................ Disclosed no confl ict of interest.Mace, Kenneth .................................... Employee: Eli Lilly and Company. MacEachern, Mark ............................. Disclosed no confl ict of interest.Macedo, Paula .................................... Disclosed no confl ict of interest.MacEwan, Joanna P. .......................... Consultant: AstraZeneca Pharmaceuticals LP. Machado, Remia ................................. Disclosed no confl ict of interest.Machann, Jürgen ................................ Disclosed no confl ict of interest.Machicao, Fausto ................................ Disclosed no confl ict of interest.Machida, Yui ........................................ Disclosed no confl ict of interest.Machnicki, Gerardo ............................ Employee: Novartis Argentina S.A. Macías-Pérez, Oliver .......................... Disclosed no confl ict of interest.Macielag, Mark ................................... Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. MacIsaac, Richard J. .......................... Advisory Panel: AstraZeneca Pharmaceuticals LP; Board

Member: AstraZeneca Pharmaceuticals LP; Other Relationship: Novo Nordisk A/S.

Mackillop, Lucy ................................... Disclosed no confl ict of interest.MacLachlan, Sharon ........................... Disclosed no confl ict of interest.MacLaren, Graeme ............................. Disclosed no confl ict of interest.MacLean, Catherine ........................... Consultant: Genentech, Inc. MacLeish, Sarah ................................. Disclosed no confl ict of interest.MacMaster, Heidemarie W. ............... Disclosed no confl ict of interest.MacMillan, Melinda H. ....................... Disclosed no confl ict of interest.MacNeil, Tara ...................................... Disclosed no confl ict of interest.Madani, Suliya .................................... Employee: Novo Nordisk A/S. Madar, Zecharia .................................. Disclosed no confl ict of interest.Maddaloni, Ernesto ............................ Disclosed no confl ict of interest.Madden, Brian W. ............................... Disclosed no confl ict of interest.Madden, Christopher .......................... Disclosed no confl ict of interest.Madden, Kenneth M. .......................... Disclosed no confl ict of interest.Madeira, Andreia ................................ Disclosed no confl ict of interest.Madej, Paweł ...................................... Disclosed no confl ict of interest.Mader, Julia K. .................................... Advisory Panel: Sanofi Pasteur SA; Consultant: BD Medical-

Diabetes Care; Speaker’s Bureau: Novo Nordisk A/S, Roche Diagnostics.

Madsbad, Sten .................................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-

A859

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Myers Squibb Company, Eli Lilly and Company, Intarcia Therapeutics, Inc., Johnson & Johnson, Merck Sharp & Dohme, Novartis AG, Novo Nordisk A/S, Sanofi U.S.; Research Support: Novo Nordisk A/S; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme, Novo Nordisk A/S, Sanofi U.S.

Madsen, Morten ................................. Disclosed no confl ict of interest.Madzio, Joanna ................................... Disclosed no confl ict of interest.Maeda, Hiromi .................................... Disclosed no confl ict of interest.Maeda, Manami .................................. Disclosed no confl ict of interest.Maeda, Shiro ....................................... Disclosed no confl ict of interest.Maeda, Yasutaka ................................ Other Relationship: American Diabetes Association. Maegawa, Hiroshi .............................. Research Support: Astellas Pharma, AstraZeneca,

Daiichi-Sankyo, Dainippon Sumitomo Pharma, Kowa Pharmaceutical, Mitsubishi Tanabe Pharma, MSD, NovoNordisk, Ono Pharmaceutical, Sunstar, Taisho Toyama Pharmaceutical, Takeda Pharmaceutical, Teijin Pharma; Speaker’s Bureau: Astellas Pharma, AstraZeneca, Boehringer Ingelheim, Kowa Pharmaceuticals, Mitsubishi Tanabe Pharma, MSD, Ono Pharmaceutical, Sanofi , Takeda Pharmaceutical.

Maekawa, Yoko ................................... Disclosed no confl ict of interest.Maezawa, Yoshiro .............................. Disclosed no confl ict of interest.Maffeis, Claudio ................................. Advisory Panel: Sanofi ; Research Support: Medtronic, Inc.,

Movi; Speaker’s Bureau: Roche. Maffi oli, Pamela .................................. Disclosed no confl ict of interest.Magaziner, Jay .................................... Disclosed no confl ict of interest.Magee, Conor ...................................... Disclosed no confl ict of interest.Magee, Michelle F. ............................. Board Member: ADA Mid-Atlantic Affi liate; Research

Support: ADA, Bayer HealthCare, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, PCORI, Sanofi U.S.; Speaker’s Bureau: ADA, PriMed, Sanofi U.S.

Maggs, David ...................................... Employee: GI Dynamics, Inc. Maghsoudlou, Panagiotis ................... Disclosed no confl ict of interest.Magi, Reedik ....................................... Disclosed no confl ict of interest.Magliano, Dianna J. ............................ Disclosed no confl ict of interest.Magnes, Christoph ............................. Disclosed no confl ict of interest.Magni, Lalo .......................................... Disclosed no confl ict of interest.Magyar, Kendra L. ............................... Other Relationship: Tandem Diabetes Care, Inc. Mahadevan, Jana ............................... Disclosed no confl ict of interest.Mahajan, Anubha ................................ Disclosed no confl ict of interest.Mahalingam, Devalingam .................. Disclosed no confl ict of interest.Mahaney, Michael C. .......................... Disclosed no confl ict of interest.Mahar, Saeed A. ................................. Disclosed no confl ict of interest.Mahesh, Doddabelavangala Mruthyunjaya ................................ Disclosed no confl ict of interest.Mahesh, Uma ...................................... Disclosed no confl ict of interest.Maheshwari, Anuj .............................. Disclosed no confl ict of interest.Mahesri, Mufaddal ............................. Disclosed no confl ict of interest.Mahmod, Hammoud ........................... Disclosed no confl ict of interest.Mahmood, Arshad .............................. Disclosed no confl ict of interest.Mahmoud, Abeer M. ........................... Disclosed no confl ict of interest.Mahon, Chantal ................................... Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &

Co., Inc. Mahon, Jeffery L. ............................... Disclosed no confl ict of interest.Mai, Yifeng .......................................... Disclosed no confl ict of interest.Mainardi-Novo, Dto ............................ Disclosed no confl ict of interest.Maione, Anna G. ................................. Disclosed no confl ict of interest.Majewski, Radoslaw .......................... Disclosed no confl ict of interest.Majidi, Shideh ..................................... Disclosed no confl ict of interest.Majima, Saori ...................................... Disclosed no confl ict of interest.Major, Melissa .................................... Disclosed no confl ict of interest.Majumdar, Devdoot ............................ Disclosed no confl ict of interest.Majumdar, Ishita D. ............................ Disclosed no confl ict of interest.Majumdar, Sachin K. ........................... Disclosed no confl ict of interest.Majumdar, Sumit R. ............................ Disclosed no confl ict of interest.Majumder, Anirban ............................. Disclosed no confl ict of interest.Majumder, Kaustav ............................. Disclosed no confl ict of interest.Makarechi, Leila .................................. Disclosed no confl ict of interest.Makaroff, Lydia E. ............................... Disclosed no confl ict of interest.Makdissi, Antoine ............................... Disclosed no confl ict of interest.Makedou, Kali ..................................... Disclosed no confl ict of interest.Maki, Toshinobu .................................. Disclosed no confl ict of interest.Makimura, Hiroaki .............................. Disclosed no confl ict of interest.Makino, Hideichi ................................. Disclosed no confl ict of interest.Makino, Hiroya .................................... Disclosed no confl ict of interest.Makino, Taketoshi ............................... Disclosed no confl ict of interest.Makrilakis, Konstantinos ................... Disclosed no confl ict of interest.Malabanan, Carlo ............................... Disclosed no confl ict of interest.Malani, Anup ....................................... Consultant: AstraZeneca Pharmaceuticals LP. Malatesta, JoAnn ............................... Employee: PhaseBio Pharmaceuticals, Inc.

Malcolm, Andrew ............................... Disclosed no confl ict of interest.Malecki, Maciej T. ............................... Disclosed no confl ict of interest.Malerbi, Fernando ............................... Disclosed no confl ict of interest.Malgor, Ramiro .................................... Disclosed no confl ict of interest.Malhotra, Atul ..................................... Disclosed no confl ict of interest.Malik, Faisal S. .................................... Disclosed no confl ict of interest.Malik, Hasan Z. ................................... Disclosed no confl ict of interest.Malik, Nehal ........................................ Disclosed no confl ict of interest.Malik, Rayaz ........................................ Disclosed no confl ict of interest.Malik, Rayaz A. ................................... Disclosed no confl ict of interest.Malik, Shaista ..................................... Disclosed no confl ict of interest.Malik, Vasanti S. ................................. Disclosed no confl ict of interest.Malin, Steven K. .................................. Disclosed no confl ict of interest.Malinska, Hana ................................... Disclosed no confl ict of interest.Maliszewska, Katarzyna .................... Disclosed no confl ict of interest.Malkani, Samir .................................... Disclosed no confl ict of interest.Mallad, Ashwini .................................. Disclosed no confl ict of interest.Mallisho, Abdullah .............................. Disclosed no confl ict of interest.Mallory, Jason M. ............................... Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline. Malmgren, Siri .................................... Disclosed no confl ict of interest.Maloney, Maura .................................. Disclosed no confl ict of interest.Mameli, Chiara .................................... Disclosed no confl ict of interest.Mammadova, Aytan S. ....................... Disclosed no confl ict of interest.Mammen, Jerry ................................... Disclosed no confl ict of interest.Mamtani, Manju ................................. Disclosed no confl ict of interest.Mamza, Jil ........................................... Disclosed no confl ict of interest.Manas, Derek ...................................... Disclosed no confl ict of interest.Mancha-Doblas, Isabel ...................... Disclosed no confl ict of interest.Mancini, Arturo ................................... Disclosed no confl ict of interest.Mancuso, Melissa S. .......................... Disclosed no confl ict of interest.Mancuso, Rubia .................................. Disclosed no confl ict of interest.Mandarino, Lawrence J. .................... Research Support: National Institute of Diabetes and

Digestive and Kidney Diseases. Manesh, Kalayil Manian .................... Employee: Acon Laboratories, Inc. Maney, Miriam .................................... Disclosed no confl ict of interest.Manfrini, Silvia .................................... Disclosed no confl ict of interest.Mangas Cruz, Miguel A. ..................... Disclosed no confl ict of interest.Mangia, Silvia ..................................... Disclosed no confl ict of interest.Mangin, Eric ........................................ Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &

Co., Inc. Mangione, Carol M. ............................ Disclosed no confl ict of interest.Mangleburg, Carl ................................ Employee: Prometheon Pharma, LLC. Mangrum, Christian ............................ Disclosed no confl ict of interest.Mangwiro, John C. ............................. Disclosed no confl ict of interest.Mani, Arya ........................................... Disclosed no confl ict of interest.Manita, Isabel ..................................... Disclosed no confl ict of interest.Manley, Susan E. ................................. Disclosed no confl ict of interest.Mann, Jim I. ......................................... Disclosed no confl ict of interest.Mann, Matthias .................................. Disclosed no confl ict of interest.Manning, Brendan D. .......................... Disclosed no confl ict of interest.Mannu, Carla ....................................... Disclosed no confl ict of interest.Mano, Mio ........................................... Disclosed no confl ict of interest.Manrique Hurtado, Helard A. ............. Disclosed no confl ict of interest.Manshad, Ahmad S. ........................... Disclosed no confl ict of interest.Manski-Nankervis, Jo-Anne E. .......... Other Relationship: Merck Sharp & Dohme, sanofi ; Research

Support: Roche Diagnostics, sanofi . Manson, JoAnn E. ............................... Disclosed no confl ict of interest.Mansoor, Saffar .................................. Disclosed no confl ict of interest.Mantovani, Alessandro ...................... Disclosed no confl ict of interest.Mantripragada, Sankaram ................. Employee: AntriaBio, Inc; Stock/Shareholder: AntriaBio, Inc. Manuylova, Ekaterina ......................... Disclosed no confl ict of interest.Manzar, Gohar S. ................................ Disclosed no confl ict of interest.Manzato, Enzo ..................................... Disclosed no confl ict of interest.Manzoli, Lamberto .............................. Disclosed no confl ict of interest.Manzoli, Vita ....................................... Disclosed no confl ict of interest.Manzoni, Giuseppina .......................... Disclosed no confl ict of interest.Mao, Yushan ........................................ Disclosed no confl ict of interest.MaoQing, Hu ....................................... Disclosed no confl ict of interest.Maple-Brown, Louise J. ..................... Other Relationship: AstraZeneca Pharmaceuticals LP, Novo

Nordisk Inc. Maravilla, Kenneth R. ......................... Disclosed no confl ict of interest.Marc, Linda G. ..................................... Disclosed no confl ict of interest.Marchand, Luc ..................................... Disclosed no confl ict of interest.Marchetti, Piero .................................. Disclosed no confl ict of interest.Marcinkevage, Jessica ....................... Disclosed no confl ict of interest.Marconvia, Santica M. ....................... Disclosed no confl ict of interest.Marcovecchio, Loredana .................... Disclosed no confl ict of interest.Marcuard, Stefan ................................ Disclosed no confl ict of interest.Marcus, Marsha D. ............................. Disclosed no confl ict of interest.Margaritidis, Charalampos ................ Disclosed no confl ict of interest.Margolis, Karen L. ............................... Disclosed no confl ict of interest.

A860

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Mari, Andrea ....................................... Disclosed no confl ict of interest.Maria García-Gala, Jose .................... Disclosed no confl ict of interest.Mariko, Hatta ...................................... Disclosed no confl ict of interest.Marin, Raffaella .................................. Disclosed no confl ict of interest.Marin, Rodrigo M. ............................... Disclosed no confl ict of interest.Marinelli Andreoli, Anna .................... Disclosed no confl ict of interest.Marion, Alan S. ................................... Disclosed no confl ict of interest.Mariotti, Luciana ................................ Disclosed no confl ict of interest.Maris, Michael .................................... Disclosed no confl ict of interest.Mark, Michael ..................................... Disclosed no confl ict of interest.Markan, Kathleen R. ........................... Disclosed no confl ict of interest.Markovic, Tania ................................... Disclosed no confl ict of interest.Markowitz, Jessica T. ........................ Disclosed no confl ict of interest.Marks-Shulman, Pam .......................... Disclosed no confl ict of interest.Marliss, Errol B. .................................. Disclosed no confl ict of interest.Marques-da-silva, Dorinda ................ Disclosed no confl ict of interest.Marquez, Farid .................................... Research Support: PhaseBio Pharmaceuticals, Inc. Marquis, Alison ................................... Research Support: Medtronic MiniMed, Inc. Marra, Camillo .................................... Disclosed no confl ict of interest.Marrano, Nicola .................................. Disclosed no confl ict of interest.Marre, Michel ..................................... Board Member: Abbott, Merck Sharp & Dohme, Novo

Nordisk A/S, Sanofi Pasteur SA, Servier; Research Support: Merck Sharp & Dohme, Novartis AG, Novo Nordisk A/S, Sanofi Pasteur SA, Servier; Speaker’s Bureau: Eli Lilly and Company, Novartis AG, Novo Nordisk A/S, Servier.

Marrero, David G. ............................... Disclosed no confl ict of interest.Marschke, Keith B. .............................. Employee: Ligand Pharmaceuticals, Inc. Marselli, Lorella .................................. Disclosed no confl ict of interest.Marshall, Amanda .............................. Consultant: Genentech, Inc. Marshall, Andrew ............................... Disclosed no confl ict of interest.Marshall, Bess .................................... Research Support: National Institutes of Health. Marshall, Janice M. ............................ Disclosed no confl ict of interest.Marshall, Sally M. ............................... Disclosed no confl ict of interest.Martí, Luc ............................................ Consultant: Genmedica Therapeutics S.L.; Stock/

Shareholder: Genmedica Therapeutics S.L. Martin, Alan A. .................................... Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline. Martin, Catherine L. ............................ Disclosed no confl ict of interest.Martin, Christopher ............................ Disclosed no confl ict of interest.Martin, Guy ......................................... Stock/Shareholder: Metabolys Inc. Martin, Pamela .................................... Disclosed no confl ict of interest.Martin, Praxedis S. ............................. Disclosed no confl ict of interest.Martin, Robert C. ................................ Disclosed no confl ict of interest.Martin, Sherry ..................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Martin, Stephan .................................. Consultant: Almased Wellness GmbH; Research Support:

Almased Wellness GmbH. Martin, Tonya ...................................... Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Martínez Brocca, Maria A. ................. Disclosed no confl ict of interest.Martínez Ortega, Antonio J. .............. Disclosed no confl ict of interest.Martinez Revuelta, Eva ...................... Disclosed no confl ict of interest.Martinez, Joe ...................................... Employee: Valeritas. Martinez, Luc ...................................... Board Member: Novo Nordisk A/S. Martinez, Mayra P. ............................. Disclosed no confl ict of interest.Martinez, Micaela .............................. Disclosed no confl ict of interest.Martinez, Rachael ............................... Disclosed no confl ict of interest.Martínez-Abundis, Esperanza ............ Disclosed no confl ict of interest.Martino, David .................................... Disclosed no confl ict of interest.Martino, Luisa ..................................... Disclosed no confl ict of interest.Martucci, Federico .............................. Disclosed no confl ict of interest.Martyn-Nemeth, Pamela ................... Disclosed no confl ict of interest.Marullo, Letizia ................................... Disclosed no confl ict of interest.Maruthur, Nisa M. .............................. Disclosed no confl ict of interest.Maruyama, Minoru ............................. Employee: Takeda Pharmaceutical Company Limited. Mascarenhas, Bruna M. ..................... Disclosed no confl ict of interest.Mascarenhas, Lorena V. ..................... Disclosed no confl ict of interest.Mascaro-Sanchez, Pedro A. ............... Disclosed no confl ict of interest.Maser, Raelene E. ............................... Disclosed no confl ict of interest.Mashall, Andrew ................................. Disclosed no confl ict of interest.Masharani, Umesh .............................. Disclosed no confl ict of interest.Mashek, Doug ..................................... Disclosed no confl ict of interest.Masiello, Pellegrino ............................ Disclosed no confl ict of interest.Masini, Matilde ................................... Disclosed no confl ict of interest.Maskari, Fatima A. .............................. Disclosed no confl ict of interest.Mason, R. Preston .............................. Research Support: Amarin Pharma, Inc. Mason, Robert .................................... Disclosed no confl ict of interest.Masone Iacobucci, Giovanna ............. Disclosed no confl ict of interest.Masood, Qamar ................................... Disclosed no confl ict of interest.Masoudpoor, Hassan .......................... Disclosed no confl ict of interest.Massaro, Elaine M. ............................. Disclosed no confl ict of interest.

Massaro, Joseph M. ........................... Research Support: Harvard Clinical Research Institute. Mastaitis, Jason ................................. Employee: Regeneron Pharmaceuticals, Inc. Mastroianno, Sandra .......................... Disclosed no confl ict of interest.Masubuchi, Yousuke ........................... Disclosed no confl ict of interest.Masuda, Daisaku ................................ Research Support: (Joint Research), Ono Pharmaceutical

Co., Ltd. Masuda, Izuru ...................................... Disclosed no confl ict of interest.Masuda, Katsuhisa ............................. Disclosed no confl ict of interest.Masuko, Reiko ..................................... Disclosed no confl ict of interest.Masuzaki, Hiroaki ............................... Disclosed no confl ict of interest.Matejko, Bartlomiej ............................ Disclosed no confl ict of interest.Mathai, Sarah ..................................... Disclosed no confl ict of interest.Mathe, Nonsi ...................................... Disclosed no confl ict of interest.Mather, Kieren J. ................................ Consultant: Boehringer Ingelheim GmbH; Research Support:

Abbott, Merck & Co., Inc., Novo Nordisk A/S, Sanofi U.S.

Matheson, Della ................................. Disclosed no confl ict of interest.Matheson, Don .................................... Board Member: Dose Safety Inc.; Employee: Dose Safety

Inc.; Stock/Shareholder: Dose Safety Inc. Mathew, Tim ....................................... Disclosed no confl ict of interest.Mathews, Clayton E. .......................... Disclosed no confl ict of interest.Mathews, Jiji E. .................................. Disclosed no confl ict of interest.Mathews, Tony ................................... Disclosed no confl ict of interest.Mathias, Susan ................................... Disclosed no confl ict of interest.Mathiesen, Elisabeth ......................... Speaker’s Bureau: Novo Nordisk Inc. Mathieu, Chantal ................................ Advisory Panel: AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, Johnson & Johnson, MannKind Corporation, Merck Sharp & Dohme, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi U.S.; Research Support: Eli Lilly and Company, Merck Sharp & Dohme, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi U.S.; Speaker’s Bureau: Eli Lilly and Company, Merck Sharp & Dohme, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Sanofi U.S.

Mathieu, Julia ..................................... Disclosed no confl ict of interest.Mathur, Gaurav ................................... Disclosed no confl ict of interest.Matilde, Masini ................................... Disclosed no confl ict of interest.Matimba, Alice .................................... Disclosed no confl ict of interest.Matoba, Reie ....................................... Disclosed no confl ict of interest.Matos, Alexandre ............................... Disclosed no confl ict of interest.Matos, Ana C. ..................................... Disclosed no confl ict of interest.Matoulek, Martin ................................ Disclosed no confl ict of interest.Matschinsky, Franz M. ....................... Disclosed no confl ict of interest.Matschke, Kyle .................................... Employee: Pfi zer Inc.; Stock/Shareholder: Pfi zer Inc. Matsen, Miles E. ................................. Disclosed no confl ict of interest.Matson, Mark ...................................... Research Support: PhaseBio Pharmaceuticals, Inc. Matsubara, Hajime ............................. Disclosed no confl ict of interest.Matsubara, Madoka ........................... Disclosed no confl ict of interest.Matsubara, Tatsuaki ........................... Disclosed no confl ict of interest.Matsuda, Masafumi ........................... Disclosed no confl ict of interest.Matsuda, Tomokazu ............................ Disclosed no confl ict of interest.Matsuhisa, Munehide ........................ Other Relationship: Sanofi , Advisor for EDITION JP studies;

Research Support: Astellas, Nikkiso, Tanabe-Mitsubishi, Terumo; Speaker’s Bureau: Novartis, Novo Nordisk, Sanofi .

Matsumoto, Motonobu ...................... Disclosed no confl ict of interest.Matsumoto, Toshio ............................. Disclosed no confl ict of interest.Matsumura, Mihoko ........................... Disclosed no confl ict of interest.Matsumura, Takeshi ........................... Disclosed no confl ict of interest.Matsunaga, Satoshi ........................... Disclosed no confl ict of interest.Matsunaga, Yasuka ............................ Disclosed no confl ict of interest.Matsuo, Yoshiyuki .............................. Disclosed no confl ict of interest.Matsuoka, Takaaki .............................. Research Support: Astellas Pharma Inc., AstraZeneca

Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Eli Lilly Japan K.K., Kissei Pharmaceutical Co., Ltd., Kowa Pharmaceuticals, Merck Sharp & Dohme, Mitsubishi Tanabe Pharma Corporation, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Ono Pharmaceutical Co., Ltd., Sanofi K.K., Shionogi Inc., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Astellas Pharma Inc., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly Japan K.K., Kissei Pharmaceutical Co., Ltd., Kowa Pharmaceuticals, Merck Sharp & Dohme, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Ono Pharmaceutical Co., Ltd., Sanofi K.K., Takeda Pharmaceutical Company Limited.

Matsushita, Kunihiro .......................... Disclosed no confl ict of interest.

A861

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Matsushita, Masayuki ....................... Disclosed no confl ict of interest.Matsuura, Bunzo ................................. Disclosed no confl ict of interest.Matsuyama, Rina ................................ Disclosed no confl ict of interest.Matsuyama, Yutaka ............................ Disclosed no confl ict of interest.Matsuzaki, Motoko ............................. Disclosed no confl ict of interest.Matsuzawa, Kazuhiko ........................ Disclosed no confl ict of interest.Matsuzawa, Yoko ............................... Disclosed no confl ict of interest.Mattern, Yvonne ................................. Disclosed no confl ict of interest.Matthaei, Stephan .............................. Advisory Panel: Abbott, AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim Pharmaceuticals, Inc., Merck & Co., Inc., MSD, Novo Nordisk Inc., Roche USA; Speaker’s Bureau: Abbott, AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Jassen-Cilag, MSD, Novo Nordisk Inc.

Mattheus, Michaela ........................... Employee: Boehringer Ingelheim GmbH. Matthews, David ................................ Advisory Panel: Novo Nordisk, GlaxoSmithKline, Novartis,

Eli Lilly, Sanofi Aventis, Janssen and Servier; Consultant: Novo Nordisk, GlaxoSmithKline, Novartis, Eli Lilly, Sanofi Aventis, Janssen and Servier; Research Support: Janssen and NIHR; Speaker’s Bureau: Novo Nordisk, Servier, Sanofi Aventis, Eli Lilly, Novartis, Janssen and Aché Laboratories.

Matthews, Jeffrey B. ......................... Disclosed no confl ict of interest.Matthews, Jessica E. ......................... Employee: GlaxoSmithKline. Matthews, Tucker J. ........................... Disclosed no confl ict of interest.Matulevicius, Valentinas .................... Disclosed no confl ict of interest.Matuleviciute, Indre ........................... Disclosed no confl ict of interest.Matulewicz, Natalia ........................... Disclosed no confl ict of interest.Maturu, Amita ..................................... Disclosed no confl ict of interest.Matveyenko, Aleksey ......................... Disclosed no confl ict of interest.Matysik, Silke ...................................... Disclosed no confl ict of interest.Matza, Louis S. .................................... Consultant: Eli Lilly and Company. Mauer, S. Michael ............................... Disclosed no confl ict of interest.Maura, Leandro ................................... Disclosed no confl ict of interest.Mauras, Nelly ...................................... Disclosed no confl ict of interest.Maurer, Patrik ..................................... Stock/Shareholder: Cytos Biotechnology AG. Mauricio, Didac ................................... Disclosed no confl ict of interest.Maurizi, Anna Rita .............................. Disclosed no confl ict of interest.Maurovich-Horvat, Pal ....................... Disclosed no confl ict of interest.Maury, Elisa ......................................... Disclosed no confl ict of interest.Mauseth, Richard ................................ Board Member: Dose Safety Inc.; Employee: Dose Safety

Inc.; Stock/Shareholder: Dose Safety Inc. Mauvais-Jarvis, Franck ...................... Research Support: Pfi zer Inc. Mavrodi, Afentoula ............................. Disclosed no confl ict of interest.Mavros, Panagiotis ............................. Employee: Merck Sharp & Dohme. Mawani, Minaz ................................... Disclosed no confl ict of interest.Maximos, Maryann ............................. Disclosed no confl ict of interest.May, Catherine L. ................................ Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. May, Marcus ....................................... Disclosed no confl ict of interest.May, Marlynn ...................................... Disclosed no confl ict of interest.May, Michael E. .................................. Disclosed no confl ict of interest.Mayaudon, Hervé ............................... Disclosed no confl ict of interest.Mayberry, Lindsay S. .......................... Disclosed no confl ict of interest.Mayer, Ken .......................................... Disclosed no confl ict of interest.Mayer-Davis, Elizabeth J. .................. Disclosed no confl ict of interest.Mayeux, Richard ................................. Disclosed no confl ict of interest.Maynard, John D. ............................... Consultant: VeraLight, Inc. Mayo, Kevin H. .................................... Disclosed no confl ict of interest.Mayo, Martha ..................................... Employee: Relypsa, Inc.; Stock/Shareholder: Relypsa, Inc. Mayoral, Eduardo ................................ Disclosed no confl ict of interest.Mayoux, Eric ........................................ Employee: Boehringer Ingelheim Pharmaceuticals, Inc. Mays, James A. .................................. Disclosed no confl ict of interest.Mazurina, Natalya V. .......................... Disclosed no confl ict of interest.Mazzanti, Francesca ........................... Disclosed no confl ict of interest.Mazze, Roger S. .................................. Consultant: Boehringer Ingelheim GmbH; Speaker’s Bureau:

Abbott Diabetes Care, Inc., Sanofi U.S. Mazzilli, Marila ................................... Disclosed no confl ict of interest.Mazzinghi, Benedetta ........................ Disclosed no confl ict of interest.McAdam-Marx, Carrie ....................... Advisory Panel: Sanofi -Aventis Deutschland GmbH;

Research Support: AstraZeneca Pharmaceuticals LP. McAndrew, Ann T. .............................. Disclosed no confl ict of interest.McAuley, Sybil A. ................................ Other Relationship: Merck Sharp & Dohme; Research

Support: Medtronic, Inc. McBride, Jeffrey D. ............................ Disclosed no confl ict of interest.McBurnie, Mary Ann .......................... Disclosed no confl ict of interest.McCall, Anthony L. .............................. Research Support: LifeScan, Inc. McCall, Kelly D. ................................... Disclosed no confl ict of interest.Mccallum, Richard .............................. Disclosed no confl ict of interest.McCann, Sheila ................................... Disclosed no confl ict of interest.McCarthy, Domenica .......................... Disclosed no confl ict of interest.McCarthy, Margaret M. ..................... Disclosed no confl ict of interest.

McCarthy, Mark I. ............................... Research Support: Pfizer, Novo Nordisk, Sanofi Aventis, Roche, Boehringer Ingelheim, Servier, Janssen & Lilly.

McCarthy, Rita M. ............................... Disclosed no confl ict of interest.McClain, Donald A. ............................. Speaker’s Bureau: Merck & Co., Inc. McClellan, Jamie ................................ Disclosed no confl ict of interest.McClintick, Jeanette N. ..................... Disclosed no confl ict of interest.McCommis, Kyle .................................. Disclosed no confl ict of interest.McConnell, Joseph P. ......................... Board Member: Health Diagnostics Laboratory, Inc.;

Employee: Health Diagnostics Laboratory, Inc. McCormack, Shana E. ......................... Disclosed no confl ict of interest.McCormick, Julie A. ........................... Disclosed no confl ict of interest.McCoy, Rozalina G. ............................. Disclosed no confl ict of interest.McCrady-Spitzer, Shelly ..................... Disclosed no confl ict of interest.McCrimmon, Rory J. ........................... Disclosed no confl ict of interest.McCrory, Mark A. ................................ Disclosed no confl ict of interest.McCulloch, Michael A. ....................... Disclosed no confl ict of interest.McDermott, John ................................ Disclosed no confl ict of interest.McDonald, Matthew W. ..................... Disclosed no confl ict of interest.McDonald, Timothy J. ........................ Disclosed no confl ict of interest.McDonald, William ............................. Employee: Metabolic Solutions Development Company,

LLC.; Stock/Shareholder: Metabolic Solutions Development Company, LLC.

McDonnell, Kevin ................................ Disclosed no confl ict of interest.McDonnell, Marie E. ........................... Disclosed no confl ict of interest.McDougal, David H. ............................ Disclosed no confl ict of interest.McDougall, Lindsay ............................ Disclosed no confl ict of interest.McDuffi e, Roberta .............................. Disclosed no confl ict of interest.McElfi sh, Pearl .................................... Disclosed no confl ict of interest.McElrath, Thomas F. ........................... Disclosed no confl ict of interest.McEwan, Philip C. ............................... Research Support: Bristol-Myers Squibb/AstraZeneca,

Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Takeda Pharmaceutical Company Limited.

McEwen, Laura N. .............................. Disclosed no confl ict of interest.McFann, Kim ........................................ Disclosed no confl ict of interest.McFarland, Raymie ............................. Employee: Glytec. McGee, James .................................... Employee: Eli Lilly and Company. Mcgee, Sean ....................................... Disclosed no confl ict of interest.McGill, Janet B. ................................... Disclosed no confl ict of interest.McGill, Margaret ................................. Advisory Panel: Janssen Pharmaceutical Companies of

Johnson & Johnson, Merck Sharp & Dohme; Speaker’s Bureau: Merck Sharp & Dohme, Novartis AG, Novo Nordisk A/S.

McGinty, James .................................. Disclosed no confl ict of interest.McGrath, Barbara C. ........................... Disclosed no confl ict of interest.McGraw, Timothy E. ........................... Disclosed no confl ict of interest.McGuigan, Karen ................................ Disclosed no confl ict of interest.McGuinness, Owen P. ......................... Disclosed no confl ict of interest.McGuire, Brian .................................... Disclosed no confl ict of interest.McGuire, Darren K. ............................. Consultant: Boehringer Ingelheim GmbH, Janssen

Pharmaceutical Companies of Johnson & Johnson, Novo Nordisk A/S, Regeneron Pharmaceuticals, Inc.; Research Support: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceutical Companies of Johnson & Johnson, Lexicon Pharmaceuticals, Inc., Merck & Co., Inc., Novo Nordisk A/S, Regeneron Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited.

McGuire, Helen C. ............................... Disclosed no confl ict of interest.McHargue, Cody ................................. Disclosed no confl ict of interest.McInnes, Natalia ................................ Other Relationship: Merck & Co., Inc. McIntyre, Harold D. ............................ Other Relationship: Novo Nordisk Inc.; Speaker’s Bureau:

Novo Nordisk Inc. McIntyre, John R. ............................... Disclosed no confl ict of interest.McIver, Kerry L. ................................... Disclosed no confl ict of interest.McKay, Siripoom V. ............................. Disclosed no confl ict of interest.McKeigue, Paul M. .............................. Other Relationship: Stakeholder in Pharmatics Ltd. McKeown, Nicola M. .......................... Disclosed no confl ict of interest.McKinney, T.D. .................................... Other Relationship: Eli Lilly and Company. McKnight, Amy J. ............................... Disclosed no confl ict of interest.McLean, Nellie .................................... Disclosed no confl ict of interest.McLennan, Sue ................................... Disclosed no confl ict of interest.McManus, Michael T. ......................... Disclosed no confl ict of interest.McManus, Ruth M. ............................. Speaker’s Bureau: Novo Nordisk Inc. McMillan, Shawna ............................. Disclosed no confl ict of interest.McMullen, William ............................. Research Support: Sanofi U.S. McNamara, James ............................. Disclosed no confl ict of interest.McNay, Ewan ...................................... Disclosed no confl ict of interest.McNeely, Andrew M. ......................... Disclosed no confl ict of interest.McNeill, Ann M. .................................. Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &

Co., Inc.

A862

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

McNeill, Annie .................................... Employee: Merck & Co., Inc.; Stock/Shareholder: Merck & Co., Inc.

McNeilly, Alison D. ............................. Disclosed no confl ict of interest.McPhail, Gary ...................................... Disclosed no confl ict of interest.McPherson, R.K. .................................. Disclosed no confl ict of interest.McPherson, Timothy ........................... Disclosed no confl ict of interest.McQuillan, Conor ................................ Disclosed no confl ict of interest.Mcquilling, John ................................. Disclosed no confl ict of interest.McWilliams, David .............................. Disclosed no confl ict of interest.Meadema-Mayer, Lynne .................... Disclosed no confl ict of interest.Meah, Farah ........................................ Disclosed no confl ict of interest.Mearns, Elizabeth S. ........................... Disclosed no confl ict of interest.Medin, Jennie ..................................... Employee: AstraZeneca. Medina, Jesús ..................................... Employee: AstraZeneca. Medina, Melany .................................. Disclosed no confl ict of interest.Mednick, Lauren ................................. Disclosed no confl ict of interest.Meegalla, Sanath ............................... Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Meehan, Rebecca J. ........................... Disclosed no confl ict of interest.Meek, Claire L. .................................... Disclosed no confl ict of interest.Meek, Shon ......................................... Disclosed no confl ict of interest.Meek, Thomas H. ................................ Disclosed no confl ict of interest.Meena, Babulal ................................... Disclosed no confl ict of interest.Megia Colet, Ana ................................ Disclosed no confl ict of interest.Mehrabi, Yadollah ............................... Disclosed no confl ict of interest.Mehran, Ladan .................................... Disclosed no confl ict of interest.Mehsen, Nadia .................................... Disclosed no confl ict of interest.Mehta, Akhil ........................................ Disclosed no confl ict of interest.Mehta, Cyrus R. .................................. Disclosed no confl ict of interest.Mehta, Deeksha .................................. Disclosed no confl ict of interest.Mehta, Raj ........................................... Disclosed no confl ict of interest.Mehta, Sanjeev N. .............................. Research Support: Sanofi U.S. Mehta, Sofi a ........................................ Disclosed no confl ict of interest.Mei, Hao .............................................. Disclosed no confl ict of interest.Meier, Alex .......................................... Disclosed no confl ict of interest.Meier, Bennett .................................... Disclosed no confl ict of interest.Meier, Daniel ....................................... Disclosed no confl ict of interest.Meier, Juris J. ..................................... Advisory Panel: AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme, Novo Nordisk A/S, Sanofi ; Research Support: Boehringer Ingelheim GmbH, Merck Sharp & Dohme, Novo Nordisk A/S, Sanofi ; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Berlin-Chemie AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, Hoffman-La Roche Limited, Merck Sharp & Dohme, Novartis AG, Novo Nordisk A/S, Sanofi .

Meiffren, Grégory ............................... Employee: Adocia; Stock/Shareholder: Adocia. Meigs, James B. ................................. Disclosed no confl ict of interest.Meijer, Rick I. ....................................... Disclosed no confl ict of interest.Meijnikman, Abraham ........................ Disclosed no confl ict of interest.Meikle, Peter J. ................................... Disclosed no confl ict of interest.Meimeti, Evangelia ............................. Disclosed no confl ict of interest.Meininger, Gary .................................. Employee: Janssen Research & Development LLC; Stock/

Shareholder: Johnson & Johnson. Meininger, Gerald A. ........................... Disclosed no confl ict of interest.Meinster, Elisa .................................... Disclosed no confl ict of interest.Meisinger, Christa .............................. Disclosed no confl ict of interest.Meisner, Søren .................................... Consultant: Boston Scientifi c Corporation, Coloplast

Denmark, Olympus Denmark, Olympus Europe. Meissner, Felix .................................... Disclosed no confl ict of interest.Meivar-Levy, Irit .................................. Disclosed no confl ict of interest.Mejia, Roberto .................................... Disclosed no confl ict of interest.Melhorn, Susan J. ............................... Disclosed no confl ict of interest.Melidonis, Andreas ............................. Disclosed no confl ict of interest.Melin, Jessika ..................................... Disclosed no confl ict of interest.Melish, John S. ................................... Disclosed no confl ict of interest.Melkus, Gail D. .................................... Disclosed no confl ict of interest.Mellander, Annika ............................... Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP. Mellett, Natalie A. .............................. Disclosed no confl ict of interest.Melling, C.W. James ........................... Disclosed no confl ict of interest.Melloul, Danielle ................................. Disclosed no confl ict of interest.Melton, Stephanie T. .......................... Disclosed no confl ict of interest.Melvin, Patrice .................................... Disclosed no confl ict of interest.Menart, Barbara ................................. Disclosed no confl ict of interest.Mende, Christian ................................ Speaker’s Bureau: AstraZeneca Pharmaceuticals LP. Mendes, Natália ................................. Disclosed no confl ict of interest.Méndez Pérez, Maria .......................... Disclosed no confl ict of interest.Méndez, Anna ..................................... Disclosed no confl ict of interest.Mendez, Armando ............................... Research Support: Berg Health.

Mendez, Jeannette ............................ Disclosed no confl ict of interest.Mendonca, Christine .......................... Disclosed no confl ict of interest.Mendoza, Jason A. ............................. Disclosed no confl ict of interest.Menduni, Marika ................................. Disclosed no confl ict of interest.Menegatti, Mirta ................................ Disclosed no confl ict of interest.Meneghini, Luigi F. .............................. Advisory Panel: Novo Nordisk, Sanofi ; Consultant: Novo

Nordisk, Sanofi . Meneilly, Graydon ............................... Disclosed no confl ict of interest.Meng, Ran ........................................... Disclosed no confl ict of interest.Meng, Shuhan ..................................... Disclosed no confl ict of interest.Meng, Xi .............................................. Disclosed no confl ict of interest.Meng, Zhaolin ..................................... Disclosed no confl ict of interest.Menge, Björn ....................................... Disclosed no confl ict of interest.Mengos, April ...................................... Disclosed no confl ict of interest.Menjivar, Marta .................................. Disclosed no confl ict of interest.Menke, Andy ....................................... Disclosed no confl ict of interest.Menne, Jan ......................................... Disclosed no confl ict of interest.Menon, Lata ........................................ Disclosed no confl ict of interest.Menon, Sarath .................................... Disclosed no confl ict of interest.Menon, Usha ....................................... Disclosed no confl ict of interest.Menon, Venu ....................................... Research Support: Takeda Pharmaceutical Company

Limited. Mensink, Ronald P. .............................. Disclosed no confl ict of interest.Mentzer, Shelly ................................... Disclosed no confl ict of interest.Menzaghi, Claudia .............................. Disclosed no confl ict of interest.Menzies, Robert A. ............................. Disclosed no confl ict of interest.Mercader, Josep M. ........................... Disclosed no confl ict of interest.Mercado, Carla I. ................................ Disclosed no confl ict of interest.Mercado-Morales, Martha ................ Disclosed no confl ict of interest.Merchant, Anwar T. ............................ Disclosed no confl ict of interest.Merchante, Agustín A. ....................... Disclosed no confl ict of interest.Mercorella, Belinda ............................ Disclosed no confl ict of interest.Merenstein, Daniel ............................. Disclosed no confl ict of interest.Merino-Trigo, Ana ............................... Employee: Sanofi . Merioud, Badreddine .......................... Disclosed no confl ict of interest.Merkely, Bela ...................................... Disclosed no confl ict of interest.Merlotti, Elena .................................... Disclosed no confl ict of interest.Merscher, Sandra ............................... Disclosed no confl ict of interest.Mertens, Ann ...................................... Disclosed no confl ict of interest.Mertens, Ilse ....................................... Disclosed no confl ict of interest.Meshulam, Tova .................................. Disclosed no confl ict of interest.Messazos, Betty P. .............................. Disclosed no confl ict of interest.Messer, Laurel .................................... Consultant: Medtronic MiniMed, Inc. Messier, Virginie ................................. Disclosed no confl ict of interest.Messinger-Rapport, Barbara ............. Disclosed no confl ict of interest.Messori, Mirko .................................... Disclosed no confl ict of interest.Mestre, Olga ....................................... Disclosed no confl ict of interest.Mete, Mihriye ..................................... Disclosed no confl ict of interest.Metzger, Boyd E. ................................. Disclosed no confl ict of interest.Metzger, Cheyenne ............................. Disclosed no confl ict of interest.Meulmann, Jéssica ............................. Disclosed no confl ict of interest.Mey, Jacob T. ...................................... Disclosed no confl ict of interest.Meyer, Christian .................................. Disclosed no confl ict of interest.Meyer, Laurent .................................... Disclosed no confl ict of interest.Meyramov, Gabit G. ............................ Disclosed no confl ict of interest.Meyrowitsch, Dan W. ......................... Disclosed no confl ict of interest.Mezza, Teresa ..................................... Disclosed no confl ict of interest.Miao, Dongmei .................................... Disclosed no confl ict of interest.Miao, Ji ................................................ Disclosed no confl ict of interest.Miao, Lining ......................................... Disclosed no confl ict of interest.Miarka, Przemysław ........................... Disclosed no confl ict of interest.Miccoli, Roberto .................................. Disclosed no confl ict of interest.Michael, M. Dodson ........................... Employee: Eli Lilly and Company, Eli Lilly and Company

(Spouse/Partner); Stock/Shareholder: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner).

Michaliszyn, Sara F. ............................ Disclosed no confl ict of interest.Michaud, Camille ................................ Disclosed no confl ict of interest.Micheletti, Thayana O. ....................... Disclosed no confl ict of interest.Michels, Aaron W. .............................. Disclosed no confl ict of interest.Michelson, Georg ................................ Disclosed no confl ict of interest.Michurina, Svetlana V. ....................... Disclosed no confl ict of interest.Miciek, Renee ..................................... Disclosed no confl ict of interest.Middelbeek, Roeland J. ...................... Disclosed no confl ict of interest.Miettinen, Pekka ................................. Disclosed no confl ict of interest.Migliorini, Adriana .............................. Disclosed no confl ict of interest.Mihailescu, Dan .................................. Disclosed no confl ict of interest.Mikamo, Hiroshige .............................. Disclosed no confl ict of interest.Mikeladze, Maia ................................. Disclosed no confl ict of interest.Miki, Takashi ....................................... Disclosed no confl ict of interest.Miki, Tetsuro ....................................... Disclosed no confl ict of interest.Mikkilä, Vera ....................................... Disclosed no confl ict of interest.Mikkola, Kirsi ...................................... Disclosed no confl ict of interest.

A863

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Milberg, William ................................. Disclosed no confl ict of interest.Milech, Adolpho .................................. Disclosed no confl ict of interest.Miles, John M. .................................... Research Support: National Institute of Diabetes and

Digestive and Kidney Diseases. Milewski, Robert ................................. Disclosed no confl ict of interest.Milicevic, Zvonko ................................ Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Miljkovic, Iva ....................................... Disclosed no confl ict of interest.Millan-Ferro, Andreina ....................... Disclosed no confl ict of interest.Millard, Ann V. ..................................... Disclosed no confl ict of interest.Miller, Carla K. .................................... Disclosed no confl ict of interest.Miller, David ........................................ Disclosed no confl ict of interest.Miller, Dawn ........................................ Disclosed no confl ict of interest.Miller, Diane ........................................ Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline. Miller, Donald R. ................................. Research Support: Smith & Nephew. Miller, Kate .......................................... Consultant: Novo Nordisk A/S. Miller, Kellee M. .................................. Disclosed no confl ict of interest.Miller, Michelle C. ............................... Disclosed no confl ict of interest.Miller, Nathaniel ................................. Disclosed no confl ict of interest.Miller, Rachel G. .................................. Disclosed no confl ict of interest.Miller, Russell ...................................... Disclosed no confl ict of interest.Miller, Samantha ................................ Board Member: Dance Biopharm; Consultant: Incarda

Inc., Pelagius Inc.; Employee: Dance Biopharm; Stock/Shareholder: Dance Biopharm.

Miller, Shahar ...................................... Disclosed no confl ict of interest.Milligan, Paul ....................................... Disclosed no confl ict of interest.Millings, Elizabeth J. .......................... Disclosed no confl ict of interest.Millis, Michael .................................... Disclosed no confl ict of interest.Millwood, Iona Y. ................................ Disclosed no confl ict of interest.Mima, Akira ......................................... Disclosed no confl ict of interest.Mimura, Masahiro .............................. Disclosed no confl ict of interest.Min, Fangyuan ..................................... Disclosed no confl ict of interest.Min, Se Hee ......................................... Disclosed no confl ict of interest.Min, So Yun ......................................... Disclosed no confl ict of interest.Min, Soo .............................................. Employee: Regeneron Pharmaceuticals, Inc. Min, Xi .................................................. Consultant: Boehringer Ingelheim GmbH. Minagawa, Takako .............................. Disclosed no confl ict of interest.Minami, Isao ........................................ Disclosed no confl ict of interest.Mine, Yusuke ....................................... Disclosed no confl ict of interest.Minervini, Gianmaria .......................... Employee: AstraZeneca Pharmaceuticals LP. Minges, Karl E. .................................... Disclosed no confl ict of interest.Minguez-Verdejo, Ramona ................. Disclosed no confl ict of interest.Minium, Judi ........................................ Disclosed no confl ict of interest.Minium, Judy ....................................... Disclosed no confl ict of interest.Mino, Akihisa ...................................... Disclosed no confl ict of interest.Minokoshi, Yasuhiko ........................... Disclosed no confl ict of interest.Minor, James M. ................................. Stock/Shareholder: MannKind Corporation. Minuto, Nicola .................................... Disclosed no confl ict of interest.Mir, Shakeel ........................................ Disclosed no confl ict of interest.Miranda Hurtado, Cesar J. ................. Disclosed no confl ict of interest.Miranda, Cesare ................................. Disclosed no confl ict of interest.Miranda, Danielle ............................... Disclosed no confl ict of interest.Miranda, Marcus ................................ Disclosed no confl ict of interest.Mirbolooki, Reza ................................. Disclosed no confl ict of interest.Miriel, Laura A. ................................... Disclosed no confl ict of interest.Mirkovic, Edvina .................................. Disclosed no confl ict of interest.Mirmira, Raghavendra G. ................... Research Support: Eli Lilly and Company. Miros, A. .............................................. Disclosed no confl ict of interest.Misaka, Ryoichi ................................... Disclosed no confl ict of interest.Mishima, Takashi ................................ Research Support: Asahi Kasei Pharm Corporation, Astellas

Pharma Inc, Daiichi Sankyo Co., Ltd, Mitsubisi Tanabe Pharma Corporation, Takeda Pharmaceutical Company Limited.

Mishina, Yuji ........................................ Disclosed no confl ict of interest.Mishra, Abhishek ................................ Employee: Novo Nordisk A/S. Mishra, Shardendu ............................. Employee: Freedom Meditech, Inc. Mishriky, Basem M. ............................ Disclosed no confl ict of interest.Miszczyszyn, Zofi a .............................. Disclosed no confl ict of interest.Mita, Tomoya ...................................... Research Support: Merck Sharp & Dohme, Takeda

Pharmaceutical Company Limited; Speaker’s Bureau: Eli Lilly Japan K.K., Kissei Pharmaceutical Co., Ltd., Kowa Pharmaceuticals, Merck Sharp & Dohme, Nippon Boehringer Ingelheim Co., Ltd., Ono Pharmaceutical Co., Ltd.

Mitani, Akio ......................................... Disclosed no confl ict of interest.Mitchell, Braxton ................................ Disclosed no confl ict of interest.Mitchell, Ryan K. ................................. Disclosed no confl ict of interest.Mithieux, Gilles ................................... Disclosed no confl ict of interest.Mitrofanova, Alla ................................ Disclosed no confl ict of interest.Mitrovich, Connor ............................... Disclosed no confl ict of interest.Mitsuishi, Sumie ................................. Disclosed no confl ict of interest.

Mittlboeck, Martina ........................... Disclosed no confl ict of interest.Miura, Katsuyuki ................................. Disclosed no confl ict of interest.Miura, Kyoko ....................................... Employee: Ajinomoto Group. Miura, Masaki ..................................... Disclosed no confl ict of interest.Miyabe, Megumi ................................. Disclosed no confl ict of interest.Miyagawa, Jun-ichiro ......................... Research Support: AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim GmbH, Daiichi-Sankyo Co., Ltd., Eli Lilly Japan K.K., Kowa Pharmaceuticals, Novartis Pharma GmbH, Ono Pharmaceutical Co., Ltd., Sanwa Kagaku Kenkyusho Co., Ltd.

Miyagawa, Toshiaki ............................ Disclosed no confl ict of interest.Miyagi, Masahiko ............................... Disclosed no confl ict of interest.Miyajima, Shin-ichi ............................. Disclosed no confl ict of interest.Miyake, Kana ....................................... Disclosed no confl ict of interest.Miyake, Masato .................................. Disclosed no confl ict of interest.Miyake, Teruki ..................................... Disclosed no confl ict of interest.Miyamoto, Chinobu ............................. Disclosed no confl ict of interest.Miyamoto, Licht .................................. Disclosed no confl ict of interest.Miyamoto, Robin ................................. Disclosed no confl ict of interest.Miyamura, Keitaro .............................. Disclosed no confl ict of interest.Miyaoka, Tomoko ................................ Disclosed no confl ict of interest.Miyashita, Shizuka ............................. Disclosed no confl ict of interest.Miyashita, Yasushi ............................. Disclosed no confl ict of interest.Miyata, Toshio ..................................... Disclosed no confl ict of interest.Miyatsuka, Takeshi ............................. Research Support: Astellas Pharma US, Inc., AstraZeneca

Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Daiichi-Sankyo Co., Ltd., Eli Lilly and Company, Johnson & Johnson, Kissei Pharmaceutical Co., Ltd., Kyowa Hakko Kirin Company,Ltd., Mitsubishi Tanabe Pharma Corporation, MSD, Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Ono Pharmaceutical Co., Ltd., Sanofi , Sumimoto Dainippon Pharma Co., Ltd., Taisho Toyama Pharmaceutical. Company, Ltd, Takeda Pharmaceutical Company Limited, Teijin Pharma; Speaker’s Bureau: Astellas Pharma US, Inc., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Eli Lilly and Company, Kissei Pharmaceutical Co., Ltd., Kowa Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation, MSD, Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Ono Pharmaceutical Co., Ltd., Sanofi U.S., Takeda Pharmaceutical Company Limited.

Miyazawa, Ken .................................... Disclosed no confl ict of interest.Mizgier, Maria L. ................................. Disclosed no confl ict of interest.Mizukami, Hiroki ................................. Disclosed no confl ict of interest.Mizutani, Makoto ................................ Disclosed no confl ict of interest.Mkparu, Uzonna .................................. Disclosed no confl ict of interest.Mlynarski, Wojciech ........................... Disclosed no confl ict of interest.Mo, Daojun .......................................... Employee: Eli Lilly and Company; Research Support: Eli Lilly

and Company; Stock/Shareholder: Eli Lilly and Company. Mobley, William .................................. Disclosed no confl ict of interest.Moeller Jensen, Dorte ....................... Advisory Panel: Novo Nordisk Inc. Moffa, Simona .................................... Disclosed no confl ict of interest.Moffet, Howard H. .............................. Disclosed no confl ict of interest.Moffett, Carol D. ................................. Disclosed no confl ict of interest.Mogami, Hideo .................................... Disclosed no confl ict of interest.Mogensen, Ulrik M. ............................ Disclosed no confl ict of interest.Mogos, Tiberius Viorel ....................... Disclosed no confl ict of interest.Mohagheghi Samarin, Azadeh .......... Disclosed no confl ict of interest.Mohamad, Marwa .............................. Disclosed no confl ict of interest.Mohamed Ali, Shahirah B. ................. Disclosed no confl ict of interest.Mohamed, Islam N. ............................ Disclosed no confl ict of interest.Mohammad, Raeesa A. ...................... Disclosed no confl ict of interest.Mohammedi, Kamel ............................ Disclosed no confl ict of interest.Mohan Anjana, Ranjit ......................... Disclosed no confl ict of interest.Mohan, Brij .......................................... Disclosed no confl ict of interest.Mohan, Viswanathan ......................... Disclosed no confl ict of interest.Mohanraj, Rajesh ................................ Disclosed no confl ict of interest.Moheet, Amir ...................................... Disclosed no confl ict of interest.Moin, Tannaz ....................................... Disclosed no confl ict of interest.Moinet, Gerard .................................... Stock/Shareholder: Metabolys Inc. Moisii, Liliana ...................................... Disclosed no confl ict of interest.Mok, Shao Feng .................................. Disclosed no confl ict of interest.Mokhrati, Tara ..................................... Disclosed no confl ict of interest.Molano, R. Damaris ............................ Disclosed no confl ict of interest.Molano, Ruth D. .................................. Disclosed no confl ict of interest.Molinari, Claudia ................................. Disclosed no confl ict of interest.Molina-Vega, María ............................ Disclosed no confl ict of interest.Molina-Wilkins, Marjorie L. ............... Disclosed no confl ict of interest.Molinski, Matthias ............................. Disclosed no confl ict of interest.

A864

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Molitch, Mark E. .................................. Consultant: Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck & Co., Inc., Novartis AG, Novo Nordisk A/S; Other Relationship: Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck & Co., Inc., Novartis AG, Novo Nordisk A/S; Research Support: Novartis AG, Novo Nordisk A/S.

Møller, Andreas B. .............................. Disclosed no confl ict of interest.Møller, Arne ........................................ Disclosed no confl ict of interest.Møller, Niels ........................................ Disclosed no confl ict of interest.Möller-Horigome, Akiko ..................... Disclosed no confl ict of interest.Mollet, Inês G. ..................................... Disclosed no confl ict of interest.Molnar, Clemens ................................. Disclosed no confl ict of interest.Molnes, Anders ................................... Disclosed no confl ict of interest.Molnes, Janne .................................... Disclosed no confl ict of interest.Molven, Anders ................................... Disclosed no confl ict of interest.Molyneaux, Lynda ............................... Disclosed no confl ict of interest.Monaghan, Maureen .......................... Disclosed no confl ict of interest.Monaro, Marco ................................... Disclosed no confl ict of interest.Moncrief, Matthew ............................ Research Support: LifeScan, Inc. Monden, Tsuyoshi ............................... Disclosed no confl ict of interest.Monnier, Vincent M. ........................... Disclosed no confl ict of interest.Monsalvo, Maria Laura ...................... Employee: Amgen Inc. Monselesan, Sandra ........................... Disclosed no confl ict of interest.Montague, Julia A. ............................. Disclosed no confl ict of interest.Montalto, Giuseppe ............................ Disclosed no confl ict of interest.Montanucci, Pia .................................. Disclosed no confl ict of interest.Monteiro Carvalho Mori Cunha, Joao Paulo

Disclosed no confl ict of interest.Monteiro, Duarte ................................ Disclosed no confl ict of interest.Monteiro, Mariana P. .......................... Disclosed no confl ict of interest.Montesano, Anna ............................... Disclosed no confl ict of interest.Montori-Grau, Marta .......................... Disclosed no confl ict of interest.Montrose-Rafi zadeh, Chahrzad ......... Employee: Eli Lilly and Company. Monyak, John ...................................... Employee: AstraZeneca; Stock/Shareholder: AstraZeneca. Monzavi, Roshanak ............................. Research Support: Astellas Pharma US, Inc., Bayer

HealthCare, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases.

Moon, Byung-Sub ............................... Disclosed no confl ict of interest.Moon, Joon Ho .................................... Disclosed no confl ict of interest.Moon, Kyung-Mee .............................. Disclosed no confl ict of interest.Moon, Min Kyong ................................ Disclosed no confl ict of interest.Moon, Seong-Su ................................. Disclosed no confl ict of interest.Moon, Shinje ....................................... Disclosed no confl ict of interest.Moon, Sung Dae .................................. Disclosed no confl ict of interest.Mooney, David .................................... Disclosed no confl ict of interest.Moore, Courtney M. ........................... Disclosed no confl ict of interest.Moore, Daniel T. .................................. Disclosed no confl ict of interest.Moore, Kelly ........................................ Disclosed no confl ict of interest.Moore, Mary C. ................................... Disclosed no confl ict of interest.Moore, Wayne V. ................................ Research Support: Astellas Pharma US, Inc., Bayer

HealthCare, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases.

Moore-Simas, Tiffanny A. .................. Disclosed no confl ict of interest.Moosa, Mahmood ............................... Disclosed no confl ict of interest.Moraes, Ana C. ................................... Disclosed no confl ict of interest.Morais, Jose A. ................................... Disclosed no confl ict of interest.Morais, Tiago ...................................... Disclosed no confl ict of interest.Morales, Victor ................................... Disclosed no confl ict of interest.Morales, Ximena A. ............................ Disclosed no confl ict of interest.Moralez, Jesus .................................... Disclosed no confl ict of interest.Moran, Antoinette .............................. Disclosed no confl ict of interest.Moran, Jason ...................................... Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP. Moran, John ........................................ Disclosed no confl ict of interest.Moran, Margaret ................................ Disclosed no confl ict of interest.Mora-Navas, Laura ............................. Disclosed no confl ict of interest.Mordes, John P. ................................... Disclosed no confl ict of interest.Moreau, Cynthia ................................. Disclosed no confl ict of interest.Morehead, Rose .................................. Disclosed no confl ict of interest.Moreira, Ângela .................................. Disclosed no confl ict of interest.Morel, Didier R. ................................... Employee: Becton, Dickinson and Company. Morel, Yves ......................................... Disclosed no confl ict of interest.Morello, Candis ................................... Disclosed no confl ict of interest.Moreno Reina, Eduardo ...................... Disclosed no confl ict of interest.Moreno, Gerardo ................................. Disclosed no confl ict of interest.Moreno, Veronica ............................... Employee: Janssen Research & Development LLC. Moreno-Fernández, Jesús ................. Disclosed no confl ict of interest.

Morgado, Karina C. ............................. Disclosed no confl ict of interest.Morgan, Farah ..................................... Disclosed no confl ict of interest.Morgantini, Cecilia ............................. Disclosed no confl ict of interest.Mori, Akihiro ....................................... Disclosed no confl ict of interest.Mori, Hiroyasu ..................................... Disclosed no confl ict of interest.Mori, Ichiro .......................................... Disclosed no confl ict of interest.Mori, Katsuhito ................................... Disclosed no confl ict of interest.Mori, Keiichi ........................................ Disclosed no confl ict of interest.Mori, Maiko ......................................... Disclosed no confl ict of interest.Mori, Marcelo ..................................... Disclosed no confl ict of interest.Mori, Masaaki ..................................... Employee: Takeda Pharmaceutical Company Limited. Mori, Tomoko ...................................... Disclosed no confl ict of interest.Mori, Yukiko ........................................ Disclosed no confl ict of interest.Mori, Yusaku ....................................... Disclosed no confl ict of interest.Mori, Yutaka ........................................ Disclosed no confl ict of interest.Morigami, Hirokazu ............................ Disclosed no confl ict of interest.Morikawa, Shuntaro ........................... Disclosed no confl ict of interest.Morikawa, Yuka .................................. Disclosed no confl ict of interest.Morikawa, Yuko .................................. Disclosed no confl ict of interest.Morimoto, Takeshi .............................. Research Support: Bayer HealthCare; Speaker’s Bureau:

Kowa Pharmaceuticals, Pfi zer Inc. Morino, Katsutaro ............................... Disclosed no confl ict of interest.Morino, Takahiro ................................. Disclosed no confl ict of interest.Morioka, Tetsu .................................... Disclosed no confl ict of interest.Morioka, Tomoaki ............................... Research Support: Asahi Kasei Pharm Corporation, Astellas

Pharma Inc, Daiichi Sankyo Co., Ltd, Mitsubisi Tanabe Pharma Corporation, Takeda Pharmaceutical Company Limited.

Morisawa, Chieko ............................... Disclosed no confl ict of interest.Morita, Hiroshi .................................... Disclosed no confl ict of interest.Morita, Hiroyuki .................................. Disclosed no confl ict of interest.Morita, Kunikazu ................................. Disclosed no confl ict of interest.Moritz, Georgina ................................. Disclosed no confl ict of interest.Moriya, Tatsumi .................................. Disclosed no confl ict of interest.Moro, Cédric ........................................ Disclosed no confl ict of interest.Morris, Andrew P. ............................... Disclosed no confl ict of interest.Morris, Julie ........................................ Disclosed no confl ict of interest.Morris, Juliet ....................................... Disclosed no confl ict of interest.Morris, Margaret A. ............................ Disclosed no confl ict of interest.Morrisey, Robin ................................... Disclosed no confl ict of interest.Morrison, Alanna C. ............................ Disclosed no confl ict of interest.Morrison, Christopher D. .................... Disclosed no confl ict of interest.Morrison, Shaun ................................. Disclosed no confl ict of interest.Morrison, Steven ................................ Disclosed no confl ict of interest.Morrison, Vicky ................................... Disclosed no confl ict of interest.Morrow, Connie .................................. Disclosed no confl ict of interest.Morrow, Linda ..................................... Employee: Eli Lilly and Company (Spouse/Partner), Profi l

Institute for Clinical Research, Inc.; Stock/Shareholder: Profi l Institute for Clinical Research, Inc.

Morsch, Marco .................................... Disclosed no confl ict of interest.Morse, Mallory ................................... Disclosed no confl ict of interest.Morsi, Amr ........................................... Disclosed no confl ict of interest.Mortensen, Brynjulf ............................ Disclosed no confl ict of interest.Morton, Gregory J. ............................. Disclosed no confl ict of interest.Morton, John ....................................... Disclosed no confl ict of interest.Morton-Eggleston, Emma B. .............. Disclosed no confl ict of interest.Moschen, Alexander M. ..................... Disclosed no confl ict of interest.Mosely, Kylie ....................................... Disclosed no confl ict of interest.Mosenzon, Ofri .................................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Eli Lilly

and Company, Novartis Corporation, Novo Nordisk Inc., Sanofi U.S.; Research Support: AstraZeneca/Bristol-Myers Squibb, Novo Nordisk Inc.; Speaker’s Bureau: AstraZeneca/Bristol-Myers Squibb, Eli Lilly and Company, MDS, Inc., Novo Nordisk Inc., Novo Nordisk Inc., Sanofi U.S.

Mossakowska, Małgorzata ............... Disclosed no confl ict of interest.Mossavar-Rahmani, Yasmin .............. Disclosed no confl ict of interest.Mossio, Elena ...................................... Disclosed no confl ict of interest.Mossuto, Sandra ................................. Disclosed no confl ict of interest.Mostoller, Kate ................................... Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &

Co., Inc. Motiani, Kumail K. .............................. Disclosed no confl ict of interest.Motiani, Piryanka ................................ Disclosed no confl ict of interest.Motoshima, Hiroyuki .......................... Disclosed no confl ict of interest.Motoyama, Koka ................................. Research Support: Asahi Kasei Pharm Corporation, Astellas

Pharma Inc, Daiichi Sankyo Co., Ltd, Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Company Limited.

Motsinger, Alison ................................ Consultant: Metabolon, Inc. Mottalib, Adham ................................. Research Support: Metagenics, Inc. Motta-Montoya, Vicky ....................... Disclosed no confl ict of interest.Mottini, Giovanni ................................ Disclosed no confl ict of interest.

A865

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Mottola, Michelle ............................... Disclosed no confl ict of interest.Mou, Jiani ............................................ Employee: Eli Lilly and Company. Mould, Diane R. ................................... Consultant: Biodel Inc. Moullé, Valentine ................................ Disclosed no confl ict of interest.Mountokalakis, Theodore .................. Disclosed no confl ict of interest.Moura, João ........................................ Disclosed no confl ict of interest.Moura, Liane ....................................... Disclosed no confl ict of interest.Mourad, Mirella .................................. Disclosed no confl ict of interest.Moutsianas, Loukas ............................ Disclosed no confl ict of interest.Movassat, Jamileh ............................. Disclosed no confl ict of interest.Moya, Benito ....................................... Disclosed no confl ict of interest.Moya, Rosa .......................................... Disclosed no confl ict of interest.Moyers, Julie S. .................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company, Eli Lilly and Company (Spouse/Partner). Moysén-Chimal, Alejandra ................ Disclosed no confl ict of interest.Mraz, Milos ......................................... Disclosed no confl ict of interest.Msengi, Eliwaza .................................. Disclosed no confl ict of interest.Mu, James ........................................... Employee: Merck Sharp & Dohme. Mu, Panwei ......................................... Disclosed no confl ict of interest.Mu, Yiming .......................................... Board Member: Novo Nordisk; Employee: Chinese PLA

General Hospital; Speaker’s Bureau: Novo Nordisk. Much, Kristen L. .................................. Disclosed no confl ict of interest.Mudaliar, Sunder ................................. Consultant: AstraZeneca Pharmaceuticals LP; Speaker’s

Bureau: AstraZeneca Pharmaceuticals LP, Takeda Pharmaceuticals U.S.A., Inc.

Mudaliar, Uma ..................................... Disclosed no confl ict of interest.Muehlbauer, Michael ......................... Disclosed no confl ict of interest.Mueller, Angelika ................................ Employee: Roche Diagnostics. Mueller, Philipp ................................... Stock/Shareholder: Cytos Biotechnology AG. Mueller-Korbsch, Michael .................. Disclosed no confl ict of interest.Muendlein, Axel .................................. Disclosed no confl ict of interest.Muessig, Karsten ................................ Disclosed no confl ict of interest.Muhamedagic, Cynthia A. .................. Disclosed no confl ict of interest.Muhammad, Ayesha ........................... Disclosed no confl ict of interest.Muir, Andrew B. .................................. Disclosed no confl ict of interest.Mukamal, Kenneth J. .......................... Disclosed no confl ict of interest.Mukerji, Geetha .................................. Disclosed no confl ict of interest.Mukherjee, Jayanti ............................. Employee: Bristol-Myers Squibb Company; Stock/

Shareholder: Bristol-Myers Squibb Company. Mulder, Hindrik .................................... Disclosed no confl ict of interest.Mull, Aaron J. ...................................... Disclosed no confl ict of interest.Muller, Dany ........................................ Disclosed no confl ict of interest.Muller, Ido ........................................... Disclosed no confl ict of interest.Müller, Werner .................................... Disclosed no confl ict of interest.Muller, Yunhua .................................... Disclosed no confl ict of interest.Mullie, Patrick ..................................... Disclosed no confl ict of interest.Mullins, Daniel .................................... Consultant: Bayer HealthCare, Bristol-Myers Squibb

Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Mundi Pharma, Pfi zer Inc.; Research Support: Bayer HealthCare, Novartis Pharmaceuticals Corporation, Pfi zer Inc.

Mullins, David ..................................... Disclosed no confl ict of interest.Mulvaney, Shelagh ............................. Disclosed no confl ict of interest.Muñoz-Garach, Araceli ....................... Disclosed no confl ict of interest.Munshi, Medha ................................... Research Support: Sanofi U.S. Muntner, Paul ...................................... Disclosed no confl ict of interest.Murabito, Joanne M. .......................... Disclosed no confl ict of interest.Muragundla, Anjaneyulu .................... Disclosed no confl ict of interest.Murakami, Kazutoshi .......................... Disclosed no confl ict of interest.Murakami, Masanori .......................... Disclosed no confl ict of interest.Muralidharan, Kavitha ........................ Disclosed no confl ict of interest.Muranaka, Kazuya .............................. Disclosed no confl ict of interest.Muraru, Sinziana ................................. Disclosed no confl ict of interest.Murawaki, Ayumi ................................ Disclosed no confl ict of interest.Murillo, Franco .................................... Disclosed no confl ict of interest.Murphy, Andrew J. ............................. Employee: Regeneron Pharmaceuticals, Inc. Murphy, Helen R. ................................ Advisory Panel: Medtronic, Inc.; Other Relationship: Eli

Lilly and Company, Medtronic, Inc., Novo Nordisk Inc., Roche Diagnostics.

Murphy, James ................................... Disclosed no confl ict of interest.Murphy, Kathryn ................................. Disclosed no confl ict of interest.Murphy, Kerry ...................................... Disclosed no confl ict of interest.Murphy, Matthew S. .......................... Advisory Panel: Boehringer Ingelheim Pharmaceuticals, Inc.,

Novo Nordisk Inc. Murphy, Suzan H. ................................ Disclosed no confl ict of interest.Murray, David ...................................... Disclosed no confl ict of interest.Murray, Joseph A. .............................. Disclosed no confl ict of interest.Murray, Mary A. .................................. Disclosed no confl ict of interest.Murray, Michael R. ............................. Disclosed no confl ict of interest.Murtuza, Mohammad M. ................... Disclosed no confl ict of interest.Muscatello, Maria R. .......................... Disclosed no confl ict of interest.Musen, Gail ......................................... Disclosed no confl ict of interest.

Musi, Nicolas ...................................... Disclosed no confl ict of interest.Muskiet, Marcel H. ............................. Disclosed no confl ict of interest.Müssig, Karsten .................................. Disclosed no confl ict of interest.Mutha, Abhay ...................................... Research Support: Novo Nordisk A/S. Myakina, Natalia E. ............................ Disclosed no confl ict of interest.Mychaleckyj, Josyf C. ........................ Disclosed no confl ict of interest.Myers, Martin G. ................................. Disclosed no confl ict of interest.Myers, Jr., Martin G. .......................... Disclosed no confl ict of interest.Myers, Kathy ....................................... Disclosed no confl ict of interest.Mysliwiec, Malgorzata ...................... Disclosed no confl ict of interest.Mysona, Barbara A. ............................ Disclosed no confl ict of interest.Myszka, Rickie .................................... Disclosed no confl ict of interest.Na, Erqian ............................................ Employee: Regeneron Pharmaceuticals, Inc. Naatz, Aaron ....................................... Disclosed no confl ict of interest.Naber, Meghan C. ............................... Disclosed no confl ict of interest.Nabil, Rabhi ......................................... Disclosed no confl ict of interest.Nabrdalik, Katarzyna .......................... Disclosed no confl ict of interest.Nabuco, Aline ...................................... Disclosed no confl ict of interest.Nadalin, Silvio ..................................... Disclosed no confl ict of interest.Nadeau, Kristen J. .............................. Disclosed no confl ict of interest.Nadkarni, Vinay ................................... Research Support: Dexcom, Inc., Edwards Scientifi c, NOVA

Biomedical. Nadler, Jerry L. .................................... Disclosed no confl ict of interest.Naerr, Gerhard .................................... Disclosed no confl ict of interest.Nagai, Takako ...................................... Disclosed no confl ict of interest.Nagakura, Joe ..................................... Disclosed no confl ict of interest.Nagalla, Srinivasa R. .......................... Employee: DiabetOmics, Inc.; Stock/Shareholder:

DiabetOmics, Inc. Nagao, Kenji ........................................ Disclosed no confl ict of interest.Nagaoka, Caroline .............................. Disclosed no confl ict of interest.Nagaraja, Haikady .............................. Disclosed no confl ict of interest.Nagarajan, Arvindhan ........................ Disclosed no confl ict of interest.Nagasawa, Masahiro ......................... Disclosed no confl ict of interest.Nagasawa, Shin-ya ............................. Disclosed no confl ict of interest.Nagase, Terumasa .............................. Disclosed no confl ict of interest.Nagashima, Kazuaki ........................... Disclosed no confl ict of interest.Nagashima, Masaharu ....................... Disclosed no confl ict of interest.Nagashima, Yuki ................................. Disclosed no confl ict of interest.Nagashimada, Mayumi ...................... Disclosed no confl ict of interest.Nagata, Naoto ..................................... Disclosed no confl ict of interest.Nagata, Takashi .................................. Disclosed no confl ict of interest.Nagel, Corey ........................................ Disclosed no confl ict of interest.Nagel, Friederike ................................. Employee: Boehringer Ingelheim Pharma GmbH & Co. KG. Naghavi, Nooshin ............................... Disclosed no confl ict of interest.Nainar, Sarah ...................................... Disclosed no confl ict of interest.Nair, Anup ............................................ Disclosed no confl ict of interest.Nair, Bala G. ........................................ Disclosed no confl ict of interest.Nair, K. Sreekumaran .......................... Disclosed no confl ict of interest.Nair, Sangeeta .................................... Disclosed no confl ict of interest.Nair, Shailesh ...................................... Disclosed no confl ict of interest.Nair, Viji ............................................... Disclosed no confl ict of interest.Naji, Ali ................................................ Disclosed no confl ict of interest.Najjar, Mejdi ........................................ Disclosed no confl ict of interest.Najmi, Laeya A. ................................... Disclosed no confl ict of interest.Nakabayashi, Hiroko ........................... Disclosed no confl ict of interest.Nakae, Jun ........................................... Disclosed no confl ict of interest.Nakagami, Tomoko ............................. Disclosed no confl ict of interest.Nakagawa, Fumiyuki .......................... Disclosed no confl ict of interest.Nakagawa, Hideaki ............................ Disclosed no confl ict of interest.Nakagawa, Kasumi ............................. Disclosed no confl ict of interest.Nakagawa, Yoshitsugu ....................... Disclosed no confl ict of interest.Nakagawa, Yuko ................................. Disclosed no confl ict of interest.Nakajima, Osamu ................................ Disclosed no confl ict of interest.Nakamae, Keiichiro ............................. Disclosed no confl ict of interest.Nakamoto, Takaaki ............................. Disclosed no confl ict of interest.Nakamura, Akie ................................... Disclosed no confl ict of interest.Nakamura, Ichiro ................................. Employee: Astellas Pharma Inc. Nakamura, Jiro .................................... Disclosed no confl ict of interest.Nakamura, Katherine .......................... Employee: Dexcom, Inc. Nakamura, Koshi ................................. Disclosed no confl ict of interest.Nakamura, Naoto ................................ Disclosed no confl ict of interest.Nakamura, Nobuhisa .......................... Disclosed no confl ict of interest.Nakamura, Takao ................................ Disclosed no confl ict of interest.Nakamura, Tomonobu ......................... Disclosed no confl ict of interest.Nakandakare, Edna R. ........................ Disclosed no confl ict of interest.Nakanishi, Risa ................................... Disclosed no confl ict of interest.Nakano, Kazuhiro ................................ Disclosed no confl ict of interest.Nakano, Koji ........................................ Disclosed no confl ict of interest.Nakano, Sayako .................................. Employee: Ajinomoto Group. Nakano, Yasuko ................................... Disclosed no confl ict of interest.Nakano, Yujiro ..................................... Disclosed no confl ict of interest.Nakao, Keiko ....................................... Disclosed no confl ict of interest.

A866

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Nakaoka, Hajime ................................. Disclosed no confl ict of interest.Nakashima, Ayumi .............................. Disclosed no confl ict of interest.Nakasone, Yasuto ............................... Disclosed no confl ict of interest.Nakatani, Kazuhiro ............................. Disclosed no confl ict of interest.Nakatani, Yuki ..................................... Disclosed no confl ict of interest.Nakatsu, Yusuke ................................. Disclosed no confl ict of interest.Nakatsuka, Atsuko .............................. Disclosed no confl ict of interest.Nakayama, Hitomi .............................. Disclosed no confl ict of interest.Nakayama, Masafumi ........................ Disclosed no confl ict of interest.Nam, Jisun ........................................... Disclosed no confl ict of interest.Nam, Moonsuk .................................... Disclosed no confl ict of interest.Nam, Soohyun ..................................... Disclosed no confl ict of interest.Nam, Yoon Jeong ................................ Disclosed no confl ict of interest.Nambam, Bimota ................................ Disclosed no confl ict of interest.Nambi, Vijay ........................................ Other Relationship: Provisional patent (patent no. 61721475)

entitled Biomarkers to Improve Prediction of Heart Failure Risk fi led By Baylor College of Medicine, Roche.

Nan, Raluca ......................................... Disclosed no confl ict of interest.Nanditha, Arun .................................... Disclosed no confl ict of interest.Nanjo, Kishio ....................................... Disclosed no confl ict of interest.Naples, Mark ....................................... Disclosed no confl ict of interest.Napoli, Nicola ...................................... Disclosed no confl ict of interest.Narain, Niven R. .................................. Disclosed no confl ict of interest.Naranjo, Diana .................................... Advisory Panel: CarbDM; Board Member: CarbDM (Spouse/

Partner); Consultant: Children with Diabetes, Inc. Narath, Sophie .................................... Disclosed no confl ict of interest.Narayan, K.M. Venkat ........................ Research Support: National Institutes of Health. Narayanan, Ram P. .............................. Disclosed no confl ict of interest.Narendran, Parth ................................ Disclosed no confl ict of interest.Narita, Ichiei ........................................ Disclosed no confl ict of interest.Narumiya, Hiromichi ........................... Disclosed no confl ict of interest.Naruse, Keiko ...................................... Disclosed no confl ict of interest.Naruse, Rika ........................................ Disclosed no confl ict of interest.Naruse, Yuchi ...................................... Disclosed no confl ict of interest.Narvencar, Kedareshwar P. ................ Disclosed no confl ict of interest.Naseem, Khalid M. ............................. Disclosed no confl ict of interest.Nasiri, Ali R. ........................................ Disclosed no confl ict of interest.Nassar, Carine ..................................... Disclosed no confl ict of interest.Nassar, Wael F. ................................... Disclosed no confl ict of interest.Nassikar, Nikhil ................................... Disclosed no confl ict of interest.Nasteska, Daniela ............................... Disclosed no confl ict of interest.Natalicchio, Annalisa ......................... Disclosed no confl ict of interest.Natarajan, Sabareesh ........................ Disclosed no confl ict of interest.Nath, Rajneesh .................................... Employee: XOMA Corporation. Nathan, Brandon ................................. Disclosed no confl ict of interest.Nathan, David M. ................................ Disclosed no confl ict of interest.Nathanson, David ............................... Disclosed no confl ict of interest.Natoli, Alaina K. .................................. Disclosed no confl ict of interest.Natovich, Rachel ................................. Disclosed no confl ict of interest.Natsuaki, Chiharu ............................... Disclosed no confl ict of interest.Natsume, Yukie ................................... Disclosed no confl ict of interest.Nauck, Michael A. .............................. Advisory Panel: AstraZeneca/Bristol-Myers Squibb, Berlin-

Chemie AG, Boehringer Ingelheim GmbH, Intarcia Therapeutics, Inc., Janssen Pharmaceutical Companies of Johnson & Johnson, Merck Sharp & Dohme, Novartis Pharma GmbH, Novo Nordisk A/S, Profi l Institute for Clinical Research, Inc., Sanofi Pasteur SA, Versartis, Inc.; Research Support: AstraZeneca/Bristol-Myers Squibb, Intarcia Therapeutics, Inc., Merck Sharp & Dohme, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S; Speaker’s Bureau: AstraZeneca/Bristol-Myers Squibb, Berlin-Chemie AG, Boehringer Ingelheim GmbH, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck Sharp & Dohme, Sanofi Pasteur SA.

Nausheen, Sidrah ............................... Disclosed no confl ict of interest.Navaneethan, Sankar D. .................... Disclosed no confl ict of interest.Navarro, Guadalupe ............................ Disclosed no confl ict of interest.Nawaz, Allah ....................................... Disclosed no confl ict of interest.Nawroth, Peter P. ................................ Disclosed no confl ict of interest.Nayak, Minakshi ................................. Disclosed no confl ict of interest.Naylor, Jacqueline .............................. Disclosed no confl ict of interest.Nazaret, Remi ...................................... Employee: Metabolys Inc. Nazarian, Arbi ..................................... Disclosed no confl ict of interest.Neal, Doss ........................................... Disclosed no confl ict of interest.Neale, Ann ........................................... Employee: XOMA Corporation. Nedelkov, Dobrin ................................. Disclosed no confl ict of interest.Nederveen, Aart ................................. Disclosed no confl ict of interest.Neeland, Ian J. .................................... Disclosed no confl ict of interest.Neergaard, Kirsten ............................. Disclosed no confl ict of interest.Neethu, Radhakrishnan ...................... Disclosed no confl ict of interest.Negoro, Nobuyuki ............................... Employee: Takeda Pharmaceutical Company Limited.

Nègre, Véronique ................................ Disclosed no confl ict of interest.Neidert, Adam ..................................... Disclosed no confl ict of interest.Neighbors, Bonita ............................... Disclosed no confl ict of interest.Neighbors, Harold ............................... Disclosed no confl ict of interest.Neinstein, Aaron ................................. Disclosed no confl ict of interest.Nelson, David L. .................................. Disclosed no confl ict of interest.Nelson, David R. .................................. Employee: Eli Lilly and Company. Nelson, Heather A. ............................. Disclosed no confl ict of interest.Nelson, James .................................... Employee: Truven Health Analytics. Nelson, Patric ...................................... Employee: Formerly Amgen Inc. Nelson, Rachael K. .............................. Disclosed no confl ict of interest.Nelson, Randall ................................... Disclosed no confl ict of interest.Nelson, Robert G. ................................ Disclosed no confl ict of interest.Nemoto, Ken-Ichi ................................ Disclosed no confl ict of interest.Nemoto, Koichiro ................................ Disclosed no confl ict of interest.Nepom, Gerald T. ................................ Other Relationship: Genentech, Inc., GlaxoSmithKline, Pfi zer

Inc.; Research Support: Astellas Pharma US, Inc., Bayer HealthCare, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases.

Neradilek, Moni B. .............................. Disclosed no confl ict of interest.Nergard, Bent-Jonny .......................... Disclosed no confl ict of interest.Nerloe, Pernille ................................... Disclosed no confl ict of interest.Nery, Marcia ........................................ Consultant: Lilly Deutschland GmbH, Novo Nordisk Inc.,

Sanofi U.S. Nesil, Tanseli ....................................... Disclosed no confl ict of interest.Neslusan, Cheryl ................................. Employee: Janssen Global Services, LLC. Net, Evcimen ....................................... Disclosed no confl ict of interest.Neubacher, Dietmar ............................ Employee: Boehringer Ingelheim GmbH. Neubauer, Michael ............................. Disclosed no confl ict of interest.Neugebauer, Romain S. ...................... Disclosed no confl ict of interest.Neumann, William L. .......................... Disclosed no confl ict of interest.Neutel, Joel M. ................................... Consultant: Oramed Pharmaceuticals. Newby, Brittney .................................. Disclosed no confl ict of interest.Newcomer, Brad R. ............................. Disclosed no confl ict of interest.Newell, John ....................................... Disclosed no confl ict of interest.Newgard, Christopher B. .................... Disclosed no confl ict of interest.Newman, Anne B. ............................... Disclosed no confl ict of interest.Newman, Tondra ................................. Disclosed no confl ict of interest.Newsom, Sean A. ............................... Disclosed no confl ict of interest.Newswanger, Brett J. ........................ Employee: employee, Xeris Pharmaceuticals, Inc. Newton, Katherine M. ........................ Disclosed no confl ict of interest.Newton-Bishop, Julia ......................... Disclosed no confl ict of interest.Newton-John, Toby ............................ Disclosed no confl ict of interest.Neyra, Luis A. ...................................... Disclosed no confl ict of interest.Nezu, Uru O. ........................................ Disclosed no confl ict of interest.Ng, Alvin .............................................. Disclosed no confl ict of interest.Ng, Eduardo ......................................... Disclosed no confl ict of interest.Ng, Enders Kwok Wai ......................... Disclosed no confl ict of interest.Ng, Hui Jin ........................................... Disclosed no confl ict of interest.Ng, Maggie C. ..................................... Disclosed no confl ict of interest.Ng, Martin ........................................... Disclosed no confl ict of interest.Ng, Martin K. ....................................... Disclosed no confl ict of interest.Ng, Poh Leng ....................................... Disclosed no confl ict of interest.Ng, Porlin ............................................. Disclosed no confl ict of interest.Ng, Sarah ............................................. Disclosed no confl ict of interest.Ng, Xiaowei ......................................... Disclosed no confl ict of interest.Ngare, Duncan .................................... Disclosed no confl ict of interest.Ngo, Betty ........................................... Disclosed no confl ict of interest.Ngo, Mylan .......................................... Disclosed no confl ict of interest.Nguewa, Jean-Louis ........................... Disclosed no confl ict of interest.Nguyen Tu, Marie-Sophie C. .............. Disclosed no confl ict of interest.Nguyen, Dung ...................................... Disclosed no confl ict of interest.Nguyen, Hiep ....................................... Employee: AstraZeneca Pharmaceuticals LP. Nguyen, Huong-Lan ............................ Disclosed no confl ict of interest.Nguyen, Nam Q. .................................. Disclosed no confl ict of interest.Nguyen, Tea ........................................ Disclosed no confl ict of interest.Nguyen, Thien-Son ............................. Disclosed no confl ict of interest.Nguyen, Tri-Hung ................................ Research Support: Eli Lilly and Company. Nguyen, Tuong-Vi ................................ Disclosed no confl ict of interest.Nguyen, Tuyen ..................................... Disclosed no confl ict of interest.Ni, Yinhua ............................................ Disclosed no confl ict of interest.Nicholas, Lisa M. ................................ Disclosed no confl ict of interest.Nichols, Gregory A. ............................. Research Support: AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim Pharmaceuticals, Inc., Merck Sharp & Dohme, Novartis Pharmaceuticals Corporation.

Nickels, John Z. ................................... Disclosed no confl ict of interest.Nickerson, D. Scott ............................. Disclosed no confl ict of interest.Nicklas, Jacinda M. ............................ Disclosed no confl ict of interest.Nicoloro, Sarah M. .............................. Disclosed no confl ict of interest.Nicolucci, Antonio ............................... Research Support: Bristol-Myers Squibb Company, Merck

Sharp & Dohme, Novo Nordisk Inc., Sanofi Pasteur SA.

A867

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Nicosia, Francesco .............................. Disclosed no confl ict of interest.Nie, Fan ................................................ Disclosed no confl ict of interest.Niedermeier, Katja .............................. Disclosed no confl ict of interest.Nielsen, Gunnar L. ............................... Disclosed no confl ict of interest.Nielsen, Jannie ................................... Research Support: Novo Nordisk Foundation. Nielsen, Søren ..................................... Disclosed no confl ict of interest.Nielsen, Thomas S. ............................. Disclosed no confl ict of interest.Niemira, Magdalena ........................... Disclosed no confl ict of interest.Nienov, Otto ........................................ Disclosed no confl ict of interest.Niessen, Hans ..................................... Disclosed no confl ict of interest.Nieuwdorp, Max ................................. Disclosed no confl ict of interest.Nieuwoudt, Stephan ........................... Disclosed no confl ict of interest.Niewczas, Monika A. .......................... Research Support: Sanofi U.S. Nigam, Somesh ................................... Disclosed no confl ict of interest.Nightingale, Peter G. .......................... Disclosed no confl ict of interest.Nigmatoulline, Denis .......................... Disclosed no confl ict of interest.Nigro, Pasquale ................................... Disclosed no confl ict of interest.Niiya, Tetsuji ....................................... Disclosed no confl ict of interest.Nikami, Fumio ...................................... Disclosed no confl ict of interest.Nikkel, Carla ........................................ Employee: Valeritas; Stock/Shareholder: Valeritas. Nikolajczyk, Barbara S. ...................... Research Support: National Institute of Diabetes and

Digestive and Kidney Diseases, National Institutes of Health.

Nikolajsen, Annie ................................ Employee: Novo Nordisk A/S. Nikolajuk, Agnieszka .......................... Disclosed no confl ict of interest.Nikolayeva, Antonina B. ..................... Research Support: Karaganda State Medical University. Nikolic, Dragana .................................. Disclosed no confl ict of interest.Nikonova, Elena .................................. Employee: Sanofi U.S. Niland, Joyce C. .................................. Disclosed no confl ict of interest.Nimitphong, Hataikarn ....................... Disclosed no confl ict of interest.Nimri, Revital ...................................... Speaker’s Bureau: Novo Nordisk Inc. Ning, Yun ............................................. Employee: Gilead; Stock/Shareholder: Gilead. Nino, Antonio ...................................... Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline. Nishi, Masahiro ................................... Disclosed no confl ict of interest.Nishida, Makoto .................................. Disclosed no confl ict of interest.Nishida, Susumu ................................. Disclosed no confl ict of interest.Nishida, Tomoyuki ............................... Employee: Novo Nordisk Inc. Nishida, Wataru .................................. Disclosed no confl ict of interest.NIshihara, Harumi ............................... Disclosed no confl ict of interest.Nishii, Naoko ....................................... Disclosed no confl ict of interest.Nishijima, Takeshi ............................... Disclosed no confl ict of interest.Nishijima, Yasuo ................................. Disclosed no confl ict of interest.Nishikawa, Hiroyoshi .......................... Disclosed no confl ict of interest.Nishikawa, Takeshi ............................. Disclosed no confl ict of interest.Nishikawa, Tetsuo .............................. Disclosed no confl ict of interest.Nishimura, Erica .................................. Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Nishimura, Rimei ................................. Advisory Panel: Abbott Diabetes Care, Inc., Astellas

Pharma US, Inc., Novo Nordisk Inc.; Consultant: Taisho Pharmaceutical Co., Ltd.; Speaker’s Bureau: Astellas Pharma US, Inc., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly Japan K.K., Kissei Pharmaceutical Co., Ltd., Novartis Corporation, Novo Nordisk Inc., Sanofi U.S., Taisho Toyama Pharmaceutical Co.,Ltd, Takeda Pharmaceutical Company Limited.

Nishimura, Takeshi ............................. Disclosed no confl ict of interest.Nishitani, Rie ....................................... Disclosed no confl ict of interest.Nisio, Shin-ichi .................................... Disclosed no confl ict of interest.Nislow, Corey ...................................... Disclosed no confl ict of interest.Nissen, Steven E. ................................ Research Support: Takeda Pharmaceutical Company

Limited. Nistala, Ravi ........................................ Disclosed no confl ict of interest.Nitta, Kosaku ...................................... Disclosed no confl ict of interest.Nitta, Kyoko ......................................... Disclosed no confl ict of interest.Niu, Fang .............................................. Disclosed no confl ict of interest.Niu, Guoguang ..................................... Disclosed no confl ict of interest.Niu, Shangmei ..................................... Disclosed no confl ict of interest.Niwa, Hiroyuki .................................... Disclosed no confl ict of interest.Njølstad, Pål R. .................................... Disclosed no confl ict of interest.Noble, Earl ........................................... Disclosed no confl ict of interest.Noblet, Jillian N. ................................. Disclosed no confl ict of interest.Nocon, Allison ..................................... Disclosed no confl ict of interest.Noda, Mitsuhiko .................................. Disclosed no confl ict of interest.Nodzenski, Michael ............................ Disclosed no confl ict of interest.Noerregaard, Pia ................................. Employee: Zealand Pharma A/S. Noguchi, Constance T. ........................ Employee: National Institute of Diabetes and Digestive and

Kidney Diseases; Research Support: National Institute of Diabetes and Digestive and Kidney Diseases.

Noguchi, Yasushi ................................ Disclosed no confl ict of interest.Noh, Hye-Lim ....................................... Disclosed no confl ict of interest.

Noh, Hyunjin ........................................ Disclosed no confl ict of interest.Noh, Yun H. .......................................... Disclosed no confl ict of interest.Noh, Yun Hee ....................................... Disclosed no confl ict of interest.Nohara, Masayuki .............................. Disclosed no confl ict of interest.Nolan, Christopher J. .......................... Disclosed no confl ict of interest.Nolan, Roger ........................................ Disclosed no confl ict of interest.Nomiyama, Takashi ............................. Disclosed no confl ict of interest.Nomoto, Mayumi ................................ Disclosed no confl ict of interest.Nomura, Hideki ................................... Disclosed no confl ict of interest.Nørgaard, Kirsten ............................... Advisory Panel: Abbott, Medtronic, Inc., Novo Nordisk

A/S; Research Support: Novo Nordisk A/S, Roche Diagnostics; Speaker’s Bureau: Animas Corporation, Novo Nordisk A/S, Roche Diagnostics, Sanofi U.S.

Norhammar, Anna ............................... Disclosed no confl ict of interest.Norheim, Frode .................................... Disclosed no confl ict of interest.Nori, Vijay ............................................ Employee: Optum Labs. Noritake, Masayuki ............................ Disclosed no confl ict of interest.Norkeviciute, Edita ............................. Disclosed no confl ict of interest.Normand, Christophe ......................... Disclosed no confl ict of interest.Noronha, Fiona .................................... Disclosed no confl ict of interest.Norquay, Lisa ....................................... Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Norrbacka, Kirsi .................................. Employee: Eli Lilly and Company. Norris, Jill ............................................ Disclosed no confl ict of interest.Norris, Keri .......................................... Disclosed no confl ict of interest.Norseth, Jon ........................................ Disclosed no confl ict of interest.North, Kari E. ....................................... Disclosed no confl ict of interest.Northam, Elizabeth A. ........................ Disclosed no confl ict of interest.Norton, Luke ........................................ Disclosed no confl ict of interest.Norvell, J.P. ......................................... Disclosed no confl ict of interest.Norwood, Paul .................................... Research Support: Eli Lilly and Company, Novo Nordisk A/S,

Sanofi -Aventis. Nosek, Leszek ..................................... Disclosed no confl ict of interest.Noto, Hiroshi ....................................... Disclosed no confl ict of interest.Nour Eldin, Hussein M. ....................... Disclosed no confl ict of interest.Nouris, Christos .................................. Disclosed no confl ict of interest.Nov, Sovanndany ................................ Disclosed no confl ict of interest.Novak, Branko ..................................... Disclosed no confl ict of interest.Novak, Daniel ...................................... Disclosed no confl ict of interest.Novak, Vera ......................................... Research Support: National Institutes of Health, National

Institutes of Health, NIH-NIA 1R01- AG0287601A2, NIH-NIDDK 5R21 DK084463.

Novaleski, Carla .................................. Disclosed no confl ict of interest.Novicoff, Wendy ................................. Disclosed no confl ict of interest.Nowak, Christoph ............................... Disclosed no confl ict of interest.Nowak, Felicia V. ................................ Disclosed no confl ict of interest.Nowak, Natalia ................................... Disclosed no confl ict of interest.Nowakowski-Grier, Lorraine .............. Disclosed no confl ict of interest.Nowotny, Bettina ................................ Disclosed no confl ict of interest.Nowotny, Irene .................................... Employee: Sanofi ; Stock/Shareholder: Sanofi . Nowotny, Peter ................................... Disclosed no confl ict of interest.Ntalla, Ioanna ...................................... Disclosed no confl ict of interest.Numaguchi, Ryutaro ........................... Disclosed no confl ict of interest.Numé, Anna-Karin .............................. Disclosed no confl ict of interest.Nunes, Alice H. ................................... Disclosed no confl ict of interest.Nunes, Anthony P. ............................... Research Support: Novo Nordisk A/S. Nunes, Valéria S. ................................ Disclosed no confl ict of interest.Nunez-Lopez, Yury .............................. Disclosed no confl ict of interest.Nuñez-Roa, Catalina ........................... Disclosed no confl ict of interest.Nunlee-Bland, Gail .............................. Disclosed no confl ict of interest.Nunoi, Hiroaki ..................................... Disclosed no confl ict of interest.Nunoue, Tomokazu .............................. Disclosed no confl ict of interest.Nuutila, Pirjo ........................................ Disclosed no confl ict of interest.Nuyt, Anne Monique .......................... Disclosed no confl ict of interest.Nwabuobi, Chinedu K. ........................ Disclosed no confl ict of interest.Nwankwo, Clementina A. .................. Disclosed no confl ict of interest.Nwankwo, Clementina U. .................. Disclosed no confl ict of interest.Nyam, Elsa ........................................... Disclosed no confl ict of interest.Nyström, Thomas ................................ Disclosed no confl ict of interest.Oakes, Nicholas D. .............................. Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP. Oats, Jeremy ....................................... Disclosed no confl ict of interest.Obanda, Diana ..................................... Disclosed no confl ict of interest.Obara, Akio .......................................... Disclosed no confl ict of interest.Obata, Atsushi .................................... Disclosed no confl ict of interest.Obendorf, Florian ................................ Disclosed no confl ict of interest.O’Brien, Kevin D. ................................. Disclosed no confl ict of interest.O’Brien, Matthew J. ........................... Disclosed no confl ict of interest.O’Brien, Phillipe D. .............................. Disclosed no confl ict of interest.O’Brien, Rebecca L. ............................. Employee: PopTest LLC; Stock/Shareholder: PopTest LLC. Obrynba, Kathryn S. ........................... Disclosed no confl ict of interest.Obuchowicz, Ewa ................................ Disclosed no confl ict of interest.

A868

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

O’Byrne, Sheila M. .............................. Disclosed no confl ict of interest.O’Callaghan, Christopher ................... Disclosed no confl ict of interest.Ochoa, Cesar ....................................... Disclosed no confl ict of interest.Ock, So Young ..................................... Disclosed no confl ict of interest.O’Connell, Jeffrey R. .......................... Disclosed no confl ict of interest.O’Connell, Kathleen M. ...................... Disclosed no confl ict of interest.O’Connell, Michele A. ......................... Research Support: Juvenile Diabetes Research Foundation,

Pfi zer Inc. O’Connor, Alice .................................... Disclosed no confl ict of interest.O’Connor, Patrick J. ............................ Disclosed no confl ict of interest.O’Connor, Timothy D. .......................... Disclosed no confl ict of interest.Odaka, Tomotada ................................ Disclosed no confl ict of interest.Odawara, Masato ............................... Advisory Panel: Eli Lilly Japan K.K., Novo Nordisk A/S,

Sanofi U.S.; Research Support: Eli Lilly Japan K.K., Novo Nordisk A/S, Sanofi U.S.; Speaker’s Bureau: Eli Lilly Japan K.K., Novo Nordisk A/S, Sanofi U.S.

O’Dea, Angela ..................................... Disclosed no confl ict of interest.O’Dea, Kerin ........................................ Disclosed no confl ict of interest.Odegaard, Andrew .............................. Disclosed no confl ict of interest.Odegard, Peggy S. ............................... Disclosed no confl ict of interest.O’Dell, Laura E. .................................... Disclosed no confl ict of interest.O’Donnell, Paul .................................... Disclosed no confl ict of interest.Odriozola, Ariel ................................... Disclosed no confl ict of interest.Odriozola, Maria ................................. Disclosed no confl ict of interest.Odriozola, Suzanna ............................. Disclosed no confl ict of interest.O’Farrell, Libbey S. .............................. Employee: Eli Lilly and Company. Offermanns, Stefan ............................ Disclosed no confl ict of interest.Ofstad, Anne Pernille .......................... Employee: Boehringer Ingelheim GmbH. Ogasawara, Junetsu .......................... Disclosed no confl ict of interest.Ogasawara, Saori ............................... Disclosed no confl ict of interest.Ogata, Makiko ..................................... Disclosed no confl ict of interest.Ogata, Nahoko .................................... Disclosed no confl ict of interest.Ogawa, Daisuke .................................. Disclosed no confl ict of interest.Ogawa, Hisao ...................................... Other Relationship: AstraZeneca Pharmaceuticals LP, Bayer

HealthCare, Daiichi-Sankyo Co., Ltd., Merck & Co., Inc., Pfi zer Inc., Sanofi U.S., Taisho Pharmaceutical Co., Ltd.; Research Support: Astellas Pharma US, Inc., AstraZeneca Pharmaceuticals LP, Bayer HealthCare, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Chugai Pharmaceutical Co., Ltd., Daiichi-Sankyo Co., Ltd., Kowa Pharmaceuticals, Merck & Co., Inc., Novartis Corporation, Otsuka Pharmaceutical Co., Ltd., Pfi zer Inc., Sanofi U.S., Sumimoto Dainippon Pharma Co., Ltd., Takeda Pharmaceutical Company Limited.

Ogawa, Kenichi ................................... Disclosed no confl ict of interest.Ogawa, Wataru ................................... Disclosed no confl ict of interest.Ogawa, Yoshihiro ................................ Disclosed no confl ict of interest.Ogihara, Takeshi ................................. Advisory Panel: Boehringer Ingelheim Pharmaceuticals,

Inc., Kowa Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Mitsubishi Tanabe Pharma Corporation.

Ogino, Jun ............................................ Disclosed no confl ict of interest.Ogle, Graham ....................................... Disclosed no confl ict of interest.Ogunkua, Lanese ................................. Disclosed no confl ict of interest.Oguri, Yasuo ........................................ Disclosed no confl ict of interest.Ogurtsova, Katherine ......................... Disclosed no confl ict of interest.Oh, Daniel ............................................ Disclosed no confl ict of interest.Oh, Eriko ............................................... Disclosed no confl ict of interest.Oh, Jae Kuen ....................................... Disclosed no confl ict of interest.Oh, Jee-Young ..................................... Disclosed no confl ict of interest.Oh, Ki-Won .......................................... Disclosed no confl ict of interest.Oh, Seok-Kyun ..................................... Disclosed no confl ict of interest.Oh, Seungjoon ..................................... Disclosed no confl ict of interest.Oh, Tae Jung ........................................ Disclosed no confl ict of interest.Oh, Young Taek .................................... Disclosed no confl ict of interest.Ohama, Tohru ...................................... Disclosed no confl ict of interest.Ohara, Norihiko ................................... Disclosed no confl ict of interest.Ohashi, Akiko ...................................... Disclosed no confl ict of interest.Ohashi, Jun .......................................... Disclosed no confl ict of interest.Ohashi, Ken ......................................... Disclosed no confl ict of interest.Ohashi, Noritsugu ............................... Disclosed no confl ict of interest.Ohashi, Yasuo ...................................... Disclosed no confl ict of interest.Ohbatake, Azusa ................................. Disclosed no confl ict of interest.Ohe, Kazuhiko ...................................... Disclosed no confl ict of interest.Ohira, Akeo .......................................... Disclosed no confl ict of interest.Ohira, Lisa ............................................ Disclosed no confl ict of interest.Ohkubo, Yohsuke ................................. Disclosed no confl ict of interest.Ohman, Peter ....................................... Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP. Ohminami, Hirokazu ............................ Disclosed no confl ict of interest.Ohn, Jung Hun ..................................... Disclosed no confl ict of interest.

Ohnishi, Tetsurou ................................ Disclosed no confl ict of interest.Ohno, Hideaki ...................................... Disclosed no confl ict of interest.Ohno, Hideki ........................................ Disclosed no confl ict of interest.Ohno, Norikazu .................................... Disclosed no confl ict of interest.Ohsawa, Nakaaki ................................ Disclosed no confl ict of interest.Ohshima, Kihachi ................................ Disclosed no confl ict of interest.Ohta, Yasuharu .................................... Disclosed no confl ict of interest.Oikawa, Yoichi ..................................... Disclosed no confl ict of interest.Ojha, Shreesh K. .................................. Disclosed no confl ict of interest.Ojike, Nwakile ..................................... Disclosed no confl ict of interest.Ojo, Anaga ........................................... Disclosed no confl ict of interest.Oka, Rie ................................................ Disclosed no confl ict of interest.Okabe, Keisuke .................................... Disclosed no confl ict of interest.Okada, Chiho ....................................... Disclosed no confl ict of interest.Okada, Hiroshi ..................................... Disclosed no confl ict of interest.Okada, Sadanori .................................. Disclosed no confl ict of interest.Okada, Shuichi .................................... Disclosed no confl ict of interest.Okada, Takeshi .................................... Disclosed no confl ict of interest.Okada-Iwabu, Miki ............................. Research Support: Mitsubishi Tanabe Pharma

Corporation, Mitsubishi Tanabe Pharma Corporation (Spouse/Partner), Novo Nordisk Inc. (Spouse/Partner), Novo Nordisk Inc., Ono Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd. (Spouse/Partner), Takeda Pharmaceutical Company Limited, Takeda Pharmaceutical Company Limited (Spouse/Partner); Speaker’s Bureau: Astellas Pharma Japan, Inc (Spouse/Partner), Mitsubishi Tanabe Pharma Corporation.

Okado, Haruo ....................................... Disclosed no confl ict of interest.Okafor, Godfrey ................................... Disclosed no confl ict of interest.Okahata, Sumie ................................... Disclosed no confl ict of interest.Okajima, Yasutomo ............................. Disclosed no confl ict of interest.Okamoto, Haruka ................................ Employee: Regeneron Pharmaceuticals, Inc. Okamoto, Koji ...................................... Disclosed no confl ict of interest.Okamoto, Shiki .................................... Disclosed no confl ict of interest.Okamoto, Shou .................................... Disclosed no confl ict of interest.Okamoto, Taro ..................................... Employee: MSD KK. Okamura, Emi ...................................... Disclosed no confl ict of interest.Okamura, Shintaro .............................. Disclosed no confl ict of interest.Okani, Chidinma .................................. Disclosed no confl ict of interest.Okano, Satoshi .................................... Disclosed no confl ict of interest.Okauchi, Seizou ................................... Disclosed no confl ict of interest.Okawa, Tetsuji ..................................... Disclosed no confl ict of interest.Okazaki, Kazunobu .............................. Disclosed no confl ict of interest.Okazaki, Kentaro ................................. Disclosed no confl ict of interest.Okazaki, Satoko ................................... Disclosed no confl ict of interest.Oki, Yutaka .......................................... Disclosed no confl ict of interest.Okitsu, Rie ........................................... Disclosed no confl ict of interest.Okubo, Tomoko .................................... Disclosed no confl ict of interest.Okubo, Yoshiaki ................................... Disclosed no confl ict of interest.Okuda, Seiya ....................................... Employee: Kurume University School of Medicine. Okumura, Megumi .............................. Disclosed no confl ict of interest.Okuno, Misako .................................... Disclosed no confl ict of interest.Okura, Tsuyoshi ................................... Disclosed no confl ict of interest.Okuyama, Kotoba ................................ Employee: MSD KK. Okuyama, Tomoko ............................... Disclosed no confl ict of interest.Olack, Barbara ..................................... Disclosed no confl ict of interest.Olateju, Tolulope O. ............................. Disclosed no confl ict of interest.Oldmeadow, Christopher .................... Disclosed no confl ict of interest.Olesen, Jonas F. .................................. Disclosed no confl ict of interest.Olesen, Kasper .................................... Employee: Steno Diabetes Center A/S. Olesen, Thomas B. .............................. Disclosed no confl ict of interest.Oli, Johnnie .......................................... Disclosed no confl ict of interest.Olimpico, Francesco ............................ Disclosed no confl ict of interest.Oliveira, Alanne L. ............................... Disclosed no confl ict of interest.Oliveira, Alexandre G. ......................... Disclosed no confl ict of interest.Oliveira, Ana L. .................................... Disclosed no confl ict of interest.Oliveira, Ana Mayra ............................ Disclosed no confl ict of interest.Oliveira, Antonio Cesar ...................... Disclosed no confl ict of interest.Oliveira, Atila ....................................... Disclosed no confl ict of interest.Oliveira, José Egídio ........................... Disclosed no confl ict of interest.Oliver, Noah G. .................................... Disclosed no confl ict of interest.Oliyarnyk, Olena .................................. Disclosed no confl ict of interest.Olsen, Birthe S. ................................... Research Support: Medtronic MiniMed, Inc. Olsen, Grith S. ..................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Olsen, Helle B. ..................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Olsen, Michael H. ................................ Disclosed no confl ict of interest.Olsen, Sjurdur F. .................................. Disclosed no confl ict of interest.Olson, Beth A. ..................................... Disclosed no confl ict of interest.Olson, Darin E. ..................................... Disclosed no confl ict of interest.

A869

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Olsson, Anders H. ............................... Disclosed no confl ict of interest.Olszanecka-Glinianowicz, Magdalena Disclosed no confl ict of interest.Oltolini, Alice ....................................... Disclosed no confl ict of interest.O’Malley, Grenye ................................ Disclosed no confl ict of interest.Omar, Bilal ........................................... Disclosed no confl ict of interest.Omar, Mohamed .................................. Advisory Panel: Boehringer Ingelheim GmbH, Eli Lilly and

Company, Novartis AG, Novo Nordisk A/S; Speaker’s Bureau: Boehringer Ingelheim GmbH, Eli Lilly and Company, Merck & Co., Inc., Novartis AG, Novo Nordisk A/S, Sanofi -Aventis.

Omi, Maiko .......................................... Disclosed no confl ict of interest.Ommen, Elizabeth S. ........................... Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &

Co., Inc. Omori, Yasue ....................................... Disclosed no confl ict of interest.Omura, Kazuki ..................................... Disclosed no confl ict of interest.Omura, Masao ..................................... Disclosed no confl ict of interest.O’Neal, David ...................................... Advisory Panel: Abbott, Firefl y, Medtronic, Inc., sanofi ;

Consultant: Medtronic, Inc.; Research Support: Medtronic, Inc., Novo Nordisk Inc., Roche Diagnostics, sanofi ; Speaker’s Bureau: Medtronic, Inc., Novo Nordisk Inc., Roche Diagnostics, sanofi .

O’Neill, Brian ....................................... Disclosed no confl ict of interest.O’Neill, Edward A. .............................. Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &

Co., Inc. Onengut-Gumuscu, Suna .................... Disclosed no confl ict of interest.Ong, Siew Hwa .................................... Employee: Novartis Pharma AG; Stock/Shareholder: Novartis

Pharma AG. Ongphiphadhanakul, Boonsong ......... Disclosed no confl ict of interest.Onishi, Yukiko ...................................... Disclosed no confl ict of interest.Ono, Junichi ......................................... Disclosed no confl ict of interest.Ono, Kaoru ........................................... Disclosed no confl ict of interest.Ono, Yashuko ....................................... Disclosed no confl ict of interest.Onodera, Masashi ............................... Disclosed no confl ict of interest.Onuma, Hiroshi .................................... Disclosed no confl ict of interest.Onuoha, Philip C. ................................. Disclosed no confl ict of interest.Ooi, Teik Chye ...................................... Disclosed no confl ict of interest.Opara, Emmanuel ................................ Disclosed no confl ict of interest.Opare-Addo, Lynn ............................... Disclosed no confl ict of interest.Op’t Roodt, Jos .................................... Disclosed no confl ict of interest.Oral, Elif A. .......................................... Advisory Panel: AstraZeneca Pharmaceuticals LP,

AstraZeneca Pharmaceuticals LP; Research Support: Aegerion, Amgen Inc., Amylin Pharmaceuticals, LLC., AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, GI Dynamics, Inc., National Institute of Diabetes and Digestive and Kidney Diseases.

Oram, Richard A. ................................. Disclosed no confl ict of interest.Orban, Paul C. ...................................... Disclosed no confl ict of interest.Orbay, Ekrem ....................................... Disclosed no confl ict of interest.Orchard, Trevor J. ............................... Advisory Panel: Eli Lilly and Company, Profi l Institute for

Clinical Research, Inc. Ord, Michelle ....................................... Disclosed no confl ict of interest.Ordovas, Jose M. ................................ Disclosed no confl ict of interest.O’Reilly, Sharleen ................................ Disclosed no confl ict of interest.Orgill, Dennis P. ................................... Disclosed no confl ict of interest.O’Riordan, MaryAnn ........................... Disclosed no confl ict of interest.Orlando, Giuseppe .............................. Disclosed no confl ict of interest.Orme, Michelle E. ................................ Consultant: AstraZeneca Pharmaceuticals LP, AstraZeneca

Pharmaceuticals LP (Spouse/Partner), AstraZeneca/Bristol-Myers Squibb, AstraZeneca/Bristol-Myers Squibb (Spouse/Partner), Bristol-Myers Squibb Company (Spouse/Partner), Bristol-Myers Squibb Company, Gilead, Gilead (Spouse/Partner), Novartis Pharmaceuticals Corporation, Novartis Pharmaceuticals Corporation (Spouse/Partner), paid consultant not in this disease area (Spouse/Partner), paid consultant not in this disease area, paid consultant not in this disease area (Spouse/Partner), paid consultant not in this disease area, paid consultant not in this disease area, paid consultant not in this disease area, paid consultant not in this disease area (Spouse/Partner), paid consultant not in this disease area (Spouse/Partner), paid consultant on other projects, paid consultant on other projects (Spouse/Partner), paid consultant on this project (Spouse/Partner), paid consultant on this project, Pfi zer Inc., Pfi zer Inc. (Spouse/Partner).

Oron, Tal ............................................... Disclosed no confl ict of interest.Orsak, Beverly ..................................... Disclosed no confl ict of interest.Orsi, Emanuela .................................... Disclosed no confl ict of interest.Orszag, Andrej ..................................... Disclosed no confl ict of interest.Ortega Moreno, Lorena ...................... Disclosed no confl ict of interest.Ortiz, Jacque ....................................... Disclosed no confl ict of interest.

Ortíz-López, Maria G. .......................... Disclosed no confl ict of interest.Ortiz-Rubio, Paulina ............................ Disclosed no confl ict of interest.Orvik, Elsa ............................................ Disclosed no confl ict of interest.Orwig, Denise ...................................... Disclosed no confl ict of interest.Orzechowski Westholm, Jakub ......... Disclosed no confl ict of interest.Osada, Uru N. ...................................... Disclosed no confl ict of interest.Osaka, Takafui ..................................... Disclosed no confl ict of interest.Osaki, Aya ............................................ Disclosed no confl ict of interest.Osamu, Hanyu ..................................... Disclosed no confl ict of interest.Osawa, Haruhiko ................................. Disclosed no confl ict of interest.Osborn, Chandra Y. ............................. Disclosed no confl ict of interest.Osborne, Danielle M. .......................... Disclosed no confl ict of interest.Osei, Kwame ........................................ Advisory Panel: Merck & Co., Inc. Oser, Sean M. ...................................... Research Support: National Institute of Diabetes and

Digestive and Kidney Diseases; Speaker’s Bureau: Children with Diabetes, Inc.

Oser, Tamara K. ................................... Research Support: National Institute of Diabetes and Digestive and Kidney Diseases; Speaker’s Bureau: Children with Diabetes, Inc.

O’Shea, Donal ..................................... Disclosed no confl ict of interest.Oshida, Yoshiharu ............................... Disclosed no confl ict of interest.Osonoi, Takeshi ................................... Research Support: AbbVie GK, Astellas Pharma US, Inc.,

Bayer HealthCare, Eli Lilly Japan K.K., GlaxoSmithKline, Kowa Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation, Novo Nordisk Inc., Sanwa Kagaku Kenkyusho Co., Ltd., Sumimoto Dainippon Pharma Co., Ltd., Taisho Pharmaceutical Co., Ltd.; Speaker’s Bureau: Astellas Pharma US, Inc., Kowa Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation, Novo Nordisk Inc., Sanwa Kagaku Kenkyusho Co., Ltd., Takeda Pharmaceutical Company Limited.

Osranek, Martin .................................. Disclosed no confl ict of interest.Ostenson, Claes-Goran ....................... Speaker’s Bureau: Merck Sharp & Dohme, Novo Nordisk

A/S, Sanofi Pasteur SA. Osterhoff, Martin ................................ Disclosed no confl ict of interest.Østoft, Signe H. ................................... Disclosed no confl ict of interest.Ostrauskas, Rytas ............................... Disclosed no confl ict of interest.Ostrovski, Ilia ...................................... Disclosed no confl ict of interest.Ostrovsky, Yana ................................... Disclosed no confl ict of interest.O’Sullivan, John F. ............................... Disclosed no confl ict of interest.Ota, Akemi ........................................... Disclosed no confl ict of interest.Ota, Chikayo ........................................ Disclosed no confl ict of interest.Ota, Hiroyo .......................................... Disclosed no confl ict of interest.Ota, Kazuki .......................................... Disclosed no confl ict of interest.Ota, Tsuguhito ..................................... Disclosed no confl ict of interest.Ota, Yausharu ...................................... Disclosed no confl ict of interest.Otabe, Shuichi ..................................... Disclosed no confl ict of interest.Otaka, Akira ......................................... Disclosed no confl ict of interest.Otani, Tamaki ...................................... Disclosed no confl ict of interest.Otero, Antonio ..................................... Employee: PHT Corporation. Otero, Jesus ........................................ Disclosed no confl ict of interest.Otero, Yolanda F. ................................. Disclosed no confl ict of interest.Othman, Noorani ................................. Disclosed no confl ict of interest.O’Tierney-Ginn, Perrie ........................ Disclosed no confl ict of interest.Otsuka, Yuichiro .................................. Disclosed no confl ict of interest.Ottaway, Nickki ................................... Disclosed no confl ict of interest.Ottosson-Laakso, Emilia .................... Disclosed no confl ict of interest.Otvos, Jim D. ....................................... Employee: LipoScience. Otziomek, Elzbieta .............................. Disclosed no confl ict of interest.Ou, Horng-Yih ...................................... Disclosed no confl ict of interest.Ouarrak, Taoufi k .................................. Disclosed no confl ict of interest.Ouchi, Hiromi ....................................... Disclosed no confl ict of interest.Oue, Keiko ............................................ Disclosed no confl ict of interest.Ouwens, Margriet ............................... Disclosed no confl ict of interest.Ouyang, Chung-Mei ............................ Disclosed no confl ict of interest.Overbergh, Lut ..................................... Disclosed no confl ict of interest.Overland, Jane .................................... Disclosed no confl ict of interest.Overmyer, Katherine A. ...................... Disclosed no confl ict of interest.Owada, Yuji ......................................... Disclosed no confl ict of interest.Owasu, Nana ....................................... Disclosed no confl ict of interest.Owczarek, Aleksander ........................ Disclosed no confl ict of interest.Owei, Ibiye ........................................... Disclosed no confl ict of interest.Owen, Katharine R. ............................. Disclosed no confl ict of interest.Owen, Lisa ........................................... Disclosed no confl ict of interest.Owen, Neville ...................................... Disclosed no confl ict of interest.Owen, Stephen .................................... Disclosed no confl ict of interest.Owens, David ...................................... Advisory Panel: Boehringer Ingelheim, Novo Nordisk, Roche

Diagnostics, Sanofi . Owens, Rebecca A. ............................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Owusu, Samuel ................................... Disclosed no confl ict of interest.Oya, Junko ........................................... Disclosed no confl ict of interest.

A870

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Oya, Takeshi ........................................ Disclosed no confl ict of interest.Oyadomari, Miho ................................ Disclosed no confl ict of interest.Oyadomari, Seiichi .............................. Disclosed no confl ict of interest.Oyedokun, Festus ................................ Disclosed no confl ict of interest.Oz, Gulin ............................................... Disclosed no confl ict of interest.Oza-Frank, Reena ................................ Disclosed no confl ict of interest.Ozaki, Risa ........................................... Disclosed no confl ict of interest.Ozawa, Shogo ..................................... Disclosed no confl ict of interest.Ozbek, Mustafa ................................... Disclosed no confl ict of interest.Ozbey, Nese C. .................................... Disclosed no confl ict of interest.Ozcan, Tulin ......................................... Disclosed no confl ict of interest.Ozcelik, Ozgur ...................................... Disclosed no confl ict of interest.Ozer Cakir, Ozlem ................................ Disclosed no confl ict of interest.Ozias, Marlies K. ................................. Disclosed no confl ict of interest.Ozkan, Tuba ......................................... Disclosed no confl ict of interest.Ozu, Hiroko .......................................... Disclosed no confl ict of interest.P.K., Sasidharan .................................. Disclosed no confl ict of interest.Pacaud, Danièle .................................. Disclosed no confl ict of interest.Pachori, Alok ....................................... Disclosed no confl ict of interest.Pachucki, Mark C. ............................... Disclosed no confl ict of interest.Pacifi ci, Francesca .............................. Disclosed no confl ict of interest.Pacilli, Antonio .................................... Disclosed no confl ict of interest.Pacini, Giovanni ................................... Research Support: Novo Nordisk A/S, Poxel Pharmaceutical

Company. Pacora, Percy ....................................... Disclosed no confl ict of interest.Paczkowska, Magdalena .................... Disclosed no confl ict of interest.Padgett, Lindsey E. ............................. Disclosed no confl ict of interest.Padilla, Jaume ..................................... Disclosed no confl ict of interest.Pagadala, Mangesh ............................ Disclosed no confl ict of interest.Page, Kathleen .................................... Disclosed no confl ict of interest.Page, Melissa M. ................................ Disclosed no confl ict of interest.Paglialunga, Sabina ............................ Disclosed no confl ict of interest.Paini, Stefano ...................................... Disclosed no confl ict of interest.Pajvani, Utpal B. .................................. Disclosed no confl ict of interest.Pak, Youngmi K. ................................... Disclosed no confl ict of interest.Pal, Aparna .......................................... Disclosed no confl ict of interest.Pal, Parasar .......................................... Employee: Novartis Healthcare Pvt. Ltd.; Stock/Shareholder:

Novartis AG. Palaniappan, Latha ............................. Disclosed no confl ict of interest.Palazzo, Viviana .................................. Disclosed no confl ict of interest.Palcza, John ........................................ Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &

Co., Inc. Paldánius, Päivi M. ............................. Employee: Novartis Pharma AG; Stock/Shareholder: Novartis

Pharma AG. Palena, Antonio ................................... Disclosed no confl ict of interest.Palermo, Andrea ................................. Disclosed no confl ict of interest.Palhegyi, Erika K. ................................ Disclosed no confl ict of interest.Palmer, Jerry P. .................................... Disclosed no confl ict of interest.Palmer, Kelly ........................................ Disclosed no confl ict of interest.Palmer, Melody R. ............................... Disclosed no confl ict of interest.Palmer, Nicholette D. .......................... Disclosed no confl ict of interest.Palnati, Madhuri .................................. Disclosed no confl ict of interest.Paloma, Diane ..................................... Disclosed no confl ict of interest.Pals, Regitze A. ................................... Employee: Steno Diabetes Center A/S. Palsson, Olafur .................................... Employee: Risk Medical Solutions; Stock/Shareholder: Risk

Medical Solutions. Pambianco, Georgia ............................ Disclosed no confl ict of interest.Pan, An ................................................. Disclosed no confl ict of interest.Pan, Changyu ....................................... Employee: Chinese PLA General Hospital. Pan, Chunshen ..................................... Consultant: Sanofi . Pan, Wentong ...................................... Disclosed no confl ict of interest.Pan, Xiaoping ....................................... Disclosed no confl ict of interest.Pan, Xiaoyue ........................................ Disclosed no confl ict of interest.Panagiotou, Dimitrios ......................... Disclosed no confl ict of interest.Pande, Reena L. ................................... Employee: AbilTo, Inc.; Stock/Shareholder: AbilTo, Inc. Pandey, Alok ........................................ Disclosed no confl ict of interest.Pandit, Harshul .................................... Disclosed no confl ict of interest.Pandya, Bee ......................................... Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline. Pang, Jianhua ...................................... Disclosed no confl ict of interest.Pang, Yong ........................................... Disclosed no confl ict of interest.Panikar, Vijay ....................................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Janssen

Pharmaceutical Companies of Johnson & Johnson. Pankow, James ................................... Disclosed no confl ict of interest.Panlasigui, Neil ................................... Disclosed no confl ict of interest.Panosian, Jennifer .............................. Disclosed no confl ict of interest.Pansa, Lucia ......................................... Disclosed no confl ict of interest.Pantalone, Kevin M. ............................ Advisory Panel: Eli Lilly and Company, Novo Nordisk Inc.;

Consultant: Merck & Co., Inc., Novo Nordisk Inc.; Research Support: Merck & Co., Inc., Novo Nordisk Inc.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck & Co., Inc.

Panzhinskiy, Evgeniy ........................... Disclosed no confl ict of interest.Paolella, Lauren ................................... Disclosed no confl ict of interest.Papadopoulou, Despina ...................... Disclosed no confl ict of interest.Papadopoulou, Maria ......................... Disclosed no confl ict of interest.Papagiannis, Chris N. .......................... Disclosed no confl ict of interest.Papangeli, Irinna ................................. Disclosed no confl ict of interest.Papaoikonomou, Stavroula ................ Disclosed no confl ict of interest.Paparo, Sabrina ................................... Disclosed no confl ict of interest.Papavasileiou, Evangelia .................... Disclosed no confl ict of interest.Papazafi ropoulou, Athanasia ............. Disclosed no confl ict of interest.Pappalardo, Zachary ........................... Disclosed no confl ict of interest.Pappas, Stavros .................................. Disclosed no confl ict of interest.Parameswaran, Reshmi ...................... Disclosed no confl ict of interest.Paranjape, Sachin ............................... Consultant: Sanofi U.S.; Employee: ProUnlimited. Parat, Sophie ....................................... Disclosed no confl ict of interest.Pardo, Scott ......................................... Employee: Bayer HealthCare LLC, Diabetes Care. Pardo, Virginia ..................................... Disclosed no confl ict of interest.Parente, Alexis .................................... Disclosed no confl ict of interest.Parihar, Anit ......................................... Disclosed no confl ict of interest.Parikh, Lisa .......................................... Disclosed no confl ict of interest.Parikh, Neehar ..................................... Disclosed no confl ict of interest.Parikh, Shamik J. ................................. Employee: AstraZeneca LP; Stock/Shareholder: AstraZeneca

LP. Parise, Carol ........................................ Disclosed no confl ict of interest.Parisi, Maria Candida ......................... Disclosed no confl ict of interest.Parisi, Monika ..................................... Employee: BD Medical-Diabetes Care. Park, Byoung-Won .............................. Disclosed no confl ict of interest.Park, Byung Soon ................................ Disclosed no confl ict of interest.Park, Cheol-Young ............................... Disclosed no confl ict of interest.Park, Heon-Seok .................................. Disclosed no confl ict of interest.Park, Hyeongkyu ................................. Disclosed no confl ict of interest.Park, Hyesook ...................................... Disclosed no confl ict of interest.Park, Hye-Sun ...................................... Disclosed no confl ict of interest.Park, Jehwan ....................................... Disclosed no confl ict of interest.Park, Jeong Hyun ................................ Disclosed no confl ict of interest.Park, Jong Suk ..................................... Disclosed no confl ict of interest.Park, Joong-Yeol ................................. Disclosed no confl ict of interest.Park, Keun-Gyu .................................... Disclosed no confl ict of interest.Park, Keun-Young ................................ Disclosed no confl ict of interest.Park, Kris .............................................. Disclosed no confl ict of interest.Park, Kyeong Seon .............................. Disclosed no confl ict of interest.Park, Kyong S. ..................................... Disclosed no confl ict of interest.Park, Kyong Soo .................................. Disclosed no confl ict of interest.Park, Kyoung Soo ................................ Disclosed no confl ict of interest.Park, Kyoungmin .................................. Disclosed no confl ict of interest.Park, Kyung Pil ..................................... Disclosed no confl ict of interest.Park, Lara K. ........................................ Disclosed no confl ict of interest.Park, Meeyoung .................................. Disclosed no confl ict of interest.Park, Se Eun ......................................... Disclosed no confl ict of interest.Park, Sejeong ...................................... Disclosed no confl ict of interest.Park, Seok Won ................................... Disclosed no confl ict of interest.Park, Sin Young ................................... Disclosed no confl ict of interest.Park, So Hyun ...................................... Disclosed no confl ict of interest.Park, So Young .................................... Disclosed no confl ict of interest.Park, Su Bin ......................................... Disclosed no confl ict of interest.Park, Su Hyun ...................................... Disclosed no confl ict of interest.Park, Sung Hee .................................... Employee: Hanmi Pharmaceuticals Inc. Park, Sung-Woo .................................. Disclosed no confl ict of interest.Park, Tae Sun ....................................... Disclosed no confl ict of interest.Park, Wook-Ha .................................... Disclosed no confl ict of interest.Park, Yong-Moon ................................ Disclosed no confl ict of interest.Park, Yongsoo ...................................... Disclosed no confl ict of interest.Park, Young Jin .................................... Disclosed no confl ict of interest.Park, Young-Min .................................. Disclosed no confl ict of interest.Parker, Kathryn .................................... Disclosed no confl ict of interest.Parkin, Christopher ............................. Consultant: CeQur SA. Parkkola, Riitta .................................... Disclosed no confl ict of interest.Parlee, Sebastian ................................ Disclosed no confl ict of interest.Parpala, Cristina .................................. Disclosed no confl ict of interest.Parra, Juan .......................................... Disclosed no confl ict of interest.Parrinello, Christina M. ...................... Disclosed no confl ict of interest.Parson, Henri ....................................... Disclosed no confl ict of interest.Partridge, Helen .................................. Disclosed no confl ict of interest.Parvaresh Rizi, Ehsan ......................... Disclosed no confl ict of interest.Parving, Hans-Henrik .......................... Stock/Shareholder: Novo Nordisk A/S. Parzynski, Craig S. .............................. Disclosed no confl ict of interest.Pascoe, Sara ........................................ Disclosed no confl ict of interest.Pascual, Conrado ................................ Disclosed no confl ict of interest.Pascual, Michael ................................. Disclosed no confl ict of interest.Pasquale, Valentina ............................ Disclosed no confl ict of interest.Pasquel, Francisco .............................. Disclosed no confl ict of interest.Pasquet, Blandine ............................... Research Support: AstraZeneca.

A871

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Paster, Ayana ...................................... Disclosed no confl ict of interest.Pastore, Donatella .............................. Disclosed no confl ict of interest.Pasupathy, Shanker ............................ Disclosed no confl ict of interest.Paszkiewicz, Rebecca L. ..................... Disclosed no confl ict of interest.Pate, Russell R. ................................... Disclosed no confl ict of interest.Patek, Stephen K. ............................... Disclosed no confl ict of interest.Patek, Steve ........................................ Disclosed no confl ict of interest.Patel Lewis, Anjana ............................ Employee: Eli Lilly and Company. Patel, Kashyap A. ................................ Disclosed no confl ict of interest.Patel, Neha S. ...................................... Disclosed no confl ict of interest.Patel, Niraja ......................................... Disclosed no confl ict of interest.Patel, Pankaj ........................................ Employee: Cadila Healthcare Limited. Patel, Parshva ...................................... Disclosed no confl ict of interest.Patel, Payal R. ..................................... Disclosed no confl ict of interest.Patel, Samir ......................................... Disclosed no confl ict of interest.Patel, Sanjay ........................................ Employee: Boehringer Ingelheim Ltd. Patel, Sheila K. .................................... Disclosed no confl ict of interest.Patel, Shivani A. .................................. Disclosed no confl ict of interest.Patel, Viraj ........................................... Disclosed no confl ict of interest.Patell, Rushad ..................................... Disclosed no confl ict of interest.Paterson, Andrew D. ........................... Disclosed no confl ict of interest.Pathak, Ram D. .................................... Disclosed no confl ict of interest.Patient, Charlotte ............................... Disclosed no confl ict of interest.Patil, Shivajirao P. ............................... Disclosed no confl ict of interest.Patinkin, Zachary ................................ Disclosed no confl ict of interest.Patorno, Elisabetta ............................. Disclosed no confl ict of interest.Patrício, Bárbara ................................. Disclosed no confl ict of interest.Patrick, Alan ........................................ Disclosed no confl ict of interest.Patrick, Avril ........................................ Disclosed no confl ict of interest.Patsch, Wolfgang ................................ Disclosed no confl ict of interest.Pattavina, Marco ................................ Disclosed no confl ict of interest.Patti, Angelo Maria ............................ Disclosed no confl ict of interest.Patti, Mary-Elizabeth .......................... Consultant: Defi ned Health, Diasome Pharmaceuticals, Inc.,

Foodminds, LLC; Research Support: Nuclea Biosciences, Sanofi U.S.

Patton, Ashley ..................................... Disclosed no confl ict of interest.Patton, John ........................................ Board Member: Dance Biopharm; Employee: Dance

Biopharm; Stock/Shareholder: Dance Biopharm. Paul, Dirk M. ........................................ Disclosed no confl ict of interest.Paul, Ludmilla ...................................... Disclosed no confl ict of interest.Paul, Narinder ...................................... Disclosed no confl ict of interest.Paul, Thomas V. ................................... Disclosed no confl ict of interest.Paulo, Joao A. ..................................... Disclosed no confl ict of interest.Paulson, Jenna .................................... Disclosed no confl ict of interest.Paulus, Andrew ................................... Disclosed no confl ict of interest.Paurer, Jozsef ...................................... Disclosed no confl ict of interest.Pavinatto, Cristina .............................. Disclosed no confl ict of interest.Pavkov, Meda E. .................................. Disclosed no confl ict of interest.Pavlides, Michael ................................ Disclosed no confl ict of interest.Pawar, Abha ........................................ Disclosed no confl ict of interest.Pawlowski, Maciej .............................. Disclosed no confl ict of interest.Payne, Dawn ....................................... Disclosed no confl ict of interest.Payne, Tammie .................................... Disclosed no confl ict of interest.Paz-Filho, Gilberto ............................... Disclosed no confl ict of interest.Pearson, Ewan R. ................................ Disclosed no confl ict of interest.Pedersen, Andreas J. .......................... Disclosed no confl ict of interest.Pedersen, Anne G. .............................. Disclosed no confl ict of interest.Pedersen, Bente K. ............................. Disclosed no confl ict of interest.Pedersen, David J. .............................. Disclosed no confl ict of interest.Pedersen, Jens .................................... Disclosed no confl ict of interest.Pedersen, Lars ..................................... Disclosed no confl ict of interest.Pedersen, Oluf ..................................... Disclosed no confl ict of interest.Pedersen, Steen B. ............................. Disclosed no confl ict of interest.Pedersen-Bjergaard, Ulrik .................. Advisory Panel: AstraZeneca/Bristol-Myers Squibb, Novo

Nordisk A/S, Sanofi U.S.; Research Support: Novo Nordisk A/S; Speaker’s Bureau: AstraZeneca/Bristol-Myers Squibb, Eli Lilly and Company, Novo Nordisk A/S, Sanofi U.S.

Pedigo, Christopher ............................ Disclosed no confl ict of interest.Peeples, Malinda ................................ Employee: WellDoc, Inc. Peerapatdit, Thavatchai ..................... Disclosed no confl ict of interest.Pei, Shaobo .......................................... Disclosed no confl ict of interest.Peinhaupt, Miriam .............................. Disclosed no confl ict of interest.Peiris, Heshan ..................................... Disclosed no confl ict of interest.Peixoto, Eduardo M. ............................ Disclosed no confl ict of interest.Pek, Sharon L.T. ................................... Disclosed no confl ict of interest.Pelcl, Tomas ......................................... Disclosed no confl ict of interest.Peleckis, Amy ...................................... Disclosed no confl ict of interest.Pelikanova, Terezie ............................. Disclosed no confl ict of interest.Pellegrini, William R. .......................... Disclosed no confl ict of interest.Peloso, Andrea .................................... Disclosed no confl ict of interest.Peltekian, Lila ...................................... Disclosed no confl ict of interest.Pelto, Emily .......................................... Disclosed no confl ict of interest.

Pena, Ana M. ....................................... Disclosed no confl ict of interest.Pena, Jessica ...................................... Disclosed no confl ict of interest.Peña, Jonathan ................................... Disclosed no confl ict of interest.Peneva, Desi ........................................ Consultant: AstraZeneca Pharmaceuticals LP. Penfold, Sally A. .................................. Disclosed no confl ict of interest.Penfornis, Alfred ................................. Board Member: Novo Nordisk A/S. Peng, Chuan ......................................... Disclosed no confl ict of interest.Peng, Danfeng ..................................... Disclosed no confl ict of interest.Peng, Hui .............................................. Disclosed no confl ict of interest.Peng, Jian ............................................ Disclosed no confl ict of interest.Peng, Limin .......................................... Disclosed no confl ict of interest.Peng, Yongde ....................................... Disclosed no confl ict of interest.Peng Qiu, Li .......................................... Disclosed no confl ict of interest.Penman, Alan ...................................... Disclosed no confl ict of interest.Pennington, Daniel .............................. Disclosed no confl ict of interest.Penno, Giuseppe ................................. Disclosed no confl ict of interest.Pennoni, Ilaria ..................................... Disclosed no confl ict of interest.Penny, Chelsea .................................... Disclosed no confl ict of interest.Peppas, Theodoros ............................. Disclosed no confl ict of interest.Peragallo-Dittko, Virginia ................... Disclosed no confl ict of interest.Perakakis, Nikolaos ............................ Disclosed no confl ict of interest.Peralta Romero, José de Jesús ......... Disclosed no confl ict of interest.Peralta, Carmen A. .............................. Disclosed no confl ict of interest.Peralta, Jesus ..................................... Disclosed no confl ict of interest.Pereira, Alexandre C. .......................... Disclosed no confl ict of interest.Pereira, Bernardo D. ........................... Disclosed no confl ict of interest.Pereira, Bruna S. ................................. Disclosed no confl ict of interest.Pereira, Maria J. ................................. Disclosed no confl ict of interest.Pereira, Renata O. ............................... Disclosed no confl ict of interest.Pereira, Sofi a S. ................................... Disclosed no confl ict of interest.Pereira, Vinit J. .................................... Disclosed no confl ict of interest.Pérez Manghi, Federico C. .................. Disclosed no confl ict of interest.Perez, Adriana ..................................... Disclosed no confl ict of interest.Perez, Alfonso T. ................................. Employee: Takeda Pharmaceutical Company Limited. Perez, Elys M. ...................................... Disclosed no confl ict of interest.Perez-Basterrechea, Marcos ............. Disclosed no confl ict of interest.Perez-López, Silvia .............................. Disclosed no confl ict of interest.Perez-Nieves, Magaly ........................ Employee: Eli Lilly and Company; Other Relationship: student

at Walden University; Stock/Shareholder: Eli Lilly and Company.

Pérez-Peralta, Liliana .......................... Disclosed no confl ict of interest.Pérez-Rubio, Karina G. ........................ Disclosed no confl ict of interest.Perez-Tilve, Diego ............................... Consultant: Calibrium; Research Support: Calibrium. Perfetti, Riccardo ................................ Employee: Sanofi ; Stock/Shareholder: Sanofi . Perfi lyev, Alexander ............................ Disclosed no confl ict of interest.Perkins, Bruce A. ................................. Advisory Panel: NeuroMetrix, Inc.; Research Support:

Boehringer Ingelheim Pharmaceuticals, Inc., Medtronic MiniMed, Inc.; Speaker’s Bureau: Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Medtronic MiniMed, Inc., Novo Nordisk Inc., Roche Diagnostics.

Perl, Shira ............................................ Employee: AstraZeneca Pharmaceuticals LP. Perls, Thomas T. .................................. Disclosed no confl ict of interest.Pernet, Andrew ................................... Disclosed no confl ict of interest.Pernigo, Matteo .................................. Disclosed no confl ict of interest.Peroni, Odile D. .................................... Disclosed no confl ict of interest.Perra, Silvia ......................................... Disclosed no confl ict of interest.Perrea, Despoina ................................. Disclosed no confl ict of interest.Perreault, Leigh ................................... Board Member: Bayer HealthCare, LipoScience, Inc., Merck

& Co., Inc.; Consultant: IHS, Novo Nordisk A/S. Perrild, Hans ........................................ Other Relationship: Novo Nordisk A/S. Perrimon, Norbert ............................... Disclosed no confl ict of interest.Perrini, Sebastio .................................. Disclosed no confl ict of interest.Perry, Christina G. ............................... Disclosed no confl ict of interest.Perry, James A. ................................... Disclosed no confl ict of interest.Perseghin, Gianluca ............................ Disclosed no confl ict of interest.Persson, Marcel .................................. Disclosed no confl ict of interest.Persson, Margaretha .......................... Disclosed no confl ict of interest.Persson, Xuan-Mai ............................. Disclosed no confl ict of interest.Pesau, Gerfried ................................... Disclosed no confl ict of interest.Pescara, Teresa ................................... Disclosed no confl ict of interest.Pescatore, Maria ................................ Research Support: LifeScan, Inc. Peschechera, Alessandro ................... Disclosed no confl ict of interest.Peshdary, Vian ..................................... Disclosed no confl ict of interest.Pessin, Jeffrey .................................... Disclosed no confl ict of interest.Pesterfi eld, Claire ............................... Disclosed no confl ict of interest.Peter, Andreas ..................................... Disclosed no confl ict of interest.Peters, Aimee ...................................... Employee: AbilTo, Inc.; Stock/Shareholder: AbilTo, Inc. Peters, Anne L. .................................... Consultant: Abbott Diabetes Care, Inc., Amgen Inc., Becton,

Dickinson and Company, Biodel Inc., Bristol-Myers Squibb/AstraZeneca, Janssen Biotech, Inc., Lexicon Pharmaceuticals, Inc., Lilly Deutschland GmbH, Medtronic MiniMed, Inc., Novo Nordisk Inc., OptumRx,

A872

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Sanofi U.S., Takeda Pharmaceutical Company Limited, Thermalin.

Petersen, Laura ................................... Disclosed no confl ict of interest.Petersen, Max C. ................................. Disclosed no confl ict of interest.Petersson, Stine J. .............................. Disclosed no confl ict of interest.Petit, Catherine ................................... Disclosed no confl ict of interest.Petit, Marie-Helene ............................ Disclosed no confl ict of interest.Petpiboonthai, Hattaya ...................... Disclosed no confl ict of interest.Petropoulos, Loannis .......................... Disclosed no confl ict of interest.Petruschke, Thorsten .......................... Employee: Bayer HealthCare. Pettis, Ronald J. .................................. Employee: Becton, Dickinson and Company; Research

Support: Juvenile Diabetes Research Foundation; Stock/Shareholder: Becton, Dickinson and Company.

Pettus, Jeremy .................................... Research Support: Dexcom, Inc. Peyrot, Mark ........................................ Advisory Panel: Eli Lilly and Company, GlaxoSmithKline,

Novo Nordisk Inc., Tethys; Consultant: Calibra Medical, Eli Lilly and Company, Novo Nordisk Inc.; Research Support: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Genentech, Inc., Novo Nordisk Inc.; Speaker’s Bureau: Novo Nordisk Inc.

Pezos, Nektaria ................................... Disclosed no confl ict of interest.Pezzolesi, Marcus ............................... Disclosed no confl ict of interest.Pfefferkorn, Jeffrey ............................ Employee: Pfi zer Inc. Pfeifer, Verena .................................... Disclosed no confl ict of interest.Pfeiffer, Andreas F. ............................. Advisory Panel: AstraZeneca Pharmaceuticals LP, Berlin-

Chemie AG, Novo Nordisk A/S; Speaker’s Bureau: Lilly Deutschland GmbH.

Pfeiffer, Kathryn M. ............................ Consultant: Novo Nordisk A/S. Pfl ug, Brian .......................................... Employee: Becton, Dickinson and Company; Stock/

Shareholder: Becton, Dickinson and Company. Pfützner, Andreas ............................... Consultant: Insuline Medical Ltd., LifeScan, Inc., Novo

Nordisk A/S, Sanofi , Unomedical; Research Support: Boehringer Ingelheim GmbH, Janssen Pharmaceutical Companies of Johnson & Johnson, LifeScan, Inc.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Berlin-Chemie, Insuline Medical Ltd., Sanofi .

Pfützner, Anke H. ................................ Consultant: Insuline Medical Ltd.; Employee: Sciema UG. Pham, Christal ..................................... Disclosed no confl ict of interest.Pham, Tam T. ....................................... Disclosed no confl ict of interest.Phan, Jennifer ..................................... Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Phan, Thanh ......................................... Disclosed no confl ict of interest.Phang, Chee Chin ................................ Disclosed no confl ict of interest.Philippe, Froguel ................................. Disclosed no confl ict of interest.Philis-Tsimikas, Athena ....................... Advisory Panel: AstraZeneca/Bristol-Myers Squibb, Merck

& Co., Inc., Novo Nordisk Inc., Sanofi U.S. Phillip, Moshe ...................................... Advisory Panel: Bristol-Myers Squibb/AstraZeneca, Eli

Lilly and Company, Medtronic, Inc., Sanofi ; Board Member: C.G.M.3. Ltd.; Consultant: Andromeda, AstraZeneca/Bristol-Myers Squibb, Bristol-Myers Squibb Company, Sanofi ; Research Support: Andromeda, Dexcom, Inc., Eli Lilly and Company, Medtronic, Inc., Merck & Co., Inc., Novo Nordisk Inc., Roche Diagnostics, Sanofi ; Speaker’s Bureau: Animas Corporation, J&J, Medtronic, Inc., Roche Diagnostics; Stock/Shareholder: C.G.M.3. Ltd.

Phillips, Erin ......................................... Disclosed no confl ict of interest.Phillips, Kevin ...................................... Disclosed no confl ict of interest.Phillips, Lawrence S. .......................... Advisory Panel: Avolonte, Boehringer Ingelheim

Pharmaceuticals, Inc., Janssen Pharmaceutical Companies of Johnson & Johnson; Other Relationship: Diasyst LLC; Research Support: Abbvie, Amylin Pharmaceuticals, LLC., Cystic Fibrosis Foundation, Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk Inc., PhaseBio Pharmaceuticals, Inc., Roche USA, Sanofi U.S., Vascular Pharmaceuticals.

Phillips, Shane A. ................................ Disclosed no confl ict of interest.Phillips, Susan A. ................................ Research Support: Raptor Pharmaceuticals. Phippard, Deborah .............................. Disclosed no confl ict of interest.Phung, Olivia J. ................................... Disclosed no confl ict of interest.Pi, Linhua ............................................. Disclosed no confl ict of interest.Piaggesi, Alberto ................................ Disclosed no confl ict of interest.Piaggi, Paolo ........................................ Disclosed no confl ict of interest.Piao, Lingjuan ...................................... Disclosed no confl ict of interest.Piao, Shan-Ji ....................................... Disclosed no confl ict of interest.Piatt, Gretchen .................................... Disclosed no confl ict of interest.Piccinin, Meghan A. ............................ Disclosed no confl ict of interest.Piccinini, Francesca ............................ Disclosed no confl ict of interest.Piché, Claude A. .................................. Disclosed no confl ict of interest.Pichiri, Isabella .................................... Disclosed no confl ict of interest.Pichotta, Philip .................................... Employee: Biodel Inc.; Stock/Shareholder: Biodel Inc. Pick, Rebecca ...................................... Employee: Janssen Research & Development LLC.

Pieber, Thomas R. ............................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, Novo Nordisk Inc., Roche Diagnostics; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Novo Nordisk Inc., Roche Diagnostics.

Piemonti, Lorenzo ................................ Disclosed no confl ict of interest.Pierce, Janet D. ................................... Disclosed no confl ict of interest.Piercy, James ...................................... Disclosed no confl ict of interest.Pierreisnard, Audrey ........................... Disclosed no confl ict of interest.Pierzchała, Krystyna ........................... Disclosed no confl ict of interest.Pietiläinen, Kirsi H. ............................. Disclosed no confl ict of interest.Pietrzycka, Agata ................................ Disclosed no confl ict of interest.Piffer, Silvano ...................................... Disclosed no confl ict of interest.Piganelli, Jon D. .................................. Disclosed no confl ict of interest.Pihlajamäki, Jussi ............................... Disclosed no confl ict of interest.Pihoker, Catherine ............................... Disclosed no confl ict of interest.Pijl, Hanno ............................................ Disclosed no confl ict of interest.Pikulska-Chrobak, Ewa ....................... Disclosed no confl ict of interest.Pilch, Paul F. ......................................... Disclosed no confl ict of interest.Pileggi, Antonello ................................ Disclosed no confl ict of interest.Piljac, Ante .......................................... Disclosed no confl ict of interest.Pillai, Pradeep Babu S. ........................ Disclosed no confl ict of interest.Pimentel, Daniela A. ........................... Disclosed no confl ict of interest.Pimentel, Samara ................................ Disclosed no confl ict of interest.Pınar, Eker.......... Disclosed no confl ict of interest.Pinckney, Ashley ................................. Disclosed no confl ict of interest.Pinelli, Juan ......................................... Disclosed no confl ict of interest.Ping, Chen ............................................ Disclosed no confl ict of interest.Pinner, Jason ....................................... Disclosed no confl ict of interest.Pinsker, Jordan .................................... Disclosed no confl ict of interest.Pintaudi, Basilio .................................. Disclosed no confl ict of interest.Pinto, Camila S. ................................... Disclosed no confl ict of interest.Pinto, Lana C. ...................................... Disclosed no confl ict of interest.Pipkin, J.D. ........................................... Employee: Ligand Pharmaceuticals, Inc. Pipkin, Joseph A. ................................ Disclosed no confl ict of interest.Pirags, Valdis ....................................... Disclosed no confl ict of interest.Pires, Karla M. ..................................... Disclosed no confl ict of interest.Piroli, Gerardo ..................................... Disclosed no confl ict of interest.Pirzgalska, Roksana ............................ Disclosed no confl ict of interest.Pissios, Pavlos ..................................... Disclosed no confl ict of interest.Pistorio, Angela ................................... Disclosed no confl ict of interest.Pistrosch, Frank ................................... Advisory Panel: Novo Nordisk Inc.; Research Support:

Medtronic, Inc., Sanofi Pasteur SA. Pitchaimani, Vigneshwaran ............... Disclosed no confl ict of interest.Pitkänen, Niina .................................... Disclosed no confl ict of interest.Pizot, Cécile ......................................... Disclosed no confl ict of interest.Place, Jerome ...................................... Disclosed no confl ict of interest.Placzkiewicz-Jankowska, Ewa .......... Disclosed no confl ict of interest.Plamboeck, Astrid ............................... Disclosed no confl ict of interest.Plank, Johannes .................................. Speaker’s Bureau: Novo Nordisk A/S. Plascencia, Salvador ........................... Disclosed no confl ict of interest.Platt, David .......................................... Employee: Boston Therapeutics Inc. Player, Mark ........................................ Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Plesner, Annette ................................. Employee: Novo Nordisk A/S. Plessmann, Amanda ............................ Disclosed no confl ict of interest.Pleus, Stefan ....................................... Disclosed no confl ict of interest.Plomgaard, Peter ................................. Disclosed no confl ict of interest.Plotkin, Diane ...................................... Consultant: Ligand Pharmaceuticals, Inc. Plummer, Mark P. ................................. Disclosed no confl ict of interest.Plunkett, Brittany ................................ Disclosed no confl ict of interest.Plutzky, Jorge ...................................... Disclosed no confl ict of interest.Pober, David ........................................ Disclosed no confl ict of interest.Pocai, Alessandro ............................... Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Pochat, Armelle ................................... Disclosed no confl ict of interest.Podell, Brendan K. ............................... Disclosed no confl ict of interest.Poffenberger, Gregory L. .................... Disclosed no confl ict of interest.Pogach, Leonard .................................. Disclosed no confl ict of interest.Pogliani, Gabriele ................................ Disclosed no confl ict of interest.Pohl, Roderike ..................................... Employee: Biodel Inc.; Research Support: National Institute

of Diabetes and Digestive and Kidney Diseases. Pohlig, Ryan T. ..................................... Disclosed no confl ict of interest.Pohlmeier, Harald ................................ Disclosed no confl ict of interest.Poitout, Vincent .................................. Board Member: Bêtagenex; Consultant: Novartis Corporation. Pokharel, Yashashwi .......................... Research Support: American Heart Association. Polak, Rani ........................................... Research Support: Metagenics, Inc. Polanco, Miguel A. .............................. Disclosed no confl ict of interest.Polat, Hakki ......................................... Disclosed no confl ict of interest.Policardo, Laura .................................. Disclosed no confl ict of interest.Polidori, David ..................................... Employee: Janssen Research & Development, LLC. Polina, Evelise R. ................................. Disclosed no confl ict of interest.

A873

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Polkinghorne, Kevan ........................... Disclosed no confl ict of interest.Pollack, Rena M. ................................. Disclosed no confl ict of interest.Pollin, Toni I. ........................................ Disclosed no confl ict of interest.Pollock, Richard ................................... Consultant: Eli Lilly and Company. Pollom, Robyn K. ................................. Employee: Eli Lilly and Company, Eli Lilly and Company

(Spouse/Partner); Stock/Shareholder: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner).

Polonsky, William H. ........................... Advisory Panel: Abbott, Boehringer Ingelheim Pharmaceuticals, Inc., Dexcom, Inc., Eli Lilly and Company, Johnson & Johnson, Novo Nordisk Inc., Roche Diagnostics, Sanofi U.S., Takeda Pharmaceuticals U.S.A., Inc.

Polus, Anna .......................................... Disclosed no confl ict of interest.Polychronakos, Constantin ................. Disclosed no confl ict of interest.Pomeroy, Jeremy ................................. Disclosed no confl ict of interest.Pongratz, Rebecca L. .......................... Disclosed no confl ict of interest.Ponirakis, Georgios ............................. Disclosed no confl ict of interest.Ponissi, Veronica ................................. Disclosed no confl ict of interest.Pons, Belén .......................................... Disclosed no confl ict of interest.Pontecorvi, Alfredo ............................. Disclosed no confl ict of interest.Pontén, Fredrik .................................... Disclosed no confl ict of interest.Pontiroli, Antonio E. ............................ Disclosed no confl ict of interest.Pontremoli, Roberto ............................ Disclosed no confl ict of interest.Poon, Tak .............................................. Disclosed no confl ict of interest.Pop-Busui, Rodica ............................... Research Support: AstraZeneca/Bristol-Myers Squibb

(Spouse/Partner), Impeto Medical (Spouse/Partner). Popescu Valceanu, Horatiu Cristian .. Disclosed no confl ict of interest.Popescu, Horatiu ................................. Disclosed no confl ict of interest.Porcellati, Francesca .......................... Advisory Panel: Bristol-Myers Squibb Company, Eli Lilly and

Company, Merck & Co., Inc., Sanofi ; Speaker’s Bureau: Bristol-Myers Squibb Company, Eli Lilly and Company, Merck & Co., Inc., Sanofi .

Pordy, Robert ....................................... Employee: Regeneron Pharmaceuticals, Inc.; Stock/Shareholder: Regeneron Pharmaceuticals, Inc.

Poretsky, Leonid .................................. Disclosed no confl ict of interest.Porksen, Niels ..................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Porneala, Bianca ................................. Disclosed no confl ict of interest.Porro, Stefania .................................... Disclosed no confl ict of interest.Porter, Christopher J. ......................... Research Support: Eli Lilly and Company. Porter, Craig ........................................ Disclosed no confl ict of interest.Porter, Lisa ........................................... Employee: Dance Biopharm; Stock/Shareholder: Dance

Biopharm. Portha, Bernard ................................... Disclosed no confl ict of interest.Portillo Sanchez, Paola ....................... Disclosed no confl ict of interest.Portugal, Jorge .................................... Disclosed no confl ict of interest.Posea, Mihaela ................................... Disclosed no confl ict of interest.Posgai, Amanda .................................. Disclosed no confl ict of interest.Post, Jessica ....................................... Disclosed no confl ict of interest.Potasso, Laura ..................................... Disclosed no confl ict of interest.Potenza, Marc N. ................................ Consultant: iNSYS, Ironwood, Lundbeck, RiverMend,

Shire. Pothier, Claire E. .................................. Disclosed no confl ict of interest.Potjer, Thomas P. ................................. Disclosed no confl ict of interest.Pottala, James V. ................................ Employee: Health Diagnostics Laboratory, Inc. Potter, Jean ......................................... Disclosed no confl ict of interest.Potter, Jennifer ................................... Disclosed no confl ict of interest.Potthoff, Matthew J. .......................... Disclosed no confl ict of interest.Pöttler, Tina ......................................... Disclosed no confl ict of interest.Poucher, Simon M. .............................. Disclosed no confl ict of interest.Poucheret, Patrick ............................... Disclosed no confl ict of interest.Poulsen, Marianne K. .......................... Disclosed no confl ict of interest.Poulsen, Per L. ..................................... Disclosed no confl ict of interest.Poulsen, Steen S. ................................ Disclosed no confl ict of interest.Powell, A. Blair .................................... Disclosed no confl ict of interest.Powell, Albert B. ................................. Disclosed no confl ict of interest.Powell, Danielle .................................. Disclosed no confl ict of interest.Powell, David ....................................... Employee: Lexicon Pharmaceuticals, Inc. Powell, Jeffrey .................................... Disclosed no confl ict of interest.Powell, Robert ..................................... Disclosed no confl ict of interest.Powell, Winter .................................... Disclosed no confl ict of interest.Power, David A. ................................... Disclosed no confl ict of interest.Power, Joseph ..................................... Disclosed no confl ict of interest.Pozzi, Ambra ........................................ Disclosed no confl ict of interest.Pozzi, Jose ........................................... Disclosed no confl ict of interest.Pozzilli, Paolo ....................................... Disclosed no confl ict of interest.Prabhakar, Prakash ............................. Employee: Intarcia Therapeutics, Inc. Prabhakaran, Dorairaj ......................... Disclosed no confl ict of interest.Prada, Patricia O. ................................ Disclosed no confl ict of interest.Pradeepa, Rajendra ............................ Disclosed no confl ict of interest.Pradhan-Nabzdyk, Leena ................... Disclosed no confl ict of interest.Pradignac, Alain .................................. Disclosed no confl ict of interest.

Prahalad, Priya .................................... Disclosed no confl ict of interest.Prajapati, Aarohi ................................. Disclosed no confl ict of interest.Prakasam, Gnanagurudasan .............. Consultant: Dexcom, Inc.; Speaker’s Bureau: Novo Nordisk

Inc., Sanofi U.S. Pramfalk, Camilla ................................ Disclosed no confl ict of interest.Prasad, Rashmi B. ............................... Disclosed no confl ict of interest.Pratley, Richard E. ............................... Disclosed no confl ict of interest.Prazny, Martin ..................................... Consultant: Dexcom, Inc., Eli Lilly and Company, Medtronic,

Inc., Novo Nordisk Inc. Preil, Simone A. ................................... Disclosed no confl ict of interest.Preiss, David ........................................ Advisory Panel: Sanofi . Preissl, Hubert ..................................... Disclosed no confl ict of interest.Preitner, Frederic ................................. Disclosed no confl ict of interest.Premaratne, Erosha ............................ Disclosed no confl ict of interest.Premkumar, Chitra .............................. Disclosed no confl ict of interest.Prendergast, Kim ................................ Disclosed no confl ict of interest.Prentice, Kacey J. ............................... Disclosed no confl ict of interest.Presley, Larraine ................................. Disclosed no confl ict of interest.Presley, Theresa .................................. Disclosed no confl ict of interest.Pressel, Sara L. ................................... Disclosed no confl ict of interest.Prestrelski, Steven J. .......................... Employee: employee, Xeris Pharmaceuticals, Inc. Prewitt, Todd ....................................... Advisory Panel: Eli Lilly and Company, Novo Nordisk Inc. Price, David A. ..................................... Employee: Dexcom, Inc. Prietl, Barbara ..................................... Disclosed no confl ict of interest.Prince, Melvin J. ................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Principato, Maria Catena ................... Disclosed no confl ict of interest.Pritchard, Melanie .............................. Disclosed no confl ict of interest.Pritchard, Nicola ................................. Disclosed no confl ict of interest.Pritzker, Sonya .................................... Disclosed no confl ict of interest.Priyadarshini, Medha ......................... Disclosed no confl ict of interest.Probstfi eld, Jeffrey L. ......................... Consultant: Sanofi U.S.Profi li, Francesco ................................. Disclosed no confl ict of interest.Prokopenko, Inga ................................. Disclosed no confl ict of interest.Pronin, Oleksii ..................................... Disclosed no confl ict of interest.Proshchina, Alexandra E. .................... Disclosed no confl ict of interest.Prosser, Hamish C. .............................. Disclosed no confl ict of interest.Protogerou, Athanasios ...................... Disclosed no confl ict of interest.Proux, Esstelle ..................................... Disclosed no confl ict of interest.Provenzano, Aldesia ........................... Disclosed no confl ict of interest.Provenzano, Francesca ....................... Disclosed no confl ict of interest.Provenzano, Vincenzo ......................... Disclosed no confl ict of interest.Province, Michael A. ........................... Disclosed no confl ict of interest.Prudente, Sabrina ............................... Disclosed no confl ict of interest.Pruett, Timothy L. ............................... Disclosed no confl ict of interest.Prünner, Marlies .................................. Disclosed no confl ict of interest.Ptacek, Peggy ...................................... Disclosed no confl ict of interest.Ptaszynska, Agata A. .......................... Employee: Bristol-Myers Squibb; Stock/Shareholder: Bristol-

Myers Squibb. Puchowicz, Michelle ........................... Disclosed no confl ict of interest.Puelles, Jorge ...................................... Employee: Takeda Pharmaceutical Company Limited. Pugliese, Alberto ................................ Disclosed no confl ict of interest.Puglisi, Francesco ............................... Disclosed no confl ict of interest.Pugovkina, Yroslava ............................ Disclosed no confl ict of interest.Pujadas, Gemma ................................. Disclosed no confl ict of interest.Pullack-McCormick, Sara ................... Disclosed no confl ict of interest.Pullara, Carmen ................................... Disclosed no confl ict of interest.Pullen, Timothy J. ................................ Disclosed no confl ict of interest.Pulliam, Lindsay .................................. Disclosed no confl ict of interest.Pulungan, Zulkarnain .......................... Disclosed no confl ict of interest.Pumar López, Alfonso ......................... Disclosed no confl ict of interest.Pumerantz, Andrew S. ........................ Disclosed no confl ict of interest.Punthakee, Zubin ................................ Other Relationship: Astra Zeneca, BMS, Boehringer

Ingelheim, Eli Lilly, Jannsen, Merck, NovoNordisk, Sanofi , Serono.

Pupyshev, Alexandr B. ........................ Disclosed no confl ict of interest.Puri, Mala ............................................ Disclosed no confl ict of interest.Puri, Srishti .......................................... Disclosed no confl ict of interest.Purizaga, Hassan ................................. Disclosed no confl ict of interest.Purwana, Indri ..................................... Disclosed no confl ict of interest.Puryear, Jennifer S. ............................ Disclosed no confl ict of interest.Pusec, Carolina M. .............................. Disclosed no confl ict of interest.Pussard, Eric ........................................ Disclosed no confl ict of interest.Puttanna, Amar ................................... Disclosed no confl ict of interest.Püttgen, Sonja ..................................... Disclosed no confl ict of interest.Pyle, Laura ........................................... Disclosed no confl ict of interest.Pyrlis, Felicity ...................................... Disclosed no confl ict of interest.Qi, Jenson ............................................ Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Qi, Lu .................................................... Disclosed no confl ict of interest.Qi, Nathan ........................................... Disclosed no confl ict of interest.Qi, Qibin ............................................... Disclosed no confl ict of interest.

A874

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Qi, Weier .............................................. Disclosed no confl ict of interest.Qi, Yajuan ............................................. Disclosed no confl ict of interest.Qi, Yue .................................................. Disclosed no confl ict of interest.Qian, Can ............................................. Disclosed no confl ict of interest.Qian, Hongwei ..................................... Disclosed no confl ict of interest.Qian, Lei ............................................... Employee: Lilly Suzhou Pharmaceutical Co. Ltd. Qiang, Guifen ....................................... Disclosed no confl ict of interest.Qiao, Qing ............................................ Employee: Astrazeneca Phamaceuticals. Qifu, Li .................................................. Disclosed no confl ict of interest.Qin, Guijun ........................................... Research Support: Becton, Dickinson and Company. Qin, Guoyou ......................................... Disclosed no confl ict of interest.Qin, Sun ................................................ Disclosed no confl ict of interest.Qiu, Liru ................................................ Disclosed no confl ict of interest.Qiu, Miaoyan ....................................... Disclosed no confl ict of interest.Qiu, Weiyu ........................................... Disclosed no confl ict of interest.Qiu, Zongyu .......................................... Disclosed no confl ict of interest.Qu, Jun ................................................. Disclosed no confl ict of interest.Qu, Mei-Hua ........................................ Disclosed no confl ict of interest.Qu, Shen .............................................. Disclosed no confl ict of interest.Qu, Xiaoxue ......................................... Disclosed no confl ict of interest.Qu, Yongming ...................................... Employee: Eli Lilly and Company, Eli Lilly and Company

(Spouse/Partner); Stock/Shareholder: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner).

Quairoli, Kristi ..................................... Disclosed no confl ict of interest.Quaresma, Paula Gabriele F. .............. Disclosed no confl ict of interest.Quayle, Annette E. .............................. Disclosed no confl ict of interest.Quedas, Elisangela S. ......................... Disclosed no confl ict of interest.Queen, Tara ......................................... Research Support: National Institute of Diabetes and

Digestive and Kidney Diseases. Quek, Timothy ..................................... Disclosed no confl ict of interest.Quesenberry, Charles ......................... Disclosed no confl ict of interest.Quinn, Charlene C. .............................. Disclosed no confl ict of interest.Quinn, Lauretta T. ............................... Disclosed no confl ict of interest.Quinn, Laurie ....................................... Disclosed no confl ict of interest.Quinn, Matthew .................................. Employee: DiabetOmics, Inc. Quinn, Michael T. ................................ Disclosed no confl ict of interest.Quinn, Sheila M. .................................. Disclosed no confl ict of interest.Quinones, Ana ..................................... Research Support: American Diabetes Association. Quirino, Alessia ................................... Disclosed no confl ict of interest.R., Chandni .......................................... Disclosed no confl ict of interest.Raal, Frederick J. ................................ Consultant: Amgen Inc., AstraZeneca, Merck, Pfi zer, Sanofi ;

Research Support: Amgen Inc., Sanofi ; Speaker’s Bureau: Amgen, AstraZeneca, Merck, Pfi zer.

Rabasa-Lhoret, Rémi .......................... Other Relationship: Owns IP for artifi cial pancreas, Sanofi U.S.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Becton, Dickinson and Company, Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, LifeScan, Inc., Medtronic, Inc., Merck & Co., Inc., Neomed, Novartis Corporation, Novo Nordisk Inc., Roche USA, Takeda Pharmaceuticals U.S.A., Inc., valeant.

Rabbone, Ivana .................................... Board Member: Bayer HealthCare, Eli Lilly and Company, Roche, Sanofi .

Rabiee, Atefeh .................................... Disclosed no confl ict of interest.Rabøl, Rasmus ..................................... Disclosed no confl ict of interest.Raccah, Denis ...................................... Advisory Panel: Astra Zeneca, Eli Lilly, Janssen, Novartis,

Novo Nordisk, Sanofi ; Board Member: Astra Zeneca, Eli Lilly, Janssen, Novartis, Novo Nordisk, Sanofi .

Racette, Susan .................................... Disclosed no confl ict of interest.Radaelli, Maria Grazia ........................ Disclosed no confl ict of interest.Radican, Larry ..................................... Employee: Merck & Co., Inc. Radizishevsky, Eugeny ........................ Disclosed no confl ict of interest.Radom-Aizik, Shlomit ......................... Disclosed no confl ict of interest.Rados, Dimitris V. ................................ Disclosed no confl ict of interest.Radulian, Gabriela ............................... Disclosed no confl ict of interest.Rady, Brian .......................................... Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson; Stock/Shareholder: Johnson & Johnson. Raeder, Helge ...................................... Disclosed no confl ict of interest.Rafi kova, Olga ..................................... Disclosed no confl ict of interest.Rafkin, Lisa E. ...................................... Disclosed no confl ict of interest.Raghavan, Arun ................................... Disclosed no confl ict of interest.Raghavan, Pooja .................................. Disclosed no confl ict of interest.Raghavan, Sridharan .......................... Disclosed no confl ict of interest.Raghupathi, Ravinarayan ................... Disclosed no confl ict of interest.Ragot, Stephanie ................................ Disclosed no confl ict of interest.Rahman, Atta U. .................................. Disclosed no confl ict of interest.Rahnenführer, Jan .............................. Disclosed no confl ict of interest.Rai, Sumita .......................................... Employee: DiabetOmics, Inc. Raichlin, Dina ...................................... Disclosed no confl ict of interest.Raiko, Juho .......................................... Disclosed no confl ict of interest.Raimundo, Luísa .................................. Disclosed no confl ict of interest.Rainho, Ana Paula A. .......................... Disclosed no confl ict of interest.

Rajamani, Kushwin ............................. Disclosed no confl ict of interest.Rajamani, Sridharan ........................... Employee: Gilead; Stock/Shareholder: Gilead. Rajan, Suja S. ...................................... Disclosed no confl ict of interest.Rajaobelina, Kalina ............................. Disclosed no confl ict of interest.Rajendran, Rajesh ............................... Disclosed no confl ict of interest.Rajendran, Saranya ............................ Disclosed no confl ict of interest.Rajpathak, Swapnil ............................. Employee: Merck & Co., Inc. Rajput, Yamina .................................... Employee: Genentech, Inc. Raju, Aditya ......................................... Consultant: Boehringer Ingelheim Pharmaceuticals, Inc. Rakheja, Rohan ................................... Disclosed no confl ict of interest.Rakshit, Kuntol .................................... Disclosed no confl ict of interest.Raleigh, Daniel P. ................................ Other Relationship: D.P.R. has fi led patent applications

for the screening of toxic intermediates, and is a co-inventor on a patent application for fl uorescent analogs of h-IAPP.

Raluy, Mireia ....................................... Disclosed no confl ict of interest.Ram, Jagannathan .............................. Disclosed no confl ict of interest.Ram, Uma ............................................ Disclosed no confl ict of interest.Ramachandran, Ambady .................... Disclosed no confl ict of interest.Ramachandran, Sabarinathan ........... Disclosed no confl ict of interest.Ramachandran, Vinitha ...................... Disclosed no confl ict of interest.Ramakrishnan, Parameswaran .......... Disclosed no confl ict of interest.Raman, Sripriya ................................... Disclosed no confl ict of interest.Ramanathan, Kavitha ......................... Disclosed no confl ict of interest.Ramchandani, Neesha ........................ Disclosed no confl ict of interest.Ramirez, Amelie .................................. Disclosed no confl ict of interest.Ramírez-Vélez, Robinson .................... Disclosed no confl ict of interest.Ramiro, Rebeca E. ............................... Disclosed no confl ict of interest.Raml, Reingard .................................... Disclosed no confl ict of interest.Ramm, Georg ....................................... Disclosed no confl ict of interest.Ramos, Clementina ............................. Disclosed no confl ict of interest.Ramos, Maria G. ................................. Disclosed no confl ict of interest.Ramsey, David ..................................... Disclosed no confl ict of interest.Ramzan, Muhammad .......................... Disclosed no confl ict of interest.Ran, Jianmin ........................................ Disclosed no confl ict of interest.Rana, Himanshu .................................. Disclosed no confl ict of interest.Rana, Jignasa ...................................... Employee: Bristol-Myers Squibb Company. Randazzo, Caroline ............................. Disclosed no confl ict of interest.Randolph, John F. ................................ Disclosed no confl ict of interest.Randrianarisoa, Elko ........................... Disclosed no confl ict of interest.Ranetti, Aurelian E. ............................. Advisory Panel: National Ethical Commission for the drug’s

clinical study (Endocrinology specialist); Research Support: Eli Lilly and Company, Pfi zer, Servier; Speaker’s Bureau: Abbott, Alfa Wasserman, Eli Lilly and Company.

Rangel Miller, Vanessa ....................... Consultant: AstraZeneca Pharmaceuticals LP. Ranjan, Ajenthen ................................ Disclosed no confl ict of interest.Ranjani, H. ........................................... Disclosed no confl ict of interest.Rankin, Matthew ................................ Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Rankin, Tim M. .................................... Disclosed no confl ict of interest.Ranson, Aymeric ................................. Employee: Adocia; Stock/Shareholder: Adocia. Ranvir, Ramchandra ............................ Employee: Cadila Healthecare Limited. Rao, Ajay D. ......................................... Disclosed no confl ict of interest.Rao, Ganesh ........................................ Disclosed no confl ict of interest.Rao, Hengyi ......................................... Disclosed no confl ict of interest.Rao, Junhua ......................................... Disclosed no confl ict of interest.Rao, Paturi V. ....................................... Stock/Shareholder: DiabetOmics, Inc. Rapaport, Robert ................................ Disclosed no confl ict of interest.Rapkin, Myron C. ................................. Employee: PopTest LLC; Stock/Shareholder: PopTest LLC. Rardin, Matthew ................................. Disclosed no confl ict of interest.Rasa, Ingvars ....................................... Disclosed no confl ict of interest.Rasbach, Lisa E. .................................. Disclosed no confl ict of interest.Raskauskiene, Diana .......................... Disclosed no confl ict of interest.Raskin, Philip ....................................... Other Relationship: Amylin Pharmaceuticals, LLC.,

Andromeda, AstraZeneca Pharmaceuticals LP, Boehringer-Ingelheim Pharmaceuticals, Boston Therapeutics, Eli Lilly and Company, GlaxoSmithKline, Intarcia, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck & Co., Inc., Novo Nordisk Inc., Pfi zer Inc.; Research Support: Astellas Pharma US, Inc., Bayer HealthCare, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases.

Rask-Madsen, Christian ..................... Disclosed no confl ict of interest.Rasmussen, Lars M. ........................... Disclosed no confl ict of interest.Rasmussen, Signe S. .......................... Research Support: Boehringer Ingelheim Pharmaceuticals,

Inc. Rasmussen, Søren .............................. Employee: Novo Nordisk; Stock/Shareholder: Novo Nordisk. Rasmussen, Steen .............................. Disclosed no confl ict of interest.Rasmussen-Torvik, Laura J. ............... Disclosed no confl ict of interest.Rasouli, Neda ...................................... Disclosed no confl ict of interest.

A875

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Rath, Akshyaya ................................... Employee: Cadila Healthcare Limited. Rathmann, Wolfgang .......................... Consultant: Sanofi . Rathner, Robert ................................... Disclosed no confl ict of interest.Ratner, Robert ..................................... Disclosed no confl ict of interest.Rattanamongkolgul, Suthee .............. Disclosed no confl ict of interest.Rauch, Lindsey B. ................................ Disclosed no confl ict of interest.Raun, Kirsten ....................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Rausaria, Smita ................................... Disclosed no confl ict of interest.Rausell-Palamos, Francisco ............... Disclosed no confl ict of interest.Ravier, Magalie ................................... Disclosed no confl ict of interest.Ravkilde, Jan ....................................... Disclosed no confl ict of interest.Ravn, Peter .......................................... Employee: AstraZeneca Pharmaceuticals LP. Ravula, Pragati .................................... Employee: Biodel Inc. Ravussin, Eric ...................................... Disclosed no confl ict of interest.Ray, Kausik .......................................... Advisory Panel: Nil; Board Member: Nil; Consultant:

AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited; Employee: Nil; Other Relationship: Nil; Research Support: Nil; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited; Stock/Shareholder: Nil.

Ray, Rebecca ....................................... Speaker’s Bureau: Valeritas. Raychaudhuri, Soumya ....................... Disclosed no confl ict of interest.Rayman, Anne ..................................... Disclosed no confl ict of interest.Rayman, Gerry ..................................... Disclosed no confl ict of interest.Raymond, Jennifer K. ......................... Disclosed no confl ict of interest.Raynal, Sophie .................................... Disclosed no confl ict of interest.Rayner, Christopher K. ........................ Research Support: AstraZeneca/Bristol-Myers Squibb,

Merck Sharp & Dohme, Novartis Pharmaceuticals Corporation.

Rayner, Nigel W. ................................. Disclosed no confl ict of interest.Rayner, Will ......................................... Disclosed no confl ict of interest.Raz, Itamar .......................................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Eli Lilly

and Company, Medscape Cardiology, Merck Sharp & Dohme, Novo Nordisk Inc., Sanofi U.S.; Consultant: AstraZeneca Pharmaceuticals LP, Insuline Medical Ltd.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Johnson & Johnson, Merck Sharp & Dohme, Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Sanofi U.S., Teva Pharmaceutical Industries Ltd.; Stock/Shareholder: Insuline Medical Ltd., Labstyle.

Razak, Hady ......................................... Disclosed no confl ict of interest.Razavian, Narges ................................ Disclosed no confl ict of interest.Razny, Urszula ..................................... Disclosed no confl ict of interest.Re, Danila ............................................ Disclosed no confl ict of interest.Reaven, Peter ...................................... Disclosed no confl ict of interest.Rebelo Pacheco, Susana .................... Disclosed no confl ict of interest.Rebollo, Pablo ...................................... Disclosed no confl ict of interest.Reddy, Himanshu ................................ Disclosed no confl ict of interest.Reddy, Kolli S. ..................................... Disclosed no confl ict of interest.Reddy-Luthmoodoo, Medini ............... Disclosed no confl ict of interest.Red-Horse, Kristy ................................ Disclosed no confl ict of interest.Redline, Susan ..................................... Disclosed no confl ict of interest.Redmond, Nicole ................................. Disclosed no confl ict of interest.Redondo, Maria J. ............................... Disclosed no confl ict of interest.Reece, Melanie S. ............................... Disclosed no confl ict of interest.Reed, Jessica ...................................... Employee: Housey Pharaceutical Research Laboratories. Reeves, Grafton .................................. Disclosed no confl ict of interest.Refsgaard, Hanne H. ........................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Regalla, Kumarswamy ........................ Disclosed no confl ict of interest.Regazzi, Romano ................................. Disclosed no confl ict of interest.Rege, Shraddha D. .............................. Disclosed no confl ict of interest.Regelmann, Molly ............................... Disclosed no confl ict of interest.Regensteiner, Judith G. ...................... Advisory Panel: AstraZeneca Pharmaceuticals LP; Research

Support: Bristol-Myers Squibb/AstraZeneca, Merck & Co., Inc.

Regife, Victor ...................................... Disclosed no confl ict of interest.Regin, Bhaskaran S. ............................ Disclosed no confl ict of interest.Regittnig, Werner ............................... Disclosed no confl ict of interest.Rehfeld, Jens F. ................................... Disclosed no confl ict of interest.Reicher-Atir, Rebecca ......................... Disclosed no confl ict of interest.Reichetzeder, Christoph ..................... Employee: Institute of Nutritional Science, University

of Potsdam, Institute of Vegetative Anatomy, CCM, Charité.

Reifel Miller, Anne .............................. Employee: Eli Lilly and Company. Reiko, Hirasawa .................................. Disclosed no confl ict of interest.Reimer, André ...................................... Disclosed no confl ict of interest.Rein, Lisa E. ......................................... Disclosed no confl ict of interest.

Rein, Phillipp ........................................ Disclosed no confl ict of interest.Rein, Raquel ........................................ Disclosed no confl ict of interest.Reinhold III, Peter E. ............................ Disclosed no confl ict of interest.Reinke, Julia ........................................ Disclosed no confl ict of interest.Reiter, Panagiota Diamantopoulou .... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S, Novo Nordisk A/S (Spouse/Partner). Reiterer, Florian ................................... Disclosed no confl ict of interest.Relimpio Astolfi , Federico .................. Disclosed no confl ict of interest.Remedi, Maria ..................................... Disclosed no confl ict of interest.Remer, Erick ......................................... Disclosed no confl ict of interest.Remonti, Luciana R. ............................ Disclosed no confl ict of interest.Ren, Wei .............................................. Disclosed no confl ict of interest.Ren, Zhuo Zhuo .................................... Disclosed no confl ict of interest.Rena, Graham ...................................... Disclosed no confl ict of interest.Renard, Eric ......................................... Advisory Panel: Abbott Diabetes Care, Inc., Cellnovo,

Dexcom, Inc.; Consultant: Eli Lilly and Company, Johnson & Johnson, Medtronic, Inc., Novo Nordisk Inc., Roche Diagnostics, Sanofi Pasteur SA; Research Support: Dexcom, Inc.

Rendas-Baum, Regina ........................ Consultant: Novo Nordisk A/S. Rendell, Marc S. .................................. Research Support: Astellas Pharma US, Inc., Bayer

HealthCare, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases.

Reno, Candace M. ............................... Disclosed no confl ict of interest.Ress, Claudia ....................................... Disclosed no confl ict of interest.Restrepo, Ivan ..................................... Disclosed no confl ict of interest.Retnakaran, Ravi ................................. Consultant: Novo Nordisk Inc., Takeda Pharmaceuticals

U.S.A., Inc.; Research Support: Novo Nordisk Inc. Reusch, Jane E. ................................... Advisory Panel: AstraZeneca Pharmaceuticals LP,

GlaxoSmithKline; Board Member: American Diabetes Association; Research Support: Bristol-Myers Squibb/AstraZeneca, Merck & Co., Inc.

Reuter, Hans-Martin ........................... Disclosed no confl ict of interest.Reutrakul, Sirimon .............................. Speaker’s Bureau: Sanofi U.S. Reviriego, Jesus .................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Rewers, Marian .................................. Disclosed no confl ict of interest.Reynolds, Andrew N. .......................... Disclosed no confl ict of interest.Reynolds, Chuck .................................. Disclosed no confl ict of interest.Reynolds, Kristi ................................... Research Support: Merck & Co., Inc. Reynolds, Laurie .................................. Disclosed no confl ict of interest.Reynolds, Nichole A. .......................... Employee: Eli Lilly and Company. Reynolds, Regina M. ........................... Disclosed no confl ict of interest.Reynolds, Shannon L. ......................... Consultant: Sanofi U.S. Rezki, Amel .......................................... Disclosed no confl ict of interest.Reznik, Yves ........................................ Other Relationship: Carried out clinical trials as co-

investigator for Medtronic, Eli Lilly and Novo Nordisk. He provided advisory services to Medtronic, Abbott, Eli Lilly and attended conferences organized by Eli Lilly.

Rhee, Byung Doo ................................. Disclosed no confl ict of interest.Rhee, Chanhaeng ................................ Research Support: Novo Nordisk Inc. Rhee, Eun-Jung ................................... Disclosed no confl ict of interest.Rhee, Jinnie J. ..................................... Disclosed no confl ict of interest.Rhee, Marie ......................................... Disclosed no confl ict of interest.Rhee, Mary K. ...................................... Disclosed no confl ict of interest.Rhee, Nicolai A. .................................. Disclosed no confl ict of interest.Rhee, Sang Youl .................................. Disclosed no confl ict of interest.Rhodes, Erinn T. ................................... Research Support: Merck & Co., Inc.; Stock/Shareholder:

Bristol-Myers Squibb Company (Spouse/Partner), GlaxoSmithKline (Spouse/Partner), Merck & Co., Inc. (Spouse/Partner), Pfi zer Inc. (Spouse/Partner), Sanofi U.S. (Spouse/Partner).

Ribeiro, Aurea C. ................................. Disclosed no confl ict of interest.Ribel, Ulla ............................................ Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Ribitsch, Anja ...................................... Advisory Panel: Eli Lilly and Company. Ricardo, Giovanna T. ........................... Disclosed no confl ict of interest.Riccardi, Gabriele ................................ Disclosed no confl ict of interest.Rich, Stephen S. .................................. Disclosed no confl ict of interest.Richard, Jeffrey .................................. Disclosed no confl ict of interest.Richards, Hunter ................................. Disclosed no confl ict of interest.Richardson, Judith D. ......................... Disclosed no confl ict of interest.Richardson, Matthew ......................... Disclosed no confl ict of interest.Richardson, Mike ................................ Disclosed no confl ict of interest.Rich-Edwards, Janet .......................... Disclosed no confl ict of interest.Richey, Joyce M. ................................. Disclosed no confl ict of interest.Richter, Erik A. ..................................... Stock/Shareholder: Novo Nordisk A/S. Richter, Hartmut .................................. Employee: IMS Health. Richter, Olaf ......................................... Disclosed no confl ict of interest.Rickels, Karl ......................................... Disclosed no confl ict of interest.

A876

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Rickels, Michael R. ............................. Consultant: Janssen Research & Development LLC; Research Support: Merck & Co., Inc.

Rickey, Leslie M. ................................. Disclosed no confl ict of interest.Ricks, Madia ........................................ Disclosed no confl ict of interest.Ricordi, Camillo ................................... Disclosed no confl ict of interest.Ridderstråle, Martin ........................... Advisory Panel: Medtronic, Inc.; Employee: Steno Diabetes

Center A/S; Research Support: Boehringer Ingelheim GmbH, Merck Sharp & Dohme, Novo Nordisk A/S, Sanofi Aventis.

Riddle, Matthew C. ............................. Consultant: Biodel Inc., Elcelyx Therapeutics, Inc., Eli Lilly and Company, Sanofi U.S., Valeritas; Research Support: AstraZeneca Pharmaceuticals LP, Novo Nordisk Inc., Pfi zer Inc., Sanofi U.S.

Riddlesworth, Tonya D. ...................... Disclosed no confl ict of interest.Ridiandries, Anisyah ........................... Disclosed no confl ict of interest.Ridley, D. Emerson .............................. Disclosed no confl ict of interest.Riedl, Michaela ................................... Disclosed no confl ict of interest.Riehle, Ellen ......................................... Employee: Truven Health Analytics. Rigalleau, Vincent ............................... Disclosed no confl ict of interest.Rigby, Alan S. ...................................... Disclosed no confl ict of interest.Rigby, Mark R. ..................................... Disclosed no confl ict of interest.Rigla, Mercedes .................................. Disclosed no confl ict of interest.Rikte, Tord ........................................... Employee: Novo Nordisk A/S. Riley, Andrew ...................................... Disclosed no confl ict of interest.Riley, Charles B. .................................. Disclosed no confl ict of interest.Riley, Jonathan ................................... Employee: Eli Lilly and Company. Rimm, Eric ............................................ Disclosed no confl ict of interest.Ringel, Bernd ....................................... Disclosed no confl ict of interest.Ringham, Brandy M. ........................... Disclosed no confl ict of interest.Risa, Igarashi ....................................... Disclosed no confl ict of interest.Rissanen, Aila ..................................... Disclosed no confl ict of interest.Ristovska, Ljubica ............................... Research Support: Eli Lilly and Company. Ritholz, Marilyn D. .............................. Disclosed no confl ict of interest.Ritter, James ....................................... Advisory Panel: Novo Nordisk A/S (Spouse/Partner);

Consultant: Novo Nordisk A/S (Spouse/Partner). Rittmeyer, Delia .................................. Disclosed no confl ict of interest.Ritzel, Robert ....................................... Advisory Panel: Astra Zeneca, Lilly, Merck Sharp and

Dohme, Novo Nordisk, Sanofi ; Speaker’s Bureau: Astra Zeneca, Bristol-Myers Squibb, Lilly, Merck Sharp and Dohme, Novartis, Novo Nordisk, Sanofi .

Rivas, Homero ..................................... Disclosed no confl ict of interest.Riveline, Jean-Pierre .......................... Disclosed no confl ict of interest.Rivellese, Angela A. ........................... Disclosed no confl ict of interest.Rivera-De La Parra, David .................. Disclosed no confl ict of interest.Rivlin, Elena ......................................... Disclosed no confl ict of interest.Rivnay, Ben .......................................... Employee: Boston Theraoeutics Inc. Rizvi, Ali A. .......................................... Disclosed no confl ict of interest.Rizvi, Faran .......................................... Disclosed no confl ict of interest.Rizza, Robert A. ................................... Disclosed no confl ict of interest.Rizzo, Manfredi ................................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Kowa

Pharmaceuticals; Other Relationship: AstraZeneca Pharmaceuticals LP, Novo Nordisk Inc., Servier; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Merck Sharp & Dohme.

Rizzotto, Jo-Anne M. .......................... Disclosed no confl ict of interest.Ro, Eun Young ...................................... Disclosed no confl ict of interest.Roat, Regan ......................................... Disclosed no confl ict of interest.Robacker, Maire .................................. Disclosed no confl ict of interest.Robb, Portia M. ................................... Disclosed no confl ict of interest.Roberto, Pamela .................................. Employee: PhRMA. Roberts, Alissa .................................... Disclosed no confl ict of interest.Roberts, Brian K. ................................. Consultant: AntriaBio, Inc; Stock/Shareholder: AntriaBio, Inc. Roberts, Charles T. .............................. Stock/Shareholder: DiabetOmics, Inc. Roberts, Drucilla J. ............................. Disclosed no confl ict of interest.Roberts, Graham A. ............................ Disclosed no confl ict of interest.Roberts, L. Jackson ............................ Disclosed no confl ict of interest.Roberts, Nathan W. ............................ Disclosed no confl ict of interest.Robertson, Hannah K. ......................... Disclosed no confl ict of interest.Robertson, Neil ................................... Disclosed no confl ict of interest.Robertson, R. Paul .............................. Disclosed no confl ict of interest.Robertson, Stacy ................................ Disclosed no confl ict of interest.Robinson, Catrina ............................... Disclosed no confl ict of interest.Robinson, Jennifer G. ......................... Advisory Panel: Merck, Pfi zer Inc., Regeneron

Pharmaceuticals, Inc., Sanofi ; Consultant: Amgen Inc., Merck, Pfi zer Inc., Regeneron Pharmaceuticals, Inc., Sanofi ; Research Support: Amarin Pharma, Inc., Amgen, AstraZeneca, Daiichi-Sankyo Co., Ltd., Esperion Therapeutics, Inc., GlaxoSmithKline, Merck, Pfi zer Inc., Regeneron Pharmaceuticals, Inc., Sanofi , Taisho Pharmaceutical Co., Ltd.

Robinson, Matthew M. ...................... Disclosed no confl ict of interest.

Robison, Brandon ................................ Disclosed no confl ict of interest.Roca-Rodriguez, M. Mar .................... Disclosed no confl ict of interest.Rocco, Michael .................................... Disclosed no confl ict of interest.Rocha Fernandes, Joao D. .................. Disclosed no confl ict of interest.Rocha, Guilherme Z. ............................ Disclosed no confl ict of interest.Rocha, Paulo N. ................................... Disclosed no confl ict of interest.Roche, Kelly ......................................... Disclosed no confl ict of interest.Rocheleau, Jonathan V. ...................... Disclosed no confl ict of interest.Rodacki, Melanie ................................ Disclosed no confl ict of interest.Rodbard, Helena W. ............................ Advisory Panel: Amylin Pharmaceuticals, LLC., AstraZeneca

Pharmaceuticals LP, Bayer HealthCare, Biodel Inc., Novo Nordisk A/S, Roche USA, Sanofi U.S., Sanofi U.S. (Spouse/Partner); Consultant: Abbott Diabetes Care, Inc. (Spouse/Partner), Biodel Inc., Halozyme Therapeutics (Spouse/Partner), Roche USA, Sanofi U.S. (Spouse/Partner), Takeda Pharmaceutical Company Limited; Research Support: AstraZeneca Pharmaceuticals LP, Biodel Inc., Boehringer Ingelheim GmbH, Eli Lilly and Company, Hamni, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, Roche USA, Sanofi U.S.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck & Co., Inc., Novo Nordisk A/S, Sanofi U.S., Takeda Pharmaceutical Company Limited.

Rodell, Anders ..................................... Disclosed no confl ict of interest.Roden, Michael ................................... Advisory Panel: Eli Lilly and Company, Genentech,

Inc., GI Dynamics, Inc., Novo Nordisk A/S, Poxel Pharmaceutical Company, Takeda Pharmaceutical Company Limited; Board Member: Eli Lilly and Company, GI Dynamics, Inc., Novo Nordisk A/S, Poxel Pharmaceutical Company, Takeda Pharmaceutical Company Limited; Consultant: GI Dynamics, Inc., JT Inc., Sanofi -Aventis Germany; Other Relationship: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Clinical trial, Clinical trial, clinical trial, clinical trial, Eli Lilly and Company, Lecture, Novartis Pharma GmbH, Roche Diagnostics; Speaker’s Bureau: Eli Lilly and Company, Novo Nordisk A/S.

Rodgers, Lauren R. .............................. Disclosed no confl ict of interest.Rodrigues, João .................................. Disclosed no confl ict of interest.Rodrigues, Maria de Lourdes G. ........ Disclosed no confl ict of interest.Rodrigues, Sandra .............................. Disclosed no confl ict of interest.Rodriguez Robles, Azucena ................ Disclosed no confl ict of interest.Rodríguez, Ángel ................................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Rodriguez, Elaine ................................ Disclosed no confl ict of interest.Rodriguez, Henry ................................. Disclosed no confl ict of interest.Rodriguez, Miguel A. .......................... Disclosed no confl ict of interest.Rodríguez-Vázquez, Héctor ................ Disclosed no confl ict of interest.Rodriguez-Ventura, Ana L. ................. Disclosed no confl ict of interest.Roduit, Raphael ................................... Disclosed no confl ict of interest.Roe, Michael W. .................................. Disclosed no confl ict of interest.Roel, Christopher ................................ Disclosed no confl ict of interest.Roelofs, Karen ..................................... Disclosed no confl ict of interest.Roessig, Julie ...................................... Employee: XOMA Corporation. Rogers, Heather M. ............................ Employee: National Institute of Diabetes and Digestive and

Kidney Diseases; Research Support: National Institute of Diabetes and Digestive and Kidney Diseases.

Rogers, Jeffrey ................................... Disclosed no confl ict of interest.Rogers, Samantha .............................. Disclosed no confl ict of interest.Roh, Eun ............................................... Disclosed no confl ict of interest.Roh, Gu Seob ....................................... Disclosed no confl ict of interest.Rohde, Luiz E. ...................................... Disclosed no confl ict of interest.Rohde, Ulrich ....................................... Disclosed no confl ict of interest.Rohland, Susan ................................... Disclosed no confl ict of interest.Rohm, Silvio ......................................... Disclosed no confl ict of interest.Rohr, Serge .......................................... Disclosed no confl ict of interest.Röhrborn, Diana .................................. Disclosed no confl ict of interest.Rohrs, Henry ........................................ Disclosed no confl ict of interest.Rohwedder, Katja ............................... Employee: AstraZeneca Pharmaceuticals LP. Rojas, Yuliana ...................................... Disclosed no confl ict of interest.Rojas-Rodriguez, Raziel ...................... Disclosed no confl ict of interest.Rokitta, Ilka ......................................... Disclosed no confl ict of interest.Rokne, Berit ......................................... Disclosed no confl ict of interest.Rolim, Luiz Clemente .......................... Disclosed no confl ict of interest.Rolim, Maria Creusa A. ...................... Disclosed no confl ict of interest.Rolin, Bidda ......................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Rolka, Deborah .................................... Disclosed no confl ict of interest.

A877

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Rolph, Timothy .................................... Disclosed no confl ict of interest.Romacho, Tania ................................... Disclosed no confl ict of interest.Romain, Benoit .................................... Disclosed no confl ict of interest.Romanchuk, Kenneth .......................... Disclosed no confl ict of interest.Romanelli, Robert J. ........................... Disclosed no confl ict of interest.Romano, Davide .................................. Disclosed no confl ict of interest.Romano, Maria .................................... Disclosed no confl ict of interest.Romano, Silvia .................................... Disclosed no confl ict of interest.Romanov, Vyacheslav V. ..................... Disclosed no confl ict of interest.Romeo, Giulio ...................................... Disclosed no confl ict of interest.Romero, Ana ........................................ Disclosed no confl ict of interest.Romero, Enrique .................................. Disclosed no confl ict of interest.Romero, Odile ...................................... Disclosed no confl ict of interest.Romero-Garcia, Tatiana ..................... Disclosed no confl ict of interest.Romijn, Johannes A. ........................... Disclosed no confl ict of interest.Ronalino, Gonzalo ............................... Disclosed no confl ict of interest.Roncal, Carlos ..................................... Disclosed no confl ict of interest.Rondinone, Cristina ............................ Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP. Rong, Peijing ........................................ Disclosed no confl ict of interest.Rosales, A.G. ....................................... Disclosed no confl ict of interest.Rosales, Alvina ................................... Disclosed no confl ict of interest.Rosas-Arellano, Patricia ..................... Disclosed no confl ict of interest.Rose, Ludger ........................................ Disclosed no confl ict of interest.Rosen, Evan D. .................................... Disclosed no confl ict of interest.Rosenberg, Alexandra ........................ Disclosed no confl ict of interest.Rosendahl, Mary S. ............................. Employee: AntriaBio, Inc; Stock/Shareholder: Antriabio, Inc. Rosenfeld, William ............................. Disclosed no confl ict of interest.Rosengren Daugaard, Jens ................ Disclosed no confl ict of interest.Rosenlund, Signe ................................ Disclosed no confl ict of interest.Rosenn, Barak ..................................... Disclosed no confl ict of interest.Rosenquist, Christian ......................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Rosenschein, Uri ................................. Disclosed no confl ict of interest.Rosenstock, Julio ................................ Advisory Panel: Boehringer Ingelheim Pharmaceuticals,

Inc., Daiichi-Sankyo Co., Ltd., Eli Lilly and Company, Eli Lilly and Company, GlaxoSmithKline, Halozyme Therapeutics, Intarcia Therapeutics, Inc., Janssen Pharmaceutical Companies of Johnson & Johnson, Lexicon Pharmaceuticals, Inc., MannKind Corporation, Merck & Co., Inc., Novartis Corporation, Novo Nordisk Inc., Sanofi U.S., Takeda Pharmaceuticals U.S.A., Inc.; Research Support: Amylin Pharmaceuticals, LLC., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Daiichi-Sankyo Co., Ltd., Eli Lilly and Company, GlaxoSmithKline, Intarcia Therapeutics, Inc., Janssen Pharmaceutical Companies of Johnson & Johnson, Lexicon Pharmaceuticals, Inc., MannKind Corporation, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Pfi zer Inc., Roche USA, Sanofi U.S., Takeda Pharmaceuticals U.S.A., Inc.

Roshandel, Delnaz .............................. Disclosed no confl ict of interest.Rosilio, Myriam ................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Ross, Glynis P. ..................................... Other Relationship: Medtronic, Inc., Merck Sharp & Dohme,

Novo Nordisk Inc., Sanofi Pasteur SA. Ross, Joseph S. ................................... Research Support: Johnson & Johnson, Medtronic, Inc. Ross, Judith ......................................... Disclosed no confl ict of interest.Ross, Kathryn M. ................................ Disclosed no confl ict of interest.Ross-Degnan, Dennis ......................... Disclosed no confl ict of interest.Rosselot, Carolina ............................... Disclosed no confl ict of interest.Rossen, Niklas B. ................................ Disclosed no confl ict of interest.Rossi da Silva, Maria Elizabeth ......... Disclosed no confl ict of interest.Rossi, Maria Chiara ............................ Disclosed no confl ict of interest.Rossing, Peter ..................................... Consultant: Bayer HealthCare; Research Support: Astellas

Pharma US, Inc., AstraZeneca/Bristol-Myers Squibb, Boehringer Ingelheim Pharmaceuticals, Inc., Novo Nordisk A/S; Speaker’s Bureau: AstraZeneca/Bristol-Myers Squibb; Stock/Shareholder: Novo Nordisk A/S.

Rotberg, Britt ...................................... Research Support: Sanofi U.S. Rotenstein, Lisa S. .............................. Disclosed no confl ict of interest.Roteta, Leslie A. .................................. Disclosed no confl ict of interest.Roth, Christian L. ................................. Disclosed no confl ict of interest.Roth, Eli ................................................ Consultant: Regeneron Pharmaceuticals, Inc., Sanofi U.S.;

Research Support: Amgen Inc.; Speaker’s Bureau: Amarin Pharma, Inc., AstraZeneca Pharmaceuticals LP, Merck & Co., Inc.

Roth, Roswith ...................................... Disclosed no confl ict of interest.Rothberg, Amy E. ................................ Disclosed no confl ict of interest.Rother, Kristina ................................... Disclosed no confl ict of interest.Rotimi, Charles N. ............................... Disclosed no confl ict of interest.

Rotter, Jerome I. ................................. Disclosed no confl ict of interest.Rotthaeuser, Baerbel .......................... Employee: Sanofi ; Stock/Shareholder: Sanofi . Rotti, Pavana ....................................... Disclosed no confl ict of interest.Round, Rachael-Marie ........................ Disclosed no confl ict of interest.Round, Rachel A. ................................. Disclosed no confl ict of interest.Rouphael, Carol ................................... Disclosed no confl ict of interest.Rouse, Michael ................................... Disclosed no confl ict of interest.Rousseau, Michel F. ............................ Disclosed no confl ict of interest.Roussel, Morgane ............................... Disclosed no confl ict of interest.Roussel, Ronan .................................... Advisory Panel: Janssen, Merck Sharp & Dohme, Sanofi ;

Board Member: Novo Nordisk; Research Support: Sanofi ; Speaker’s Bureau: AstraZeneca, Boehringer Ingelheim.

Roust, Lori ........................................... Research Support: American Diabetes Association, National Institute of Diabetes and Digestive and Kidney Diseases.

Rovinski, Randy ................................... Disclosed no confl ict of interest.Roy, Ambuj ........................................... Disclosed no confl ict of interest.Roy, Anirban ........................................ Employee: Medtronic MiniMed, Inc. Roy, Sayon ........................................... Disclosed no confl ict of interest.Roy-Duval, Christine ........................... Employee: Sanofi ; Stock/Shareholder: Sanofi . Roysman, Alisa .................................... Disclosed no confl ict of interest.Rozas-Moreno, Pedro ......................... Disclosed no confl ict of interest.Rozenberg, Aliza ................................. Disclosed no confl ict of interest.Rozzo, Aldo .......................................... Disclosed no confl ict of interest.Ruan, Qiao Nan ................................... Disclosed no confl ict of interest.Ruan, Xiangbo ..................................... Disclosed no confl ict of interest.Ruan, Xiaoping .................................... Employee: Eli Lilly and Company, Eli Lilly and Company

(Spouse/Partner); Stock/Shareholder: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner).

Rubanzana, Wilson ............................. Disclosed no confl ict of interest.Rubin, Daniel J. ................................... Research Support: Merck & Co., Inc. Rubin, Lee ............................................ Disclosed no confl ict of interest.Rubin, Paul ........................................... Employee: XOMA Corporation. Rubinstein, Marcelo ........................... Disclosed no confl ict of interest.Ruck, John D. ....................................... Disclosed no confl ict of interest.Ruderman, Neil B. ............................... Disclosed no confl ict of interest.Rudland, Victoria L. ............................. Disclosed no confl ict of interest.Rudser, Kyle D. .................................... Disclosed no confl ict of interest.Rueda, Angelica .................................. Disclosed no confl ict of interest.Ruedy, Katrina J. ................................. Disclosed no confl ict of interest.Rueedi, Rico ......................................... Disclosed no confl ict of interest.Rüegg, Markus .................................... Disclosed no confl ict of interest.Ruggles, James ................................... Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP. Ruhé, Henricus .................................... Disclosed no confl ict of interest.Rui, Xianliang ...................................... Disclosed no confl ict of interest.Ruige, Johannes B. ............................. Disclosed no confl ict of interest.Ruiz Esponda, Raul .............................. Disclosed no confl ict of interest.Ruiz, Luis N. ......................................... Employee: Investigatorion en Saludy Metabolismo S.C.

Hospital CIMA. Ruiz, Mo ............................................... Disclosed no confl ict of interest.Rungby, Jørgen ................................... Advisory Panel: Eli Lilly and Company, Merck & Co., Inc.,

Novo Nordisk A/S, Sanofi U.S.; Employee: Novo Nordisk A/S (Spouse/Partner); Research Support: Amylin Pharmaceuticals, LLC., Eli Lilly and Company, Novo Nordisk A/S; Speaker’s Bureau: AstraZeneca/Bristol-Myers Squibb, Johnson & Johnson, Merck & Co., Inc., Novo Nordisk A/S, Sanofi U.S.

Runion, Asher ...................................... Employee: Type 1 Diabetes Exchange. Runzis, Sarah ....................................... Board Member: Medtronic International Trading Sarl;

Employee: Medtronic International Trading Sarl; Research Support: Medtronic International Trading Sarl.

Rupnow, Marcia .................................. Employee: Janssen Pharmaceutical Companies of Johnson & Johnson.

Rurali, Erica ......................................... Disclosed no confl ict of interest.Rush, William A. .................................. Disclosed no confl ict of interest.Rushakoff, Robert J. ........................... Disclosed no confl ict of interest.Russell, Grant ...................................... Disclosed no confl ict of interest.Russell, James W. ............................... Disclosed no confl ict of interest.Russell, Steven J. ............................... Advisory Panel: Companion Medical, Tandem Diabetes Care,

Inc.; Consultant: Sanofi ; Other Relationship: Abbott Diabetes Care, Inc., Dexcom, Inc., Eli Lilly and Company, Insulet Corporation, International Biomedical, Medtronic MiniMed, Inc., Sanofi U.S., Tandem Diabetes Care, Inc.

Russell-Jones, David .......................... Advisory Panel: Eli Lilly and Company, Novo Nordisk, Sanofi ; Consultant: Eli Lilly and Company, Novo Nordisk, Sanofi ; Research Support: Eli Lilly and Company, Novo Nordisk, Sandoz, Sanofi .

Russo, Eleonora .................................. Disclosed no confl ict of interest.Rusu, Emilia ......................................... Disclosed no confl ict of interest.Rusu, Florin .......................................... Disclosed no confl ict of interest.

A878

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Rutkowski, Mary Anne ....................... Employee: Merck & Co., Inc.; Stock/Shareholder: Merck & Co., Inc.

Rutlin, Jerrel ........................................ Disclosed no confl ict of interest.Rutter, Guy A. ...................................... Disclosed no confl ict of interest.Rutter, Martin ..................................... Disclosed no confl ict of interest.Rütter, Ruth ......................................... Disclosed no confl ict of interest.Rwabufi giri, Bernard ........................... Disclosed no confl ict of interest.Ryals, Janelle ...................................... Disclosed no confl ict of interest.Ryan, Alexander J. .............................. Disclosed no confl ict of interest.Ryan, Denine ....................................... Disclosed no confl ict of interest.Ryan, John G. ...................................... Disclosed no confl ict of interest.Ryan, Kathy ......................................... Disclosed no confl ict of interest.Ryan, Michael T. .................................. Disclosed no confl ict of interest.Rybin, Denis ......................................... Disclosed no confl ict of interest.Rychlik, Karen ...................................... Disclosed no confl ict of interest.Ryder, Justin R. ................................... Disclosed no confl ict of interest.Rye, Kerry-Anne .................................. Disclosed no confl ict of interest.Rynders, Corey A. ............................... Disclosed no confl ict of interest.Ryu, Jiyoon .......................................... Disclosed no confl ict of interest.Ryu, Seonyoung .................................. Employee: Genentech, Inc. Rzodkiewicz, Joanna .......................... Disclosed no confl ict of interest.Saad, Abdelnaser ................................ Disclosed no confl ict of interest.Saad, Mário José A. ........................... Disclosed no confl ict of interest.Saada, Ann .......................................... Disclosed no confl ict of interest.Saaddine, Jinan .................................. Disclosed no confl ict of interest.Saaevedra, Ana ................................... Disclosed no confl ict of interest.Saari, Teemu ........................................ Disclosed no confl ict of interest.Saberi, Sima ........................................ Disclosed no confl ict of interest.Saboo, Banshi D. ................................. Disclosed no confl ict of interest.Sachinidou, Anastasia ........................ Disclosed no confl ict of interest.Sacks, David B. .................................... Disclosed no confl ict of interest.Sacks, Frank M. ................................... Disclosed no confl ict of interest.Sadacca, Leigh A. ............................... Disclosed no confl ict of interest.Sadagurski, Marianna ........................ Disclosed no confl ict of interest.Sadhu, Archana R. .............................. Disclosed no confl ict of interest.Sadler, Lois .......................................... Disclosed no confl ict of interest.Saeki, Akio ........................................... Disclosed no confl ict of interest.Saely, Christoph H. ............................. Disclosed no confl ict of interest.Saenz, Ashleigh M. ............................. Disclosed no confl ict of interest.Sáenz-Gutiérrez, Antonio ................... Disclosed no confl ict of interest.Saetung, Sunee ................................... Disclosed no confl ict of interest.Saey, Jean ........................................... Disclosed no confl ict of interest.Saez, Enrique ....................................... Disclosed no confl ict of interest.Safai, Narges ...................................... Disclosed no confl ict of interest.Safarov, Dilmurod M. .......................... Disclosed no confl ict of interest.Saffery, Richard .................................. Disclosed no confl ict of interest.Safford, Monika M. ............................ Disclosed no confl ict of interest.Safo, Sandra ........................................ Disclosed no confl ict of interest.Sagara, Masaaki ................................. Disclosed no confl ict of interest.Sager, Philip T. ..................................... Board Member: Anthera Inc; Consultant: Acadia, Aerpio,

Biomedical Systems, Celgene Corporation, Chemo, Eli Lilly and Company, Genentech, Inc., Helssin, iCardiac, Medtronic, Inc., Milestone, Shire, SK Science, SNBL, Viamet; Other Relationship: Cardiac Safety Research Consortium Exec Committee.

Saghatelian, Alan ............................... Other Relationship: Inventor on patent relating to the lipids presented in this abstract.

Sagi Adamov, Yarden .......................... Disclosed no confl ict of interest.Saglani, Bhavik .................................... Disclosed no confl ict of interest.Saha, Asish K. ..................................... Disclosed no confl ict of interest.Saha, Chandan .................................... Disclosed no confl ict of interest.Sahakian, Pierre .................................. Employee: Alize Pharma; Stock/Shareholder: Alize Pharma. Sahasrabudhe, Vaishali ...................... Employee: Pfi zer Inc., Pfi zer Inc. (Spouse/Partner); Stock/

Shareholder: Pfi zer Inc., Pfi zer Inc. (Spouse/Partner). Sahay, Rakesh K. ................................. Disclosed no confl ict of interest.Sahin, Ibrahim ..................................... Disclosed no confl ict of interest.Sahu, Giriraj ......................................... Disclosed no confl ict of interest.Saini, Vaibhav ...................................... Disclosed no confl ict of interest.Saini, Vishnu K. ................................... Disclosed no confl ict of interest.Sainsbury, Christopher A. .................. Advisory Panel: Novo Nordisk Inc. Saintilus, Molain ................................. Disclosed no confl ict of interest.Saint-Pierre, Nathalie ......................... Disclosed no confl ict of interest.Sairyou, Masami ................................. Disclosed no confl ict of interest.Saito, Akihiko ...................................... Research Support: Daiichi-Sankyo Co., Ltd., Daiichi-

Sankyo Co., Ltd., Eli Lilly Japan K.K., Kissei Pharmaceutical Co., Ltd., Kyowa Hakko Kirin Co., Ltd., Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation, Ono Pharmaceutical Co., Ltd., Sanofi K.K., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Torii Pharmaceutical Co., Ltd.

Saito, Akira .......................................... Disclosed no confl ict of interest.

Saito, Isao ............................................ Disclosed no confl ict of interest.Saito, Jun ............................................. Disclosed no confl ict of interest.Saito, Kazumi ...................................... Disclosed no confl ict of interest.Saito, Satoko ....................................... Disclosed no confl ict of interest.Saito, Tsugumichi ................................ Disclosed no confl ict of interest.Saito, Yoshihiko ................................... Consultant: Ono Pharmaceutical Co., Ltd.; Research Support:

Astellas Pharma US, Inc., AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Chugai Pharmaceutical Co., Ltd., Daiichi-Sankyo Co., Ltd., Eisai Co., Ltd., GlaxoSmithKline, Medtronic, Inc., Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., Novartis Corporation, Otsuka Pharmaceutical Co., Ltd., Shionogi Inc., Sumimoto Dainippon Pharma Co., Ltd., Taisho Pharmaceutical Co., Ltd., Taisho Pharmaceutical Co., Ltd., Terumo Medical Corporation; Speaker’s Bureau: Daiichi-Sankyo Co., Ltd., Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation, Otsuka Pharmaceutical Co., Ltd., Pfi zer Inc., Takeda Pharmaceutical Company Limited.

Sajan, Joshua ...................................... Disclosed no confl ict of interest.Sajan, Mini P. ....................................... Disclosed no confl ict of interest.Sajuthi, Satria ..................................... Disclosed no confl ict of interest.Sakaguchi, Masaji .............................. Disclosed no confl ict of interest.Sakai, Chieko ....................................... Disclosed no confl ict of interest.Sakai, Kentaro ..................................... Disclosed no confl ict of interest.Sakai, Mariko ...................................... Disclosed no confl ict of interest.Sakai, Soichi ........................................ Employee: Taisho Pharmaceutical Co., Ltd. Sakaki, Yuka ........................................ Disclosed no confl ict of interest.Sakamoto, Kei ..................................... Disclosed no confl ict of interest.Sakamoto, Kenichi .............................. Disclosed no confl ict of interest.Sakamoto, Kentaro ............................. Disclosed no confl ict of interest.Sakamoto, Masaya ............................. Disclosed no confl ict of interest.Sakashita, Anna .................................. Disclosed no confl ict of interest.Sakata, Yasushi ................................... Disclosed no confl ict of interest.Sakaue, Hiroshi ................................... Disclosed no confl ict of interest.Sakoda, Hideyuki ................................ Disclosed no confl ict of interest.Sakr, Mahmoud ................................... Disclosed no confl ict of interest.Sakuma, Kensuke ................................ Employee: Takeda Pharmaceutical Company Limited. Sakuma, Mio ....................................... Disclosed no confl ict of interest.Sakuma, Yukie ..................................... Disclosed no confl ict of interest.Sakura, Takeshi ................................... Disclosed no confl ict of interest.Sakurada, Brian ................................... Employee: Novo Nordisk Inc. Sakurai, Kenichi .................................. Disclosed no confl ict of interest.Sakurai, Masaru .................................. Disclosed no confl ict of interest.Sakurai, Shintaro ................................ Disclosed no confl ict of interest.Sakurai, Shintarou .............................. Disclosed no confl ict of interest.Sakuramoto-Tsuchida, Sumiyo .......... Disclosed no confl ict of interest.Salamati, Sarah E. .............................. Disclosed no confl ict of interest.Salamucha, Ilona ................................. Disclosed no confl ict of interest.Salari, Hamid ....................................... Disclosed no confl ict of interest.Salaye, Lipika ...................................... Disclosed no confl ict of interest.Salazar, Tatiana ................................... Disclosed no confl ict of interest.Saldana, Santiago ............................... Disclosed no confl ict of interest.Saldivar-Salazar, Sergio ..................... Disclosed no confl ict of interest.Saleem, Moin A. ................................. Disclosed no confl ict of interest.Saleh, Jurainah B. ............................... Disclosed no confl ict of interest.Salem, Rany M. ................................... Disclosed no confl ict of interest.Sales-Sanz, Jorge ............................... Consultant: AstraZeneca/Bristol-Myers Squibb, Novo

Nordisk A/S. Salgado, Anna ..................................... Employee: LifeScan, Inc. Salim, Asmat ....................................... Disclosed no confl ict of interest.Saliu, Drilon ......................................... Employee: BD Medical-Diabetes Care. Sallum Filho, Celso .............................. Disclosed no confl ict of interest.Salomaa, Veikko .................................. Disclosed no confl ict of interest.Salomon, Joshua A. ............................ Disclosed no confl ict of interest.Salsali, Afshin ..................................... Employee: Boehringer Ingelheim Pharmaceuticals, Inc. Salter, Rhys ......................................... Disclosed no confl ict of interest.Saltiel-Berzin, Rita .............................. Employee: BD Medical-Diabetes Care. Salvemini, Lucia .................................. Disclosed no confl ict of interest.Salzsieder, Eckhard ............................. Disclosed no confl ict of interest.Samarasekera, Thanya ....................... Disclosed no confl ict of interest.Sambamoorthi, Usha .......................... Research Support: Sanofi U.S. Samczuk, Paulina ................................ Disclosed no confl ict of interest.Sameshima, Azusa .............................. Disclosed no confl ict of interest.Samoa, Raynald .................................. Disclosed no confl ict of interest.Samonigg, Judith ................................ Disclosed no confl ict of interest.Sampanis, Christos ............................. Disclosed no confl ict of interest.Sampol, Gabriel ................................... Disclosed no confl ict of interest.Samuel, Rekha .................................... Disclosed no confl ict of interest.Samuel, Varman T. .............................. Disclosed no confl ict of interest.Samuelsson, My .................................. Disclosed no confl ict of interest.

A879

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Samukawa, Yoshishige ....................... Employee: Taisho Pharmaceutical Co., Ltd. Sanagorski, Rebecca .......................... Disclosed no confl ict of interest.Sanal, Geethu ...................................... Disclosed no confl ict of interest.Sánchez, Carlos ................................... Disclosed no confl ict of interest.Sánchez, Enric ..................................... Disclosed no confl ict of interest.Sánchez, Enrique ................................. Disclosed no confl ict of interest.Sánchez, Friman .................................. Disclosed no confl ict of interest.Sanchez, Gabriela ............................... Disclosed no confl ict of interest.Sanchez, Manuel ................................ Disclosed no confl ict of interest.Sanchez, Milva .................................... Disclosed no confl ict of interest.Sanchez, Sergio .................................. Disclosed no confl ict of interest.Sanchez, Sixto E. ................................. Disclosed no confl ict of interest.Sánchez-Flores, Alejandro ................. Disclosed no confl ict of interest.Sanchez-Pozos, Katy ........................... Disclosed no confl ict of interest.Sancho Bornez, Veronica .................... Disclosed no confl ict of interest.Sanda, Srinath ..................................... Disclosed no confl ict of interest.Sandbæk, Annelli ................................ Disclosed no confl ict of interest.Sandberg, Jonathan ........................... Disclosed no confl ict of interest.Sander, Dirk ......................................... Disclosed no confl ict of interest.Sanders, Linda L. ................................. Disclosed no confl ict of interest.Sanders, Phillip ................................... Disclosed no confl ict of interest.Sandholm, Niina .................................. Disclosed no confl ict of interest.Sandoval, Darleen A. .......................... Research Support: Boehringer Ingelheim Pharmaceuticals,

Inc., Ethicon Endo-Surgery, Inc., Novo Nordisk Inc. Sandoval, Hugo ................................... Disclosed no confl ict of interest.Sandre-Banon, Dorian ........................ Disclosed no confl ict of interest.Sandru, Andra Iulia ............................. Disclosed no confl ict of interest.Sands, Chirs ......................................... Disclosed no confl ict of interest.Sands, Stephen ................................... Disclosed no confl ict of interest.Sandu, Oana A. ................................... Disclosed no confl ict of interest.Sandy, P. ............................................... Disclosed no confl ict of interest.Sanematsu, Helen Y. ........................... Disclosed no confl ict of interest.Sango, Kazunori .................................. Disclosed no confl ict of interest.Sanguankeo, Anawin .......................... Disclosed no confl ict of interest.Sankar, A. ............................................ Disclosed no confl ict of interest.Sanna, Alessandro .............................. Disclosed no confl ict of interest.Sanna, Rashel S. ................................. Disclosed no confl ict of interest.Sano, Hiroyuki ..................................... Disclosed no confl ict of interest.Santa-Cruz Calvo, Sara ...................... Disclosed no confl ict of interest.Santana, Ewaldo E. ............................. Disclosed no confl ict of interest.Santana, Lucas S. ............................... Disclosed no confl ict of interest.Santaren, Ingrid D. .............................. Disclosed no confl ict of interest.Santi, Lorenza ..................................... Disclosed no confl ict of interest.Santilli, Francesca .............................. Disclosed no confl ict of interest.Santolini, Valerio ................................. Disclosed no confl ict of interest.Santomauro Junior, Augusto C. ......... Disclosed no confl ict of interest.Santomauro, Ana Teresa M. .............. Disclosed no confl ict of interest.Santoni, Federico ................................ Disclosed no confl ict of interest.Santos, A.S. ......................................... Disclosed no confl ict of interest.Santos, Aline D. .................................. Disclosed no confl ict of interest.Santos, Andressa ................................ Disclosed no confl ict of interest.Santos, Bárbara M. ............................. Disclosed no confl ict of interest.Santos, Itamar S. ................................ Disclosed no confl ict of interest.Santos, Jose L. .................................... Disclosed no confl ict of interest.Santos, Katia G. .................................. Disclosed no confl ict of interest.Santos, Manoella F. ............................ Disclosed no confl ict of interest.Santos, R.F. .......................................... Disclosed no confl ict of interest.Santos, Rosa F. .................................... Disclosed no confl ict of interest.Sanz, Javier ......................................... Disclosed no confl ict of interest.Sarac, Fulden ....................................... Disclosed no confl ict of interest.Sarac, Sefa .......................................... Disclosed no confl ict of interest.Sarah Anissa, Hannou ........................ Disclosed no confl ict of interest.Sarai, Karnjit ....................................... Disclosed no confl ict of interest.Sarangarajan, Rangaprasad .............. Disclosed no confl ict of interest.Saravanan, Ponnusamy ...................... Disclosed no confl ict of interest.Sarfaraz, Aqiba ................................... Disclosed no confl ict of interest.Sargent, Samantha L. ......................... Disclosed no confl ict of interest.Sargin, Mehmet .................................. Disclosed no confl ict of interest.Sargsyan, Ashot .................................. Disclosed no confl ict of interest.Sarma, Aruna ...................................... Disclosed no confl ict of interest.Sarmidi, Mohamad Roji ...................... Disclosed no confl ict of interest.Sarosiek, Irene .................................... Disclosed no confl ict of interest.Sarra-Bournet, François ..................... Disclosed no confl ict of interest.Sartore, Giovanni ................................ Disclosed no confl ict of interest.Sartori, Daniel J. ................................. Disclosed no confl ict of interest.Sarvetnick, Nora E. ............................. Disclosed no confl ict of interest.Sarwar, Komil N. ................................. Disclosed no confl ict of interest.Sasagawa, Taiji ................................... Disclosed no confl ict of interest.Sasaki, Hideyuki .................................. Disclosed no confl ict of interest.Sasaki, Shigekazu ............................... Disclosed no confl ict of interest.Sasaki, Shuji ........................................ Disclosed no confl ict of interest.Sasaoka, Toshiyasu ............................ Disclosed no confl ict of interest.

Sasinowski, Maciek ............................ Employee: Health Diagnostics Laboratory, Inc. Sassenfeld, Bettina M. ....................... Employee: Profi l Institute for Clinical Research, Inc. Sassoon, Daniel J. .............................. Disclosed no confl ict of interest.Satake, Eiichiro ................................... Disclosed no confl ict of interest.Sathyapalan, Thozhukat ..................... Disclosed no confl ict of interest.Satman, Ilhan ...................................... Advisory Panel: Merck Sharp & Dohme, Novo Nordisk

A/S; Board Member: Novo Nordisk A/S; Consultant: AstraZeneca/Bristol-Myers Squibb, Eli Lilly and Company, Sanofi U.S.

Sato, Asako ......................................... Employee: MSD KK. Sato, Daisuke ...................................... Disclosed no confl ict of interest.Sato, Koji ............................................. Disclosed no confl ict of interest.Sato, Kyoko K. ..................................... Disclosed no confl ict of interest.Sato, Tatsuya ...................................... Disclosed no confl ict of interest.Sato, Yuka ............................................ Disclosed no confl ict of interest.Satoh, Hiroaki ..................................... Disclosed no confl ict of interest.Satoh, Jo ............................................. Disclosed no confl ict of interest.Satoh, Shinobu .................................... Disclosed no confl ict of interest.Satoh-Asahara, Noriko ....................... Disclosed no confl ict of interest.Satomi, Hayato ................................... Employee: Astellas Pharma Inc. Satonin, Darlene K. ............................. Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Satoru, Kodama .................................. Disclosed no confl ict of interest.Sattar, Naveed A. ............................... Advisory Panel: Amgen Inc., AstraZeneca, Boehringer-

Ingelheim, Bristol Myers Squibb, Lilly, Sanofi . Saudan, Philippe ................................. Stock/Shareholder: Cytos Biotechnology AG. Sauder, Katherine A. ........................... Disclosed no confl ict of interest.Sauerwein, Tom .................................. Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Merck

& Co., Inc. Saulnier, Pierre-Jean .......................... Other Relationship: Roche Diagnostics, travel grant. Saulsberry, Whitney J. ....................... Disclosed no confl ict of interest.Saunavaara, Virva ............................... Disclosed no confl ict of interest.Saunders, Rhodri ................................. Consultant: Eli Lilly and Company. Saura, Gabriella .................................. Disclosed no confl ict of interest.Sauter, Jerry ........................................ Disclosed no confl ict of interest.Sauvé, Meghan ................................... Disclosed no confl ict of interest.Savage, David ..................................... Disclosed no confl ict of interest.Savari, Omid ........................................ Disclosed no confl ict of interest.Savas, Sumru ...................................... Disclosed no confl ict of interest.Saveliev, Sergey V. ............................. Disclosed no confl ict of interest.Savinov, Alexei Y. ................................ Disclosed no confl ict of interest.Savoia, Elena ....................................... Disclosed no confl ict of interest.Savolainen, Anna ................................ Disclosed no confl ict of interest.Savopoulos, Christos .......................... Disclosed no confl ict of interest.Savu, Anamaria ................................... Disclosed no confl ict of interest.Sawada, Tomonobu ............................ Disclosed no confl ict of interest.Sawaguchi, Tatsuya ............................ Disclosed no confl ict of interest.Sawai, Mizuki ...................................... Disclosed no confl ict of interest.Sawamura, Mami S. ........................... Disclosed no confl ict of interest.Sawasaki, Tatsuya .............................. Disclosed no confl ict of interest.Saxon, David ....................................... Disclosed no confl ict of interest.Saydah, Sharon ................................... Disclosed no confl ict of interest.Sayki Arslan, Muyesser ..................... Disclosed no confl ict of interest.Sborgia, Cristina ................................. Disclosed no confl ict of interest.Sbraccia, Paolo .................................... Disclosed no confl ict of interest.Scaramuzza, Andrea ........................... Advisory Panel: Medtronic, Inc., Sanofi ; Board Member:

Medtronic, Inc., Sanofi ; Research Support: Abbott, Harmonium, Terumo Medical Corporation; Speaker’s Bureau: Eli Lilly and Company, Roche, Sanofi .

Scardapane, Marco ............................ Disclosed no confl ict of interest.Scarpelli, Sophia ................................. Disclosed no confl ict of interest.Scatena, Fabrizio ................................ Disclosed no confl ict of interest.Scatena, Roberto ................................ Disclosed no confl ict of interest.Scavuzzo, Marissa Ann ...................... Disclosed no confl ict of interest.Scelsi, Amanda R. ............................... Disclosed no confl ict of interest.Schacht, Anna ..................................... Disclosed no confl ict of interest.Schadewaldt, Peter ............................ Disclosed no confl ict of interest.Schaeverbeke, Thierry ........................ Disclosed no confl ict of interest.Schaffer, Jean E. ................................. Research Support: Actelion Pharmaceuticals Ltd. (Spouse/

Partner), Fondation Leducq, Juvenile Diabetes Research Foundation, National Institutes of Health, National Institutes of Health (Spouse/Partner).

Schalkwijk, Casper G. ......................... Disclosed no confl ict of interest.Schaller, Hans-Eberhard ..................... Disclosed no confl ict of interest.Schaller, Matthew .............................. Disclosed no confl ict of interest.Scharfmann, Raphael ......................... Disclosed no confl ict of interest.Scharp, David ...................................... Disclosed no confl ict of interest.Schatz, Desmond ................................ Disclosed no confl ict of interest.Schaub, Rebecca L. ............................. Disclosed no confl ict of interest.Schauer, Irene E. ................................. Disclosed no confl ict of interest.Schauer, Philip R. ................................ Disclosed no confl ict of interest.Schauerhamer, Marisa ....................... Disclosed no confl ict of interest.

A880

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Scheer, Marsel .................................... Disclosed no confl ict of interest.Scheler, Mika ...................................... Disclosed no confl ict of interest.Schenck, Lindsay ................................ Disclosed no confl ict of interest.Schenker, Nina .................................... Disclosed no confl ict of interest.Scheper, Nikolaus ............................... Disclosed no confl ict of interest.Scherer, Philipp E. ............................... Disclosed no confl ict of interest.Schernthaner, Gerit ............................ Disclosed no confl ict of interest.Schernthaner, Guntram ...................... Board Member: AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Takeda Pharmaceutical Company Limited; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Takeda Pharmaceutical Company Limited.

Schettini, Marcele .............................. Disclosed no confl ict of interest.Schiavon, Michele .............................. Disclosed no confl ict of interest.Schick, Fritz ......................................... Disclosed no confl ict of interest.Schierloh, Ulrike .................................. Research Support: Abbott Diabetes Care, Inc., Dexcom, Inc. Schigt, Arvid ........................................ Disclosed no confl ict of interest.Schindler, Christoph ............................ Disclosed no confl ict of interest.Schindler, John .................................... Employee: Eli Lilly and Company. Schioldan, Anne Grethe ...................... Disclosed no confl ict of interest.Schleicher, Erwin ................................ Disclosed no confl ict of interest.Schleinitz, Dorit ................................... Disclosed no confl ict of interest.Schlensak, Matthias ........................... Disclosed no confl ict of interest.Schliess, Freimut ................................. Disclosed no confl ict of interest.Schlisserman, Seth ............................. Disclosed no confl ict of interest.Schlitt, Axel ......................................... Disclosed no confl ict of interest.Schloot, Nanette C. ............................ Employee: Lilly Deutschland GmbH. Schlossman, Deborah ......................... Disclosed no confl ict of interest.Schmahl, Jennifer P. ........................... Employee: Regeneron Pharmaceuticals, Inc. Schmid, Helena ................................... Disclosed no confl ict of interest.Schmidt, Ann Marie ............................ Other Relationship: Filed a patent application for the

screening of IAPP toxic intermediatesSchmidt, Christian .............................. Disclosed no confl ict of interest.Schmidt, Friedemann .......................... Disclosed no confl ict of interest.Schmidt, Harald H. .............................. Disclosed no confl ict of interest.Schmidt, Karen .................................... Disclosed no confl ict of interest.Schmidt, Kathleen .............................. Disclosed no confl ict of interest.Schmidt, Lisa ....................................... Disclosed no confl ict of interest.Schmidt, Maria Inês ........................... Research Support: Eli Lilly Company. Schmidt, Signe .................................... Advisory Panel: Roche Diagnostics; Consultant: Novo

Nordisk A/S, Unomedical; Other Relationship: Medtronic, Inc., Novo Nordisk A/S, Roche Diagnostics; Speaker’s Bureau: Roche Diagnostics, Sanofi U.S.

Schmidt, Thorsten ............................... Employee: Sanofi ; Stock/Shareholder: Sanofi . Schmidt, Ulrike .................................... Disclosed no confl ict of interest.Schmied, Laurent ................................ Disclosed no confl ict of interest.Schmieder, Roland E. .......................... Board Member: Boehringer Ingelheim GmbH,

Novartis Pharma GmbH; Consultant: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company; Research Support: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company; Speaker’s Bureau: Boehringer Ingelheim GmbH, Novartis Pharma GmbH.

Schmitt, Andreas ................................ Disclosed no confl ict of interest.Schmitt, Melanie L. ............................ Disclosed no confl ict of interest.Schmitt, Patricia ................................. Disclosed no confl ict of interest.Schmittdiel, Julie A. ........................... Employee: Kaiser Permanente of Northern California;

Research Support: National Institute of Diabetes and Digestive and Kidney Diseases.

Schmitz, Gerd ...................................... Disclosed no confl ict of interest.Schneck, Karen ................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Schneeweiss, Sebastian .................... Consultant: Aetion Inc., LLC, WHISCON; Research Support:

Boehringer Ingelheim GmbH, NHLBI, Novartis, PCORI, U.S. Food and Drug Administration; Stock/Shareholder: Aetion Inc.

Schneider, Michael ............................. Employee: Boehringer Ingelheim GmbH. Schnell, Kerstin ................................... Disclosed no confl ict of interest.Schnellinger, Pamala .......................... Disclosed no confl ict of interest.Schneyer, Alan .................................... Research Support: Grant, Juvenile Diabetes Research

Foundation; Stock/Shareholder: Fairbanks Pharmaceuticals, CEO/CSO.

Schober, Joseph .................................. Disclosed no confl ict of interest.Schoenle, Eugen J. .............................. Disclosed no confl ict of interest.Schofi eld, Jonathan ............................ Disclosed no confl ict of interest.Scholl, Theresa O. ............................... Disclosed no confl ict of interest.Scholtens, Denise ............................... Disclosed no confl ict of interest.Scholz, Claus J. ................................... Disclosed no confl ict of interest.Schooling, C.M. ................................... Disclosed no confl ict of interest.

Schorderet, Daniel F. .......................... Disclosed no confl ict of interest.Schorr, Alan ......................................... Consultant: AstraZeneca Pharmaceuticals LP. Schreiner, Birgit .................................. Disclosed no confl ict of interest.Schreiner, Pamela ............................... Disclosed no confl ict of interest.Schroeder, Emily B. ............................. Stock/Shareholder: Boston Scientifi c Corporation. Schroer, Stephanie A. ......................... Disclosed no confl ict of interest.Schroeter, Katrin ................................. Disclosed no confl ict of interest.Schuett, Morten .................................. Disclosed no confl ict of interest.Schulman, Rifka .................................. Disclosed no confl ict of interest.Schulz, Tim .......................................... Disclosed no confl ict of interest.Schulze, Gunnar .................................. Disclosed no confl ict of interest.Schuman, Brooke ................................ Disclosed no confl ict of interest.Schuppan, Detlef ................................ Consultant: Bayer, Boehringer-Ingelheim, Eli Lilly,

Mitsubishi-Tanabe, Silence, Takeda; Employee: University Medical Center of the Johannes Gutenberg University Mainz; Research Support: European Research Council (ERC), Federal Ministry of Education and Research (BMBF), German Research Foundation (DFG).

Schur, Ellen .......................................... Disclosed no confl ict of interest.Schürmann, Annette ........................... Disclosed no confl ict of interest.Schuster, Dara ..................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Schwacha, Henning ............................ Disclosed no confl ict of interest.Schwahn, Uwe .................................... Employee: Sanofi ; Stock/Shareholder: Sanofi . Schwartz, Eric A. ................................ Disclosed no confl ict of interest.Schwartz, Frank L. .............................. Disclosed no confl ict of interest.Schwartz, Gary J. ............................... Disclosed no confl ict of interest.Schwartz, Michael W. ........................ Disclosed no confl ict of interest.Schwartz, Stanley ............................... Disclosed no confl ict of interest.Schwarzenberg, Sarah J. ................... Disclosed no confl ict of interest.Schweizer, Anja .................................. Employee: Novartis Pharma AG; Stock/Shareholder: Novartis

Pharma AG. Schwenke, Dawn C. ............................ Disclosed no confl ict of interest.Schwitzgebel, Valerie ......................... Disclosed no confl ict of interest.Scifres, Christina ................................ Disclosed no confl ict of interest.Scioscia, Marco .................................. Disclosed no confl ict of interest.Scirica, Benjamin M. ........................... Consultant: Arena Pharmaceuticals, Inc., AstraZeneca

Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Boston Clinical Research Institute, Bristol-Myers Squibb Company, Covance, Eisai Co., Ltd., Elsevier Practice Update Cardiology, Forest Pharmaceuticals, Inc., GE Healthcare, Gilead, GlaxoSmithKline, Lexicon Pharmaceuticals, Inc., St. Jude’s Medical, University of Calgary; Research Support: AstraZeneca/Bristol-Myers Squibb, Bayer HealthCare, Daiichi-Sankyo, Eisai Co., Ltd., Gilead, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc.

Scolaro, Laura ..................................... Disclosed no confl ict of interest.Sconocchia, Giuseppe ........................ Disclosed no confl ict of interest.Scorsone, Alessandro ......................... Disclosed no confl ict of interest.Scott, Donald K. .................................. Disclosed no confl ict of interest.Scott, Gwen ......................................... Disclosed no confl ict of interest.Scott, Laura J. ..................................... Disclosed no confl ict of interest.Scott, Robert A. .................................. Disclosed no confl ict of interest.Scott, Rodney J. .................................. Disclosed no confl ict of interest.Scroggins, Rebecca J. ........................ Disclosed no confl ict of interest.Seah, Jas-Mine ................................... Disclosed no confl ict of interest.Seal, Marc L. ....................................... Disclosed no confl ict of interest.Sealls, Whitney ................................... Employee: Eli Lilly and Company. Seaquist, Elizabeth R. ......................... Disclosed no confl ict of interest.Sébastien Annicotte, Annicotte ........ Disclosed no confl ict of interest.Seborg, Dale E. .................................... Disclosed no confl ict of interest.Seeger, John ....................................... Consultant: Optum, WHISCON. Seeley, Randy J. .................................. Consultant: Boehringer Ingelheim Pharmaceuticals, Inc.,

Eisai Co., Ltd., Endobetix, Ethicon Endo-Surgery, Inc., Forest Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Sanofi U.S., Takeda Pharmaceuticals U.S.A., Inc.; Research Support: Boehringer Ingelheim Pharmaceuticals, Inc., Eisai Co., Ltd., Ethicon Endo-Surgery, Inc., Givaudan, Novo Nordisk Inc.; Speaker’s Bureau: Ethicon Endo-Surgery, Inc., Novo Nordisk Inc.; Stock/Shareholder: Zafgen.

Seelig, Amber ...................................... Disclosed no confl ict of interest.Seelig, Eleonora .................................. Disclosed no confl ict of interest.Seely, Ellen W. .................................... Disclosed no confl ict of interest.Segal, Alissa ........................................ Disclosed no confl ict of interest.Segal, Jodi B. ...................................... Disclosed no confl ict of interest.Segal-Lieberman, Gabriella ............... Disclosed no confl ict of interest.Seghieri, Chiara ................................... Disclosed no confl ict of interest.Seghieri, Giuseppe .............................. Disclosed no confl ict of interest.Seino, Susumu ..................................... Disclosed no confl ict of interest.

A881

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Sejling, Anne-Sophie .......................... Disclosed no confl ict of interest.Sekido, Keiko ....................................... Disclosed no confl ict of interest.Sekido, Takashi ................................... Disclosed no confl ict of interest.Sekine, Osamu .................................... Research Support: Merck & Co., Inc. Sekioka, Risa ....................................... Disclosed no confl ict of interest.Selagamsetty, Rajendranath ............. Disclosed no confl ict of interest.Selam, Jean-Louis .............................. Disclosed no confl ict of interest.Seligman, Hilary K. ............................. Disclosed no confl ict of interest.Sell, David R. ....................................... Disclosed no confl ict of interest.Sell, Henrike ........................................ Disclosed no confl ict of interest.Seltmann, Anne-Cathrin ..................... Disclosed no confl ict of interest.Seltzer, Earl ......................................... Disclosed no confl ict of interest.Selvaggi, Erica ..................................... Disclosed no confl ict of interest.Selvarajah, Dinesh .............................. Disclosed no confl ict of interest.Selvin, Elizabeth .................................. Disclosed no confl ict of interest.Semenkovich, Katherine A. ................ Disclosed no confl ict of interest.Semzezem, C. ...................................... Disclosed no confl ict of interest.Sen, Sabyasachi .................................. Disclosed no confl ict of interest.Senda, Satoko ..................................... Disclosed no confl ict of interest.Senesi, Pamela .................................... Disclosed no confl ict of interest.Senior, Peter A. ................................... Advisory Panel: AstraZeneca/Bristol-Myers Squibb, Eli Lilly

and Company, Janssen Biotech, Inc., Novo Nordisk A/S; Research Support: Janssen Biotech, Inc., Novo Nordisk Inc.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Novartis Corporation, Novo Nordisk Inc., Sanofi U.S.

Senokuchi, Takafumi ........................... Disclosed no confl ict of interest.Senra Moniz, Catarina ........................ Disclosed no confl ict of interest.Seo, Dongju ......................................... Disclosed no confl ict of interest.Seo, Ji A ............................................... Disclosed no confl ict of interest.Seo, Ji Young ....................................... Disclosed no confl ict of interest.Seo, Jihye ............................................ Disclosed no confl ict of interest.Seo, Ju Hyun ....................................... Disclosed no confl ict of interest.Seo, Minchul ....................................... Disclosed no confl ict of interest.Seok, Hannah ...................................... Disclosed no confl ict of interest.Sepe, Priscilla ...................................... Disclosed no confl ict of interest.Sequeira Duarte, João ....................... Disclosed no confl ict of interest.Serafi nceanu, Cristian ........................ Disclosed no confl ict of interest.Serafi ni, Paolo ..................................... Disclosed no confl ict of interest.Seraglia, Roberta ................................ Disclosed no confl ict of interest.Serban, Viorel ...................................... Disclosed no confl ict of interest.Sereda, Sam ........................................ Disclosed no confl ict of interest.Sereika, Susan M. ............................... Disclosed no confl ict of interest.Sergeev, Igor N. .................................. Disclosed no confl ict of interest.Serlie, Mireille J. ................................. Disclosed no confl ict of interest.Sermadiras, Isabelle ........................... Disclosed no confl ict of interest.Serne, Erik H. ....................................... Disclosed no confl ict of interest.Seroussi, Cyril ..................................... Employee: Adocia. Serra, Filipa ......................................... Disclosed no confl ict of interest.Serrano-Moreno, Clara ...................... Disclosed no confl ict of interest.Sert, Murat .......................................... Disclosed no confl ict of interest.Seshadri, Mandalam S. ...................... Disclosed no confl ict of interest.Seshadri, Suresh ................................. Disclosed no confl ict of interest.Sesso, Howard D. ............................... Disclosed no confl ict of interest.Setford, Steven ................................... Employee: LifeScan, Inc. Sethi, Bipin .......................................... Disclosed no confl ict of interest.Sethupathy, Praveen .......................... Disclosed no confl ict of interest.Setiadi, Hendra ................................... Disclosed no confl ict of interest.Seufert, Jochen .................................. Disclosed no confl ict of interest.Seuring, Till ......................................... Disclosed no confl ict of interest.Sever, Dror ........................................... Disclosed no confl ict of interest.Severo, Milton ..................................... Disclosed no confl ict of interest.Seyhan, Attila ...................................... Disclosed no confl ict of interest.Seymour, Mark .................................... Employee: XCeleron Inc. Seyoum, Berhane ................................ Disclosed no confl ict of interest.Sfi kakis, Petros P. ................................ Disclosed no confl ict of interest.Sha, Feng ............................................. Disclosed no confl ict of interest.Sha, Sue ............................................... Employee: Janssen Research & Development, LLC. Shabeer, Muhammed ......................... Disclosed no confl ict of interest.Shaefer, Charles .................................. Consultant: AstraZeneca, Bristol-Myers Squibb Company,

Sanofi , Sanofi U.S.; Speaker’s Bureau: Abbott, Amylin, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb Company, Eli Lilly and Company, Forest Pharmaceuticals, Inc., Novartis, Sanofi U.S.

Shah, Amy S. ....................................... Disclosed no confl ict of interest.Shah, Arti ............................................. Disclosed no confl ict of interest.Shah, Asha N. ...................................... Disclosed no confl ict of interest.Shah, Avni C. ....................................... Disclosed no confl ict of interest.Shah, Baiju R. ...................................... Disclosed no confl ict of interest.Shah, Chahan ...................................... Disclosed no confl ict of interest.

Shah, Chirag S. .................................... Disclosed no confl ict of interest.Shah, Hetal .......................................... Disclosed no confl ict of interest.Shah, Meera ........................................ Disclosed no confl ict of interest.Shah, Nilay D. ...................................... Disclosed no confl ict of interest.Shah, Nishit ......................................... Disclosed no confl ict of interest.Shah, Rajiv V. ....................................... Employee: Medtronic, Inc. Shah, Sanket H. ................................... Disclosed no confl ict of interest.Shah, Shashank S. .............................. Disclosed no confl ict of interest.Shah, Syed M. ..................................... Disclosed no confl ict of interest.Shah, Vallabh ...................................... Disclosed no confl ict of interest.Shah, Viral N. ...................................... Disclosed no confl ict of interest.Shahar, Jacqueline ............................. Disclosed no confl ict of interest.Shaheen, Zachary R. ........................... Disclosed no confl ict of interest.Shahid, Muhammad ............................ Disclosed no confl ict of interest.Shaibi, Gabriel Q. ................................ Disclosed no confl ict of interest.Shaikh, Shiraz ...................................... Disclosed no confl ict of interest.Shakeev, Kairat T. ............................... Research Support: Karaganda State Medical University. Shalev, Anath ...................................... Disclosed no confl ict of interest.Shalev, Varda ...................................... Research Support: Novo Nordisk. Shamiss, Ari ........................................ Disclosed no confl ict of interest.Shan, Guogen ...................................... Disclosed no confl ict of interest.Shan, Kevin .......................................... Employee: Orexigen Therapeutics, Inc.; Stock/Shareholder:

Orexigen Therapeutics, Inc. Shan, Zhilei .......................................... Disclosed no confl ict of interest.Shanbhogue, Vikram V. ....................... Disclosed no confl ict of interest.Shankar, Arun ...................................... Disclosed no confl ict of interest.Shankar, Nandita ................................ Disclosed no confl ict of interest.Shankar, R. Ravi .................................. Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &

Co., Inc. Shankar, Sudha S. ............................... Employee: Eli Lilly and Company. Shankarappa, Manjunatha ................. Disclosed no confl ict of interest.Shanthirani, Coimbatore S. ................ Disclosed no confl ict of interest.Shao, Mengle ...................................... Disclosed no confl ict of interest.Shao, Weijuan ..................................... Disclosed no confl ict of interest.Shapira, Amit ...................................... Disclosed no confl ict of interest.Shapiro, Allison B. ............................... Disclosed no confl ict of interest.Shapiro, Allison L. ............................... Disclosed no confl ict of interest.Shapiro, James ................................... Disclosed no confl ict of interest.Shara, Nawar ...................................... Disclosed no confl ict of interest.Shariat-Madar, Zia .............................. Disclosed no confl ict of interest.Sharifi , Amin ........................................ Disclosed no confl ict of interest.Sharma, Andrea J. .............................. Disclosed no confl ict of interest.Sharma, Andria G. ............................... Disclosed no confl ict of interest.Sharma, Arun ...................................... Employee: Medimmune. Sharma, Bikram ................................... Disclosed no confl ict of interest.Sharma, Charu ..................................... Disclosed no confl ict of interest.Sharma, Jugal K. ................................. Disclosed no confl ict of interest.Sharma, Neeraj ................................... Disclosed no confl ict of interest.Sharma, Rakshit .................................. Disclosed no confl ict of interest.Sharma, Rashmi .................................. Disclosed no confl ict of interest.Sharon, Ofer ........................................ Employee: Merck & Co., Inc. Shaw, Christopher S. .......................... Disclosed no confl ict of interest.Shaw, Collin ......................................... Disclosed no confl ict of interest.Shaw, James A. .................................. Speaker’s Bureau: Lilly Deutschland GmbH. Shaw, Jonathan .................................. Advisory Panel: Janssen Pharmaceutical Companies of

Johnson & Johnson, Merck Sharp & Dohme, Novartis Pharmaceuticals Corporation; Research Support: AstraZeneca Pharmaceuticals LP, Merck Sharp & Dohme, Novartis Pharmaceuticals Corporation; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Sanofi U.S.

Shawki, Sameh ................................... Disclosed no confl ict of interest.Shay, Christina M. ............................... Disclosed no confl ict of interest.Shaybek, Altynai S. ............................ Disclosed no confl ict of interest.She, Jin-Xiong ..................................... Disclosed no confl ict of interest.Shea, Jacqueline J. ............................ Disclosed no confl ict of interest.Shea, Jennifer A. ................................ Disclosed no confl ict of interest.Sheehan, John .................................... Employee: AstraZeneca Pharmaceuticals LP. Shehab, Tamer .................................... Disclosed no confl ict of interest.Shehabeldin, Mohamed ..................... Disclosed no confl ict of interest.Shehadeh, Naim .................................. Advisory Panel: AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim GmbH, Eli Lilly and Company, Merck Sharp & Dohme, Novo Nordisk A/S, Sanofi U.S.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH, Eli Lilly and Company, Merck Sharp & Dohme, Novo Nordisk A/S, Sanofi U.S.

Sheibani, Nader .................................. Disclosed no confl ict of interest.Sheikh, Aisha ...................................... Disclosed no confl ict of interest.Sheikh, Azimullah ............................... Disclosed no confl ict of interest.Sheikh, Lumaan ................................... Disclosed no confl ict of interest.Sheikh-Ali, Mae .................................. Research Support: Novo Nordisk. Shelestova, Elena L. ........................... Disclosed no confl ict of interest.

A882

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Shellhaas, Cynthia .............................. Disclosed no confl ict of interest.Shelton, Pernille T. .............................. Employee: Zealand Pharma A/S. Shen, Changyu .................................... Disclosed no confl ict of interest.Shen, Huaqiong ................................... Disclosed no confl ict of interest.Shen, Jian ............................................ Disclosed no confl ict of interest.Shen, Li ................................................ Disclosed no confl ict of interest.Shen, Lishuang .................................... Disclosed no confl ict of interest.Shen, Qiuhua ....................................... Disclosed no confl ict of interest.Shen, Shanmei .................................... Disclosed no confl ict of interest.Shen, Shichen ...................................... Disclosed no confl ict of interest.Shen, Weili .......................................... Disclosed no confl ict of interest.Shen, Xian ............................................ Disclosed no confl ict of interest.Shen, Yun ............................................. Disclosed no confl ict of interest.Sheng, Quanhu .................................... Disclosed no confl ict of interest.Shenolikar, Rahul ................................ Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline. Shepard, Desti .................................... Disclosed no confl ict of interest.Shepard, Jaclyn A. .............................. Disclosed no confl ict of interest.Shepherd, Sam O. ............................... Disclosed no confl ict of interest.Sheridan, Paul J. ................................. Disclosed no confl ict of interest.Sherifali, Diana ................................... Disclosed no confl ict of interest.Sherman, Arthur ................................. Disclosed no confl ict of interest.Sherman, Jerome ................................ Disclosed no confl ict of interest.Sherman, Marianna ............................ Disclosed no confl ict of interest.Sherr, Jennifer L. ................................. Disclosed no confl ict of interest.Sherry, Nicole A. ................................. Other Relationship: MacroGenics, Inc., Novo Nordisk Inc.;

Research Support: Astellas Pharma US, Inc., Bayer HealthCare, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases.

Sherwin, Catherine M. ....................... Disclosed no confl ict of interest.Sherwin, Robert S. .............................. Advisory Panel: AstraZeneca Pharmaceuticals LP; Board

Member: MannKind Corporation, Merck & Co., Inc., Novartis Pharmaceuticals Corporation; Consultant: Bristol-Myers Squibb Company, Eli Lilly and Company, McKinsey & Company, Merck & Co., Inc., Pfi zer Inc.; Research Support: Merck & Co., Inc.

Shestakova, Marina V. ....................... Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Merck Sharp & Dohme, Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Sanofi U.S., Servier.

Shetty, Greeshma K. ........................... Disclosed no confl ict of interest.Shetty, Samith A. ................................ Disclosed no confl ict of interest.Shetty, Sharash ................................... Employee: Boehringer Ingelheim Pharmaceuticals, Inc. Sheu, Wayne ....................................... Disclosed no confl ict of interest.Shevrin, Caroline A. ............................ Disclosed no confl ict of interest.Shi, Chunmei ....................................... Disclosed no confl ict of interest.Shi, Haihong ........................................ Employee: Pfi zer Inc. Shi, Hang ............................................. Research Support: NuSirt Biopharma. Shi, Huan ............................................. Disclosed no confl ict of interest.Shi, Leon .............................................. Consultant: PhaseBio Pharmaceuticals, Inc. Shi, Lizheng ......................................... Disclosed no confl ict of interest.Shi, Qian .............................................. Disclosed no confl ict of interest.Shi, Sally Y. .......................................... Disclosed no confl ict of interest.Shi, Sen ................................................ Disclosed no confl ict of interest.Shi, Xiajie ............................................. Disclosed no confl ict of interest.Shi, Zhenwei ........................................ Disclosed no confl ict of interest.Shiba, Teruo ......................................... Speaker’s Bureau: Daiichi-Sankyo Co., Ltd., Kowa

Pharmaceuticals, Merck Sharp & Dohme, Pfi zer Inc., Shionogi Inc.

Shibata, Hiroshi .................................. Disclosed no confl ict of interest.Shibata, Yusuke .................................. Disclosed no confl ict of interest.Shibayma, Yui ...................................... Disclosed no confl ict of interest.Shibue, Kimitaka ................................. Disclosed no confl ict of interest.Shibusawa, Ryo ................................... Disclosed no confl ict of interest.Shibuta, Tomomi ................................. Disclosed no confl ict of interest.Shibuya, Takashi ................................. Disclosed no confl ict of interest.Shichiri, Masayoshi ............................ Disclosed no confl ict of interest.Shieh, Yi-Shing .................................... Disclosed no confl ict of interest.Shields, Beverely ................................ Disclosed no confl ict of interest.Shifrut, Eric .......................................... Disclosed no confl ict of interest.Shigeko, Hara ...................................... Disclosed no confl ict of interest.Shigenaga, Akira ................................. Disclosed no confl ict of interest.Shigeta, Ayako .................................... Disclosed no confl ict of interest.Shih, Yi-Ju ........................................... Disclosed no confl ict of interest.Shiinoki, Kikuko ................................... Disclosed no confl ict of interest.Shikama, Yosuke ................................. Disclosed no confl ict of interest.Shillo, Pallai Rappai ............................ Disclosed no confl ict of interest.Shim, Woo Young ................................ Disclosed no confl ict of interest.Shima, Yuuki ........................................ Disclosed no confl ict of interest.Shimabukuro, Michio .......................... Disclosed no confl ict of interest.Shimada, Akira .................................... Disclosed no confl ict of interest.

Shimada, Yuichi J. ............................... Disclosed no confl ict of interest.Shimano, Hitoshi ................................. Disclosed no confl ict of interest.Shimatsu, Akira ................................... Disclosed no confl ict of interest.Shimizu, Hiroyuki ................................ Disclosed no confl ict of interest.Shimizu, Jyunichi ................................ Disclosed no confl ict of interest.Shimo, Naoki ....................................... Research Support: Boehringer Ingelheim Pharmaceuticals,

Inc., Kissei Pharmaceutical Co., Ltd. Shimoda, Seiya ................................... Disclosed no confl ict of interest.Shimoda, Yoko ..................................... Disclosed no confl ict of interest.Shimomura, Lichiro ............................. Advisory Panel: AstraZeneca KK, Kowa Pharmaceutical Co.

Ltd, Novo Nordisk Pharma Ltd., Ono Pharmaceutical CO.Ltd, Pfi zer Japan Inc., Sanofi K.K; Research Support: Astellas Pharma Inc, AstraZeneca K.K., Boehringer Ingelheim Japan, Eli Lilly Japan K.K., Kaken Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd., Kowa Pharmaceutical Co. Ltd., Kyowa Hakko Kirin Co., Ltd., Merck & Co.Inc, Mitsubishi Tanabe Pharma Co., Mochida Pharmaceutical Co., Ltd., Novartis Pharma K.K., Novo Nordisk Pharma Ltd., Ono Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Sanofi K.K., Shionogi & Co. Ltd., Sumitomo Dainippon Pharma Co., Ltd., Takeda Pharmaceutical Co., Ltd., Teijin Pharma Ltd.; Speaker’s Bureau: Astellas Pharma Inc, AstraZenecaK.K., Boehringer Ingelheim Japan, Inc., Daiichi Sankyo Co., Ltd., Daiichi Sankyo Co., Ltd., Eli Lilly Japan K.K., Kowa Pharmaceutical Co. Ltd., Kyowa Hakko Kirin Co., Ltd., Merck & Co., Inc., Mitsubishi Tanabe Pharma Co., Mochida Pharmaceutical Co., Ltd., Novo Nordisk Pharma Ltd, Ono Pharmaceutical Co., Ltd., Sanofi K.K., Sanwa Kagaku Kenkyusho Co., Ltd., Shionogi & Co., Ltd., Taisho Toyama Pharmaceutical Co., Takeda Pharmaceutical Co., Ltd., Teijin Pharma Ltd.

Shimony, Joshua ................................. Disclosed no confl ict of interest.Shin, Andy ........................................... Disclosed no confl ict of interest.Shin, Chol ............................................. Disclosed no confl ict of interest.Shin, Hyun Joo .................................... Disclosed no confl ict of interest.Shin, Jang Yel ...................................... Disclosed no confl ict of interest.Shin, John ............................................ Employee: Medtronic MiniMed, Inc. Shin, Min Young .................................. Disclosed no confl ict of interest.Shin, Shyi J. ......................................... Disclosed no confl ict of interest.Shina, Avi ............................................. Disclosed no confl ict of interest.Shinmura, Kyoko ................................. Disclosed no confl ict of interest.Shinnmura, Satomi ............................. Disclosed no confl ict of interest.Shinohara, Yasushi ............................. Disclosed no confl ict of interest.Shinozaki, Shohei ................................ Disclosed no confl ict of interest.Shintaku, Haruo .................................. Disclosed no confl ict of interest.Shiny, Abhijit ....................................... Disclosed no confl ict of interest.Shiochi, Hideki .................................... Disclosed no confl ict of interest.Shioi, Atsushi ...................................... Disclosed no confl ict of interest.Shiota, Masakazu ............................... Disclosed no confl ict of interest.Shiotsu, Yayoi ...................................... Disclosed no confl ict of interest.Shirakawa, Jun ................................... Disclosed no confl ict of interest.Shiramoto, Masanari .......................... Disclosed no confl ict of interest.Shirihai, Orian ...................................... Disclosed no confl ict of interest.Shiroma, Isao ...................................... Disclosed no confl ict of interest.Shishido, Alexander ............................ Disclosed no confl ict of interest.Shiu, Sammy W. .................................. Disclosed no confl ict of interest.Shivashankar, Roopa .......................... Disclosed no confl ict of interest.Shivaswamy, Vijay .............................. Disclosed no confl ict of interest.Shobatake, Ryogo ............................... Disclosed no confl ict of interest.Shockley, Travis .................................. Employee: Eli Lilly and Company. Shoelson, Steven E. ............................ Disclosed no confl ict of interest.Shoemaker, Dan .................................. Disclosed no confl ict of interest.Shojaee-Moradie, Fariba ................... Disclosed no confl ict of interest.Shoji, Kyoko ......................................... Disclosed no confl ict of interest.Shoji, Tetsuo ........................................ Research Support: Asahi Kasei Pharm Corporation, Astellas

Pharma Inc, Daiichi Sankyo Co., Ltd, Mitsubisi Tanabe Pharma Corporation, Takeda Pharmaceutical Company Limited.

Shojima, Nobuhiro .............................. Disclosed no confl ict of interest.Shomali, Mansur E. ............................. Employee: WellDoc, Inc. Shoraka, Ali ......................................... Disclosed no confl ict of interest.Short, Megan M. ................................. Disclosed no confl ict of interest.Shrestha, Neha ................................... Disclosed no confl ict of interest.Shrestha, Sundar ................................ Disclosed no confl ict of interest.Shriner, Daniel ..................................... Disclosed no confl ict of interest.Shristavata, Vipul ............................... Disclosed no confl ict of interest.Shubina, Maria .................................... Disclosed no confl ict of interest.Shubrook, Jay H. ................................. Disclosed no confl ict of interest.Shuldiner, Alan R. ................................ Employee: Regeneron Pharmaceuticals, Inc.; Stock/

Shareholder: Regeneron Pharmaceuticals, Inc. Shulman, Gerald I. ............................... Disclosed no confl ict of interest.

A883

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Shumin, Yang ....................................... Disclosed no confl ict of interest.Shuster, Jonathan J. ........................... Disclosed no confl ict of interest.Shvangiradze, Teona A. ...................... Disclosed no confl ict of interest.Siahmansur, Tarza ............................... Disclosed no confl ict of interest.Siaw, Melanie ..................................... Disclosed no confl ict of interest.Sibomana, Laurien .............................. Disclosed no confl ict of interest.Sidani, Reem M. .................................. Disclosed no confl ict of interest.Siddall, Parker ..................................... Disclosed no confl ict of interest.Siddaramaiah, Naveen H. .................. Disclosed no confl ict of interest.Siddique, Kauser U. ............................. Disclosed no confl ict of interest.Sidibeh, Cherno O. .............................. Disclosed no confl ict of interest.Sidossis, Labros .................................. Disclosed no confl ict of interest.Siebel, Andrew L. ................................ Disclosed no confl ict of interest.Siega-Riz, Anna Maria ........................ Disclosed no confl ict of interest.Siegel-Axel, Dorothea I. ..................... Disclosed no confl ict of interest.Siegmund, Thorsten ............................ Advisory Panel: Sanofi . Siesky, Angela M. ............................... Employee: Eli Lilly and Company. Sigel, Aster .......................................... Disclosed no confl ict of interest.Sihabout, Amanda .............................. Disclosed no confl ict of interest.Sijbrands, Eric ..................................... Disclosed no confl ict of interest.Sijing, Chen .......................................... Disclosed no confl ict of interest.Sikes, Kaitlin ........................................ Disclosed no confl ict of interest.Sikes, Kristin ....................................... Disclosed no confl ict of interest.Sikirica, Mirko ..................................... Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline. Siljander, Heli ...................................... Disclosed no confl ict of interest.Siller, Alejandro F. ............................... Disclosed no confl ict of interest.Silva, Amélia M. .................................. Disclosed no confl ict of interest.Silva, Crislaine C. ................................ Disclosed no confl ict of interest.Silva, Maria Elizabeth R. .................... Disclosed no confl ict of interest.Silva, Mer ............................................ Disclosed no confl ict of interest.Silva, Pamuditha N. ............................ Disclosed no confl ict of interest.Silva, Paolo S. ...................................... Disclosed no confl ict of interest.Silva, Priscilla ...................................... Disclosed no confl ict of interest.Silva, Tiago N. ..................................... Disclosed no confl ict of interest.Silva, Ticiana P. ................................... Disclosed no confl ict of interest.Silveiro, Sandra P. ............................... Disclosed no confl ict of interest.Silver, David ........................................ Disclosed no confl ict of interest.Silver, Kristi D. ..................................... Disclosed no confl ict of interest.Silverstein, Janet ................................ Disclosed no confl ict of interest.Sima, Alexandra .................................. Disclosed no confl ict of interest.Simabuco, Fernando ........................... Disclosed no confl ict of interest.Simcox, Judith ..................................... Disclosed no confl ict of interest.Simell, Barbara .................................... Disclosed no confl ict of interest.Simell, Olli G. ....................................... Disclosed no confl ict of interest.Simeone, Paola G. ............................... Disclosed no confl ict of interest.Siminerio, Linda M. ............................. Research Support: Becton, Dickinson and Company. Simmons, David .................................. Advisory Panel: GlaxoSmithKline; Other Relationship: sanofi ;

Speaker’s Bureau: Novo Nordisk Inc. Simmons, Jill H. .................................. Disclosed no confl ict of interest.Simmons, Kimber M. .......................... Disclosed no confl ict of interest.Simmons, Lisa ..................................... Disclosed no confl ict of interest.Simó, Rafael ........................................ Disclosed no confl ict of interest.Simoda, Masashi ................................ Disclosed no confl ict of interest.Simon Muela, Inma ............................. Disclosed no confl ict of interest.Simon, Christian .................................. Disclosed no confl ict of interest.Simon, Eric ........................................... Disclosed no confl ict of interest.Simon, Marie-Christine ...................... Disclosed no confl ict of interest.Simonsen, Lene ................................... Disclosed no confl ict of interest.Simonson, Donald C. ........................... Disclosed no confl ict of interest.Simpson, Richard W. ........................... Advisory Panel: Novo Nordisk A/S, Sanofi U.S.; Research

Support: AstraZeneca Pharmaceuticals LP, Novo Nordisk A/S.

Simpson, Scot H. ................................. Disclosed no confl ict of interest.Simpson, Sean .................................... Disclosed no confl ict of interest.Sims, Carl ............................................. Disclosed no confl ict of interest.Sims, Deborah ..................................... Disclosed no confl ict of interest.Sims, Emily K. ...................................... Disclosed no confl ict of interest.Sinaiko, Alan ....................................... Disclosed no confl ict of interest.Sinari, Shripad ..................................... Disclosed no confl ict of interest.Sinclair, Alan J. ................................... Disclosed no confl ict of interest.Sinco, Brandy ...................................... Disclosed no confl ict of interest.Sindelar, Dana K. ................................. Employee: Eli Lilly and Company. Sindi, Ghadir ........................................ Disclosed no confl ict of interest.Singer, Joseph ..................................... Consultant: Genentech, Inc. Singh, Baldev M. ................................. Disclosed no confl ict of interest.Singh, Davinder ................................... Disclosed no confl ict of interest.Singh, Devendra P. .............................. Disclosed no confl ict of interest.Singh, Kavita ....................................... Disclosed no confl ict of interest.Singh, Kulvinder .................................. Disclosed no confl ict of interest.Singh, R.R. ........................................... Disclosed no confl ict of interest.Singh, Ravinder ................................... Disclosed no confl ict of interest.

Singh, Renu ......................................... Disclosed no confl ict of interest.Singh, Sharwan ................................... Disclosed no confl ict of interest.Singh, Shashi Sekhar .......................... Disclosed no confl ict of interest.Singh, Shashikant ............................... Disclosed no confl ict of interest.Singh, Veer Bahadur ........................... Disclosed no confl ict of interest.Singh, Veerendra K. ............................ Disclosed no confl ict of interest.Singhal, Mukul .................................... Disclosed no confl ict of interest.Singhal, Shubham ............................... Disclosed no confl ict of interest.Sinha, Kundan ..................................... Disclosed no confl ict of interest.Sinha, Madhumita .............................. Disclosed no confl ict of interest.Sinha, Manasi ..................................... Disclosed no confl ict of interest.Sinha, Rajita ........................................ Consultant: Embera Neurotherapeutics, RiverMend Health. Sinha, Sunita ....................................... Disclosed no confl ict of interest.Sinha, Vikram P. ................................... Employee: MacroGenics, Inc. (Spouse/Partner). Sinn, Kate ............................................ Disclosed no confl ict of interest.Sippl, Rachel M. .................................. Disclosed no confl ict of interest.Sirkirica, Mirko .................................... Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline. Siscovick, David S. .............................. Disclosed no confl ict of interest.Sitnik, Debora ..................................... Disclosed no confl ict of interest.Sivasubramaniyam, Tharini ................ Disclosed no confl ict of interest.Sivitz, William I. .................................. Disclosed no confl ict of interest.Siwarasanond, Nantaporn ................. Disclosed no confl ict of interest.Sjöstrand, Mikaela .............................. Disclosed no confl ict of interest.Sjöström, David ................................... Employee: AstraZeneca; Stock/Shareholder: AstraZeneca. Skalska, Anna ...................................... Disclosed no confl ict of interest.Skarbaliene, Jolanta ........................... Disclosed no confl ict of interest.Skare, Sharon ...................................... Employee: Elcelyx Therapeutics, Inc. Skene, Alison ....................................... Disclosed no confl ict of interest.Skeva, Irini ........................................... Disclosed no confl ict of interest.Skinner, Timothy C. ............................. Disclosed no confl ict of interest.Skjøth, Trine V. .................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Skolnik, Neil ........................................ Advisory Panel: Amgen Inc., AstraZeneca Pharmaceuticals

LP, Lilly, Teva Pharmaceutical Industries Ltd.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP.

Skopkova, Martina .............................. Disclosed no confl ict of interest.Skouboe, Annete G. ............................ Disclosed no confl ict of interest.Skovlund, Soren E ............................... Employee: Novo Nordisk A/S. Skovsø, Søs ......................................... Disclosed no confl ict of interest.Skrami, Edlira ...................................... Disclosed no confl ict of interest.Skratsky, Melissa ............................... Disclosed no confl ict of interest.Skrha, Jan ............................................ Advisory Panel: Boehringer Ingelheim GmbH, Eli Lilly

and Company, Novo Nordisk A/S; Speaker’s Bureau: Boehringer Ingelheim GmbH.

Skrha Jr., Jan ...................................... Disclosed no confl ict of interest.Skrha, Pavel ......................................... Disclosed no confl ict of interest.Skrivanek, Zachary ............................. Employee: Eli Lilly and Company; Research Support: Eli Lilly

and Company; Stock/Shareholder: Eli Lilly and Company. Škrtic, Marko ....................................... Disclosed no confl ict of interest.Skupien, Jan ........................................ Disclosed no confl ict of interest.Skurnik, Geraldine ............................... Disclosed no confl ict of interest.Skyler, Jay S. ....................................... Disclosed no confl ict of interest.Slabaugh, Stephen L. .......................... Research Support: Eli Lilly and Company. Slama, Michael ................................... Disclosed no confl ict of interest.Slee, April ............................................ Employee: Axio Research. Slim, Ines ............................................. Disclosed no confl ict of interest.Sloan, John H. ..................................... Employee: Eli Lilly and Company.Sloan, Karin ......................................... Disclosed no confl ict of interest.Sloop, Kyle W. ..................................... Employee: Eli Lilly and Company. Slover, Robert ...................................... Disclosed no confl ict of interest.Slyvka, Yuriy ........................................ Disclosed no confl ict of interest.Smaldone, Arlene M. .......................... Disclosed no confl ict of interest.Small, Dana M. .................................... Disclosed no confl ict of interest.Small, Lewin ........................................ Disclosed no confl ict of interest.Šmid, Katja .......................................... Disclosed no confl ict of interest.Smiles, Adam M. ................................. Disclosed no confl ict of interest.Smiley, Dawn D. .................................. Research Support: Abbott, Merck Sharp & Dohme. Smith, Ada ........................................... Disclosed no confl ict of interest.Smith, Alan .......................................... Disclosed no confl ict of interest.Smith, Andrew .................................... Disclosed no confl ict of interest.Smith, Avi ............................................ Disclosed no confl ict of interest.Smith, Caren E. .................................... Disclosed no confl ict of interest.Smith, Charles H. ................................ Employee: Merck & Co., Inc. (Spouse/Partner). Smith, Colleen M. ............................... Disclosed no confl ict of interest.Smith, Drew H. .................................... Disclosed no confl ict of interest.Smith, Gordon ..................................... Disclosed no confl ict of interest.Smith, Helen T. .................................... Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline. Smith, Jessica ..................................... Disclosed no confl ict of interest.Smith, Kathleen .................................. Disclosed no confl ict of interest.Smith, Kevin W. ................................... Disclosed no confl ict of interest.

A884

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Smith, Laura B. .................................... Disclosed no confl ict of interest.Smith, Lynette ..................................... Disclosed no confl ict of interest.Smith, Marta ....................................... Disclosed no confl ict of interest.Smith, Steven A. ................................. Disclosed no confl ict of interest.Smith, Steven R. ................................. Disclosed no confl ict of interest.Smith, Susan C. ................................... Disclosed no confl ict of interest.Smith-McLallen, Aaron ...................... Disclosed no confl ict of interest.Smith-Strøm, Hilde ............................. Disclosed no confl ict of interest.Smits, Mark M. ................................... Disclosed no confl ict of interest.Smolskis, John .................................... Employee: United Health Group-Optum. Smouse, Hannah ................................. Disclosed no confl ict of interest.Smulders, Yvo M. ................................ Disclosed no confl ict of interest.Snehalatha, Chamukuttan ................. Disclosed no confl ict of interest.Snelgrove, Rebecca K. ........................ Disclosed no confl ict of interest.Snell-Bergeon, Janet K. ..................... Advisory Panel: Roche Diagnostics; Research Support:

LipoScience, Inc. Snyder, Kenneth .................................. Disclosed no confl ict of interest.Snyder, Lydia ....................................... Disclosed no confl ict of interest.So, Wai-Kin .......................................... Disclosed no confl ict of interest.So, Wing-Yee ....................................... Disclosed no confl ict of interest.Soare, Andreea ................................... Disclosed no confl ict of interest.Sobel, Jack D. ...................................... Disclosed no confl ict of interest.Sobieraj, Diana M. .............................. Disclosed no confl ict of interest.Sobol, Mary ......................................... Employee: Promega Corp. Sobrepena, Leorino ............................. Advisory Panel: Aztra Zeneca Asia-Pacifi c, Boehringer

Ingelheim Philippines, Novo Nordisk Philippines. Sobrin, Lucia ........................................ Disclosed no confl ict of interest.Soejima, Hirofumi ............................... Disclosed no confl ict of interest.Soeters, Maarten R. ........................... Disclosed no confl ict of interest.Softic, Samir ........................................ Disclosed no confl ict of interest.Sohn, Min-Woong ............................... Disclosed no confl ict of interest.Sohn, Tae Seo ...................................... Disclosed no confl ict of interest.Soiferman, Devorah ............................ Disclosed no confl ict of interest.Sokal, Etienne M. ................................ Disclosed no confl ict of interest.Soker, Shay .......................................... Disclosed no confl ict of interest.Solà, Cristina ....................................... Disclosed no confl ict of interest.Solano, Francix X. ............................... Disclosed no confl ict of interest.Soleymanlou, Nima ............................. Employee: Boehringer Ingelheim Pharmaceuticals, Inc. Solheim, Marie H. ............................... Disclosed no confl ict of interest.Solin, Olof ............................................ Disclosed no confl ict of interest.Solis, Silvana ....................................... Disclosed no confl ict of interest.Solís-Cruz, Maria del Carmen ............ Disclosed no confl ict of interest.Sollinger, Daniel .................................. Employee: Medizinische Klinik, Universitätsmedizin Mainz. Solomon, Alexandra ........................... Disclosed no confl ict of interest.Solomon, Thomas P. ............................ Disclosed no confl ict of interest.Somal, Vikram S. ................................. Disclosed no confl ict of interest.Somaratne, Ransi ................................ Employee: Amgen Inc.; Stock/Shareholder: Amgen Inc. Somayaji, Veena ................................. Disclosed no confl ict of interest.Somer, Adir .......................................... Disclosed no confl ict of interest.Sommerfeld, Mark .............................. Disclosed no confl ict of interest.Son, Seok Man .................................... Disclosed no confl ict of interest.Søndergaard, Esben ............................ Disclosed no confl ict of interest.Sone, Hirohito ..................................... Disclosed no confl ict of interest.Sonenberg, Nahum ............................. Disclosed no confl ict of interest.Sonesson, Christian ............................ Employee: AstraZeneca Pharmaceuticals LP. Song, Do Kyeong ................................. Disclosed no confl ict of interest.Song, Gengqing ................................... Disclosed no confl ict of interest.Song, Guangyao .................................. Disclosed no confl ict of interest.Song, Hee-Jung .................................. Disclosed no confl ict of interest.Song, Kexiu .......................................... Disclosed no confl ict of interest.Song, Ki-Ho .......................................... Employee: Yeouido St. Mary’s Hospital. Song, Lili .............................................. Disclosed no confl ict of interest.Song, Miaomiao .................................. Disclosed no confl ict of interest.Song, Min ............................................ Employee: Eli Lilly and Company. Song, Shije ........................................... Disclosed no confl ict of interest.Song, Sun Ok ....................................... Disclosed no confl ict of interest.Song, Wei ............................................ Disclosed no confl ict of interest.Song, Xiaomin ..................................... Disclosed no confl ict of interest.Song, Yang ........................................... Disclosed no confl ict of interest.Song, Ye ............................................... Disclosed no confl ict of interest.Songini, Marco .................................... Disclosed no confl ict of interest.Soni, Kanupriya ................................... Disclosed no confl ict of interest.Soni, Navin K. ...................................... Disclosed no confl ict of interest.Sonne, David P. .................................... Disclosed no confl ict of interest.Sonnen, Joshua A. .............................. Disclosed no confl ict of interest.Sonnenberg, Gabriele E. ..................... Employee: Pfi zer Inc. Sonoda, Noriyuki ................................ Disclosed no confl ict of interest.Sontag, David ...................................... Disclosed no confl ict of interest.Soon, Mirian ........................................ Disclosed no confl ict of interest.Soong, Shelley .................................... Disclosed no confl ict of interest.Soppe, Carol L. .................................... Disclosed no confl ict of interest.Soprovich, Allison ............................... Disclosed no confl ict of interest.

Soran, Handrean ................................. Disclosed no confl ict of interest.Sordi, Valeria ....................................... Disclosed no confl ict of interest.Sørensen, Birgitte N. .......................... Disclosed no confl ict of interest.Sørensen, Ditte ................................... Disclosed no confl ict of interest.Sorensen, Lars Peter ........................... Disclosed no confl ict of interest.Sorice, Gian Pio ................................... Disclosed no confl ict of interest.Sorisky, Alexander .............................. Disclosed no confl ict of interest.Soroka, Orysya .................................... Disclosed no confl ict of interest.Sorrell, Joyce ...................................... Disclosed no confl ict of interest.Sörstadius, Elisabeth .......................... Employee: AstraZeneca Pharmaceuticals LP. Sosenko, Jay M. .................................. Disclosed no confl ict of interest.Sosina, Olukayode A. .......................... Disclosed no confl ict of interest.Sotiropoulos, Alexios ......................... Disclosed no confl ict of interest.Soto Moreno, Alfonso M. ................... Disclosed no confl ict of interest.Soto, Jamie ......................................... Disclosed no confl ict of interest.Soto-Rivera, Carmen L. ...................... Disclosed no confl ict of interest.Sotres-Alvarez, Daniela ..................... Disclosed no confl ict of interest.Soty, Maud .......................................... Disclosed no confl ict of interest.Soty-Roca, Maud ................................ Disclosed no confl ict of interest.Soula, Olivier ....................................... Employee: Adocia; Stock/Shareholder: Adocia. Soumerai, Stephen ............................. Disclosed no confl ict of interest.Soupal, Jan .......................................... Advisory Panel: advisory panel member, advisory panel

member, Boehringer Ingelheim GmbH, Roche Diagnostics; Speaker’s Bureau: Boehringer Ingelheim GmbH, Eli Lilly and Company, Medtronic, Inc., Sanofi U.S.

Sourij, Harald ...................................... Advisory Panel: AstraZeneca/Bristol-Myers Squibb, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Merck Sharp & Dohme, Novartis Pharma GmbH, Novo Nordisk A/S, Sanofi Pasteur SA; Research Support: AstraZeneca/Bristol-Myers Squibb, Boehringer Ingelheim Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited.

Sourris, Karly C. .................................. Disclosed no confl ict of interest.Sousa, Maysa V. ................................. Disclosed no confl ict of interest.Souto, Ricardo P. ................................. Disclosed no confl ict of interest.Souza, Leticia ...................................... Disclosed no confl ict of interest.Souza, Rodrigo M. ............................... Other Relationship: Co-owner of the game (InsuOnLine)

assessed in this study. Sowers, James R. ............................... Disclosed no confl ict of interest.Sowinski, Janice ................................. Disclosed no confl ict of interest.Soysal-Atile, Neslihan ........................ Disclosed no confl ict of interest.Spada, Anna ........................................ Disclosed no confl ict of interest.Spaic, Tamara ...................................... Research Support: NovoNordisk Canada; Speaker’s Bureau:

Boehrinher Ingelheim Canada, Speaker. Spangler, Kevin ................................... Disclosed no confl ict of interest.Spano, Lucia ........................................ Disclosed no confl ict of interest.Spanou, Marianna .............................. Disclosed no confl ict of interest.Sparrow, Harlan G. ............................. Disclosed no confl ict of interest.Spatz, Erica S. ..................................... Disclosed no confl ict of interest.Spatz, Jan ............................................ Disclosed no confl ict of interest.Spatz, Jordan ...................................... Disclosed no confl ict of interest.Spégel, Peter ....................................... Disclosed no confl ict of interest.Speier, Stephan ................................... Research Support: Boehringer Ingelheim GmbH. Speight, Jane ...................................... Advisory Panel: Roche Diagnostics; Consultant: AstraZeneca

Pharmaceuticals LP, Roche Diagnostics, Sanofi U.S.; Research Support: AstraZeneca Pharmaceuticals LP, Roche Diagnostics, Sanofi U.S.; Speaker’s Bureau: Johnson & Johnson, Roche Diagnostics, Sanofi U.S.

Speight, Jane ...................................... Disclosed no confl ict of interest.Spencer, Michael S. ............................ Disclosed no confl ict of interest.Sperl-Hillen, JoAnn M. ....................... Disclosed no confl ict of interest.Spigarelli, Michael G. ......................... Disclosed no confl ict of interest.Spohn, Gunther ................................... Stock/Shareholder: Cytos Biotechnology AG. Spurgeon, Benjamin ............................ Disclosed no confl ict of interest.Sreeedhar, Remya ............................... Disclosed no confl ict of interest.Sreenan, Seamus ................................ Disclosed no confl ict of interest.Srinivasan, Shylaja ............................. Disclosed no confl ict of interest.Srivastava, Anand K. .......................... Disclosed no confl ict of interest.Srivastava, Anshuman ........................ Disclosed no confl ict of interest.Srivastava, Piyush M. ......................... Disclosed no confl ict of interest.Stacey, Holly M. .................................. Disclosed no confl ict of interest.Stadion, Mandy ................................... Disclosed no confl ict of interest.Stadlmayr, Andreas ............................ Disclosed no confl ict of interest.Stadtheim, Hans K. ............................. Disclosed no confl ict of interest.Stafford, Jeanette M. ........................ Disclosed no confl ict of interest.Stafylas, Panagiotis ............................ Disclosed no confl ict of interest.Stage, Tore B. ...................................... Disclosed no confl ict of interest.Stager, William ................................... Consultant: Sanofi . Stagi, Stefano ..................................... Disclosed no confl ict of interest.Stahre, Christina A. ............................ Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP. Staiger, Harald .................................... Disclosed no confl ict of interest.

A885

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Staimez, Lisa R. ................................... Disclosed no confl ict of interest.Stallings, Devita .................................. Disclosed no confl ict of interest.Stamler, Jeremiah ............................... Disclosed no confl ict of interest.Stanescu, Diana E. .............................. Disclosed no confl ict of interest.Stanford, Amy ..................................... Consultant: Bristol-Myers Squibb Company. Stang, Paul E. ...................................... Employee: Janssen Pharmaceutical Companies of Johnson &

Johnson. Staniak, Henrique L. ........................... Disclosed no confl ict of interest.Stanik, Juraj ........................................ Disclosed no confl ict of interest.Stanikova, Daniela .............................. Disclosed no confl ict of interest.Stanley, Charles A. ............................. Disclosed no confl ict of interest.Stano, Sarah ........................................ Disclosed no confl ict of interest.Stark Casagrande, Sarah ................... Disclosed no confl ict of interest.Starling, Anne P. .................................. Disclosed no confl ict of interest.Stasiv, Yuri ........................................... Employee: Relypsa, Inc.; Stock/Shareholder: Relypsa, Inc. Stechemesser, Lars ............................ Disclosed no confl ict of interest.Steck, Andrea K. ................................. Disclosed no confl ict of interest.Steck, Susan E. .................................... Disclosed no confl ict of interest.Steckelings, Ulreke M. ....................... Disclosed no confl ict of interest.Stefan, Norbert ................................... Disclosed no confl ict of interest.Stefanadis, Christodoulos .................. Disclosed no confl ict of interest.Stefanelli, Giovanna ........................... Disclosed no confl ict of interest.Stefanovski, Darko .............................. Disclosed no confl ict of interest.Stefanowicz, Magdalena ................... Disclosed no confl ict of interest.Stefansson, Einar ................................ Board Member: Risk medical Solutions; Stock/Shareholder:

Risk Medical Solutions. Steffen, Lyn S. ..................................... Disclosed no confl ict of interest.Steffes, Michael ................................. Disclosed no confl ict of interest.Steffes, Michael W. ............................ Disclosed no confl ict of interest.Steg, P.H. Gabriel ................................ Consultant: Amarin Pharma, Inc., AstraZeneca

Pharmaceuticals LP; Research Support: Bayer HealthCare, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Daiichi-Sankyo Co., Ltd., GlaxoSmithKline, Medtronic, Inc., Merck Sharp & Dohme, Novartis Corporation, Otsuka Pharmaceutical Co., Ltd., Pfi zer Inc., Sanofi U.S., Sanofi U.S., Servier, Servier, The Medicines Company, Vivus Inc.; Stock/Shareholder: Aterovax.

Stehouwer, Coen D. ............................ Disclosed no confl ict of interest.Steil, Garry M. ..................................... Research Support: DexCom. Stein, Daniel T. .................................... Disclosed no confl ict of interest.Stein, Joanna ...................................... Disclosed no confl ict of interest.Steinberg, Helmut O. .......................... Disclosed no confl ict of interest.Steinberg, John S. .............................. Disclosed no confl ict of interest.Steinberger, Julia ................................ Disclosed no confl ict of interest.Steiner, Derek ...................................... Employee: Janssen Research & Development LLC. Steiner, John F. .................................... Disclosed no confl ict of interest.Steiniche, Torben S. ............................ Disclosed no confl ict of interest.Stell, Carol A. ...................................... Disclosed no confl ict of interest.Stella, Peter ......................................... Employee: Sanofi . Stem, Maxwell S. ............................... Disclosed no confl ict of interest.Stender, Sarah .................................... Disclosed no confl ict of interest.Stender-Petersen, Kirstine ................. Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Stengelin, Siegfried ............................ Employee: Sanofi ; Stock/Shareholder: Sanofi . Stenlöf, Kaj .......................................... Disclosed no confl ict of interest.Stentz, Frankie B. ................................ Disclosed no confl ict of interest.Stephenson, Judith J. ......................... Other Relationship: Employee of HealthCore, a research-

consulting organization. All of my research is industry-sponsored.

Sterlicchio, Michele ............................ Disclosed no confl ict of interest.Stern, Alexa ......................................... Disclosed no confl ict of interest.Sternberg, Rosa Maria ....................... Disclosed no confl ict of interest.Sternfeld, Barbara .............................. Disclosed no confl ict of interest.Sternhufvud, Catarina ........................ Employee: AstraZeneca Pharmaceuticals LP. Steven, Sarah ...................................... Disclosed no confl ict of interest.Stevens, Robert .................................. Disclosed no confl ict of interest.Stevenson, Teri D. ............................... Disclosed no confl ict of interest.Steverson, Dennis ............................... Disclosed no confl ict of interest.Stewart, Caroline A. ........................... Disclosed no confl ict of interest.Stewart, Kerry ..................................... Disclosed no confl ict of interest.Stewart, Lorna S. ................................ Employee: LifeScan, Inc. Stewart, Zoe ....................................... Disclosed no confl ict of interest.Stier, Christine K. ................................ Disclosed no confl ict of interest.Stierstorfer, Birgit ............................... Disclosed no confl ict of interest.Stiles, Bangyan L. ............................... Disclosed no confl ict of interest.Stillitano, Alexia ................................. Disclosed no confl ict of interest.Stillman, Isaac E. ................................. Disclosed no confl ict of interest.Stinkens, Rudi ..................................... Disclosed no confl ict of interest.Stitt, Trevor N. .................................... Employee: Regeneron Pharmaceuticals, Inc. Stødkilde-Jørgensen, Hans ................ Disclosed no confl ict of interest.Stoffers, Doris A. ................................ Disclosed no confl ict of interest.

Stohr, Oliver ......................................... Disclosed no confl ict of interest.Stoian, Marilena ................................. Disclosed no confl ict of interest.Stojadinovic, Olivera ........................... Disclosed no confl ict of interest.Stoll, Maria K. ..................................... Disclosed no confl ict of interest.Stolte, Manuela .................................. Disclosed no confl ict of interest.Stömmer, Kathrin ................................ Disclosed no confl ict of interest.Stone, Michael H. ............................... Disclosed no confl ict of interest.Stone, Patricia W. ............................... Disclosed no confl ict of interest.Stone, Stephen .................................... Research Support: National Institutes of Health. Stone, William L. ................................. Disclosed no confl ict of interest.Stoner, Julie ........................................ Disclosed no confl ict of interest.Storey, Helen L. ................................... Disclosed no confl ict of interest.Storkholm, Jan H. ............................... Disclosed no confl ict of interest.Storm, Petter ....................................... Disclosed no confl ict of interest.Strachan, David P. ............................... Disclosed no confl ict of interest.Straczkowski, Marek .......................... Disclosed no confl ict of interest.Strain, W. David .................................. Advisory Panel: Novartis, Janssen Pharmaceuticals, Inc.;

Research Support: Novo Nordisk; Speaker’s Bureau: Novartis, Bayer, Boehringer Ingelheim, Pfi zer.

Strand, Jorma ..................................... Disclosed no confl ict of interest.Strandberg, Charlotte ......................... Disclosed no confl ict of interest.Strange, Poul ....................................... Consultant: PhaseBio Pharmaceuticals, Inc.; Stock/

Shareholder: PhaseBio Pharmaceuticals, Inc. Strassburger, Klaus ............................ Disclosed no confl ict of interest.Strasser, Michael ................................ Disclosed no confl ict of interest.Stratmann, Bernd ................................ Disclosed no confl ict of interest.Stratta, Robert J. ................................ Disclosed no confl ict of interest.Stratton, Andra ................................... Consultant: Amylin Pharmaceuticals, LLC., AstraZeneca

Pharmaceuticals LP, AstraZeneca/Bristol-Myers Squibb. Stratton, Irene M. ............................... Disclosed no confl ict of interest.Straubhaar, Juerg ............................... Disclosed no confl ict of interest.Strauss, Allison ................................... Disclosed no confl ict of interest.Strauss, Elisabeth ............................... Disclosed no confl ict of interest.Strawbridge, Rona .............................. Disclosed no confl ict of interest.Streisand, Randi .................................. Disclosed no confl ict of interest.Stricker, Bruno H. ................................ Disclosed no confl ict of interest.Stride, Annie E. ................................... Disclosed no confl ict of interest.Strock, Ellie ......................................... Consultant: Boehringer Ingelheim GmbH. Strohmeyer, Christine ......................... Disclosed no confl ict of interest.Strojek, Krzysztof ................................ Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Bristol-

Myers Squibb Company, Eli Lilly and Company, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Servier.

Strollo, Rocky ...................................... Disclosed no confl ict of interest.Strom, Alexander ................................ Disclosed no confl ict of interest.Strom, Terry B. .................................... Disclosed no confl ict of interest.Strum, Matthew ................................. Disclosed no confl ict of interest.Strutt, Brenda ..................................... Disclosed no confl ict of interest.Strycker, Lisa ....................................... Disclosed no confl ict of interest.Stuart, Bruce C. ................................... Advisory Panel: Merck & Co., Inc.; Research Support: Merck &

Co., Inc. Stuart, Charles A. ............................... Disclosed no confl ict of interest.Stuart, Jennifer ................................... Disclosed no confl ict of interest.Stubblefi eld, Tianna ............................ Disclosed no confl ict of interest.Stuck, Rodney ..................................... Disclosed no confl ict of interest.Stuckey, Heather L. ............................. Research Support: National Institute of Diabetes and

Digestive and Kidney Diseases, Novo Nordisk A/S. Stump, Mike ........................................ Disclosed no confl ict of interest.Stumvoll, Michael ............................... Disclosed no confl ict of interest.Sturis, Jeppe ....................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Sturmey, Roger G. ............................... Disclosed no confl ict of interest.Stylopoulos, Nicholas ......................... Disclosed no confl ict of interest.Su, Benli ............................................... Disclosed no confl ict of interest.Su, Qing ............................................... Disclosed no confl ict of interest.Su, Xin .................................................. Disclosed no confl ict of interest.Suarez Sanchez, Fernando ................. Disclosed no confl ict of interest.Suarez, Fernando ................................ Disclosed no confl ict of interest.Suárez-Álvarez, Beatriz ...................... Disclosed no confl ict of interest.Subauste, Angela ................................ Disclosed no confl ict of interest.Suchy, Yana ......................................... Research Support: National Institute of Diabetes and

Digestive and Kidney Diseases. Suckow, Arthur ................................... Employee: Medimmune LLC. Sudini, Preethi ..................................... Disclosed no confl ict of interest.Sudit, Bella .......................................... Disclosed no confl ict of interest.Suefke, Sven ........................................ Disclosed no confl ict of interest.Suematsu, Hiroyuki ............................. Disclosed no confl ict of interest.Suetomi, Risa ...................................... Disclosed no confl ict of interest.Suetsugu, Mariko ................................ Disclosed no confl ict of interest.Sugano, Yoko ....................................... Disclosed no confl ict of interest.Sugg, Jennifer ..................................... Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP.

A886

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Sugino, Masakazu ............................... Disclosed no confl ict of interest.Sugiyama, Hiroyuki ............................. Employee: Teijin Pharma Limited. Sugrue, Daniel ..................................... Disclosed no confl ict of interest.Suh, Kyo-il ............................................ Disclosed no confl ict of interest.Sui, Yi ................................................... Disclosed no confl ict of interest.Suka, Machi ......................................... Disclosed no confl ict of interest.Suleiman, Mara ................................... Disclosed no confl ict of interest.Sullivan, Brooke .................................. Disclosed no confl ict of interest.Sullivan, David .................................... Consultant: Abbott, Merck Sharp & Dohme; Research

Support: AstraZeneca Pharmaceuticals LP; Speaker’s Bureau: Novo Nordisk A/S.

Sullivan, Jeffrey .................................. Consultant: AstraZeneca Pharmaceuticals LP. Sullivan, Mary M. ................................ Disclosed no confl ict of interest.Sullivan, Mitchell A. ........................... Disclosed no confl ict of interest.Sulowicz, Wladyslaw ......................... Disclosed no confl ict of interest.Sum, Chee Fang ................................... Disclosed no confl ict of interest.Suma, Radhakrishnan ......................... Disclosed no confl ict of interest.Sumi, Keisuke ...................................... Disclosed no confl ict of interest.Sumi, Mariko ....................................... Employee: Sanofi . Sumitani, Yoshikazu ............................ Disclosed no confl ict of interest.Sumner, Anne E. .................................. Disclosed no confl ict of interest.Sun, Bei ................................................ Disclosed no confl ict of interest.Sun, Chia-Cheng .................................. Disclosed no confl ict of interest.Sun, Fangui .......................................... Disclosed no confl ict of interest.Sun, Guofeng ....................................... Employee: Crown Bioscience, Inc. Sun, Jennifer K. ................................... Consultant: Kowa Pharmaceuticals, Regeneron

Pharmaceuticals, Inc.; Research Support: Genentech, Inc., KalVista Pharmaceuticals Inc.

Sun, Jiangming .................................... Disclosed no confl ict of interest.Sun, Jiayu ............................................ Disclosed no confl ict of interest.Sun, Lei ................................................ Disclosed no confl ict of interest.Sun, Ling-Jun ....................................... Disclosed no confl ict of interest.Sun, Qingyi .......................................... Disclosed no confl ict of interest.Sun, Taoping ........................................ Disclosed no confl ict of interest.Sun, Vinsin A. ...................................... Disclosed no confl ict of interest.Sun, Wei .............................................. Disclosed no confl ict of interest.Sun, Wen ............................................. Employee: Medizinische Klinik, Universitätsmedizin Mainz. Sun, Yadong ......................................... Disclosed no confl ict of interest.Sun, Yan ............................................... Disclosed no confl ict of interest.Sun, Zhe ............................................... Disclosed no confl ict of interest.Sun, Zhen ............................................. Disclosed no confl ict of interest.Sun, Zhongjie ....................................... Disclosed no confl ict of interest.Sun, Zilin .............................................. Research Support: Becton, Dickinson and Company. Sunagawa, Hiroshi .............................. Disclosed no confl ict of interest.Sunagawa, Kenji ................................. Disclosed no confl ict of interest.Sundararajan, Pragalath .................... Disclosed no confl ict of interest.Sundbom, Magnus .............................. Disclosed no confl ict of interest.Sundström, Johan ............................... Disclosed no confl ict of interest.Sung, Yeon-Ah ..................................... Disclosed no confl ict of interest.Sunny, Nishanth .................................. Disclosed no confl ict of interest.Suppere, Corinne ................................ Disclosed no confl ict of interest.Surmont, Filip A. ................................. Employee: AstraZeneca, Merck (Spouse/Partner); Stock/

Shareholder: AstraZeneca, Merck (Spouse/Partner). Suryana, Eurwin .................................. Disclosed no confl ict of interest.Susaki, Yuka ........................................ Disclosed no confl ict of interest.Sutherland, Calum .............................. Disclosed no confl ict of interest.Sutherland, David E. ........................... Disclosed no confl ict of interest.Sutter, Diane E. ................................... Employee: Becton, Dickinson and Company; Stock/

Shareholder: Becton, Dickinson and Company. Suttiratana, Sakinah ........................... Disclosed no confl ict of interest.Suwa, Makoto ..................................... Disclosed no confl ict of interest.Suwanai, Hirotsugu ............................ Disclosed no confl ict of interest.Suzuki, Hiroaki ..................................... Disclosed no confl ict of interest.Suzuki, Hirofumi .................................. Disclosed no confl ict of interest.Suzuki, Hiroshi ..................................... Disclosed no confl ict of interest.Suzuki, Jun .......................................... Disclosed no confl ict of interest.Suzuki, Junichi .................................... Disclosed no confl ict of interest.Suzuki, Katsuya ................................... Employee: Ajinomoto Group. Suzuki, Kazuyo .................................... Disclosed no confl ict of interest.Suzuki, Kenji ........................................ Disclosed no confl ict of interest.Suzuki, Kunihiro ................................... Disclosed no confl ict of interest.Suzuki, Masayuki ................................ Disclosed no confl ict of interest.Suzuki, Natsuko .................................. Disclosed no confl ict of interest.Suzuki, Ruriko ...................................... Disclosed no confl ict of interest.Suzuki, Ryo .......................................... Disclosed no confl ict of interest.Suzuki, Satoru ..................................... Disclosed no confl ict of interest.Suzuki, Tatsuhiko ................................ Disclosed no confl ict of interest.Suzuki, Toru ......................................... Disclosed no confl ict of interest.Suzuki, Yoshifumi ................................ Disclosed no confl ict of interest.Suzuki, Yoshiki ..................................... Disclosed no confl ict of interest.Suzuki, Yuki ......................................... Disclosed no confl ict of interest.Suzuki, Yuko ......................................... Disclosed no confl ict of interest.

Svacina, Stepan .................................. Disclosed no confl ict of interest.Svane, Maria ....................................... Disclosed no confl ict of interest.Svare, Jens A. ..................................... Disclosed no confl ict of interest.Svendsen, Lars B. ................................ Disclosed no confl ict of interest.Svensson, Maria ................................. Disclosed no confl ict of interest.Svetkey, Laura P. ................................. Disclosed no confl ict of interest.Swain, Prabodha ................................. Employee: Cadila Healthcare Limited. Swamy, Lakshmana ............................ Disclosed no confl ict of interest.Swanson, Ronald ................................ Employee: Janssen Research & Development LLC. Swartling, Ulrica ................................. Disclosed no confl ict of interest.Swee, Du Soon .................................... Disclosed no confl ict of interest.Sweet, Laurel J. .................................. Disclosed no confl ict of interest.Swinney, Monica ................................ Employee: BD Medical-Diabetes Care; Stock/Shareholder:

Becton, Dickinson and Company. Syed, Farooq ........................................ Disclosed no confl ict of interest.Syed, Ismail ......................................... Disclosed no confl ict of interest.Syed, Samreen K. ................................ Employee: Eli Lilly and Company. Sylvetsky Meni, Allison C. ................. Disclosed no confl ict of interest.Syu, Stephanie .................................... Disclosed no confl ict of interest.Szabat, Marta ..................................... Disclosed no confl ict of interest.Szabo, Shelagh .................................... Disclosed no confl ict of interest.Szczerbinski, Lukasz ........................... Disclosed no confl ict of interest.Szendroedi, Julia ................................ Disclosed no confl ict of interest.Szeto, Angela ...................................... Disclosed no confl ict of interest.Szewczyk, Jerzy .................................. Disclosed no confl ict of interest.Szopa, Magdalena .............................. Disclosed no confl ict of interest.Szymanska-Garbacz, Elektra ............. Disclosed no confl ict of interest.Szyndralewiez, Cedric ........................ Disclosed no confl ict of interest.Tabák, Adam ........................................ Disclosed no confl ict of interest.Tabara, Yasuharu ................................ Disclosed no confl ict of interest.Tabassum, Juveria .............................. Disclosed no confl ict of interest.Tabassum, Shehla ............................... Disclosed no confl ict of interest.Tabata, Mitsuhisa ............................... Disclosed no confl ict of interest.Tabet, Eddy J. ...................................... Other Relationship: Merck Sharp & Dohme, Takeda

Pharmaceutical Company Limited. Tabrizian, Tahmineh ............................ Disclosed no confl ict of interest.Tack, Cees J. ....................................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Merck

Sharp & Dohme, Novo Nordisk A/S; Research Support: Novo Nordisk A/S.

Tadinada, Satya M. ............................. Disclosed no confl ict of interest.Tagaya, Yuko ....................................... Disclosed no confl ict of interest.Tagett, Rebecca .................................. Disclosed no confl ict of interest.Taghizadeh, Farnaz ............................. Disclosed no confl ict of interest.Taguchi, Koichiro ................................. Disclosed no confl ict of interest.Tahara, Yumiko .................................... Disclosed no confl ict of interest.Taher, Jennifer .................................... Disclosed no confl ict of interest.Tajima, Toshihiro ................................. Disclosed no confl ict of interest.Tajiri, Yuji ............................................. Disclosed no confl ict of interest.Takagi, Ayano ...................................... Disclosed no confl ict of interest.Takagi, Miyuki ..................................... Disclosed no confl ict of interest.Takahara, Kazuna ................................ Disclosed no confl ict of interest.Takahara, Yusuke ................................ Disclosed no confl ict of interest.Takahashi, Atsushi .............................. Disclosed no confl ict of interest.Takahashi, Hideyuki ............................ Employee: Astellas Pharma Inc. Takahashi, Hirokazu ............................ Disclosed no confl ict of interest.Takahashi, Yoshihiko ........................... Disclosed no confl ict of interest.Takaishi, Tetsuo .................................. Disclosed no confl ict of interest.Takamura, Toshinari ............................ Speaker’s Bureau: Eli Lilly Japan K.K., Novo Nordisk A/S. Takane, Karen ...................................... Disclosed no confl ict of interest.Takao, Toshiko ..................................... Disclosed no confl ict of interest.Takasawa, Shin ................................... Disclosed no confl ict of interest.Takashi, Yuichi ..................................... Disclosed no confl ict of interest.Takata, Yasunori ................................. Disclosed no confl ict of interest.Takatani, Tomozumi ............................ Disclosed no confl ict of interest.Takayama, Chitoshi ............................. Disclosed no confl ict of interest.Takayanagi, Ryoichi ............................ Disclosed no confl ict of interest.Take, Kazumi ........................................ Employee: Takeda Pharmaceutical Company Limited, Takeda

Pharmaceutical Company Limited (Spouse/Partner). Takebayashi, Kohzo ............................ Disclosed no confl ict of interest.Takebe, Noriko .................................... Disclosed no confl ict of interest.Takeda, Eiji .......................................... Disclosed no confl ict of interest.Takeda, Hiroyuki .................................. Disclosed no confl ict of interest.Takeda, Jun ......................................... Disclosed no confl ict of interest.Takeda, Maiko ..................................... Disclosed no confl ict of interest.Takeda, Ryosuke ................................. Disclosed no confl ict of interest.Takeda, Yoshiyu .................................. Disclosed no confl ict of interest.Takeda, Yukimasa ............................... Disclosed no confl ict of interest.Takeishi, Soichi ................................... Disclosed no confl ict of interest.Takemoto, Koji ..................................... Disclosed no confl ict of interest.Takemoto, Minoru ............................... Disclosed no confl ict of interest.Takeno, Kageumi ................................. Disclosed no confl ict of interest.Taketani, Yutaka ................................. Disclosed no confl ict of interest.

A887

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Takeuchi, Jun ....................................... Disclosed no confl ict of interest.Takeuchi, Koji ...................................... Employee: Takeda Pharmaceutical Company Limited. Takeuchi, Takato ................................. Disclosed no confl ict of interest.Taki, Iman ............................................ Disclosed no confl ict of interest.Takihata, Masahiro ............................. Speaker’s Bureau: Astellas Pharma Inc, Boehringer

Ingelheim GmbH, Daiichi-Sankyo Co., Ltd., DaiNippon-Sumitomo, Kissei Pharmaceutical Co., Ltd., Kowa Pharmaceuticals, Kyowa Hakko Kirin Co., Ltd., Merck Sharp & Dohme, Novartis Corporation, Novo Nordisk Inc., Ono Pharmaceutical Co., Ltd., Sanofi .K.K., Taisho Pharmaceutical Co., Ltd., Tanabe-Mitsubishi Pharma.

Takikawa, Akiko .................................. Disclosed no confl ict of interest.Takita, Yasushi .................................... Employee: Eli Lilly Japan K.K. Takiyama, Yumi ................................... Research Support: Boehringer Ingelheim GmbH, Eli

Lilly Japan K.K., Merck Sharp & Dohme, Taisho Pharmaceutical Co., Ltd.; Speaker’s Bureau: Kowa Pharmaceuticals.

Takizawa, Miho ................................... Disclosed no confl ict of interest.Talal, Talal K. ....................................... Disclosed no confl ict of interest.Talavera, Laura .................................... Disclosed no confl ict of interest.Taleb, Nadine ...................................... Disclosed no confl ict of interest.Tam, Charmaine .................................. Disclosed no confl ict of interest.Tam, Karen ........................................... Disclosed no confl ict of interest.Tam, Wing Hung .................................. Disclosed no confl ict of interest.Tamaki, Motoyuki ............................... Disclosed no confl ict of interest.Tamaki, Toshiaki .................................. Disclosed no confl ict of interest.Tamariz, Leonardo ............................... Disclosed no confl ict of interest.Tamboli, Robyn A. ............................... Disclosed no confl ict of interest.Tamborlane, William V. ....................... Consultant: Boehringer Ingelheim GmbH, Halozyme

Therapeutics, Insuline Medical Ltd., Janssen Pharmaceutical Companies of Johnson & Johnson, Locemia, Medtronic, Inc., Novo Nordisk Inc., Sanofi U.S., Unomedical, Viacyte; Research Support: Boehringer Ingelheim Pharmaceuticals, Inc., Janssen Pharmaceutical Companies of Johnson & Johnson, VeroScience, LLC; Speaker’s Bureau: Novo Nordisk Inc.

Tamler, Ronald ..................................... Disclosed no confl ict of interest.Tamori, Yoshikazu ............................... Disclosed no confl ict of interest.Tamura, Ayako ..................................... Disclosed no confl ict of interest.Tamura, Azusa ..................................... Employee: Teijin Pharma Limited. Tamura, Yoshifumi .............................. Research Support: AstraZeneca/Bristol-Myers Squibb,

Boehringer Ingelheim GmbH, Daiichi-Sankyo Co., Ltd., Dainippon Sumitomo Phama, Eli Lilly Japan K.K., Kissei Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., MSD, Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Pfi zer Inc., Sanofi -Aventis, Sanwa Kagaku Kenkyusho Co., Ltd., Shionogi Inc., Takeda Pharmaceutical Company Limited, Terumo Medical Corporation; Speaker’s Bureau: Boehringer Ingelheim GmbH, Eli Lilly Japan K.K., Kissei Pharmaceutical Co., Ltd., MSD, Novartis Pharmaceuticals Corporation, Sanofi -Aventis.

Tamvakos, Elias ................................... Disclosed no confl ict of interest.Tan, Andre ........................................... Disclosed no confl ict of interest.Tan, Beesan ......................................... Disclosed no confl ict of interest.Tan, Chuen Seng ................................. Disclosed no confl ict of interest.Tan, Hong Chang ................................. Disclosed no confl ict of interest.Tan, Horng Kai ..................................... Disclosed no confl ict of interest.Tan, Joanne T. ..................................... Disclosed no confl ict of interest.Tan, Kai ................................................ Disclosed no confl ict of interest.Tan, Kathryn C. .................................... Disclosed no confl ict of interest.Tan, Kelly ............................................. Disclosed no confl ict of interest.Tan, Matthew ...................................... Disclosed no confl ict of interest.Tan, Meng H. ....................................... Disclosed no confl ict of interest.Tan, Rongshao ..................................... Disclosed no confl ict of interest.Tan, Ruo-Ding ...................................... Disclosed no confl ict of interest.Tan, Sih Min ......................................... Disclosed no confl ict of interest.Tan, Xinle ............................................. Disclosed no confl ict of interest.Tan, Yi .................................................. Disclosed no confl ict of interest.Tan, Yuyu ............................................. Disclosed no confl ict of interest.Tanabe, Katsuya .................................. Disclosed no confl ict of interest.Tanabe, Naohito .................................. Disclosed no confl ict of interest.Tanaka, Akira ....................................... Disclosed no confl ict of interest.Tanaka, Aya ......................................... Disclosed no confl ict of interest.Tanaka, Daisuke .................................. Disclosed no confl ict of interest.Tanaka, Hideaki ................................... Disclosed no confl ict of interest.Tanaka, Hideki ..................................... Disclosed no confl ict of interest.Tanaka, Hiroto ..................................... Disclosed no confl ict of interest.Tanaka, Masami .................................. Disclosed no confl ict of interest.Tanaka, Masashi ................................. Disclosed no confl ict of interest.Tanaka, Muhei ..................................... Disclosed no confl ict of interest.

Tanaka, Naonobu ................................ Disclosed no confl ict of interest.Tanaka, Sachiko .................................. Disclosed no confl ict of interest.Tanaka, Shiro ....................................... Disclosed no confl ict of interest.Tanaka, Tomoko ................................... Disclosed no confl ict of interest.Tanaka, Yasushi ................................... Advisory Panel: Novo Nordisk Inc.; Consultant: TOP, inc;

Research Support: Astellas Pharma, Inc, AstraZeneca LP, Daiichi-Sankyo, Inc, Kissei Pharmaceutical Co., Ltd., Mitsubishi-Tanabe Pharma Co.Ltd, MSD, Inc, Novo Nordisk Inc., Ono Pharmaceutical Co., Ltd., Sanofi , Inc, Sanwa Kagaku Kenkyusho Co., Ltd., Sumimoto Dainippon Pharma Co., Ltd., Takeda Pharmaceutical Company, Ltd; Speaker’s Bureau: Astellas Pharma, Inc, Astrazeneca LP, Daiichi-Sankyo Co., Ltd., Eli Lilly and Company, Kissei Pharmaceutical Co., Ltd., Kowa Company, Ltd., MSD, Inc, Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Ono Pharmaceutical Co., Ltd., Sanofi , Inc, Sanwa Kagaku Kenkyusho Co., Ltd., Sumimoto Dainippon Pharma Co., Ltd., Takeda Pharmaceutical Company, Ltd.

Tanaka, Yoshinobu .............................. Disclosed no confl ict of interest.Tandon, Nikhil ..................................... Disclosed no confl ict of interest.Tanenbaum, Molly L. ........................... Disclosed no confl ict of interest.Tanenberg, Robert J. .......................... Research Support: Novo Nordisk Inc., Sanofi U.S. Tang, Jackson ...................................... Consultant: Asclepius Analytics. Tang, Junling ....................................... Disclosed no confl ict of interest.Tang, Songtao ..................................... Disclosed no confl ict of interest.Tang, Sunyinyan .................................. Disclosed no confl ict of interest.Tang, Tricia S. ...................................... Disclosed no confl ict of interest.Tang, Wanxin ....................................... Disclosed no confl ict of interest.Tang, Weifeng ..................................... Employee: AstraZeneca Pharmaceuticals LP. Tang, Weimin ....................................... Employee: Crown Bioscience, Inc. Tang, Wern Ee ..................................... Disclosed no confl ict of interest.Tang, Xixiang ....................................... Disclosed no confl ict of interest.Tangen, Daniel S. ................................ Disclosed no confl ict of interest.Tanigawa, Takeshi .............................. Disclosed no confl ict of interest.Taniguchi, Mariko ................................ Disclosed no confl ict of interest.Taniguchi, Shin-ichi ............................. Disclosed no confl ict of interest.Taniguchi, Yukiko ................................ Disclosed no confl ict of interest.Tanioka, Toshihiro ............................... Disclosed no confl ict of interest.Tanizawa, Yukio .................................. Disclosed no confl ict of interest.Tanti, Jean-François ........................... Disclosed no confl ict of interest.Tao, Caroline ........................................ Disclosed no confl ict of interest.Taplin, Craig E. ..................................... Disclosed no confl ict of interest.Tarabra, Elena ..................................... Disclosed no confl ict of interest.Tarassenko, Lionel .............................. Disclosed no confl ict of interest.Tardivo, João Paulo ............................. Disclosed no confl ict of interest.Targher, Giovanni ................................ Disclosed no confl ict of interest.Targhetta, Clara .................................. Disclosed no confl ict of interest.Tarnoki, Adam D. ................................. Disclosed no confl ict of interest.Tarnoki, David L. .................................. Disclosed no confl ict of interest.Tarnow, Lise ........................................ Advisory Panel: Novo Nordisk A/S; Employee: Steno

Diabetes Center A/S; Research Support: Novo Nordisk A/S; Speaker’s Bureau: Novo Nordisk A/S; Stock/Shareholder: Novo Nordisk A/S.

Tarp-Johansen, Mads Jeppe ............. Employee: Novo Nordisk A/S. Tarr, Amanda ....................................... Research Support: AstraZeneca Pharmaceuticals LP,

Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc.

Tartaro, Armando ................................ Disclosed no confl ict of interest.Tarter, M. Sean ................................... Disclosed no confl ict of interest.Tashkandi, Nedaa ............................... Disclosed no confl ict of interest.Tate, Donna ......................................... Disclosed no confl ict of interest.Tater, Priyanka ..................................... Disclosed no confl ict of interest.Tateya, Sanshiro ................................. Disclosed no confl ict of interest.Tatsumi, Yasuaki ................................. Disclosed no confl ict of interest.Tauber, Marie-Thérèse ....................... Disclosed no confl ict of interest.Tauschmann, Martin ........................... Disclosed no confl ict of interest.Tavakoli, Mitra .................................... Disclosed no confl ict of interest.Tavares Bello, Carlos .......................... Disclosed no confl ict of interest.Tavares, Ruben .................................... Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline. Tavintharan, Subramaniam ................ Disclosed no confl ict of interest.Tay, Yu Kwang Donovan ..................... Disclosed no confl ict of interest.Taylor, Andrew R. ................................ Disclosed no confl ict of interest.Taylor, Ann G. ...................................... Disclosed no confl ict of interest.Taylor Jr., Charles G. ........................... Disclosed no confl ict of interest.Taylor, Kent .......................................... Disclosed no confl ict of interest.Taylor, Kent D. ..................................... Disclosed no confl ict of interest.Taylor, Lenise ....................................... Disclosed no confl ict of interest.Taylor, Roy ........................................... Disclosed no confl ict of interest.Taylor, Simeon I. .................................. Consultant: Aegerion Pharmaceuticals, Inc., Calibrium LLC,

Isis Pharmaceuticals, Inc., Yabao, Zydus Discovery;

A888

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Employee: Bristol-Myers Squibb Company; Stock/Shareholder: Bristol-Myers Squibb Company, Celgene Corporation, Gilead, Regeneron Pharmaceuticals, Inc.

Teare, Julian ........................................ Consultant: GI Dynamics, Inc. Teede, Helena ..................................... Disclosed no confl ict of interest.Teff, Karen L. ....................................... Disclosed no confl ict of interest.Teh, Ming Ming ................................... Disclosed no confl ict of interest.Teixeira, Mauro M. ............................. Disclosed no confl ict of interest.Tekin, Buket ......................................... Disclosed no confl ict of interest.Tekin, Sakin ......................................... Disclosed no confl ict of interest.Tekin, Zehra ......................................... Disclosed no confl ict of interest.Tekola-Ayele, Fasil .............................. Disclosed no confl ict of interest.Teles, Milena G. .................................. Disclosed no confl ict of interest.Tellechea, Ana ..................................... Disclosed no confl ict of interest.Teló, Gabriela H. .................................. Disclosed no confl ict of interest.Temizkan, Sule ..................................... Disclosed no confl ict of interest.Temple, Rosemary C. .......................... Disclosed no confl ict of interest.Templin, Andrew T. ............................. Disclosed no confl ict of interest.Temraz, Mahmoud .............................. Disclosed no confl ict of interest.Ten Kulve, Jennifer S. ......................... Disclosed no confl ict of interest.Teng, Gim Gee ..................................... Disclosed no confl ict of interest.Teng, Ruifeng ...................................... Employee: National Institutes of Health; Research Support:

National Institutes of Health. Teng, Yanping ...................................... Research Support: Medtronic MiniMed, Inc. Tenma, Jin ........................................... Disclosed no confl ict of interest.Tennagels, Norbert ............................. Employee: Sanofi ; Stock/Shareholder: Sanofi . Tenta, Masafumi ................................. Disclosed no confl ict of interest.Tentolouris, Nikolaos .......................... Advisory Panel: Merck Sharp & Dohme, Novo Nordisk Inc.;

Research Support: Novartis AG, Sanofi U.S.; Speaker’s Bureau: Eli Lilly and Company, Sanofi U.S.

Teo, Adrian K. ...................................... Disclosed no confl ict of interest.Teo, Yvonne ......................................... Disclosed no confl ict of interest.Teodoru, Ileana ................................... Disclosed no confl ict of interest.Teoh, Hwee .......................................... Disclosed no confl ict of interest.Teoh, Kristine ...................................... Disclosed no confl ict of interest.Teoh, Wei Leng .................................... Disclosed no confl ict of interest.Tepla, Olena ......................................... Disclosed no confl ict of interest.Ter Horst, Kasper W. ........................... Disclosed no confl ict of interest.Terami, Naoto ...................................... Disclosed no confl ict of interest.Terasaki, Michishige ........................... Disclosed no confl ict of interest.Terasawa, Tomoko .............................. Disclosed no confl ict of interest.Terauchi, Yasuo ................................... Other Relationship: Sanofi , Advisor for EDITION JP studies;

Research Support: Astellas, AstraZeneca, Bayer Yakuhin, Boehringer Ingelheim, Daiichi-Sankyo, Dainippon-Sumitomo, Eli Lilly, Kissei, Kowa Pharmaceutical, Merck (MSD), Novartis, Novo Nordisk, Ono, Sanofi , Sanwa Kagaku Kenkyusho, Shionogi, Takeda, Tanabe-Mitsubishi; Speaker’s Bureau: Astellas, AstraZeneca, Bayer Yakuhin, Boehringer Ingelheim, Chugai, Daiichi-Sankyo, Dainippon-Sumitomo, Eli Lilly, Johnson & Johnson, Kissei, Kowa Pharmaceutical, Merck (MSD), Mochida, Novartis, Novo Nordisk, Ono, Pfi zer, Roche Diagnostics, Sanofi , Sanwa Kagaku Kenkyusho, Shionogi, Takeda, Tanabe-Mitsubishi, Teijin.

Terra, Steven ....................................... Employee: Pfi zer Inc.; Stock/Shareholder: Pfi zer Inc. Terruzzi, Ileana .................................... Disclosed no confl ict of interest.Terry, James ........................................ Disclosed no confl ict of interest.Terry, Martha ...................................... Disclosed no confl ict of interest.Tersey, Sarah ....................................... Disclosed no confl ict of interest.Teruyama, Kyoko ................................. Disclosed no confl ict of interest.Tesauro, Manfredi .............................. Disclosed no confl ict of interest.Tesfaye, Solomon ................................ Disclosed no confl ict of interest.Teshigawara, Sanae ........................... Disclosed no confl ict of interest.Testa, Marcia A. .................................. Disclosed no confl ict of interest.Tetiker, Tamer ...................................... Disclosed no confl ict of interest.Tetsuro, Kobayashi ............................. Disclosed no confl ict of interest.Tez, Didem K. ....................................... Disclosed no confl ict of interest.Tezza, Sara .......................................... Disclosed no confl ict of interest.Tfaily, Ahmad ...................................... Disclosed no confl ict of interest.Tfayli, Hala .......................................... Disclosed no confl ict of interest.Thabit, Hood ........................................ Disclosed no confl ict of interest.Thacker, Hemant P. ............................. Advisory Panel: Sanofi U.S. Thadhani, Ravi ..................................... Disclosed no confl ict of interest.Thai, Kerri ............................................ Disclosed no confl ict of interest.Thallas-Bonke, Vicki ........................... Disclosed no confl ict of interest.Tham, Kwang Wei ............................... Disclosed no confl ict of interest.Tham, Lai San ...................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Thandavarayan, Rajarajan A. ............. Disclosed no confl ict of interest.Thangiah, Geetha ................................ Disclosed no confl ict of interest.The, Natalie S. .................................... Disclosed no confl ict of interest.Theilade, Simone ................................ Disclosed no confl ict of interest.

Theis, Stefan ....................................... Disclosed no confl ict of interest.Theise, Neil D. ..................................... Employee: PopTest LLC; Stock/Shareholder: PopTest LLC. Theodorou, Kiki ................................... Disclosed no confl ict of interest.Thethi, Tina K. ..................................... Research Support: National Institutes of Health. Thibodeaux, Stefan ............................ Employee: Eli Lilly and Company. Thiemann, Sandra ............................... Employee: Boehringer Ingelheim GmbH & Co. KG. Thienel, Constanze ............................. Disclosed no confl ict of interest.Thiering, Elisabeth .............................. Disclosed no confl ict of interest.Thio, Guene ......................................... Employee: Life Technologies - manufacturer of microarrays

used in study. Thiselton, Dawn L. .............................. Employee: Health Diagnostics Laboratory, Inc. Thivolet, Charles ................................. Disclosed no confl ict of interest.Thomakos, Petros ............................... Disclosed no confl ict of interest.Thomas, Abraham ............................... Disclosed no confl ict of interest.Thomas, Andreas ................................ Disclosed no confl ict of interest.Thomas, Dylan ..................................... Disclosed no confl ict of interest.Thomas, Gordon A. ............................. Disclosed no confl ict of interest.Thomas, Melissa ................................. Disclosed no confl ict of interest.Thomas, Merlin C. ............................... Disclosed no confl ict of interest.Thomas, Nihal J. ................................. Disclosed no confl ict of interest.Thomas, Varghese .............................. Disclosed no confl ict of interest.Thomas, William ................................. Disclosed no confl ict of interest.Thomou, Thomas ................................. Disclosed no confl ict of interest.Thompson, Caroline R. ........................ Disclosed no confl ict of interest.Thompson, David M. ........................... Advisory Panel: Eli Lilly and Company, Merck & Co., Inc. Thompson, Kyle ................................... Consultant: Boehringer Ingelheim GmbH. Thompson, Spencer J. ........................ Disclosed no confl ict of interest.Thompson, Ted .................................... Disclosed no confl ict of interest.Thomsen, Niels O. ............................... Disclosed no confl ict of interest.Thomsen, Soren .................................. Disclosed no confl ict of interest.Thomson, Hilary J. .............................. Disclosed no confl ict of interest.Thorand, Barbara ................................ Disclosed no confl ict of interest.Thorburn, David R. .............................. Disclosed no confl ict of interest.Thorén, Fredrik A. ............................... Employee: AstraZeneca. Thorens, Bernard ................................ Disclosed no confl ict of interest.Thoreson, Caroline K. ......................... Disclosed no confl ict of interest.Thorner, Lauren ................................... Disclosed no confl ict of interest.Thornley, Thomas B. ........................... Disclosed no confl ict of interest.Thorsson, Lars ..................................... Employee: Novo Nordisk A/S. Thorsted, Brian .................................... Employee: Novo Nordisk; Stock/Shareholder: Novo Nordisk. Thorsteinsson, Birger ......................... Advisory Panel: Eli Lilly and Company. Thuesen, Anne Cathrine B. ................ Disclosed no confl ict of interest.Thum, Thomas ..................................... Disclosed no confl ict of interest.Thuma, Jean ........................................ Disclosed no confl ict of interest.Thunander, Maria ................................ Speaker’s Bureau: Novo Nordisk A/S. Thuresson, Marcus ............................. Disclosed no confl ict of interest.Thurheimer, Jennifer L. ...................... Disclosed no confl ict of interest.Thurman, Jerry .................................... Research Support: Novo Nordisk A/S; Speaker’s Bureau:

Abbvie, AstraZeneca Pharmaceuticals LP, Novo Nordisk A/S, Sanofi U.S.

Thurmond, Debbie C. .......................... Disclosed no confl ict of interest.Thurner, Mathias ................................. Disclosed no confl ict of interest.Thyagarajan, Bharat ........................... Disclosed no confl ict of interest.Tian, Chen ............................................ Disclosed no confl ict of interest.Tian, Haoming ..................................... Disclosed no confl ict of interest.Tian, Huiguang .................................... Disclosed no confl ict of interest.Tian, Jingyan ....................................... Disclosed no confl ict of interest.Tian, Li ................................................. Disclosed no confl ict of interest.Tian, Lili ............................................... Disclosed no confl ict of interest.Tian, Tian ............................................. Disclosed no confl ict of interest.Tibudan, Martin .................................. Disclosed no confl ict of interest.Tichy, Eileen ........................................ Disclosed no confl ict of interest.Tickoo, Mayanka ................................. Disclosed no confl ict of interest.Tierney, Edward .................................. Disclosed no confl ict of interest.Tierney, Marie ..................................... Disclosed no confl ict of interest.Tikkanen, Ilkka .................................... Disclosed no confl ict of interest.Tilg, Herbert ........................................ Disclosed no confl ict of interest.Tilves, Debra ....................................... Disclosed no confl ict of interest.Timar, Bogdan ..................................... Disclosed no confl ict of interest.Timar, Romulus .................................... Disclosed no confl ict of interest.Timper, Katharina ............................... Disclosed no confl ict of interest.Timpson, Nicholas J. .......................... Disclosed no confl ict of interest.Tinahones, Francisco J. ...................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Eli Lilly

and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, MSD Spain, Novo Nordisk Inc., Sanofi Spain.

Tinahones-Madueño, Francisco ........ Disclosed no confl ict of interest.Ting, Isabelle ....................................... Disclosed no confl ict of interest.Tingstad, Ragna H. .............................. Disclosed no confl ict of interest.Tinsley, Liane J. ................................... Disclosed no confl ict of interest.Tio, Jospeh .......................................... Disclosed no confl ict of interest.Tirosh, Amir ......................................... Disclosed no confl ict of interest.

A889

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Tisch, Roland ....................................... Disclosed no confl ict of interest.Tiwari, Akankasha .............................. Disclosed no confl ict of interest.Tiwari, Shiwani ................................... Disclosed no confl ict of interest.To, Tu My ............................................. Disclosed no confl ict of interest.Tobe, Kazuyuki .................................... Research Support: Daiichi-Sankyo Co., Ltd., Kissei

Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, National Center for Grobal Health and Medicine, Japan; Speaker’s Bureau: Kowa Pharmaceutical Co., Ltd., Merck & Co., Inc., Mitsubishi Tanabe Pharma Corporation, Novo nordisk pharma Ltd., Sanofi K.K., Takeda Pharmaceutical Company Limited.

Tobias, Deirdre K. ................................ Disclosed no confl ict of interest.Tobin, Garry S. ..................................... Advisory Panel: Roche USA; Speaker’s Bureau: Boehringer

Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson.

Toda, Katsuyo ...................................... Disclosed no confl ict of interest.Toda, Kyoko ......................................... Disclosed no confl ict of interest.Toda, Kyoko Toda ................................ Disclosed no confl ict of interest.Todd, Jennifer ..................................... Disclosed no confl ict of interest.Todd, John ........................................... Disclosed no confl ict of interest.Todkar, Jayashree S. ........................... Disclosed no confl ict of interest.Todo, Yasuhiko .................................... Disclosed no confl ict of interest.Toffanin, Chiara ................................... Disclosed no confl ict of interest.Tofteng Shelton, Pernille .................... Disclosed no confl ict of interest.Togashi, Hirofumi ................................ Disclosed no confl ict of interest.Toh, Sue-Anne ..................................... Disclosed no confl ict of interest.Tohidi, Maryam ................................... Disclosed no confl ict of interest.Tokubuchi, Ichiro ................................. Disclosed no confl ict of interest.Tokumoto, Shinsuke ............................ Disclosed no confl ict of interest.Tokumoto, Yoshio ................................ Disclosed no confl ict of interest.Tokunaga, Katsushi ............................. Disclosed no confl ict of interest.Tokunou, Tomotake ............................. Research Support: Mitsubishi Tanabe Pharma Corporation. Toledano, Yoel ..................................... Disclosed no confl ict of interest.Tolwinska, Joanna .............................. Disclosed no confl ict of interest.Tomalka, Jeffrey ................................. Disclosed no confl ict of interest.Tomasselli, Alfredo ............................. Consultant: Metabolic Solutions Development Company,

LLC. Tomei, Alice A. .................................... Disclosed no confl ict of interest.Tomic-Canic, Marjana ......................... Disclosed no confl ict of interest.Tomida, Yosuke ................................... Disclosed no confl ict of interest.Tomino, Yasuhiko ................................ Disclosed no confl ict of interest.Tomita, Masuomi ................................ Disclosed no confl ict of interest.Tomizawa, Nobuko .............................. Other Relationship: NTT DOCOMO. Tomoda, Kouichi .................................. Disclosed no confl ict of interest.Tomolo, Anne ....................................... Disclosed no confl ict of interest.Tomoyasu, Masako ............................. Disclosed no confl ict of interest.Tonarely, Niza A. ................................. Disclosed no confl ict of interest.Tonascia, James ................................. Disclosed no confl ict of interest.Tong, Cindy .......................................... Employee: Janssen Research & Development, LLC. Tong, Peter C. ...................................... Disclosed no confl ict of interest.Tong, Qingchun .................................... Disclosed no confl ict of interest.Tong, Wenxin ....................................... Disclosed no confl ict of interest.Tong, Xin .............................................. Disclosed no confl ict of interest.Tong, Yan ............................................. Disclosed no confl ict of interest.Toni, Sonia ........................................... Advisory Panel: Eli Lilly and Company, Sanofi Aventis; Board

Member: Eli Lilly and Company, Sanofi Aventis. Tonneijck, Lennart ............................... Disclosed no confl ict of interest.Topolcan, Ondrej ................................. Disclosed no confl ict of interest.Topor-Madry, Roman .......................... Disclosed no confl ict of interest.Toppari, Jorma .................................... Disclosed no confl ict of interest.Toppila, Iiro .......................................... Disclosed no confl ict of interest.Toräng, Signe ...................................... Disclosed no confl ict of interest.Torekov, Signe S. ................................. Disclosed no confl ict of interest.Tornøe, Karen ...................................... Employee: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Torp-Pedersen, Christian .................... Disclosed no confl ict of interest.Torrents, David .................................... Disclosed no confl ict of interest.Tortosa, Federica ................................ Disclosed no confl ict of interest.Tosaki, Takahiro .................................. Disclosed no confl ict of interest.Toschi, Elena ........................................ Disclosed no confl ict of interest.Toth, James ......................................... Employee: Eli Lilly and Company. Totomirova, Tzvetelina ....................... Disclosed no confl ict of interest.Tousoulis, Dimitrios ............................ Disclosed no confl ict of interest.Toussi, Massoud ................................. Employee: IMS Health. Tovaglieri, Alessio ............................... Disclosed no confl ict of interest.Towers, Meghan ................................. Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Townsend, Claire K. ............................ Disclosed no confl ict of interest.Townsend, Kristy L. ............................ Disclosed no confl ict of interest.Toyoda, Masao .................................... Disclosed no confl ict of interest.Tracey, Irene ........................................ Disclosed no confl ict of interest.

Trachta, Pavel ...................................... Disclosed no confl ict of interest.Traci, Meg Ann .................................... Disclosed no confl ict of interest.Tracy, Russell P. ................................... Disclosed no confl ict of interest.Trafford, Andrew W. ........................... Disclosed no confl ict of interest.Trahair, Laurence G. ............................ Disclosed no confl ict of interest.Traina, Shana ...................................... Employee: Janssen Global Services, LLC. Trajcevski, Karin .................................. Disclosed no confl ict of interest.Trakhtenberg, Julia ............................. Disclosed no confl ict of interest.Tran, Duy A. ......................................... Disclosed no confl ict of interest.Tran, Lee .............................................. Research Support: American Diabetes Association, National

Institute of Diabetes and Digestive and Kidney Diseases.

Tran, Quang Khanh .............................. Disclosed no confl ict of interest.Trast, Jeniece ...................................... Disclosed no confl ict of interest.Trauner, Dirk ........................................ Disclosed no confl ict of interest.Trautmann, Michael ............................ Advisory Panel: Merck & Co., Inc.; Consultant: AstraZeneca

Pharmaceuticals LP, Merck & Co., Inc., Servier; Stock/Shareholder: Eli Lilly and Company.

Travert, Florence ................................. Advisory Panel: Novo Nordisk Inc., TECOS advisory board MSD; Board Member: Research board member of Lilly France; Other Relationship: Conferences for Novartis France.

Traylor, Louise ..................................... Employee: Bristol-Myers Squibb Company (Spouse/Partner), Sanofi U.S.; Stock/Shareholder: Sanofi .

Tregouet, David ................................... Disclosed no confl ict of interest.Treiber, Gerlies .................................... Disclosed no confl ict of interest.Tremblay, Mikaël ................................. Disclosed no confl ict of interest.Trenchevska, Olgica ............................ Disclosed no confl ict of interest.Trescoli Serrano, Carlos ..................... Disclosed no confl ict of interest.Trescoli, Carlos .................................... Disclosed no confl ict of interest.Trevaskis, James ................................. Disclosed no confl ict of interest.Trevino, Michelle B. ............................ Disclosed no confl ict of interest.Triantafyllou, Areti ............................. Disclosed no confl ict of interest.Trief, Paula M. ..................................... Research Support: National Institute of Diabetes and

Digestive and Kidney Diseases. Trigo, Enrique ...................................... Disclosed no confl ict of interest.Trimble, Lee Ann ................................. Disclosed no confl ict of interest.Trinquet, Eric ....................................... Disclosed no confl ict of interest.Triolo, Taylor M. .................................. Disclosed no confl ict of interest.Tripathi, Kamlakar ............................... Disclosed no confl ict of interest.Tripathy, Devjit .................................... Consultant: Health Diagnostics Laboratory, Inc. Triplitt, Curtis ...................................... Speaker’s Bureau: AstraZeneca Pharmaceuticals LP. Trischitta, Vincenzo ............................ Disclosed no confl ict of interest.Trivedi, Chitrang .................................. Employee: Cadila Healthcare Limited. Trivedi, Nitin ........................................ Board Member: New England Chapter of AACE; Speaker’s

Bureau: Bristol-Myers Squibb/AstraZeneca, Novo Nordisk A/S.

Trofi movsky, Elina ............................... Disclosed no confl ict of interest.Trojak, Aleksandra .............................. Disclosed no confl ict of interest.Tromberg, Bruce J. .............................. Disclosed no confl ict of interest.Trombetta, Maddalena ....................... Disclosed no confl ict of interest.Troshina, Ekaterina A. ........................ Disclosed no confl ict of interest.Trounce, Ian A. .................................... Disclosed no confl ict of interest.Troup, John .......................................... Employee: Metagenics, Inc. Trubitsyna, Yelena .............................. Employee: VeroScience, LLC. Trucco, Massimo ................................. Disclosed no confl ict of interest.Trudeau, Kyle M. ................................. Disclosed no confl ict of interest.True, Mark ........................................... Disclosed no confl ict of interest.Trujillo, Jennifer .................................. Disclosed no confl ict of interest.Truman, Benedict I. ............................. Disclosed no confl ict of interest.Tryggvason, Karl ................................. Disclosed no confl ict of interest.Tsai, Ai-Lin ........................................... Disclosed no confl ict of interest.Tsai, Kun-Wei ...................................... Disclosed no confl ict of interest.Tsai, Michael Y. ................................... Disclosed no confl ict of interest.Tsai, Sarah ........................................... Disclosed no confl ict of interest.Tsaklis, Panagiotis .............................. Disclosed no confl ict of interest.Tsalikian, Eva ....................................... Research Support: Astellas Pharma US, Inc., Bayer

HealthCare, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases.

Tsatralis, Tania .................................... Disclosed no confl ict of interest.Tschapeller, Bernd .............................. Disclosed no confl ict of interest.Tschirhart, Holly .................................. Disclosed no confl ict of interest.Tschöpe, Diethelm .............................. Board Member: AstraZeneca Pharmaceuticals LP, Bristol-

Myers Squibb Company, Novartis Pharma GmbH; Research Support: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, Sanofi U.S.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Novartis Pharma GmbH, Sanofi U.S., Servier.

Tse, Hubert M. ..................................... Disclosed no confl ict of interest.

A890

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Tseng, Chi-Hong .................................. Disclosed no confl ict of interest.Tseng, Chin-Lin .................................... Disclosed no confl ict of interest.Tseng, Eva ............................................ Disclosed no confl ict of interest.Tseng, Yu-Hua ..................................... Disclosed no confl ict of interest.Tshuva-Laban, Anat ............................ Disclosed no confl ict of interest.Tsopozidi, Maria .................................. Disclosed no confl ict of interest.Tsoukas, Michael A. ............................ Disclosed no confl ict of interest.Tsuchida, Chikatsugu .......................... Disclosed no confl ict of interest.Tsuchida, Hiromi .................................. Disclosed no confl ict of interest.Tsuchiya, Ken ...................................... Disclosed no confl ict of interest.Tsuchiya, Koichiro ............................... Disclosed no confl ict of interest.Tsuchiya, Mariko ................................. Disclosed no confl ict of interest.Tsuchiya, Takafumi ............................. Disclosed no confl ict of interest.Tsugawa, Kazue .................................. Disclosed no confl ict of interest.Tsuji, Ken ............................................. Disclosed no confl ict of interest.Tsujihata, Yoshiyuki ............................ Employee: Takeda Pharmaceutical Company Limited. Tsujii, Satoru ........................................ Disclosed no confl ict of interest.Tsujinaka, Hiroki .................................. Disclosed no confl ict of interest.Tsujino, Daisuke .................................. Disclosed no confl ict of interest.Tsukada, Akiko .................................... Disclosed no confl ict of interest.Tsukada, Yoshie ................................... Disclosed no confl ict of interest.Tsukagoshi, Chihiro M. ....................... Disclosed no confl ict of interest.Tsukiyama, Katsushi ........................... Disclosed no confl ict of interest.Tsumura, Yoshinori ............................. Employee: Teijin Pharma Limited. Tsuneki, Hiroshi ................................... Disclosed no confl ict of interest.Tsuprykov, Oleg ................................... Disclosed no confl ict of interest.Tsuriya, Daisuke .................................. Disclosed no confl ict of interest.Tsuruta, Megumi ................................. Disclosed no confl ict of interest.Tsuruta, Munehisa .............................. Disclosed no confl ict of interest.Tsushima, Yu ........................................ Employee: Teijin Pharma Limited. Tsutskiridze, Liana R. .......................... Disclosed no confl ict of interest.Tsutsui, Hideyo .................................... Disclosed no confl ict of interest.Tsutsumi, Yoko .................................... Disclosed no confl ict of interest.Tu, Ling-Hsien ...................................... Disclosed no confl ict of interest.Tu, Yinfang ........................................... Disclosed no confl ict of interest.Tuccinardi, Dario ................................. Disclosed no confl ict of interest.Tufa, Uilki ............................................. Disclosed no confl ict of interest.Tufan, Hasan A. ................................... Disclosed no confl ict of interest.Tugrul, Armagan .................................. Disclosed no confl ict of interest.Tu Rul, Gamze ...................................... Disclosed no confl ict of interest.Tumini, Stefano ................................... Advisory Panel: Novo Nordisk Inc.; Board Member: Eli Lilly

and Company, LifeScan, Inc., Sanofi ; Other Relationship: LifeScan, Inc., Novo Nordisk Inc., Roche, Sanofi .

Tunceli, Kaan ....................................... Employee: Merck Sharp & Dohme. Tunceli, Ozgur ...................................... Disclosed no confl ict of interest.Tune, Johnathan D. ............................. Disclosed no confl ict of interest.Tuomi, Tiinamaija ................................ Disclosed no confl ict of interest.Tuomilehto, Jaakko ............................. Disclosed no confl ict of interest.Tuominen, Lauri ................................... Disclosed no confl ict of interest.Tupone, Domenico .............................. Disclosed no confl ict of interest.Tura, Andrea ........................................ Disclosed no confl ict of interest.Turchin, Alexander .............................. Advisory Panel: Monarch Medical Technologies, Novo

Nordisk A/S; Research Support: Merck & Co., Inc. Turgunova, Ludmila G. ........................ Disclosed no confl ict of interest.Turk, Norman ....................................... Disclosed no confl ict of interest.Turner, Kirsty ....................................... Disclosed no confl ict of interest.Turner, Nigel ........................................ Disclosed no confl ict of interest.Turner, Sara ......................................... Disclosed no confl ict of interest.Turner, Scott ........................................ Employee: KineMed, Inc. Turpcu, Adam ...................................... Employee: Genentech, Inc.; Stock/Shareholder: Genentech,

Inc. Turvey, Katherine ................................ Employee: IMS Brogan; Research Support: GlaxoSmithKline. Tuttle, Edward ..................................... Disclosed no confl ict of interest.Tuttle, Katherine R. ............................. Consultant: Amgen Inc., Eli Lilly and Company, NOXXON

Pharma AG. Tutuncu, Yildiz ..................................... Disclosed no confl ict of interest.Tütüncüoglu, Aliye P. .......................... Disclosed no confl ict of interest.Twig, Gilad ........................................... Disclosed no confl ict of interest.Twigg, Stephen M. .............................. Advisory Panel: Abbott, AstraZeneca Pharmaceuticals LP, Eli

Lilly and Company, Novo Nordisk A/S, Sanofi Aventis, Takeda Pharmaceutical Company Limited; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Merck Sharp & Dohme, Novartis Pharmaceuticals Corporation, Novo Nordisk A/S, sanofi aventis, Servier, Takeda Pharmaceutical Company Limited.

Twum-Barima, David Y. ...................... Advisory Panel: AstraZeneca/Bristol-Myers Squibb, Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Novo Nordisk Inc., Sanofi U.S.; Consultant: AstraZeneca/Bristol-Myers Squibb, Novo Nordisk Inc., Sanofi U.S.; Research Support: AstraZeneca/Bristol-Myers Squibb, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company,

Janssen Pharmaceutical Companies of Johnson & Johnson, Novo Nordisk Inc., Sanofi U.S., Takeda Pharmaceutical Company Limited.

Tyagi, Vidhi .......................................... Disclosed no confl ict of interest.Tyan, Nadezda V. ................................. Disclosed no confl ict of interest.Tybulewicz, Victor ............................... Disclosed no confl ict of interest.Tykezhanova, Gulmira M. ................... Disclosed no confl ict of interest.Tyrrell, Heidi ........................................ Disclosed no confl ict of interest.Tyrshanova, Sayagul S. ...................... Disclosed no confl ict of interest.Tzeel, Benjamin ................................... Disclosed no confl ict of interest.Tziomalos, Konstantinos .................... Disclosed no confl ict of interest.Tzur, Dorit ............................................. Disclosed no confl ict of interest.U. Din, Mueez ...................................... Disclosed no confl ict of interest.Ucar, Ugur ............................................ Disclosed no confl ict of interest.Uchigata, Yasuko ................................ Disclosed no confl ict of interest.Uchii, Masako ...................................... Disclosed no confl ict of interest.Uchino, Hiroshi .................................... Disclosed no confl ict of interest.Uda, Yuhei ........................................... Disclosed no confl ict of interest.Ueda, Haruka ....................................... Disclosed no confl ict of interest.Ueda, Seiji ........................................... Employee: Kurume University School of Medicine. Ueda, Shinichiro .................................. Disclosed no confl ict of interest.Uehara, Shinichiro .............................. Disclosed no confl ict of interest.Ueki, Kohjiro ........................................ Research Support: AstraZeneca Pharmaceuticals LP, Eli Lilly

and Company, Merck Sharp & Dohme, Novo Nordisk Inc., Sanofi U.S., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals, Inc., Merck Sharp & Dohme, Merck Sharp & Dohme, Mitsubishi Tanabe Pharma Corporation, Novo Nordisk Inc., Takeda Pharmaceutical Company Limited.

Ueland, Thor ........................................ Disclosed no confl ict of interest.Ueno, Hideki ........................................ Disclosed no confl ict of interest.Ueyama, Eiji ......................................... Employee: Astellas Pharma Inc. Ugi, Satoshi ......................................... Disclosed no confl ict of interest.Ükinç, Kubilay ...................................... Disclosed no confl ict of interest.Ukropcova, Barbara ............................ Disclosed no confl ict of interest.Ukropec, Jozef .................................... Disclosed no confl ict of interest.Ullal, Jagdeesh ................................... Disclosed no confl ict of interest.Ulloa Valdez, Aldo ............................... Disclosed no confl ict of interest.Ulman, Mira ......................................... Disclosed no confl ict of interest.Ulrik Fog, Jacob ................................... Disclosed no confl ict of interest.Ume, Adaku ......................................... Disclosed no confl ict of interest.Umekwe, Nkiru ................................... Disclosed no confl ict of interest.Umland, Oliver ..................................... Disclosed no confl ict of interest.Umpierrez, Guillermo E. ...................... Consultant: Boehringer Ingelheim Pharmaceuticals, Inc.,

Merck & Co., Inc., Novo Nordisk Inc., Regeneron Pharmaceuticals, Inc., Sanofi U.S.; Research Support: American Diabetes Association, Boehringer Ingelheim Pharmaceuticals, Inc., Merck & Co., Inc., National Institutes of Health, Novo Nordisk Inc., Sanofi U.S.

Umpleby, Margot ................................ Disclosed no confl ict of interest.Underwood, Patricia ........................... Disclosed no confl ict of interest.Unger, Thomas .................................... Disclosed no confl ict of interest.Ungerleider, Nathan ........................... Disclosed no confl ict of interest.Unmehopa, Unga A. ............................ Disclosed no confl ict of interest.Unni, Sudhir ......................................... Disclosed no confl ict of interest.Unnikrishnan, A.G. .............................. Disclosed no confl ict of interest.Unnikrishnan, Ranjit ........................... Disclosed no confl ict of interest.Uno, Kenji ............................................ Disclosed no confl ict of interest.Unwin, Nigel ........................................ Disclosed no confl ict of interest.Upadhyay, Swapna ............................. Disclosed no confl ict of interest.Upala, Sikarin ...................................... Disclosed no confl ict of interest.Upton, Bridget E. ................................. Disclosed no confl ict of interest.Urakami, Tatsuhiko ............................. Disclosed no confl ict of interest.Urano, Fumihiko .................................. Research Support: Amarantus Bio Science Holdings,

American Diabetes Association, Juvenile Diabetes Research Foundation, National Institute of Diabetes and Digestive and Kidney Diseases, Ono Pharmaceutical Co., Ltd.

Urano, Tetsumei .................................. Disclosed no confl ict of interest.Urato, Matthew .................................. Disclosed no confl ict of interest.Uratsu, Connie S. ................................ Disclosed no confl ict of interest.Urbanavicius, Vaidotas ....................... Disclosed no confl ict of interest.Urbanek, Margrit ................................ Disclosed no confl ict of interest.Urbani, Luca ........................................ Disclosed no confl ict of interest.Urbina, Elaine ...................................... Disclosed no confl ict of interest.Urcid-Velarde, Saul ............................. Disclosed no confl ict of interest.Urhammer, Søren ................................ Disclosed no confl ict of interest.Uribe, Claudia ...................................... Consultant: Sanofi U.S. Urquhart, Brad L. ................................. Disclosed no confl ict of interest.Urschitz, Martina ................................ Disclosed no confl ict of interest.Ursoleo, Paola ..................................... Disclosed no confl ict of interest.

A891

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Urwin, Andrea ..................................... Disclosed no confl ict of interest.Usherwood, Tim .................................. Disclosed no confl ict of interest.Usmani-Brown, Sahar ........................ Disclosed no confl ict of interest.Ussar, Siegfried ................................... Disclosed no confl ict of interest.Usui, Isao ............................................. Disclosed no confl ict of interest.Usui, Shuki ........................................... Disclosed no confl ict of interest.Utsunomiya, Kazunori ......................... Disclosed no confl ict of interest.Uygur, Melin ........................................ Disclosed no confl ict of interest.Uzu, Takashi ......................................... Disclosed no confl ict of interest.Uzun, Yasin .......................................... Disclosed no confl ict of interest.V., Padmanaban ................................... Disclosed no confl ict of interest.Vaag, Allan A. ...................................... Consultant: Novo Nordisk A/S; Stock/Shareholder: Novo

Nordisk A/S. Vaala, Sarah E. .................................... Disclosed no confl ict of interest.Vaicik, Marcella K. .............................. Disclosed no confl ict of interest.Vaitaitis, Gisela ................................... Disclosed no confl ict of interest.Vajda, Eric G. ....................................... Employee: Ligand Pharmaceuticals, Inc. Vakarcs, Trisha .................................... Disclosed no confl ict of interest.Vakkalagadda, Blisse .......................... Consultant: GlaxoSmithKline (Spouse/Partner); Employee:

Bristol-Myers Squibb Company; Stock/Shareholder: Bristol-Myers Squibb Company, Bristol-Myers Squibb Company (Spouse/Partner).

Valcarce, Carmen ................................ Employee: TransTech Pharma, LLC. Valcarcel, Bryan .................................. Disclosed no confl ict of interest.Valdecantos, Pilar ............................... Disclosed no confl ict of interest.Valderrama-Vasquez, Alessandro ..... Disclosed no confl ict of interest.Valdes, Jorge ....................................... Employee: Dexcom, Inc. Valdez, Ivan A. ..................................... Disclosed no confl ict of interest.Valença, Debora T. .............................. Disclosed no confl ict of interest.Valencia, Willy .................................... Disclosed no confl ict of interest.Valensi, Paul ........................................ Disclosed no confl ict of interest.Valent, Amy ......................................... Disclosed no confl ict of interest.Valentine, Joseph M. .......................... Disclosed no confl ict of interest.Valentine, Rudy J. ............................... Disclosed no confl ict of interest.Valentine, William .............................. Consultant: Eli Lilly and Company. Valentini, Umberto .............................. Disclosed no confl ict of interest.Valentinova, Lucia ............................... Disclosed no confl ict of interest.Valenzuela, David M. .......................... Employee: Regeneron Pharmaceuticals, Inc. Valera, Paolo ....................................... Disclosed no confl ict of interest.Valeur, Anders ..................................... Disclosed no confl ict of interest.Valiyapurayil, Neha V. ........................ Disclosed no confl ict of interest.Valladares Salgado, Adán .................. Disclosed no confl ict of interest.Valladares, Adan ................................. Disclosed no confl ict of interest.Valley, Michael .................................... Employee: Promega Corp, Promega Corp (Spouse/Partner). Valo, Erkka ........................................... Disclosed no confl ict of interest.Valtat, Bérengère ................................ Disclosed no confl ict of interest.Valverde, Angela M. ........................... Disclosed no confl ict of interest.Vamadevan Sarala, Ajay .................... Disclosed no confl ict of interest.van Asten, Suzanne ............................ Disclosed no confl ict of interest.Van Bergen, Nicole J. ......................... Disclosed no confl ict of interest.van Bloemendaal, Liselotte ................ Disclosed no confl ict of interest.van Brunt, Kate ................................... Employee: Eli Lilly and Company. van de Bunt, Martijn ........................... Disclosed no confl ict of interest.van de Laar, Arnold ............................. Disclosed no confl ict of interest.Van den Enyde, Amber ........................ Disclosed no confl ict of interest.Van der Borght, Wout ......................... Disclosed no confl ict of interest.van der Lely, Aart Jan ......................... Consultant: Alize Pharma. Van der Schueren, Bart ....................... Disclosed no confl ict of interest.van der Vaart, Robert ......................... Disclosed no confl ict of interest.van der Valk, Fleur M. ......................... Disclosed no confl ict of interest.van Duinkerken, Eelco ........................ Disclosed no confl ict of interest.Van Gaal, Luc ....................................... Advisory Panel: AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck Sharp & Dohme, Novartis Corporation, Novo Nordisk Inc., Sanofi U.S.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck Sharp & Dohme, Novartis Corporation, Novo Nordisk Inc., Sanofi U.S.

van Hall, Gerrit .................................... Disclosed no confl ict of interest.van Herpt, Thijs T. ............................... Disclosed no confl ict of interest.van Hinsbergh, Victor W. .................... Disclosed no confl ict of interest.van Hoek, Mandy ................................ Disclosed no confl ict of interest.Van Houten, Holly ............................... Disclosed no confl ict of interest.van Leeuwen, Elisabeth M. ................ Disclosed no confl ict of interest.Van Natta, Mark L. .............................. Disclosed no confl ict of interest.van Nierop, Samuel ............................. Disclosed no confl ict of interest.Van Pelt, Douglas W. .......................... Disclosed no confl ict of interest.

Van Pelt, Maurits ................................ Disclosed no confl ict of interest.Van Pelt, Rachael E. ............................ Disclosed no confl ict of interest.van Poppel, Mireille ............................ Disclosed no confl ict of interest.van Raalte, Daniël H. .......................... Disclosed no confl ict of interest.van Rooij, F.J.A. .................................. Disclosed no confl ict of interest.van Wagensveld, Bart A. .................... Disclosed no confl ict of interest.Van Zuydam, Natalie .......................... Disclosed no confl ict of interest.Vanags, Laura Z. .................................. Disclosed no confl ict of interest.VanDeMark, Cynthia ........................... Disclosed no confl ict of interest.Vanderpuye-Orgle, Jacqueline .......... Consultant: AstraZeneca Pharmaceuticals LP. Vang, Kim ............................................. Disclosed no confl ict of interest.Vang, Souriya ...................................... Disclosed no confl ict of interest.Vangala, Divya .................................... Disclosed no confl ict of interest.Vangoitsenhoven, Roman ................... Disclosed no confl ict of interest.van Haaren, Marcus ............................ Disclosed no confl ict of interest.Vannest, Jennifer ................................ Disclosed no confl ict of interest.Vardhman, Rakyan .............................. Disclosed no confl ict of interest.Varghese, Deny ................................... Disclosed no confl ict of interest.Varghese, Ron T. ................................. Disclosed no confl ict of interest.Varin, Elodie ........................................ Disclosed no confl ict of interest.Varker, Helen ....................................... Employee: Truven Health Analytics. Varshney, Manika ............................... Disclosed no confl ict of interest.Varthakavi, Premlata .......................... Disclosed no confl ict of interest.Varvel, Stephen A. .............................. Employee: Health Diagnostics Laboratory, Inc. Vasan, R.S. .......................................... Disclosed no confl ict of interest.Vasanthakumar, Sheran ..................... Disclosed no confl ict of interest.Vasavada, Rupangi C. ......................... Disclosed no confl ict of interest.Vasconcelos, Carlos ............................ Disclosed no confl ict of interest.Vasen, Hans F. ..................................... Disclosed no confl ict of interest.Vasilache, Lucian ................................ Disclosed no confl ict of interest.Vatner, Daniel F. .................................. Disclosed no confl ict of interest.Vaudel, Marc ....................................... Disclosed no confl ict of interest.Vaughn, Ian .......................................... Disclosed no confl ict of interest.Vaz, Frédéric M. .................................. Disclosed no confl ict of interest.Vazirani, Reema P. ............................... Disclosed no confl ict of interest.Vazquez Benitez, Gabriela .................. Disclosed no confl ict of interest.Vazquez, Vanessa ............................... Employee: PHT Corporation. Vazquez-Mateo, Cristina .................... Disclosed no confl ict of interest.Vedtofte, Louise .................................. Research Support: Novo Nordisk A/S; Speaker’s Bureau:

Novo Nordisk A/S. Veedfald, Simon .................................. Disclosed no confl ict of interest.Veettil, Sona ........................................ Disclosed no confl ict of interest.Vega-Hernandez, Gabriela ................. Employee: Novo Nordisk A/S. Vehik, Kendra ...................................... Disclosed no confl ict of interest.Veijola, Riitta ....................................... Disclosed no confl ict of interest.Veinberg, Ester .................................... Employee: Insuline Medical Ltd. Velardo, Carmelo ................................. Disclosed no confl ict of interest.Velasco, Katherine .............................. Disclosed no confl ict of interest.Velasco-Fuentes, Miriam C. ............... Disclosed no confl ict of interest.Velayoudom-Cephise, Fritz-Line ........ Disclosed no confl ict of interest.Velho, Gilberto .................................... Disclosed no confl ict of interest.Vella, Adrian ........................................ Advisory Panel: Genentech, Inc.; Research Support: Biokier,

GI Dynamics, Inc., Novartis Corporation. Vellanki, Priyathama ........................... Disclosed no confl ict of interest.Veltman, Dick J. .................................. Disclosed no confl ict of interest.Venclovas, Zilvinas ............................. Disclosed no confl ict of interest.Vendelbo, Mikkel H. ............................ Disclosed no confl ict of interest.Venditti, Elizabeth M. ......................... Disclosed no confl ict of interest.Vendrell Ortega, Joan ......................... Disclosed no confl ict of interest.Vendrell, Joan ..................................... Disclosed no confl ict of interest.Venesmaa, Sari ................................... Disclosed no confl ict of interest.Veneza, Lorena M. .............................. Disclosed no confl ict of interest.Venkat, Manu V. .................................. Disclosed no confl ict of interest.Venkataraman, Hema ......................... Disclosed no confl ict of interest.Venn, Bernard J. .................................. Disclosed no confl ict of interest.Venn, Karri ........................................... Disclosed no confl ict of interest.Ventura, Adriana D. ............................ Disclosed no confl ict of interest.Verbeke, Catia ..................................... Disclosed no confl ict of interest.Verchere, Bruce ................................... Disclosed no confl ict of interest.Verdin, Eric M. ..................................... Disclosed no confl ict of interest.Veresiu, Andrei I. ................................. Consultant: Worwag Pharma. Vergidou, Paraskevi ............................ Disclosed no confl ict of interest.Verkauskiene, Rasa ............................. Disclosed no confl ict of interest.Verleyen, Jerome ................................ Disclosed no confl ict of interest.Verma, Anu .......................................... Disclosed no confl ict of interest.Verma, Narsingh ................................. Disclosed no confl ict of interest.Vernon, Ashley .................................... Disclosed no confl ict of interest.Verona Rinati, Maria ........................... Disclosed no confl ict of interest.Verrijken, An ........................................ Disclosed no confl ict of interest.Verrina, Enrico ..................................... Disclosed no confl ict of interest.Vespasiani, Giacomo .......................... Disclosed no confl ict of interest.Vetere, Amedeo .................................. Disclosed no confl ict of interest.

A892

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Vethe, Heidrun .................................... Disclosed no confl ict of interest.Vetter, Marion ..................................... Employee: Bristol-Myers Squibb Company. Vettorazzi, Jean .................................. Disclosed no confl ict of interest.Veves, Aristidis ................................... Disclosed no confl ict of interest.Viberti, Giancarlo ................................ Disclosed no confl ict of interest.Vick, Andy ............................................ Consultant: Dance Biopharm; Employee: WIL Research. Vickers, Kasey C. ................................. Disclosed no confl ict of interest.Vickers, Steve P. .................................. Disclosed no confl ict of interest.Vidal, J. ................................................ Disclosed no confl ict of interest.Vidal, Josep ......................................... Disclosed no confl ict of interest.Vidugiriene, Jolanta ........................... Employee: Promega Corp, Promega Corp (Spouse/Partner). Vieira-Potter, Victoria J. ..................... Disclosed no confl ict of interest.Vierra, Nicholas C. .............................. Disclosed no confl ict of interest.Vignati, Laila ....................................... Disclosed no confl ict of interest.Vigo, Alvaro ......................................... Disclosed no confl ict of interest.Vijapurkar, Ujjwala ............................. Employee: Janssen Research & Development LLC; Stock/

Shareholder: Johnson & Johnson. Vijayakumar, Archana ......................... Disclosed no confl ict of interest.Vikman, Jenny ..................................... Disclosed no confl ict of interest.Vikman, Petter ..................................... Disclosed no confl ict of interest.Villa, Chiara ......................................... Disclosed no confl ict of interest.Villa-Caballero, Leonel ....................... Disclosed no confl ict of interest.Villafl or, Ciriaco ................................... Disclosed no confl ict of interest.Villalta, Maria Luisa ............................ Disclosed no confl ict of interest.Villaplana, Maria ................................. Disclosed no confl ict of interest.Villar Vicente, Rosa ............................ Disclosed no confl ict of interest.Villena, Jaime E. .................................. Advisory Panel: Johnson & Johnson, Novo Nordisk

Inc., Sanofi U.S.; Research Support: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Johnson & Johnson, Merck Sharp & Dohme, Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Abbott, Johnson & Johnson, Novo Nordisk Inc.

Vilmann, Peter ..................................... Disclosed no confl ict of interest.Vilor-Tejedor, Natàlia .......................... Disclosed no confl ict of interest.Vilsbøll, Tina ........................................ Advisory Panel: AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, GI Dynamics, Inc., Merck Sharp & Dohme, Novo Nordisk A/S, Sanofi U.S., Takeda Pharmaceutical Company Limited; Consultant: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme, Novo Nordisk A/S, Sanofi U.S., Takeda Pharmaceutical Company Limited, Zealand Pharma A/S; Research Support: Novo Nordisk A/S; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Eli Lilly and Company, Merck Sharp & Dohme, Novartis Pharma GmbH, Novo Nordisk A/S, Sanofi U.S., Takeda Pharmaceutical Company Limited, Zealand Pharma A/S.

Vinales, Karyne ................................... Disclosed no confl ict of interest.Vinera, Jennifer .................................. Disclosed no confl ict of interest.Vines, Katie ......................................... Disclosed no confl ict of interest.Vinik, Aaron I. ...................................... Advisory Panel: Worwag Pharma; Board Member: American

Association of Clinical Endocrinologists; Consultant: Pamlab-A Nestle Health Science Company; Research Support: VeroScience, LLC; Speaker’s Bureau: Pamlab-A Nestle Health Science Company.

Vinik, Etta J. ........................................ Other Relationship: Licensing Tool to Worwag Pharma. Vintila, Madalina ................................. Disclosed no confl ict of interest.Viñuela-González, Laura ..................... Disclosed no confl ict of interest.Viollet, Benoit ...................................... Disclosed no confl ict of interest.Virani, Salim S. .................................... Research Support: American Diabetes Association. Virella, Gabriel .................................... Disclosed no confl ict of interest.Virmani, Anju ....................................... Disclosed no confl ict of interest.Virtanen, Kirsi A. ................................. Disclosed no confl ict of interest.Visentin, Roberto ................................ Disclosed no confl ict of interest.Vishnudas, Vivek ................................. Disclosed no confl ict of interest.Vistisen, Dorte .................................... Employee: Steno Diabetes Center A/S; Stock/Shareholder:

Novo Nordisk A/S. Viswanathan, Vijay ............................. Disclosed no confl ict of interest.Vitai, Marta ......................................... Disclosed no confl ict of interest.Vitale, Rebecca J. ............................... Disclosed no confl ict of interest.Vivot, Kevin ......................................... Disclosed no confl ict of interest.Vlachaki Walker, Julia ........................ Disclosed no confl ict of interest.Vlacholpoulou, Efthymia .................... Disclosed no confl ict of interest.Vlachovâ, Zuzana ................................ Disclosed no confl ict of interest.Vlad, Adrian ......................................... Disclosed no confl ict of interest.Vlad, Mihaela ...................................... Disclosed no confl ict of interest.Vlajnic, Aleksandra ............................. Employee: SANOFI. Vlasakova, Zuzana .............................. Disclosed no confl ict of interest.Vogel, Heike ......................................... Disclosed no confl ict of interest.

Vogt, Lutz ............................................. Disclosed no confl ict of interest.Volchuk, Allen ...................................... Disclosed no confl ict of interest.Volkening, Lisa K. ................................ Disclosed no confl ict of interest.Volpi, Elena .......................................... Disclosed no confl ict of interest.von Websky, Karoline ......................... Employee: Institute of Nutritional Science, University of

Potsdam. Vonbank, Alexander ............................ Disclosed no confl ict of interest.Vons, Corinne ...................................... Disclosed no confl ict of interest.Vora, Jiten ........................................... Advisory Panel: Abbott, AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Eli Lilly, GlaxoSmithKline, Merck Sharp & Dohme, Novartis, Novo Nordisk, Roche, Sanofi , Takeda Pharmaceutical Company Limited; Research Support: Boehringer Ingelheim Pharmaceuticals, Inc., Takeda Pharmaceuticals Company Limited, GlaxoSmithKline, Roche, Abbott, Sanofi , Eli Lilly, Novo Nordisk, Merck Sharp & Dohme, Bristol-Myers Squibb Company, AstraZeneca Pharmaceuticals LP, Novartis; Speaker’s Bureau: Boehringer Ingelheim Pharmaceuticals, Inc., Takeda Pharmaceuticals Company Limited, GlaxoSmithKline, Roche, Abbott, Sanofi , Eli Lilly, Novo Nordisk, Merck Sharp & Dohme, Bristol-Myers Squibb Company, AstraZeneca Pharmaceuticals LP, Novartis.

Voros, Szilard ...................................... Employee: Health Diagnostics Laboratory, Inc. Voros, Viktor ........................................ Disclosed no confl ict of interest.Vorrink, Linda ...................................... Employee: Medtronic, Inc. Vostokova, Natalia ............................. Disclosed no confl ict of interest.Vupputuri, Suma .................................. Disclosed no confl ict of interest.Vyas, Neha V. ...................................... Disclosed no confl ict of interest.Wa, Chrystal ........................................ Disclosed no confl ict of interest.Wada, Jun ........................................... Disclosed no confl ict of interest.Wada, Nobuhiko .................................. Disclosed no confl ict of interest.Wada, Tsutomu ................................... Disclosed no confl ict of interest.Wada, Yoshiharu ................................. Disclosed no confl ict of interest.Wadden, Thomas A. ........................... Board Member: Novo Nordisk Inc., Nutrisystem, Inc.,

Orexigen Therapeutics, Inc.; Consultant: Boehringer Ingelheim Pharmaceuticals, Inc.; Research Support: Novo Nordisk Inc., Nutrisystem, Inc., Weight Watchers International, Inc.

Wadsack, Christian ............................. Disclosed no confl ict of interest.Wadwa, Paul ....................................... Consultant: Medtronic MiniMed, Inc., Novo Nordisk Inc. Wadwa, R.P. ........................................ Consultant: MannKind Corporation, Medtronic MiniMed,

Inc., Novo Nordisk Inc. Wagenknecht, Lynne E. ...................... Disclosed no confl ict of interest.Wagenmakers, Anton J. ..................... Disclosed no confl ict of interest.Wagner, Bridget .................................. Disclosed no confl ict of interest.Wagner, David ..................................... Board Member: Colorado ADA Board; Research Support:

ADA, National Institutes of Health; Stock/Shareholder: Op-T-Mune, Inc.

Wagner, Florence ................................ Disclosed no confl ict of interest.Wagner, Holger ................................... Disclosed no confl ict of interest.Wagner, Paige ..................................... Disclosed no confl ict of interest.Wagner, Robert ................................... Disclosed no confl ict of interest.Wahlgren, Camilla D. .......................... Disclosed no confl ict of interest.Wai, Bryan ........................................... Disclosed no confl ict of interest.Wainright, Katherine S. ...................... Disclosed no confl ict of interest.Wainstein, Julio .................................. Disclosed no confl ict of interest.Waitman, Jorge .................................. Research Support: Novartis Corporation, Novo Nordisk A/S;

Speaker’s Bureau: Novartis Corporation, Servier. Waitzfelder, Beth ................................ Disclosed no confl ict of interest.Wajapeyee, Narendra ........................ Disclosed no confl ict of interest.Wajchenberg, Bernardo L. .................. Disclosed no confl ict of interest.Waki, Hironori ..................................... Research Support: Banyu Life Science Foundation

International, Boehringer Ingelheim Pharmaceuticals, Inc., Novartis AG, Sanofi U.S.; Speaker’s Bureau: Daiichi-Sankyo Co., Ltd.

Waki, Kayo ........................................... Other Relationship: NTT DOCOMO; Research Support: Merck & Co., Inc., Takeda Pharmaceutical Company Limited, Terumo Medical Corporation; Speaker’s Bureau: Merck & Co., Inc., Takeda Pharmaceutical Company Limited, Terumo Medical Corporation.

Waki, Masako ..................................... Disclosed no confl ict of interest.Wakil, Ammar ...................................... Disclosed no confl ict of interest.Wakuta, Kenichiro .............................. Disclosed no confl ict of interest.Wald, Jeffrey A. .................................. Employee: GlaxoSmithKline. Waldecker, Ute .................................... Disclosed no confl ict of interest.Walder, Ken ......................................... Disclosed no confl ict of interest.Waldman, Gretchen ............................ Disclosed no confl ict of interest.Waldman, Lindsey ............................... Disclosed no confl ict of interest.Walford, Geoffrey A. .......................... Disclosed no confl ict of interest.Wali, Aisha .......................................... Disclosed no confl ict of interest.

A893

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Walia, Pankhuri ................................... Disclosed no confl ict of interest.Walker, Ashby F. .................................. Disclosed no confl ict of interest.Walker, Chris ....................................... Disclosed no confl ict of interest.Walker, Rowan .................................... Disclosed no confl ict of interest.Walker, Susan ..................................... Disclosed no confl ict of interest.Walkinshaw, Emma ............................ Disclosed no confl ict of interest.Wall, Mark J. ....................................... Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Wall, Martha L. ................................... Disclosed no confl ict of interest.Wallace, Jane ..................................... Employee: Bayer HealthCare. Wallace, Nathaniel ............................. Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson; Stock/Shareholder: Johnson & Johnson. Wallach, Elizabeth .............................. Disclosed no confl ict of interest.Wallenius, Kristina ............................. Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP. Wallia, Amisha .................................... Research Support: Bayer HealthCare, Merck & Co., Inc. Wallis, Charlotte ................................. Disclosed no confl ict of interest.Walls, Danielle .................................... Disclosed no confl ict of interest.Walpita, Deepika ................................ Disclosed no confl ict of interest.Walsh, Brandon ................................... Employee: Orexigen Therapeutics, Inc.; Stock/Shareholder:

Orexigen Therapeutics, Inc. Walter, Martin ..................................... Disclosed no confl ict of interest.Walters, Robin G. ................................ Disclosed no confl ict of interest.Walthall, Johanna C. .......................... Disclosed no confl ict of interest.Walus-Miarka, Malgorzata ................ Disclosed no confl ict of interest.Wan Mahmood, Wan Aizad ............... Disclosed no confl ict of interest.Wan, Jim .............................................. Disclosed no confl ict of interest.Wan, Lijuan .......................................... Disclosed no confl ict of interest.Wanda, Sine ........................................ Disclosed no confl ict of interest.Wang, Bingdi ....................................... Employee: Crown Bioscience, Inc. Wang, Binhui ....................................... Employee: Novartis Pharmaceuticals Corporation. Wang, Carol ......................................... Disclosed no confl ict of interest.Wang, Catherine ................................. Employee: GlaxoSmithKline. Wang, Chao ......................................... Disclosed no confl ict of interest.Wang, Chen-Pin .................................. Disclosed no confl ict of interest.Wang, Dan ........................................... Disclosed no confl ict of interest.Wang, Fang .......................................... Disclosed no confl ict of interest.Wang, Feng-Bin ................................... Disclosed no confl ict of interest.Wang, Guijing ...................................... Disclosed no confl ict of interest.Wang, Haiyan ...................................... Disclosed no confl ict of interest.Wang, Heng ......................................... Disclosed no confl ict of interest.Wang, Hong ......................................... Disclosed no confl ict of interest.Wang, Hongjun ................................... Disclosed no confl ict of interest.Wang, Hongwei .................................. Employee: Sanofi . Wang, Hongying .................................. Disclosed no confl ict of interest.Wang, Hye Jin ..................................... Disclosed no confl ict of interest.Wang, Jianxin ..................................... Disclosed no confl ict of interest.Wang, Jie ............................................ Disclosed no confl ict of interest.Wang, Jing .......................................... Disclosed no confl ict of interest.Wang, Jingjing .................................... Disclosed no confl ict of interest.Wang, Jinping ..................................... Disclosed no confl ict of interest.Wang, Joshua J. ................................. Disclosed no confl ict of interest.Wang, Juanjuan .................................. Disclosed no confl ict of interest.Wang, Jun ........................................... Disclosed no confl ict of interest.Wang, Junkui ...................................... Disclosed no confl ict of interest.Wang, Jun-Sing ................................... Disclosed no confl ict of interest.Wang, Ke ............................................. Employee: Eli Lilly and Company. Wang, Lei ............................................. Disclosed no confl ict of interest.Wang, Leishen ..................................... Disclosed no confl ict of interest.Wang, Li ............................................... Employee: University of Macau; Research Support: National

Institute of Diabetes and Digestive and Kidney Diseases.

Wang, Liangsu ..................................... Employee: Merck & Co., Inc. Wang, Lu .............................................. Disclosed no confl ict of interest.Wang, Lu-Juan .................................... Disclosed no confl ict of interest.Wang, Manman ................................... Disclosed no confl ict of interest.Wang, Mei ........................................... Disclosed no confl ict of interest.Wang, Mingming ................................. Disclosed no confl ict of interest.Wang, Minquan ................................... Disclosed no confl ict of interest.Wang, Na ............................................. Disclosed no confl ict of interest.Wang, Peili .......................................... Disclosed no confl ict of interest.Wang, Qi .............................................. Disclosed no confl ict of interest.Wang, Qiang ........................................ Disclosed no confl ict of interest.Wang, Qiong A. ................................... Disclosed no confl ict of interest.Wang, Qunan ....................................... Disclosed no confl ict of interest.Wang, Ronald Chi Chiu ....................... Disclosed no confl ict of interest.Wang, Rong ......................................... Disclosed no confl ict of interest.Wang, Rui ............................................ Disclosed no confl ict of interest.Wang, Shan ......................................... Disclosed no confl ict of interest.Wang, Shanshan ................................. Disclosed no confl ict of interest.Wang, Shaohua ................................... Disclosed no confl ict of interest.Wang, Shuxing .................................... Disclosed no confl ict of interest.

Wang, Simeng ..................................... Disclosed no confl ict of interest.Wang, Steven Chialin ......................... Other Relationship: Azure Institute Inc. Wang, Tao ............................................ Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Wang, Thomas J. ................................ Disclosed no confl ict of interest.Wang, Weiqing ................................... Employee: Rui Jin Hospital. Wang, Weizhong ................................. Disclosed no confl ict of interest.Wang, Xiaoli ........................................ Employee: Crown Bioscience, Inc. Wang, Xiaonan .................................... Disclosed no confl ict of interest.Wang, Xiaoqiang ................................. Disclosed no confl ict of interest.Wang, Xiaoxin ..................................... Disclosed no confl ict of interest.Wang, Xiao-Yu ..................................... Disclosed no confl ict of interest.Wang, Xingchun .................................. Disclosed no confl ict of interest.Wang, Xinhui ....................................... Disclosed no confl ict of interest.Wang, Xinye S. .................................... Disclosed no confl ict of interest.Wang, Xuanchun ................................. Disclosed no confl ict of interest.Wang, Xueyan ..................................... Employee: AntriaBio, Inc; Stock/Shareholder: AntriaBio, Inc. Wang, Xueyin ...................................... Disclosed no confl ict of interest.Wang, Xuhong ..................................... Disclosed no confl ict of interest.Wang, Yaxin ........................................ Disclosed no confl ict of interest.Wang, Yi .............................................. Disclosed no confl ict of interest.Wang, Ying-Ying ................................. Disclosed no confl ict of interest.Wang, Yiting ........................................ Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson; Stock/Shareholder: Janssen Pharmaceutical Companies of Johnson & Johnson.

Wang, Yi-Xin (Jim) .............................. Employee: Crown Bioscience, Inc. Wang, Yong ......................................... Employee: Eli Lilly and Company. Wang, Yonghui .................................... Disclosed no confl ict of interest.Wang, Yu ............................................. Disclosed no confl ict of interest.Wang, Yuanping .................................. Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Wang, Yuanyuan ................................. Disclosed no confl ict of interest.Wang, Yuehui ...................................... Disclosed no confl ict of interest.Wang, Zhanjian ................................... Disclosed no confl ict of interest.Wang, Zhixiao ..................................... Employee: Eisai Co., Ltd. Wang, Zhixin ....................................... Disclosed no confl ict of interest.Wang, Zongwei ................................... Disclosed no confl ict of interest.Wannaiampikul, Sivaporn .................. Disclosed no confl ict of interest.Ward, Glenn M. ................................... Research Support: Medtronic, Inc. Ward, Micheal S. ................................ Disclosed no confl ict of interest.Warner, Jay ......................................... Employee: CeQur SA. Warnick, G. Russell ............................. Board Member: Health Diagnostics Laboratory, Inc.;

Employee: Health Diagnostics Laboratory, Inc. Warram, James H. .............................. Disclosed no confl ict of interest.Warren, Laura ..................................... Disclosed no confl ict of interest.Warren, Mark ...................................... Advisory Panel: Eli Lilly, Novo Nordisk; Research Support:

Boehringer Ingleheim, Eli Lilly, Forest, Janssen, Merck, Mylan, Novo Nordisk, NPS, Pfi zer, Sanofi , Takeda, VPI; Speaker’s Bureau: AstraZeneca, Boehringer Ingleheim, Eli Lilly, Janssen, Merck, Novo Nordisk, Sanofi , Vivus.

Warren, Robert ................................... Disclosed no confl ict of interest.Warren-Mears, Victoria ..................... Disclosed no confl ict of interest.Warshak, Carri .................................... Disclosed no confl ict of interest.Waseem, Muhammad ........................ Disclosed no confl ict of interest.Washer, Sophie L. ............................... Disclosed no confl ict of interest.Wassef, Hanny .................................... Disclosed no confl ict of interest.Wasserfall, Clive ................................. Disclosed no confl ict of interest.Wasserman, David H. ......................... Disclosed no confl ict of interest.Wasserman, Scott M. ......................... Employee: Amgen Inc.; Stock/Shareholder: Amgen Inc. Watada, Hirotaka ..............................Advisory Panel: Astellas Pharma US, Inc., AstraZeneca

Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Kowa Pharmaceuticals, Kowa Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Ono Pharmaceutical Co., Ltd., Pfi zer Inc., Sanofi U.S., Sumimoto Dainippon Pharma Co., Ltd., Takeda Pharmaceutical Company Limited; Research Support: Astellas Pharma US, Inc., AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Daiichi-Sankyo Co., Ltd., Eli Lilly and Company, Johnson & Johnson, Kissei Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Ono Pharmaceutical Co., Ltd., Sanofi U.S., Sumimoto Dainippon Pharma Co., Ltd., Taisho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited; Speaker’s Bureau: Astellas Pharma US, Inc., AstraZeneca Pharmaceuticals LP, Bayer HealthCare, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi-Sankyo Co., Ltd., Eli Lilly and Company, Kissei

A894

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Pharmaceutical Co., Ltd., Kowa Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., Novartis Pharmaceuticals Corporation, Novo Nordisk Inc., Ono Pharmaceutical Co., Ltd., Sanofi U.S., Sanwa Kagaku Kenkyusho Co., Ltd., Sumimoto Dainippon Pharma Co., Ltd., Takeda Pharmaceutical Company Limited.

Watanabe, Hiroshi .............................. Disclosed no confl ict of interest.Watanabe, Jonathan H. ..................... Disclosed no confl ict of interest.Watanabe, Kazuhisa ........................... Disclosed no confl ict of interest.Watanabe, Kenichi ............................. Disclosed no confl ict of interest.Watanabe, Kurando ............................ Disclosed no confl ict of interest.Watanabe, Nobuyuki .......................... Disclosed no confl ict of interest.Watanabe, Richard M. ....................... Disclosed no confl ict of interest.Watanabe, Shigeyuki ......................... Disclosed no confl ict of interest.Watanabe, Takahiro ........................... Disclosed no confl ict of interest.Watanabe, Takayuki ........................... Disclosed no confl ict of interest.Watanabe, Takuya .............................. Disclosed no confl ict of interest.Watanabe, Tamiko .............................. Disclosed no confl ict of interest.Watanabe, Tsuyoshi ........................... Disclosed no confl ict of interest.Watanabe, Yui ..................................... Disclosed no confl ict of interest.Waterman, Pamela D. ......................... Disclosed no confl ict of interest.Waters, Matthew F. ............................ Disclosed no confl ict of interest.Waters, Thaddeus P. ........................... Disclosed no confl ict of interest.Watkins, Elaine ................................... Employee: Profi l Institute for Clinical Research, Inc. Watkins, Renecia ................................ Disclosed no confl ict of interest.Watkins, Steven M. ............................ Disclosed no confl ict of interest.Watson, Kathleen T. ........................... Disclosed no confl ict of interest.Watson, Nina ...................................... Disclosed no confl ict of interest.Watt, Richard ...................................... Disclosed no confl ict of interest.Waugh, Kathleen C. ............................ Disclosed no confl ict of interest.Wawrusiewicz-Kurylonek, Natalia ... Disclosed no confl ict of interest.Waxman, Elaine .................................. Disclosed no confl ict of interest.Weatherall, James ............................. Employee: Novo Nordisk A/S. Weaver, Jeff ........................................ Disclosed no confl ict of interest.Weaver, Mark A. ................................. Research Support: National Institutes of Health. Webb, Jason A. ................................... Disclosed no confl ict of interest.Webb, Mary ......................................... Disclosed no confl ict of interest.Webber, Jill ......................................... Disclosed no confl ict of interest.Webber, Jonathan .............................. Disclosed no confl ict of interest.Weber, Dietmar ................................... Disclosed no confl ict of interest.Weber, Katharina S. ............................ Disclosed no confl ict of interest.Weber, Mary Beth ............................... Disclosed no confl ict of interest.Wee, Shun Yuh .................................... Disclosed no confl ict of interest.Weedon, Michael N. ........................... Disclosed no confl ict of interest.Weerasekara, Sahani M. ................... Disclosed no confl ict of interest.Wei, Cheng-Yu ..................................... Disclosed no confl ict of interest.Wei, Cheryl .......................................... Employee: AstraZeneca Pharmaceuticals LP. Wei, Feng ............................................. Disclosed no confl ict of interest.Wei, Tao ............................................... Disclosed no confl ict of interest.Wei, Wenhui ........................................ Employee: Sanofi U.S. Wei, Xiaoping ...................................... Disclosed no confl ict of interest.Wei, Xiaoxiong .................................... Employee: Medpace, Inc. Wei, Zheng .......................................... Employee: Becton, Dickinson and Company. Weigert, Cora ...................................... Disclosed no confl ict of interest.Weigl, Bernhard H. .............................. Disclosed no confl ict of interest.Weigle, D.S. ......................................... Disclosed no confl ict of interest.Weikel, Karen ...................................... Disclosed no confl ict of interest.Weil, Jennifer ...................................... Disclosed no confl ict of interest.Wein, Marc .......................................... Disclosed no confl ict of interest.Weiner, Lauren .................................... Disclosed no confl ict of interest.Weiner, Lia J. ...................................... Disclosed no confl ict of interest.Weiner, Rudolf .................................... Disclosed no confl ict of interest.Weinger, Katie .................................... Disclosed no confl ict of interest.Weinhold, Kellie .................................. Disclosed no confl ict of interest.Weinrauch, Larry A. ............................ Disclosed no confl ict of interest.Weinstock, Ruth S. ............................. Research Support: AstraZeneca Pharmaceuticals LP,

Biodel Inc., Calibra, Inc., Eli Lilly and Company, Intarcia Therapeutics, Inc., Jaeb Center for Health Research, Joslin Diabetes Center, Leona and Harry Helmsley Charitable Trust, Medtronic, Inc., Mylan, Inc., Novo Nordisk Inc., Sanofi U.S.

Weinzimer, Stuart A. .......................... Consultant: Insulet Corporation, Medtronic, Inc., Novo Nordisk Inc., Tandem Diabetes Care, Inc.; Research Support: Medtronic, Inc.; Stock/Shareholder: Insuline Medical Ltd.

Weir, Gordon C. ................................... Disclosed no confl ict of interest.Weir, Jacquelyn M. ............................. Disclosed no confl ict of interest.Weir, Matthew .................................... Advisory Panel: AbbVie, Akebia, Amgen, Astra Zeneca,

Boston Sandoz, Janssen, MSD, Novartis, Otsuka, Relypsa, Inc., ZS Pharma.

Weiser, Thomas .................................. Disclosed no confl ict of interest.

Weisman, Alanna ................................ Disclosed no confl ict of interest.Weiss, Guenter ................................... Disclosed no confl ict of interest.Weiss, Helmut ..................................... Disclosed no confl ict of interest.Weiss, Jürgen ..................................... Disclosed no confl ict of interest.Weiss, Melanie ................................... Disclosed no confl ict of interest.Weissberg-Benchell, Jill .................... Speaker’s Bureau: Roche Diagnostics. Weissmann, Jörg ................................ Employee: Roche Diagnostics. Weissmann, Laís ................................. Disclosed no confl ict of interest.Weitman, Steven ................................ Disclosed no confl ict of interest.Weitzman, Elissa R. ............................ Disclosed no confl ict of interest.Weksler-Zangen, Sarah ...................... Disclosed no confl ict of interest.Wellenius, Gregory A. ........................ Disclosed no confl ict of interest.Wellman, Andrew D. ........................... Disclosed no confl ict of interest.Welly, Rebecca J. ............................... Disclosed no confl ict of interest.Welsh, Nicholas .................................. Disclosed no confl ict of interest.Weltman, Arthur ................................. Disclosed no confl ict of interest.Weltman, Judy Y. ................................ Disclosed no confl ict of interest.Wen, Li ................................................. Disclosed no confl ict of interest.Wen, Xiaorong .................................... Disclosed no confl ict of interest.Wende, Adam R. ................................. Disclosed no confl ict of interest.Wender-Ozegowska, Ewa .................. Consultant: Novo Nordisk Inc. Weng, Jianping ................................... Disclosed no confl ict of interest.Weng, Shih-Yen ................................... Disclosed no confl ict of interest.Weng, Wayne ...................................... Employee: Novo Nordisk Inc. Wenger, Julia ...................................... Disclosed no confl ict of interest.Werner, Ulrich ..................................... Employee: Sanofi ; Stock/Shareholder: Sanofi . Wess, Jurgen ...................................... Disclosed no confl ict of interest.Wessel, Jennifer ................................. Disclosed no confl ict of interest.Wessells, Hunter ................................. Disclosed no confl ict of interest.West Strum, Donna ............................ Disclosed no confl ict of interest.West, Cæcilie ...................................... Disclosed no confl ict of interest.Westfall, Emily .................................... Disclosed no confl ict of interest.Westlin, William F. .............................. Disclosed no confl ict of interest.Westwell-Roper, Clara ....................... Disclosed no confl ict of interest.Wettergren, André .............................. Disclosed no confl ict of interest.Wewalka, Marlene ............................. Disclosed no confl ict of interest.Wewer Albrechtsen, Nicolai .............. Disclosed no confl ict of interest.Wexler, Deborah J. ............................. Disclosed no confl ict of interest.Weyman, Kate ..................................... Disclosed no confl ict of interest.Whaley, Jean ...................................... Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson; Stock/Shareholder: Johnson & Johnson. Whaley-Connell, Adam ....................... Disclosed no confl ict of interest.Whang Kong, Hyerim .......................... Disclosed no confl ict of interest.Wharam, James F. .............................. Disclosed no confl ict of interest.Wheatcroft, Stephen B. ..................... Disclosed no confl ict of interest.Wheeler, Eleanor ................................ Disclosed no confl ict of interest.Wheeler, Jean ..................................... Employee: Metabolic Solutions Development Company, LLC. Wheeler, Michael B. ........................... Disclosed no confl ict of interest.Wheeler, Sarah E. ............................... Disclosed no confl ict of interest.Wheelock, Kevin M. ........................... Disclosed no confl ict of interest.Whitaker, Robert C. ............................ Disclosed no confl ict of interest.Whitbread, Cherie .............................. Disclosed no confl ict of interest.White, Andrew .................................... Disclosed no confl ict of interest.White, C.M. ......................................... Disclosed no confl ict of interest.White, Douglas B. ............................... Disclosed no confl ict of interest.White, Emily ........................................ Disclosed no confl ict of interest.White, Kathryn E. ................................ Disclosed no confl ict of interest.White, Morris F. .................................. Board Member: Housey Pharmaceutical Research

Laboratories. White, Neil H. ...................................... Consultant: Daiichi-Sankyo Co., Ltd., Novo Nordisk A/S;

Research Support: Janssen Research & Development LLC.

White, Perrin C. ................................... Disclosed no confl ict of interest.White, Steve ....................................... Disclosed no confl ict of interest.White, William B. ................................ Advisory Panel: Takeda Pharmaceuticals U.S.A., Inc.;

Consultant: Takeda Pharmaceuticals U.S.A., Inc. Whitehead, Marlo ............................... Disclosed no confl ict of interest.Whitener, Robert L. ............................ Stock/Shareholder: MacroGenics, Inc. Whitmire, Natalie ............................... Disclosed no confl ict of interest.Whittemore, Robin ............................. Disclosed no confl ict of interest.Whittington, Ayanna .......................... Disclosed no confl ict of interest.Wichert, Stefan .................................. Disclosed no confl ict of interest.Wickramanayake, Anneka ................. Disclosed no confl ict of interest.Wicksteed, Barton .............................. Disclosed no confl ict of interest.Wickwire, Brian .................................. Disclosed no confl ict of interest.Wiebe, Deborah J. .............................. Research Support: National Institute of Diabetes and

Digestive and Kidney Diseases. Wiecek, Andrzej .................................. Disclosed no confl ict of interest.Wiehe, Sarah E. .................................. Disclosed no confl ict of interest.Wielandner, Alice ............................... Disclosed no confl ict of interest.Wierup, Nils ........................................ Disclosed no confl ict of interest.Wiesel, Philippe .................................. Other Relationship: Employee of Genkyotex Inc.

A895

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Wiessner, Gregory .............................. Disclosed no confl ict of interest.Wiitala, Ellen ....................................... Disclosed no confl ict of interest.Wilding, John P. .................................. Advisory Panel: AstraZeneca Pharmaceuticals LP,

Bristol-Myers Squibb Company, Janssen Research & Development LLC, Novo Nordisk A/S; Consultant: Pfi zer Inc.; Research Support: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Novo Nordisk A/S; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Janssen Research & Development LLC, Merck Sharp & Dohme, Novo Nordisk A/S.

Wiles, Timothy .................................... Disclosed no confl ict of interest.Wilhelm, Jean-Marie ......................... Disclosed no confl ict of interest.Wilhelm, Joshua ................................. Disclosed no confl ict of interest.Wilinska, Malgorzata E. ..................... Consultant: BD Medical-Diabetes Care. Wilke, Lindsey ..................................... Disclosed no confl ict of interest.Wilkinson, Iain .................................... Disclosed no confl ict of interest.Willaing, Ingrid .................................... Employee: Steno Diabetes Center A/S. Willard, Belinda .................................. Disclosed no confl ict of interest.Willard, Joshua R. .............................. Disclosed no confl ict of interest.Willers, Joerg ...................................... Stock/Shareholder: Cytos Biotechnology AG. Willey, Vincent .................................... Disclosed no confl ict of interest.Willi, Steven M. .................................. Research Support: Astellas Pharma US, Inc., Bayer

HealthCare, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases.

Williams, Ashley S. ............................. Disclosed no confl ict of interest.Williams, Ian M. .................................. Disclosed no confl ict of interest.Williams, Jean .................................... Employee: MacroGenics, Inc.; Other Relationship: Merck &

Co., Inc. Williams, Jonathan J. ......................... Disclosed no confl ict of interest.Williams, Kevin Jon ............................ Stock/Shareholder: Hygieia. Williams, Kevin W. .............................. Disclosed no confl ict of interest.Williams, Michelle A. ......................... Disclosed no confl ict of interest.Williams, Paul ..................................... Employee: Freedom Meditech, Inc. Williams, Phil ...................................... Disclosed no confl ict of interest.Williams, Robin ................................... Disclosed no confl ict of interest.Willis, Wayne T. .................................. Disclosed no confl ict of interest.Willmes, Diana .................................... Disclosed no confl ict of interest.Wills, Rachel ....................................... Disclosed no confl ict of interest.Wilson, Bryan R. ................................. Employee: Biodel Inc. Wilson, Bula ........................................ Disclosed no confl ict of interest.Wilson, Christopher S. ........................ Disclosed no confl ict of interest.Wilson, Colin ....................................... Disclosed no confl ict of interest.Wilson, Craig ....................................... Employee: Takeda Pharmaceuticals U.S.A., Inc. Wilson, Daniel ..................................... Employee: Relypsa, Inc.; Stock/Shareholder: Relypsa, Inc. Wilson, James G. ................................ Disclosed no confl ict of interest.Wilson, Lisa ......................................... Disclosed no confl ict of interest.Wilson, Tim H. ..................................... Employee: GlaxoSmithKline; Stock/Shareholder:

GlaxoSmithKline. Winchester, David .............................. Disclosed no confl ict of interest.Windham MacMaster, Heidemarie ... Disclosed no confl ict of interest.Windrichova, Jindra ........................... Disclosed no confl ict of interest.Winer, Daniel A. .................................. Disclosed no confl ict of interest.Wing, Rena R. ...................................... Disclosed no confl ict of interest.Wingate, La’Marcus ........................... Disclosed no confl ict of interest.Wingert, Ashley .................................. Disclosed no confl ict of interest.Wingert, Bentley ................................. Disclosed no confl ict of interest.Winkelmayer, Wolfgang C. ................ Advisory Panel: Bayer HealthCare, Merck Sharp & Dohme. Winnay, Jonathon ............................... Disclosed no confl ict of interest.Winnick, Joel ...................................... Disclosed no confl ict of interest.Winship, Sue ....................................... Disclosed no confl ict of interest.Winters, Michael P. ............................ Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Wisk, Lauren E. ................................... Disclosed no confl ict of interest.Wisniewski, Eric ................................. Disclosed no confl ict of interest.Wisnivesky, Juan P. ............................ Disclosed no confl ict of interest.Witkin, Linda ....................................... Disclosed no confl ict of interest.Witkowska, Agnieszka ....................... Disclosed no confl ict of interest.Witkowski, Piotr ................................. Disclosed no confl ict of interest.Witt, Henning ...................................... Disclosed no confl ict of interest.Witte, Daniel ....................................... Stock/Shareholder: Novo Nordisk A/S. Wittgrove, Alan C. .............................. Disclosed no confl ict of interest.Woerle, Hans-Juergen ....................... Employee: Boehringer Ingelheim GmbH. Wohland, Tobias ................................. Disclosed no confl ict of interest.Wojcikiewicz, Richard J. .................... Disclosed no confl ict of interest.Wojczynski, Mary K. ........................... Disclosed no confl ict of interest.Wojtaszewski, Jørgen F. .................... Disclosed no confl ict of interest.Wojtusciszyn, Anne ............................ Disclosed no confl ict of interest.Wojtyna, Ewa ...................................... Disclosed no confl ict of interest.Wolczynski, Slawomir ........................ Disclosed no confl ict of interest.Wolden, Michael L. ............................. Employee: Novo Nordisk A/S.

Wolfe, Cindy ........................................ Employee: Metabolic Solutions Development Company, LLC. Wolfe, Honor ....................................... Disclosed no confl ict of interest.Wolffenbuttel, Bruce H. ..................... Advisory Panel: AstraZeneca Pharmaceuticals LP, Eli Lilly

and Company, Novo Nordisk Inc.; Other Relationship: Boehringer Ingelheim Pharmaceuticals, Inc.; Research Support: Eli Lilly and Company, Novartis Pharmaceuticals Corporation, Pfi zer Inc., Sanofi Aventis.

Wolfsdorf, Joseph .............................. Disclosed no confl ict of interest.Wolkow, Joanna ................................. Disclosed no confl ict of interest.Wolpert, Howard A. ............................ Consultant: Abbott Diabetes Care, Inc., Dexcom, Inc., Insulet

Corporation, Novo Nordisk A/S. Won, Hee-Kwan .................................. Disclosed no confl ict of interest.Won, Kyoung Jae ................................ Disclosed no confl ict of interest.Wong, Chi-Ming .................................. Disclosed no confl ict of interest.Wong, David T. .................................... Advisory Panel: RNAmeTRIX Inc.; Consultant: PeriRx; Other

Relationship: RNAmeTRIX Inc. Wong, Gerard ...................................... Disclosed no confl ict of interest.Wong, Jencia ...................................... Disclosed no confl ict of interest.Wong, Jenise C. .................................. Disclosed no confl ict of interest.Wong, Lindsay L. ................................. Disclosed no confl ict of interest.Wong, Lydia A. .................................... Disclosed no confl ict of interest.Wong, Mayme ..................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Wong, Norman .................................... Employee: Resverlogix Corp. Wong, Tung Po .................................... Disclosed no confl ict of interest.Wong, Ying .......................................... Disclosed no confl ict of interest.Woo, Jeong-Taek ................................ Disclosed no confl ict of interest.Woo, Jung Hoon .................................. Disclosed no confl ict of interest.Woo, Minna ......................................... Disclosed no confl ict of interest.Wood, Richard S. ................................ Disclosed no confl ict of interest.Wood, Robert ...................................... Disclosed no confl ict of interest.Woodard, LeChauncy .......................... Disclosed no confl ict of interest.Woodley, Wendy D. ............................ Employee: Becton, Dickinson and Company. Woodlief, Tracey ................................. Disclosed no confl ict of interest.Woodruff, Robert ................................ Disclosed no confl ict of interest.Woods, Thomas C. .............................. Disclosed no confl ict of interest.Woodward, Mark ................................ Disclosed no confl ict of interest.Woodward, Richmond L. .................... Disclosed no confl ict of interest.Woolcott, Orison O. ............................ Disclosed no confl ict of interest.Woon, Kaing ........................................ Disclosed no confl ict of interest.Wooten, Joshua .................................. Disclosed no confl ict of interest.Worme, Amanda ................................. Disclosed no confl ict of interest.Worthington, Anne ............................. Disclosed no confl ict of interest.Wortzman-Show, Genevieve ............. Employee: AstraZeneca Pharmaceuticals LP. Wraith, Katie S. ................................... Disclosed no confl ict of interest.Wray, Nelda P. ..................................... Disclosed no confl ict of interest.Wright, David C. .................................. Disclosed no confl ict of interest.Wright, Douglas E. .............................. Disclosed no confl ict of interest.Wright, Forrest A. ............................... Disclosed no confl ict of interest.Wright, Jason ...................................... Disclosed no confl ict of interest.Wright, Kathryn .................................. Disclosed no confl ict of interest.Wright, Tina ......................................... Disclosed no confl ict of interest.Wronkowitz, Nina ............................... Disclosed no confl ict of interest.Wu, Bing .............................................. Disclosed no confl ict of interest.Wu, Bingbing ....................................... Disclosed no confl ict of interest.Wu, Bingcao ........................................ Disclosed no confl ict of interest.Wu, Chunyi .......................................... Disclosed no confl ict of interest.Wu, Eric ............................................... Employee: Analysis Group. Wu, Fan ................................................ Employee: MSD R&D (China) Ltd. Wu, Feng .............................................. Disclosed no confl ict of interest.Wu, Ginger Y. ....................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Wu, Haiya ............................................ Employee: Eli Lilly and Company. Wu, Hao ............................................... Disclosed no confl ict of interest.Wu, Henry ............................................ Consultant: AstraZeneca Pharmaceuticals LP. Wu, Huaizhu ........................................ Disclosed no confl ict of interest.Wu, I-Hsien .......................................... Disclosed no confl ict of interest.Wu, Jethro ........................................... Disclosed no confl ict of interest.Wu, Jichuan ......................................... Disclosed no confl ict of interest.Wu, Jing ............................................... Disclosed no confl ict of interest.Wu, Jingxia ......................................... Disclosed no confl ict of interest.Wu, Joseph C. ..................................... Disclosed no confl ict of interest.Wu, Jun ................................................ Disclosed no confl ict of interest.Wu, Junlong ........................................ Employee: Sanofi . Wu, Licheng ......................................... Disclosed no confl ict of interest.Wu, Margaret ...................................... Employee: Merck Sharp & Dohme. Wu, Mengrui ....................................... Disclosed no confl ict of interest.Wu, Minjie ........................................... Disclosed no confl ict of interest.Wu, Qiang ............................................ Disclosed no confl ict of interest.Wu, Qin ................................................ Disclosed no confl ict of interest.Wu, Qingsi ........................................... Disclosed no confl ict of interest.

A896

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Wu, Sherry ........................................... Disclosed no confl ict of interest.Wu, Stephanie C. ................................ Disclosed no confl ict of interest.Wu, Ted ................................................ Disclosed no confl ict of interest.Wu, Tongzhi ......................................... Research Support: AstraZeneca/Bristol-Myers Squibb. Wu, Wen-Chih ..................................... Disclosed no confl ict of interest.Wu, Xiangdong .................................... Disclosed no confl ict of interest.Wu, Xiaobin ......................................... Disclosed no confl ict of interest.Wu, Xing .............................................. Disclosed no confl ict of interest.Wu, Ying .............................................. Disclosed no confl ict of interest.Wu, Yixin ............................................. Disclosed no confl ict of interest.Wu, You M. .......................................... Disclosed no confl ict of interest.Wu, Yuanyuan ..................................... Disclosed no confl ict of interest.Wu, Yueh C. ......................................... Disclosed no confl ict of interest.Wu, Yueyue ......................................... Disclosed no confl ict of interest.Wu, Yuxin ............................................. Disclosed no confl ict of interest.Wudelehu, Wu .................................... Disclosed no confl ict of interest.Wueest, Stephan ................................ Disclosed no confl ict of interest.Wybranska, Iwona .............................. Disclosed no confl ict of interest.Wykoff, Charles C. .............................. Disclosed no confl ict of interest.Wysham, Carol H. ............................... Consultant: AstraZeneca Pharmaceuticals LP, Janssen

Pharmaceutical Companies of Johnson & Johnson, Sanofi U.S.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Endocrine Society, Janssen Pharmaceutical Companies of Johnson & Johnson, Novo Nordisk Inc., Sanofi U.S.

Wysocki, Tim ....................................... Disclosed no confl ict of interest.Wystrychowski, Antoni ...................... Research Support: Astellas Pharma US, Inc., Roche Polska,

Teva Pharmaceutical Industries Ltd. Wystrychowski, Grzegorz .................. Research Support: Roche Polska. Xhaard, Ilham ...................................... Disclosed no confl ict of interest.Xi, Guangxia ........................................ Disclosed no confl ict of interest.Xia, Lian ............................................... Disclosed no confl ict of interest.Xia, Mingfeng ...................................... Disclosed no confl ict of interest.Xia, Qianghua ...................................... Disclosed no confl ict of interest.Xia, Wenqing ....................................... Disclosed no confl ict of interest.Xiang, Anny H. ..................................... Disclosed no confl ict of interest.Xiao, Changting ................................... Disclosed no confl ict of interest.Xiao, Da Wei ........................................ Disclosed no confl ict of interest.Xiao, Gary ............................................ Disclosed no confl ict of interest.Xiao, Haipeng ...................................... Disclosed no confl ict of interest.Xiao, Hong ........................................... Disclosed no confl ict of interest.Xiao, Lan .............................................. Disclosed no confl ict of interest.Xiao, Lin ............................................... Disclosed no confl ict of interest.Xiao, Ting ............................................. Disclosed no confl ict of interest.Xiao, Xiangwei .................................... Disclosed no confl ict of interest.Xiao, Xiaoqiu ....................................... Disclosed no confl ict of interest.Xiao, Xinhua ........................................ Disclosed no confl ict of interest.Xiao, Yongfu ........................................ Disclosed no confl ict of interest.Xiao, Yong-Fu ...................................... Employee: Crown Bioscience, Inc. Xiao, Yunfeng ...................................... Disclosed no confl ict of interest.Xiaochuan, Ma .................................... Disclosed no confl ict of interest.XiaoWei, Zhong ................................... Disclosed no confl ict of interest.Xiaoyan, Xing ...................................... Disclosed no confl ict of interest.Xie, Changqing .................................... Disclosed no confl ict of interest.Xie, John .............................................. Employee: Janssen Research & Development, LLC. Xie, Lin ................................................. Consultant: Employee of STATinMED Research, under

contract with Sanofi U.S., Inc. Xie, Liran .............................................. Disclosed no confl ict of interest.Xie, Xinmin (Simon) ............................. Disclosed no confl ict of interest.Xin, Xiaoban ........................................ Disclosed no confl ict of interest.Xin, Yurong .......................................... Employee: Regeneron Pharmaceuticals, Inc. Xing, Ann ............................................. Disclosed no confl ict of interest.Xing, Hanying ...................................... Disclosed no confl ict of interest.Xing, Junhui ......................................... Disclosed no confl ict of interest.Xing, Xiaoyan ...................................... Disclosed no confl ict of interest.Xing, Yun-Zhi ....................................... Disclosed no confl ict of interest.Xiong, Yan ............................................ Disclosed no confl ict of interest.Xu, Aimin ............................................. Disclosed no confl ict of interest.Xu, Beibei ............................................. Disclosed no confl ict of interest.Xu, Fen ................................................. Disclosed no confl ict of interest.Xu, Guangfeng ..................................... Disclosed no confl ict of interest.Xu, Guanlan ......................................... Disclosed no confl ict of interest.Xu, Guowang ....................................... Disclosed no confl ict of interest.Xu, Hailing ........................................... Disclosed no confl ict of interest.Xu, Haixia ............................................. Disclosed no confl ict of interest.Xu, Hong .............................................. Disclosed no confl ict of interest.Xu, Hongyan ........................................ Disclosed no confl ict of interest.Xu, Jian ................................................ Disclosed no confl ict of interest.Xu, Jianzhao ........................................ Disclosed no confl ict of interest.Xu, Jiong .............................................. Disclosed no confl ict of interest.

Xu, John ............................................... Employee: AstraZeneca Pharmaceuticals LP. Xu, June ............................................... Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Xu, Ke ................................................... Disclosed no confl ict of interest.Xu, Lei .................................................. Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &

Co., Inc. Xu, Liang .............................................. Disclosed no confl ict of interest.Xu, Lijuan ............................................. Disclosed no confl ict of interest.Xu, Lin .................................................. Disclosed no confl ict of interest.Xu, Michael M. .................................... Disclosed no confl ict of interest.Xu, Qiang ............................................. Disclosed no confl ict of interest.Xu, Tian ................................................ Disclosed no confl ict of interest.Xu, Wang ............................................. Disclosed no confl ict of interest.Xu, Wanghong ..................................... Disclosed no confl ict of interest.Xu, Wen ............................................... Disclosed no confl ict of interest.Xu, Wen-Juan ...................................... Disclosed no confl ict of interest.Xu, Wenting ......................................... Disclosed no confl ict of interest.Xu, XiaoJing ........................................ Disclosed no confl ict of interest.Xu, Yang ............................................... Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &

Co., Inc. Xu, Yao-Chang ..................................... Disclosed no confl ict of interest.Xu, Yong ............................................... Disclosed no confl ict of interest.Xu, Yuanzhong ..................................... Disclosed no confl ict of interest.Xu, Zhonggao ....................................... Disclosed no confl ict of interest.Xu, Zihui ............................................... Disclosed no confl ict of interest.Xu, Ziqian ............................................. Disclosed no confl ict of interest.Xuan, Lei .............................................. Disclosed no confl ict of interest.Xue, Bingzhong .................................... Research Support: NuSirt Biopharma. Xue, Ruidan .......................................... Disclosed no confl ict of interest.Xue, Zhenyi .......................................... Employee: Becton, Dickinson and Company; Stock/

Shareholder: Becton, Dickinson and Company. Xuesi, Wan .......................................... Disclosed no confl ict of interest.Yaakob, Harisun .................................. Disclosed no confl ict of interest.Yabuki, Chiori ...................................... Employee: Takeda Pharmaceutical Company Limited. Yagi, Kunimasa .................................... Disclosed no confl ict of interest.Yagihashi, Soroku ............................... Disclosed no confl ict of interest.Yagnik, Deepak .................................... Disclosed no confl ict of interest.Yagyu, Hiroaki ..................................... Disclosed no confl ict of interest.Yalamanchi, Swaytha ......................... Disclosed no confl ict of interest.Yale, Jean-François ............................ Advisory Panel: Abbott, AstraZeneca, Bayer, Boehringer-

Ingelheim, Eli Lilly, Janssen, Medtronic, Merck, NovoNordisk, Sanofi ; Research Support: AstraZeneca, Boehringer-Ingelheim, Eli Lilly, Janssen, Medtronic, Merck, NovoNordisk, Sanofi ; Speaker’s Bureau: Abbott, AstraZeneca, Bayer, Boehringer-Ingelheim, Eli Lilly, Janssen, Medtronic, Merck, NovoNordisk, Sanofi .

Yalla, Sai V. .......................................... Disclosed no confl ict of interest.Yamada, Eijiro ...................................... Disclosed no confl ict of interest.Yamada, Kazuya .................................. Disclosed no confl ict of interest.Yamada, Kenichi .................................. Disclosed no confl ict of interest.Yamada, Kentaro ................................. Research Support: Astellas Pharma. Yamada, Masanobu ............................ Disclosed no confl ict of interest.Yamada, Nobuhiro .............................. Disclosed no confl ict of interest.Yamada, Sarie ..................................... Disclosed no confl ict of interest.Yamada, Satoru ................................... Disclosed no confl ict of interest.Yamada, Takatsugu ............................. Disclosed no confl ict of interest.Yamada, Testuya ................................. Disclosed no confl ict of interest.Yamada, Tomohide .............................. Disclosed no confl ict of interest.Yamada, Yoshifumi ............................. Disclosed no confl ict of interest.Yamada, Yuichiro ................................ Disclosed no confl ict of interest.Yamagishi, Masakazu ......................... Disclosed no confl ict of interest.Yamagishi, Sho-ichi ............................ Employee: Kurume University School of Medicine. Yamagishi, Yuka .................................. Disclosed no confl ict of interest.Yamaguchi, Eriko ................................. Disclosed no confl ict of interest.Yamaguchi, Naohito ............................ Disclosed no confl ict of interest.Yamaguchi, Satoshi ............................ Disclosed no confl ict of interest.Yamaguchi, Suguru ............................. Disclosed no confl ict of interest.Yamakage, Hajime .............................. Disclosed no confl ict of interest.Yamakawa, Tadashi ............................ Disclosed no confl ict of interest.Yamamoto, Kazuhiro ........................... Disclosed no confl ict of interest.Yamamoto, Ken ................................... Disclosed no confl ict of interest.Yamamoto, Naomune ......................... Disclosed no confl ict of interest.Yamamoto, Shin .................................. Disclosed no confl ict of interest.Yamamoto, Toshikazu ......................... Disclosed no confl ict of interest.Yamamoto, Wataru ............................. Disclosed no confl ict of interest.Yamamoto-Mitani, Noriko .................. Disclosed no confl ict of interest.Yamane, Shunsuke .............................. Disclosed no confl ict of interest.Yamanouchi, Masayuki ...................... Disclosed no confl ict of interest.Yamaoka, Tomomi ............................... Disclosed no confl ict of interest.Yamasaki, Toshihide ........................... Disclosed no confl ict of interest.Yamashina, Yoshihiro ......................... Disclosed no confl ict of interest.

A897

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Yamashita, Kaoru ................................ Disclosed no confl ict of interest.Yamashita, Shizuya ............................. Research Support: (Joint Research), Ono Pharmaceutical

Co., Ltd. Yamatani, Keiichi ................................ Disclosed no confl ict of interest.Yamato, Mayumi ................................. Disclosed no confl ict of interest.Yamauchi, Akiyo .................................. Disclosed no confl ict of interest.Yamauchi, Keishi ................................. Other Relationship: Astellas Pharma US, Inc., Eli Lilly Japan

K.K., Novartis Pharmaceuticals Corporation. Yamauchi, Masahiro ........................... Disclosed no confl ict of interest.Yamauchi, Motoo ................................ Disclosed no confl ict of interest.Yamauchi, Toshimasa ......................... Research Support: Astellas, Daiichi-Sankyo, NovoNordisk,

Ono, Takeda, Tanabe-Mitsubishi; Speaker’s Bureau: Astellas, AstraZeneca, Boehringer Ingelheim, Daiichi-Sankyo, Eli Lilly, Kowa, Kyowahakko Kirin, MSD, NovoNordisk, Ono, Tahisho, Takeda, Tanabe-Mitsubishi.

Yamauti, Masahiro .............................. Disclosed no confl ict of interest.Yamazaki, Masahiro ........................... Disclosed no confl ict of interest.Yamazaki, Satoru ................................ Disclosed no confl ict of interest.Yamazaki, Tsutomu ............................. Research Support: AstraZeneca Pharmaceuticals LP,

Kowa Pharmaceuticals, Merck Sharp & Dohme, Pfi zer Inc., Shionogi Inc.; Speaker’s Bureau: AstraZeneca Pharmaceuticals LP, Bayer HealthCare, Daiichi-Sankyo Co., Ltd., Kowa Pharmaceuticals, Merck Sharp & Dohme, Pfi zer Inc., Shionogi Inc.

Yamazaki, Yuko ................................... Research Support: Asahi Kasei Pharm Corporation, Astellas Pharma Inc, Daiichi Sankyo Co., Ltd.,, Mitsubisi Tanabe Pharma Corporation,, Takeda Pharmaceutical Company Limited.

Yan, Chaoying ...................................... Disclosed no confl ict of interest.Yan, Dien .............................................. Disclosed no confl ict of interest.Yan, Fei ................................................ Disclosed no confl ict of interest.Yan, Hongmei ...................................... Disclosed no confl ict of interest.Yan, Jin ................................................ Disclosed no confl ict of interest.Yan, Jinhua .......................................... Disclosed no confl ict of interest.Yan, Kunimasa ..................................... Disclosed no confl ict of interest.Yan, Qingtao ........................................ Disclosed no confl ict of interest.Yan, Xiaoyun ........................................ Disclosed no confl ict of interest.Yan, Yuanqing ...................................... Disclosed no confl ict of interest.Yan, Yujie ............................................. Disclosed no confl ict of interest.Yanagimachi, Tsuyoshi ....................... Disclosed no confl ict of interest.Yanagisawa, Hiromi ............................ Disclosed no confl ict of interest.Yanagisawa, Hiroyuki ......................... Disclosed no confl ict of interest.Yanase, Toshihiko ............................... Disclosed no confl ict of interest.Yancey, Danielle .................................. Disclosed no confl ict of interest.Yancopoulos, George D. ..................... Employee: Regeneron Pharmaceuticals, Inc. Yancy, Jr., William S. .......................... Disclosed no confl ict of interest.Yanes, Oscar ........................................ Disclosed no confl ict of interest.Yanez, Vanessa ................................... Disclosed no confl ict of interest.Yang, Burton B. ................................... Disclosed no confl ict of interest.Yang, Chengwei .................................. Disclosed no confl ict of interest.Yang, Diane ......................................... Disclosed no confl ict of interest.Yang, Gangyi ....................................... Disclosed no confl ict of interest.Yang, Gary K. ....................................... Disclosed no confl ict of interest.Yang, Hae Kyung ................................. Disclosed no confl ict of interest.Yang, Hsiu-Chiung ............................... Employee: Eli Lilly and Company. Yang, Huabing ..................................... Disclosed no confl ict of interest.Yang, Jimin .......................................... Disclosed no confl ict of interest.Yang, Jin-Kui ....................................... Disclosed no confl ict of interest.Yang, Jun ............................................. Employee: Eli Lilly and Company, Jun Yang. Yang, Keke ........................................... Disclosed no confl ict of interest.Yang, Ling ............................................ Disclosed no confl ict of interest.Yang, Maoguang ................................. Disclosed no confl ict of interest.Yang, Min ............................................. Disclosed no confl ict of interest.Yang, Ming .......................................... Disclosed no confl ict of interest.Yang, Peng ........................................... Disclosed no confl ict of interest.Yang, Qinglin ....................................... Disclosed no confl ict of interest.Yang, Shaolin ....................................... Disclosed no confl ict of interest.Yang, Shihe .......................................... Disclosed no confl ict of interest.Yang, Taeyoung ................................... Disclosed no confl ict of interest.Yang, Tsan ........................................... Disclosed no confl ict of interest.Yang, Wei-Shun ................................... Disclosed no confl ict of interest.Yang, Wenjia ....................................... Disclosed no confl ict of interest.Yang, Wenying .................................... Disclosed no confl ict of interest.Yang, Xiaohua ..................................... Disclosed no confl ict of interest.Yang, Xiaoyong ................................... Disclosed no confl ict of interest.Yang, Ye Seul ....................................... Disclosed no confl ict of interest.Yang, Yeo-Ree ..................................... Disclosed no confl ict of interest.Yang, Yi-Sun ........................................ Disclosed no confl ict of interest.Yang, Yu Hsuan Carol .......................... Disclosed no confl ict of interest.Yang, Yuchan ....................................... Disclosed no confl ict of interest.Yang, Zhengyuan ................................. Disclosed no confl ict of interest.Yang, Zhongnan ................................... Disclosed no confl ict of interest.

Yang, Zunyuan ..................................... Disclosed no confl ict of interest.Yanik, Brandon .................................... Disclosed no confl ict of interest.Yaniv, Gal ............................................. Disclosed no confl ict of interest.Yanuv, Ilan ........................................... Disclosed no confl ict of interest.Yao, Baodong ...................................... Disclosed no confl ict of interest.Yao, Bin ................................................ Disclosed no confl ict of interest.Yao, Hua ............................................... Employee: Prometheon Pharma, LLC. Yao, Ting .............................................. Disclosed no confl ict of interest.Yao, Xiaoxi ........................................... Disclosed no confl ict of interest.Yao, Xiuzhong ...................................... Disclosed no confl ict of interest.Yao, Zunwei ......................................... Disclosed no confl ict of interest.Yaqoob, Muhammad M. ..................... Disclosed no confl ict of interest.Yara, Tomohiro .................................... Disclosed no confl ict of interest.Yarragudi, Rajashri ............................. Disclosed no confl ict of interest.Yarrington, Christina D. ...................... Disclosed no confl ict of interest.Yasar, Mehmet .................................... Disclosed no confl ict of interest.Yassin, Sayf ......................................... Disclosed no confl ict of interest.Yassine, Hussein ................................. Disclosed no confl ict of interest.Yasuda, Kazuki .................................... Disclosed no confl ict of interest.Yasui, Akira .......................................... Disclosed no confl ict of interest.Yasuji, Arase ....................................... Disclosed no confl ict of interest.Yates, Christopher J. .......................... Consultant: Novo Nordisk Pharmaceuticals; Research

Support: Ipsen Bioscience, Inc., Novartis Pharmaceuticals Corporation, Novo Nordisk Pharmaceuticals, Sanofi Aventis.

Yates, Thomas ..................................... Disclosed no confl ict of interest.Yavuz, Dilek ......................................... Disclosed no confl ict of interest.Ybanez, Patria ..................................... Disclosed no confl ict of interest.Yderstræde, Knud B. ........................... Disclosed no confl ict of interest.Ye, Byeong Jin ..................................... Disclosed no confl ict of interest.Ye, Cheng ............................................. Disclosed no confl ict of interest.Ye, Chenglin ......................................... Disclosed no confl ict of interest.Ye, Fen ................................................. Employee: Sanofi U.S. Ye, Lingyu L. ......................................... Disclosed no confl ict of interest.Ye, Risheng .......................................... Disclosed no confl ict of interest.Ye, Xiangyang ...................................... Disclosed no confl ict of interest.Yeager, Mark ....................................... Disclosed no confl ict of interest.Yee, Christine ...................................... Disclosed no confl ict of interest.Yee, Judy ............................................. Disclosed no confl ict of interest.Yeh, Helen ............................................ Employee: AstraZeneca Pharmaceuticals LP; Stock/

Shareholder: AstraZeneca Pharmaceuticals LP, AstraZeneca Pharmaceuticals LP (Spouse/Partner).

Yeh, Hsin-Chieh ................................... Disclosed no confl ict of interest.Yehiel, Nava ........................................ Disclosed no confl ict of interest.Yengo, Loïc .......................................... Disclosed no confl ict of interest.Yeo, Chang dong ................................. Disclosed no confl ict of interest.Yeo, Hui Ling ........................................ Disclosed no confl ict of interest.Yeoh, Lee Ying ..................................... Disclosed no confl ict of interest.Yerges-Armstrong, Laura ................... Disclosed no confl ict of interest.Yeung, Roseanne O. ............................ Disclosed no confl ict of interest.Yfanti, Christina .................................. Disclosed no confl ict of interest.Yi, Yun .................................................. Disclosed no confl ict of interest.Yi, Zhengping ...................................... Disclosed no confl ict of interest.Yiangou, Yiangos ................................ Disclosed no confl ict of interest.Yi-Frazier, Joyce .................................. Disclosed no confl ict of interest.Yilmaz, Temel ...................................... Consultant: Eli Lilly and Company, Servier. Yin, Hongshan ..................................... Disclosed no confl ict of interest.Yin, Lei ................................................. Disclosed no confl ict of interest.Yin, Raynold V. .................................... Disclosed no confl ict of interest.Yin, Ruonan ......................................... Disclosed no confl ict of interest.Yin, Wes .............................................. Consultant: AstraZeneca Pharmaceuticals LP. Yin, Xiaoyan ......................................... Disclosed no confl ict of interest.Yip, Linda ............................................. Disclosed no confl ict of interest.Yip, Paul M. ......................................... Disclosed no confl ict of interest.Yki-Järvinen, Hannele ........................ Advisory Panel: Eli Lilly, Merck Sharp & Dohme, Sanofi ;

Consultant: Eli Lilly, Sanofi . Yoder, Jennifer .................................... Disclosed no confl ict of interest.Yoder, Mervin ...................................... Disclosed no confl ict of interest.Yoder, Stephanie M. ........................... Employee: Eli Lilly and Company. Yoko, Yachi .......................................... Disclosed no confl ict of interest.Yokokawa, Takumi .............................. Disclosed no confl ict of interest.Yokomizo, Hisashi ............................... Disclosed no confl ict of interest.Yokota, Tamotsu .................................. Disclosed no confl ict of interest.Yokote, Koutaro ................................... Disclosed no confl ict of interest.Yokoyama, Hisayo ............................... Disclosed no confl ict of interest.Yokoyama, Yoshihiko .......................... Disclosed no confl ict of interest.Yolba , Servet ...................................... Disclosed no confl ict of interest.Yoneda, Chihiro ................................... Disclosed no confl ict of interest.Yonezawa, Rika ................................... Disclosed no confl ict of interest.Yong, Xiaolan ...................................... Disclosed no confl ict of interest.Yoo, Hye Jin ......................................... Disclosed no confl ict of interest.Yoo, Myunghi ...................................... Disclosed no confl ict of interest.

A898

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Yoo, Woo-Kyoung ................................ Disclosed no confl ict of interest.Yoon, Hye-Jin ...................................... Disclosed no confl ict of interest.Yoon, Ji Won ....................................... Disclosed no confl ict of interest.Yoon, Kun-Ho ....................................... Disclosed no confl ict of interest.Yore, Mark M. ..................................... Disclosed no confl ict of interest.Yoriko, Heianza .................................... Disclosed no confl ict of interest.Yoshida, Hiroki .................................... Disclosed no confl ict of interest.Yoshida, Mami .................................... Disclosed no confl ict of interest.Yoshida, Noriko ................................... Disclosed no confl ict of interest.Yoshida, Osamu ................................... Disclosed no confl ict of interest.Yoshida, Satoshi ................................. Employee: Astellas Pharma Inc. Yoshida, Shigeru ................................. Disclosed no confl ict of interest.Yoshida, Taro ....................................... Disclosed no confl ict of interest.Yoshida, Yuki ....................................... Disclosed no confl ict of interest.Yoshikawa, Fukumi ............................. Disclosed no confl ict of interest.Yoshikawa, Masanori ......................... Disclosed no confl ict of interest.Yoshimoto, Kiyomi .............................. Disclosed no confl ict of interest.Yoshimoto, Takanobu .......................... Disclosed no confl ict of interest.Yoshimura, Yukio ................................. Disclosed no confl ict of interest.Yoshinobu, Satoko .............................. Disclosed no confl ict of interest.You, Jia ................................................ Disclosed no confl ict of interest.Youn, Jang ........................................... Disclosed no confl ict of interest.Youn, Ju Ho .......................................... Disclosed no confl ict of interest.Young, Cheryl ...................................... Disclosed no confl ict of interest.Young, Doris ........................................ Research Support: Roche Diagnostics, Roche Diagnostics

(Spouse/Partner), Sanofi , Sanofi (Spouse/Partner). Young, Heather ................................... Disclosed no confl ict of interest.Young, Jamey D. ................................. Disclosed no confl ict of interest.Young, Kendra A. ................................ Disclosed no confl ict of interest.Young, Laura A. ................................... Research Support: AstraZeneca/Bristol-Myers Squibb,

Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, GI Dynamics, Inc., Halozyme Therapeutics, Johnson & Johnson, Lexicon Pharmaceuticals, Inc., Medtronic MiniMed, Inc., Novo Nordisk Inc., Orexigen Therapeutics, Inc., Sanofi U.S., Scion NeuroStim.

Young, Malcolm A. .............................. Employee: GlaxoSmithKline. Young, Michael ................................... Disclosed no confl ict of interest.Young, Richard L. ................................ Research Support: Pfi zer Inc. Younge, Phin ........................................ Disclosed no confl ict of interest.Younk, Lisa ........................................... Disclosed no confl ict of interest.Yu, Caiguo ............................................ Disclosed no confl ict of interest.Yu, Daohai ........................................... Disclosed no confl ict of interest.Yu, De-Min ........................................... Disclosed no confl ict of interest.Yu, Haoyong ........................................ Disclosed no confl ict of interest.Yu, Hongping ....................................... Disclosed no confl ict of interest.Yu, Hongwei ........................................ Disclosed no confl ict of interest.Yu, Jeremy ........................................... Disclosed no confl ict of interest.Yu, Ji Hee ............................................. Disclosed no confl ict of interest.Yu, Jing ................................................ Disclosed no confl ict of interest.Yu, Ke ................................................... Disclosed no confl ict of interest.Yu, Lili ................................................... Disclosed no confl ict of interest.Yu, Liping ............................................. Disclosed no confl ict of interest.Yu, Mi Ra ............................................. Disclosed no confl ict of interest.Yu, Miles .............................................. Disclosed no confl ict of interest.Yu, Paul ................................................ Disclosed no confl ict of interest.Yu, Qian ................................................ Disclosed no confl ict of interest.Yu, Shengsheng ................................... Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &

Co., Inc. Yu, Tae Yang ........................................ Disclosed no confl ict of interest.Yu, Tian ................................................ Disclosed no confl ict of interest.Yu, Wei ................................................. Disclosed no confl ict of interest.Yu, Wenzhi ........................................... Disclosed no confl ict of interest.Yu, Yang ............................................... Disclosed no confl ict of interest.Yu, Yanqin ............................................ Disclosed no confl ict of interest.Yu, Yue ................................................. Disclosed no confl ict of interest.Yu, Zhexin ............................................ Disclosed no confl ict of interest.Yuan, Jian-Min .................................... Disclosed no confl ict of interest.Yuan, Jun ............................................. Disclosed no confl ict of interest.Yuan, Xiaojing ..................................... Disclosed no confl ict of interest.Yuan, Ya ............................................... Disclosed no confl ict of interest.Yudkin, John S. .................................... Disclosed no confl ict of interest.Yue, Dennis .......................................... Disclosed no confl ict of interest.Yue, Kevin K. ........................................ Disclosed no confl ict of interest.Yue, Wang ........................................... Disclosed no confl ict of interest.Yui, Mary ............................................. Disclosed no confl ict of interest.Yüksel, Muhammed ............................ Disclosed no confl ict of interest.Yuldasheva, Nadira Y. ......................... Disclosed no confl ict of interest.Yumura, Takayuki ................................ Disclosed no confl ict of interest.Yun, Hye Jin ......................................... Disclosed no confl ict of interest.Yun, Jae-Seung ................................... Disclosed no confl ict of interest.Yun, Kyung-Jin .................................... Disclosed no confl ict of interest.Yun, Mi Ra ........................................... Disclosed no confl ict of interest.

Yun, Mijung ......................................... Disclosed no confl ict of interest.Yun, Yujung .......................................... Disclosed no confl ict of interest.Zaccaro, Eric ........................................ Disclosed no confl ict of interest.Zacharie, Boulos ................................. Disclosed no confl ict of interest.Zaitlen, Noah ....................................... Disclosed no confl ict of interest.Zajdenverg, Lenita .............................. Disclosed no confl ict of interest.Zakaria, Ahmed S. ............................... Disclosed no confl ict of interest.Zako, Tamotsu ..................................... Disclosed no confl ict of interest.Zaldivar, Frank ..................................... Disclosed no confl ict of interest.Zaman Huri, Hasniza ........................... Disclosed no confl ict of interest.Zane, Doris T. ....................................... Disclosed no confl ict of interest.Zanette, Giorgio .................................. Disclosed no confl ict of interest.Zang, Mengwei ................................... Disclosed no confl ict of interest.Zanga, Joseph ..................................... Disclosed no confl ict of interest.Zannad, Faeiz ...................................... Advisory Panel: Takeda Pharmaceuticals U.S.A., Inc.;

Consultant: Takeda Pharmaceuticals U.S.A., Inc. Zanolin, Daniela .................................. Disclosed no confl ict of interest.Zanotto, Tamires ................................. Disclosed no confl ict of interest.Zaoui, Philippe Z. ................................. Disclosed no confl ict of interest.Zarra, Emanuela .................................. Disclosed no confl ict of interest.Zarrouki, Bader .................................... Disclosed no confl ict of interest.Zasadny, Frederick .............................. Disclosed no confl ict of interest.Zavattari, Patrizia ............................... Disclosed no confl ict of interest.Zavazava, Nicholas ............................. Disclosed no confl ict of interest.Zavjalov, Eugene E. ............................. Disclosed no confl ict of interest.Zawiesjka, Agnieszka ......................... Disclosed no confl ict of interest.Zdrojewski, Tomasz ............................ Disclosed no confl ict of interest.Zdzienicka, Anna ................................. Disclosed no confl ict of interest.Zech, Gernot ........................................ Disclosed no confl ict of interest.Zeidel, Mark L. ..................................... Disclosed no confl ict of interest.Zeitler, Philip ....................................... Advisory Panel: Merck & Co., Inc.; Consultant: Merck & Co.,

Inc., Daiichi Sankyo, BMS, takeda. Zelada, Henry J. .................................. Disclosed no confl ict of interest.Zeller, Cordula ..................................... Employee: Boehringer Ingelheim GmbH. Zelmanovitz, Themis ........................... Disclosed no confl ict of interest.Zemel, Michael B. ............................... Board Member: NuSirt Biopharma; Employee: NuSirt

Biopharma; Stock/Shareholder: NuSirt Bopharma. Zeng, Aliya ........................................... Employee: Gilead; Stock/Shareholder: Gilead. Zeng, Chan ........................................... Disclosed no confl ict of interest.Zeng, Kejing ......................................... Disclosed no confl ict of interest.Zeng, Longyi ........................................ Disclosed no confl ict of interest.Zeng, Ni ............................................... Disclosed no confl ict of interest.Zeng, Wen ........................................... Disclosed no confl ict of interest.Zent, Roy .............................................. Disclosed no confl ict of interest.Zenz, Sabine ........................................ Disclosed no confl ict of interest.Zera, Chloe .......................................... Disclosed no confl ict of interest.Zgibor, Janice C. .................................. Disclosed no confl ict of interest.Zha, Ying .............................................. Disclosed no confl ict of interest.Zhai, Xu ................................................ Disclosed no confl ict of interest.Zhang, Bo ............................................. Disclosed no confl ict of interest.Zhang, Charles .................................... Disclosed no confl ict of interest.Zhang, Chen ......................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Zhang, Chenying ................................. Disclosed no confl ict of interest.Zhang, Chunfang ................................. Disclosed no confl ict of interest.Zhang, Chuntao ................................... Disclosed no confl ict of interest.Zhang, Cuilin ........................................ Disclosed no confl ict of interest.Zhang, Danyi ....................................... Disclosed no confl ict of interest.Zhang, Deqiang ................................... Disclosed no confl ict of interest.Zhang, Dongyan .................................. Disclosed no confl ict of interest.Zhang, Fang ......................................... Disclosed no confl ict of interest.Zhang, Feifei ........................................ Disclosed no confl ict of interest.Zhang, Guangxiang Zhang .................. Disclosed no confl ict of interest.Zhang, Haibin ...................................... Disclosed no confl ict of interest.Zhang, Haifeng .................................... Disclosed no confl ict of interest.Zhang, Hong ........................................ Disclosed no confl ict of interest.Zhang, Hongbin ................................... Disclosed no confl ict of interest.Zhang, Hongtian .................................. Disclosed no confl ict of interest.Zhang, Hua .......................................... Disclosed no confl ict of interest.Zhang, Huabing ................................... Disclosed no confl ict of interest.Zhang, Huashi ..................................... Disclosed no confl ict of interest.Zhang, Jiajia ........................................ Disclosed no confl ict of interest.Zhang, Jian W. .................................... Disclosed no confl ict of interest.Zhang, Jingwen ................................... Disclosed no confl ict of interest.Zhang, Jun ........................................... Disclosed no confl ict of interest.Zhang, Kaisi ......................................... Disclosed no confl ict of interest.Zhang, Kebin ........................................ Disclosed no confl ict of interest.Zhang, Kehao ....................................... Disclosed no confl ict of interest.Zhang, Lei ............................................ Disclosed no confl ict of interest.Zhang, Li .............................................. Disclosed no confl ict of interest.Zhang, Lihua ........................................ Disclosed no confl ict of interest.Zhang, Liu ............................................ Disclosed no confl ict of interest.

A899

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Zhang, Mary ........................................ Disclosed no confl ict of interest.Zhang, Ming-Zhi .................................. Disclosed no confl ict of interest.Zhang, Nanhua .................................... Disclosed no confl ict of interest.Zhang, Ning ......................................... Disclosed no confl ict of interest.Zhang, Pengyuan ................................. Disclosed no confl ict of interest.Zhang, Pengzi ...................................... Disclosed no confl ict of interest.Zhang, Pili ............................................ Disclosed no confl ict of interest.Zhang, Ping .......................................... Disclosed no confl ict of interest.Zhang, Qianyi ...................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Zhang, Qiujin ....................................... Disclosed no confl ict of interest.Zhang, QuanJiang ............................... Disclosed no confl ict of interest.Zhang, Quanwu ................................... Employee: Sanofi U.S. Zhang, Rong ......................................... Disclosed no confl ict of interest.Zhang, Ruyi .......................................... Disclosed no confl ict of interest.Zhang, Sarah X. ................................... Disclosed no confl ict of interest.Zhang, Shihong ................................... Disclosed no confl ict of interest.Zhang, Shuang .................................... Disclosed no confl ict of interest.Zhang, Shuyu ....................................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Zhang, Simin ........................................ Disclosed no confl ict of interest.Zhang, Taishan .................................... Disclosed no confl ict of interest.Zhang, Wei .......................................... Disclosed no confl ict of interest.Zhang, Weihua .................................... Disclosed no confl ict of interest.Zhang, Wenlong .................................. Disclosed no confl ict of interest.Zhang, Xia ............................................ Disclosed no confl ict of interest.Zhang, Xiangmin ................................. Disclosed no confl ict of interest.Zhang, Xiaoli ........................................ Disclosed no confl ict of interest.Zhang, Xiaoxi ....................................... Disclosed no confl ict of interest.Zhang, Xilin .......................................... Disclosed no confl ict of interest.Zhang, Xingli ........................................ Disclosed no confl ict of interest.Zhang, Xingyou ................................... Disclosed no confl ict of interest.Zhang, Xiujuan .................................... Disclosed no confl ict of interest.Zhang, Xiuying ..................................... Disclosed no confl ict of interest.Zhang, Xiuzhen .................................... Disclosed no confl ict of interest.Zhang, Xuanping ................................. Disclosed no confl ict of interest.Zhang, Xuemei .................................... Disclosed no confl ict of interest.Zhang, Yahong ..................................... Employee: VeroScience, LLC. Zhang, Yan ........................................... Disclosed no confl ict of interest.Zhang, Yi .............................................. Disclosed no confl ict of interest.Zhang, Ying .......................................... Disclosed no confl ict of interest.Zhang, Yizhu ........................................ Disclosed no confl ict of interest.Zhang, Yong ......................................... Disclosed no confl ict of interest.Zhang, Yuanyuan ................................. Disclosed no confl ict of interest.Zhang, Yugen ....................................... Disclosed no confl ict of interest.Zhang, Yuyao ....................................... Disclosed no confl ict of interest.Zhao, Bangfeng ................................... Disclosed no confl ict of interest.Zhao, Dong .......................................... Disclosed no confl ict of interest.Zhao, Hailu ........................................... Disclosed no confl ict of interest.Zhao, Hai-Lu ........................................ Disclosed no confl ict of interest.Zhao, Huiying ...................................... Disclosed no confl ict of interest.Zhao, Jie .............................................. Disclosed no confl ict of interest.Zhao, Jingsong .................................... Employee: XOMA Corporation. Zhao, Lina ............................................ Disclosed no confl ict of interest.Zhao, Liping ......................................... Disclosed no confl ict of interest.Zhao, Menghan ................................... Disclosed no confl ict of interest.Zhao, Na .............................................. Disclosed no confl ict of interest.Zhao, Qian ............................................ Disclosed no confl ict of interest.Zhao, Shujun ........................................ Disclosed no confl ict of interest.Zhao, Shuyuan ..................................... Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Zhao, Wen ........................................... Disclosed no confl ict of interest.Zhao, Wenhui ...................................... Disclosed no confl ict of interest.Zhao, Xiaojian ...................................... Disclosed no confl ict of interest.Zhao, Xinjie .......................................... Disclosed no confl ict of interest.Zhao, Xue-Qiao .................................... Disclosed no confl ict of interest.Zhao, Yanping ...................................... Disclosed no confl ict of interest.Zhao, Yaping ........................................ Disclosed no confl ict of interest.Zhao, Yinan .......................................... Disclosed no confl ict of interest.Zhao, Yong ........................................... Disclosed no confl ict of interest.Zhao, Zhiyuan ...................................... Disclosed no confl ict of interest.Zhao, Zhuoxian .................................... Disclosed no confl ict of interest.Zheng, Chao ......................................... Disclosed no confl ict of interest.Zheng, Hui ........................................... Disclosed no confl ict of interest.Zheng, Jie ............................................ Disclosed no confl ict of interest.Zheng, Louise D. .................................. Disclosed no confl ict of interest.Zheng, Sheng ...................................... Disclosed no confl ict of interest.Zheng, Yan ........................................... Disclosed no confl ict of interest.Zhi, Lin .................................................. Employee: Ligand Pharmaceuticals, Inc. Zhong, Jianhu ...................................... Disclosed no confl ict of interest.Zhong, Victor W. ................................. Disclosed no confl ict of interest.Zhou, Fangli ......................................... Disclosed no confl ict of interest.

Zhou, Hongyi ....................................... Disclosed no confl ict of interest.Zhou, Jian-Bo ...................................... Disclosed no confl ict of interest.Zhou, Jie .............................................. Disclosed no confl ict of interest.Zhou, Joseph ....................................... Disclosed no confl ict of interest.Zhou, Lingli .......................................... Disclosed no confl ict of interest.Zhou, Liye ............................................ Disclosed no confl ict of interest.Zhou, Qiao ........................................... Disclosed no confl ict of interest.Zhou, Qiong L. ...................................... Disclosed no confl ict of interest.Zhou, Rong ........................................... Employee: Medpace, Inc. Zhou, Steve .......................................... Employee: Sanofi U.S.; Research Support: Sanofi U.S.; Stock/

Shareholder: Sanofi U.S. Zhou, Xiang Hai ................................... Disclosed no confl ict of interest.Zhou, Xu ............................................... Disclosed no confl ict of interest.Zhou, Yingsheng ................................. Disclosed no confl ict of interest.Zhou, You M. ....................................... Disclosed no confl ict of interest.Zhou, Yuanyuan ................................... Disclosed no confl ict of interest.Zhou, Zhiguang .................................... Disclosed no confl ict of interest.Zhu, Beibei ........................................... Disclosed no confl ict of interest.Zhu, Bilian ............................................ Disclosed no confl ict of interest.Zhu, Bingqian ....................................... Disclosed no confl ict of interest.Zhu, Chengjun ..................................... Disclosed no confl ict of interest.Zhu, Da-Long ....................................... Disclosed no confl ict of interest.Zhu, Haiqing ........................................ Disclosed no confl ict of interest.Zhu, Jie ................................................ Disclosed no confl ict of interest.Zhu, Kavin ............................................ Disclosed no confl ict of interest.Zhu, Min ............................................... Research Support: National Institutes of Health. Zhu, Ping .............................................. Disclosed no confl ict of interest.Zhu, Qibo .............................................. Disclosed no confl ict of interest.Zhu, Shankuan ..................................... Disclosed no confl ict of interest.Zhu, Vivienne ....................................... Employee: Janssen Pharmaceutical Companies of Johnson

& Johnson. Zhu, Wanling ....................................... Disclosed no confl ict of interest.Zhu, Yamei ........................................... Disclosed no confl ict of interest.Zhu, Yanhua ......................................... Disclosed no confl ict of interest.Zhu, Yeyi .............................................. Disclosed no confl ict of interest.Zhu, Yi .................................................. Disclosed no confl ict of interest.Zhu, Yu ................................................. Disclosed no confl ict of interest.Zhuang, Aowen ................................... Disclosed no confl ict of interest.Zhuge, Fen ........................................... Disclosed no confl ict of interest.Zhumasheva, Karligash A. .................. Disclosed no confl ict of interest.Zhuo, Hanjing ...................................... Disclosed no confl ict of interest.Zhuo, Hsnjinh ....................................... Disclosed no confl ict of interest.Zhuo, Xiaohui ....................................... Employee: Merck & Co., Inc. Zhuplatov, Sergey ............................... Employee: AstraZeneca Pharmaceuticals LP. Zhuzbaeva, Gulmira O. ........................ Disclosed no confl ict of interest.Zidon, Terese M. ................................. Disclosed no confl ict of interest.Ziegler, Anette G. ................................ Disclosed no confl ict of interest.Ziegler, Dan ......................................... Disclosed no confl ict of interest.Ziegler, Iris ........................................... Disclosed no confl ict of interest.Ziegler, Julie ........................................ Disclosed no confl ict of interest.Zielinska, Anna .................................... Disclosed no confl ict of interest.Zielonka, Jason S. ............................... Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly

and Company. Ziemer, David C. .................................. Disclosed no confl ict of interest.Zierath, Juleen R. ................................ Disclosed no confl ict of interest.Zijlstra, Eric ......................................... Disclosed no confl ict of interest.Zilov, Alexey ........................................ Speaker’s Bureau: Novartis Pharma GmbH, Novo Nordisk

A/S. Zimmerman, Malin .............................. Disclosed no confl ict of interest.Zimmermann, Alan G. ......................... Employee: Eli Lilly and Company, Eli Lilly and Company

(Spouse/Partner); Stock/Shareholder: Eli Lilly and Company, Eli Lilly and Company (Spouse/Partner).

Zimmet, Paul ........................................ Disclosed no confl ict of interest.Zink, Richard ........................................ Employee: Eli Lilly and Company. Zinman, Bernard .................................. Consultant: Abbott, AstraZeneca Pharmaceuticals LP,

Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company, Janssen Pharmaceutical Companies of Johnson & Johnson, Merck & Co., Inc., Novo Nordisk Inc., Sanofi U.S., Takeda Pharmaceutical Company Limited; Research Support: Boehringer Ingelheim Pharmaceuticals, Inc., Merck & Co., Inc., Novo Nordisk Inc.

Ziol, Marianne ..................................... Disclosed no confl ict of interest.Zisman, Ariel ....................................... Advisory Panel: Sanofi . Zisser, Howard C. ................................ Employee: Insulet Corporation. Zitle-García, Edgar Jesús ................... Disclosed no confl ict of interest.Zitoun, Carine ...................................... Disclosed no confl ict of interest.Zitur, Laura .......................................... Disclosed no confl ict of interest.Zivehe, Fariba ...................................... Disclosed no confl ict of interest.Zmuda, Joseph .................................... Disclosed no confl ict of interest.Zoetis, Tracey ...................................... Disclosed no confl ict of interest.Zografou, Ioanna ................................. Disclosed no confl ict of interest.

A900

AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY

AU

THO

R D

ISCL

OSU

RE

Zoldan, Maira ...................................... Disclosed no confl ict of interest.Zollars, Harry ....................................... Disclosed no confl ict of interest.Zon, Leonard ........................................ Disclosed no confl ict of interest.Zona, Debora ....................................... Disclosed no confl ict of interest.Zontini, Alexis ..................................... Disclosed no confl ict of interest.Zorina, Olesya ..................................... Employee: Boehringer Ingelheim GmbH. Zorlu, Mehmet ..................................... Disclosed no confl ict of interest.Zorn, Kristen E. .................................... Disclosed no confl ict of interest.Zornitzki, Taiba .................................... Disclosed no confl ict of interest.Zoso, Alessia ....................................... Disclosed no confl ict of interest.Zou, Bende ........................................... Disclosed no confl ict of interest.Zou, Dajin ............................................. Disclosed no confl ict of interest.Zou, Jing .............................................. Disclosed no confl ict of interest.Zou, Xia ................................................ Disclosed no confl ict of interest.Zou, Xiantong ...................................... Disclosed no confl ict of interest.

Zoughbie, Daniel E. ............................. Disclosed no confl ict of interest.Zoungas, Sophia .................................. Disclosed no confl ict of interest.Zoupas, Christos ................................. Disclosed no confl ict of interest.Zraika, Sakeneh ................................... Disclosed no confl ict of interest.Zrebiec, John F. ................................... Disclosed no confl ict of interest.Zu, Yuan ............................................... Disclosed no confl ict of interest.Zuccotti, Gian Vincenzo ...................... Disclosed no confl ict of interest.Zukowska-Szczechowska, Ewa .......... Research Support: Roche Polska. Zulewski, Henryk ................................ Disclosed no confl ict of interest.Zulfi qar, Tehzeeb ................................. Disclosed no confl ict of interest.Zumaeta Beramendi, Rina R. .............. Disclosed no confl ict of interest.Zuñiga, Laura Y. ................................... Disclosed no confl ict of interest.Zushi, Yoshinori ................................... Disclosed no confl ict of interest.Zushin, Peter-James ........................... Disclosed no confl ict of interest